0001193125-23-206195.txt : 20230808 0001193125-23-206195.hdr.sgml : 20230808 20230808160738 ACCESSION NUMBER: 0001193125-23-206195 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 87 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230808 DATE AS OF CHANGE: 20230808 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SLR Investment Corp. CENTRAL INDEX KEY: 0001418076 IRS NUMBER: 261381340 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 814-00754 FILM NUMBER: 231151275 BUSINESS ADDRESS: STREET 1: 500 PARK AVENUE STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212) 993-1670 MAIL ADDRESS: STREET 1: 500 PARK AVENUE STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: Solar Capital Ltd. DATE OF NAME CHANGE: 20071109 10-Q 1 d518171d10q.htm 10-Q 10-Q
falseQ20001418076--12-31NYhttp://fasb.org/us-gaap/2023#UnrealizedGainLossOnInvestmentshttp://fasb.org/us-gaap/2023#UnrealizedGainLossOnInvestmentsInvestment is on non-accrual status.Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SUNS SPV LLC (the “SUNS SPV”). Such investments are pledged as collateral under the Senior Secured Revolving SPV Credit Facility (the “SPV Credit Facility”) (see Note 7 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company.Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of June 30, 2023, on a fair value basis, non-qualifying assets in the portfolio represented 24.5% of the total assets of the Company.Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (the “1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the six months ended June 30, 2023 in these controlled investments are as follows:Indicates an investment that is wholly held by the Company through NEFPASS LLC.Denotes a subsidiary of SLR Equipment Finance.Non-income producing security.See note 13 to the consolidated financial statements.Kingsbridge Holdings, LLC is held through KBH Topco LLC, a Delaware corporation.See note 15 to the consolidated financial statements.See note 9 to the consolidated financial statements.See note 14 to the consolidated financial statements.See note 17 to the consolidated financial statements.Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2022, on a fair value basis, non-qualifying assets in the portfolio represented 24.2% of the total assets of the Company.Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (“1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2022 in these controlled investments are as follows: SLR Equipment Finance is held through NEFCORP LLC, a wholly-owned consolidated taxable subsidiary and NEFPASS LLC, a wholly-owned consolidated subsidiary.See note 11 to the consolidated financial statements.Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR” or “L”), the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of June 30, 2023.Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR, SOFR or PRIME rate. These instruments are often subject to a LIBOR, SOFR or PRIME rate floor.Denotes investments in which we are an “Affiliated Person” but not exercising a controlling influence, as defined in the 1940 Act, due to beneficially owning, either directly or through one or more controlled companies, more than 5% but less than 25% of the outstanding voting securities of the investment. Transactions during the six months ended June 30, 2023 (beginning with the date at which the Company became an Affiliated Person) in these affiliated investments are as follows:AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each co-Borrowers.Kaseya, Inc. may elect to defer up to 2.50% of the coupon as PIK.Interest is paid in kind (“PIK”).iCIMS, Inc. may elect to defer up to 3.875% of the coupon as PIK.BridgeBio Pharma, Inc. may elect to defer up to 3.00% of the coupon as PIK.OmniGuide Holdings, Inc., Domain Surgical, Inc. and OmniGuide, Inc. are co-borrowers.OmniGuide Holdings, Inc. may elect to defer up to 10.00% of the coupon as PIK. Vapotherm, Inc. may elect to defer up to 9.00% of the coupon as PIK. The Company’s investment in SOINT, LLC includes a one dollar investment in common shares.Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR” or “L”), the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of December 31, 2022.AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each co-Borrowers. Amerimark may elect to defer up to 8.00% of the coupon as PIK.Spread is 5.75% Cash / 0.50% PIK. Vapotherm, Inc. may elect to defer up to 8.00% of the coupon as PIK.Spread is 1.00% Cash / 6.00% PIK.Denotes a Level 1 investment.Through this entity and other intermediate entities, the Company owns approximately 7.3% of the underlying common units of ASC Holdco, LLC, a joint venture which owns certain assets of the former Amerimark Interactive, LLC.Aggregate net unrealized depreciation for U.S. federal income tax purposes is $3,002; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $154,967 and $157,969, respectively, based on a tax cost of $2,184,428. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated. In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The portfolio investment in this category is SSLP. See Note 17 for more information on this investment, including its investment strategy and the Company’s unfunded equity commitment to SSLP. This investment is not redeemable by the Company absent an election by the members of the entity to liquidate all investments and distribute the proceeds to the members.Aggregate net unrealized appreciation for U.S. federal income tax purposes is $17,187; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $161,053 and $143,866, respectively, based on a tax cost of $2,069,489. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.The Company controls the funding of the SLR Credit Solutions and SLR Healthcare ABL commitments and may cancel them at its discretion.On April 1, 2022, in connection with the Merger (as defined in Note 1 “Organization”), the Company acquired net assets of $244,691 for the total stock consideration of $226,839.The Company also holds this security on its Consolidated Statements of Assets and Liabilities.Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR. These instruments are typically subject to a SOFR floor.Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.Floating rate debt investments typically bear interest at a rate determined by reference to the SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of June 30, 2023.Service fees are included within the Company’s Consolidated Statements of Operations as other income.Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented.The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of June 30, 2023, asset coverage was 180.4%.The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it.Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014 and 2013 periods was $100,175, $98,196, $94,301 and $93,392, respectively. 0001418076 2023-01-01 2023-06-30 0001418076 2023-04-01 2023-06-30 0001418076 2022-04-01 2022-06-30 0001418076 2022-01-01 2022-06-30 0001418076 2023-06-30 0001418076 2022-12-31 0001418076 2022-06-30 0001418076 2023-08-04 0001418076 2023-05-09 0001418076 2023-05-09 2023-05-09 0001418076 2022-01-01 2022-12-31 0001418076 2021-12-31 0001418076 2022-12-12 0001418076 2019-12-18 2019-12-18 0001418076 2022-04-01 2022-04-01 0001418076 2013-12-31 0001418076 2015-12-31 0001418076 2014-12-31 0001418076 2017-12-31 0001418076 2016-12-31 0001418076 2019-12-31 0001418076 2018-12-31 0001418076 2020-12-31 0001418076 2022-03-31 0001418076 2023-03-31 0001418076 slrc:CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember 2023-06-30 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-06-30 0001418076 slrc:SlramiTopcoBlockerLlcMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:VertosMedicalInc.WarrantsMember 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:BaysideParentLLCMember 2023-06-30 0001418076 slrc:CardioFocusIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:SlrEquipmentFinanceEquityInterestsMember 2023-06-30 0001418076 slrc:SlrHealthcareAblMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-06-30 0001418076 slrc:AtyrPharmaIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-06-30 0001418076 slrc:DelphinusMedicalTechnologiesIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-06-30 0001418076 slrc:EssenceGroupHoldingsCorporationLumerisMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-06-30 0001418076 slrc:KbhTopcoLlcKingsbridgeMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-06-30 0001418076 slrc:RdHoldcoIncClassBMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-06-30 0001418076 slrc:VenusConceptLtdMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-06-30 0001418076 slrc:SlrSeniorLendingProgramLlcMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-06-30 0001418076 slrc:SlrCreditSolutionsMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-06-30 0001418076 slrc:VapothermIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-06-30 0001418076 slrc:SpectrumPharmaceuticalsInc.WarrantsMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-06-30 0001418076 slrc:RdHoldcoIncWarrantsMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-06-30 0001418076 slrc:SenseonicsHoldingsIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-06-30 0001418076 slrc:SlrBusinessCreditMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:NspcHoldingsLlcNationalSpineMember 2023-06-30 0001418076 slrc:RdHoldcoIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-06-30 0001418076 slrc:MeditrinaIncWarrantsMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-06-30 0001418076 slrc:ConventusOrthopaedicsIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-06-30 0001418076 slrc:CentrexionTherapeuticsIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:PinnacleTreatmentCentersInc.Member 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:PediatricHomeRespiratoryServicesLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:TilleyDistributionIncMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SunmedGroupHoldingsLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:BasicFunInc.Member 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AmericanTeleconferencingServicesLtd.Member 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:NspcIntermediateCorpMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FertilityInvestmentHoldcoLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:WorldInsuranceAssociatesLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:UrologyManagementHoldingsIncMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:VesscoMidcoHoldingsLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcBluefinMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:DeepintentInc.Member 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SouthernOrthodonticPartnersManagementLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:RxsenseHoldingsLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:PhynetDermatologyLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:PlasticsManagementLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:UnitedDigestiveMsoParentLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AllStateAgPartsLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CompositeTechnologyAcquisitionCorp.Member 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:EnhancedPermanentCapitalLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:BaymarkHealthServicesIncMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:KaseyaIncMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:HigginbothamInsuranceAgencyIncMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:RscAcquisitionIncMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:KingsbridgeHoldingsLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:LogixHoldingCompanyLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:MontefioreNyackHospitalMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:OneTouchDirectLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AmericanTeleconferencingServicesLtdOneMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:OrthopedicCarePartnersManagementLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:UltimateBakedGoodsMidcoLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:StrytenResourcesLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:TaucManagementLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ShoHoldingICorporationShoesForCrewsMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SparMarketingForceInc.Member 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ScpEyeCareLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:RqmCorp.Member 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:MaxorAcquisitionInc.Member 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:OnsMsoLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:PeterCFoyandAssociatesInsuranceServicesLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:LuxuryAssetCapitalLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:MauricesIncorporatedMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:KidDistroHoldingsLlcDistroKidMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:KoreWirelessGroupInc.Member 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:IcimsInc.Member 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:HighStreetBuyerIncMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:HumanInterestIncMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FoundationConsumerBrandsLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:GsmAcquisitionCorpMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:EnverusHoldingsIncFkaDrillingInfoHoldingsMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ErieConstructionMidwestLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CopperRiverSeafoodsInc.Member 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:BdgMediaInc.Member 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ApexServicesPartnersLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AtriaWealthSolutionsIncMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AmerimarkIntermediateHoldingsLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AegisToxicologySciencesCorporationMember 2023-06-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:BaysideParentLLCMember 2023-06-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:CVAUSAManagementLLCMember 2023-06-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FgiWorldwideLlcMember slrc:SecondLienAssetbasedSeniorSecuredLoansMember 2023-06-30 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AcresCommercialMortgageLlcMember 2023-06-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:AmeriMarkIntermediateHoldingsLLCOneMember 2023-06-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:BaysideOpcoLLCMember 2023-06-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:BaysideOpcoLLCOneMember 2023-06-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SecondLienBankDebtOrSeniorSecuredLoansMember slrc:RdHoldcoInc.Member 2023-06-30 0001418076 slrc:GmtCorporationMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:EasyPakLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:ExtremeSteelCraneRiggingLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:BazziniLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:FreightsolLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:RottenRockHardscapingAndTreeServiceMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:LuxVendingLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:DrillersChoiceIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:CarolinasContractingLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:SuperiorTransportationIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:CapitalCityJetCenterIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:UpTruckingServicesLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:AfgDallasIiiLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:StCoachesLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:SignetMarineCorporationMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:EquipmentOperatingLeasesLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:FirstNationalCapitalLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:GardaClTechnicalServicesIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:ClubcorpHoldingsIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:CompleteEquipmentRentalsLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:LocPerformanceProductsLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:HtiLogisticsCorporationMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:U.s.CraneAndRiggingLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:WindRiverEnvironmentalLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:WorldwideFlightServicesInc.Member slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:WombleCompanyIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:TheSmedleyCompanySmedleyServicesIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:SmileyLiftingSolutionsLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:ZamborelliEnterprisesPacificSoutherFoundationMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:TrinityEquipmentRentalsIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:SlrEquipmentFinanceMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:StarCoachesIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:RangoIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:RaneLightMetalCastingsIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:PcxAerostructuresLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:RoyalExpressIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:RoyalCoachLinesIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:MountainAirHelicoptersIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:LuxCreditConsultantsLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:KoolPakLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:OzziesIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:LoyerCapitalLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:GeorgiaJetIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:HawkeyeContractingCompanyLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:InternationalAutomotiveComponentsGroupNorthAmericaIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:FirstAmericanCommercialBancorpIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:EnergyDrillingServicesLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:ArcutisBiotherapeuticsInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-06-30 0001418076 slrc:SpectrumPharmaceuticalsInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-06-30 0001418076 slrc:EnvironmentalProtectionImprovementCompanyLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:CPortStoneLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:CkdHoldingsInc.Member slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:BowmanEnergySolutionsLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:RhLandConstructionLlcHarborDredgingLaIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:WasteProOfFloridaInc.WasteProUsaIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:NoLimitConstructionServicesLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:RayzorsEdgeLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:MirandaLogisticsEnterpriseIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:VertosMedicalInc.Member 2023-06-30 0001418076 slrc:U.s.TreasuryBillMember slrc:CashEquivalentsThirtyFourPointZeroPercentMember 2023-06-30 0001418076 slrc:OmniguideHoldingsInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-06-30 0001418076 slrc:OutsetMedicalInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-06-30 0001418076 slrc:VapothermInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-06-30 0001418076 slrc:BridgebioPharmaInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-06-30 0001418076 slrc:CentrexionTherapeuticsInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-06-30 0001418076 slrc:MeditrinaInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-06-30 0001418076 slrc:NeuroneticsInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-06-30 0001418076 slrc:DongwonAutopartTechnologyIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:AaCraneAndRiggingLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:AeroOperatingLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:AirMethodsCorporationMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:CerapedicsInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-06-30 0001418076 slrc:GlookoInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-06-30 0001418076 slrc:AmeraMexInternationalIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:BoartLongyearCompanyMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:AlimeraSciencesInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-06-30 0001418076 slrc:ApeelTechnologyIncMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-06-30 0001418076 slrc:ArdelyxInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-06-30 0001418076 slrc:SointLlcMember slrc:PreferredEquityzeroPointFourPercentMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-06-30 0001418076 slrc:TotalInvestmentMember 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-06-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-06-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SecondLienAssetbasedSeniorSecuredLoansMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-06-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member slrc:InvestmentInSeniorSecuredLoansMember 2023-06-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member slrc:EquipmentFinancingMember 2023-06-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member slrc:EquipmentFinancingMember 2023-06-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember slrc:EquipmentFinancingMember 2023-06-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2023-06-30 0001418076 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember slrc:InvestmentInSeniorSecuredLoansMember 2023-06-30 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:PreferredEquityMember 2023-06-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:EquipmentFinancingMember 2023-06-30 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:EquitySecuritiesMember 2023-06-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember us-gaap:EquitySecuritiesMember 2023-06-30 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember slrc:PreferredEquityMember 2023-06-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 us-gaap:FairValueInputsLevel3Member slrc:InvestmentInSeniorSecuredLoansMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember 2023-06-30 0001418076 us-gaap:FairValueInputsLevel3Member slrc:InvestmentInSeniorSecuredLoansMember slrc:ValuationTechniqueRecoveryApproachMember slrc:MeasurementInputRecoverableAmountMember 2023-06-30 0001418076 us-gaap:FairValueInputsLevel3Member slrc:EquipmentFinancingMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember 2023-06-30 0001418076 us-gaap:FairValueInputsLevel3Member slrc:EquipmentFinancingMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember 2023-06-30 0001418076 us-gaap:FairValueInputsLevel3Member slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember 2023-06-30 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember 2023-06-30 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember 2023-06-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:MinimumMember 2023-06-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:MaximumMember 2023-06-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:WeightedAverageMember 2023-06-30 0001418076 slrc:EquipmentFinancingMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:MinimumMember 2023-06-30 0001418076 slrc:EquipmentFinancingMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:MaximumMember 2023-06-30 0001418076 slrc:EquipmentFinancingMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:WeightedAverageMember 2023-06-30 0001418076 slrc:EquipmentFinancingMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:MinimumMember 2023-06-30 0001418076 slrc:EquipmentFinancingMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:MaximumMember 2023-06-30 0001418076 slrc:EquipmentFinancingMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:WeightedAverageMember 2023-06-30 0001418076 slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:MinimumMember 2023-06-30 0001418076 slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:MaximumMember 2023-06-30 0001418076 slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:WeightedAverageMember 2023-06-30 0001418076 us-gaap:EquitySecuritiesMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:MinimumMember 2023-06-30 0001418076 us-gaap:EquitySecuritiesMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:MaximumMember 2023-06-30 0001418076 us-gaap:EquitySecuritiesMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:WeightedAverageMember 2023-06-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember srt:MinimumMember 2023-06-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember srt:MaximumMember 2023-06-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember srt:WeightedAverageMember 2023-06-30 0001418076 us-gaap:FairValueInputsLevel3Member slrc:BlackScholesPricingModelMember 2023-06-30 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember 2023-06-30 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2023-06-30 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2023-06-30 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2023-06-30 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2023-06-30 0001418076 slrc:CreditFacilityOneMember 2023-06-30 0001418076 slrc:TermLoanAndCreditFacilityMember 2023-06-30 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2023-06-30 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2023-06-30 0001418076 slrc:NmcSeniorCreditFacilityMember 2023-06-30 0001418076 slrc:SeniorSecuredCommitmentsMember slrc:SlrBusinessCreditMember 2023-06-30 0001418076 slrc:SlrBusinessCreditMember 2023-06-30 0001418076 slrc:KbhtMember 2023-06-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2023-06-30 0001418076 slrc:CreditFacilityMember 2023-06-30 0001418076 slrc:SeniorSecuredCommitmentsMember 2023-06-30 0001418076 slrc:SlrHealthcareAblCreditMember 2023-06-30 0001418076 slrc:BridgeBioPharmaIncMember 2023-06-30 0001418076 slrc:OmniGuideHoldingsIncMember 2023-06-30 0001418076 slrc:VapothermInc.Member 2023-06-30 0001418076 slrc:IcimsInc.Member 2023-06-30 0001418076 slrc:KaseyaIncMember 2023-06-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2023-06-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:CreditFacilityMember slrc:CitiBankNaMember 2023-06-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember us-gaap:LineOfCreditMember 2023-06-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember slrc:TermLoanMember 2023-06-30 0001418076 slrc:SlrBusinessCreditFacilityMember 2023-06-30 0001418076 slrc:SlrEquipmentFinanceMember 2023-06-30 0001418076 slrc:CVAUSAManagementLLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:VertosMedicalInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:BaysideOpcoLLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:AmerimarkIntermediateHoldingsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:MontefioreNyackHospitalMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ErieConstructionMidwestLlcMember 2023-06-30 0001418076 slrc:CompositeTechnologyAcquisitionCorpMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:GsmAcquisitionCorpMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:EnsHoldingsIiiCorpLlcMember 2023-06-30 0001418076 slrc:ApeelTechnologyIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:GlookoInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:IcimsInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CopperRiverSeafoodsInc.Member 2023-06-30 0001418076 slrc:ArdelyxIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:CerapedicsInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:UnitedDigestiveMsoParentLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SparMarketingForceInc.Member 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:UrologyManagementHoldingsIncMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OneTouchDirectLlcMember 2023-06-30 0001418076 slrc:SpectrumPharmaceuticalsInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrEquipmentFinanceMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:KidDistroHoldingsLlcDistroKidMember 2023-06-30 0001418076 slrc:RscAcquisitionIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MauricesIncorporatedMember 2023-06-30 0001418076 slrc:BasicFunInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:DeepintentInc.Member 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrHealthcareAblMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AmericanTeleconferencingServicesLtd.Member 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PinnacleTreatmentCentersInc.Member 2023-06-30 0001418076 slrc:RxsenseHoldingsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:EnverusHoldingsIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:TilleyDistributionIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:PediatricHomeRespiratoryServicesLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:HighStreetBuyerIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2023-06-30 0001418076 slrc:TaucManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:IvyFertilityServicesLlcMember 2023-06-30 0001418076 slrc:BaymarkHealthServicesIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrCreditSolutionsMember 2023-06-30 0001418076 slrc:BdgMediaInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ArcutisBiotherapeuticsInc.Member 2023-06-30 0001418076 slrc:VesscoMidcoHoldingsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:FoundationConsumerBrandsLlcMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AllStateAgPartsLlcMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:NacHoldingsCorporationMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OnsMsoLlcMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ScpEyeCareLlcMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SouthernOrthodonticPartnersManagementLlcMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OrthopedicCarePartnersManagementLlcMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SunmedGroupHoldingsLlcMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OutsetMedicalInc.Member 2023-06-30 0001418076 slrc:HumanInterestIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:WorldInsuranceAssociatesLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AtriaWealthSolutionsIncMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:LuxuryAssetCapitalLlcMember 2023-06-30 0001418076 slrc:KaseyaIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MeditrinaInc.Member 2023-06-30 0001418076 slrc:PlasticsManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:PeterC.FoyAssociatesInsuranceServicesLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:UltimateBakedGoodsMidcoLlcMember 2023-06-30 0001418076 slrc:FootwearMember 2023-06-30 0001418076 slrc:FoodAndStaplesRetailingMember 2023-06-30 0001418076 slrc:ConstructionAndEngineeringMember 2023-06-30 0001418076 slrc:DiversifiedConsumerServicesMember 2023-06-30 0001418076 slrc:LifeSciencesToolsAndServicesMember 2023-06-30 0001418076 slrc:InternetSoftwareServicesMember 2023-06-30 0001418076 slrc:HealthCareTechnologyMember 2023-06-30 0001418076 slrc:InternetAndCatalogRetailMember 2023-06-30 0001418076 slrc:SpecialtyRetailMember 2023-06-30 0001418076 slrc:AirlinesMember 2023-06-30 0001418076 slrc:FoodProductsMember 2023-06-30 0001418076 slrc:WaterUtilitiesMember 2023-06-30 0001418076 slrc:EnergyEquipmentAndServicesMember 2023-06-30 0001418076 slrc:HealthCareProvidersAndServicesMember 2023-06-30 0001418076 slrc:SoftwareMember 2023-06-30 0001418076 slrc:MediaMember 2023-06-30 0001418076 slrc:AutoPartsAndEquipmentMember 2023-06-30 0001418076 slrc:CommercialServicesAndSuppliesMember 2023-06-30 0001418076 slrc:BuildingProductsMember 2023-06-30 0001418076 slrc:TransportationInfrastructureMember 2023-06-30 0001418076 slrc:AutoComponentsMember 2023-06-30 0001418076 slrc:MachineryMember 2023-06-30 0001418076 slrc:MetalsAndMiningMember 2023-06-30 0001418076 slrc:ConsumerFinanceMember 2023-06-30 0001418076 slrc:ContainersAndPackagingMember 2023-06-30 0001418076 slrc:DiversifiedFinancialServicesMember 2023-06-30 0001418076 slrc:HealthCareEquipmentAndSuppliesMember 2023-06-30 0001418076 slrc:TradingCompaniesAndDistributorsMember 2023-06-30 0001418076 slrc:ItServicesMember 2023-06-30 0001418076 slrc:LeisureEquipmentAndProductsMember 2023-06-30 0001418076 slrc:HotelsRestaurantsAndLeisureMember 2023-06-30 0001418076 slrc:AerospaceAndDefenseMember 2023-06-30 0001418076 slrc:OilGasAndConsumableFuelsMember 2023-06-30 0001418076 slrc:PersonalProductsMember 2023-06-30 0001418076 slrc:RoadAndRailMember 2023-06-30 0001418076 slrc:PackagedFoodsAndMeatsMember 2023-06-30 0001418076 slrc:WirelessTelecommunicationServicesMember 2023-06-30 0001418076 us-gaap:AssetManagement1Member 2023-06-30 0001418076 slrc:CommunicationsEquipmentMember 2023-06-30 0001418076 slrc:MultiSectorHoldingsMember 2023-06-30 0001418076 slrc:PharmaceuticalsMember 2023-06-30 0001418076 slrc:InsuranceMember 2023-06-30 0001418076 slrc:BiotechnologyMember 2023-06-30 0001418076 slrc:CapitalMarketsMember 2023-06-30 0001418076 slrc:ThriftsMortgageFinanceMember 2023-06-30 0001418076 slrc:CreditFacilityMember 2023-06-30 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2023-06-30 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2023-06-30 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2023-06-30 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2023-06-30 0001418076 slrc:CreditFacilityOneMember 2023-06-30 0001418076 slrc:TermLoansMember 2023-06-30 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2023-06-30 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2023-06-30 0001418076 slrc:InsuranceMember slrc:RscAcquisitionIncMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 us-gaap:HealthcareSectorMember slrc:PlasticsManagementLlcMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 us-gaap:TechnologySectorMember slrc:KidDistroHoldingsLlcMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:PersonalProductsMember slrc:FoundationConsumerBrandsLlcMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:InsuranceMember slrc:HighStreetBuyerIncMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 us-gaap:HealthcareSectorMember slrc:BaymarkHealthServicesIncMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:TradingCompaniesDistributorsMember slrc:TilleyDistributionIncMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:RxsenseHoldingsLlcMember slrc:SlrSeniorLendingProgramLlcMember slrc:DiversifiedConsumerServicesMember 2023-06-30 0001418076 us-gaap:HealthcareSectorMember slrc:PhynetDermatologyLlcMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 us-gaap:TechnologySectorMember slrc:IcimsIncMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:InsuranceMember slrc:HigginbothamInsuranceAgencyIncMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 us-gaap:HealthcareSectorMember slrc:AegisToxicologySciencesCorporationMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 us-gaap:HealthcareSectorMember slrc:PinnacleTreatmentCentersIncMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:LifeSciencesToolsAndServicesMember slrc:RqmCorpMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 us-gaap:HealthcareSectorMember slrc:UrologyManagementHoldingsIncMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:HealthCareEquipmentAndSuppliesMember slrc:SunmedGroupHoldingsLlcMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 us-gaap:FinancialServicesSectorMember slrc:AtriaWealthSolutionsIncMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:TradingCompaniesDistributorsMember slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 us-gaap:HealthcareSectorMember slrc:OnsMsoLlcMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:FertilityItcInvestmentHoldcoLlcMember slrc:SlrSeniorLendingProgramLlcMember us-gaap:HealthcareSectorMember 2023-06-30 0001418076 slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:SlrSeniorLendingProgramLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember us-gaap:InvestorMember 2023-06-30 0001418076 slrc:SlrSeniorLendingProgramLlcMember srt:ManagementMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:SlrSeniorLendingProgramSpvLlcMember slrc:SeniorSecuredRevolvingCreditFacilityMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:ASCHoldcoLLCMember 2023-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SpectrumPharmaceuticalsInc.WarrantsMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SlrCreditSolutionsMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SlrHealthcareAblMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SenseonicsHoldingsIncMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SlrBusinessCreditMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:RdHoldcoIncClassBMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:RdHoldcoIncWarrantsMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:MeditrinaIncWarrantsMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:RdHoldcoIncMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:EssenceGroupHoldingsCorporationLumerisMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:KbhTopcoLlcKingsbridgeMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:ConventusOrthopaedicsIncMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:DelphinusMedicalTechnologiesIncMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:CardioFocusIncMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:CentrexionTherapeuticsIncMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:AtyrPharmaIncMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:VapothermIncMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:VenusConceptLtdMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SlrEquipmentFinanceEquityInterestsMember 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ArdelyxInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:BridgebioPharmaInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:GlookoInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:MeditrinaInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:NeuroneticsInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:VapothermInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ApeelTechnologyIncMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:CentrexionTherapeuticsInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:OmniguideHoldingsInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:OutsetMedicalInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AlimeraSciencesInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ArcutisBiotherapeuticsInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:CerapedicsInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:SpectrumPharmaceuticalsInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:AfgDallasIiiLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:AmeraMexInternationalIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:BowmanEnergySolutionsLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:CPortStoneLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:ChampionAirLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:CkdHoldingsInc.Member slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:DongwonAutopartTechnologyIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:EquipmentOperatingLeasesLlcMember 2022-12-31 0001418076 slrc:FirstNationalCapitalLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:FreightsolLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:GardaClTechnicalServicesIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:GmtCorporationMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:HtiLogisticsCorporationMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:LocPerformanceProductsLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:LuxVendingLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:MountainAirHelicoptersIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:RoyalExpressIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:RottenRockHardscapingAndTreeServiceMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:SlrEquipmentFinanceMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:StarCoachesIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:U.s.CraneAndRiggingLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:WindRiverEnvironmentalLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:WorldwideFlightServicesInc.Member slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:InternationalAutomotiveComponentsGroupNorthAmericaIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:KoolPakLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:PcxAerostructuresLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:RaneLightMetalCastingsIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:RangoIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:AeroOperatingLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:AirMethodsCorporationMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:BoartLongyearCompanyMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:CapitalCityJetCenterIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:DrillersChoiceIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:EnvironmentalProtectionImprovementCompanyLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:FirstAmericanCommercialBancorpIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:SmileyLiftingSolutionsLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:SuperiorTransportationIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:TrinityEquipmentRentalsIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:WombleCompanyIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:SignetMarineCorporationMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:StCoachesLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:TheSmedleyCompanySmedleyServicesIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:UpTruckingServicesLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:ZamborelliEnterprisesPacificSoutherFoundationMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:LoyerCapitalLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LuxCreditConsultantsLlcMember 2022-12-31 0001418076 slrc:OzziesIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:RoyalCoachLinesIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:EnergyDrillingServicesLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:GeorgiaJetIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:HawkeyeContractingCompanyLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:BazziniLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:ClubcorpHoldingsIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:EasyPakLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 slrc:KoreWirelessGroupInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:MontefioreNyackHospitalMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:EnverusHoldingsIncFkaDrillingInfoHoldingsMember 2022-12-31 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:HumanInterestIncMember 2022-12-31 0001418076 slrc:AmericanTeleconferencingServicesLtd.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:AmerimarkIntermediateHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:OneTouchDirectLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:PeterCFoyandAssociatesInsuranceServicesLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:PlasticsManagementLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ScpEyeCareLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ShoHoldingICorporationShoesForCrewsMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:CompositeTechnologyAcquisitionCorp.Member 2022-12-31 0001418076 slrc:AtriaWealthSolutionsIncMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:BasicFunInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:BaymarkHealthServicesIncMember 2022-12-31 0001418076 slrc:AegisToxicologySciencesCorporationMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AllStateAgPartsLlcMember 2022-12-31 0001418076 slrc:AcresCommercialMortgageLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:SecondLienAssetbasedSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:KingsbridgeHoldingsLlcMember 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:SecondLienBankDebtOrSeniorSecuredLoansMember slrc:RdHoldcoIncMember 2022-12-31 0001418076 slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:IvyFertilityServicesLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:AmericanTeleconferencingServicesLtdOneMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:HighStreetBuyerIncMember 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:PediatricHomeRespiratoryServicesLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcBluefinMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:GsmAcquisitionCorpMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:SparMarketingForceInc.Member 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:DeepintentInc.Member 2022-12-31 0001418076 slrc:PinnacleTreatmentCentersInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:PptManagementHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:RscAcquisitionIncMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:TaucManagementLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:WorldInsuranceAssociatesLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:VesscoMidcoHoldingsLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:TilleyDistributionIncMember 2022-12-31 0001418076 slrc:UltimateBakedGoodsMidcoLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:SouthernOrthodonticPartnersManagementLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:StrytenResourcesLlcMember 2022-12-31 0001418076 slrc:SunmedGroupHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:RqmCorp.Member 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:RxsenseHoldingsLlcMember 2022-12-31 0001418076 slrc:PhynetDermatologyLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:NationalSpineAndPainCentersLlcMember 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:OrthopedicCarePartnersManagementLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:LuxuryAssetCapitalLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:MauricesIncorporatedMember 2022-12-31 0001418076 slrc:NacHoldingsCorporationJaguarMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:LogixHoldingCompanyLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:KaseyaIncMember 2022-12-31 0001418076 slrc:KidDistroHoldingsLlcDistroKidMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:IcimsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:HigginbothamInsuranceAgencyIncMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ErieConstructionMidwestLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:BdgMediaInc.Member 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:EnhancedPermanentCapitalLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:CopperRiverSeafoodsInc.Member 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:ApexServicesPartnersLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember 2022-12-31 0001418076 slrc:SointLlcMember slrc:PreferredEquityzeroPointFourPercentMember 2022-12-31 0001418076 slrc:CashEquivalentsAtFortyOnePointEightMember slrc:U.s.TreasuryBillMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-12-31 0001418076 slrc:TotalInvestmentMember 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:InvestmentInSeniorSecuredLoansMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member slrc:EquipmentFinancingMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member slrc:PreferredEquityMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember us-gaap:EquitySecuritiesMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember slrc:PreferredEquityMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember slrc:PreferredEquityMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember slrc:EquipmentFinancingMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member slrc:PreferredEquityMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:PreferredEquityMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:EquitySecuritiesMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember slrc:InvestmentInSeniorSecuredLoansMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasuredAtNetAssetValueMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember slrc:EquipmentFinancingMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member slrc:EquipmentFinancingMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:EquipmentFinancingMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel3Member slrc:InvestmentInSeniorSecuredLoansMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel3Member slrc:InvestmentInSeniorSecuredLoansMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel3Member slrc:EquipmentFinancingMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel3Member slrc:EquipmentFinancingMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel3Member slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:MinimumMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:MaximumMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:WeightedAverageMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:MinimumMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:MaximumMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:WeightedAverageMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:MinimumMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:MaximumMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:WeightedAverageMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:MinimumMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:MaximumMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:WeightedAverageMember 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:MinimumMember 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:MaximumMember 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:WeightedAverageMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:MinimumMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:MaximumMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:WeightedAverageMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember srt:MinimumMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember srt:MaximumMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember srt:WeightedAverageMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel3Member slrc:BlackScholesPricingModelMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember 2022-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2022-12-31 0001418076 slrc:SeniorSecuredCommitmentsMember slrc:SlrBusinessCreditMember 2022-12-31 0001418076 slrc:NmcSeniorCreditFacilityMember 2022-12-31 0001418076 slrc:SlrBusinessCreditMember 2022-12-31 0001418076 slrc:KbhtMember 2022-12-31 0001418076 slrc:KingsbridgeHoldingsLlcMember 2022-12-31 0001418076 slrc:SeniorSecuredCommitmentsMember 2022-12-31 0001418076 slrc:SlrHealthcareAblCreditMember slrc:SeniorSecuredCommitmentsMember 2022-12-31 0001418076 slrc:SlrHealthcareAblCreditMember 2022-12-31 0001418076 slrc:AmerimarkMember 2022-12-31 0001418076 slrc:BridgeBioPharmaIncMember 2022-12-31 0001418076 slrc:OmniGuideHoldingsIncMember 2022-12-31 0001418076 slrc:VapothermInc.Member 2022-12-31 0001418076 slrc:IcimsInc.Member 2022-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember 2022-12-31 0001418076 slrc:SlrEquipmentFinanceMember 2022-12-31 0001418076 slrc:CVAUSAManagementLLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:VertosMedicalInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:BaysideOpcoLLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:AmerimarkIntermediateHoldingsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:PediatricHomeRespiratoryServicesLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrHealthcareAblMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PinnacleTreatmentCentersInc.Member 2022-12-31 0001418076 slrc:TilleyDistributionIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrCreditSolutionsMember 2022-12-31 0001418076 slrc:HumanInterestIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:BdgMediaInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OnsMsoLlcMember 2022-12-31 0001418076 slrc:IcimsInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ArcutisBiotherapeuticsInc.Member 2022-12-31 0001418076 slrc:ArdelyxIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:LuxuryAssetCapitalLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MeditrinaInc.Member 2022-12-31 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:VesscoMidcoHoldingsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:RscAcquisitionIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:ErieConstructionMidwestLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BasicFunInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ScpEyeCareLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:DeepintentInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SunmedGroupHoldingsLlcMember 2022-12-31 0001418076 slrc:RxsenseHoldingsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:EnverusHoldingsIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:HighStreetBuyerIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OrthopedicCarePartnersManagementLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SouthernOrthodonticPartnersManagementLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AllStateAgPartsLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:NacHoldingsCorporationMember 2022-12-31 0001418076 slrc:PeterC.FoyAssociatesInsuranceServicesLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OutsetMedicalInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:GlookoInc.Member 2022-12-31 0001418076 slrc:WorldInsuranceAssociatesLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AtriaWealthSolutionsIncMember 2022-12-31 0001418076 slrc:CerapedicsInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:KaseyaIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MauricesIncorporatedMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:EnsHoldingsIiiCorpLlcMember 2022-12-31 0001418076 slrc:PlasticsManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnitedDigestiveMsoParentLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:KidDistroHoldingsLlcDistroKidMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:UltimateBakedGoodsMidcoLlcMember 2022-12-31 0001418076 slrc:MontefioreNyackHospitalMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AmericanTeleconferencingServicesLtd.Member 2022-12-31 0001418076 slrc:CompositeTechnologyAcquisitionCorpMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:GsmAcquisitionCorpMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:ApeelTechnologyIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:SpectrumPharmaceuticalsInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CopperRiverSeafoodsInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrEquipmentFinanceMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OneTouchDirectLlcMember 2022-12-31 0001418076 slrc:TaucManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:IvyFertilityServicesLlcMember 2022-12-31 0001418076 slrc:BaymarkHealthServicesIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:UrologyManagementHoldingsIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SparMarketingForceInc.Member 2022-12-31 0001418076 slrc:DiversifiedFinancialServicesMember 2022-12-31 0001418076 slrc:HealthCareProvidersAndServicesMember 2022-12-31 0001418076 slrc:HealthCareEquipmentAndSuppliesMember 2022-12-31 0001418076 slrc:InsuranceMember 2022-12-31 0001418076 slrc:RoadAndRailMember 2022-12-31 0001418076 slrc:PersonalProductsMember 2022-12-31 0001418076 slrc:AirlinesMember 2022-12-31 0001418076 slrc:MachineryMember 2022-12-31 0001418076 slrc:ConsumerFinanceMember 2022-12-31 0001418076 slrc:FoodAndStaplesRetailingMember 2022-12-31 0001418076 slrc:PharmaceuticalsMember 2022-12-31 0001418076 slrc:MediaMember 2022-12-31 0001418076 slrc:LifeSciencesToolsAndServicesMember 2022-12-31 0001418076 slrc:CommercialServicesAndSuppliesMember 2022-12-31 0001418076 slrc:PackagedFoodsAndMeatsMember 2022-12-31 0001418076 slrc:LeisureEquipmentAndProductsMember 2022-12-31 0001418076 slrc:TransportationInfrastructureMember 2022-12-31 0001418076 us-gaap:AssetManagement1Member 2022-12-31 0001418076 slrc:HotelsRestaurantsAndLeisureMember 2022-12-31 0001418076 slrc:AutoComponentsMember 2022-12-31 0001418076 slrc:OilGasAndConsumableFuelsMember 2022-12-31 0001418076 slrc:ConstructionAndEngineeringMember 2022-12-31 0001418076 slrc:MultiSectorHoldingsMember 2022-12-31 0001418076 slrc:BiotechnologyMember 2022-12-31 0001418076 slrc:SoftwareMember 2022-12-31 0001418076 slrc:DiversifiedConsumerServicesMember 2022-12-31 0001418076 slrc:ThriftsMortgageFinanceMember 2022-12-31 0001418076 slrc:InternetAndCatalogRetailMember 2022-12-31 0001418076 slrc:FootwearMember 2022-12-31 0001418076 slrc:MetalsAndMiningMember 2022-12-31 0001418076 slrc:WaterUtilitiesMember 2022-12-31 0001418076 slrc:EnergyEquipmentAndServicesMember 2022-12-31 0001418076 slrc:ContainersAndPackagingMember 2022-12-31 0001418076 slrc:HealthCareTechnologyMember 2022-12-31 0001418076 slrc:CommunicationsEquipmentMember 2022-12-31 0001418076 slrc:ItServicesMember 2022-12-31 0001418076 slrc:SpecialtyRetailMember 2022-12-31 0001418076 slrc:FoodProductsMember 2022-12-31 0001418076 slrc:AerospaceAndDefenseMember 2022-12-31 0001418076 slrc:CapitalMarketsMember 2022-12-31 0001418076 slrc:AutoPartsAndEquipmentMember 2022-12-31 0001418076 slrc:WirelessTelecommunicationServicesMember 2022-12-31 0001418076 slrc:InternetSoftwareServicesMember 2022-12-31 0001418076 slrc:BuildingProductsMember 2022-12-31 0001418076 slrc:TradingCompaniesAndDistributorsMember 2022-12-31 0001418076 slrc:CreditFacilityOneMember 2022-12-31 0001418076 slrc:CreditFacilityMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2022-12-31 0001418076 slrc:CreditFacilityOneMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-12-31 0001418076 slrc:TermLoansMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-12-31 0001418076 slrc:TradingCompaniesDistributorsMember slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:InsuranceMember slrc:HighStreetBuyerIncMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 us-gaap:TechnologySectorMember slrc:KidDistroHoldingsLlcDistroKidMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 us-gaap:FinancialServicesSectorMember slrc:AtriaWealthSolutionsIncMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:BaymarkHealthServicesIncMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 us-gaap:HealthcareSectorMember slrc:IvyFertilityServicesLlcMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:PersonalProductsMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2023-04-01 2023-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember 2023-04-01 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-04-01 2023-06-30 0001418076 slrc:AdvisoryAgreementMember 2023-04-01 2023-06-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2023-04-01 2023-06-30 0001418076 us-gaap:EquitySecuritiesMember 2023-04-01 2023-06-30 0001418076 slrc:EquipmentFinancingMember 2023-04-01 2023-06-30 0001418076 slrc:PreferredEquityMember 2023-04-01 2023-06-30 0001418076 slrc:SlrBusinessCreditMember 2023-04-01 2023-06-30 0001418076 slrc:SharesIssuedInConnectionWithTheMergersMember 2023-04-01 2023-06-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2023-04-01 2023-06-30 0001418076 slrc:SlrHealthcareAblCreditMember 2023-04-01 2023-06-30 0001418076 slrc:SlrEquipmentFinanceMember 2023-04-01 2023-06-30 0001418076 slrc:SlrBusinessCreditFacilityMember 2023-04-01 2023-06-30 0001418076 slrc:SlrSeniorLendingProgramLlcMember 2023-04-01 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-04-01 2022-06-30 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2022-04-01 2022-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember 2022-04-01 2022-06-30 0001418076 slrc:AdvisoryAgreementMember 2022-04-01 2022-06-30 0001418076 slrc:SlrBusinessCreditMember 2022-04-01 2022-06-30 0001418076 slrc:SharesIssuedInConnectionWithTheMergersMember 2022-04-01 2022-06-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2022-04-01 2022-06-30 0001418076 slrc:SlrHealthcareAblCreditMember 2022-04-01 2022-06-30 0001418076 slrc:SlrEquipmentFinanceMember 2022-04-01 2022-06-30 0001418076 slrc:SlrBusinessCreditFacilityMember 2022-04-01 2022-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember 2022-01-01 2022-06-30 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2022-01-01 2022-06-30 0001418076 slrc:AdvisoryAgreementMember 2022-01-01 2022-06-30 0001418076 slrc:SlrBusinessCreditMember 2022-01-01 2022-06-30 0001418076 slrc:SharesIssuedInConnectionWithTheMergersMember 2022-01-01 2022-06-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2022-01-01 2022-06-30 0001418076 slrc:SlrHealthcareAblCreditMember 2022-01-01 2022-06-30 0001418076 slrc:SlrEquipmentFinanceMember 2022-01-01 2022-06-30 0001418076 slrc:SlrBusinessCreditFacilityMember 2022-01-01 2022-06-30 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-06-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AmericanTeleconferencingServicesLtd.Member slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2023-01-01 2023-06-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AmericanTeleconferencingServicesLtdOneMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2023-01-01 2023-06-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ApexServicesPartnersLlcMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2023-01-01 2023-06-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AtriaWealthSolutionsIncMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:BdgMediaInc.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CompositeTechnologyAcquisitionCorp.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:DeepintentInc.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:EnhancedPermanentCapitalLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ErieConstructionMidwestLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FoundationConsumerBrandsLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:HighStreetBuyerIncMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:KaseyaIncMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:KidDistroHoldingsLlcDistroKidMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:KoreWirelessGroupInc.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:PeterCFoyandAssociatesInsuranceServicesLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:RxsenseHoldingsLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:VesscoMidcoHoldingsLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:WorldInsuranceAssociatesLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SparMarketingForceInc.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CopperRiverSeafoodsInc.Member 2023-01-01 2023-06-30 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AcresCommercialMortgageLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:LogixHoldingCompanyLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:HigginbothamInsuranceAgencyIncMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:BasicFunInc.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:RscAcquisitionIncMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ShoHoldingICorporationShoesForCrewsMember 2023-01-01 2023-06-30 0001418076 slrc:SecondLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:RdHoldcoInc.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:IcimsInc.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:KingsbridgeHoldingsLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:EnverusHoldingsIncFkaDrillingInfoHoldingsMember 2023-01-01 2023-06-30 0001418076 slrc:HumanInterestIncMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:LuxuryAssetCapitalLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:MaxorAcquisitionInc.Member slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:MontefioreNyackHospitalMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:NspcIntermediateCorpMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:OneTouchDirectLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:OnsMsoLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:OrthopedicCarePartnersManagementLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:PediatricHomeRespiratoryServicesLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:PhynetDermatologyLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:PinnacleTreatmentCentersInc.Member slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:PlasticsManagementLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:RqmCorp.Member slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:ScpEyeCareLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SouthernOrthodonticPartnersManagementLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:StrytenResourcesLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SunmedGroupHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:TaucManagementLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:TilleyDistributionIncMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:UltimateBakedGoodsMidcoLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:UnitedDigestiveMsoParentLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:UrologyManagementHoldingsIncMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FgiWorldwideLlcMember 2023-01-01 2023-06-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:AegisToxicologySciencesCorporationMember 2023-01-01 2023-06-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:AllStateAgPartsLlcMember 2023-01-01 2023-06-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:AmerimarkIntermediateHoldingsLlcMember 2023-01-01 2023-06-30 0001418076 slrc:AmeriMarkIntermediateHoldingsLLCOneMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:BaymarkHealthServicesIncMember 2023-01-01 2023-06-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:BaysideOpcoLLCMember 2023-01-01 2023-06-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:BaysideOpcoLLCOneMember 2023-01-01 2023-06-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:BaysideParentLLCMember 2023-01-01 2023-06-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:CVAUSAManagementLLCMember 2023-01-01 2023-06-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcBluefinMember 2023-01-01 2023-06-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:FertilityInvestmentHoldcoLlcMember 2023-01-01 2023-06-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:GsmAcquisitionCorpMember 2023-01-01 2023-06-30 0001418076 slrc:MauricesIncorporatedMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:ApeelTechnologyIncMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:BridgebioPharmaInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:CentrexionTherapeuticsInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:SpectrumPharmaceuticalsInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:AlimeraSciencesInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:ArcutisBiotherapeuticsInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:RoyalExpressIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:SmileyLiftingSolutionsLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:StCoachesLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:StarCoachesIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:SuperiorTransportationIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:TheSmedleyCompanySmedleyServicesIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:OzziesIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:PcxAerostructuresLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:RangoIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:RayzorsEdgeLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:RhLandConstructionLlcHarborDredgingLaIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:RoyalCoachLinesIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:HtiLogisticsCorporationMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:KoolPakLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:LuxCreditConsultantsLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:MirandaLogisticsEnterpriseIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:MountainAirHelicoptersIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:NoLimitConstructionServicesLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:EasyPakLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:EnvironmentalProtectionImprovementCompanyLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:ExtremeSteelCraneRiggingLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:FreightsolLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:GardaClTechnicalServicesIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:HawkeyeContractingCompanyLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:BowmanEnergySolutionsLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:CPortStoneLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:CkdHoldingsInc.Member slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:ClubcorpHoldingsIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:CompleteEquipmentRentalsLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:DrillersChoiceIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:VertosMedicalInc.Member 2023-01-01 2023-06-30 0001418076 slrc:AaCraneAndRiggingLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:AeroOperatingLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:AmeraMexInternationalIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:BazziniLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:BoartLongyearCompanyMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:EnergyDrillingServicesLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:MeditrinaInc.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:NeuroneticsInc.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:OmniguideHoldingsInc.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:OutsetMedicalInc.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:VapothermInc.Member 2023-01-01 2023-06-30 0001418076 slrc:ZamborelliEnterprisesPacificSoutherFoundationMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:AirMethodsCorporationMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:LoyerCapitalLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:LuxVendingLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:RottenRockHardscapingAndTreeServiceMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:CapitalCityJetCenterIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:SignetMarineCorporationMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:SlrEquipmentFinanceMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:WindRiverEnvironmentalLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:WorldwideFlightServicesInc.Member slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentOperatingLeasesLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:FirstNationalCapitalLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:FirstAmericanCommercialBancorpIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:GeorgiaJetIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:GmtCorporationMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:InternationalAutomotiveComponentsGroupNorthAmericaIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:LocPerformanceProductsLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:RaneLightMetalCastingsIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:CerapedicsInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:ArdelyxInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:GlookoInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:AfgDallasIiiLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:CarolinasContractingLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:DongwonAutopartTechnologyIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:EssenceGroupHoldingsCorporationLumerisMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-01-01 2023-06-30 0001418076 slrc:KbhTopcoLlcKingsbridgeMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-01-01 2023-06-30 0001418076 slrc:RdHoldcoIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-01-01 2023-06-30 0001418076 slrc:RdHoldcoIncWarrantsMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-01-01 2023-06-30 0001418076 slrc:SlrBusinessCreditMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-01-01 2023-06-30 0001418076 slrc:AtyrPharmaIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-01-01 2023-06-30 0001418076 slrc:TrinityEquipmentRentalsIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:U.s.CraneAndRiggingLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:UpTruckingServicesLlcMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:WasteProOfFloridaInc.WasteProUsaIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:WombleCompanyIncMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:BaysideParentLLCMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:CardioFocusIncMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:ConventusOrthopaedicsIncMember 2023-01-01 2023-06-30 0001418076 slrc:CentrexionTherapeuticsIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-01-01 2023-06-30 0001418076 slrc:SlrCreditSolutionsMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-01-01 2023-06-30 0001418076 slrc:SpectrumPharmaceuticalsInc.WarrantsMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-01-01 2023-06-30 0001418076 slrc:RdHoldcoIncClassBMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-01-01 2023-06-30 0001418076 slrc:SlrHealthcareAblMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-01-01 2023-06-30 0001418076 slrc:SlrSeniorLendingProgramLlcMember slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:DelphinusMedicalTechnologiesIncMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:MeditrinaIncWarrantsMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:NspcHoldingsLlcNationalSpineMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:SenseonicsHoldingsIncMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:SlramiTopcoBlockerLlcMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:VapothermIncMember 2023-01-01 2023-06-30 0001418076 slrc:SlrEquipmentFinanceEquityInterestsMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-01-01 2023-06-30 0001418076 slrc:SointLlcMember slrc:PreferredEquityzeroPointFourPercentMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:VenusConceptLtdMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:VertosMedicalInc.WarrantsMember 2023-01-01 2023-06-30 0001418076 slrc:U.s.TreasuryBillMember slrc:CashEquivalentsThirtyFourPointZeroPercentMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:AeroOperatingLlcMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:AeroOperatingLlcMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:AfgDallasIiiLlcMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:AfgDallasIiiLlcMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:FreightsolLlcMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:FreightsolLlcMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:HtiLogisticsCorporationMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:DrillersChoiceIncMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:DrillersChoiceIncMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:EnergyDrillingServicesLlcMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:EnergyDrillingServicesLlcMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:FirstAmericanCommercialBancorpIncMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:FirstAmericanCommercialBancorpIncMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:CkdHoldingsInc.Member 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:CkdHoldingsInc.Member 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:ClubcorpHoldingsIncMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:ClubcorpHoldingsIncMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:CompleteEquipmentRentalsLlcMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:CompleteEquipmentRentalsLlcMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:AirMethodsCorporationMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:AirMethodsCorporationMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:BoartLongyearCompanyMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:BoartLongyearCompanyMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:CarolinasContractingLlcMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:CarolinasContractingLlcMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:SuperiorTransportationIncMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:SuperiorTransportationIncMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:TrinityEquipmentRentalsIncMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:TrinityEquipmentRentalsIncMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:WindRiverEnvironmentalLlcMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:WindRiverEnvironmentalLlcMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:RayzorsEdgeLlcMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:RayzorsEdgeLlcMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:SmileyLiftingSolutionsLlcMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:SmileyLiftingSolutionsLlcMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:StCoachesLlcMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:StCoachesLlcMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:LuxCreditConsultantsLlcMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:LuxCreditConsultantsLlcMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:LuxVendingLlcMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:LuxVendingLlcMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:RangoIncMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:RangoIncMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:WorldwideFlightServicesInc.Member 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:WorldwideFlightServicesInc.Member 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:HtiLogisticsCorporationMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:LoyerCapitalLlcMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:LoyerCapitalLlcMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:CapitalCityJetCenterIncMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:CapitalCityJetCenterIncMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember 2023-01-01 2023-06-30 0001418076 slrc:AdvisoryAgreementMember srt:MaximumMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:AdvisoryAgreementMember 2023-01-01 2023-06-30 0001418076 slrc:AdvisoryAgreementMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingMember 2023-01-01 2023-06-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2023-01-01 2023-06-30 0001418076 us-gaap:EquitySecuritiesMember 2023-01-01 2023-06-30 0001418076 slrc:PreferredEquityMember 2023-01-01 2023-06-30 0001418076 slrc:SpreadOneMember 2023-01-01 2023-06-30 0001418076 us-gaap:FairValueInputsLevel3Member slrc:InvestmentInSeniorSecuredLoansMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember 2023-01-01 2023-06-30 0001418076 us-gaap:FairValueInputsLevel3Member slrc:InvestmentInSeniorSecuredLoansMember slrc:ValuationTechniqueRecoveryApproachMember slrc:MeasurementInputRecoverableAmountMember 2023-01-01 2023-06-30 0001418076 us-gaap:FairValueInputsLevel3Member slrc:EquipmentFinancingMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember 2023-01-01 2023-06-30 0001418076 us-gaap:FairValueInputsLevel3Member slrc:EquipmentFinancingMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember 2023-01-01 2023-06-30 0001418076 us-gaap:FairValueInputsLevel3Member slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember 2023-01-01 2023-06-30 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember 2023-01-01 2023-06-30 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember 2023-01-01 2023-06-30 0001418076 slrc:SlrBusinessCreditMember 2023-01-01 2023-06-30 0001418076 slrc:SharesIssuedInConnectionWithTheMergersMember 2023-01-01 2023-06-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2023-01-01 2023-06-30 0001418076 slrc:CreditFacilityMember 2023-01-01 2023-06-30 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2023-01-01 2023-06-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:CitiBankNaMember slrc:SunsSpvLlcMember 2023-01-01 2023-06-30 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2023-01-01 2023-06-30 0001418076 slrc:SlrHealthcareAblCreditMember 2023-01-01 2023-06-30 0001418076 slrc:SlrEquipmentFinanceEquityMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-06-30 0001418076 slrc:LoyerCapitalLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-06-30 0001418076 slrc:KingsbridgeHoldingsLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-06-30 0001418076 slrc:SlrCreditSolutionsMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-06-30 0001418076 slrc:RdHoldcoIncWarrantsMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-06-30 0001418076 slrc:SlrBusinessCreditMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-06-30 0001418076 slrc:SointLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-06-30 0001418076 slrc:RdHoldcoIncDebtMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-06-30 0001418076 slrc:SlrEquipmentFinanceDebtMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-06-30 0001418076 slrc:SlrHealthcareAblMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-06-30 0001418076 slrc:RdHoldcoIncClassBMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-06-30 0001418076 slrc:KbhTopcoLlcKingsbridgeMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-06-30 0001418076 slrc:SlrSeniorLendingProgramLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentOperatingLeasesLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-06-30 0001418076 slrc:RdHoldcoIncCommonEquityMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2023-01-01 2023-06-30 0001418076 slrc:BaysideOpcoLLCMember slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2023-01-01 2023-06-30 0001418076 slrc:AmeriMarkIntermediateHoldingsOneLLCMember slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2023-01-01 2023-06-30 0001418076 slrc:AmerimarkIntermediateHoldingsLlcMember slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:SlramiTopcoBlockerLlcMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideParentLlcEquityMember 2023-01-01 2023-06-30 0001418076 slrc:BaysideOpcoLLCOneMember slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideParentLlcLoanMember 2023-01-01 2023-06-30 0001418076 slrc:TermLoanAndCreditFacilityMember srt:MaximumMember slrc:LondonInterbankOfferedRateMember slrc:CitiBankNaMember 2023-01-01 2023-06-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:CitiBankNaMember slrc:SunsSpvLlcMember srt:MinimumMember 2023-01-01 2023-06-30 0001418076 slrc:SlrEquipmentFinanceMember 2023-01-01 2023-06-30 0001418076 us-gaap:RevolvingCreditFacilityMember slrc:SlrBusinessCreditFacilityMember 2023-01-01 2023-06-30 0001418076 slrc:SlrBusinessCreditFacilityMember 2023-01-01 2023-06-30 0001418076 slrc:FertilityItcInvestmentHoldcoLlcMember slrc:SlrSeniorLendingProgramLlcMember us-gaap:HealthcareSectorMember 2023-01-01 2023-06-30 0001418076 us-gaap:HealthcareSectorMember slrc:OnsMsoLlcMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:TradingCompaniesDistributorsMember slrc:TilleyDistributionIncMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:PersonalProductsMember slrc:FoundationConsumerBrandsLlcMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:InsuranceMember slrc:HighStreetBuyerIncMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:InsuranceMember slrc:RscAcquisitionIncMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:HealthCareEquipmentAndSuppliesMember slrc:SunmedGroupHoldingsLlcMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 us-gaap:FinancialServicesSectorMember slrc:AtriaWealthSolutionsIncMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 us-gaap:TechnologySectorMember slrc:KidDistroHoldingsLlcMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 us-gaap:HealthcareSectorMember slrc:PinnacleTreatmentCentersIncMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 us-gaap:HealthcareSectorMember slrc:UrologyManagementHoldingsIncMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 us-gaap:HealthcareSectorMember slrc:AegisToxicologySciencesCorporationMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 us-gaap:HealthcareSectorMember slrc:BaymarkHealthServicesIncMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:TradingCompaniesDistributorsMember slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:InsuranceMember slrc:HigginbothamInsuranceAgencyIncMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 us-gaap:TechnologySectorMember slrc:IcimsIncMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 us-gaap:HealthcareSectorMember slrc:PhynetDermatologyLlcMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 us-gaap:HealthcareSectorMember slrc:PlasticsManagementLlcMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:LifeSciencesToolsAndServicesMember slrc:RqmCorpMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:RxsenseHoldingsLlcMember slrc:SlrSeniorLendingProgramLlcMember slrc:DiversifiedConsumerServicesMember 2023-01-01 2023-06-30 0001418076 slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ArcutisBiotherapeuticsInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ArdelyxInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:BridgebioPharmaInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:GlookoInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AlimeraSciencesInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ApeelTechnologyIncMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:CentrexionTherapeuticsInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:CerapedicsInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:SpectrumPharmaceuticalsInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:CapitalCityJetCenterIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:EquipmentOperatingLeasesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstNationalCapitalLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:GeorgiaJetIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:LoyerCapitalLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:LuxVendingLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:SlrEquipmentFinanceMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:WindRiverEnvironmentalLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:WorldwideFlightServicesInc.Member slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:SlrEquipmentFinanceEquityInterestsMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:InternationalAutomotiveComponentsGroupNorthAmericaIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:LocPerformanceProductsLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:SignetMarineCorporationMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:DongwonAutopartTechnologyIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:ZamborelliEnterprisesPacificSoutherFoundationMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:RaneLightMetalCastingsIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:RottenRockHardscapingAndTreeServiceMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:EnergyDrillingServicesLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:FirstAmericanCommercialBancorpIncMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:GmtCorporationMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:AfgDallasIiiLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:AirMethodsCorporationMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:ChampionAirLlcMember slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AeroOperatingLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AmeraMexInternationalIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:BazziniLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:BoartLongyearCompanyMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:BowmanEnergySolutionsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:CPortStoneLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:CkdHoldingsInc.Member 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:ClubcorpHoldingsIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:DrillersChoiceIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:EasyPakLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:EnvironmentalProtectionImprovementCompanyLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:FreightsolLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:GardaClTechnicalServicesIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:HawkeyeContractingCompanyLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:HtiLogisticsCorporationMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:KoolPakLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LuxCreditConsultantsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:MountainAirHelicoptersIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:OzziesIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:PcxAerostructuresLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RangoIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RoyalCoachLinesIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RoyalExpressIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SmileyLiftingSolutionsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:StCoachesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:StarCoachesIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SuperiorTransportationIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:TheSmedleyCompanySmedleyServicesIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:TrinityEquipmentRentalsIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:U.s.CraneAndRiggingLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:UpTruckingServicesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:WombleCompanyIncMember 2022-01-01 2022-12-31 0001418076 slrc:MeditrinaInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:NeuroneticsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:OmniguideHoldingsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:OutsetMedicalInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:VapothermInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:AmericanTeleconferencingServicesLtd.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:AmericanTeleconferencingServicesLtdOneMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ApexServicesPartnersLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AtriaWealthSolutionsIncMember 2022-01-01 2022-12-31 0001418076 slrc:BdgMediaInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2022-01-01 2022-12-31 0001418076 slrc:SouthernOrthodonticPartnersManagementLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:StrytenResourcesLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:SunmedGroupHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:TaucManagementLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:TilleyDistributionIncMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:UltimateBakedGoodsMidcoLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:PhynetDermatologyLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:PinnacleTreatmentCentersInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:PlasticsManagementLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:PptManagementHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:RqmCorp.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:ScpEyeCareLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:LuxuryAssetCapitalLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:MontefioreNyackHospitalMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:NationalSpineAndPainCentersLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:OneTouchDirectLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:OrthopedicCarePartnersManagementLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:PediatricHomeRespiratoryServicesLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:AmerimarkIntermediateHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:BaymarkHealthServicesIncMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcBluefinMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:GsmAcquisitionCorpMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:HumanInterestIncMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:IvyFertilityServicesLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:AegisToxicologySciencesCorporationMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:AllStateAgPartsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:KingsbridgeHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:AcresCommercialMortgageLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:SecondLienAssetbasedSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:KoreWirelessGroupInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:LogixHoldingCompanyLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:ShoHoldingICorporationShoesForCrewsMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:CopperRiverSeafoodsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:RdHoldcoIncMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:SecondLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:WorldInsuranceAssociatesLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:DeepintentInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:EnverusHoldingsIncFkaDrillingInfoHoldingsMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:MauricesIncorporatedMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:HighStreetBuyerIncMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:NacHoldingsCorporationJaguarMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:PeterCFoyandAssociatesInsuranceServicesLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:RscAcquisitionIncMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:RxsenseHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:SparMarketingForceInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:VesscoMidcoHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:CompositeTechnologyAcquisitionCorp.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:EnhancedPermanentCapitalLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:ErieConstructionMidwestLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:IcimsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:KaseyaIncMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:KidDistroHoldingsLlcDistroKidMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:CashEquivalentsAtFortyOnePointEightMember slrc:U.s.TreasuryBillMember 2022-01-01 2022-12-31 0001418076 slrc:SointLlcMember slrc:PreferredEquityzeroPointFourPercentMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:AtyrPharmaIncMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:CardioFocusIncMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:CentrexionTherapeuticsIncMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:ConventusOrthopaedicsIncMember 2022-01-01 2022-12-31 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:HigginbothamInsuranceAgencyIncMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:BasicFunInc.Member slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:RdHoldcoIncWarrantsMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SenseonicsHoldingsIncMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SlrBusinessCreditMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SlrCreditSolutionsMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SlrHealthcareAblMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:DelphinusMedicalTechnologiesIncMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:EssenceGroupHoldingsCorporationLumerisMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:KbhTopcoLlcKingsbridgeMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:MeditrinaIncWarrantsMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:RdHoldcoIncMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:RdHoldcoIncClassBMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SpectrumPharmaceuticalsInc.WarrantsMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:VapothermIncMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:VenusConceptLtdMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MinimumMember slrc:AeroOperatingLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MaximumMember slrc:AeroOperatingLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MinimumMember slrc:AirMethodsCorporationMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MaximumMember slrc:AirMethodsCorporationMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MinimumMember slrc:BoartLongyearCompanyMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MaximumMember slrc:BoartLongyearCompanyMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MinimumMember slrc:CkdHoldingsInc.Member 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MaximumMember slrc:CkdHoldingsInc.Member 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MinimumMember slrc:ClubcorpHoldingsIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MaximumMember slrc:ClubcorpHoldingsIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MinimumMember slrc:EnergyDrillingServicesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MaximumMember slrc:EnergyDrillingServicesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MinimumMember slrc:FirstAmericanCommercialBancorpIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MaximumMember slrc:FirstAmericanCommercialBancorpIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MinimumMember slrc:FreightsolLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MaximumMember slrc:FreightsolLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MinimumMember slrc:GardaClTechnicalServicesIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MaximumMember slrc:GardaClTechnicalServicesIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MinimumMember slrc:HtiLogisticsCorporationMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MaximumMember slrc:HtiLogisticsCorporationMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MinimumMember slrc:LoyerCapitalLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MaximumMember slrc:LoyerCapitalLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MinimumMember slrc:LuxCreditConsultantsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MaximumMember slrc:LuxCreditConsultantsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MinimumMember slrc:LuxVendingLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MaximumMember slrc:LuxVendingLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MinimumMember slrc:RangoIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MaximumMember slrc:RangoIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MinimumMember slrc:SmileyLiftingSolutionsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MaximumMember slrc:SmileyLiftingSolutionsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MinimumMember slrc:StCoachesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MaximumMember slrc:StCoachesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MinimumMember slrc:SuperiorTransportationIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MaximumMember slrc:SuperiorTransportationIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MinimumMember slrc:TrinityEquipmentRentalsIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MaximumMember slrc:TrinityEquipmentRentalsIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MinimumMember slrc:WindRiverEnvironmentalLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MaximumMember slrc:WindRiverEnvironmentalLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MinimumMember slrc:WorldwideFlightServicesInc.Member 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MaximumMember slrc:WorldwideFlightServicesInc.Member 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MinimumMember slrc:AfgDallasIiiLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MaximumMember slrc:AfgDallasIiiLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MinimumMember slrc:CapitalCityJetCenterIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember srt:MaximumMember slrc:CapitalCityJetCenterIncMember 2022-01-01 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember 2022-01-01 2022-12-31 0001418076 slrc:PreferredEquityMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingMember 2022-01-01 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-01-01 2022-12-31 0001418076 slrc:SpreadOneMember 2022-01-01 2022-12-31 0001418076 us-gaap:FairValueInputsLevel3Member slrc:InvestmentInSeniorSecuredLoansMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember 2022-01-01 2022-12-31 0001418076 us-gaap:FairValueInputsLevel3Member slrc:InvestmentInSeniorSecuredLoansMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember 2022-01-01 2022-12-31 0001418076 us-gaap:FairValueInputsLevel3Member slrc:EquipmentFinancingMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember 2022-01-01 2022-12-31 0001418076 us-gaap:FairValueInputsLevel3Member slrc:EquipmentFinancingMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember 2022-01-01 2022-12-31 0001418076 us-gaap:FairValueInputsLevel3Member slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember 2022-01-01 2022-12-31 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember 2022-01-01 2022-12-31 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember 2022-01-01 2022-12-31 0001418076 slrc:SlrHealthcareAblCreditMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncDebtMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SoaggLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrHealthcareAblMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrBusinessCreditMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2022-01-01 2022-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember 2022-01-01 2022-12-31 0001418076 slrc:TradingCompaniesDistributorsMember slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:InsuranceMember slrc:HighStreetBuyerIncMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:PersonalProductsMember slrc:FoundationConsumerBrandsLlcMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 us-gaap:HealthcareSectorMember slrc:BaymarkHealthServicesIncMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 us-gaap:HealthcareSectorMember slrc:IvyFertilityServicesLlcMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 us-gaap:TechnologySectorMember slrc:KidDistroHoldingsLlcDistroKidMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 us-gaap:FinancialServicesSectorMember slrc:AtriaWealthSolutionsIncMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 us-gaap:IPOMember 2010-02-10 2010-02-10 0001418076 us-gaap:PrivatePlacementMember 2010-02-10 2010-02-10 0001418076 us-gaap:OverAllotmentOptionMember 2010-02-10 0001418076 us-gaap:PrivatePlacementMember 2010-02-10 0001418076 us-gaap:CommonStockMember slrc:SunsCompanyMergerMember 2022-04-01 2022-04-01 0001418076 slrc:CreditFacilityOneMember 2022-04-01 0001418076 us-gaap:CommonStockMember slrc:SunsCompanyMergerMember 2022-04-01 0001418076 slrc:SlrHealthcareAblCreditMember 2023-01-01 2023-03-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2021-12-31 0001418076 slrc:CreditFacilityOneMember 2021-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2021-12-31 0001418076 slrc:CreditFacilityMember 2021-12-31 0001418076 slrc:NefpassFacilityMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-12-31 0001418076 slrc:TermLoansMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-01-06 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2021-09-14 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2019-12-18 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2019-12-18 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2017-11-22 2021-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember srt:MinimumMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2011-08-26 0001418076 slrc:CitiBankNaMember slrc:SunsSpvLlcMember slrc:TermLoanAndCreditFacilityMember srt:MaximumMember 2011-08-26 0001418076 slrc:CitiBankNaMember slrc:TermLoanAndCreditFacilityMember srt:MinimumMember slrc:SecuredOvernightFinancingRateMember 2011-08-26 2011-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember srt:MaximumMember slrc:CitiBankNaMember slrc:SecuredOvernightFinancingRateMember 2011-08-26 2011-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember slrc:TermLoanMember 2021-12-28 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember us-gaap:LineOfCreditMember 2021-12-28 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2021-12-28 0001418076 slrc:TermLoanAndCreditFacilityMember srt:MaximumMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2021-12-28 2021-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember srt:MinimumMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2021-12-28 2021-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember slrc:CrystalFinancialMember 2012-11-30 2012-11-30 0001418076 slrc:CrystalFinancialMember 2012-11-30 0001418076 slrc:CrystalFinancialMember slrc:SlrBusinessCreditFacilityMember 2012-12-28 2012-12-28 0001418076 slrc:CrystalFinancialMember slrc:SlrBusinessCreditFacilityMember 2012-12-28 0001418076 us-gaap:RevolvingCreditFacilityMember 2012-12-28 0001418076 slrc:SlrBusinessCreditFacilityMember 2016-07-28 2016-07-28 0001418076 slrc:CrystalFinancialMember slrc:SlrBusinessCreditFacilityMember 2016-07-28 0001418076 slrc:SlrBusinessCreditFacilityMember slrc:CrystalCapitalFinancialHoldingsLlcMember 2016-07-28 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2022-12-12 0001418076 slrc:SlrBusinessCreditFacilityMember 2022-12-12 0001418076 slrc:SeniorSecuredRevolvingCreditFacilityMember slrc:SlrSeniorLendingProgramSpvLlcMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-12 0001418076 slrc:SlrEquipmentFinanceMember 2017-07-31 0001418076 slrc:SlrEquipmentFinanceMember 2019-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2020-11-03 2020-11-03 0001418076 slrc:KingsbridgeHoldingsLlcMember srt:MaximumMember 2020-11-03 0001418076 srt:MinimumMember slrc:KingsbridgeHoldingsLlcMember 2020-11-03 0001418076 slrc:KingsbridgeHoldingsLlcMember 2020-11-03 0001418076 slrc:SlrHealthcareAblMember 2013-09-30 0001418076 srt:MaximumMember slrc:SlrHealthcareAblCreditMember 2013-09-30 0001418076 srt:MinimumMember slrc:SlrHealthcareAblCreditMember 2013-09-30 0001418076 slrc:SlrHealthcareAblMember srt:MinimumMember 2022-09-30 0001418076 slrc:SlrHealthcareAblMember srt:MaximumMember 2022-09-30 0001418076 srt:MinimumMember slrc:SlrHealthcareAblCreditMember 2014-03-31 0001418076 slrc:SlrHealthcareAblCreditMember 2014-06-27 0001418076 srt:MinimumMember slrc:SlrHealthcareAblCreditMember 2016-05-27 0001418076 srt:MaximumMember slrc:SlrHealthcareAblCreditMember 2016-05-27 0001418076 slrc:EspSscCorporationMember 2017-10-20 0001418076 slrc:NorthMillCapitalLlcMember 2017-10-20 0001418076 slrc:EspSscCorporationMember 2018-05-01 0001418076 slrc:NorthMillCapitalLlcMember 2018-05-01 0001418076 slrc:SummitFinancialResourcesMember 2019-06-28 0001418076 slrc:NmHoldcoMember 2019-06-28 0001418076 slrc:NmcsCreditFacilityMember 2019-06-28 0001418076 slrc:SlrHealthcareAblCreditMember 2019-06-28 0001418076 slrc:FastPayPartnersLlcMember 2021-06-03 2021-06-03 0001418076 slrc:SunsMember 2021-06-03 0001418076 slrc:NmcsCreditFacilityMember 2021-06-03 0001418076 slrc:FastPayPartnersLlcMember 2021-06-03 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrSeniorLendingProgramLlcMember 2022-10-12 0001418076 us-gaap:InvestorMember slrc:SlrSeniorLendingProgramLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-10-12 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember srt:ManagementMember slrc:SlrSeniorLendingProgramLlcMember 2022-10-12 0001418076 slrc:SlrSeniorLendingProgramSpvLlcMember slrc:SeniorSecuredRevolvingCreditFacilityMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-12 2022-12-12 0001418076 slrc:SeniorSecuredRevolvingCreditFacilityMember slrc:SlrSeniorLendingProgramSpvLlcMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-12 2022-12-12 0001418076 slrc:SlrSeniorLendingProgramLlcMember 2022-12-01 2022-12-31 0001418076 slrc:BoardMember us-gaap:SubsequentEventMember 2023-08-08 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2013-01-01 2013-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2014-01-01 2014-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2015-01-01 2015-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2016-01-01 2016-12-31 0001418076 slrc:BoardMember us-gaap:SubsequentEventMember 2023-07-05 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2019-12-18 2019-12-18 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2017-11-22 0001418076 slrc:SlrEquipmentFinanceMember 2019-09-30 2019-09-30 0001418076 slrc:SlrHealthcareAblCreditMember 2016-05-27 2016-05-27 0001418076 slrc:SlrHealthcareAblCreditMember 2019-06-28 2019-06-28 0001418076 slrc:SlrHealthcareAblCreditMember 2023-03-31 0001418076 slrc:SlrHealthcareAblCreditMember 2013-09-30 2013-09-30 0001418076 slrc:TermLoansMember 2013-12-31 0001418076 slrc:CreditFacilityMember 2013-12-31 0001418076 slrc:SeniorSecuredNotesMember 2013-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2013-12-31 0001418076 slrc:CreditFacilityMember 2014-12-31 0001418076 slrc:TermLoansMember 2014-12-31 0001418076 slrc:SeniorSecuredNotesMember 2014-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2014-12-31 0001418076 slrc:CreditFacilityMember 2015-12-31 0001418076 slrc:TermLoansMember 2015-12-31 0001418076 slrc:SeniorSecuredNotesMember 2015-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2015-12-31 0001418076 slrc:CreditFacilityMember 2016-12-31 0001418076 slrc:TermLoansMember 2016-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2016-12-31 0001418076 slrc:SeniorSecuredNotesMember 2016-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2016-12-31 0001418076 slrc:CreditFacilityMember 2017-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2017-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2017-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2017-12-31 0001418076 slrc:TermLoansMember 2017-12-31 0001418076 slrc:SeniorSecuredNotesMember 2017-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2017-12-31 0001418076 slrc:CreditFacilityMember 2018-12-31 0001418076 slrc:SslpFacilityMember 2018-12-31 0001418076 slrc:NefpassFacilityMember 2018-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2018-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2018-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2018-12-31 0001418076 slrc:TermLoansMember 2018-12-31 0001418076 slrc:CreditFacilityMember 2019-12-31 0001418076 slrc:SslpFacilityMember 2019-12-31 0001418076 slrc:NefpassFacilityMember 2019-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2019-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2019-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2019-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2019-12-31 0001418076 slrc:TermLoansMember 2019-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2019-12-31 0001418076 slrc:CreditFacilityMember 2020-12-31 0001418076 slrc:NefpassFacilityMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2020-12-31 0001418076 slrc:TermLoansMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2020-12-31 0001418076 slrc:EquipmentFinancingMember 2023-03-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2023-03-31 0001418076 us-gaap:EquitySecuritiesMember 2023-03-31 0001418076 slrc:PreferredEquityMember 2023-03-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2023-06-30 0001418076 us-gaap:EquitySecuritiesMember 2023-06-30 0001418076 slrc:EquipmentFinancingMember 2023-06-30 0001418076 slrc:PreferredEquityMember 2023-06-30 0001418076 slrc:PreferredEquityMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember 2022-12-31 0001418076 slrc:RdHoldcoIncDebtMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:SlrEquipmentFinanceDebtMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:SlrEquipmentFinanceEquityMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:SointLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:SlrCreditSolutionsMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:RdHoldcoIncCommonEquityMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:SlrHealthcareAblMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:SlrSeniorLendingProgramLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:EquipmentOperatingLeasesLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:SlrBusinessCreditMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:KingsbridgeHoldingsLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:KbhTopcoLlcKingsbridgeMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:RdHoldcoIncWarrantsMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:LoyerCapitalLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:RdHoldcoIncClassBMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:AmeriMarkIntermediateHoldingsOneLLCMember slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:AmerimarkIntermediateHoldingsLlcMember slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:BaysideOpcoLLCMember slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideParentLlcEquityMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:SlramiTopcoBlockerLlcMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:BaysideOpcoLLCOneMember slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideParentLlcLoanMember 2022-12-31 0001418076 slrc:SlrEquipmentFinanceDebtMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-06-30 0001418076 slrc:RdHoldcoIncWarrantsMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-06-30 0001418076 slrc:SlrHealthcareAblMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-06-30 0001418076 slrc:SlrBusinessCreditMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-06-30 0001418076 slrc:SointLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-06-30 0001418076 slrc:LoyerCapitalLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-06-30 0001418076 slrc:RdHoldcoIncCommonEquityMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-06-30 0001418076 slrc:SlrCreditSolutionsMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-06-30 0001418076 slrc:SlrSeniorLendingProgramLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-06-30 0001418076 slrc:RdHoldcoIncDebtMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-06-30 0001418076 slrc:RdHoldcoIncClassBMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-06-30 0001418076 slrc:KingsbridgeHoldingsLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-06-30 0001418076 slrc:EquipmentOperatingLeasesLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-06-30 0001418076 slrc:KbhTopcoLlcKingsbridgeMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-06-30 0001418076 slrc:SlrEquipmentFinanceEquityMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2023-06-30 0001418076 slrc:BaysideOpcoLLCOneMember slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2023-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideParentLlcLoanMember 2023-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideParentLlcEquityMember 2023-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:SlramiTopcoBlockerLlcMember 2023-06-30 0001418076 slrc:BaysideOpcoLLCMember slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2023-06-30 0001418076 slrc:AmerimarkIntermediateHoldingsLlcMember slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2023-06-30 0001418076 slrc:AmeriMarkIntermediateHoldingsOneLLCMember slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2023-06-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember 2021-12-31 0001418076 slrc:PreferredEquityMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrBusinessCreditMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrSeniorLendingProgramLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrHealthcareAblMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SoaggLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncDebtMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SoaggLlcMember 2022-12-31 iso4217:USD xbrli:shares xbrli:pure utr:Day utr:Year iso4217:USD xbrli:shares slrc:issuers slrc:loans slrc:fund slrc:Customers
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM
10-Q
 
 
 
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the Quarter Ended June 30, 2023
 
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Commission File Number:
814-00754
 
 
SLR INVESTMENT CORP.
(Exact name of registrant as specified in its charter)
 
 
 
Maryland  
26-1381340
(State of Incorporation)
 
(I.R.S. Employer
Identification No.)
500 Park Avenue
New York, N.Y.
 
10022
(Address of principal executive offices)
 
(Zip Code)
(212993-1670
(Registrant’s telephone number, including area code)
 
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of Each Class
 
Trading Symbol(s)
 
Name of Each Exchange on Which Registered
Common Stock, par value $0.01 per share   SLRC   The NASDAQ Global Select Market
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No    ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of
Regulation S-T
(§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule
12b-2
of the Exchange Act.
 
Large accelerated filer      Accelerated filer  
Non-accelerated
filer
     Smaller Reporting company  
Emerging growth company       
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Exchange Act).    Yes  ☐    No    
The number of shares of the registrant’s Common Stock, $0.01 par value, outstanding as of August 4, 2023 was 54,554,634.
 
 
 

SLR INVESTMENT CORP.
FORM
10-Q
FOR THE QUARTER ENDED JUNE 30, 2023
TABLE OF CONTENTS
 
    
PAGE
 
  
Item 1.
  Financial Statements   
  Consolidated Statements of Assets and Liabilities as of June 30, 2023 (unaudited) and December 31, 2022      1  
  Consolidated Statements of Operations for the three and six months ended June 30, 2023 (unaudited) and the three and six months ended June 30, 2022 (unaudited)      2  
  Consolidated Statements of Changes in Net Assets for the three and six months ended June 30, 2023 (unaudited) and the three and six months ended June 30, 2022 (unaudited)      3  
  Consolidated Statements of Cash Flows for the six months ended June 30, 2023 (unaudited) and the six months ended June 30, 2022 (unaudited)      4  
  Consolidated Schedule of Investments as of June 30, 2023 (unaudited)      5  
  Consolidated Schedule of Investments as of December 31, 2022      10  
  Notes to Consolidated Financial Statements (unaudited)      15  
  Report of Independent Registered Public Accounting Firm      36  
Item 2.
  Management’s Discussion and Analysis of Financial Condition and Results of Operations      37  
Item 3.
  Quantitative and Qualitative Disclosures About Market Risk      56  
Item 4.
  Controls and Procedures      56  
  
Item 1.
  Legal Proceedings      57  
Item 1A.
  Risk Factors      57  
Item 2.
  Unregistered Sales of Equity Securities and Use of Proceeds      58  
Item 3.
  Defaults Upon Senior Securities      58  
Item 4.
  Mine Safety Disclosures      58  
Item 5.
  Other Information      58  
Item 6.
  Exhibits      59  
  Signatures      60  

PART I. FINANCIAL INFORMATION
In this Quarterly Report, “Company”, “we”, “us”, and “our” refer to SLR Investment Corp. unless the context states otherwise.
 
Item 1.
Financial Statements
SLR INVESTMENT CORP.
CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES
(in thousands, except share amounts)
 
    
June 30, 2023
(unaudited)
   
December 31,
2022
 
Assets
    
Investments at fair value:
    
Companies less than 5% owned (cost: $1,358,634 and $1,312,701, respectively)
   $ 1,340,356     $ 1,289,082  
Companies 5% to 25% owned (cost: $59,803 and $0, respectively)
     42,157           
Companies more than 25% owned (cost: $831,089 and $821,886, respectively)
     798,913       797,594  
Cash
     14,428       10,743  
Cash equivalents (cost: $333,200 and $417,590, respectively)
     333,200       417,590  
Dividends receivable
     10,754       11,192  
Interest receivable
     11,071       9,706  
Receivable for investments sold
     1,469       1,124  
Prepaid expenses and other assets
     882       664  
  
 
 
   
 
 
 
Total assets
   $ 2,553,230     $ 2,537,695  
  
 
 
   
 
 
 
Liabilities
    
Debt ($1,219,200 and $1,093,200 face amounts, respectively, reported net of unamortized debt issuance costs of $6,167 and $7,202, respectively. See notes 6 and 7)
   $ 1,213,033     $ 1,085,998  
Payable for investments and cash equivalents purchased
     333,200       417,611  
Distributions payable
              7,481  
Management fee payable (see note 3)
     7,878       7,964  
Performance-based incentive fee payable (see note 3)
     5,513       5,422  
Interest payable (see note 7)
     6,937       7,943  
Administrative services payable (see note 3)
     2,166       1,488  
Other liabilities and accrued expenses
     3,698       4,057  
  
 
 
   
 
 
 
Total liabilities
   $ 1,572,425     $ 1,537,964  
  
 
 
   
 
 
 
Commitments and contingencies (see note 10)
    
Net Assets
    
Common stock, par value $0.01 per share, 200,000,000 and 200,000,000 common shares authorized, respectively, and 54,554,634 and 54,555,380 shares issued and outstanding, respectively
   $ 546     $ 546  
Paid-in
capital in excess of par
     1,162,559       1,162,569  
Accumulated distributable net loss
     (182,300     (163,384
  
 
 
   
 
 
 
Total net assets
   $ 980,805     $ 999,731  
  
 
 
   
 
 
 
Net Asset Value Per Share
   $ 17.98     $ 18.33  
  
 
 
   
 
 
 
See notes to consolidated financial statements.
 
1

SLR INVESTMENT CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)
(in thousands, except share amounts)
 
    
Three months ended
   
Six months ended
 
    
June 30, 2023
   
June 30, 2022
   
June 30, 2023
   
June 30, 2022
 
INVESTMENT INCOME:
        
Interest:
        
Companies less than 5% owned
   $ 41,267     $ 28,855     $ 78,605     $ 49,517  
Companies 5% to 25% owned
     265                265           
Companies more than 25% owned
     2,814       1,922       5,525       4,483  
Dividends:
        
Companies more than 25% owned
     11,177       11,083       22,353       20,798  
Other income:
        
Companies less than 5% owned
     757       925       3,079       988  
Companies more than 25% owned
     57       (5     57           
  
 
 
   
 
 
   
 
 
   
 
 
 
Total investment income
     56,337       42,780       109,884       75,786  
  
 
 
   
 
 
   
 
 
   
 
 
 
EXPENSES:
        
Management fees (see note 3)
   $ 7,878     $ 6,913     $ 15,584     $ 14,129  
Performance-based incentive fees (see note 3)
     5,638       4,734       11,147       4,734  
Interest and other credit facility expenses (see note 7)
     17,842       10,352       33,128       18,680  
Administrative services expense (see note 3)
     1,480       1,369       2,988       2,552  
Other general and administrative expenses
     948       476       2,449       3,277  
  
 
 
   
 
 
   
 
 
   
 
 
 
Total expenses
     33,786       23,844       65,296       43,372  
  
 
 
   
 
 
   
 
 
   
 
 
 
Performance-based incentive fees waived (see note 3)
     (125     (1,358     (235     (1,358
  
 
 
   
 
 
   
 
 
   
 
 
 
Net expenses
     33,661       22,486       65,061       42,014  
  
 
 
   
 
 
   
 
 
   
 
 
 
Net investment income
   $ 22,676     $ 20,294     $ 44,823     $ 33,772  
  
 
 
   
 
 
   
 
 
   
 
 
 
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND CASH EQUIVALENTS:
        
Net realized gain (loss) on investments and cash equivalents (companies less than 5% owned)
   $ 498     $ (105   $ 1,185     $ (75
  
 
 
   
 
 
   
 
 
   
 
 
 
Net change in unrealized gain (loss) on investments and cash equivalents:
        
Companies less than 5% owned
     5,181       (11,764     (9,090     (25,262
Companies 5% to 25% owned
     (3,216              (3,216         
Companies more than 25% owned
     (6,144     (24,071     (7,883     (22,618
  
 
 
   
 
 
   
 
 
   
 
 
 
Net change in unrealized loss on investments and cash equivalents
     (4,179     (35,835     (20,189     (47,880
  
 
 
   
 
 
   
 
 
   
 
 
 
Net realized and unrealized loss on investments and cash equivalents
     (3,681     (35,940     (19,004     (47,955
  
 
 
   
 
 
   
 
 
   
 
 
 
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS
   $ 18,995     $ (15,646   $ 25,819     $ (14,183
  
 
 
   
 
 
   
 
 
   
 
 
 
EARNINGS (LOSS) PER SHARE (see note 5)
   $ 0.35     $ (0.29   $ 0.47     $ (0.29
  
 
 
   
 
 
   
 
 
   
 
 
 
See notes to consolidated financial statements.
 
2
SLR INVESTMENT CORP.
CONSOLIDATED STATEMENTS OF CHANGES IN NET ASSETS (unaudited)
(in thousands, except share amounts)
 
    
Three months ended
   
Six months ended
 
    
June 30, 2023
   
June 30, 2022
   
June 30, 2023
   
June 30, 2022
 
Increase (decrease) in net assets resulting from operations:
        
Net investment income
   $ 22,676     $ 20,294     $ 44,823     $ 33,772  
Net realized gain (loss)
     498       (105     1,185       (75
Net change in unrealized loss
     (4,179     (35,835     (20,189     (47,880
  
 
 
   
 
 
   
 
 
   
 
 
 
Net increase (decrease) in net assets resulting from operations
     18,995       (15,646     25,819       (14,183
  
 
 
   
 
 
   
 
 
   
 
 
 
Distributions to stockholders:
        
From net investment income
     (22,588     (22,457     (44,735     (39,784
From return of capital
     220                             
  
 
 
   
 
 
   
 
 
   
 
 
 
Net distributions to stockholders
     (22,368     (22,457     (44,735     (39,784
  
 
 
   
 
 
   
 
 
   
 
 
 
Capital transactions
(see note 12)
:
        
Issuance of common stock
              226,839                226,839  
Repurchases of common stock
                       (10         
  
 
 
   
 
 
   
 
 
   
 
 
 
Net capital transactions
              226,839       (10     226,839  
  
 
 
   
 
 
   
 
 
   
 
 
 
Total increase (decrease) in net assets
     (3,373     188,736       (18,926     172,872  
Net assets at beginning of period
     984,178       826,417       999,731       842,281  
  
 
 
   
 
 
   
 
 
   
 
 
 
Net assets at end of period
   $ 980,805     $ 1,015,153     $ 980,805     $ 1,015,153  
  
 
 
   
 
 
   
 
 
   
 
 
 
Capital stock activity
(see note 12)
:
        
Issuance of common stock
              12,511,825                12,511,825  
Repurchases of common stock
                       (746         
  
 
 
   
 
 
   
 
 
   
 
 
 
Net capital stock activity
              12,511,825       (746     12,511,825  
  
 
 
   
 
 
   
 
 
   
 
 
 
See notes to consolidated financial statements.
 
3

SLR INVESTMENT CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)
(in thousands)
 
    
Six months ended
 
    
June 30, 2023
   
June 30, 2022
 
Cash Flows from Operating Activities:
    
Net increase (decrease) in net assets resulting from
operations
   $ 25,819     $ (14,183
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
    
Net realized (gain) loss on investments and cash equivalents
     (1,185     75  
Net change in unrealized loss on investments
     20,189       47,880  
(Increase) decrease in operating assets:
    
Purchase of investments
     (368,924     (160,973
Proceeds from disposition of investments
     267,224       179,122  
Net accretion of discount on investments
     (5,850     (4,769
Capitalization of
payment-in-kind
income
     (6,206     (1,019
Collections of
payment-in-kind
income
     2       898  
Receivable for investments sold
     (345     293  
Interest receivable
     (1,365     (1,863
Dividends receivable
     438       (1,615
Prepaid expenses and other assets
     (218     (360
Cash acquired in merger
              2,313  
Increase (decrease) in operating liabilities:
    
Payable for investments and cash equivalents purchased
     (84,411     28,871  
Management fee payable
     (86     (519
Performance-based incentive fee payable
     91       1,512  
Administrative services expense payable
     678       (1,733
Interest payable
     (1,006     2,618  
Other liabilities and accrued expenses
     (359     1,619  
Deferred financing costs/market discount
     1,035       1,009  
  
 
 
   
 
 
 
Net Cash Provided by (Used in) Operating Activities
     (154,479     79,176  
  
 
 
   
 
 
 
Cash Flows from Financing Activities:
    
Cash distributions paid
     (52,216     (49,625
Proceeds from unsecured borrowings
              134,914  
Repayment of unsecured borrowings
     (75,000     (150,000
Proceeds from secured borrowings
     400,000       338,404  
Repayment of secured borrowings
     (199,000     (298,100
Repurchase of common stock
     (10         
  
 
 
   
 
 
 
Net Cash Provided by (Used in) Financing Activities
     73,774       (24,407
  
 
 
   
 
 
 
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
     (80,705     54,769  
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD
     428,333       322,935  
  
 
 
   
 
 
 
CASH AND CASH EQUIVALENTS AT END OF PERIOD
   $ 347,628     $ 377,704  
  
 
 
   
 
 
 
Supplemental disclosure of cash flow information:
    
Cash paid for interest
   $ 34,134     $ 16,062  
Issuance of shares in connection with the Merger(1)
              226,839  
  
 
 
   
 
 
 
 
(1)
On April 1, 2022, in connection with the Merger (as defined in Note 1 “Organization”), the Company acquired net assets of $244,691 for the total stock consideration of $226,839.
See notes to consolidated financial statements.
 
4

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (unaudited)
June 30, 2023
(in thousands, except share/unit amounts)
 
Description
 
Industry
 
Spread
Above
Index
(7)
   
Floor
   
Interest
Rate
(1)
   
Acquisition
Date
   
Maturity

Date
   
Par Amount
   
Cost
   
Fair

Value
 
Senior Secured Loans — 134.4%
                 
First Lien Bank Debt/Senior Secured Loans
                 
Aegis Toxicology Sciences Corporation(16)
  Health Care Providers & Services     S+550       1.00     10.84     5/7/2018       5/9/2025     $ 13,480     $ 13,249     $ 13,480  
All State Ag Parts, LLC(16)
  Trading Companies & Distributors     S+575       1.00     11.25     4/1/2022       9/1/2026       4,494       4,393       4,494  
American Teleconferencing Services, Ltd.**
  Communications Equipment     L+650       1.00              5/5/2016       9/9/2021       36,135       25,926           
American Teleconferencing Services, Ltd.**
  Communications Equipment     L+650       1.00              9/17/2021       4/7/2023       6,115       5,971           
AmeriMark Intermediate Holdings, LLC(14)(27)
  Internet & Catalog Retail     P+475       1.00     13.00     6/16/2023       8/4/2023       464       464       464  
AmeriMark Intermediate Holdings, LLC(14)(27)**
  Internet & Catalog Retail     S+800       1.00              7/28/2021       10/15/2026       18,743       17,071       5,134  
Apex Services Partners, LLC(16)
  Diversified Consumer Services     S+525       1.00     10.66     8/31/2022       7/31/2025       13,916       13,607       13,916  
Atria Wealth Solutions, Inc.(16)
  Diversified Financial Services     S+650       1.00     12.00     9/14/2018       2/29/2024       8,098       8,074       8,098  
Basic Fun, Inc.(16)
  Specialty Retail     S+650       1.00     12.04     10/30/2020       10/30/2023       2,150       2,146       2,150  
BayMark Health Services, Inc.(16)
  Health Care Providers & Services     S+500       1.00     10.50     4/1/2022       6/11/2027       8,308       8,026       8,308  
Bayside Opco, LLC(27)
  Healthcare Providers & Services     S+700
(15)
 
    1.00     12.73     5/31/2023       5/31/2026       846       846       846  
Bayside Opco, LLC(27)
  Healthcare Providers & Services     S+725
(11)
 
    1.00     12.64     5/31/2023       5/31/2026       18,224       18,224       18,224  
Bayside Parent, LLC(27)
  Healthcare Providers & Services     S+1000
(11)
 
    1.00     15.39     5/31/2023       5/31/2026       4,773       4,773       4,773  
BDG Media, Inc.
  Media     L+900       0.25     14.52     7/18/2022       7/31/2025       6,461       6,461       6,461  
CC SAG Holdings Corp. (Spectrum Automotive)(16)
  Diversified Consumer Services     S+575       0.75     11.25     6/29/2021       6/29/2028       39,680       39,053       39,680  
Composite Technology Acquisition Corp.(16)
  Building Products     S+450       1.00     9.89     4/1/2022       2/1/2025       10,999       10,691       10,999  
Copper River Seafoods, Inc.
  Food Products     P+275                11.75     8/31/2022       4/23/2025       3,842       3,842       3,842  
CVAUSA Management, LLC,,
  Health Care Providers & Services     S+650       1.00     11.59     5/22/2023       5/22/2029       14,260       13,837       13,832  
DeepIntent, Inc.
  Media     P+175                10.00     10/12/2022       3/25/2025       18,075       18,075       18,075  
Enhanced Permanent Capital, LLC(3)
  Capital Markets     S+700       1.00     11.93     12/29/2020       12/29/2025       43,435       42,618       43,435  
ENS Holdings III Corp. & ES Opco USA LLC (Bluefin)(16)
  Trading Companies & Distributors     S+475       1.00     10.09     4/1/2022       12/31/2025       4,640       4,504       4,640  
Enverus Holdings, Inc. (fka Drilling Info Holdings)(16)
  IT Services     S+450                9.70     4/1/2022       7/30/2025       11,312       10,941       11,312  
Erie Construction
Mid-west,
LLC(16)
  Building Products     S+475       1.00     10.34     4/1/2022       7/30/2027       8,686       8,391       8,686  
Fertility (ITC) Investment Holdco, LLC
  Health Care Providers & Services     S+650       1.00     11.63     1/4/2023       1/3/2029       22,710       22,068       22,710  
Foundation Consumer Brands, LLC(16)
  Personal Products     S+625       1.00     11.47     2/12/2021       2/12/2027       30,088       29,411       30,088  
GSM Acquisition Corp.(16)
  Leisure Equipment & Products     S+500       1.00     10.50     4/1/2022       11/16/2026       10,967       10,573       10,857  
Higginbotham Insurance Agency, Inc.(16)
  Insurance     S+525       1.00     10.45     4/1/2022       11/25/2026       4,898       4,724       4,898  
High Street Buyer, Inc.(16)
  Insurance     S+600       0.75     11.39     4/1/2022       4/16/2028       5,162       4,897       5,162  
Human Interest Inc.
  Internet Software & Services     S+785       1.00     13.01     6/30/2022       7/1/2027       20,104       19,863       20,104  
iCIMS, Inc.
  Software     S+725       0.75     12.38 %
(26)
 
    8/18/2022       8/18/2028       30,468       30,016       30,468  
Kaseya, Inc.(16)
  Software     S+575       0.75     10.86 %
(29)
 
    6/22/2022       6/23/2029       33,290       32,845       33,290  
Kid Distro Holdings, LLC (Distro Kid)(16)
  Software     S+575       1.00     11.14     9/24/2021       10/1/2027       23,326       22,975       23,326  
Kingsbridge Holdings, LLC(2)
  Multi-Sector Holdings     S+700       1.00     12.22     12/21/2018       12/21/2024       80,000       79,847       80,000  
KORE Wireless Group, Inc.(16)
  Wireless Telecommunication Services     S+550                10.84     12/21/2018       12/21/2024       23,465       23,112       23,465  
Logix Holding Company, LLC(16)
  Communications Equipment     L+575       1.00     11.48     9/14/2018       12/22/2024       14,009       13,423       13,729  
Luxury Asset Capital, LLC(16)
  Thrifts & Mortgage Finance     S+675       1.00     12.02     7/15/2022       7/15/2027       30,500       29,978       30,500  
Maurices, Incorporated(16)
  Specialty Retail     S+675       1.00     9.78     8/27/2021       6/1/2024       8,343       8,262       8,343  
Maxor Acquisition, Inc.
  Health Care Providers & Services     S+675       1.00     12.16     3/1/2023       3/1/2029       23,843       23,155       23,128  
Montefiore Nyack Hospital
  Health Care Providers & Services     S+495                10.60     8/9/2022       11/15/2025       5,097       5,097       5,097  
NSPC Intermediate Corp. (National Spine)
  Health Care Providers & Services     S+850       1.00     12.90     4/1/2022       2/13/2026       2,216       2,129       2,216  
One Touch Direct, LLC
  Commercial Services & Supplies     P+75                9.00     4/3/2020       3/30/2024       3,929       3,929       3,929  
ONS MSO, LLC
  Health Care Providers & Services     S+625       1.00     11.32     2/10/2023       7/8/2025       17,235       16,791       16,718  
Orthopedic Care Partners Management, LLC
  Health Care Providers & Services     S+650       1.00     11.83     8/17/2022       5/16/2024       4,176       4,156       4,176  
Pediatric Home Respiratory Services, LLC
  Health Care Providers & Services     S+625       1.00     11.45     8/19/2022       12/4/2024       1,976       1,953       1,976  
Peter C. Foy & Associates Insurance Services, LLC
  Insurance     S+600       0.75     11.22     4/1/2022       11/1/2028       11,888       11,729       11,888  
PhyNet Dermatology LLC
  Health Care Providers & Services     S+625       1.00     11.45     9/5/2018       8/16/2024       11,896       11,873       11,896  
Pinnacle Treatment Centers, Inc.(16)
  Health Care Providers & Services     S+675       1.00     12.10     1/22/2020       1/2/2026       26,652       26,266       26,652  
Plastics Management, LLC(16)
  Health Care Providers & Services     S+500       1.00     10.44     4/1/2022       8/18/2027       17,225       16,500       17,225  
RQM+ Corp.(16)
  Life Sciences Tools & Services     S+575       1.00     11.51     8/20/2021       8/12/2026       23,757       23,395       23,757  
RSC Acquisition, Inc.(16)
  Insurance     S+550       0.75     10.64     4/1/2022       11/1/2026       21,841       21,664       21,841  
RxSense Holdings LLC(16)
  Diversified Consumer Services     S+500       1.00     10.15     4/1/2022       3/13/2026       8,700       8,362       8,700  
SCP Eye Care, LLC
  Health Care Providers & Services     S+575       1.00     10.93     10/6/2022       10/5/2029       9,089       8,814       9,089  
SHO Holding I Corporation (Shoes for Crews)(16)
  Footwear     S+523       1.00     10.52     4/1/2022       4/27/2024       5,674       5,456       5,391  
Southern Orthodontic Partners Management, LLC(16)
  Health Care Providers & Services     S+600       1.00     11.50     6/3/2022       1/27/2026       2,791       2,767       2,791  
SPAR Marketing Force, Inc.
  Media     P+190                10.15     7/18/2022       10/10/2024       6,767       6,767       6,767  
Stryten Resources LLC
  Auto Parts & Equipment     S+800       1.00     13.50     8/11/2021       10/12/2026       25,791       25,423       25,791  
SunMed Group Holdings, LLC(16)
  Health Care Equipment & Supplies     S+575       0.75     11.09     6/16/2021       6/16/2028       21,565       21,144       21,565  
TAUC Management, LLC(16)
  Health Care Providers & Services     L+525       1.00     10.59     4/1/2022       2/12/2027       6,895       6,615       6,550  
Tilley Distribution, Inc.(16)
  Trading Companies & Distributors     S+600       1.00     11.39     4/1/2022       12/31/2026       3,857       3,691       3,857  
Ultimate Baked Goods Midco LLC (Rise Baking)(16)
  Packaged Foods & Meats     S+625       1.00     11.45     8/12/2021       8/13/2027       23,895       23,244       23,895  
United Digestive MSO Parent, LLC
  Health Care Providers & Services     S+675       1.00     11.99     3/30/2023       3/30/2029       13,290       12,903       12,891  
Urology Management Holdings, Inc.
  Health Care Providers & Services     S+625       1.00     11.36     2/7/2023       6/15/2026       7,156       6,962       6,941  
Vessco Midco Holdings, LLC(16)
  Water Utilities     L+450       1.00     9.56     4/1/2022       11/2/2026       2,931       2,866       2,931  
World Insurance Associates, LLC(16)
  Insurance     S+575       1.00     10.81     4/1/2022       4/1/2026       48,371       47,337       48,371  
               
 
 
   
 
 
 
Total First Lien Bank Debt/Senior Secured Loans
 
  $ 964,165     $ 933,818  
 
 
 
   
 
 
 
Second Lien Asset-Based Senior Secured Loans
                 
ACRES Commercial Mortgage, LLC
  Diversified Financial Services     S+705       1.00     12.31     12/24/2021       8/21/2028       29,925     $ 29,435     $ 29,925  
FGI Worldwide LLC
  Diversified Financial Services     S+650       1.00     11.61     4/17/2023       4/17/2028       8,206       8,007       8,001  
               
 
 
   
 
 
 
                $ 37,442     $ 37,926  
               
 
 
   
 
 
 
Second Lien Bank Debt/Senior Secured Loans
                 
RD Holdco, Inc.** (2)
  Diversified Consumer Services     S+975
(11)
 
    1.00              12/23/2013       10/12/2026       14,498     $ 12,297     $ 7,249  
               
 
 
   
 
 
 
 
See notes to consolidated financial statements.
 
5
SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (unaudited) (continued)
June 30, 2023
(in thousands, except share/unit amounts)
 
Description
 
Industry
 
Spread
Above
Index
(7)
   
Floor
   
Interest
Rate
(1)
   
Acquisition
Date
   
Maturity

Date
   
Par Amount
   
Cost
   
Fair

Value
 
Senior Secured Loans (continued) —
                 
First Lien Life Science Senior Secured Loans
                 
Alimera Sciences, Inc.(16)
  Pharmaceuticals     S+515       4.60     10.32     12/31/2019       5/1/2028     $ 34,738     $ 34,769     $ 34,738  
Apeel Technology, Inc
  Biotechnology     S+625       1.00     8.75     6/29/2022       6/1/2027       3,643       3,634       3,652  
Arcutis Biotherapeutics, Inc.(3)
  Pharamceuticals     L+745       0.10     12.61     12/22/2021       1/1/2027       66,849       67,618       67,685  
Ardelyx, Inc.(3)
  Pharmaceuticals     S+795       1.00     13.15     2/23/2022       3/1/2027       9,475       9,496       9,570  
BridgeBio Pharma, Inc.(3)
  Biotechnology                       9.00 %
(22)
 
    11/17/2021       11/17/2026       40,446       40,101       40,446  
Centrexion Therapeutics, Inc.
  Pharmaceuticals     L+725       2.45     12.41     6/28/2019       1/1/2024       6,377       7,018       7,171  
Cerapedics, Inc.
  Biotechnology     S+620       2.75     11.37     12/27/2022       1/1/2028       26,939       26,958       27,007  
Glooko, Inc.(16)
  Health Care Technology     L+790       0.10     13.06     9/30/2021       10/1/2026       15,883       15,941       16,002  
Meditrina, Inc.
  Health Care Equipment & Supplies     S+550       3.45     10.67     12/20/2022       12/1/2027       3,367       3,356       3,367  
Neuronetics, Inc.(16)
  Health Care Equipment & Supplies     S+565       3.95     10.82     3/2/2020       3/29/2028       19,299       19,201       19,347  
OmniGuide Holdings, Inc. (13)
  Health Care Equipment & Supplies     S+1415       0.10     19.21 %
(23)
 
    7/30/2018       8/1/2023       20,192       20,977       21,101  
Outset Medical, Inc.(3)
  Health Care Equipment & Supplies     S+515       2.75     10.32     11/3/2022       11/1/2027       35,084       35,067       35,084  
Spectrum Pharmaceuticals, Inc.(16)
  Biotechnology     S+570       2.30     10.87     9/21/2022       9/1/2027       10,525       11,167       11,341  
Vapotherm, Inc.
  Health Care Equipment & Supplies     S+930       1.00     14.57 %
(24)
 
    2/18/2022       2/1/2027       35,992       36,096       36,441  
Vertos Medical, Inc.
  Health Care Equipment & Supplies     S+515       4.75     10.25     6/14/2023       7/1/2028       6,651       6,570       6,567  
               
 
 
   
 
 
 
Total First Lien Life Science Senior Secured Loans
                $ 337,969     $ 339,519  
               
 
 
   
 
 
 
Total Senior Secured Loans
               
$
1,351,873
 
 
$
1,318,512
 
               
 
 
   
 
 
 
 
Description
 
Industry
 
Interest Rate
(1)
 
Acquisition
Date
 
Maturity

Date
 
Par Amount
   
Cost
   
Fair

Value
 
Equipment Financing — 27.7%
             
A&A Crane and Rigging, LLC (10)
  Commercial Services & Supplies   7.78%   3/27/2023   3/27/2028   $ 75     $ 75     $ 75  
Aero Operating LLC (10)
  Commercial Services & Supplies  
8.47-9.64%
  2/12/2021  
3/1/2025-12/1/2026
    1,813       1,811       1,811  
AFG Dallas III, LLC (10)
  Diversified Consumer Services  
10.00-11.29%
  8/11/2022  
8/11/2026-3/1/2027
    1,263       1,263       1,263  
Air Methods Corporation (10)
  Airlines  
7.08-7.13%
  11/3/2021  
11/3/2026-11/23/2026
    3,356       3,405       3,356  
AmeraMex International, Inc. (10)
  Commercial Services & Supplies   10.00%   3/29/2019   4/15/2025     720       720       727  
Bazzini, LLC (10)
  Food & Staples Retailing   10.46%   12/23/2022   1/1/2028     2,180       2,247       2,180  
Boart Longyear Company (10)
  Metals & Mining  
8.31-10.44%
  5/28/2020  
7/1/2024-10/7/2026
    3,283       3,283       3,283  
Bowman Energy Solutions, LLC (10)
  Commercial Services & Supplies   7.42%   7/1/2022   8/1/2026     134       134       134  
C-Port/Stone
LLC (10)
  Oil, Gas & Consumable Fuels   8.54%   10/7/2022   11/1/2027     6,482       6,311       6,288  
Capital City Jet Center, Inc. (10)
  Airlines   10.00%   4/4/2018  
10/4/2023-6/22/2026
    1,777       1,777       1,762  
Carolina’s Contracting, LLC (10)
  Diversified Consumer Services  
8.40-8.72%
  3/7/2023  
3/7/2028-5/18/2028
    3,850       3,887       3,850  
CKD Holdings, Inc. (10)
  Road & Rail  
8.10-8.60%
  9/22/2022  
6/22/2026-9/22/2027
    3,285       3,285       3,285  
Clubcorp Holdings, Inc. (10)
  Hotels, Restaurants & Leisure  
9.36-13.01%
  5/27/2021  
4/1/2025-5/1/2028
    7,254       7,254       7,254  
Complete Equipment Rentals, LLC (10)
  Commercial Services & Supplies  
6.75-7.15%
  3/23/2023  
4/1/2028-6/1/2028
    2,013       1,980       1,978  
Dongwon Autopart Technology Inc. (10)
  Auto Components   7.96%   2/2/2021   1/1/2026     1,553       1,568       1,553  
Drillers Choice, Inc. (10)
  Commercial Services & Supplies  
8.00-10.08%
  10/31/2022  
11/1/2027-6/1/2029
    2,050       2,053       2,050  
EasyPak, LLC (10)
  Containers & Packaging   9.01%   1/6/2021   1/1/2024     94       94       94  
Energy Drilling Services, LLC (10)
  Diversified Consumer Services  
6.58-9.16%
  8/26/2022  
11/9/2025-9/1/2027
    1,201       1,201       1,177  
Environmental Protection & Improvement Company, LLC (10)
  Road & Rail   8.25%   9/30/2020   10/1/2027     4,925       4,949       4,925  
Equipment Operating Leases, LLC (2)(12)
  Multi-Sector Holdings   8.37%   4/27/2018   4/27/2025     3,614       3,614       3,523  
Extreme Steel Crane & Rigging, LLC (10)
  Commercial Services & Supplies   9.52%   3/3/2023   3/3/2027     955       964       955  
First American Commercial Bancorp, Inc. (10)
  Diversified Financial Services  
7.50-9.02%
  10/28/2021  
10/1/2026-3/1/2027
    2,615       2,617       2,615  
First National Capital, LLC (10)
  Diversified Financial Services   9.00%   11/5/2021   8/1/2026     6,179       6,179       6,179  
Freightsol LLC (10)
  Road & Rail  
12.51-12.89%
  4/9/2019   11/1/2023     457       459       457  
Garda CL Technical Services, Inc. (10)
  Commercial Services & Supplies   8.31%   3/22/2018   10/5/2023     55       55       55  
Georgia Jet, Inc. (10)
  Airlines   8.00%   12/4/2017   1/4/2024     229       229       229  
GMT Corporation (10)
  Machinery   10.71%   10/23/2018   1/1/2026     4,320       4,324       4,320  
Hawkeye Contracting Company, LLC (10)
  Construction & Engineering   10.50%   10/8/2021   11/1/2025     847       847       847  
HTI Logistics Corporation (10)
  Commercial Services & Supplies  
9.69-9.94%
  11/15/2018  
5/1/2024-9/1/2025
    223       223       218  
International Automotive Components Group, North America, Inc. (10)
  Auto Components   7.95%   6/23/2021   6/23/2025     4,952       4,976       4,853  
Kool Pak, LLC (10)
  Road & Rail   8.58%   2/5/2018   3/1/2024     113       113       113  
Loc Performance Products, LLC (10)
  Machinery   10.50%   12/29/2022   6/1/2027     709       709       709  
Loyer Capital LLC (2)(12)
  Multi-Sector Holdings  
8.73-11.52%
  5/16/2019  
5/16/2024-9/25/2024
    7,500       7,500       7,361  
Lux Credit Consultants, LLC (10)
  Road & Rail  
8.28-12.09%
  6/17/2021  
12/1/2024-12/1/2026
    13,260       13,260       13,260  
Lux Vending, LLC (10)
  Consumer Finance  
12.46-13.26%
  8/20/2021  
7/20/2024-10/1/2024
    1,151       1,163       1,151  
Miranda Logistics Enterprise, Inc. (10)
  Construction & Engineering   7.69%   4/14/2023   4/14/2028     862       862       862  
Mountain Air Helicopters, Inc. (10)
  Commercial Services & Supplies   10.00%   7/31/2017   2/28/2025     310       309       310  
No Limit Construction Services, LLC (10)
  Commercial Services & Supplies   7.73%   5/5/2023   6/1/2028     129       129       129  
Ozzies, Inc. (10)
  Commercial Services & Supplies   10.72%   12/23/2022   1/1/2027     1,837       1,895       1,837  
PCX Aerostructures LLC (10)
  Aerospace & Defense   9.32%   11/23/2022   12/1/2028     2,489       2,489       2,489  
Rane Light Metal Castings Inc. (10)
  Machinery   10.00%   6/1/2020   6/1/2024     109       109       109  
Rango, Inc. (10)
  Commercial Services & Supplies  
9.33-9.79%
  9/24/2019  
8/1/2023-11/1/2024
    1,023       1,038       1,004  
Rayzor’s Edge LLC (10)
  Diversified Consumer Services  
7.69-8.27%
  5/19/2023  
5/18/2030-6/30/2030
    753       753       753  
RH Land Construction, LLC & Harbor Dredging LA, Inc. (10)
  Construction & Engineering   8.08%   5/10/2023   5/10/2026     135       135       135  
Royal Coach Lines, Inc.(10)
  Road & Rail   9.56%   11/21/2019   8/1/2025     718       718       655  
Royal Express Inc. (10)
  Road & Rail   9.53%   1/17/2019   2/1/2024     291       292       291  
Rotten Rock Hardscaping & Tree Service (10)
  Diversified Consumer Services   8.21%   12/6/2022   12/6/2027     225       225       225  
Signet Marine Corporation (10)
  Transportation Infrastructure   8.50%   10/31/2022   11/1/2029     13,275       13,320       13,275  
SLR Equipment Finance(2)
  Multi-Sector Holdings   8.50%   1/24/2022   1/27/2024     2,500       2,500       2,500  
Smiley Lifting Solutions, LLC(10)
  Commercial Services & Supplies  
7.82-8.61%
  6/30/2022  
9/15/2026-6/27/2030
    6,297       6,297       6,297  
ST Coaches, LLC (10)
  Road & Rail  
8.47-8.58%
  7/31/2017  
7/1/2023-1/25/2025
    1,442       1,442       1,383  
Star Coaches Inc. (10)
  Road & Rail   8.42%   3/9/2018   4/1/2025     2,613       2,613       2,345  
Superior Transportation, Inc. (10)
  Road & Rail  
10.22-10.69%
  7/31/2017   1/1/2026     2,800       2,800       2,800  
The Smedley Company & Smedley Services, Inc. (10)
  Commercial Services & Supplies   4.07%   7/31/2017   1/15/2028     1,553       1,553       1,553  
Trinity Equipment Rentals, Inc. (10)
  Commercial Services & Supplies  
7.94-8.93%
  10/8/2021  
11/1/2024-12/1/2026
    1,939       1,939       1,939  
U.S. Crane & Rigging, LLC (10)
  Commercial Services & Supplies   10.92%   12/23/2022   3/1/2027     1,848       1,848       1,848  
Up Trucking Services, LLC (10)
  Road & Rail   11.21%   3/23/2018   8/1/2024     329       331       329  
Waste Pro of Florida, Inc. & Waste Pro USA, Inc. (10)
  Commercial Services & Supplies   9.17%   4/18/2023   4/18/2028     9,735       9,904       9,735  
Wind River Environmental, LLC (10)
  Diversified Consumer Services  
8.43-10.00%
  7/31/2019  
8/1/2024-10/5/2025
    461       462       461  
Womble Company, Inc. (10)
  Energy Equipment & Services   9.11%   12/27/2019   1/1/2025     300       300       289  
Worldwide Flight Services, Inc. (10)
  Transportation Infrastructure  
8.32-9.93%
  9/23/2022  
9/23/2027-6/23/2028
    2,426       2,463       2,426  
Zamborelli Enterprises Pacific Souther Foundation (10)
  Diversified Consumer Services   8.91%   12/7/2022   1/1/2027     644       650       644  
 
See notes to consolidated financial statements.
 
6
SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (unaudited) (continued)
June 30, 2023
(in thousands, except share/unit amounts)
 
Description
 
Industry
 
                        
   
Acquisition
Date
   
                
   
Shares/Units
   
Cost
   
Fair

Value
 
Equipment Financing (continued) —
             
SLR Equipment Finance Equity Interests (2)(9)(17)*
 
Multi-Sector Holdings
      7/31/2017         200       145,000       120,820  
           
 
 
   
 
 
 
Total Equipment Financing
           
$
296,905
 
 
$
271,333
 
           
 
 
   
 
 
 
 
Description
 
Industry
 
Interest Rate
(1)
   
Acquisition
Date
   
Maturity

Date
   
Par Amount
    
Cost
    
Fair

Value
 
Preferred Equity – 0.4%
               
SOINT, LLC (2)(3)(4)
  Aerospace & Defense     5.00 %
(11)
 
    6/8/2012       6/30/2025               $ 5,050      $ 3,801  
            
 
 
    
 
 
 
 
Description
 
Industry
 
                        
   
Acquisition
Date
   
                
   
Shares/Units
   
Cost
   
Fair

Value
 
Common Equity/Equity Interests/Warrants—59.9%
             
aTyr Pharma, Inc. Warrants *
  Pharmaceuticals       11/18/2016         6,347     $ 106     $     
Bayside Parent, LLC (27)*
  Health Care Providers & Services       5/31/2023         6,526       11,411       3,819  
CardioFocus, Inc. Warrants *
  Health Care Equipment & Supplies       3/31/2017         90       51           
Centrexion Therapeutics, Inc. Warrants *
  Pharmaceuticals       6/28/2019         289,102       136       51  
Conventus Orthopaedics, Inc. Warrants *
  Health Care Equipment & Supplies       6/15/2016         157,500       65           
Delphinus Medical Technologies, Inc. Warrants *
  Health Care Equipment & Supplies       8/18/2017         444,388       74       82  
Essence Group Holdings Corporation (Lumeris) Warrants *
  Health Care Technology       3/22/2017         260,000       129       341  
KBH Topco LLC (Kingsbridge) (2)(5)(18)
  Multi-Sector Holdings       11/3/2020         73,500,000       136,596       148,444  
Meditrina, Inc. Warrants *
  Health Care Equipment & Supplies       12/20/2022         29,366       23       19  
NSPC Holdings, LLC (National Spine) *
  Health Care Providers & Services       2/13/2023         207,043       657       403  
RD Holdco, Inc. (Rug Doctor) (2)*
  Diversified Consumer Services       12/23/2013         231,177       15,683           
RD Holdco, Inc. (Rug Doctor) Class B (2)*
  Diversified Consumer Services       12/23/2013         522       5,216           
RD Holdco, Inc. (Rug Doctor) Warrants (2)*
  Diversified Consumer Services       12/23/2013         30,370       381           
Senseonics Holdings, Inc. (3)(8)*
  Health Care Equipment & Supplies       7/25/2019         469,353       235       358  
SLR-AMI
Topco Blocker, LLC (27)(28)*
  Internet & Catalog Retail       6/16/2023                  7,014       8,897  
SLR Business Credit (2)(3)(19)
  Diversified Financial Services       4/1/2022         100       81,583       90,370  
SLR Credit Solutions (2)(3)(20)
  Diversified Financial Services       12/28/2012         280,303       280,737       279,000  
SLR Healthcare ABL (2)(3)(21)
  Diversified Financial Services       4/1/2022         32,839       34,335       34,850  
SLR Senior Lending Program LLC (2)(3)(25)
  Asset Management       12/1/2022                  20,750       20,995  
Spectrum Pharmaceuticals, Inc. Warrants *
  Biotechnology       9/21/2022         159,470       51       80  
Vapotherm, Inc. Warrants*
  Health Care Equipment & Supplies       2/18/2022         207,117       262       20  
Venus Concept Ltd. Warrants* (f/k/a Restoration Robotics)
  Health Care Equipment & Supplies       5/10/2018         2,230       152           
Vertos Medical, Inc. Warrants*
  Health Care Equipment & Supplies       6/14/2023         161,761       51       51  
           
 
 
   
 
 
 
Total Common Equity/Equity Interests/Warrants
           
$
595,698
 
 
$
587,780
 
       
 
 
   
 
 
 
Total Investments (6) — 222.4%
           
$
2,249,526
 
 
$
2,181,426
 
       
 
 
   
 
 
 
 
Description
 
Industry
 
                        
   
Acquisition
Date
   
Maturity

Date
   
Par Amount
               
Cash Equivalents — 34.0%
               
U.S. Treasury Bill
  Government       6/30/2023       8/10/2023     $ 335,000      $ 333,200      $ 333,200  
            
 
 
    
 
 
 
Total Investments & Cash Equivalents —256.4%
            
$
2,582,726
 
  
$
2,514,626
 
               
Liabilities in Excess of Other Assets — (156.4%)
                  (1,533,821
               
 
 
 
Net Assets — 100.0%
               
$
980,805
 
               
 
 
 
 
(1)
Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR” or “L”), the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of June 30, 2023.
(2)
Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (the “1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the six months ended June 30, 2023 in these controlled investments are as follows:
 
Name of Issuer
  
Fair Value at

December 31, 2022
    
Gross

Additions
    
Gross

Reductions
    
Realized
Gain
(Loss)
    
Change in
Unrealized
Gain
(Loss)
   
Interest/Dividend/Misc
Income
    
Fair Value at

June 30, 2023
 
Equipment Operating Leases, LLC
   $ 3,741      $         $ 224      $         $ 6     $ 156      $ 3,523  
Kingsbridge Holdings, LLC
     80,000                                      (46     4,875        80,000  
KBH Topco, LLC (Kingsbridge)
     148,444                                               7,000        148,444  
Loyer Capital LLC
     7,361                                               374        7,361  
RD Holdco, Inc. (Rug Doctor, common equity)
                                                                    
RD Holdco, Inc. (Rug Doctor, class B)
                                                                    
RD Holdco, Inc. (Rug Doctor, warrants)
                                                                    
RD Holdco, Inc. (debt)
     6,521        507                            221                 7,249  
SLR Business Credit
     89,370                                      1,000       3,500        90,370  
SLR Credit Solutions
     288,760                                      (9,760     10,000        279,000  
SLR Equipment Finance (equity)
     120,820                                                         120,820  
SLR Equipment Finance (debt)
     5,000        2,500        5,000                           120        2,500  
SLR Healthcare ABL
     34,350                                      500       1,730        34,850  
SLR Senior Lending Program LLC
     9,426        11,250                            319       57        20,995  
SOINT, LLC
     3,801        123                            (123     123        3,801  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
 
   $ 797,594      $ 14,380      $ 5,224      $         $ (7,883   $ 27,935      $ 798,913  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
 
 
See notes to consolidated financial statements.
 
7
SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (unaudited) (continued)
June 30, 2023
(in thousands)
 
(3)
Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making
follow-on
investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of June 30, 2023, on a fair value basis,
non-qualifying
assets in the portfolio represented 24.5% of the total assets of the Company.
(4)
The Company’s investment in SOINT, LLC includes a one dollar investment in common shares.
(5)
Kingsbridge Holdings, LLC is held through KBH Topco LLC, a Delaware corporation.
(6)
Aggregate net unrealized depreciation for U.S. federal income tax purposes is $3,002; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $154,967 and $157,969, respectively, based on a tax cost of $2,184,428. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.
(7)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR, SOFR or PRIME rate. These instruments are often subject to a LIBOR, SOFR or PRIME rate floor.
(8)
Denotes a Level 1 investment.
(9)
SLR Equipment Finance is held through NEFCORP LLC, a wholly-owned consolidated taxable subsidiary and NEFPASS LLC, a wholly-owned consolidated subsidiary.
(10)
Indicates an investment that is wholly held by the Company through NEFPASS LLC.
(11)
Interest is paid in kind (“PIK”).
(12)
Denotes a subsidiary of SLR Equipment Finance.
(13)
OmniGuide Holdings, Inc., Domain Surgical, Inc. and OmniGuide, Inc. are
co-borrowers.
(14)
AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each
co-Borrowers.
(15)
Spread is 1.00% Cash / 6.00% PIK.
(16)
Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SUNS SPV LLC (the “SUNS SPV”). Such investments are pledged as collateral under the Senior Secured Revolving SPV Credit Facility (the “SPV Credit Facility”) (see Note 7 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company.
(17)
See note 11 to the consolidated financial statements.
(18)
See note 13 to the consolidated financial statements.
(19)
See note 15 to the consolidated financial statements.
(20)
See note 9 to the consolidated financial statements.
(21)
See note 14 to the consolidated financial statements.
(22)
BridgeBio Pharma, Inc. may elect to defer up to 3.00% of the coupon as PIK.
(23) OmniGuide Holdings, Inc. may elect to defer up to 10.00% of the coupon as PIK.
(24) Vapotherm, Inc. may elect to defer up to 9.00% of the coupon as PIK.
(25)
See note 17 to the consolidated financial statements.
(26)
iCIMS, Inc. may elect to defer up to 3.875% of the coupon as PIK.
(27)
Denotes investments in which we are an “Affiliated Person” but not exercising a controlling influence, as defined in the 1940 Act, due to beneficially owning, either directly or through one or more controlled companies, more than 5% but less than 25% of the outstanding voting securities of the investment. Transactions during the six months ended June 30, 2023 (beginning with the date at which the Company became an Affiliated Person) in these affiliated investments are as follows:
 
Name of Issuer
  
Fair Value at

Date of
Affiliation(30)
    
Gross

Additions
    
Gross

Reductions
    
Realized
Gain
(Loss)
    
Change in
Unrealized
Gain (Loss)
   
Interest
Income
    
Fair Value at

June 30, 2023
 
AmeriMark Intermediate Holdings, LLC
   $         $ 464      $         $         $        $         $ 464  
AmeriMark Intermediate Holdings, LLC
     9,371                                      (4,237               5,134  
Bayside Opco, LLC
     846                                               9        846  
Bayside Opco, LLC
     18,224                                               194        18,224  
Bayside Parent, LLC (loan)
     4,773                                               62        4,773  
Bayside Parent, LLC (equity)
     4,681                                      (862               3,819  
SLR-AMI
Topco Blocker, LLC
     7,014                                      1,883                 8,897  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
 
   $ 44,909      $ 464      $         $         $ (3,216   $ 265      $ 42,157  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
 
 
(28)
Through this entity and other intermediate entities, the Company owns approximately 7.3% of the underlying common units of ASC Holdco, LLC, a joint venture which owns certain assets of the former Amerimark Interactive, LLC.
(29)
Kaseya, Inc. may elect to defer up to 2.50% of the coupon as PIK.
(30)
The Company became an Affiliated Person to Bayside Opco, LLC and Bayside Parent, LLC on May 31, 2023 and to Amerimark Intermediate Holdings, LLC and
SLR-AMI
Topco Blocker, LLC on June 16, 2023.
*
Non-income
producing security.
**
Investment is on
non-accrual
status.
 
See notes to consolidated financial statements.
 
8

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (unaudited) (continued)
June 30, 2023
(in thousands)
 
Industry Classification
  
Percentage of Total

Investments (at fair value) as

of June 30, 2023
 
Diversified Financial Services (includes SLR Credit Solutions, SLR Business Credit and SLR Healthcare ABL)
     21.0
Multi-Sector Holdings (includes Kingsbridge Holdings, LLC, SLR Equipment Finance, Equipment Operating Leases, LLC and Loyer Capital LLC)
     16.6
Health Care Providers & Services
     10.7
Health Care Equipment & Supplies
     6.6
Pharmaceuticals
     5.5
Insurance
     4.2
Software
     4.0
Biotechnology
     3.8
Diversified Consumer Services
     3.6
Capital Markets
     2.0
Commercial Services & Supplies
     1.7
Media
     1.4
Thrifts & Mortgage Finance
     1.4
Personal Products
     1.4
Road & Rail
     1.4
Auto Parts & Equipment
     1.2
Packaged Foods & Meats
     1.1
Life Sciences Tools & Services
     1.1
Wireless Telecommunication Services
     1.1
Asset Management
     1.0
Internet Software & Services
     0.9
Building Products
     0.9
Health Care Technology
     0.7
Transportation Infrastructure
     0.7
Internet & Catalog Retail
     0.7
Communications Equipment
     0.6
Trading Companies & Distributors
     0.6
IT Services
     0.5
Leisure Equipment & Products
     0.5
Specialty Retail
     0.5
Hotels, Restaurants & Leisure
     0.3
Auto Components
     0.3
Aerospace & Defense
     0.3
Oil, Gas & Consumable Fuels
     0.3
Footwear
     0.2
Airlines
     0.2
Machinery
     0.2
Food Products
     0.2
Metals & Mining
     0.2
Water Utilities
     0.1
Food & Staples Retailing
     0.1
Construction & Engineering
     0.1
Consumer Finance
     0.1
Energy Equipment & Services
     0.0
Containers & Packaging
     0.0
  
 
 
 
Total Investments
     100.0
  
 
 
 
 
See notes to consolidated financial statements.
 
9

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS
December 31, 2022
(in thousands, except share/unit amounts)
 
Description
 
Industry
 
Spread
Above
Index
(7)
   
Floor
   
Interest
Rate
(1)
   
Acquisition
Date
   
Maturity

Date
   
Par Amount
   
Cost
   
Fair

Value
 
Senior Secured Loans — 124.6%
                 
First Lien Bank Debt/Senior Secured Loans
                 
Aegis Toxicology Sciences Corporation(16)
  Health Care Providers & Services     L+550       1.00     10.09     5/7/2018       5/9/2025     $ 17,103     $ 16,793     $ 17,103  
All State Ag Parts, LLC(16)
  Trading Companies & Distributors     S+575       1.00     10.19     4/1/2022       9/1/2026       4,197       4,081       4,197  
American Teleconferencing Services, Ltd.**
  Communications Equipment     L+650       1.00              5/5/2016       9/9/2021       36,135       25,926           
American Teleconferencing Services, Ltd.**
  Communications Equipment     L+650       1.00              9/17/2021       1/31/2023       6,405       6,254       224  
AmeriMark Intermediate Holdings, LLC(14)
  Internet & Catalog Retail     L+800       1.00     14.77     7/28/2021       10/15/2026       24,087       23,711       22,882  
Apex Services Partners, LLC(16)
  Diversified Consumer Services     S+525       1.00     9.80     8/31/2022       7/31/2025       14,021       13,644       14,021  
Atria Wealth Solutions, Inc.(16)
  Diversified Financial Services     S+600       1.00     10.84     9/14/2018       2/29/2024       8,149       8,107       8,149  
Basic Fun, Inc.(16)
  Specialty Retail     L+550       1.00     10.27     10/30/2020       10/30/2023       2,162       2,152       2,162  
BayMark Health Services, Inc.(16)
  Health Care Providers & Services     L+500       1.00     9.73     4/1/2022       6/11/2027       9,432       9,078       9,432  
BDG Media, Inc
  Media     L+900       0.25     13.17     7/18/2022       4/27/2023       14,454       14,454       14,454  
CC SAG Holdings Corp. (Spectrum Automotive)(16)
  Diversified Consumer Services     L+575       0.75     10.48     6/29/2021       6/29/2028       20,427       20,057       20,427  
Composite Technology Acquisition
Corp.(16)
  Building Products     L+475       1.00     9.73     4/1/2022       2/1/2025       10,386       9,983       10,386  
Copper River Seafoods, Inc.
  Food Products     P+275                10.25     8/31/2022       4/23/2025       8,405       8,405       8,405  
DeepIntent, Inc.
  Media     P+175                9.25     10/12/2022       3/25/2025       16,951       16,951       16,951  
Enhanced Permanent Capital, LLC(3)
  Capital Markets     L+700       1.00     10.13     12/29/2020       12/29/2025       35,205       34,496       35,205  
ENS Holdings III Corp. & ES Opco USA LLC (Bluefin)(16)
  Trading Companies & Distributors     S+475       1.00     9.43     4/1/2022       12/31/2025       4,978       4,804       4,978  
Enverus Holdings, Inc. (fka Drilling Info Holdings)(16)
  IT Services     L+450                8.88     4/1/2022       7/30/2025       11,598       11,129       11,598  
Erie Construction
Mid-west,
LLC(16)
  Building Products     S+475       1.00     9.79     4/1/2022       7/30/2027       8,915       8,580       8,915  
Foundation Consumer Brands, LLC(16)
  Personal Products     L+550       1.00     10.15     2/12/2021       2/12/2027       35,273       34,421       35,273  
GSM Acquisition Corp.(16)
  Leisure Equipment & Products     S+500       1.00     9.03     4/1/2022       11/16/2026       11,022       10,562       10,912  
Higginbotham Insurance Agency, Inc.(16)
  Insurance     L+525       0.75     9.63     4/1/2022       11/25/2026       6,223       5,994       6,223  
High Street Buyer, Inc.(16)
  Insurance     L+600       0.75     10.73     4/1/2022       4/16/2028       5,188       4,900       5,188  
Human Interest Inc
  Internet Software & Services     S+785       1.00     11.97     6/30/2022       7/1/2027       20,104       19,783       20,104  
iCIMS, Inc.
  Software     S+725       0.75     11.52 %
(26)
 
    8/18/2022       8/18/2028       32,084       31,548       31,522  
Ivy Fertility Services, LLC
  Health Care Providers & Services     L+625       1.00     10.39     12/22/2021       2/25/2026       30,092       29,415       30,393  
Kaseya, Inc.(16)
  Software     S+575       0.75     10.33     6/22/2022       6/23/2029       32,426       31,966       32,426  
Kid Distro Holdings, LLC (Distro Kid)(16)
  Software     L+575       1.00     10.48     9/24/2021       10/1/2027       26,452       26,015       26,452  
Kingsbridge Holdings, LLC(2)
  Multi-Sector Holdings     L+700       1.00     10.75     12/21/2018       12/21/2024       80,000       79,800       80,000  
KORE Wireless Group, Inc.(16)
  Wireless Telecommunication Services     S+550                10.08     12/21/2018       12/21/2024       23,588       23,123       23,588  
Logix Holding Company, LLC(16)
  Communications Equipment     L+575       1.00     10.13     9/14/2018       12/22/2024       14,009       13,246       13,449  
Luxury Asset Capital, LLC(16)
  Thrifts & Mortgage Finance     S+675       1.00     10.99     7/15/2022       7/15/2027       27,500       26,991       27,500  
Maurices, Incorporated(16)
  Specialty Retail     S+675       1.00     8.74     8/27/2021       6/1/2024       7,808       7,678       7,808  
Montefiore Nyack Hospital
  Health Care Providers & Services     L+495                9.72     8/9/2022       11/15/2024       3,966       3,966       3,966  
NAC Holdings Corporation (Jaguar)(16)
  Insurance     S+525       1.00     9.45     7/30/2021       9/28/2024       28,603       28,214       28,603  
National Spine and Pain Centers, LLC
  Health Care Providers & Services     L+500       1.00     7.31     4/1/2022       6/2/2024       2,681       2,564       2,547  
One Touch Direct, LLC
  Commercial Services & Supplies     P+75                8.25     4/3/2020       3/30/2024       4,431       4,431       4,431  
Orthopedic Care Partners Management, LLC
  Health Care Providers & Services     S+650       1.00     10.91     8/17/2022       5/16/2024       3,111       3,092       3,111  
Pediatric Home Respiratory Services, LLC
  Health Care Providers & Services     S+625       1.00     10.67     8/19/2022       12/4/2024       1,327       1,309       1,313  
Peter C. Foy & Associates Insurance Services, LLC
  Insurance     S+600       0.75     10.44     4/1/2022       11/1/2028       10,854       10,699       10,854  
PhyNet Dermatology LLC
  Health Care Providers & Services     S+625
(15)
 
    1.00     9.81     9/5/2018       8/16/2024       14,458       14,420       14,458  
Pinnacle Treatment Centers, Inc.(16)
  Health Care Providers & Services     S+650       1.00     10.57     1/22/2020       1/2/2026       27,997       27,528       27,367  
Plastics Management, LLC(16)
  Health Care Providers & Services     S+500       1.00     9.89     4/1/2022       8/18/2027       9,491       9,161       9,491  
PPT Management Holdings, LLC(16)
  Health Care Providers & Services     L+850
(11)
 
    1.00     12.83     9/14/2018       1/30/2023       32,163       31,987       25,827  
RQM+ Corp.(16)
  Life Sciences Tools & Services     S+575       1.00     10.97     8/20/2021       8/12/2026       26,823       26,455       26,823  
RSC Acquisition, Inc.(16)
  Insurance     S+550       0.75     9.26     4/1/2022       11/1/2026       6,985       6,813       6,985  
RxSense Holdings LLC(16)
  Diversified Consumer Services     L+500       1.00     9.41     4/1/2022       3/13/2026       11,775       11,357       11,775  
SCP Eye Care, LLC
  Health Care Providers & Services     S+575       1.00     9.46     10/6/2022       10/5/2029       8,314       8,050       8,044  
SHO Holding I Corporation (Shoes for Crews)(16)
  Footwear     L+523       1.00     9.66     4/1/2022       4/27/2024       5,704       5,361       5,419  
Southern Orthodontic Partners Management, LLC(16)
  Health Care Providers & Services     S+600       1.00     10.77     6/3/2022       1/27/2026       1,399       1,387       1,399  
SPAR Marketing Force, Inc.
  Media     P+95                8.45     7/18/2022       10/10/2024       9,162       9,162       9,162  
Stryten Resources LLC
  Auto Parts & Equipment     S+800       1.00     12.44     8/11/2021       10/12/2026       25,922       25,506       25,922  
SunMed Group Holdings, LLC(16)
  Health Care Equipment & Supplies     L+575       0.75     10.48     6/16/2021       6/16/2028       24,953       24,446       24,953  
TAUC Management, LLC(16)
  Health Care Providers & Services     L+525       1.00     9.98     4/1/2022       2/12/2027       6,899       6,585       6,864  
Tilley Distribution, Inc.(16)
  Trading Companies & Distributors     S+550       1.00     10.14     4/1/2022       12/31/2026       9,996       9,527       9,996  
Ultimate Baked Goods Midco LLC (Rise Baking)(16)
  Packaged Foods & Meats     L+650       1.00     10.88     8/12/2021       8/13/2027       24,789       24,038       24,789  
Vessco Midco Holdings, LLC(16)
  Water Utilities     L+450       1.00     7.87     4/1/2022       11/2/2026       1,728       1,668       1,728  
World Insurance Associates, LLC(16)
  Insurance     S+575       1.00     9.31     4/1/2022       4/1/2026       31,624       30,785       30,359  
               
 
 
   
 
 
 
Total First Lien Bank Debt/Senior Secured Loans
                $ 912,558     $ 886,513  
 
 
 
   
 
 
 
Second Lien Asset-Based Senior Secured Loans
                 
ACRES Commercial Mortgage, LLC
  Diversified Financial Services     S+705       1.00     11.38     12/24/2021       8/21/2028       29,925     $ 29,398     $ 29,925  
               
 
 
   
 
 
 
Second Lien Bank Debt/Senior Secured Loans
                 
RD Holdco, Inc.** (2)
  Diversified Consumer Services     S+975
(11)
 
    1.00              12/23/2013       10/12/2026       13,043     $ 11,791     $ 6,521  
               
 
 
   
 
 
 
 
See notes to consolidated financial statements.
 
10
SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2022
(in thousands, except share/unit amounts)
 
Description
 
Industry
 
Spread
Above
Index
(7)
   
Floor
   
Interest
Rate
(1)
   
Acquisition
Date
   
Maturity

Date
   
Par Amount
   
Cost
   
Fair

Value
 
Senior Secured Loans (continued) —
                 
First Lien Life Science Senior Secured Loans
                 
Alimera Sciences, Inc.(16)
  Pharmaceuticals     L+765       1.78     11.82     12/31/2019       7/1/2024     $ 23,159     $ 23,894     $ 24,433  
Apeel Technology, Inc
  Biotechnology     S+625       1.00     8.75     6/29/2022       6/1/2027       3,643       3,620       3,643  
Arcutis Biotherapeutics, Inc.(3)
  Pharamceuticals     L+745       0.10     11.62     12/22/2021       1/1/2027       66,849       67,077       67,685  
Ardelyx, Inc.(3)
  Pharmaceuticals     L+795       0.10     12.12     2/23/2022       3/1/2027       9,475       9,437       9,499  
BridgeBio Pharma, Inc.(3)
  Biotechnology                       9.00 %
(22)
 
    11/17/2021       11/17/2026       39,839       39,340       39,839  
Centrexion Therapeutics, Inc.
  Pharmaceuticals     L+725       2.45     11.42     6/28/2019       1/1/2024       11,844       12,372       12,555  
Cerapedics, Inc.
  Biotechnology     S+620       2.75     10.52     12/27/2022       1/1/2028       26,939       26,874       26,872  
Glooko, Inc.(16)
  Health Care Technology     L+790       0.10     12.07     9/30/2021       10/1/2026       15,883       15,867       15,922  
Meditrina, Inc.
  Health Care Equipment & Supplies     S+550       3.45     9.82     12/20/2022       12/1/2027       3,367       3,338       3,359  
Neuronetics, Inc.(16)
  Health Care Equipment & Supplies     L+765       1.66     11.82     3/2/2020       2/28/2025       18,012       18,450       19,003  
OmniGuide Holdings, Inc. (13)
  Health Care Equipment & Supplies     L+1405       0.10     18.22 %
(23)
 
    7/30/2018       7/1/2023       19,201       19,380       19,777  
Outset Medical, Inc.(3)
  Health Care Equipment & Supplies     S+515       2.75     9.33     11/3/2022       11/1/2027       35,084       34,880       34,820  
Spectrum Pharmaceuticals, Inc.(16)
  Biotechnology     S+570       2.30     9.88     9/21/2022       9/1/2027       10,525       10,406       10,420  
Vapotherm, Inc.
  Health Care Equipment & Supplies     S+830       1.00     12.58 %
(24)
 
    2/18/2022       2/1/2027       34,455       34,270       34,628  
               
 
 
   
 
 
 
Total First Lien Life Science Senior Secured Loans
 
  $ 319,205     $ 322,455  
 
 
 
   
 
 
 
Total Senior Secured Loans
 
 
$
1,272,952
 
 
$
1,245,414
 
 
 
 
   
 
 
 
 
Description
 
Industry
   
Interest
Rate
(1)
   
Acquisition
Date
   
Maturity

Date
   
Par Amount
   
Cost
   
Fair

Value
 
Equipment Financing — 26.6%
             
Aero Operating LLC (10)
    Commercial Services & Supplies      
8.47-9.64%
      2/12/2021      
3/1/2025-12/1/2026
    $ 2,264     $ 2,262     $ 2,262  
AFG Dallas III, LLC (10)
    Diversified Consumer Services       10.00%       8/11/2022      
8/11/2026-8/29/2026
      1,036       1,036       1,036  
Air Methods Corporation (10)
    Airlines      
7.08-7.13%
      11/3/2021      
11/3/2026-11/23/2026
      3,600       3,660       3,600  
AmeraMex International, Inc. (10)
    Commercial Services & Supplies       10.00%       3/29/2019       9/15/2024       1,059       1,059       1,069  
Bazzini, LLC (10)
    Food & Staples Retailing       10.46%       12/23/2022       1/1/2028       2,365       2,440       2,365  
Boart Longyear Company (10)
    Metals & Mining      
8.31-10.44%
      5/28/2020      
7/1/2024-10/7/2026
      4,568       4,568       4,568  
Bowman Energy Solutions, LLC (10)
    Commercial Services & Supplies       7.42%       7/1/2022       8/1/2026       153       153       153  
C-Port/Stone
LLC (10)
    Oil, Gas & Consumable Fuels       8.54%       10/7/2022       11/1/2027       6,708       6,514       6,507  
Capital City Jet Center, Inc. (10)
    Airlines       10.00%       4/4/2018      
10/4/2023-6/22/2026
      2,241       2,241       2,214  
Champion Air, LLC (10)
    Airlines       10.00%       3/19/2018       1/1/2023       1,055       1,055       1,055  
CKD Holdings, Inc. (10)
    Road & Rail      
8.10-8.60%
      9/22/2022      
3/22/2026-9/22/2027
      3,690       3,690       3,690  
Clubcorp Holdings, Inc. (10)
    Hotels, Restaurants & Leisure      
9.36-13.01%
      5/27/2021      
4/1/2025-1/1/2028
      6,539       6,539       6,539  
Dongwon Autopart Technology Inc. (10)
    Auto Components       7.96%       2/2/2021       1/1/2026       1,828       1,849       1,828  
Drillers Choice, Inc. (10)
    Commercial Services & Supplies       8.00%       10/31/2022       11/1/2027       1,589       1,589       1,589  
EasyPak, LLC (10)
    Containers & Packaging       9.01%       1/6/2021       1/1/2024       276       276       276  
Energy Drilling Services, LLC (10)
    Diversified Consumer Services      
6.58-9.16%
      8/26/2022      
12/9/2025-9/1/2027
      1,321       1,321       1,295  
Environmental Protection & Improvement Company, LLC (10)
    Road & Rail       8.25%       9/30/2020       10/1/2027       5,270       5,300       5,270  
Equipment Operating Leases, LLC (2)(12)
    Multi-Sector Holdings       8.37%       4/27/2018       4/27/2025       3,837       3,837       3,741  
First American Commercial Bancorp, Inc. (10)
    Diversified Financial Services      
7.50-9.02%
      10/28/2021      
10/1/2026-3/1/2027
      2,938       2,941       2,938  
First National Capital, LLC (10)
    Diversified Financial Services       9.00%       11/5/2021       8/1/2026       7,116       7,116       7,116  
Freightsol LLC (10)
    Road & Rail      
12.51-12.89%
      4/9/2019       11/1/2023       779       784       779  
Garda CL Technical Services, Inc. (10)
    Commercial Services & Supplies      
8.30-8.77%
      3/22/2018      
6/5/2023-10/5/2023
      469       469       468  
Georgia Jet, Inc. (10)
    Airlines       8.00%       12/4/2017       1/4/2024       425       425       425  
GMT Corporation (10)
    Machinery       10.71%       10/23/2018       1/1/2026       4,801       4,806       4,801  
Hawkeye Contracting Company, LLC (10)
    Construction & Engineering       10.50%       10/8/2021       11/1/2025       997       997       997  
HTI Logistics Corporation (10)
    Commercial Services & Supplies      
9.69-9.94%
      11/15/2018      
5/1/2024-9/1/2025
      290       290       283  
International Automotive Components Group, North America, Inc. (10)
    Auto Components       7.95%       6/23/2021       6/23/2025       6,072       6,109       5,951  
Kool Pak, LLC (10)
    Road & Rail       8.58%       2/5/2018       3/1/2024       194       194       194  
Loc Performance Products, LLC (10)
    Machinery       10.50%       12/29/2022       6/1/2027       767       767       767  
Loyer Capital LLC (2)(12)
    Multi-Sector Holdings      
8.73-11.52%
      5/16/2019      
5/16/2024-9/25/2024
      7,500       7,500       7,361  
Lux Credit Consultants, LLC (10)
    Road & Rail      
8.28-12.09%
      6/17/2021      
12/1/2024-12/1/2026
      16,411       16,411       16,411  
Lux Vending, LLC (10)
    Consumer Finance      
12.46-13.26%
      8/20/2021      
8/20/2024-10/1/2024
      1,638       1,663       1,638  
Mountain Air Helicopters, Inc. (10)
    Commercial Services & Supplies       10.00%       7/31/2017       2/28/2025       369       368       369  
Ozzies, Inc. (10)
    Commercial Services & Supplies       10.72%       12/23/2022       1/1/2027       2,005       2,072       2,005  
PCX Aerostructures LLC (10)
    Aerospace & Defense       9.32%       11/23/2022       12/1/2028       2,658       2,658       2,658  
Rane Light Metal Castings Inc. (10)
    Machinery       10.00%       6/1/2020       6/1/2024       159       159       159  
Rango, Inc. (10)
    Commercial Services & Supplies      
9.33-9.79%
      9/24/2019      
4/1/2023-11/1/2024
      1,940       1,960       1,904  
Royal Coach Lines, Inc.(10)
    Road & Rail       9.56%       11/21/2019       8/1/2025       849       849       775  
Royal Express Inc. (10)
    Road & Rail       9.53%       1/17/2019       2/1/2024       428       431       428  
Rotten Rock Hardscaping & Tree Service (10)
    Diversified Consumer Services       8.21%       12/6/2022       12/6/2027       245       245       245  
Signet Marine Corporation (10)
    Transportation Infrastructure       8.50%       10/31/2022       7/1/2029       14,102       14,152       14,102  
SLR Equipment Finance(2)
    Multi-Sector Holdings       8.50%       1/24/2022       1/24/2023       5,000       5,000       5,000  
Smiley Lifting Solutions, LLC(10)
    Commercial Services & Supplies      
7.82-8.28%
      6/30/2022      
9/15/2026-12/29/2029
      4,139       4,139       4,139  
ST Coaches, LLC (10)
    Road & Rail      
8.47-8.58%
      7/31/2017      
7/1/2023-1/25/2025
      1,521       1,521       1,459  
Star Coaches Inc. (10)
    Road & Rail       8.42%       3/9/2018       4/1/2025       2,887       2,887       2,591  
Superior Transportation, Inc. (10)
    Road & Rail      
10.22-10.63%
      7/31/2017       1/1/2026       3,369       3,369       3,369  
The Smedley Company & Smedley Services, Inc. (10)
    Commercial Services & Supplies       4.07%       7/31/2017       1/15/2028       1,706       1,706       1,706  
Trinity Equipment Rentals, Inc. (10)
    Commercial Services & Supplies      
7.94-8.75%
      10/8/2021      
11/1/2024-12/1/2026
      577       577       577  
U.S. Crane & Rigging, LLC (10)
    Commercial Services & Supplies       10.92%       12/23/2022       3/1/2027       2,005       2,005       2,005  
Up Trucking Services, LLC (10)
    Road & Rail       11.21%       3/23/2018       8/1/2024       469       473       469  
Wind River Environmental, LLC (10)
    Diversified Consumer Services      
8.43-10.00%
      7/31/2019      
8/1/2024-10/5/2025
      604       605       604  
Womble Company, Inc. (10)
    Energy Equipment & Services       9.11%       12/27/2019       1/1/2025       386       386       371  
Worldwide Flight Services, Inc. (10)
    Transportation Infrastructure      
8.32-9.36%
      9/23/2022      
9/23/2027-10/28/2027
      304       308       304  
Zamborelli Enterprises Pacific Souther Foundation (10)
    Diversified Consumer Services       8.91%       12/7/2022       1/1/2027       707       714       707  
                           
Shares/Units
             
SLR Equipment Finance Equity Interests
(2)(9)(17)*
    Multi-Sector Holdings         7/31/2017         200       145,000       120,820  
           
 
 
   
 
 
 
Total Equipment Financing
           
$
291,445
 
 
$
265,952
 
           
 
 
   
 
 
 
 
See notes to consolidated financial statements.
 
11
SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2022
(in thousands, except share/unit amounts)
 
Description
 
Industry
   
Interest
Rate
(1)
   
Acquisition
Date
   
 
   
Maturity

Date
   
Par Amount
   
Cost
   
Fair

Value
 
Preferred Equity – 0.4%
               
SOINT, LLC (2)(3)(4)
    Aerospace &
Defense
 
 
    5.00%
(11)
      6/8/2012         6/30/2023       49,273     $ 4,927     $ 3,801  
             
 
 
   
 
 
 
 
Description
 
Industry
   
Acquisition
Date
   
Shares/Units
   
Cost
   
Fair

Value
 
Common Equity/Equity Interests/Warrants—57.1%
         
aTyr Pharma, Inc. Warrants *
    Pharmaceuticals       11/18/2016       6,347     $ 106     $     
CardioFocus, Inc. Warrants *
    Health Care Equipment & Supplies       3/31/2017       90       51           
Centrexion Therapeutics, Inc. Warrants *
    Pharmaceuticals       6/28/2019       289,102       136       82  
Conventus Orthopaedics, Inc. Warrants *
    Health Care Equipment &
Supplies
 
 
    6/15/2016       157,500       65           
Delphinus Medical Technologies, Inc. Warrants *
    Health Care Equipment &
Supplies
 
 
    8/18/2017       444,388       74       103  
Essence Group Holdings Corporation (Lumeris) Warrants *
    Health Care Technology       3/22/2017       260,000       129       366  
KBH Topco LLC (Kingsbridge) (2)(5)(18)
    Multi-Sector Holdings       11/3/2020       73,500,000       136,596       148,444  
Meditrina, Inc. Warrants *
    Health Care Equipment &
Supplies
 
 
    12/20/2022       29,366       23       23  
RD Holdco, Inc. (Rug Doctor) (2)*
    Diversified Consumer Services       12/23/2013       231,177       15,683           
RD Holdco, Inc. (Rug Doctor) Class B (2)*
    Diversified Consumer Services       12/23/2013       522       5,216           
RD Holdco, Inc. (Rug Doctor) Warrants (2)*
    Diversified Consumer Services       12/23/2013       30,370       381           
Senseonics Holdings, Inc. (3)(8)*
    Health Care Equipment &
Supplies
 
 
    7/25/2019       469,353       235       483  
SLR Business Credit (2)(3)(19)
    Diversified Financial Services       4/1/2022       100       81,583       89,370  
SLR Credit Solutions (2)(3)(20)
    Diversified Financial Services       12/28/2012       280,303       280,737       288,760  
SLR Healthcare ABL (2)(3)(21)
    Diversified Financial Services       4/1/2022       32,839       34,335       34,350  
SLR Senior Lending Program LLC (2)(3)(25)
    Asset Management       12/1/2022                9,500       9,426  
Spectrum Pharmaceuticals, Inc. Warrants *
    Biotechnology       9/21/2022       159,470       51       15  
Vapotherm, Inc. Warrants*
    Health Care Equipment &
Supplies
 
 
    2/18/2022       36,996       210       87  
Venus Concept Ltd. Warrants* (f/k/a Restoration Robotics)
    Health Care Equipment &
Supplies
 
 
    5/10/2018       33,430       152           
       
 
 
   
 
 
 
Total Common Equity/Equity Interests/Warrants
 
     
$
565,263
 
 
$
571,509
 
     
 
 
   
 
 
 
Total Investments (6) — 208.7%
 
     
$
2,134,587
 
 
$
2,086,676
 
     
 
 
   
 
 
 
 
Description
  
Industry
    
Acquisition
Date
    
Maturity

Date
    
Par Amount
               
Cash Equivalents — 41.8%
                 
U.S. Treasury Bill
     Government        12/30/2022        2/23/2023      $ 420,000      $ 417,590      $ 417,590  
              
 
 
    
 
 
 
Total Investments & Cash Equivalents —250.5%
              
$
2,552,177
 
  
$
2,504,266
 
Liabilities in Excess of Other Assets — (150.5%)
                    (1,504,535
                 
 
 
 
Net Assets — 100.0%
                 
$
999,731
 
                 
 
 
 
 
(1)
Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR” or “L”), the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of December 31, 2022.
(2)
Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (“1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2022 in these controlled investments are as follows:
 
Name of Issuer
  
Fair Value at

December 31, 2021
    
Gross

Additions
    
Gross

Reductions
    
Realized
Gain
(Loss)
    
Change in
Unrealized
Gain (Loss)
   
Interest/Dividend
Income
   
Fair Value at

December 31, 2022
 
Equipment Operating Leases, LLC
   $ 18,939      $         $ 15,833      $         $ 635     $ 749     $ 3,741  
Kingsbridge Holdings, LLC
     80,000                                      (87     7,402       80,000  
KBH Topco, LLC (Kingsbridge)
     145,996                                      2,448       15,225       148,444  
Loyer Capital LLC
     10,725                  3,500                  136       1,003       7,361  
RD Holdco, Inc. (Rug Doctor, common equity)
                                                                   
RD Holdco, Inc. (Rug Doctor, class B)
     5,216                                      (5,216                  
RD Holdco, Inc. (Rug Doctor, warrants)
                                                                   
RD Holdco, Inc. (debt)
     11,829      685                            (5,280     (18     6,521  
SLR Business Credit
               81,583                            7,787       5,150       89,370  
SLR Credit Solutions
     298,766                                      (10,006     20,500       288,760  
SLR Equipment Finance (equity)
     129,102                                      (8,282              120,820  
SLR Equipment Finance (debt)
               5,000                                     379       5,000  
SLR Healthcare ABL
               34,335                            15       2,595       34,350  
SLR Senior Lending Program LLC
               9,500                            (74              9,426  
SOAGG LLC
     1,121                  447                  (674     647           
SOINT, LLC
     4,509        266        942                  (32     266       3,801  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
   $ 706,203      $ 131,369      $ 20,722      $         $ (18,630   $ 53,898     $ 797,594  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
 
See notes to consolidated financial statements.
 
12
SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2022
(in thousands)
 
(3)
Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making
follow-on
investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2022, on a fair value basis,
non-qualifying
assets in the portfolio represented 24.2% of the total assets of the Company.
(4)
The Company’s investment in SOINT, LLC includes a one dollar investment in common shares.
(5)
Kingsbridge Holdings, LLC is held through KBH Topco LLC, a Delaware corporation.
(6)
Aggregate net unrealized appreciation for U.S. federal income tax purposes is $17,187; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $161,053 and $143,866, respectively, based on a tax cost of $2,069,489. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.
(7)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR, SOFR or PRIME rate. These instruments are often subject to a LIBOR, SOFR or PRIME rate floor.
(8)
Denotes a Level 1 investment.
(9)
SLR Equipment Finance is held through NEFCORP LLC, a wholly-owned consolidated taxable subsidiary and NEFPASS LLC, a wholly-owned consolidated subsidiary.
(10)
Indicates an investment that is wholly held by the Company through NEFPASS LLC.
(11)
Interest is paid in kind (“PIK”).
(12)
Denotes a subsidiary of SLR Equipment Finance.
(13)
OmniGuide Holdings, Inc., Domain Surgical, Inc. and OmniGuide, Inc. are
co-borrowers.
(14)
AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each
co-Borrowers.
Amerimark may elect to defer up to 8.00% of the coupon as PIK.
(15)
Spread is 5.75% Cash / 0.50% PIK.
(16)
Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SUNS SPV LLC (the “SUNS SPV”). Such investments are pledged as collateral under the Senior Secured Revolving SPV Credit Facility (the “SPV Credit Facility”) (see Note 7 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company.
(17)
See note 11 to the consolidated financial statements.
(18)
See note 13 to the consolidated financial statements.
(19)
See note 15 to the consolidated financial statements.
(20)
See note 9 to the consolidated financial statements.
(21)
See note 14 to the consolidated financial statements.
(22)
BridgeBio Pharma, Inc. may elect to defer up to 3.00% of the coupon as PIK.
(23) OmniGuide Holdings, Inc. may elect to defer up to 10.00% of the coupon as PIK.
(24) Vapotherm, Inc. may elect to defer up to 8.00% of the coupon as PIK.
(25)
See note 17 to the consolidated financial statements.
(26)
iCIMS, Inc. may elect to defer up to 3.875% of the coupon as PIK.
*
Non-income
producing security.
**
Investment is on
non-accrual
status.
 
See notes to consolidated financial statements.
 
13

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2022
(in thousands)
 
Industry Classification
  
Percentage of Total

Investments (at fair value) as

of December 31, 2022
 
Diversified Financial Services (includes SLR Credit Solutions, SLR Business Credit and SLR Healthcare ABL)
     22.1
Multi-Sector Holdings (includes Kingsbridge Holdings, LLC, SLR Equipment Finance, Equipment Operating Leases, LLC and Loyer Capital LLC)
     17.5
Health Care Providers & Services
     7.7
Health Care Equipment & Supplies
     6.6
Pharmaceuticals
     5.5
Software
     4.3
Insurance
     4.2
Biotechnology
     3.9
Diversified Consumer Services
     2.7
Media
     1.9
Road & Rail
     1.7
Personal Products
     1.7
Capital Markets
     1.7
Thrifts & Mortgage Finance
     1.3
Life Sciences Tools & Services
     1.3
Auto Parts & Equipment
     1.2
Packaged Foods & Meats
     1.2
Wireless Telecommunication Services
     1.1
Commercial Services & Supplies
     1.1
Internet & Catalog Retail
     1.1
Internet Software & Services
     1.0
Building Products
     0.9
Trading Companies & Distributors
     0.9
Health Care Technology
     0.8
Transportation Infrastructure
     0.7
Communications Equipment
     0.7
IT Services
     0.6
Leisure Equipment & Products
     0.5
Specialty Retail
     0.5
Asset Management
     0.5
Food Products
     0.4
Auto Components
     0.4
Airlines
     0.3
Hotels, Restaurants & Leisure
     0.3
Oil, Gas & Consumable Fuels
     0.3
Aerospace & Defense
     0.3
Machinery
     0.3
Footwear
     0.3
Metals & Mining
     0.2
Food & Staples Retailing
     0.1
Water Utilities
     0.1
Consumer Finance
     0.1
Construction & Engineering
     0.0
Energy Equipment & Services
     0.0
Containers & Packaging
     0.0
  
 
 
 
Total Investments
     100.0
  
 
 
 
 
See notes to consolidated financial statements.
 
14

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
June 30, 2023
(in thousands, except share amounts)
Note 1. Organization
SLR Investment Corp. (the “Company”, “SLRC”, “we”, “us” or “our”), a Maryland corporation formed in November 2007, is a
closed-end,
externally managed,
non-diversified
management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). Furthermore, as the Company is an investment company, it continues to apply the guidance in FASB Accounting Standards Codification (“ASC”) Topic 946. In addition, for U.S. federal income tax purposes, the Company has elected to be treated, and intends to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).
On February 9, 2010, the Company priced its initial public offering, selling 5.68 million shares of common stock, including the underwriters’ over-allotment, at a price of $18.50 per share. Concurrent with this offering, the Company’s senior management purchased an additional 600,000 shares through a private placement, also at $18.50 per share.
The Company’s investment objective is to maximize both current income and capital appreciation through debt and equity investments. The Company directly and indirectly invests primarily in leveraged middle market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. From time to time, we may also invest in public companies that are thinly traded.
On April 1, 2022, we acquired SLR Senior Investment Corp., a Maryland corporation (“SUNS”) pursuant to that certain Agreement and Plan of Merger (the “Merger Agreement”), dated as of December 1, 2021, by and among us, SUNS, Solstice Merger Sub, Inc., a Maryland corporation and our wholly-owned subsidiary (“Merger Sub”), and, solely for the limited purposes set forth therein, SLR Capital Partners, LLC (the “Investment Adviser”). Pursuant to the Merger Agreement, Merger Sub merged with and into SUNS, with SUNS continuing as the surviving company and as SUNS’s wholly-owned subsidiary (the “Merger”) and, immediately thereafter, SUNS merged with and into us, with us continuing as the surviving company (together with the Merger, the “Mergers”). In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each outstanding share of SUNS’s common stock was converted into the right to receive 0.7796 shares of our common stock (with SUNS’s stockholders receiving cash in lieu of fractional shares of our common stock). As a result of the Mergers, we issued an aggregate of 12,511,825 shares of our common stock to former SUNS stockholders.
Note 2. Significant Accounting Policies
The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“GAAP”), and include the accounts of the Company and certain wholly-owned subsidiaries. The consolidated financial statements reflect all adjustments and reclassifications which, in the opinion of management, are necessary for the fair presentation of the results of the operations and financial condition for the periods presented. All significant intercompany balances and transactions have been eliminated. Certain prior period amounts may have been reclassified to conform to the current period presentation.
Interim consolidated financial statements are prepared in accordance with GAAP for interim financial information and pursuant to the requirements for reporting on Form
10-Q
and Regulation
S-X,
as appropriate. Accordingly, they may not include all of the information and notes required by GAAP for annual consolidated financial statements. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reported periods. Changes in the economic environment, financial markets and any other parameters used in determining these estimates could cause actual results to differ materially. The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the fiscal year ending on December 31, 2023.
 
15

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
June 30, 2023
(in thousands, except share amounts)
 
In the opinion of management, all adjustments, which are of a normal recurring nature, considered necessary for the fair presentation of financial statements, have been included.
The significant accounting policies consistently followed by the Company are:
 
  (a)
Investment transactions are accounted for on the trade date;
 
  (b)
Under procedures established by the board of directors (the “Board”), we value investments, including certain senior secured debt, subordinated debt and other debt securities with maturities greater than 60 days, for which market quotations are readily available and deemed to represent fair value under GAAP, at such market quotations (unless they are deemed not to represent fair value). A market quotation is readily available for a security only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. If the Company anticipates using a market quotation for a security, it will also monitor for circumstances that may necessitate the use of fair value, such as significant events that may cause concern over the reliability of a market quotation. We attempt to obtain market quotations from at least two brokers or dealers (if available, otherwise from a principal market maker or a primary market dealer or other independent pricing service). We utilize
mid-market
pricing as a practical expedient for fair value unless a different point within the range is more representative. If and when market quotations are deemed not to represent fair value, we may utilize independent third-party valuation firms to assist us in determining the fair value of material assets. Accordingly, such investments go through our multi-step valuation process as described below. In each such case, independent valuation firms, that may from time to time be engaged by the Board, consider observable market inputs together with significant unobservable inputs in arriving at their valuation recommendations. Debt investments with maturities of 60 days or less shall each be valued at cost plus accreted discount, or minus amortized premium, which is expected to approximate fair value, unless such valuation, in the judgment of the Investment Adviser, does not represent fair value, in which case such investments shall be valued at fair value as determined in good faith by or under the direction of the Board. Investments that are not publicly traded or whose market quotations are not readily available are valued at fair value as determined in good faith by or under the direction of the Board. Such determination of fair values involves subjective judgments and estimates.
With respect to investments for which market quotations are not readily available or when such market quotations are deemed not to represent fair value under GAAP, the Board has approved a multi-step valuation process each quarter, as described below:
 
  (1)
our quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of the Investment Adviser responsible for the portfolio investment;
 
  (2)
preliminary valuation conclusions are then documented and discussed with senior management of the Investment Adviser;
 
  (3)
independent valuation firms engaged by the Board conduct independent appraisals and review the Investment Adviser’s preliminary valuations and make their own independent assessment for all material assets;
 
  (4)
the audit committee of the Board reviews the preliminary valuation of the Investment Adviser and that of the independent valuation firm and responds to the valuation recommendation of the independent valuation firm, if any, to reflect any comments; and
 
  (5)
the Board discusses valuations and determines the fair value of each investment in our portfolio in good faith based on the input of the Investment Adviser, the respective independent valuation firm, if any, and the audit committee.
The valuation principles set forth above may be modified from time to time, in whole or in part, as determined by the Board in its sole discretion. The Board will also (1) periodically assess and manage valuation risks; (2) establish and apply fair value methodologies; (3) test fair value methodologies; (4) oversee and evaluate third-party pricing services, as applicable; (5) oversee the reporting required by Rule
2a-5
under the 1940 Act; and (6) maintain recordkeeping requirements under Rule
2a-5.
 
16

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
June 30, 2023
(in thousands, except share amounts)
 
Investments in all asset classes are valued utilizing a market approach, an income approach, or both approaches, as appropriate. However, in accordance with ASC
820-10,
certain investments that qualify as investment companies in accordance with ASC 946, may be valued using net asset value as a practical expedient for fair value. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities (including a business). The income approach uses valuation approaches to convert future amounts (for example, cash flows or earnings) to a single present amount (discounted). The measurement is based on the value indicated by current market expectations about those future amounts. In following these approaches, the types of factors that we may take into account in fair value pricing our investments include, as relevant: available current market data, including relevant and applicable market trading and transaction comparables, applicable market yields and multiples, security covenants, call protection provisions, the nature and realizable value of any collateral, the portfolio company’s ability to make payments, its earnings and discounted cash flows, the markets in which the portfolio company does business, comparisons of financial ratios of peer companies that are public, M&A comparables, our principal market (as the reporting entity) and enterprise values, among other factors. When available, broker quotations and/or quotations provided by pricing services are considered as an input in the valuation process. For the six months ended June 30, 2023, there has been no change to the Company’s valuation approaches or techniques and the nature of the related inputs considered in the valuation process.
ASC Topic 820 classifies the inputs used to measure these fair values into the following hierarchy:
Level
 1
: Unadjusted quoted prices in active markets for identical assets or liabilities, accessible by the Company at the measurement date.
Level
 2
: Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or other observable inputs other than quoted prices.
Level
 3
: Unobservable inputs for the asset or liability.
In all cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each investment. The exercise of judgment is based in part on our knowledge of the asset class and our prior experience.
 
  (c)
Gains or losses on investments are calculated by using the specific identification method.
 
  (d)
The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Loan origination fees, original issue discount, and market discounts are capitalized and we amortize such amounts into income using the effective interest method. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record call premiums received on loans repaid as interest income when we receive such amounts. Capital structuring fees, amendment fees, consent fees, and any other
non-recurring
fee income as well as a management fee and other fee income for services rendered, if any, are recorded as other income when earned.
 
  (e)
The Company intends to comply with the applicable provisions of the Code pertaining to
RICs
to make distributions of taxable income sufficient to relieve it of substantially all U.S. federal income taxes. The Company, at its discretion, may carry forward taxable income in excess of calendar year distributions and pay a 4% excise tax on this income. The Company will accrue excise tax on such estimated excess taxable income as appropriate.
 
  (f)
Book and tax basis differences relating to stockholder distributions and other permanent book and tax differences are typically reclassified among the Company’s capital accounts annually. In addition, the character of income and gains to be distributed is determined in accordance with income tax regulations that may differ from GAAP.
 
  (g)
Distributions to common stockholders are recorded as of the record date. The amount to be paid out as a distribution is determined by the Board. Net realized capital gains, if any, are generally distributed or deemed distributed at least annually.
 
  (h)
In accordance with Regulation
S-X
and ASC Topic 810—
Consolidation
, the Company consolidates its interest in controlled investment company subsidiaries, financing subsidiaries and certain wholly-owned holding companies that serve to facilitate investment in portfolio companies. In addition, the Company may also consolidate any controlled operating companies substantially all of whose business consists of providing services to the Company.
 
17

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
June 30, 2023
(in thousands, except share amounts)
 
  (i)
The accounting records of the Company are maintained in U.S. dollars. Any assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the rate of exchange of such currencies against U.S. dollars on the date of valuation. The Company will not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. Such fluctuations would be included with the net unrealized gain or loss from investments. The Company’s investments in foreign securities, if any, may involve certain risks, including without limitation: foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments in terms of U.S. dollars and therefore the earnings of the Company.
 
  (j)
In accordance with ASC
835-30,
the Company reports origination and other expenses related to certain debt issuances as a direct deduction from the carrying amount of the debt liability. Applicable expenses are deferred and amortized using either the effective interest method or the straight-line method over the stated life. The straight-line method may be used on revolving facilities and/or when it approximates the effective yield method.
 
  (k)
The Company may enter into forward exchange contracts in order to hedge against foreign currency risk. These contracts are
marked-to-market
by recognizing the difference between the contract exchange rate and the current market rate as unrealized appreciation or depreciation. Realized gains or losses are recognized when contracts are settled.
 
  (l)
The Company records expenses related to shelf registration statements and applicable equity offering costs as prepaid assets. These expenses are typically charged as a reduction of capital upon the sale of shares or expensed, in accordance with ASC
946-20-25.
 
  (m)
Investments that are expected to pay regularly scheduled interest in cash are generally placed on
non-accrual
status when principal or interest cash payments are past due 30 days or more (90 days or more for equipment financing) and/or when it is no longer probable that principal or interest cash payments will be collected. Such
non-accrual
investments are restored to accrual status if past due principal and interest are paid in cash, and in management’s judgment, are likely to continue timely payment of their remaining principal and interest obligations. Cash interest payments received on such investments may be recognized as income or applied to principal depending on management’s judgment.
 
  (n)
The Company defines cash equivalents as securities that are readily convertible into known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only securities with a maturity of three months or less would qualify, with limited exceptions. The Company believes that certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities would qualify as cash equivalents.
 
18

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
June 30, 2023
(in thousands, except share amounts)
 
Note 3. Agreements
The Company has an investment advisory and management agreement (the “Advisory Agreement”) with the Investment Adviser, under which the Investment Adviser manages the
day-to-day
operations of, and provides investment advisory services to the Company. For providing these services, the Investment Adviser receives a fee from the Company, consisting of two components—a base management fee and a performance-based incentive fee. The base management fee is determined by taking the average value of the Company’s gross assets at the end of the two most recently completed calendar quarters calculated at an annual rate of 1.50% on gross assets up to 200% of the Company’s total net assets as of the immediately preceding quarter end and 1.00% on gross assets that exceed 200% of the Company’s total net assets as of the immediately preceding quarter end. For purposes of computing the base management fee, gross assets exclude temporary assets acquired at the end of each fiscal quarter for purposes of preserving investment flexibility in the next fiscal quarter. Temporary assets include, but are not limited to, U.S. treasury bills, other short-term U.S. government or government agency securities, repurchase agreements or cash borrowings.
The performance-based incentive fee has two parts, as follows: one part is calculated and payable quarterly in arrears based on the Company’s
pre-incentive
fee net investment income for the immediately preceding calendar quarter. For this purpose,
pre-incentive
fee net investment income means interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that we receive from portfolio companies) accrued during the calendar quarter, minus the Company’s operating expenses for the quarter (including the base management fee, any expenses payable under the Administration Agreement, and any interest expense and distributions paid on any issued and outstanding preferred stock, but excluding the performance-based incentive fee).
Pre-incentive
fee net investment income does not include any realized capital gains or losses, or unrealized capital appreciation or depreciation.
Pre-incentive
fee net investment income, expressed as a rate of return on the value of the Company’s net assets at the end of the immediately preceding calendar quarter, is compared to the hurdle rate of 1.75% per quarter (7% annualized). The Company pays the Investment Adviser a performance-based incentive fee with respect to the Company’s
pre-incentive
fee net investment income in each calendar quarter as follows: (1) no performance-based incentive fee in any calendar quarter in which the Company’s
pre-incentive
fee net investment income does not exceed the hurdle rate; (2) 100% of the Company’s
pre-incentive
fee net investment income with respect to that portion of such
pre-incentive
fee net investment income, if any, that exceeds the hurdle rate but is less than
2.1875
% in any calendar quarter; and (3) 20% of the amount of the Company’s
pre-incentive
fee net investment income, if any, that exceeds
2.1875
% in any calendar quarter. These calculations are appropriately
pro-rated
for any period of less than three months.
The second part of the performance-based incentive fee is determined and payable in arrears as of the end of each calendar year (or upon termination of the Advisory Agreement, as of the termination date), and will equal 20% of the Company’s cumulative realized capital gains less cumulative realized capital losses, unrealized capital depreciation (unrealized depreciation on a gross
investment-by-investment
basis at the end of each calendar year) and all net capital gains upon which prior performance-based capital gains incentive fee payments were previously made to the Investment Adviser. For financial statement purposes, the second part of the performance-based incentive fee is accrued based upon 20% of cumulative net realized gains and net unrealized capital appreciation. No accrual was required for the three and six months ended June 30, 2023 and 2022.
For the three and six months ended June 30, 2023, the Company recognized $7,878 and $15,584, respectively, in base management fees and $5,638 and $11,147, respectively, in performance-based incentive fees. For the three and six months ended June 30, 2023, $125 and $235, respectively, of such performance-based incentive fees were waived. For the three and six months ended June 30, 2022, the Company recognized $6,913 and $14,129, respectively, in base management fees and $4,734 and $4,734, respectively, in gross performance-based incentive fees. For the three and six months ended June 30, 2022, $1,358 and $1,358 of such performance-based incentive fees were waived. The Investment Adviser has agreed to waive incentive fees resulting from income earned due to the accretion of purchase discount allocated to investments acquired as a result of the Mergers. Fees waived pursuant to the above are not subject to recoupment by the Investment Adviser.
The Company has also entered into an Administration Agreement with SLR Capital Management, LLC (the “Administrator”) under which the Administrator provides administrative services to the Company. For providing these services, facilities and personnel, the Company reimburses the Administrator for the Company’s allocable portion of overhead and other expenses incurred by the Administrator in performing its obligations under the Administration Agreement, including rent. The Administrator will also provide, on the Company’s behalf, managerial assistance to those portfolio companies to which the Company is required to provide such assistance. The Company typically reimburses the Administrator on a quarterly basis.
For the three and six months ended June 30, 2023, the Company recognized expenses under the Administration Agreement of $1,480 and $2,988 respectively. For the three and six months ended June 30, 2022, the Company recognized expenses under the Administration Agreement of $1,369 and $2,552 respectively. No managerial assistance fees were accrued or collected for the three and six months ended June 30, 2023 and 2022.
 
19

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
June 30, 2023
(in thousands, except share amounts)
 
Note 4. Net Asset Value Per Share
At June 30, 2023, the Company’s total net assets and net asset value per share were $980,805 and $17.98, respectively. This compares to total net assets and net asset value per share at December 31, 2022 of $999,731 and $18.33, respectively.
Note 5. Earnings Per Share
The following table sets forth the computation of basic and diluted net increase in net assets per share resulting from operations, pursuant to ASC
260-10,
for the three and six months ended June 30, 2023 and 2022:
 
    
Three months ended June 30,
    
Six months ended June 30,
 
    
2023
    
2022
    
2023
    
2022
 
Earnings (loss) per share (basic & diluted)
           
Numerator - net increase (decrease) in net assets resulting from operations:
   $ 18,995      $ (15,646    $ 25,819      $ (14,183
Denominator - weighted average shares:
     54,554,634        54,772,651        54,554,642        48,551,302  
Earnings (loss) per share:
   $ 0.35      ($ 0.29    $ 0.47      ($ 0.29
Note 6. Fair Value
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a framework for measuring fair value that includes a hierarchy used to classify the inputs used in measuring fair value. The hierarchy prioritizes the inputs to valuations used to measure fair value into three levels. The level in the fair value hierarchy within which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The levels of the fair value hierarchy are as follows:
Level
 1.
 Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company has the ability to access.
Level
 2.
 Financial assets and liabilities whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 2 inputs include the following:
 
  a)
Quoted prices for similar assets or liabilities in active markets;
 
  b)
Quoted prices for identical or similar assets or liabilities in
non-active
markets;
 
  c)
Pricing models whose inputs are observable for substantially the full term of the asset or liability; and
 
  d)
Pricing models whose inputs are derived principally from or corroborated by observable market data through correlation or other means for substantially the full term of the asset or liability.
Level
 3.
Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s and, if applicable, an independent third-party valuation firm’s own assumptions about the assumptions a market participant would use in pricing the asset or liability.
When the inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3).
Gains and losses for assets and liabilities categorized within the Level 3 table below may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3).
A review of fair value hierarchy classifications is conducted on a quarterly basis. Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. Such reclassifications involving Level 3 assets and liabilities are reported as transfers in/out of Level 3 as of the end of the quarter in which the reclassifications occur. Within the fair value hierarchy tables below, cash and cash equivalents are excluded but could be classified as Level 1.
 
20
SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
June 30, 2023
(in thousands, except share amounts)
 
The following tables present the balances of assets measured at fair value on a recurring basis, as of June 30, 2023 and December 31, 2022:
Fair Value Measurements
As of June 30, 2023
 
    
Level 1
    
Level 2
    
Level 3
    
Measured at
Net Asset Value*
    
Total
 
Assets:
              
Senior Secured Loans
   $       $         $ 1,318,512      $         $ 1,318,512  
Equipment Financing
                         271,333                  271,333  
Preferred Equity
                         3,801                  3,801  
Common Equity/Equity Interests/Warrants
     358                  566,427        20,995        587,780  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
   $ 358    $         $ 2,160,073      $ 20,995      $ 2,181,426  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Fair Value Measurements
As of December 31, 2022
 
    
Level 1
    
Level 2
    
Level 3
    
Measured at
Net Asset Value*
    
Total
 
Assets:
              
Senior Secured Loans
   $       $         $ 1,245,414      $         $ 1,245,414  
Equipment Financing
                         265,952                  265,952  
Preferred Equity
                         3,801                  3,801  
Common Equity/Equity Interests/Warrants
     483                  561,600        9,426        571,509  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
   $ 483    $      $ 2,076,767      $ 9,426      $ 2,086,676  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
*
In accordance with ASC
820-10,
certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The portfolio investment in this category is SSLP. See Note 17 for more information on this investment, including its investment strategy and the Company’s unfunded equity commitment to SSLP. This investment is not redeemable by the Company absent an election by the members of the entity to liquidate all investments and distribute the proceeds to the members.
 
21

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
June 30, 2023
(in thousands, except share amounts)
 
The following tables provide a summary of the changes in fair value of Level 3 assets for the three and six months ended June 30, 2023, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at June 30, 2023:
Fair Value Measurements Using Level 3 Inputs
 
    
Senior Secured

Loans
   
Equipment

Financing
   
Preferred Equity
   
Common Equity/

Equity

Interests/

Warrants
   
Total
 
Fair value, March
 31, 2023
   $ 1,256,830     $ 258,044     $ 3,801     $ 559,919     $ 2,078,594  
Total gains or losses included in earnings:
          
Net realized gain
     333                                  333  
Net change in unrealized gain (loss)
     7,647       (138     (62     (11,998     (4,551
Purchase of investment securities
     166,766       22,739       62       18,506       208,073  
Proceeds from dispositions of investment securities
     (113,064     (9,312                       (122,376
Transfers in/out of Level 3
                                             
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Fair value, June
 30, 2023
   $ 1,318,512     $ 271,333     $ 3,801     $ 566,427     $ 2,160,073  
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
          
Net change in unrealized gain (loss)
   $ 1,207     $ (138   $ (62   $ (11,998   $ (10,991
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
    
Senior Secured

Loans
   
Equipment

Financing
   
Preferred Equity
   
Common Equity/

Equity

Interests/

Warrants
   
Total
 
Fair value, December
 31, 2022
   $ 1,245,414     $ 265,952     $ 3,801     $ 561,600     $ 2,076,767  
Total gains or losses included in earnings:
          
Net realized gain
     1,157                                  1,157  
Net change in unrealized loss
     (5,823     (78     (123     (14,358     (20,382
Purchase of investment securities
     320,336       30,084       123       19,185       369,728  
Proceeds from dispositions of investment securities
     (242,572     (24,625                       (267,197
Transfers in/out of Level 3
                                             
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Fair value, June
 30, 2023
   $ 1,318,512     $ 271,333     $ 3,801     $ 566,427     $ 2,160,073  
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
          
Net change in unrealized loss.
   $ (11,594   $ (78   $ (123   $ (14,358   $ (26,153
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
While the Company has not made an election to apply the fair value option of accounting to any of its current debt obligations, if the Company’s debt obligations were carried at fair value at June 30, 2023, the fair value of the Credit Facility, SPV Credit Facility, 2024 Unsecured Notes, 2025 Unsecured Notes, 2026 Unsecured Notes, 2027 Unsecured Notes and 2027 Series F Unsecured Notes would be $582,000, $167,200, $119,688, $80,325, $68,250, $43,125 and $118,463, respectively.
 
22

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
June 30, 2023
(in thousands, except share amounts)
 
The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2022, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2022:
Fair Value Measurements Using Level 3 Inputs
 
    
Senior Secured

Loans
   
Equipment

Financing
   
Preferred Equity
   
Common Equity/

Equity

Interests/

Warrants
   
Total
 
Fair value, December
 31, 2021
   $ 939,690     $ 273,795     $ 5,630     $ 450,381     $ 1,669,496  
Total gains or losses included in earnings:
          
Net realized gain (loss)
     (36,244                       6       (36,238
Net change in unrealized loss
     (8,065     (6,924     (706     (5,048     (20,743
Purchase of investment securities(1)
     796,389       84,168       266       116,272       997,095  
Proceeds from dispositions of investment securities
     (446,356     (85,087     (1,389     (11     (532,843
Transfers in/out of Level 3
                                             
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Fair value, December
 31, 2022
   $ 1,245,414     $ 265,952     $ 3,801     $ 561,600     $ 2,076,767  
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
          
Net change in unrealized loss
   $ (8,920   $ (6,924   $ (706   $ (5,048   $ (21,598
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
(1)
Includes positions acquired from SUNS as a result of the Mergers.
The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the year ended December 31, 2022:
 
2022 Unsecured Notes
  
For the year ended
December 31, 2022
 
Beginning fair value
   $ 150,000  
Net realized (gain) loss
         
Net change in unrealized (gain) loss
         
Borrowings
         
Repayments
     (150,000
Transfers in/out of Level 3
         
  
 
 
 
Ending fair value
   $     
  
 
 
 
The Company made an election to apply the fair value option of accounting to the 2022 Unsecured Notes, in accordance with ASC
825-10.
On May 8, 2022, the borrowings were repaid in full. While the Company has not made an election to apply the fair value option of accounting to any of its other debt obligations, if the Company’s debt obligations were carried at fair value at December 31, 2022, the fair value of the Credit Facility, SPV Credit Facility, 2023 Unsecured Notes, 2024 Unsecured Notes, 2025 Unsecured Notes, 2026 Unsecured Notes, 2027 Unsecured Notes and 2027 Series F Unsecured Notes would be $393,000, $155,200, $75,000, $118,750, $79,688, $68,250, $42,875 and $118,125, respectively.
 
23

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
June 30, 2023
(in thousands, except share amounts)
 
Quantitative Information about Level 3 Fair Value Measurements
The Company typically determines the fair value of its performing debt investments utilizing a yield analysis. In a yield analysis, a price is ascribed for each investment based upon an assessment of current and expected market yields for similar investments and risk profiles. Additional consideration is given to current contractual interest rates, relative maturities and other key terms and risks associated with an investment. Among other factors, a significant determinant of risk is the amount of leverage used by the portfolio company relative to the total enterprise value of the company, and the rights and remedies of our investment within each portfolio company.
Significant unobservable quantitative inputs typically used in the fair value measurement of the Company’s Level 3 assets and liabilities primarily reflect current market yields, including indices, and readily available quotes from brokers, dealers, and pricing services as indicated by comparable assets and liabilities, as well as enterprise values, returns on equity and earnings before income taxes, depreciation and amortization (“EBITDA”) multiples of similar companies, and comparable market transactions for equity securities.
Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of June 30, 2023 is summarized in the table below:
 
    
Asset or
Liability
  
Fair Value at

June 30, 2023
    
Principal Valuation
Technique/Methodology
  
Unobservable Input
  
Range (Weighted

Average)
Senior Secured Loans
   Asset   
$
$
1,306,129
12,383
 
 
  
Income Approach
Recovery Analysis
  
Market Yield
Recoverable Amount
   9.9% – 20.8% (12.8%)
N/A
Equipment Financing
   Asset    $
$
150,513
120,820
 
 
  
Income Approach
Market Multiple
(1)
  
Market Yield
Comparable Multiple
   8.5% – 9.7% (9.6%)
1.1x-1.4x (1.2x)
Preferred Equity
   Asset    $ 3,801      Income Approach    Market Yield    5.0% – 5.0% (5.0%)
Common Equity/Equity Interests/Warrants
   Asset    $
$
162,207
404,220
 
 
  
Market Multiple
(2)
Market Approach
  
Comparable Multiple
Return on Equity
   6.3x – 11.5x (8.7x)
4.7% – 32.4% (10.7%)
 
(1)
Includes $120,820 of investments valued using an implied multiple.
(2)
Includes $1,047 of investments valued using a Black-Scholes model and $161,160 of investments valued using an EBITDA multiple.
Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of December 31, 2022 is summarized in the table below:
 
    
Asset or
Liability
  
Fair Value at

December 31, 2022
    
Principal Valuation
Technique/Methodology
  
Unobservable Input
  
Range (Weighted

Average)
Senior Secured Loans
   Asset    $
$
1,212,842
32,572
 
 
  
Income Approach
Market Multiple
(1)
  
Market Yield
Comparable Multiple
   9.4% – 18.2% (12.0%)
0.1x-21.4x (12.4x)
Equipment Financing
   Asset    $
$
145,132
120,820
 
 
  
Income Approach
Market Multiple
(2)
  
Market Yield
Comparable Multiple
   8.5% – 9.7% (9.7%)
1.1x-1.4x (1.2x)
Preferred Equity
   Asset    $ 3,801      Income Approach    Market Yield    5.0% – 5.0% (5.0%)
Common Equity/Equity Interests/Warrants
   Asset    $
$
149,120
412,480
 
 
  
Market Multiple
(3)
Market Approach
  
Comparable Multiple
Return on Equity
   7.8x – 9.8x (8.8x)
6.6% – 35.2% (9.2%)
 
(1)
Investments are valued using a
sum-of-the
parts analysis, using expected revenue multiples for certain segments of the businesses and expected EBITDA multiples for certain segments of the businesses.
(2)
Includes $120,820 of investments valued using an implied multiple.
(3)
Includes $676 of investments valued using a Black-Scholes model and $148,444 of investments valued using an EBITDA multiple.
Significant increases or decreases in any of the above unobservable inputs in isolation, including unobservable inputs used in deriving
bid-ask
spreads, if applicable, could result in significantly lower or higher fair value measurements for such assets and liabilities. Generally, an increase in market yields or decrease in EBITDA multiples may result in a decrease in the fair value of certain of the Company’s investments.
 
24

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
June 30, 2023
(in thousands, except share amounts)
 
Note 7. Debt
Our debt obligations consisted of the following as of June 30, 2023 and December 31, 2022:
 
    
June 30, 2023
   
December 31, 2022
 
Facility
  
Face Amount
    
Carrying Value
   
Face Amount
    
Carrying Value
 
Credit Facility
   $ 582,000      $ 577,843
(1)
 
  $ 393,000      $ 388,254
(1)
 
SPV Credit Facility
     167,200        166,433
(2)
 
    155,200        154,302
(2)
 
2023 Unsecured Notes
                        75,000        74,979
(3)
 
2024 Unsecured Notes
     125,000        124,563
(4)
 
    125,000        124,421
(4)
 
2025 Unsecured Notes
     85,000        84,696
(5)
 
    85,000        84,613
(5)
 
2026 Unsecured Notes
     75,000        74,556
(6)
 
    75,000        74,498
(6)
 
2027 Unsecured Notes
     50,000        49,959
(7)
 
    50,000        49,953
(7)
 
2027 Series F Unsecured Notes
     135,000        134,983
(8)
 
    135,000        134,978
(8)
 
    
 
 
    
 
 
   
 
 
    
 
 
 
     $ 1,219,200      $ 1,213,033     $ 1,093,200      $ 1,085,998  
    
 
 
    
 
 
   
 
 
    
 
 
 
 
(1)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $4,157 and $4,746 as of June 30, 2023 and December 31, 2022, respectively.
(2)
Carrying Value equals the Face Amount net of unamortized market discount of $767 and $898 as of June 30, 2023 and December 31, 2022, respectively.
(3)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $21 as of December 31, 2022.
(4)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $437 and $579 as of June 30, 2023 and December 31, 2022, respectively.
(5)
Carrying Value equals the Face Amount net of unamortized market discount of $304 and $387 as of June 30, 2023 and December 31, 2022, respectively.
(6)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $444 and $502 as of June 30, 2023 and December 31, 2022, respectively.
(7)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $41 and $47 as of June 30, 2023 and December 31, 2022, respectively.
(8)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $17 and $22 as of June 30, 2023 and December 31, 2022, respectively.
Unsecured Notes
On April 1, 2022, the Company entered into an assumption agreement (the “Note Assumption Agreement”), effective as of the closing of the Mergers. The Note Assumption Agreement relates to the Company’s assumption of $85,000 in aggregate principal amount of five-year, 3.90% senior unsecured notes, due March 31, 2025 (the “2025 Unsecured Notes”) and other obligations of SUNS under the Note Purchase Agreement, dated as of March 31, 2020 (the “Note Purchase Agreement”), among SUNS and certain institutional investors. Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30. Pursuant to the Note Assumption Agreement, the Company expressly assumed on behalf of SUNS the due and punctual payment of the principal of (and premium, if any) and interest on all the 2025 Unsecured Notes outstanding, and the due and punctual performance and observance of every covenant and every condition of the Note Purchase Agreement, to be performed or observed by SUNS.
On January 6, 2022, the Company closed a private offering of $135,000 of the 2027 Series F Unsecured Notes with a fixed interest rate of 3.33% and a maturity date of January 6, 2027. Interest on the 2027 Series F Unsecured Notes is due semi-annually on January 6 and July 6. The 2027 Series F Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On September 14, 2021, the Company closed a private offering of $50,000 of the 2027 Unsecured Notes with a fixed interest rate of 2.95% and a maturity date of March 14, 2027. Interest on the 2027 Unsecured Notes is due semi-annually on March 14 and September 14. The 2027 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 18, 2019, the Company closed a private offering of $125,000 of the 2024 Unsecured Notes with a fixed interest rate of 4.20% and a maturity date of December 15, 2024. Interest on the 2024 Unsecured Notes is due semi-annually on June 15 and December 15. The 2024 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
 
25

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
June 30, 2023
(in thousands, except share amounts)
 
On December 18, 2019, the Company closed a private offering of $75,000 of the 2026 Unsecured Notes with a fixed interest rate of 4.375% and a maturity date of December 15, 2026. Interest on the 2026 Unsecured Notes is due semi-annually on June 15 and December 15. The 2026 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On November 22, 2017, we issued $75,000 in aggregate principal amount of publicly registered 2023 Unsecured Notes for net proceeds of $73,846. Interest on the 2023 Unsecured Notes is paid semi-annually on January 20 and July 20, at a fixed rate of 4.50% per year, commencing on January 20, 2018. The 2023 Unsecured Notes were repaid in full on the maturity date, January 20, 2023.
Revolving and Term Loan Facilities
On April 1, 2022, the Company entered into an assumption agreement (the “CF Assumption Agreement”), effective as of the closing of the Mergers. The CF Assumption Agreement relates to the Company’s assumption of the Revolving Credit Facility, originally entered into on August 26, 2011 (as amended from time to time, the “SPV Credit Facility”), by and among SUNS SPV LLC (the “SUNS SPV”), a wholly-owned subsidiary of SUNS, acting as borrower, Citibank, N.A., acting as administrative agent and collateral agent, and the other parties thereto. Currently, the commitment under the SPV Credit Facility is $225,000; however, the commitment can also be expanded up to $600,000. The stated interest rate on the SPV Credit Facility is
SOFR
plus
2.00%-2.50%
with no
SOFR
floor requirement and the current final maturity date is June 1, 2026. The SPV Credit Facility is secured by all of the assets held by SUNS SPV. Under the terms of the SPV Credit Facility and related transaction documents, the Company as successor to SUNS, and SUNS SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SPV Credit Facility also includes usual and customary events of default for credit facilities of this nature. At June 30, 2023, outstanding USD equivalent borrowings under the SPV Credit Facility totaled $167,200.
On December 28, 2021, the Company closed on Amendment No. 1 to its August 28, 2019 senior secured credit agreement (the “Credit Facility”). Following the amendment and a November 2022 upsizing, the Credit Facility is composed of $625,000 of revolving credit and $100,000 of term loans. Borrowings generally bear interest at a rate per annum equal to the base rate plus a range of
1.75%-2.00%
or the alternate base rate plus
0.75%-1.00%.
The Credit Facility has a 0% floor and matures in December 2026 and includes ratable amortization in the final year. The Credit Facility may be increased up to $800,000 with additional new lenders or an increase in commitments from current lenders. The Credit Facility contains certain customary affirmative and negative covenants and events of default. In addition, the Credit Facility contains certain financial covenants that among other things, requires the Company to maintain a minimum shareholder’s equity and a minimum asset coverage ratio. At June 30, 2023, outstanding USD equivalent borrowings under the Credit Facility totaled $582,000, composed of $482,000 of revolving credit and $100,000 of term loans.
Certain covenants on our issued debt may restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our status as a RIC under Subchapter M of the Code.
The average annualized interest cost for all borrowings for the six months ended June 30, 2023 and the year ended December 31, 2022 was 5.60% and 4.09%, respectively. These costs are exclusive of other credit facility expenses such as unused fees, agency fees and other prepaid expenses related to establishing and/or amending the Credit Facility, the SPV Credit Facility, the 2023 Unsecured Notes, the 2024 Unsecured Notes, the 2025 Unsecured Notes, the 2026 Unsecured Notes, the 2027 Unsecured Notes and the 2027 Series F Unsecured Notes (collectively the “Debt Instruments”), if any. The maximum amounts borrowed on the Debt Instruments during the six months ended June 30, 2023 and the year ended December 31, 2022 were $1,219,200 and $1,164,200, respectively.
 
26

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
June 30, 2023
(in thousands, except share amounts)
 
Note 8. Financial Highlights
The following is a schedule of financial highlights for the six months ended June 30, 2023 and 2022:
 
    
Six months ended

June 30, 2023
   
Six months ended

June 30, 2022
 
Per Share Data: (a)
    
Net asset value, beginning of year
   $ 18.33     $ 19.93  
  
 
 
   
 
 
 
Net investment income
     0.82       0.70  
Net realized and unrealized loss
     (0.35     (0.97 )* 
  
 
 
   
 
 
 
Net increase (decrease) in net assets resulting from operations
     0.47       (0.27
Issuance of common stock in connection with the Merger
     —         (0.31
Distributions to stockholders:
    
From distributable earnings
     (0.82     (0.82
From return of capital
                  
  
 
 
   
 
 
 
Net asset value, end of period
   $ 17.98     $ 18.53  
  
 
 
   
 
 
 
Per share market value, end of period
   $ 14.27     $ 14.63  
Total Return (b)(c)
     8.41     (19.85 %) 
Net assets, end of period
   $ 980,805     $ 1,015,153  
Shares outstanding, end of period
     54,554,634       54,772,651  
Ratios to average net assets (c):
    
Net investment income
     4.52     3.53
  
 
 
   
 
 
 
Operating expenses
     3.22 %**      2.44 %** 
Interest and other credit facility expenses
     3.34     1.95
  
 
 
   
 
 
 
Total expenses
     6.56 %**      4.39 %** 
  
 
 
   
 
 
 
Average debt outstanding
   $ 1,125,576     $ 880,327  
Portfolio turnover ratio
     12.6     9.0
 
(a)
Calculated using the average shares outstanding method, except for the issuance of common stock in connection with the Merger, which reflects the actual amount per share for the applicable period.
(b)
Total return is based on the change in market price per share during the period and takes into account distributions, if any, reinvested in accordance with the dividend reinvestment plan. The market price per share as of December 31, 2022 and December 31, 2021 was $13.91 and $18.43, respectively. Total return does not include a sales load.
(c)
Not annualized for periods less than one year.
*
The amount shown may not correspond with the aggregate amount for the period as it includes the effect of the timing of the Merger.
**
The ratio of operating expenses to average net assets and the ratio of total expenses to average net assets is shown net of the performance-based incentive fee waiver (see note 3). For the six months ended June 30, 2023, the ratios of operating expenses to average net assets and total expenses to average net assets would be 3.24% and 6.58%, respectively, without the performance-based incentive fee waiver. For the six months ended June 30, 2022, the ratios of operating expenses to average net assets and total expenses to average net assets would be 2.58% and 4.53%, respectively, without the performance-based incentive fee waiver.
Note 9. SLR Credit Solutions
On December 28, 2012, we acquired an equity interest in Crystal Capital Financial Holdings LLC (“Crystal Financial”) for $275,000 in cash. Crystal Financial owned approximately 98% of the outstanding ownership interest in SLR Credit Solutions (“SLR Credit”), f/k/a Crystal Financial LLC. The remaining financial interest was held by various employees of SLR Credit, through their investment in Crystal Management LP. SLR Credit had a diversified portfolio of 23 loans having a total par value of approximately $400,000 at November 30, 2012 and a $275,000 committed revolving credit facility. On July 28, 2016, the Company purchased Crystal Management LP’s approximately 2% equity interest in SLR Credit for approximately $5,737. Upon the closing of this transaction, the Company holds 100% of the equity interest in SLR Credit. On September 30, 2016, Crystal Capital Financial Holdings LLC was dissolved. As of June 30, 2023, total commitments to the revolving credit facility are $300,000.
As of June 30, 2023 SLR Credit had 29 funded commitments to 25 different issuers with total funded loans of approximately $425,019 on total assets of $443,024. As of December 31, 2022 SLR Credit had 29 funded commitments to 25 different issuers with total funded loans of approximately $439,484 on total assets of $460,683. As of June 30, 2023 and December 31, 2022, the largest loan outstanding totaled $30,000 and $33,420, respectively. For the same periods, the average exposure per issuer was $17,001 and $17,579, respectively. SLR Credit’s credit facility, which is
non-recourse
to the Company, had approximately $216,947 and $224,325 of borrowings outstanding at June 30, 2023 and December 31, 2022, respectively. For the three months ended June 30, 2023 and 2022, SLR Credit had net income of $6,767 and $1,880, respectively, on gross income of $13,897 and $6,882, respectively. For the six months ended June 30, 2023 and 2022, SLR Credit had net income (loss) of ($2,905) and $4,660, respectively, on gross income of $28,452 and $13,575, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions.
 
27

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
June 30, 2023
(in thousands, except share amounts)
 
Note 10. Commitments and Contingencies
Off-Balance
Sheet Arrangements
The Company had unfunded debt and equity commitments to various revolving and delayed-draw term loans as well as to SLR Credit and SLR Healthcare. The total amount of these unfunded commitments as of June 30, 2023 and December 31, 2022 is $325,858 and $323,663, respectively, comprised of the following:
 
    
June 30, 2023
    
December 31, 2022
 
SLR Credit Solutions*
   $ 44,263      $ 44,263  
Outset Medical, Inc.
     35,084        35,084  
Apeel Technology, Inc.
     32,786        32,786  
CVAUSA Management, LLC
     22,882            
Human Interest, Inc
     20,104        20,104  
Glooko, Inc.
     17,868        17,868  
BDG Media, Inc.
     11,539        3,546  
ONS MSO, LLC
     10,961            
iCIMS, Inc
     10,800        11,435  
Arcutis Biotherapeutics, Inc.
     8,356        8,356  
Atria Wealth Solutions, Inc.
     8,215        8,215  
Copper River Seafoods, Inc.
     8,158        3,595  
Ardelyx, Inc
     7,752        7,752  
Cerapedics, Inc.
     6,735        6,735  
United Digestive MSO Parent, LLC
     5,259            
Luxury Asset Capital, LLC
     4,500        7,500  
Kaseya, Inc.
     3,768        3,936  
SPAR Marketing Force, Inc.
     3,733        1,338  
Urology Management Holdings, Inc.
     3,596            
One Touch Direct, LLC
     3,571        3,069  
Spectrum Pharmaceuticals, Inc.
     3,508        8,771  
SLR Equipment Finance
     3,500        1,000  
Meditrina, Inc.
     3,367        3,367  
Vertos Medical, Inc.
     3,325            
Foundation Consumer Brands, LLC
     3,009        3,009  
Vessco Midco Holdings, LLC
     2,677        3,892  
Kid Distro Holdings, LLC
     2,650        2,650  
RSC Acquisition, Inc.
     2,487        7,498  
Erie Construction
Mid-west,
LLC
     2,403        1,248  
Ultimate Baked Goods Midco LLC
     2,361        1,636  
Maurices, Incorporated
     2,353        4,314  
Basic Fun, Inc.
     2,150        2,675  
SCP Eye Care, LLC
     1,955        2,771  
DeepIntent, Inc.
     1,925        3,049  
SunMed Group Holdings, LLC
     1,621        843  
SLR Healthcare ABL*
     1,400        1,400  
American Teleconferencing Services, Ltd
     1,380        1,090  
Montefiore Nyack Hospital
     1,301        1,034  
Pinnacle Treatment Centers, Inc.
     1,286        1,745  
RxSense Holdings LLC
     1,250        1,250  
Bayside Opco, LLC
     1,247            
Enverus Holdings, Inc.
     1,233        1,004  
Tilley Distribution, Inc.
     1,158        525  
Pediatric Home Respiratory Services, LLC
     1,147        1,805  
GSM Acquisition Corp
     862        784  
Composite Technology Acquisition Corp
     825        1,537  
High Street Buyer, Inc.
     631        327  
CC SAG Holdings Corp. (Spectrum Automotive)
     548        20,670  
Orthopedic Care Partners Management, LLC
     536        1,620  
Southern Orthodontic Partners Management, LLC
     519        1,918  
ENS Holdings III Corp, LLC
     461        144  
World Insurance Associates, LLC
     295        17,117  
TAUC Management, LLC
     294        294  
AmeriMark Intermediate Holdings, LLC
     221            
All State Ag Parts, LLC
     43        135  
Plastics Management, LLC
               2,424  
Ivy Fertility Services, LLC
               1,571  
NAC Holdings Corporation
               1,479  
Peter C. Foy & Associates Insurance Services, LLC
               1,094  
BayMark Health Services, Inc.
               391  
  
 
 
    
 
 
 
Total Commitments
   $ 325,858      $ 323,663  
  
 
 
    
 
 
 
 
*
The Company controls the funding of the SLR Credit Solutions and SLR Healthcare ABL commitments and may cancel them at its discretion.
 
28
SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
June 30, 2023
(in thousands, except share amounts)
 
In addition to the above, please see Note 17. SLR Senior Lending Program LLC herein, which describes that the Company has an equity commitment of $29,250 in SSLP and that the Company also controls such funding. The credit agreements of the above loan commitments contain customary lending provisions and/or are subject to the portfolio company’s achievement of certain milestones that allow relief to the Company from funding obligations for previously made commitments in instances where the underlying company experiences materially adverse events that affect the financial condition or business outlook for the company. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company. As of June 30, 2023 and December 31, 2022, the Company had sufficient cash available and/or liquid securities available to fund its commitments and had reviewed them for any appropriate fair value adjustment.
Note 11. SLR Equipment Finance
On July 31, 2017, we acquired a 100% equity interest in NEF Holdings, LLC, which conducts its business through its wholly-owned subsidiary Nations Equipment Finance, LLC. Effective February 25, 2021, Nations Equipment Finance, LLC and its related companies are doing business as SLR Equipment Finance (“SLR Equipment”). SLR Equipment is an independent equipment finance company that provides senior secured loans and leases primarily to U.S. based companies. We invested $209,866 in cash to effect the transaction, of which $145,000 was invested in the equity of SLR Equipment through our wholly-owned consolidated taxable subsidiary NEFCORP LLC and our wholly-owned consolidated subsidiary NEFPASS LLC and $64,866 was used to purchase certain leases and loans held by SLR Equipment through NEFPASS LLC. Concurrent with the transaction, SLR Equipment refinanced its existing senior secured credit facility into a $150,000
non-recourse
facility with an accordion feature to expand up to $250,000. In September 2019, SLR Equipment amended the facility, increasing commitments to $213,957 with an accordion feature to expand up to $313,957 and extended the maturity date of the facility to July 31, 2023. In June 2023, the facility was amended to extend the maturity date to January 31, 2024, with updated commitments totaling $152,147, effective August 1, 2023.
As of June 30, 2023, SLR Equipment had 129 funded equipment-backed leases and loans to 54 different customers with a total net investment in leases and loans of approximately $197,694 on total assets of $246,528. As of December 31, 2022, SLR Equipment had 131 funded equipment-backed leases and loans to 59 different customers with a total net investment in leases and loans of approximately $190,830 on total assets of $241,813. As of June 30, 2023 and December 31, 2022, the largest position outstanding totaled $18,243 and $19,259, respectively. For the same periods, the average exposure per customer was $3,661 and $3,234, respectively. SLR Equipment’s credit facility, which is
non-recourse
to the Company, had approximately $124,732 and $114,977 of borrowings outstanding at June 30, 2023 and December 31, 2022, respectively. For the three months ended June 30, 2023 and June 30, 2022, SLR Equipment had net loss of $2,055 and $1,753, respectively, on gross income of $4,054 and $4,045, respectively. For the six months ended June 30, 2023 and June 30, 2022, SLR Equipment had net loss of $1,017 and $1,159, respectively, on gross income of $10,391 and $9,218, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions.
Note 12. Capital Share Transactions
As of June 30, 2023 and June 30, 2022, 200,000,000 shares of $0.01 par value capital stock were authorized.
Transactions in capital stock were as follows:
 
    
Shares
    
Amount
 
    
Three months ended
June 30, 2023
    
Three months ended
June 30, 2022
    
Three months ended
June 30, 2023
    
Three months ended
June 30, 2022
 
Shares issued in connection with the Mergers
               12,511,825      $         $ 226,839  
    
 
 
    
 
 
    
 
 
    
 
 
 
Net increase
               12,511,825      $         $ 226,839  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
    
Shares
    
Amount
 
    
  Six months ended  
June 30, 2023
    
  Six months ended  
June 30, 2022
    
   Six months ended   
June 30, 2023
    
  Six months ended  
June 30, 2022
 
Shares issued in connection with the Mergers
               12,511,825      $         $ 226,839  
Shares repurchased
     (746              $ (10    $     
    
 
 
    
 
 
    
 
 
    
 
 
 
Net increase
     (746      12,511,825      $ (10    $ 226,839  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
29

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
June 30, 2023
(in thousands, except share amounts)
 
Note 13. Kingsbridge Holdings, LLC
On November 3, 2020, the Company acquired 87.5% of the equity securities of Kingsbridge Holdings, LLC (“KBH”) through KBH Topco LLC (“KBHT”), a Delaware corporation. KBH is a residual focused independent
mid-ticket
lessor of equipment primarily to U.S. investment grade companies. The Company invested $216,596 to effect the transaction, of which $136,596 was invested to acquire 87.5% of KBHT’s equity and $80,000 in KBH’s debt. The existing management team of KBH committed to continuing to lead KBH after the transaction. Following the transaction, the Company owns 87.5% of KBHT equity and the KBH management team owns the remaining 12.5% of KBHT’s equity.
As of June 30, 2023 and December 31, 2022, KBHT had total assets of $797,930 and $777,151, respectively. For the same periods, debt recourse to KBHT totaled $246,294 and $222,094, respectively, and
non-recourse
debt totaled $356,929 and $353,128, respectively. None of the debt is recourse to the Company. For the three months ended June 30, 2023 and 2022, KBHT had net income of $3,287 and $3,657, respectively, on gross income of $75,500 and $77,316, respectively. For the six months ended June 30, 2023 and 2022, KBHT had net income of $5,914 and $7,066, respectively, on gross income of $143,507 and $143,741, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in KBHT’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that KBHT will be able to maintain consistent dividend payments to us.
Note 14. SLR Healthcare ABL
SUNS acquired an equity interest in SLR Healthcare ABL, f/k/a Gemino Healthcare Finance, LLC (“SLR Healthcare”) on September 30, 2013. SLR Healthcare is a commercial finance company that originates, underwrites, and manages primarily secured, asset-based loans for small and
mid-sized
companies operating in the healthcare industry. SUNS initial investment in SLR Healthcare ABL was $32,839. The management team of SLR Healthcare
co-invested
in the transaction and continues to lead SLR Healthcare. As of June 30, 2023, SLR Healthcare’s management team and the Company own approximately 7% and 93% of the equity in SLR Healthcare, respectively. SLRC acquired SLR Healthcare in connection with the Mergers on April 1, 2022.
Concurrent with the closing of the transaction, SLR Healthcare entered into a new, four-year,
non-recourse,
$100,000 credit facility with
non-affiliates,
which was expandable to $150,000 under its accordion feature. Effective March 31, 2014, the credit facility was expanded to $105,000 and again on June 27, 2014 to $110,000. On May 27, 2016, SLR Healthcare entered into a new $125,000 credit facility which replaced the previously existing facility. The new facility has similar terms as compared to the previous facility and includes an accordion feature increase to $200,000 and had a maturity date of May 27, 2020. On June 28, 2019, this $125,000 facility was amended, extending the maturity date to June 28, 2023. On March 31, 2023, the facility was again amended, adjusting capacity to $100,000 and extending the maturity date to March 31, 2026.
SLR Healthcare currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of June 30, 2023, the portfolio totaled approximately $261,600 of commitments with a total net investment in loans of $99,555 on total assets of $106,837. As of December 31, 2022, the portfolio totaled approximately $242,106 of commitments with a total net investment in loans of $92,383 on total assets of $108,705. At June 30, 2023, the portfolio consisted of 40 issuers with an average balance of approximately $2,489 versus 41 issuers with an average balance of approximately $2,253 at December 31, 2022. All of the commitments in SLR Healthcare’s portfolio are floating-rate, senior-secured,
cash-pay
loans. SLR Healthcare’s credit facility, which is
non-recourse
to us, had approximately $74,900 and $77,000 of borrowings outstanding at June 30, 2023 and December 31, 2022, respectively. For the three months ended June 30, 2023 and 2022, SLR Healthcare had net income of $1,273 and $847, respectively, on gross income of $4,439 and $2,487, respectively. For the six months ended June 30, 2023 and 2022, SLR Healthcare had net income of $2,393 and $1,721, respectively, on gross income of $8,276 and $4,878, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions.
 
30

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
June 30, 2023
(in thousands, except share amounts)
 
Note 15. SLR Business Credit
SUNS acquired 100% of the equity interests of North Mill Capital LLC (“NMC”) on October 20, 2017. NMC is a leading asset-backed lending commercial finance company that provides senior secured asset-backed financings to U.S. based
small-to-medium-sized
businesses primarily in the manufacturing, services and distribution industries. SUNS invested approximately $51,000 to effect the transaction. Subsequently, SUNS contributed 1% of its equity interest in NMC to ESP SSC Corporation. Immediately thereafter, SUNS and ESP SSC Corporation contributed their equity interests to NorthMill LLC (“North Mill”). On May 1, 2018, North Mill merged with and into NMC, with NMC being the surviving company. SUNS and ESP SSC Corporation then owned 99% and 1% of the equity interests of NMC, respectively. The management team of NMC continues to lead NMC. On June 28, 2019, North Mill Holdco LLC (“NM Holdco”), a newly formed entity and ESP SSC Corporation acquired 100% of Summit Financial Resources, a Salt Lake City-based provider of asset-backed financing to small and
medium-sized
businesses. As part of this transaction, SUNS 99% interest in the equity of NMC was contributed to NM Holdco. This approximately $15,500 transaction was financed with borrowings on NMC’s credit facility. Effective February 25, 2021, NMC and its related companies are doing business as SLR Business Credit. On June 3, 2021, NMC acquired 100% of Fast Pay Partners LLC, a Los Angeles-based provider of asset-backed financing to digital media companies. The transaction purchase price of $66,671 was financed with equity from SUNS of $19,000 and borrowings on NMC’s credit facility of $47,671. SLRC acquired SLR Business Credit in connection with the Mergers on April 1, 2022.
SLR Business Credit currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of June 30, 2023, the portfolio totaled approximately $620,232 of commitments, of which $255,169 were funded, on total assets of $300,645. As of December 31, 2022, the portfolio totaled approximately $603,432 of commitments, of which $286,006 were funded, on total assets of $332,247. At June 30, 2023, the portfolio consisted of 101 issuers with an average balance of approximately $2,526 versus 108 issuers with an average balance of approximately $2,648 at December 31, 2022. NMC has a senior credit facility with a bank lending group for $285,307 which expires on November 13, 2025. Borrowings are secured by substantially all of NMC’s assets. NMC’s credit facility, which is
non-recourse
to us, had approximately $198,571 and $214,425 of borrowings outstanding at June 30, 2023 and December 31, 2022, respectively. For the three months ended June 30, 2023 and 2022, SLR Business Credit had net income of $1,414 and $1,857 respectively, on gross income of $8,827 and $6,626, respectively. For the six months ended June 30, 2023 and 2022, SLR Business Credit had net income of $3,431 and $3,726 respectively, on gross income of $11,067 and $12,772, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Business Credit’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Business Credit will be able to maintain consistent dividend payments to us.
Note 16. Stock Repurchase Program
On May 9, 2023, our Board authorized an extension of a program for the purpose of repurchasing up to $50,000 of our outstanding shares of common stock. Under the repurchase program, we may, but are not obligated to, repurchase shares of our outstanding common stock in the open market from time to time provided that we comply with our code of ethics and the guidelines specified in Rule
10b-18
of the Exchange Act, including certain price, market volume and timing constraints. In addition, any repurchases will be conducted in accordance with the 1940 Act. Unless further amended or extended by our Board, we expect the repurchase program to be in place until the earlier of May 10, 2024 or until $50,000 of our outstanding shares of common stock have been repurchased. The timing and number of additional shares to be repurchased will depend on a number of factors, including market conditions. There are no assurances that we will engage in any repurchases beyond what is reported herein. For the six months ended June 30, 2023, the Company repurchased 746 shares at an average price of approximately $14.02 per share, inclusive of commissions. The total dollar amount of shares repurchased for the six months ended June 30, 2023 was $10. During the fiscal year ended December 31, 2022, the Company repurchased 217,271 shares at an average price of approximately $13.98 per share, inclusive of commissions. The total dollar amount of shares repurchased for the fiscal year ended December 31, 2022 was $3,038.
 
31

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
June 30, 2023
(in thousands, except share amounts)
 
Note 17. SLR Senior Lending Program LLC
On October 12, 2022, the Company entered into an amended and restated limited liability company agreement with Sunstone Senior Credit L.P. (the “Investor”) to create a joint venture vehicle, SLR Senior Lending Program LLC (“SSLP”). SSLP is expected to invest primarily in senior secured cash flow loans. The Company and the Investor each have made initial equity commitments of $50,000, resulting in a total equity commitment of $100,000. Investment decisions and all material decisions in respect of SSLP must be approved by representatives of the Company and the Investor.
On December 1, 2022, SSLP commenced operations. On December 12, 2022, SSLP as servicer and SLR Senior Lending Program SPV LLC (“SSLP SPV”), a newly formed wholly owned subsidiary of SSLP, as borrower entered into a $100,000 senior secured revolving credit facility (the “SSLP Facility”) with Goldman Sachs Bank USA acting as administrative agent. The SSLP Facility is scheduled to mature on December 12, 2027. The SSLP Facility generally bears interest at a rate of SOFR plus 3.25%. SSLP and SSLP SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SSLP Facility also includes usual and customary events of default for credit facilities of this nature. At June 30, 2023, there were $38,400 of borrowings outstanding on the SSLP Facility.
As of June 30, 2023, the Company and the Investor had contributed combined equity capital in the amount of $41,500. As of June 30, 2023, the Company and the Investors’ remaining commitments to SSLP totaled $29,250 and $29,250, respectively. The Company, along with the Investor, controls the funding of SSLP and SSLP may not call the unfunded commitments of the Company or the Investor without the approval of both the Company and the Investor.
As of June 30, 2023 and December 31, 2022, SSLP had total assets of $79,411 and $19,105, respectively. For the same periods, SSLP’s portfolio consisted of floating rate senior secured loans to 20 and 7 different borrowers, respectively. For the three months ended June 30, 2023, SSLP invested $32,557 in 9 portfolio companies. Investments prepaid totaled $182 for the three months ended June 30, 2023. For the period December 1, 2022 (commencement of operations) through December 31, 2022, SSLP invested $18,100 in 7 portfolio companies. Investments prepaid totaled $68 for the period December 1, 2022 (commencement of operations) through December 31, 2022.
 
32

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)
June 30, 2023
(in thousands, except share amounts)
SSLP Portfolio as of June 30, 2023
 
Description
  
Industry
  
Spread
Above
Index
(1)
    
Floor
   
Interest
Rate
(2)
   
Maturity
Date
    
Par
Amount
    
Cost
    
Fair
Value
(3)
 
Aegis Toxicology Sciences Corporation
(4)
  
Health Care Providers & Services
     S+550        1.00     10.84     5/9/25      $ 2,974      $ 2,974      $ 2,974  
Atria Wealth Solutions, Inc.
(4)
  
Diversified Financial Services
     S+650        1.00     12.00     2/29/24        2,481        2,481        2,481  
BayMark Health Services, Inc.
(4)
  
Health Care Providers & Services
     S+500        1.00     10.50     6/11/27        4,054        4,054        4,054  
ENS Holdings III Corp. & ES Opco USA LLC
(4)
  
Trading Companies & Distributors
     S+475        1.00     10.09     12/31/25        1,091        1,091        1,091  
Fertility (ITC) Investment Holdco, LLC
(4)
  
Health Care Providers & Services
     S+650        1.00     11.63     1/3/29        5,985        5,809        5,985  
Foundation Consumer Brands, LLC
(4)
  
Personal Products
     S+625        1.00     11.47     2/12/27        6,863        6,863        6,863  
Higginbotham Insurance Agency, Inc.
(4)
  
Insurance
     S+525        1.00     10.45     11/25/26        1,293        1,293        1,293  
High Street Buyer, Inc.
(4)
  
Insurance
     S+600        0.75     11.39     4/16/28        2,481        2,481        2,481  
iCIMS, Inc.
(4)
  
Software
     S+725        0.75     12.38     8/18/28        3,029        2,991        3,029  
Kid Distro Holdings, LLC
(4)
  
Software
     S+575        1.00     11.14     10/1/27        5,970        5,970        5,970  
ONS MSO, LLC
(4)
  
Health Care Providers & Services
     S+625        1.00     11.32     7/8/25        5,951        5,774        5,773  
PhyNet Dermatology LLC
(4)
  
Health Care Providers & Services
     S+625        1.00     11.45     8/16/24        2,481        2,481        2,481  
Pinnacle Treatment Centers, Inc.
(4)
  
Health Care Providers & Services
     S+675        1.00     12.10     1/2/26        2,487        2,487        2,487  
Plastics Management, LLC
(4)
  
Health Care Providers & Services
     S+500        1.00     10.44     8/18/27        5,666        5,481        5,666  
RQM+ Corp.
(4)
  
Life Sciences Tools & Services
     S+575        1.00     11.51     8/12/26        5,985        5,985        5,985  
RSC Acquisition, Inc.
(4)
  
Insurance
     S+550        0.75     10.64     11/1/26        5,045        5,045        5,045  
RxSense Holdings LLC
(4)
  
Diversified Consumer Services
     S+500        1.00     10.15     3/13/26        2,985        2,985        2,985  
SunMed Group Holdings, LLC
(4)
  
Health Care Equipment & Supplies
     S+575        0.75     11.09     6/16/28        2,487        2,487        2,487  
Tilley Distribution, Inc.
(4)
  
Trading Companies & Distributors
     S+550        1.00     11.39     12/31/26        5,978        5,978        5,978  
Urology Management Holdings, Inc.
(4)
  
Health Care Providers & Services
     S+625        1.00     11.36     6/15/26        2,471        2,404        2,397  
                                                    
 
 
    
 
 
 
                                                     $ 77,114      $ 77,505  
                                                    
 
 
    
 
 
 
 
(1)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR. These instruments are typically subject to a SOFR floor.
(2)
Floating rate debt investments typically bear interest at a rate determined by reference to the SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of June 30, 2023.
(3)
Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
(4)
The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
 
33

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)
June 30, 2023
(in thousands, except share amounts)
 
SSLP Portfolio as of December 31, 2022
 
Description
  
Industry
  
Spread
Above
Index
(1)
    
Floor
   
Interest
Rate
(2)
   
Maturity
Date
    
Par
Amount
    
Cost
    
Fair
Value
(3)
 
Atria Wealth Solutions, Inc.
(4)
  
Diversified Financial Services
     S+600        1.00     10.84     2/29/24      $ 2,494      $ 2,494      $ 2,494  
BayMark Health Services, Inc.
(4)
  
Health Care Providers & Services
     L+500        1.00     9.73     6/11/27        2,992        2,992        2,992  
ENS Holdings III Corp. & ES Opco USA LLC
(4)
  
Trading Companies & Distributors
     L+475        1.00     9.43     12/31/25        1,097        1,097        1,097  
Foundation Consumer Brands, LLC
(4)
  
Personal Products
     L+550        1.00     10.15     2/12/27        2,963        2,963        2,963  
High Street Buyer, Inc.
(4)
  
Insurance
     L+600        0.75     10.73     4/16/28        2,494        2,494        2,494  
Ivy Fertility Services, LLC
(4)
  
Health Care Providers & Services
     L+625        1.00     10.39     2/25/26        3,000        3,000        3,030  
Kid Distro Holdings, LLC
(4)
  
Software
     L+575        1.00     10.48     10/1/27        2,992        2,992        2,992  
                                                    
 
 
    
 
 
 
                                                     $ 18,032      $ 18,062  
                                                    
 
 
    
 
 
 
 
(1)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or SOFR. These instruments are typically subject to a LIBOR or SOFR floor.
(2)
Floating rate debt investments typically bear interest at a rate determined by reference to either the LIBOR (“L”) or SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2022.
(3)
Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
(4)
The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
Below is certain summarized financial information for SSLP as of June 30, 2023 and December 31, 2022 and for the three and six months ended June 30, 2023 and for the period December 1, 2022 (commencement of operations) through December 31, 2022:
 

 
  
June 30, 2023
 
  
December 31,

2022
 
Selected Balance Sheet Information for SSLP:
                 
Investments at fair value (cost $77,114 and $18,032, respectively)
   $ 77,505      $ 18,062  
Cash and other assets
     1,906        1,043  
    
 
 
    
 
 
 
Total assets
   $ 79,411      $ 19,105  
    
 
 
    
 
 
 
Debt outstanding
   $ 36,944      $     
Interest payable and other credit facility related expenses
     345        165  
Accrued expenses and other payables
     131        89  
    
 
 
    
 
 
 
Total liabilities
   $ 37,420      $ 254  
    
 
 
    
 
 
 
Members’ equity
   $ 41,991      $ 18,851  
    
 
 
    
 
 
 
Total liabilities and members’ equity
   $ 79,411      $ 19,105  
    
 
 
    
 
 
 
 
34
SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited) (continued)
June 30, 2023
(in thousands, except share amounts)
 

 
  
For the three

months ended June

30, 2023
 
  
For the six
months ended June

30, 2023
 
  
For the period
December 1, 2022
(commencement
of operations) to
December 31,
2022
 
Selected Income Statement Information
for SSLP:
                          
Interest income
   $ 1,605      $ 2,614      $ 152  
    
 
 
    
 
 
    
 
 
 
Service fees*
     38        57      $ 4  
Interest and other credit facility expenses
     1,447        2,252        166  
Organizational costs
                         73  
Other general and administrative expenses
     19        57        88  
    
 
 
    
 
 
    
 
 
 
Total expenses
     1,504        2,366        331  
    
 
 
    
 
 
    
 
 
 
Net investment income (loss)
   $ 101      $ 248      $ (179
    
 
 
    
 
 
    
 
 
 
Realized gain on investments
               30            
Net change in unrealized gain on investments
     321        361        30  
    
 
 
    
 
 
    
 
 
 
Net realized and unrealized gain on investments
   $ 321      $ 391        30  
    
 
 
    
 
 
    
 
 
 
Net income (loss)
   $ 422      $ 639      $ (149
    
 
 
    
 
 
    
 
 
 
 
*
Service fees are included within the Company’s Consolidated Statements of Operations as other income.
Note 18. Subsequent Events
The Company has evaluated the need for disclosures and/or adjustments resulting from subsequent events through the date the consolidated financial statements were issued.
On July 5, 2023, the Board declared a monthly distribution of $0.136667 per share payable on August 1, 2023 to holders of record as of July 20, 2023.
On August 8, 2023, the Board declared a monthly distribution of $0.136667 per share payable on August 30, 2023 to holders of record as of August 18, 2023
.
Timing of Future Distributions
Effective with the fourth quarter of 2023, SLRC’s board of directors intends to adjust the timing of declaring and paying distributions to SLRC’s shareholders from monthly to quarterly. As a result, SLRC’s management anticipates that the last monthly distribution, if declared by SLRC’s board of directors, will be for September 2023 and the next distribution after that, if declared by SLRC’s board of directors, will be a quarterly distribution for the fourth quarter of 2023. The amount and timing of past distributions are not a guarantee of any future distributions or the amount thereof. The payment, timing and amount of any future distributions will be determined by SLRC’s board of directors.
 
3
5

Report of Independent Registered Public Accounting Firm
To the Stockholders and Board of Directors
SLR Investment Corp.:
Results of Review of Interim Financial Information
We have reviewed the consolidated statement of assets and liabilities of SLR Investment Corp. (and subsidiaries) (the Company), including the consolidated schedule of investments, as of June 30, 2023, the related consolidated statements of operations and changes in net assets, for the three-month and
six-month
periods ended June 30, 2023 and 2022, the related consolidated statements of cash flows for the
six-month
periods ended June 30, 2023 and 2022, and the related notes (collectively, the consolidated interim financial information). Based on our reviews, we are not aware of any material modifications that should be made to the consolidated interim financial information for it to be in conformity with U.S. generally accepted accounting principles.
We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated statement of assets and liabilities, including the consolidated schedule of investments, of the Company as of December 31, 2022, and the related consolidated statements of operations, changes in net assets, and cash flows for the year then ended (not presented herein); and in our report dated February 28, 2023, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying consolidated statement of assets and liabilities, including the consolidated schedule of investments, as of December 31, 2022, is fairly stated, in all material respects, in relation to the consolidated statement of assets and liabilities, including the consolidated schedule of investments, from which it has been derived.
Basis for Review Results
This consolidated interim financial information is the responsibility of the Company’s management. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our reviews in accordance with the standards of the PCAOB. A review of consolidated interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.
/s/ KPMG LLP
New York, New York
August 8, 2023
 
36

Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
The information contained in this section should be read in conjunction with our consolidated financial statements and notes thereto appearing elsewhere in this report.
Some of the statements in this report constitute forward-looking statements, which relate to future events or our future performance or financial condition. The forward-looking statements contained herein involve risks and uncertainties, including statements as to:
 
   
our future operating results, including our ability to achieve objectives;
 
   
our business prospects and the prospects of our portfolio companies;
 
   
the impact of investments that we expect to make;
 
   
our contractual arrangements and relationships with third parties;
 
   
the dependence of our future success on the general economy and its impact on the industries in which we invest;
 
   
the impact of any protracted decline in the liquidity of credit markets on our business;
 
   
the ability of our portfolio companies to achieve their objectives;
 
   
the valuation of our investments in portfolio companies, particularly those having no liquid trading market;
 
   
market conditions and our ability to access alternative debt markets and additional debt and equity capital;
 
   
our expected financings and investments;
 
   
the adequacy of our cash resources and working capital;
 
   
the timing of cash flows, if any, from the operations of our portfolio companies;
 
   
the ability of our investment adviser to locate suitable investments for us and to monitor and administer our investments;
 
   
the ability of the Investment Adviser to attract and retain highly talented professionals;
 
   
the ability of the Investment Adviser to adequately allocate investment opportunities among the Company and its other advisory clients;
 
   
any conflicts of interest posed by the structure of the management fee and incentive fee to be paid to the Investment Adviser;
 
   
changes in political, economic or industry conditions, relations between the United States, Russia, Ukraine and other nations, the interest rate environment or conditions affecting the financial and capital markets;
 
   
changes in the general economy, slowing economy, rising inflation, risk of recession and risks in respect of a failure to increase the U.S. debt ceiling; and
 
   
our ability to anticipate and identify evolving market expectations with respect to environmental, social and governance matters, including the environmental impacts of our portfolio companies’ supply chain and operations.
These statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including without limitation:
 
   
an economic downturn could impair our portfolio companies’ ability to continue to operate, which could lead to the loss of some or all of our investments in such portfolio companies;
 
   
a contraction of available credit and/or an inability to access the equity markets could impair our lending and investment activities;
 
   
interest rate volatility could adversely affect our results, particularly because we use leverage as part of our investment strategy;
 
   
currency fluctuations could adversely affect the results of our investments in foreign companies, particularly to the extent that we receive payments denominated in foreign currency rather than U.S. dollars;
 
   
the risks, uncertainties and other factors we identify in Item 1A. — Risk Factors contained in our Annual Report on Form
10-K
for the year ended December 31, 2022, elsewhere in this Quarterly Report on Form
10-Q
and in our other filings with the SEC.
We generally use words such as “anticipates,” “believes,” “expects,” “intends” and similar expressions to identify forward-looking statements. Our actual results could differ materially from those projected in the forward-looking statements for any reason, including any factors set forth in “Risk Factors” and elsewhere in this report.
We have based the forward-looking statements included in this report on information available to us on the date of this report, and we assume no obligation to update any such forward-looking statements. Although we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, you are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the SEC, including any annual reports on Form
10-K,
quarterly reports on Form
10-Q
and current reports on Form
8-K.
 
37

Overview
Solar Capital LLC, a Maryland limited liability company, was formed in February 2007 and commenced operations on March 13, 2007 with initial capital of $1.2 billion of which 47.04% was funded by affiliated parties.
SLR Investment Corp. (the “Company”, “SLRC”, “we” or “our”), a Maryland corporation formed in November 2007, is a
closed-end,
externally managed,
non-diversified
management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). Furthermore, as the Company is an investment company, it continues to apply the guidance in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946. In addition, for U.S federal income tax purposes, the Company has elected to be treated as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).
On February 9, 2010, we priced our initial public offering, selling 5.68 million shares of our common stock. Concurrent with our initial public offering, Michael S. Gross, our Chairman,
Co-Chief
Executive Officer and President, and Bruce Spohler, our
Co-Chief
Executive Officer and Chief Operating Officer, collectively purchased an additional 0.6 million shares of our common stock through a private placement transaction exempt from registration under the Securities Act.
We invest primarily in privately held U.S. middle-market companies, where we believe the supply of primary capital is limited and the investment opportunities are most attractive. Our investment objective is to generate both current income and capital appreciation through debt and equity investments. We invest primarily in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. From time to time, we may also invest in public companies that are thinly traded. Our business is focused primarily on the direct origination of investments through portfolio companies or their financial sponsors. Our investments generally range between $5 million and $100 million each, although we expect that this investment size will vary proportionately with the size of our capital base and/or with strategic initiatives. Our investment activities are managed by SLR Capital Partners, LLC (the “Investment Adviser”) and supervised by the board of directors (the “Board)”, a majority of whom are
non-interested,
as such term is defined in the 1940 Act. SLR Capital Management, LLC (the “Administrator”) provides the administrative services necessary for us to operate.
In addition, we may invest a portion of our portfolio in other types of investments, which we refer to as opportunistic investments, which are not our primary focus but are intended to enhance our overall returns. These investments may include, but are not limited to, direct investments in public companies that are not thinly traded and securities of leveraged companies located in select countries outside of the United States.
Recent Developments
On July 5, 2023, the Board declared a monthly distribution of $0.136667 per share payable on August 1, 2023 to holders of record as of July 20, 2023.
On August 8, 2023, the Board declared a monthly distribution of $0.136667 per share payable on August 30, 2023 to holders of record as of August 18, 2023.
Timing of Future Distributions
Effective with the fourth quarter of 2023, SLRC’s board of directors intends to adjust the timing of declaring and paying distributions to SLRC’s shareholders from monthly to quarterly. As a result, SLRC’s management anticipates that the last monthly distribution, if declared by SLRC’s board of directors, will be for September 2023 and the next distribution after that, if declared by SLRC’s board of directors, will be a quarterly distribution for the fourth quarter of 2023. The amount and timing of past distributions are not a guarantee of any future distributions or the amount thereof. The payment, timing and amount of any future distributions will be determined by SLRC’s board of directors.
Investments
Our level of investment activity can and does vary substantially from period to period depending on many factors, including the amount of debt and equity capital available to middle market companies, the level of merger and acquisition activity for such companies, the general economic environment and the competitive environment for the types of investments we make. As a BDC, we must not acquire any assets other than “qualifying assets” specified in the 1940 Act unless, at the time the acquisition is made, at least 70% of our total assets are qualifying assets (with certain limited exceptions). Qualifying assets include investments in “eligible portfolio companies.” The definition of “eligible portfolio company” includes certain public companies that do not have any securities listed on a national securities exchange and companies whose securities are listed on a national securities exchange but whose market capitalization is less than $250 million.
Revenue
We generate revenue primarily in the form of interest and dividend income from the securities we hold and capital gains, if any, on investment securities that we may sell. Our debt investments generally have a stated term of three to seven years and typically bear interest at a floating rate usually determined on the basis of a benchmark London interbank offered rate (“LIBOR”), the Secured Overnight Financing Rate (“SOFR”), commercial paper rate, or the prime rate. Interest on our debt investments is generally payable monthly or quarterly but may be
bi-monthly
or semi-annually. In addition, our investments may provide
payment-in-kind
(“PIK”) income. Such amounts of accrued PIK income are added to the cost of the investment on the respective capitalization dates and generally become due at maturity of the investment or upon the investment being called by the issuer. We may also generate revenue in the form of commitment, origination, structuring fees, fees for providing managerial assistance and, if applicable, consulting fees, etc.
 
38

Expenses
All investment professionals of the investment adviser and their respective staffs, when and to the extent engaged in providing investment advisory and management services, and the compensation and routine overhead expenses of such personnel allocable to such services, are provided and paid for by the Investment Adviser. We bear all other costs and expenses of our operations and transactions, including (without limitation):
 
   
the cost of our organization and public offerings;
 
   
the cost of calculating our net asset value, including the cost of any third-party valuation services;
 
   
the cost of effecting sales and repurchases of our shares and other securities;
 
   
interest payable on debt, if any, to finance our investments;
 
   
fees payable to third parties relating to, or associated with, making investments, including fees and expenses associated with performing due diligence reviews of prospective investments and advisory fees;
 
   
transfer agent and custodial fees;
 
   
fees and expenses associated with marketing efforts;
 
   
federal and state registration fees, any stock exchange listing fees;
 
   
federal, state and local taxes;
 
   
independent directors’ fees and expenses;
 
   
brokerage commissions;
 
   
fidelity bond, directors and officers errors and omissions liability insurance and other insurance premiums;
 
   
direct costs and expenses of administration, including printing, mailing, long distance telephone and staff;
 
   
fees and expenses associated with independent audits and outside legal costs;
 
   
costs associated with our reporting and compliance obligations under the 1940 Act and applicable federal and state securities laws; and
 
   
all other expenses incurred by either SLR Capital Management or us in connection with administering our business, including payments under the Administration Agreement that will be based upon our allocable portion of overhead and other expenses incurred by SLR Capital Management in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions, and our allocable portion of the costs of compensation and related expenses of our chief compliance officer and our chief financial officer and their respective staffs.
We expect our general and administrative operating expenses related to our ongoing operations to increase moderately in dollar terms. During periods of asset growth, we generally expect our general and administrative operating expenses to decline as a percentage of our total assets and increase during periods of asset declines. Incentive fees, interest expense and costs relating to future offerings of securities, among others, may also increase or reduce overall operating expenses based on portfolio performance, interest rate benchmarks, and offerings of our securities relative to comparative periods, among other factors.
 
39

Portfolio and Investment Activity
During the three months ended June 30, 2023, we invested approximately $212.9 million across 44 portfolio companies. This compares to investing, exclusive of assets acquired through the Merger, approximately $94.7 million in 29 portfolio companies for the three months ended June 30, 2022. Investments sold, prepaid or repaid during the three months ended June 30, 2023 totaled approximately $122.4 million versus approximately $78.5 million for the three months ended June 30, 2022.
At June 30, 2023, our portfolio consisted of 156 portfolio companies and was invested 33.7% in cash flow senior secured loans, 27.8% in asset-based senior secured loans / SLR Credit Solutions (“SLR Credit”) / SLR Healthcare ABL / SLR Business Credit, 22.9% in equipment senior secured financings / SLR Equipment Finance (“SLR Equipment”) / Kingsbridge Holdings, LLC (“KBH”) and 15.6% in life science senior secured loans, in each case, measured at fair value, versus 127 portfolio companies invested 30.0% in cash flow senior secured loans, 30.9% in asset-based senior secured loans / SLR Credit, 24.3% in equipment senior secured financings / SLR Equipment / KBH, and 14.8% in life science senior secured loans, in each case, measured at fair value, at June 30, 2022.
At June 30, 2023, 78.0% or $1.68 billion of our income producing investment portfolio
*
is floating rate and 22.0% or $473.9 million is fixed rate, measured at fair value. At June 30, 2022, 77.1% or $1.53 billion of our income producing investment portfolio
*
is floating rate and 22.9% or $453.7 million is fixed rate, measured at fair value. As of June 30, 2023 and 2022, we had three and two issuers, respectively, on
non-accrual
status.
 
*
 
We have included SLR Credit Solutions, SLR Equipment Finance, SLR Healthcare ABL, SLR Business Credit and Kingsbridge Holdings, LLC within our income producing investment portfolio.
SLR Credit Solutions
On December 28, 2012, we acquired an equity interest in Crystal Capital Financial Holdings LLC (“Crystal Financial”) for $275 million in cash. Crystal Financial owned approximately 98% of the outstanding ownership interest in SLR Credit Solutions (“SLR Credit”), f/k/a Crystal Financial LLC. The remaining financial interest was held by various employees of SLR Credit, through their investment in Crystal Management LP. SLR Credit had a diversified portfolio of 23 loans having a total par value of approximately $400 million at November 30, 2012 and a $275 million committed revolving credit facility. On July 28, 2016, the Company purchased Crystal Management LP’s approximately 2% equity interest in SLR Credit for approximately $5.7 million. Upon the closing of this transaction, the Company holds 100% of the equity interest in SLR Credit. On September 30, 2016, Crystal Capital Financial Holdings LLC was dissolved. As of June 30, 2023, total commitments to the revolving credit facility are $300 million.
As of June 30, 2023, SLR Credit had 29 funded commitments to 25 different issuers with total funded loans of approximately $425.0 million on total assets of $443.0 million. As of December 31, 2022, SLR Credit had 29 funded commitments to 25 different issuers with total funded loans of approximately $439.5 million on total assets of $460.7 million. As of June 30, 2023 and December 31, 2022, the largest loan outstanding totaled $30.0 million and $33.4 million, respectively. For the same periods, the average exposure per issuer was $17.0 million and $17.6 million, respectively. SLR Credit’s credit facility, which is
non-recourse
to the Company, had approximately $216.9 million and $224.3 million of borrowings outstanding at June 30, 2023 and December 31, 2022, respectively. For the three months ended June 30, 2023 and 2022, SLR Credit had net income of $6.8 million and $1.9 million, respectively, on gross income of $14.6 million and $6.9 million, respectively. For the six months ended June 30, 2023 and 2022, SLR Credit had net income (loss) of ($2.9) million and $4.7 million, respectively, on gross income of $28.5 million and $13.6 million, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Credit’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Credit will be able to maintain consistent dividend payments to us.
SLR Equipment Finance
On July 31, 2017, we acquired a 100% equity interest in NEF Holdings, LLC, which conducts its business through its wholly-owned subsidiary Nations Equipment Finance, LLC. Effective February 25, 2021, Nations Equipment Finance, LLC and its related companies are doing business as SLR Equipment Finance (“SLR Equipment”). SLR Equipment is an independent equipment finance company that provides senior secured loans and leases primarily to U.S. based companies. We invested $209.9 million in cash to effect the transaction, of which $145.0 million was invested in the equity of SLR Equipment through our wholly-owned consolidated taxable subsidiary NEFCORP LLC and our wholly-owned consolidated subsidiary NEFPASS LLC and $64.9 million was used to purchase certain leases and loans held by SLR Equipment through NEFPASS LLC. Concurrent with the transaction, SLR Equipment refinanced its existing senior secured credit facility into a $150.0 million
non-recourse
facility with an accordion feature to expand up to $250.0 million. In September 2019, SLR Equipment amended the facility, increasing commitments to $214.0 million with an accordion feature to expand up to $314.0, million and extended the maturity date of the facility to July 31, 2023. In June 2023, the facility was amended to extend the maturity date to January 31, 2024, with updated commitments totaling $152.1 million, effective August 1, 2023.
 
40

As of June 30, 2023, SLR Equipment had 129 funded equipment-backed leases and loans to 54 different customers with a total net investment in leases and loans of approximately $197.7 million on total assets of $246.5 million. As of December 31, 2022, SLR Equipment had 131 funded equipment-backed leases and loans to 59 different customers with a total net investment in leases and loans of approximately $190.8 million on total assets of $241.8 million. As of June 30, 2023 and December 31, 2022, the largest position outstanding totaled $18.2 million and $19.3 million, respectively. For the same periods, the average exposure per customer was $3.7 million and $3.2 million, respectively. SLR Equipment’s credit facility, which is
non-recourse
to the Company, had approximately $124.7 million and $115.0 million of borrowings outstanding at June 30, 2023 and December 31, 2022, respectively. For the three months ended June 30, 2023 and 2022, SLR Equipment had net loss of $2.1 million and $1.8 million, respectively, on gross income of $4.1 million and $4.0 million, respectively. For the six months ended June 30, 2023 and 2022, SLR Equipment had net loss of $1.0 million and $1.2 million, respectively, on gross income of $10.4 million and $9.2 million, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Equipment’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Equipment will be able to maintain consistent dividend payments to us.
Kingsbridge Holdings, LLC
On November 3, 2020, the Company acquired 87.5% of the equity securities of Kingsbridge Holdings, LLC (“KBH”) through KBH Topco LLC (“KBHT”), a Delaware corporation. KBH is a residual focused independent
mid-ticket
lessor of equipment primarily to U.S. investment grade companies. The Company invested $216.6 million to effect the transaction, of which $136.6 million was invested to acquire 87.5% of KBHT’s equity and $80.0 million in KBH’s debt. The existing management team of KBH committed to continuing to lead KBH after the transaction. Following the transaction, the Company owns 87.5% of KBHT equity and the KBH management team owns the remaining 12.5% of KBHT’s equity.
As of June 30, 2023 and December 31, 2022, KBHT had total assets of $797.9 million and $777.2 million, respectively. For the same periods, debt recourse to KBHT totaled $246.3 million and $222.1 million, respectively, and
non-recourse
debt totaled $356.9 million and $353.1 million, respectively. None of the debt is recourse to the Company. For the three months ended June 30, 2023 and 2022, KBHT had net income of $3.3 million and $3.7 million, respectively, on gross income of $75.5 million and $77.3 million, respectively. For the six months ended June 30, 2023 and 2022, KBHT had net income of $5.9 million and $7.1 million, respectively, on gross income of $143.5 million and $143.7 million, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in KBHT’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that KBHT will be able to maintain consistent dividend payments to us.
SLR Healthcare ABL
SUNS acquired an equity interest in SLR Healthcare ABL, f/k/a Gemino Healthcare Finance, LLC (“SLR Healthcare”) on September 30, 2013. SLR Healthcare is a commercial finance company that originates, underwrites, and manages primarily secured, asset-based loans for small and
mid-sized
companies operating in the healthcare industry. SUNS initial investment in SLR Healthcare ABL was $32.8 million. The management team of SLR Healthcare
co-invested
in the transaction and continues to lead SLR Healthcare. As of June 30, 2023, SLR Healthcare’s management team and the Company own approximately 7% and 93% of the equity in SLR Healthcare, respectively. SLRC acquired SLR Healthcare in connection with the Mergers on April 1, 2022.
Concurrent with the closing of the transaction, SLR Healthcare entered into a new, four-year,
non-recourse,
$100 million credit facility with
non-affiliates,
which was expandable to $150 million under its accordion feature. Effective March 31, 2014, the credit facility was expanded to $105 million and again on June 27, 2014 to $110 million. On May 27, 2016, SLR Healthcare entered into a new $125 million credit facility which replaced the previously existing facility. The new facility has similar terms as compared to the previous facility and includes an accordion feature increase to $200 million and had a maturity date of May 27, 2020. On June 28, 2019, this $125 million facility was amended, extending the maturity date to June 28, 2023. On March 31, 2023, the facility was again amended, adjusting capacity to $100 million and extending the maturity date to March 31, 2026.
SLR Healthcare currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of June 30, 2023, the portfolio totaled approximately $261.6 million of commitments with a total net investment in loans of $99.6 million on total assets of $106.8 million. As of December 31, 2022, the portfolio totaled approximately $242.1 million of commitments with a total net investment in loans of $92.4 million on total assets of $108.7 million. At June 30, 2023, the portfolio consisted of 40 issuers with an average balance of approximately $2.5 million versus 41 issuers with an average balance of approximately $2.3 million at December 31, 2022. All of the commitments in SLR Healthcare’s portfolio are floating-rate, senior-secured,
cash-pay
loans. SLR Healthcare’s credit facility, which is
non-recourse
to us, had approximately $74.9 million and $77.0 million of borrowings outstanding at June 30, 2023 and December 31, 2022, respectively. For the three months ended June 30, 2023 and 2022, SLR Healthcare had net income of $1.3 million and $0.8 million, respectively, on gross income of $4.4 million and $2.5 million, respectively. For the six months ended June 30, 2023 and 2022, SLR Healthcare had net income of $2.4 million and $1.7 million, respectively, on gross income of $8.3 million and $4.9 million, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Healthcare’s funded commitments, the timing of originations, and the repayment of financings, the Company cannot guarantee that SLR Healthcare will be able to maintain consistent dividend payments to us.
 
41

SLR Business Credit
SUNS acquired 100% of the equity interests of North Mill Capital LLC (“NMC”) on October 20, 2017. NMC is a leading asset-backed lending commercial finance company that provides senior secured asset-backed financings to U.S. based
small-to-medium-sized
businesses primarily in the manufacturing, services and distribution industries. SUNS invested approximately $51.0 million to effect the transaction. Subsequently, SUNS contributed 1% of its equity interest in NMC to ESP SSC Corporation. Immediately thereafter, SUNS and ESP SSC Corporation contributed their equity interests to NorthMill LLC (“North Mill”). On May 1, 2018, North Mill merged with and into NMC, with NMC being the surviving company. SUNS and ESP SSC Corporation then owned 99% and 1% of the equity interests of NMC, respectively. The management team of NMC continues to lead NMC. On June 28, 2019, North Mill Holdco LLC (“NM Holdco”), a newly formed entity and ESP SSC Corporation acquired 100% of Summit Financial Resources, a Salt Lake City-based provider of asset-backed financing to small and
medium-sized
businesses. As part of this transaction, SUNS 99% interest in the equity of NMC was contributed to NM Holdco. This approximately $15.5 million transaction was financed with borrowings on NMC’s credit facility. Effective February 25, 2021, NMC and its related companies are doing business as SLR Business Credit. On June 3, 2021, NMC acquired 100% of Fast Pay Partners LLC, a Los Angeles-based provider of asset-backed financing to digital media companies. The transaction purchase price of $66.7 million was financed with equity from SUNS of $19.0 million and borrowings on NMC’s credit facility of $47.7 million. SLRC acquired SLR Business Credit in connection with the Mergers on April 1, 2022.
SLR Business Credit currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of June 30, 2023, the portfolio totaled approximately $620.2 million of commitments, of which $255.2 million were funded, on total assets of $300.6 million. As of December 31, 2022, the portfolio totaled approximately $603.4 million of commitments, of which $286.0 million were funded, on total assets of $332.2 million. At June 30, 2023, the portfolio consisted of 101 issuers with an average balance of approximately $2.5 million versus 108 issuers with an average balance of approximately $2.6 million at December 31, 2022. NMC has a senior credit facility with a bank lending group for $285.3 million, which expires on November 13, 2025. Borrowings are secured by substantially all of NMC’s assets. NMC’s credit facility, which is
non-recourse
to us, had approximately $198.6 million and $214.4 million of borrowings outstanding at June 30, 2023 and December 31, 2022, respectively. For the three months ended June 30, 2023 and 2022, SLR Business Credit had net income of $1.4 million and $1.9 million, respectively, on gross income of $8.8 million and $6.6 million, respectively. For the six months ended June 30, 2023 and 2022, SLR Business Credit had net income of $3.4 million and $3.7 million, respectively, on gross income of $11.1 million and $12.8 million, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Business Credit’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Business Credit will be able to maintain consistent dividend payments to us.
Stock Repurchase Program
On May 9, 2023, our Board authorized an extension of a program for the purpose of repurchasing up to $50 million of our outstanding shares of common stock. Under the repurchase program, we may, but are not obligated to, repurchase shares of our outstanding common stock in the open market from time to time provided that we comply with our code of ethics and the guidelines specified in Rule
10b-18
of the Exchange Act, including certain price, market volume and timing constraints. In addition, any repurchases will be conducted in accordance with the 1940 Act. Unless further amended or extended by our Board, we expect the repurchase program to be in place until the earlier of May 10, 2024 or until $50 million of our outstanding shares of common stock have been repurchased. The timing and number of additional shares to be repurchased will depend on a number of factors, including market conditions. There are no assurances that we will engage in any repurchases beyond what is reported herein. For the six months ended June 30, 2023, the Company repurchased 746 shares at an average price of approximately $14.02 per share, inclusive of commissions. The total dollar amount of shares repurchased for the six months ended June 30, 2023 was $0.01 million. During the fiscal year ended December 31, 2022, the Company repurchased 217,271 shares at an average price of approximately $13.98 per share, inclusive of commissions. The total dollar amount of shares repurchased for the fiscal year ended December 31, 2022 was $3.0 million.
SLR Senior Lending Program LLC
On October 12, 2022, the Company entered into an amended and restated limited liability company agreement with Sunstone Senior Credit L.P. (the “Investor”) to create a joint venture vehicle, SLR Senior Lending Program LLC (“SSLP”). SSLP is expected to invest primarily in senior secured cash flow loans. The Company and the Investor each have made initial equity commitments of $50 million, resulting in a total equity commitment of $100 million. Investment decisions and all material decisions in respect of SSLP must be approved by representatives of the Company and the Investor.
 
42

On December 1, 2022, SSLP commenced operations. On December 12, 2022, SSLP as servicer and SLR Senior Lending Program SPV LLC (“SSLP SPV”), a newly formed wholly owned subsidiary of SSLP, as borrower entered into a $100 million senior secured revolving credit facility (the “SSLP Facility”) with Goldman Sachs Bank USA acting as administrative agent. The SSLP Facility is scheduled to mature on December 12, 2027. The SSLP Facility generally bears interest at a rate of SOFR plus 3.25%. SSLP and SSLP SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SSLP Facility also includes usual and customary events of default for credit facilities of this nature. At June 30, 2023, there were $38.4 million of borrowings outstanding on the SSLP Facility.
As of June 30, 2023 the Company and the Investor had contributed combined equity capital in the amount of $41.5 million. As of June 30, 2023, the Company and the Investor’s remaining commitments to SSLP totaled $29.25 million and $29.25 million, respectively. The Company, along with the Investor, controls the funding of SSLP, and SSLP may not call the unfunded commitments of the Company or the Investor without approval of both the Company and the Investor.
As of June 30, 2023 and December 31, 2022, SSLP had total assets of $79.4 million and $19.1 million, respectively. For the same periods, SSLP’s portfolio consisted of floating rate senior secured loans to 20 and 7 different borrowers, respectively. For the three months ended June 30, 2023, SSLP invested $32.6 million in 9 portfolio companies. Investments prepaid totaled $0.2 million for the three months ended June 30, 2023. For the period December 1, 2022 (commencement of operations) through December 31, 2022, SSLP invested $18.1 million in 7 portfolio companies. Investments prepaid totaled $0.1 million for the period December 1, 2022 (commencement of operations) through December 31, 2022.
SSLP Portfolio as of June 30, 2023 (dollar amounts in thousands)
 
Description
  
Industry
  
Spread
Above
Index
(1)
    
Floor
   
Interest
Rate
(2)
   
Maturity
Date
    
Par
Amount
    
Cost
    
Fair
Value
(3)
 
Aegis Toxicology Sciences Corporation
(4)
  
Health Care Providers & Services
     S+550        1.00     10.84     5/9/25      $ 2,974      $ 2,974      $ 2,974  
Atria Wealth Solutions, Inc.
(4)
  
Diversified Financial Services
     S+650        1.00     12.00     2/29/24        2,481        2,481        2,481  
BayMark Health Services, Inc.
(4)
  
Health Care Providers & Services
     S+500        1.00     10.50     6/11/27        4,054        4,054        4,054  
ENS Holdings III Corp. & ES Opco USA LLC
(4)
  
Trading Companies & Distributors
     S+475        1.00     10.09     12/31/25        1,091        1,091        1,091  
Fertility (ITC) Investment Holdco, LLC
(4)
  
Health Care Providers & Services
     S+650        1.00     11.63     1/3/29        5,985        5,809        5,985  
Foundation Consumer Brands, LLC
(4)
  
Personal Products
     S+625        1.00     11.47     2/12/27        6,863        6,863        6,863  
Higginbotham Insurance Agency, Inc.
(4)
  
Insurance
     S+525        0.75     10.45     11/25/26        1,293        1,293        1,293  
High Street Buyer, Inc.
(4)
  
Insurance
     S+600        0.75     11.39     4/16/28        2,481        2,481        2,481  
iCIMS, Inc.
(4)
  
Software
     S+725        0.75     12.38     8/18/28        3,029        2,991        3,029  
Kid Distro Holdings, LLC
(4)
  
Software
     S+575        1.00     11.14     10/1/27        5,970        5,970        5,970  
ONS MSO, LLC
(4)
  
Health Care Providers & Services
     S+625        1.00     11.32     7/8/25        5,951        5,774        5,773  
PhyNet Dermatology LLC
(4)
  
Health Care Providers & Services
     S+625        1.00     11.45     8/16/24        2,481        2,481        2,481  
Pinnacle Treatment Centers, Inc.
(4)
  
Health Care Providers & Services
     S+675        1.00     12.10     1/2/26        2,487        2,487        2,487  
Plastics Management, LLC
(4)
  
Health Care Providers & Services
     S+500        1.00     10.44     8/18/27        5,666        5,481        5,666  
RQM+ Corp.
(4)
  
Life Sciences Tools & Services
     S+575        1.00     11.51     8/12/26        5,985        5,985        5,985  
RSC Acquisition, Inc.
(4)
  
Insurance
     S+550        0.75     10.64     11/1/26        5,045        5,045        5,045  
RxSense Holdings LLC
(4)
  
Diversified Consumer Services
     S+500        1.00     10.15     3/13/26        2,985        2,985        2,985  
SunMed Group Holdings, LLC
(4)
  
Health Care Equipment & Supplies
     S+575        0.75     11.09     6/16/28        2,487        2,487        2,487  
Tilley Distribution, Inc.
(4)
  
Trading Companies & Distributors
     S+550        1.00     11.39     12/31/26        5,978        5,978        5,978  
Urology Management Holdings, Inc.
(4)
  
Health Care Providers & Services
     S+625        1.00     11.36     6/15/26        2,471        2,404        2,397  
                  
 
 
    
 
 
 
                   $ 77,114      $ 77,505  
                  
 
 
    
 
 
 
 
43

(1)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR. These instruments are typically subject to a SOFR floor.
(2)
Floating rate debt investments typically bear interest at a rate determined by reference to the SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of June 30, 2023.
(3)
Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
(4)
The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
SSLP Portfolio as of December 31, 2022 (dollar amounts in thousands)
 
Description
  
Industry
  
Spread
Above
Index
(1)
    
Floor
   
Interest
Rate
(2)
   
Maturity
Date
    
Par
Amount
    
Cost
    
Fair
Value
(3)
 
Atria Wealth Solutions, Inc.
(4)
  
Diversified Financial Services
     S+600        1.00     10.84     2/29/24      $ 2,494      $ 2,494      $ 2,494  
BayMark Health Services, Inc.
(4)
  
Health Care Providers & Services
     L+500        1.00     9.73     6/11/27        2,992        2,992        2,992  
ENS Holdings III Corp. & ES Opco USA LLC
(4)
  
Trading Companies & Distributors
     L+475        1.00     9.43     12/31/25        1,097        1,097        1,097  
Foundation Consumer Brands, LLC
(4)
  
Personal Products
     L+550        1.00     10.15     2/12/27        2,963        2,963        2,963  
High Street Buyer, Inc.
(4)
  
Insurance
     L+600        0.75     10.73     4/16/28        2,494        2,494        2,494  
Ivy Fertility Services, LLC
(4)
  
Health Care Providers & Services
     L+625        1.00     10.39     2/25/26        3,000        3,000        3,030  
Kid Distro Holdings, LLC
(4)
  
Software
     L+575        1.00     10.48     10/1/27        2,992        2,992        2,992  
                  
 
 
    
 
 
 
                   $ 18,032      $ 18,062  
                  
 
 
    
 
 
 
 
(1)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or SOFR. These instruments are typically subject to a LIBOR or SOFR floor.
(2)
Floating rate debt investments typically bear interest at a rate determined by reference to either the LIBOR (“L”) or SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2022.
(3)
Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
(4)
The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
Below is certain summarized financial information for SSLP as of June 30, 2023 and December 31, 2022 and for the three and six months ended June 30, 2023 and for the period December 1, 2022 (commencement of operations) through December 31, 2022:
 
    
June 30, 2023
    
December 31,
2022
 
Selected Balance Sheet Information for SSLP (in thousands):
     
Investments at fair value (cost $77,114 and $18,032, respectively)
   $ 77,505      $ 18,062  
Cash and other assets
     1,906        1,043  
  
 
 
    
 
 
 
Total assets
   $ 79,411      $ 19,105  
  
 
 
    
 
 
 
Debt outstanding
   $ 36,944      $ —    
Interest payable and other credit facility related expenses
     345        165  
Accrued expenses and other payables
     131        89  
  
 
 
    
 
 
 
Total liabilities
   $ 37,420      $ 254  
  
 
 
    
 
 
 
Members’ equity
   $ 41,991      $ 18,851  
  
 
 
    
 
 
 
Total liabilities and members’ equity
   $ 79,411      $ 19,105  
  
 
 
    
 
 
 
 
44

    
For the three
months ended June

30, 2023
    
For the six
months ended
June 30, 2023
    
For the period
December 1, 2022
(commencement
of operations) to
December 31,
2022
 
Selected Income Statement Information for SSLP (in thousands):
        
Interest income
   $ 1,605      $ 2,614      $ 152  
  
 
 
    
 
 
    
 
 
 
Service fees*
     38        57      $ 4  
Interest and other credit facility expenses
     1,447        2,252        166  
Organizational costs
     —          —          73  
Other general and administrative expenses
     19        57        88  
  
 
 
    
 
 
    
 
 
 
Total expenses
     1,504        2,366        331  
  
 
 
    
 
 
    
 
 
 
Net investment income (loss)
   $ 101      $ 248      $ (179
  
 
 
    
 
 
    
 
 
 
Realized gain on investments
     —          30        —    
Net change in unrealized gain on investments
     321        361        30  
  
 
 
    
 
 
    
 
 
 
Net realized and unrealized gain on investments
   $ 321      $ 391        30  
  
 
 
    
 
 
    
 
 
 
Net income (loss)
   $ 422      $ 639      $ (149
  
 
 
    
 
 
    
 
 
 
 
*
Service fees are included within the Company’s Consolidated Statements of Operations as other income.
Critical Accounting Policies
The preparation of consolidated financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and revenues and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following items as critical accounting policies. Within the context of these critical accounting policies and disclosed subsequent events herein, we are not currently aware of any other reasonably likely events or circumstances that would result in materially different amounts being reported.
Valuation of Portfolio Investments
In December 2020, the SEC adopted new Rule
2a-5
under the 1940 Act addressing fair valuation of fund investments. The new rule sets forth requirements for good faith determinations of fair value, as well as for the performance of fair value determinations, including related oversight and reporting obligations. The new rule also defines “readily available market quotations” for purposes of the definition of “value” under the 1940 Act, and the SEC noted that this definition will apply in all contexts under the 1940 Act. The Company complies with Rule
2a-5’s
valuation requirements.
We conduct the valuation of our assets, pursuant to which our net asset value is determined, at all times consistent with GAAP, and the 1940 Act. The Board will (1) periodically assess and manage valuation risks; (2) establish and apply fair value methodologies; (3) test fair value methodologies; (4) oversee and evaluate third-party pricing services, as applicable; (5) oversee the reporting required by Rule
2a-5
under the 1940 Act; and (6) maintain recordkeeping requirements under Rule
2a-5.
It is anticipated that in respect of many of the Company’s assets, readily available market quotations will not be obtainable and that such assets will be valued at fair value. A market quotation is readily available for a security only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. If the Company anticipates using a market quotation for a security, it will also monitor for circumstances that may necessitate the use of fair value, such as significant events that may cause concern over the reliability of a market quotation.
Our valuation procedures are set forth in more detail in Note 2(b) to the Company’s Consolidated Financial Statements. Determination of fair value involves subjective judgments and estimates. Accordingly, the notes to our consolidated financial statements express the uncertainty with respect to the possible effect of such valuations, and any change in such valuations, on our consolidated financial statements.
 
45

Revenue Recognition
The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Investments that are expected to pay regularly scheduled interest and/or dividends in cash are generally placed on
non-accrual
status when principal or interest/dividend cash payments are past due 30 days or more (90 days or more for equipment financing) and/or when it is no longer probable that principal or interest/dividend cash payments will be collected. Such
non-accrual
investments are restored to accrual status if past due principal and interest or dividends are paid in cash, and in management’s judgment, are likely to continue timely payment of their remaining interest or dividend obligations. Interest or dividend cash payments received on investments may be recognized as income or applied to principal depending upon management’s judgment. Some of our investments may have contractual PIK income. PIK income computed at the contractual rate, as applicable, is accrued and reflected as a receivable up to the capitalization date. PIK investments offer issuers the option at each payment date of making payments in cash or in additional securities. When additional securities are received, they typically have the same terms, including maturity dates and interest rates as the original securities issued. On these payment dates, the Company capitalizes the accrued interest or dividends receivable (reflecting such amounts as the basis in the additional securities received). PIK generally becomes due at the maturity of the investment or upon the investment being called by the issuer. At the point the Company believes PIK is not expected to be realized, the PIK investment will be placed on
non-accrual
status. When a PIK investment is placed on
non-accrual
status, the accrued, uncapitalized interest or dividends is reversed from the related receivable through interest or dividend income, respectively. The Company does not reverse previously capitalized PIK income. Upon capitalization, PIK is subject to the fair value estimates associated with their related investments. PIK investments on
non-accrual
status are restored to accrual status if the Company again believes that PIK is expected to be realized. Loan origination fees, original issue discount, and market discounts are capitalized and amortized into income using the effective interest method. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record prepayment premiums on loans and other investments as interest income when we receive such amounts. Capital structuring fees are recorded as other income when earned.
The typically higher yields and interest rates on PIK securities, to the extent we invested, reflects the payment deferral and increased credit risk associated with such instruments and that such investments may represent a significantly higher credit risk than coupon loans. PIK securities may have unreliable valuations because their continuing accruals require continuing judgments about the collectability of the deferred payments and the value of any associated collateral. PIK income has the effect of generating investment income and increasing the incentive fees payable at a compounding rate. In addition, the deferral of PIK income also increases the
loan-to-value
ratio at a compounding rate. PIK securities create the risk that incentive fees will be paid to the Investment Adviser based on
non-cash
accruals that ultimately may not be realized, but the Investment Adviser will be under no obligation to reimburse the Company for these fees. For the three and six months ended June 30, 2023, capitalized PIK income totaled $3.0 million and $6.2 million, respectively. For the three and six months ended June 30, 2022, capitalized PIK income totaled $0.7 million and $1.0 million, respectively.
Net Realized Gain or Loss and Net Change in Unrealized Gain or Loss
We generally measure realized gain or loss by the difference between the net proceeds from the repayment or sale and the amortized cost basis of the investment, without regard to unrealized appreciation or depreciation previously recognized, but considering unamortized origination or commitment fees and prepayment penalties. The net change in unrealized gain or loss reflects the change in portfolio investment values during the reporting period, including the reversal of previously recorded unrealized gain or loss, when gains or losses are realized. Gains or losses on investments are calculated by using the specific identification method.
Income Taxes
SLRC, a U.S. corporation, has elected to be treated, and intends to qualify annually, as a RIC under Subchapter M of the Code. In order to qualify for U.S. federal income taxation as a RIC, the Company is required, among other things, to timely distribute to its stockholders at least 90% of investment company taxable income, as defined by the Code, for each year. Depending on the level of taxable income earned in a given tax year, we may choose to carry forward taxable income in excess of current year distributions into the next tax year and pay a nondeductible 4% U.S. federal excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income will be in excess of estimated current year distributions, the Company accrues an estimated excise tax, if any, on estimated excess taxable income.
Recent Accounting Pronouncements
None.
 
46

RESULTS OF OPERATIONS
Results comparisons are for the three and six months ended June 30, 2023 and June 30, 2022:
Investment Income
For the three and six months ended June 30, 2023, gross investment income totaled $56.3 million and $109.9 million, respectively. For the three and six months ended June 30, 2022, gross investment income totaled $42.8 million and $75.8 million, respectively. The increase in gross investment income for the year over year three month periods was primarily due to net growth of the income producing portfolio as well as an increase in index rates.
Expenses
Net expenses totaled $33.7 million and $65.1 million, respectively, for the three and six months ended June 30, 2023, of which $13.5 million and $26.7 million, respectively, were base management fees and performance-based incentive fees and $17.8 million and $33.1 million, respectively, were interest and other credit facility expenses. Administrative services and other general and administrative expenses totaled $2.4 million and $5.4 million, respectively, for the three and six months ended June 30, 2023. Over the same periods, $0.1 million and $0.2 million of performance-based incentive fees were waived. Net expenses totaled $22.5 million and $42.0 million, respectively, for the three and six months ended June 30, 2022, of which $11.6 million and $18.9 million, respectively, were base management fees and performance-based incentive fees and $10.4 million and $18.7 million, respectively, were interest and other credit facility expenses. Administrative services and other general and administrative expenses totaled $1.9 million and $5.8 million, respectively, for the three and six months ended June 30, 2022. Over the same periods, $1.4 million and $1.4 million of performance-based incentive fees were waived. Expenses generally consist of management and performance-based incentive fees, interest and other credit facility expenses, administrative services fees, insurance expenses, legal fees, directors’ fees, transfer agency fees, printing and proxy expenses, audit and tax services expenses, and other general and administrative expenses. Interest and other credit facility expenses generally consist of interest, unused fees, agency fees and loan origination fees, if any, among others. The increase in expenses for the three and six months ended June 30, 2023 versus the three and six months ended June 30, 2022 was primarily due to higher management fees, incentive fees and interest expense on a larger portfolio resulting from the Mergers. Additionally, there was an increase in index rates on borrowings.
Net Investment Income
The Company’s net investment income totaled $22.7 million and $44.8 million, or $0.42 and $0.82, per average share, respectively, for the three and six months ended June 30, 2023. The Company’s net investment income totaled $20.3 million and $33.8 million, or $0.37 and $0.70, per average share, respectively, for the three and six months ended June 30, 2022.
Net Realized Gain (Loss)
The Company had investment sales and prepayments totaling approximately $122 million and $267 million, respectively, for the three and six months ended June 30, 2023. Net realized gains over the same periods were $0.5 million and $1.2 million, respectively. The Company had investment sales and prepayments totaling approximately $79 million and $180 million, respectively, for the three and six months ended June 30, 2022. Net realized losses over the same periods were $0.1 million and $0.1 million, respectively. Net realized gain for the three and six months ended June 30, 2023 was primarily due to sales of selected assets. Net realized losses for the three and six months ended June 30, 2022 were de minimis.
Net Change in Unrealized Loss
For the three and six months ended June 30, 2023, net change in unrealized loss on the Company’s assets totaled $4.2 million and $20.2 million, respectively. For the three and six months ended June 30, 2022, net change in unrealized loss on the Company’s assets and liabilities totaled $35.8 million and $47.9 million, respectively. Net unrealized loss for the three months ended June 30, 2023 is primarily due to depreciation in the value of our investments in SLR Credit Solutions, among others, partially offset by appreciation in the value of our investments in World Insurance Associates, LLC, among others. Net unrealized loss for the six months ended June 30, 2023 is primarily due to depreciation in the value of our investments in SLR Credit Solutions and AmeriMark Intermediate Holdings, LLC and, among others, partially offset by appreciation in the value of our investments in World Insurance Associates, LLC and SLR Business Credit, among others. Net unrealized loss for the three and six months ended June 30, 2022 is primarily due to depreciation in the value of our investments in PhyMed Management LLC, Rug Doctor LLC, American Teleconferencing Services, Ltd., SLR Credit Solutions and SLR Equipment Finance, among others, partially offset by unrealized appreciation on assets acquired in the Mergers due to the accounting treatment of the purchase discount.
 
47

Net Increase (Decrease) in Net Assets From Operations
For the three and six months ended June 30, 2023, the Company had a net increase in net assets resulting from operations of $19.0 million and $25.8 million, respectively. For the same periods, earnings per average share were $0.35 and $0.47, respectively. For the three and six months ended June 30, 2022, the Company had a net decrease in net assets resulting from operations of $15.6 million and $14.2 million, respectively. For the same periods, losses per average share were $0.29 and $0.29, respectively.
LIQUIDITY AND CAPITAL RESOURCES
The Company’s liquidity and capital resources are generated and generally available through its Credit Facility and SPV Credit Facility (as defined below), the 2024 Unsecured Notes, the 2025 Unsecured Notes, the 2026 Unsecured Notes, the 2027 Unsecured Notes and the 2027 Series F Unsecured Notes, through cash flows from operations, investment sales, prepayments of senior and subordinated loans, income earned on investments and cash equivalents, and periodic
follow-on
equity and/or debt offerings. As of June 30, 2023, we had a total of $200.8 million of unused borrowing capacity under the Credit Facility and SPV Credit Facility, subject to borrowing base limits.
We may from time to time issue equity and/or debt securities in either public or private offerings. The issuance of such securities will depend on future market conditions, funding needs and other factors and there can be no assurance that any such issuance will occur or be successful. The primary uses of existing funds and any funds raised in the future is expected to be for investments in portfolio companies, repayment of indebtedness, cash distributions to our stockholders, or for other general corporate purposes.
On April 1, 2022, we entered into an assumption agreement (the “CF Assumption Agreement”), effective as of the closing of the Mergers. The CF Assumption Agreement relates to our assumption of the Revolving Credit Facility, originally entered into on August 26, 2011 (as amended from time to time, the “SPV Credit Facility”), by and among SUNS SPV LLC (the “SUNS SPV”), a wholly-owned subsidiary of SUNS, acting as borrower, Citibank, N.A., acting as administrative agent and collateral agent, and the other parties thereto. Currently, the commitment under the SPV Credit Facility is $225 million; however, the commitment can also be expanded up to $600 million. The stated interest rate on the SPV Credit Facility is SOFR plus
2.00%-2.50%
with no SOFR floor requirement and the current final maturity date is June 1, 2026. The SPV Credit Facility is secured by all of the assets held by SUNS SPV. Under the terms of the SPV Credit Facility and related transaction documents, we as successor to SUNS, and SUNS SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SPV Credit Facility also includes usual and customary events of default for credit facilities of this nature.
On April 1, 2022, we entered into an assumption agreement (the “Note Assumption Agreement”), effective as of the closing of the Mergers. The Note Assumption Agreement relates to our assumption of $85 million in aggregate principal amount of five-year, 3.90% senior unsecured notes, due March 31, 2025 (the “2025 Unsecured Notes”) and other obligations of SUNS under the Note Purchase Agreement, dated as of March 31, 2020 (the “Note Purchase Agreement”), among SUNS and certain institutional investors. Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30. Pursuant to the Note Assumption Agreement, we expressly assumed on behalf of SUNS the due and punctual payment of the principal of (and premium, if any) and interest on all the 2025 Unsecured Notes outstanding, and the due and punctual performance and observance of every covenant and every condition of the Note Purchase Agreement, to be performed or observed by SUNS.
On January 6, 2022, the Company closed a private offering of $135 million of the 2027 Series F Unsecured Notes with a fixed interest rate of 3.33% and a maturity date of January 6, 2027. Interest on the 2027 Series F Unsecured Notes is due semi-annually on January 6 and July 6. The 2027 Series F Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 28, 2021, the Company closed on Amendment No. 1 to its August 28, 2019 senior secured credit agreement (the “Credit Facility”). Following the amendment and a November 2022 upsizing, the Credit Facility is composed of $625 million of revolving credit and $100 million of term loans. Borrowings generally bear interest at a rate per annum equal to the base rate plus a range of
1.75%-2.00%
or the alternate base rate plus
0.75%-1.00%.
The Credit Facility has a 0% floor and matures in December 2026 and includes ratable amortization in the final year.
On September 14, 2021, the Company closed a private offering of $50 million of the 2027 Unsecured Notes with a fixed interest rate of 2.95% and a maturity date of March 14, 2027. Interest on the 2027 Unsecured Notes is due semi-annually on March 14 and September 14. The 2027 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 18, 2019, the Company closed a private offering of $125 million of the 2024 Unsecured Notes with a fixed interest rate of 4.20% and a maturity date of December 15, 2024. Interest on the 2024 Unsecured Notes is due semi-annually on June 15 and December 15. The 2024 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 18, 2019, the Company closed a private offering of $75 million of the 2026 Unsecured Notes with a fixed interest rate of 4.375% and a maturity date of December 15, 2026. Interest on the 2026 Unsecured Notes is due semi-annually on June 15 and December 15. The 2026 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
 
48

On November 22, 2017, we issued $75 million in aggregate principal amount of publicly registered 2023 Unsecured Notes for net proceeds of $73.8 million. Interest on the 2023 Unsecured Notes is paid semi-annually on January 20 and July 20, at a fixed rate of 4.50% per year, commencing on January 20, 2018. The 2023 Unsecured Notes were repaid in full at maturity on January 20, 2023.
Cash Equivalents
We deem certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities as cash equivalents. The Company makes purchases that are consistent with its purpose of making investments in securities described in paragraphs 1 through 3 of Section 55(a) of the 1940 Act. From time to time, including at or near the end of each fiscal quarter, we consider using various temporary investment strategies for our business. One strategy includes taking proactive steps by utilizing cash equivalents as temporary assets with the objective of enhancing our investment flexibility pursuant to Section 55 of the 1940 Act. More specifically, from time to time we may purchase U.S. Treasury bills or other high-quality, short-term debt securities at or near the end of the quarter and typically close out the position on a net cash basis subsequent to quarter end. We may also utilize repurchase agreements or other balance sheet transactions, including drawing down on the Credit Facility, as deemed appropriate. The amount of these transactions or such drawn cash for this purpose is excluded from total assets for purposes of computing the asset base upon which the management fee is determined. We held approximately $335 million in cash equivalents as of June 30, 2023.
Debt
Unsecured Notes
On April 1, 2022, we entered into the Note Assumption Agreement, effective as of the closing of the Mergers. The Note Assumption Agreement relates to our assumption of $85 million of the 2025 Unsecured Notes and other obligations of SUNS under the Note Purchase Agreement, among SUNS and certain institutional investors. Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30. Pursuant to the Note Assumption Agreement, we expressly assumed on behalf of SUNS the due and punctual payment of the principal of (and premium, if any) and interest on all the 2025 Unsecured Notes outstanding, and the due and punctual performance and observance of every covenant and every condition of the Note Purchase Agreement, to be performed or observed by SUNS.
On January 6, 2022, the Company closed a private offering of $135 million of the 2027 Series F Unsecured Notes with a fixed interest rate of 3.33% and a maturity date of January 6, 2027. Interest on the 2027 Series F Unsecured Notes is due semi-annually on January 6 and July 6. The 2027 Series F Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On September 14, 2021, the Company closed a private offering of $50 million of the 2027 Unsecured Notes with a fixed interest rate of 2.95% and a maturity date of March 14, 2027. Interest on the 2027 Unsecured Notes is due semi-annually on March 14 and September 14. The 2027 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 18, 2019, the Company closed a private offering of $125 million of the 2024 Unsecured Notes with a fixed interest rate of 4.20% and a maturity date of December 15, 2024. Interest on the 2024 Unsecured Notes is due semi-annually on June 15 and December 15. The 2024 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 18, 2019, the Company closed a private offering of $75 million of the 2026 Unsecured Notes with a fixed interest rate of 4.375% and a maturity date of December 15, 2026. Interest on the 2026 Unsecured Notes is due semi-annually on June 15 and December 15. The 2026 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On November 22, 2017, we issued $75 million in aggregate principal amount of publicly registered 2023 Unsecured Notes for net proceeds of $73.8 million. Interest on the 2023 Unsecured Notes is paid semi-annually on January 20 and July 20, at a fixed rate of 4.50% per year, commencing on January 20, 2018. The 2023 Unsecured Notes were repaid in full at maturity on January 20, 2023.
Revolving & Term Loan Facilities
On April 1, 2022, we entered into the CF Assumption Agreement, effective as of the closing of the Mergers. The CF Assumption Agreement relates to our assumption of the SPV Credit Facility, by and among SUNS SPV, a wholly-owned subsidiary of SUNS, acting as borrower, Citibank, N.A., acting as administrative agent and collateral agent, and the other parties thereto. Currently, the commitment under the SPV Credit Facility is $225 million; however, the commitment can also be expanded up to $600 million. The stated interest rate on the SPV Credit Facility is LIBOR plus
2.00%-2.50%
with no LIBOR floor requirement and the current final maturity date is June 1, 2026. The SPV Credit Facility is secured by all of the assets held by SUNS SPV. Under the terms of the SPV Credit Facility and related transaction documents, we as successor to SUNS, and SUNS SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SPV Credit Facility also includes usual and customary events of default for credit facilities of this nature. At June 30, 2023, outstanding USD equivalent borrowings under the SPV Credit Facility totaled $167.2 million.
On December 28, 2021, the Company closed on Amendment No. 1 to the Credit Facility. Following the amendment and a November 2022 upsizing, the Credit Facility is composed of $625 million of revolving credit and $100 million of term loans.

Borrowings generally bear interest at a rate per annum equal to the base rate plus a range of
1.75%-2.00%
or the alternate base rate plus
0.75%-1.00%.
The Credit Facility has a 0% floor and matures in December 2026 and includes ratable amortization in the final year. The Credit Facility may be increased up to $800 million with additional new lenders or an increase in commitments from current lenders. The Credit Facility contains certain customary affirmative and negative covenants and events of default. In addition, the Credit Facility contains certain financial covenants that among other things, require the Company to maintain a minimum shareholder’s equity and a minimum asset coverage ratio. At June 30, 2023, outstanding USD equivalent borrowings under the Credit Facility totaled $582.0 million, composed of $482.0 million of revolving credit and $100.0 million of term loans.
Certain covenants on our issued debt may restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our status as a RIC under Subchapter M of the Code. At June 30, 2023, the Company was in compliance with all financial and operational covenants required by the Debt Instruments.
Contractual Obligations
A summary of our significant contractual payment obligations is as follows as of June 30, 2023:
Payments Due by Period (in millions)
 
    
Total
    
Less than

1 Year
    
1-3 Years
    
3-5 Years
    
More Than

5 Years
 
Revolving credit facilities (1)
   $ 649.2      $ —      $ —        $ 649.2      $ —  
Unsecured senior notes
     470.0        —          210.0      260.0      —    
Term loans
     100.0        —          —          100.0        —    
 
(1)
As of June 30, 2023, we had a total of $200.8 million of unused borrowing capacity under our revolving credit facilities, subject to borrowing base limits.
Under the provisions of the 1940 Act, we are permitted, as a BDC, to issue senior securities in amounts such that our asset coverage ratio, as defined in the 1940 Act, equals at least 150% of gross assets less all liabilities and indebtedness not represented by senior securities, after each issuance of senior securities. If the value of our assets declines, we may be unable to satisfy the asset coverage test. If that happens, we may be required to sell a portion of our investments and, depending on the nature of our leverage, repay a portion of our indebtedness at a time when such sales may be disadvantageous. Also, any amounts that we use to service our indebtedness would not be available for distributions to our common stockholders. Furthermore, as a result of issuing senior securities, we would also be exposed to typical risks associated with leverage, including an increased risk of loss.
We have also entered into two contracts under which we have future commitments: the Advisory Agreement, pursuant to which the Investment Adviser has agreed to serve as our investment adviser, and the Administration Agreement, pursuant to which the Administrator has agreed to furnish us with the facilities and administrative services necessary to conduct our
day-to-day
operations and provide on our behalf managerial assistance to those portfolio companies to which we are required to provide such assistance. Payments under the Advisory Agreement are equal to (1) a percentage of the value of our average gross assets and (2) a
two-part
incentive fee. Payments under the Administration Agreement are equal to an amount based upon our allocable portion of the Administrator’s overhead in performing its obligations under the Administration Agreement, including rent, technology systems, insurance and our allocable portion of the costs of our chief financial officer and chief compliance officer and their respective staffs. Either party may terminate each of the Advisory Agreement and administration agreement without penalty upon 60 days written notice to the other. See note 3 to our Consolidated Financial Statements.
On July 31, 2017, the Company, NEFPASS LLC and NEFCORP LLC entered into a servicing agreement. NEFCORP LLC was engaged to provide NEFPASS LLC with administrative services related to the loans and capital leases held by NEFPASS LLC. NEFPASS LLC may terminate this agreement upon 30 days written notice to NEFCORP LLC.
On October 7, 2022, the Company committed $50 million to SSLP and entered into a servicing agreement. SSLP engaged and retained the Company to provide certain administrative services relating to the facilities, supplies and necessary ongoing overhead support services for the operation of SSLP’s ongoing business affairs in exchange for a fee.
 
50

Senior Securities
Information about our senior securities is shown in the following table (in thousands) as of the quarter ended June 30, 2023 and each year ended December 31 for the past ten years, unless otherwise noted. The “—” indicates information which the SEC expressly does not require to be disclosed for certain types of senior securities.
 
Class and Year
  
Total Amount

Outstanding(1)
    
Asset

Coverage

Per Unit(2)
    
Involuntary

Liquidating

Preference

Per Unit(3)
    
Average

Market Value

Per Unit(4)
 
Credit Facility
           
Fiscal 2023 (through June 30, 2023)
   $ 482,000      $ 713                  N/A  
Fiscal 2022
     293,000        513                  N/A  
Fiscal 2021
     222,500        552                  N/A  
Fiscal 2020
     126,000        421                  N/A  
Fiscal 2019
     42,900        182                  N/A  
Fiscal 2018
     96,400        593                  N/A  
Fiscal 2017
     245,600        1,225                  N/A  
Fiscal 2016
     115,200        990                  N/A  
Fiscal 2015
     207,900        1,459                  N/A  
Fiscal 2014
                                   N/A  
Fiscal 2013
                                   N/A  
SPV Credit Facility
           
Fiscal 2023 (through June 30, 2023)
     167,200        247                  N/A  
Fiscal 2022
     155,200        272                  N/A  
2022 Unsecured Notes
           
Fiscal 2022
                                   N/A  
Fiscal 2021
     150,000        372                  N/A  
Fiscal 2020
     150,000        501                  N/A  
Fiscal 2019
     150,000        638                  N/A  
Fiscal 2018
     150,000        923                  N/A  
Fiscal 2017
     150,000        748                  N/A  
Fiscal 2016
     50,000        430                  N/A  
2022 Tranche C Notes
           
Fiscal 2022
                                   N/A  
Fiscal 2021
     21,000        52                  N/A  
Fiscal 2020
     21,000        70                  N/A  
Fiscal 2019
     21,000        89                  N/A  
Fiscal 2018
     21,000        129                  N/A  
Fiscal 2017
     21,000        105                  N/A  
2023 Unsecured Notes
           
Fiscal 2023 (through June 30, 2023)
                                   N/A  
Fiscal 2022
     75,000        131                  N/A  
Fiscal 2021
     75,000        186                  N/A  
Fiscal 2020
     75,000        250                  N/A  
Fiscal 2019
     75,000        319                  N/A  
Fiscal 2018
     75,000        461                  N/A  
Fiscal 2017
     75,000        374                  N/A  
2024 Unsecured Notes
           
Fiscal 2023 (through June 30, 2023)
     125,000        185                  N/A  
Fiscal 2022
     125,000        219                  N/A  
Fiscal 2021
     125,000        309                  N/A  
Fiscal 2020
     125,000        417                  N/A  
Fiscal 2019
     125,000        531                  N/A  
2025 Unsecured Notes
           
Fiscal 2023 (through June 30, 2023)
     85,000        126                  N/A  
Fiscal 2022
     85,000        149                  N/A  
2026 Unsecured Notes
           
 
51

Class and Year
  
Total Amount

Outstanding(1)
    
Asset

Coverage

Per Unit(2)
    
Involuntary

Liquidating

Preference

Per Unit(3)
    
Average

Market Value

Per Unit(4)
 
Fiscal 2023 (through June 30, 2023)
     75,000        111                  N/A  
Fiscal 2022
     75,000        131                  N/A  
Fiscal 2021
     75,000        186                  N/A  
Fiscal 2020
     75,000        250                  N/A  
Fiscal 2019
     75,000        319                  N/A  
2027 Unsecured Notes
           
Fiscal 2023 (through June 30, 2023)
     50,000        74                  N/A  
Fiscal 2022
     50,000        88                  N/A  
Fiscal 2021
     50,000        124                  N/A  
2027 Series F Unsecured Notes
           
Fiscal 2023 (through June 30, 2023)
     135,000        200                  N/A  
Fiscal 2022
     135,000        237                  N/A  
2042 Unsecured Notes
           
Fiscal 2017
                                   N/A  
Fiscal 2016
     100,000        859                $ 1,002  
Fiscal 2015
     100,000        702                  982  
Fiscal 2014
     100,000        2,294                  943  
Fiscal 2013
     100,000        2,411                  934  
Senior Secured Notes
           
Fiscal 2017
                                   N/A  
Fiscal 2016
     75,000        645                  N/A  
Fiscal 2015
     75,000        527                  N/A  
Fiscal 2014
     75,000        1,721                  N/A  
Fiscal 2013
     75,000        1,808                  N/A  
Term Loans
           
Fiscal 2023 (through June 30, 2023)
     100,000        148                  N/A  
Fiscal 2022
     100,000        175                  N/A  
Fiscal 2021
     100,000        248                  N/A  
Fiscal 2020
     75,000        250                  N/A  
Fiscal 2019
     75,000        319                  N/A  
Fiscal 2018
     50,000        308                  N/A  
Fiscal 2017
     50,000        250                  N/A  
Fiscal 2016
     50,000        430                  N/A  
Fiscal 2015
     50,000        351                  N/A  
Fiscal 2014
     50,000        1,147                  N/A  
Fiscal 2013
     50,000        1,206                  N/A  
NEFPASS Facility
           
Fiscal 2021
                                   N/A  
Fiscal 2020
     30,000        100                  N/A  
Fiscal 2019
     30,000        128                  N/A  
Fiscal 2018
     30,000        185                  N/A  
SSLP Facility
           
Fiscal 2019
                                   N/A  
Fiscal 2018
     53,785        331                  N/A  
Total Senior Securities
           
Fiscal 2023 (through June 30, 2023)
   $ 1,219,200      $ 1,804                  N/A  
Fiscal 2022
     1,093,200        1,915                  N/A  
Fiscal 2021
     818,500        2,029                  N/A  
Fiscal 2020
     677,000        2,259                  N/A  
Fiscal 2019
     593,900        2,525                  N/A  
Fiscal 2018
     476,185        2,930                  N/A  
Fiscal 2017
     541,600        2,702                  N/A  
Fiscal 2016
     390,200        3,354                  N/A  
Fiscal 2015
     432,900        3,039                  N/A  
Fiscal 2014
     225,000        5,162                  N/A  
Fiscal 2013
     225,000        5,425                  N/A  
 
(1)
Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented.
(2)
The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of June 30, 2023, asset coverage was 180.4%.
(3)
The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it.
(4)
Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014 and 2013 periods was $100,175, $98,196, $94,301 and $93,392, respectively.
 
52
Off-Balance
Sheet Arrangements
From time to time and in the normal course of business, the Company may make unfunded capital commitments to current or prospective portfolio companies. Typically, the Company may agree to provide delayed-draw term loans or, to a lesser extent, revolving loan or equity commitments. These unfunded capital commitments always take into account the Company’s liquidity and cash available for investment, portfolio and issuer diversification, and other considerations. Accordingly, the Company had the following unfunded capital commitments at June 30, 2023 and December 31, 2022, respectively:
 
    
June 30, 2023
    
December 31, 2022
 
(in millions)
             
SLR Credit Solutions*
   $ 44.3      $ 44.3  
Outset Medical, Inc
     35.1        35.1  
Apeel Technology, Inc
     32.8        32.8  
CVAUSA Management, LLC
     22.9        —    
Human Interest, Inc
     20.1        20.1  
Glooko, Inc
     17.9        17.9  
BDG Media, Inc
     11.5        3.5  
ONS MSO, LLC
     11.0        —    
iCIMS, Inc
     10.8        11.4  
Arcutis Biotherapeutics, Inc
     8.4        8.4  
Atria Wealth Solutions, Inc
     8.2        8.2  
Copper River Seafoods, Inc.
     8.2        3.6  
Ardelyx, Inc
     7.8        7.8  
Cerapedics, Inc
     6.7        6.7  
United Digestive MSO Parent, LLC
     5.3        —    
Luxury Asset Capital, LLC
     4.5        7.5  
Kaseya, Inc
     3.8        3.9  
SPAR Marketing Force, Inc.
     3.7        1.3  
Urology Management Holdings, Inc
     3.6        —    
One Touch Direct, LLC
     3.6        3.1  
Spectrum Pharmaceuticals, Inc.
     3.5        8.8  
SLR Equipment Finance
     3.5        1.0  
Meditrina, Inc
     3.4        3.4  
Vertos Medical, Inc
     3.3        —    
Foundation Consumer Brands, LLC
     3.0        3.0  
Vessco Midco Holdings, LLC
     2.7        3.9  
Kid Distro Holdings, LLC
     2.6        2.7  
RSC Acquisition, Inc
     2.5        7.5  
Erie Construction
Mid-west,
LLC
     2.4        1.3  
Ultimate Baked Goods Midco LLC
     2.4        1.6  
Maurices, Incorporated
     2.4        4.3  
Basic Fun, Inc
     2.1        2.7  
SCP Eye Care, LLC
     2.0        2.8  
DeepIntent, Inc
     1.9        3.1  
SunMed Group Holdings, LLC
     1.6        0.8  
SLR Healthcare ABL*
     1.4        1.4  
American Teleconferencing Services, Ltd
     1.4        1.1  
Montefiore Nyack Hospital
     1.3        1.0  
Pinnacle Treatment Centers, Inc.
     1.3        1.7  
RxSense Holdings LLC
     1.2        1.3  
Bayside Opco, LLC
     1.2        —    
Enverus Holdings, Inc
     1.2        1.0  
Tilley Distribution, Inc.
     1.2        0.5  
Pediatric Home Respiratory Services, LLC
     1.1        1.8  
GSM Acquisition Corp
     0.9        0.8  
Composite Technology Acquisition Corp
     0.8        1.5  
High Street Buyer, Inc.
     0.6        0.3  
CC SAG Holdings Corp. (Spectrum Automotive)..
     0.5        20.7  
Orthopedic Care Partners Management, LLC.
     0.5        1.6  
Southern Orthodontic Partners Management, LLC
     0.5        1.9  
ENS Holdings III Corp, LLC
     0.5        0.1  
World Insurance Associates, LLC
     0.3        17.1  
TAUC Management, LLC
     0.3        0.3  
AmeriMark Intermediate Holdings, LLC
     0.2        —    
All State Ag Parts, LLC
     0.0        0.1  
Plastics Management, LLC
     —          2.4  
Ivy Fertility Services, LLC
     —          1.6  
NAC Holdings Corporation
     —          1.5  
Peter C. Foy & Associates Insurance Services, LLC.
     —          1.1  
BayMark Health Services, Inc.
     —          0.4  
  
 
 
    
 
 
 
Total Commitments
   $ 325.9      $ 323.7  
  
 
 
    
 
 
 
 
*
The Company controls the funding of the SLR Credit Solutions and SLR Healthcare commitments and may cancel them at its discretion.
 
53

In addition to the above, please see Note 17. SLR Senior Lending Program LLC herein, which describes that the Company has an equity commitment of $29.25 million in SSLP and that the Company also controls such funding. The credit agreements of the above loan commitments contain customary lending provisions and/or are subject to the portfolio company’s achievement of certain milestones that allow relief to the Company from funding obligations for previously made commitments in instances where the underlying company experiences materially adverse events that affect the financial condition or business outlook for the company. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company. As of June 30, 2023 and December 31, 2022, the Company had sufficient cash available and/or liquid securities available to fund its commitments and had reviewed them for any appropriate fair value adjustment.
In the normal course of business, we invest or trade in various financial instruments and may enter into various investment activities with
off-balance
sheet risk, which may include forward foreign currency contracts. Generally, these financial instruments represent future commitments to purchase or sell other financial instruments at specific terms at future dates. These financial instruments contain varying degrees of
off-balance
sheet risk whereby changes in the market value or our satisfaction of the obligations may exceed the amount recognized in our Consolidated Statements of Assets and Liabilities.
Distributions
The following table reflects the cash distributions per share on our common stock for the two most recent fiscal years and the current fiscal year to date:
 
Date Declared
  
Record Date
    
Payment Date
    
Amount
 
Fiscal 2023
        
August 8, 2023
     August 18, 2023        August 30, 2023      $ 0.136667  
July 5, 2023
     July 20, 2023        August 1, 2023        0.136667  
June 1, 2023
     June 20, 2023        June 29, 2023        0.136667  
May 10, 2023
     May 24, 2023        June 1, 2023        0.136667  
April 4, 2023
     April 20, 2023        May 2, 2023        0.136667  
February 28, 2023
     March 23, 2023        April 4, 2023        0.136667  
February 2, 2023
     February 16, 2023        March 1, 2023        0.136667  
January 10, 2023
     January 26, 2023        February 2, 2023        0.136667  
        
 
 
 
Total 2023
         $ 1.093336  
        
 
 
 
Fiscal 2022
        
December 6, 2022
     December 22, 2022        January 5, 2023      $ 0.136667  
November 2, 2022
     November 17, 2022        December 1, 2022        0.136667  
October 5, 2022
     October 20, 2022        November 2, 2022        0.136667  
September 2, 2022
     September 20, 2022        October 4, 2022        0.136667  
August 2, 2022
     August 18, 2022        September 1, 2022        0.136667  
July 6, 2022
     July 21, 2022        August 2, 2022        0.136667  
June 3, 2022
     June 23, 2022        July 5, 2022        0.136667  
May 3, 2022
     May 19, 2022        June 2, 2022        0.136667  
April 4, 2022
     April 21, 2022        May 3, 2022        0.136667  
March 1, 2022
     March 18, 2022        April 1, 2022        0.41  
        
 
 
 
Total 2022
         $ 1.64  
        
 
 
 
Fiscal 2021
        
November 3, 2021
     December 16, 2021        January 5, 2022      $ 0.41  
August 3, 2021
     September 23, 2021        October 5, 2021        0.41  
May 5, 2021
     June 23, 2021        July 2, 2021        0.41  
February 24, 2021
     March 18, 2021        April 2, 2021        0.41  
        
 
 
 
Total 2021
         $ 1.64  
        
 
 
 
Tax characteristics of all distributions will be reported to stockholders on Form 1099 after the end of the calendar year. Future monthly distributions, if any, will be determined by the Board. We expect that our distributions to stockholders will generally be from accumulated net investment income, from net realized capital gains or
non-taxable
return of capital, if any, as applicable.
We have elected to be taxed as a RIC under Subchapter M of the Code. To maintain our RIC tax treatment, we must distribute at least 90% of our ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any, out of the assets legally available for distribution. In addition, although we currently intend to distribute realized net capital gains (
i.e.
, net long-term capital gains in excess of short-term capital losses), if any, at least annually, out of the assets legally available for such distributions, we may in the future decide to retain such capital gains for investment.
 
54

We maintain an “opt out” dividend reinvestment plan for our common stockholders. As a result, if we declare a distribution, then stockholders’ cash distributions will be automatically reinvested in additional shares of our common stock, unless they specifically “opt out” of the dividend reinvestment plan so as to receive cash distributions.
We may not be able to achieve operating results that will allow us to make distributions at a specific level or to increase the amount of these distributions from time to time. In addition, due to the asset coverage test applicable to us as a business development company, we may in the future be limited in our ability to make distributions. Also, the Credit Facility may limit our ability to declare distributions if we default under certain provisions. If we do not distribute a certain percentage of our income annually, we will suffer adverse tax consequences, including possible loss of the tax benefits available to us as a RIC. In addition, in accordance with GAAP and tax regulations, we include in income certain amounts that we have not yet received in cash, such as contractual
payment-in-kind
income, which represents contractual income added to the loan balance that becomes due at the end of the loan term, or the accrual of original issue or market discount. Since we may recognize income before or without receiving cash representing such income, we may have difficulty meeting the requirement to distribute at least 90% of our investment company taxable income to obtain tax benefits as a RIC.
With respect to the distributions to stockholders, income from origination, structuring, closing and certain other upfront fees associated with investments in portfolio companies are treated as taxable income and accordingly, distributed to stockholders.
Related Parties
We have entered into a number of business relationships with affiliated or related parties, including the following:
 
   
We have entered into the Advisory Agreement with the Investment Adviser. Mr. Gross, our Chairman,
Co-Chief
Executive Officer and President and Mr. Spohler, our
Co-Chief
Executive Officer, Chief Operating Officer and board member, are managing members and senior investment professionals of, and have financial and controlling interests in, the Investment Adviser. In addition, Mr. Kajee, our Chief Financial Officer, Treasurer and Secretary serves as the Chief Financial Officer for the Investment Adviser.
 
   
The Administrator provides us with the office facilities and administrative services necessary to conduct
day-to-day
operations pursuant to our Administration Agreement. We reimburse the Administrator for the allocable portion of overhead and other expenses incurred by it in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions, and the compensation of our chief compliance officer, our chief financial officer and their respective staffs.
 
   
We have entered into a license agreement with the Investment Adviser, pursuant to which the Investment Adviser has granted us a
non-exclusive,
royalty-free license to use the licensed marks “SOLAR” and “SLR”.
The Investment Adviser may also manage other funds in the future that may have investment mandates that are similar, in whole and in part, with ours. For example, the Investment Adviser presently serves as investment adviser to SCP Private Credit Income BDC LLC, an unlisted BDC that focuses on investing primarily in senior secured loans, including
non-traditional
asset-based loans and first lien loans, SLR HC BDC LLC, an unlisted BDC whose principal focus is to invest directly and indirectly in senior secured loans and other debt instruments typically to middle market companies within the healthcare industry, and SLR Private Credit BDC II LLC, an unlisted BDC focused on first lien senior secured floating rate loans. In addition, Michael S. Gross, our Chairman,
Co-Chief
Executive Officer and President, Bruce Spohler, our
Co-Chief
Executive Officer and Chief Operating Officer, and Shiraz Kajee, our Chief Financial Officer, serve in similar capacities for SCP Private Credit Income BDC LLC, SLR HC BDC LLC and SLR Private Credit BDC II LLC. The Investment Adviser and certain investment advisory affiliates may determine that an investment is appropriate for us and for one or more of those other funds. In such event, depending on the availability of such investment and other appropriate factors, the Investment Adviser or its affiliates may determine that we should invest
side-by-side
with one or more other funds. Any such investments will be made only to the extent permitted by applicable law and interpretive positions of the SEC and its staff, and consistent with the Investment Adviser’s allocation procedures. On June 13, 2017, the Investment Adviser received an exemptive order that permits the Company to participate in
negotiated co-investment transactions
with certain affiliates, in a manner consistent with the Company’s investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors, and pursuant to various conditions (the “Order”). If the Company is unable to rely on the Order for a particular opportunity, such opportunity will be allocated first to the entity whose investment strategy is the most consistent with the opportunity being allocated, and second, if the terms of the opportunity are consistent with more than one entity’s investment strategy, on an alternating basis. Although the Investment Adviser’s investment professionals will endeavor to allocate investment opportunities in a fair and equitable manner, the Company and its stockholders could be adversely affected to the extent investment opportunities are allocated among us and other investment vehicles managed or sponsored by, or affiliated with, our executive officers, directors and members of the Investment Adviser.
 
55

Related party transactions may occur among us, SLR Senior Lending Program LLC, SLR Senior Lending Program SPV LLC, SLR Credit, Equipment Operating Leases LLC, KBH, Loyer Capital LLC, SLR Business Credit, SLR Healthcare ABL and SLR Equipment. These transactions may occur in the normal course of business. No administrative or other fees are paid to the Investment Adviser by SLR Senior Lending Program LLC, SLR Senior Lending Program SPV LLC, SLR Credit, Equipment Operating Leases LLC, KBH, Loyer Capital LLC, SLR Business Credit, SLR Healthcare ABL or SLR Equipment.
In addition, we have adopted a formal code of ethics that governs the conduct of our officers and directors. Our officers and directors also remain subject to the duties imposed by both the 1940 Act and the Maryland General Corporation Law.
 
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
We are subject to financial market risks, including changes in interest rates. Uncertainty with respect to the rising interest rates, inflationary pressures, risks in respect of a failure to increase the U.S. debt ceiling or a downgrade in the U.S. credit rating, the war between Ukraine and Russia and health epidemics and pandemics introduced significant volatility in the financial markets, and the effects of this volatility has materially impacted and could continue to materially impact our market risks. Because we fund a portion of our investments with borrowings, our net investment income is affected by the difference between the rate at which we invest and the rate at which we borrow. As a result, there can be no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income. In a low interest rate environment, including a reduction of LIBOR and SOFR to zero, the difference between the total interest income earned on interest earning assets and the total interest expense incurred on interest bearing liabilities may be compressed, reducing our net interest income and potentially adversely affecting our operating results. Conversely, in a rising interest rate environment, such as the current economic environment, such difference could potentially increase thereby increasing our net investment income. During the six months ended June 30, 2023, certain investments in our comprehensive investment portfolio had floating interest rates. These floating rate investments were primarily based on floating LIBOR or SOFR and typically have durations of one to three months after which they reset to current market interest rates. Additionally, some of these investments have floors. The Company also has revolving credit facilities that are generally based on floating SOFR. Assuming no changes to our balance sheet as of June 30, 2023 and no new defaults by portfolio companies, a hypothetical one percent decrease in LIBOR and SOFR on our comprehensive floating rate assets and liabilities would decrease our net investment income by eight cents per average share over the next twelve months. Assuming no changes to our balance sheet as of June 30, 2023 and no new defaults by portfolio companies, a hypothetical one percent increase in LIBOR and SOFR on our comprehensive floating rate assets and liabilities would increase our net investment income by approximately eight cents per average share over the next twelve months. However, we may hedge against interest rate fluctuations from time to time by using standard hedging instruments such as futures, options, swaps and forward contracts subject to the requirements of the 1940 Act. While hedging activities may insulate us against adverse changes in interest rates, they may also limit our ability to participate in any benefits of certain changes in interest rates with respect to our portfolio of investments. At June 30, 2023, we had no interest rate hedging instruments outstanding on our balance sheet.
 
Increase (Decrease) in LIBOR and SOFR
  
 
(1.00
%) 
 
 
1.00
Increase (Decrease) in Net Investment Income Per Share Per Year
  
$
(0.08
 
$
0.08
 
We may also have exposure to foreign currencies through various investments. These investments are converted into U.S. dollars at the balance sheet date, exposing us to movements in foreign exchange rates. In order to reduce our exposure to fluctuations in foreign exchange rates, we may borrow from time to time in such currencies under our multi-currency revolving credit facility or enter into forward currency or similar contracts.
 
Item 4.
Controls and Procedures
(a) Evaluation of Disclosure Controls and Procedures
As of June 30, 2023 (the end of the period covered by this report), we, including our
Co-Chief
Executive Officers and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule
13a-15(e)
of the 1934 Act). Based on that evaluation, our management, including the
Co-Chief
Executive Officers and Chief Financial Officer, concluded that our disclosure controls and procedures were effective and provided reasonable assurance that information required to be disclosed in our periodic SEC filings is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. However, in evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of such possible controls and procedures.
 
56

(b) Changes in Internal Controls Over Financial Reporting
Management has not identified any change in the Company’s internal control over financial reporting that occurred during the second quarter of 2023 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
PART II. OTHER INFORMATION
 
Item 1.
Legal Proceedings
We and our consolidated subsidiaries are not currently subject to any material legal proceedings, nor, to our knowledge, is any material legal proceeding threatened against us or our consolidated subsidiaries. From time to time, we and our consolidated subsidiaries may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of our rights under contracts with our portfolio companies. While the outcome of these legal proceedings cannot be predicted with certainty, we do not expect that these proceedings will have a material effect upon our financial condition or results of operations.
 
Item 1A.
Risk Factors
In addition to the other information set forth in this report, you should carefully consider the factors discussed in “Risk Factors” in the February 28, 2023 filing of our Annual Report on
Form 10-K, which
could materially affect our business, financial condition and/or operating results. The risks described in our Annual Report are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially and adversely affect our business, financial condition and/or operating results. Other than the risk factors set forth below, there have been no material changes during the period ended June 30, 2023 to the risk factors discussed in “Risk Factors” in the February 28, 2023 filing of our Annual Report on Form
10-K.
Adverse developments affecting the financial services industry, such as actual events or concerns involving liquidity, defaults or
non-performance
by financial institutions or transactional counterparties could have a material adverse effect on us, the Investment Adviser and our portfolio companies.
Cash not held in custody accounts and held by us, our Investment Adviser and by our portfolio companies in
non-interest-bearing
and interest-bearing operating accounts could, at times, exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limits. If such banking institutions were to fail, we, our Investment Adviser, or our portfolio companies could lose all or a portion of those amounts held in excess of such insurance limits. In addition, actual events involving limited liquidity, defaults,
non-performance
or other adverse developments that affect financial institutions, transactional counterparties or other companies in the financial services industry or the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems, which could adversely affect our, our Investment Adviser’s and our portfolio companies’ business, financial condition, results of operations, or prospects.
Although we and our Investment Adviser assess our and our portfolio companies’ banking and financing relationships as we believe necessary or appropriate, our and our portfolio companies’ access to funding sources and other credit arrangements in amounts adequate to finance or capitalize current and projected future business operations could be significantly impaired by factors that affect the financial institutions with which we, our Investment Adviser or our portfolio companies have arrangements directly or the financial services industry or economy in general. These factors could include, among others, events such as liquidity constraints or failures, the ability to perform obligations under various types of financial, credit or liquidity agreements or arrangements, disruptions or instability in the financial services industry or financial markets, or concerns or negative expectations about the prospects for companies in the financial services industry. These factors could involve financial institutions or financial services industry companies with which we, our Investment Adviser or our portfolio companies have financial or business relationships, but could also include factors involving financial markets or the financial services industry generally.
In addition, investor concerns regarding the U.S. or international financial systems could result in less favorable commercial financing terms, including higher interest rates or costs and tighter financial and operating covenants, or systemic limitations on access to credit and liquidity sources, thereby making it more difficult for us, our Investment Adviser, or our portfolio companies to acquire financing on acceptable terms or at all.
Our stock repurchase program could affect the price of our common stock and increase volatility and may be suspended or terminated at any time, which may result in a decrease in the trading price of our common stock.
 
57

On May 9, 2023, the Board most recently extended our share repurchase program (the “Program”), under which we can repurchase up to $50 million of our outstanding common stock. Under the Program, purchases can be made at management’s discretion from time to time in open-market transactions, in accordance with all applicable securities laws and regulations, at prices below the Company’s NAV as reported in its most recently published consolidated financial statements. We have in the past, and could in the future, enter into a plan to repurchase shares of our common stock pursuant to the Program in a manner intended to comply with the requirements of Rule
10b5-1
under the Exchange Act.
The Program is discretionary and whether purchases will be made under the Program and how much will be purchased at any time is uncertain and dependent on prevailing market prices and trading volumes, all of which we cannot predict. These activities could have the effect of maintaining the market price of our common stock or retarding a decline in the market price of the common stock, and, as a result, the price of our common stock could be higher than the price that otherwise might exist in the open market. Repurchases pursuant to the Program could affect the price of our common stock and increase its volatility. The existence of the Program could also cause the price of our common stock to be higher than it would be in the absence of such a program and could potentially reduce the market liquidity for our common stock. There can be no assurance that any stock repurchases will enhance stockholder value because the market price of our common stock could decline below the levels at which we repurchased such shares. Any failure to repurchase shares after we have announced our intention to do so could negatively impact our reputation and investor confidence in us and could negatively impact our stock price. Although the Program is intended to enhance long-term stockholder value, short-term stock price fluctuations could reduce the Program’s
effectiveness.
The alternative reference rates that have replaced LIBOR in our credit arrangements and other financial instruments may not yield the same or similar economic results as LIBOR over the life of such transactions.
The London Interbank Offered Rate (“LIBOR”) is an index rate that historically was widely used in lending transactions and was a common reference rate for setting the floating interest rate on private loans. LIBOR was typically the reference rate used in floating-rate loans extended to our portfolio companies.
The ICE Benchmark Administration (“IBA”) (the entity that is responsible for calculating LIBOR) ceased providing overnight, one, three, six and twelve months USD LIBOR tenors on June 30, 2023. In addition, the United Kingdom’s Financial Conduct Authority (“FCA”), which oversees the IBA, now prohibits entities supervised by the FCA from using LIBORs, including USD LIBOR, except in very limited circumstances.
In the United States, the Secured Overnight Financing Rate (“SOFR”) is the preferred alternative rate for LIBOR. SOFR is a measure of the cost of borrowing cash overnight, collateralized by U.S. Treasury securities, and is based on directly observable U.S. Treasury-backed repurchase transactions. SOFR is published by the Federal Reserve Bank of New York each U.S. Government Securities Business Day, for transactions made on the immediately preceding U.S. Government Securities Business Day. Alternative reference rates that may replace LIBOR, including SOFR for USD transactions, may not yield the same or similar economic results as LIBOR over the lives of such transactions.
As of the filing date of this Quarterly Report on Form 10-Q, many of our loans that referenced LIBOR have been amended to reference the forward-looking term rate published by CME Group Benchmark Administration Limited based on SOFR (“CME Term SOFR”) or CME Term SOFR plus a fixed spread adjustment. CME Term SOFR rates are forward-looking rates that are derived by compounding projected overnight SOFR rates over one, three, and six months taking into account the values of multiple consecutive, executed, one-month and three-month CME Group traded SOFR futures contracts and, in some cases, over-the-counter SOFR Overnight Indexed Swaps as an indicator of CME Term SOFR reference rate values. CME Term SOFR and the inputs on which it is based are derived from SOFR. Since CME Term SOFR is a relatively new market rate, there will likely be no established trading market for credit agreements or other financial instruments when they are issued, and an established market may never develop or may not be liquid. Market terms for instruments referencing CME Term SOFR rates may be lower than those of later-issued CME Term SOFR indexed instruments. Similarly, if CME Term SOFR does not prove to be widely used, the trading price of instruments referencing CME Term SOFR may be lower than those of instruments indexed to indices that are more widely used. Further, the composition and characteristics of SOFR and CME Term SOFR are not the same as those of LIBOR. Even with the application of a fixed spread adjustment, LIBOR and CME Term SOFR will not have the same composition and characteristics, and there can be no assurance that the replacement rate, as so adjusted, will be a direct substitute for LIBOR.
There can be no guarantee that SOFR will not be discontinued or fundamentally altered in a manner that is materially adverse to the interests of investors in loans referencing SOFR. If the manner in which SOFR or CME Term SOFR is calculated is changed, that change may result in a reduction of the amount of interest payable on such loans and the trading prices of the SOFR Loans. In addition, there can be no guarantee that loans referencing SOFR or CME Term SOFR will continue to reference those rates until maturity or that, in the future, our loans will reference benchmark rates other than CME Term SOFR. Should any of these events occur, our loans, and the yield generated thereby, could be affected. Specifically, the anticipated yield on our loans may not be fully realized and our loans may be subject to increased pricing volatility and market risk.
 
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
We did not engage in unregistered sales of securities during the quarter ended June 30, 2023.
 
Item 3.
Defaults Upon Senior Securities
None.
 
Item 4.
Mine Safety Disclosures
Not applicable.
 
Item 5.
Other Information
Rule
10b5-1
Trading Plans
During the fiscal quarter ended June 30, 2023
none of
our directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities to satisfy the affirmative defense conditions of Rule
10b5-1(c)
under the Exchange Act or any
“non-Rule
10b5-1
trading arrangement” as defined in Item 408(c) of Regulation S-K.
 
58

Item 6.
Exhibits
The following exhibits are filed as part of this report or hereby incorporated by reference to exhibits previously filed with the SEC:
 
Exhibit
Number
  
Description
2.1
  
3.1
  
3.2
  
4.1
  
4.2
  
23.1
  
31.1
  
31.2
  
31.3
  
32.1
  
32.2
  
32.3
  
101.INS
  
Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.*
101.SCH
  
Inline XBRL Taxonomy Extension Schema Document*
101.CAL
  
Inline XBRL Taxonomy Extension Calculation Linkbase Document*
101.DEF
  
Inline XBRL Taxonomy Extension Definition Linkbase Document*
101.LAB
  
Inline XBRL Taxonomy Extension Label Linkbase Document*
101.PRE
  
Inline XBRL Taxonomy Extension Presentation Linkbase Document*
104
  
Cover Page Interactive Data File – The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
 
(1)
Previously filed in connection with SLR Investment Corp.’s registration statement on Form N-2 Pre-Effective Amendment No. 7 (File No. 333-148734) filed on January 7, 2010.
(2)
Previously filed in connection with SLR Investment Corp.’s registration statement on Form N-2 (File No 333-148734) filed on February 9, 2010.
(3)
Previously filed in connection with SLR Investment Corp.’s registration statement on Form N-2 Post-Effective Amendment No. 6 (File No. 333-172968) filed on November 16, 2012.
(4)
Previously filed in connection with SLR Investment Corp.’s report on Form 8-K filed on December 1, 2021.
*
Filed herewith.
 
59

SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on August 8, 2023.
 
SLR INVESTMENT CORP.
By:  
/s/ M
ICHAEL
S. G
ROSS
 
Michael S. Gross
Co-Chief Executive Officer
(Principal Executive Officer)
By:  
/s/ B
RUCE
J. S
POHLER
 
Bruce J. Spohler
Co-Chief Executive Officer
(Principal Executive Officer)
By:  
/s/ S
HIRAZ
Y. K
AJEE
 
Shiraz Y. Kajee
Chief Financial Officer
(Principal Financial and Accounting Officer)
 
60
EX-23.1 2 d518171dex231.htm EX-23.1 EX-23.1

Exhibit 23.1

August 8, 2023

SLR Investment Corp.

New York, New York

Re: Registration Statement No. 333-255662

With respect to the subject registration statement, we acknowledge our awareness of the use therein of our report dated August 8, 2023 related to our review of interim financial information.

Pursuant to Rule 436 under the Securities Act of 1933 (the Act), such report is not considered part of a registration statement prepared or certified by an independent registered public accounting firm, or a report prepared or certified by an independent registered public accounting firm within the meaning of Sections 7 and 11 of the Act.

/s/ KPMG LLP

New York, New York

EX-31.1 3 d518171dex311.htm EX-31.1 EX-31.1

EXHIBIT 31.1

CERTIFICATION OF CO-CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Michael S. Gross, certify that:

1. I have reviewed this quarterly report on Form 10-Q of SLR Investment Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated this 8th day of August, 2023

 

/s/ MICHAEL S. GROSS

Michael S. Gross
EX-31.2 4 d518171dex312.htm EX-31.2 EX-31.2

EXHIBIT 31.2

CERTIFICATION OF CO-CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Bruce J. Spohler, certify that:

1. I have reviewed this quarterly report on Form 10-Q of SLR Investment Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated this 8th day of August, 2023

 

/s/ BRUCE J. SPOHLER

Bruce J. Spohler
EX-31.3 5 d518171dex313.htm EX-31.3 EX-31.3

EXHIBIT 31.3

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Shiraz Y. Kajee, certify that:

1. I have reviewed this quarterly report on Form 10-Q of SLR Investment Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated this 8th day of August, 2023

 

/s/ SHIRAZ Y. KAJEE

Shiraz Y. Kajee
EX-32.1 6 d518171dex321.htm EX-32.1 EX-32.1

EXHIBIT 32.1

CERTIFICATION OF CO-CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. 1350)

In connection with the Quarterly Report on Form 10-Q for the period ended June 30, 2023 (the “Report”) of SLR Investment Corp. (the “Registrant”), as filed with the Securities and Exchange Commission on the date hereof, I, MICHAEL S. GROSS, the Co-Chief Executive Officer of the Registrant, hereby certify, to the best of my knowledge, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

 

/s/ MICHAEL S. GROSS

Name:   Michael S. Gross
Date:   August 8, 2023
EX-32.2 7 d518171dex322.htm EX-32.2 EX-32.2

EXHIBIT 32.2

CERTIFICATION OF CO-CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. 1350)

In connection with the Quarterly Report on Form 10-Q for the period ended June 30, 2023 (the “Report”) of SLR Investment Corp. (the “Registrant”), as filed with the Securities and Exchange Commission on the date hereof, I, BRUCE J. SPOHLER, the Co-Chief Executive Officer of the Registrant, hereby certify, to the best of my knowledge, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

 

/s/ BRUCE J. SPOHLER

Name:   Bruce J. Spohler
Date:   August 8, 2023
EX-32.3 8 d518171dex323.htm EX-32.3 EX-32.3

EXHIBIT 32.3

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. 1350)

In connection with the Quarterly Report on Form 10-Q for the period ended June 30, 2023 (the “Report”) of SLR Investment Corp. (the “Registrant”), as filed with the Securities and Exchange Commission on the date hereof, I, SHIRAZ Y. KAJEE, the Chief Financial Officer of the Registrant, hereby certify, to the best of my knowledge, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

 

/s/ SHIRAZ Y. KAJEE

Name:   Shiraz Y. Kajee
Date:   August 8, 2023
EX-101.SCH 9 slrc-20230630.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - Consolidated Statements of Assets And Liabilities link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - Consolidated Statements of Assets And Liabilities (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - Consolidated Statements of Operations link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - Consolidated Statements of Changes In Net Assets link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 1007 - Statement - Consolidated Statements of Cash Flows (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1008 - Statement - Consolidated Schedule of Investments link:presentationLink link:definitionLink link:calculationLink 1009 - Statement - Consolidated Schedule of Investments (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 999001 - Disclosure - Organization link:presentationLink link:definitionLink link:calculationLink 999002 - Disclosure - Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 999003 - Disclosure - Agreements link:presentationLink link:definitionLink link:calculationLink 999004 - Disclosure - Net Asset Value Per Share link:presentationLink link:definitionLink link:calculationLink 999005 - Disclosure - Earnings Per Share link:presentationLink link:definitionLink link:calculationLink 999006 - Disclosure - Fair Value link:presentationLink link:definitionLink link:calculationLink 999007 - Disclosure - Debt link:presentationLink link:definitionLink link:calculationLink 999008 - Disclosure - Financial Highlights link:presentationLink link:definitionLink link:calculationLink 999009 - Disclosure - SLR Credit Solutions link:presentationLink link:definitionLink link:calculationLink 999010 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 999011 - Disclosure - SLR Equipment Finance link:presentationLink link:definitionLink link:calculationLink 999012 - Disclosure - Capital Share Transactions link:presentationLink link:definitionLink link:calculationLink 999013 - Disclosure - Kingsbridge Holdings, LLC link:presentationLink link:definitionLink link:calculationLink 999014 - Disclosure - SLR Healthcare ABL link:presentationLink link:definitionLink link:calculationLink 999015 - Disclosure - SLR Business Credit link:presentationLink link:definitionLink link:calculationLink 999016 - Disclosure - Stock Repurchase Program link:presentationLink link:definitionLink link:calculationLink 999017 - Disclosure - SLR Senior Lending Program LLC link:presentationLink link:definitionLink link:calculationLink 999018 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 999019 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:definitionLink link:calculationLink 999020 - Disclosure - Fair Value (Tables) link:presentationLink link:definitionLink link:calculationLink 999021 - Disclosure - Debt (Tables) link:presentationLink link:definitionLink link:calculationLink 999022 - Disclosure - Financial Highlights (Tables) link:presentationLink link:definitionLink link:calculationLink 999023 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:definitionLink link:calculationLink 999024 - Disclosure - Capital Share Transactions (Tables) link:presentationLink link:definitionLink link:calculationLink 999025 - Disclosure - SLR Senior Lending Program LLC (Tables) link:presentationLink link:definitionLink link:calculationLink 999026 - Disclosure - Organization - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999027 - Disclosure - Significant Accounting Policies - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999028 - Disclosure - Agreements - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999029 - Disclosure - Net Asset Value Per Share - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999030 - Disclosure - Earnings Per Share - Summary of Computation of Basic and Diluted Net (Details) link:presentationLink link:definitionLink link:calculationLink 999031 - Disclosure - Fair Value - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) link:presentationLink link:definitionLink link:calculationLink 999032 - Disclosure - Fair Value - Summary of Changes in Fair Value of Level 3 Assets and Liabilities (Details) link:presentationLink link:definitionLink link:calculationLink 999033 - Disclosure - Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Details) link:presentationLink link:definitionLink link:calculationLink 999034 - Disclosure - Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Parenthetical) (Details) link:presentationLink link:definitionLink link:calculationLink 999035 - Disclosure - Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Details) link:presentationLink link:definitionLink link:calculationLink 999036 - Disclosure - Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Parenthetical) (Details) link:presentationLink link:definitionLink link:calculationLink 999037 - Disclosure - Debt - Schedule of Long-term Debt Instruments (Details) link:presentationLink link:definitionLink link:calculationLink 999038 - Disclosure - Debt - Schedule of Long-term Debt Instruments (Parenthetical) (Details) link:presentationLink link:definitionLink link:calculationLink 999039 - Disclosure - Debt - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999040 - Disclosure - Financial Highlights - Schedule of Financial Highlights (Details) link:presentationLink link:definitionLink link:calculationLink 999041 - Disclosure - Financial Highlights - Schedule of Financial Highlights (Parentheticals) (Details) link:presentationLink link:definitionLink link:calculationLink 999042 - Disclosure - SLR Credit Solutions - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999043 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999044 - Disclosure - Commitments and Contingencies - Summary of Unfunded Debt and Equity Commitments (Details) link:presentationLink link:definitionLink link:calculationLink 999045 - Disclosure - SLR Equipment Finance - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999046 - Disclosure - Capital Share Transactions - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999047 - Disclosure - Capital Share Transactions - Summary of Transactions In Capital Stock (Details) link:presentationLink link:definitionLink link:calculationLink 999048 - Disclosure - Kingsbridge Holdings, LLC - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999049 - Disclosure - SLR Healthcare ABL - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999050 - Disclosure - SLR Business Credit - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999051 - Disclosure - Stock Repurchase Program - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999052 - Disclosure - SLR Senior Lending Program LLC - Summary of SSLP's portfolio (Details) link:presentationLink link:definitionLink link:calculationLink 999053 - Disclosure - SLR Senior Lending Program LLC - Summary financial information for SSLP (Details) link:presentationLink link:definitionLink link:calculationLink 999054 - Disclosure - SLR Senior Lending Program LLC - Summary financial information for SSLP (Parenthetical) (Details) link:presentationLink link:definitionLink link:calculationLink 999055 - Disclosure - SLR Senior Lending Program LLC - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999056 - Disclosure - Subsequent Events - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 10 slrc-20230630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 11 slrc-20230630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 12 slrc-20230630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 13 slrc-20230630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 14 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover Page - shares
6 Months Ended
Jun. 30, 2023
Aug. 04, 2023
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Jun. 30, 2023  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q2  
Entity Registrant Name SLR INVESTMENT CORP.  
Securities Act File Number 814-00754  
Entity Tax Identification Number 26-1381340  
Trading Symbol SLRC  
Entity Central Index Key 0001418076  
Current Fiscal Year End Date --12-31  
Document Quarterly Report true  
Document Transition Report false  
Entity Current Reporting Status Yes  
Entity Filer Category Large Accelerated Filer  
Entity Interactive Data Current Yes  
City Area Code 212  
Local Phone Number 993-1670  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Address, Address Line One 500 Park Avenue  
Entity Shell Company false  
Title of 12(b) Security Common Stock, par value $0.01 per share  
Security Exchange Name NASDAQ  
Entity Address, State or Province NY  
Entity Address, City or Town New York  
Entity Address, Postal Zip Code 10022  
Entity Incorporation, State or Country Code MD  
Entity Common Stock, Shares Outstanding   54,554,634
XML 15 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Assets And Liabilities - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Investments at fair value:    
Cash $ 14,428 $ 10,743
Cash equivalents (cost: $333,200 and $417,590, respectively) 333,200 417,590
Dividends receivable 10,754 11,192
Interest receivable 11,071 9,706
Receivable for investments sold 1,469 1,124
Prepaid expenses and other assets 882 664
Total assets 2,553,230 2,537,695
Liabilities    
Debt ($1,219,200 and $1,093,200 face amounts, respectively, reported net of unamortized debt issuance costs of $6,167 and $7,202, respectively. See notes 6 and 7) 1,213,033 1,085,998
Payable for investments and cash equivalents purchased 333,200 417,611
Distributions payable 0 7,481
Management fee payable (see note 3) 7,878 7,964
Performance-based incentive fee payable (see note 3) 5,513 5,422
Interest payable (see note 7) 6,937 7,943
Administrative services payable (see note 3) 2,166 1,488
Other liabilities and accrued expenses 3,698 4,057
Total liabilities 1,572,425 1,537,964
Commitments and contingencies (see note 10)
Net Assets    
Common stock, par value $0.01 per share, 200,000,000 and 200,000,000 common shares authorized, respectively, and 54,554,634 and 54,555,380 shares issued and outstanding, respectively 546 546
Paid-in capital in excess of par 1,162,559 1,162,569
Accumulated distributable net loss (182,300) (163,384)
Total net assets $ 980,805 $ 999,731
Net Asset Value Per Share $ 17.98 $ 18.33
Companies less than 5% owned [Member]    
Investments at fair value:    
Investments at fair value: $ 1,340,356 $ 1,289,082
Companies more than 25% owned [Member]    
Investments at fair value:    
Investments at fair value: 798,913 797,594
Companies 5% to 25% owned [Member]    
Investments at fair value:    
Investments at fair value: $ 42,157 $ 0
XML 16 R3.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Assets And Liabilities (Parenthetical) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Investment owned, at cost $ 2,582,726,000 $ 2,552,177,000
Cash equivalents at cost 333,200,000 417,590,000
Debt instrument, face amount 1,219,200,000 1,093,200,000
Debt issuance costs $ 6,167,000 $ 7,202,000
Common stock, par or stated value per share $ 0.01 $ 0.01
Common Stock, shares authorized 200,000,000 200,000,000
Common stock, shares, issued 54,554,634 54,555,380
Common stock, shares, outstanding 54,554,634 54,555,380
Companies less than 5% owned [Member]    
Investment owned, at cost $ 1,358,634 $ 1,312,701
Companies 5% to 25% owned [Member]    
Investment owned, at cost 59,803 0
Companies more than 25% owned [Member]    
Investment owned, at cost $ 831,089 $ 821,886
XML 17 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
INVESTMENT INCOME:        
Total investment income $ 56,337 $ 42,780 $ 109,884 $ 75,786
EXPENSES:        
Management fees (see note 3) 7,878 6,913 15,584 14,129
Performance-based incentive fees (see note 3) 5,638 4,734 11,147 4,734
Interest and other credit facility expenses (see note 7) 17,842 10,352 33,128 18,680
Administrative services expense (see note 3) 1,480 1,369 2,988 2,552
Other general and administrative expenses 948 476 2,449 3,277
Total expenses 33,786 23,844 65,296 43,372
Performance-based incentive fees waived (see note 3) (125) (1,358) (235) (1,358)
Net expenses 33,661 22,486 65,061 42,014
Net investment income 22,676 20,294 44,823 33,772
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND CASH EQUIVALENTS:        
Net realized gain (loss) on investments and cash equivalents (companies less than 5% owned) 498 (105) 1,185 (75)
Net change in unrealized gain (loss) on investments and cash equivalents:        
Net change in unrealized gain (loss) on investments and cash equivalents (4,179) (35,835) (20,189) (47,880)
Net realized and unrealized gain (loss) on investments and cash equivalents (3,681) (35,940) (19,004) (47,955)
Net increase (decrease) in net assets resulting from operations $ 18,995 $ (15,646) $ 25,819 $ (14,183)
Earnings (loss) Per Share, Basic $ 0.35 $ (0.29) $ 0.47 $ (0.29)
Earnings (loss) Per Share, Diluted $ 0.35 $ (0.29) $ 0.47 $ (0.29)
Companies less than 5% owned [Member]        
INVESTMENT INCOME:        
Interest $ 41,267 $ 28,855 $ 78,605 $ 49,517
Other income 757 925 3,079 988
Net change in unrealized gain (loss) on investments and cash equivalents:        
Net change in unrealized gain (loss) on investments and cash equivalents 5,181 (11,764) (9,090) (25,262)
Companies 5% to 25% owned [Member]        
INVESTMENT INCOME:        
Interest 265 0 265 0
Net change in unrealized gain (loss) on investments and cash equivalents:        
Net change in unrealized gain (loss) on investments and cash equivalents (3,216) 0 (3,216) 0
Companies more than 25% owned [Member]        
INVESTMENT INCOME:        
Interest 2,814 1,922 5,525 4,483
Dividends 11,177 11,083 22,353 20,798
Other income 57 (5) 57 0
Net change in unrealized gain (loss) on investments and cash equivalents:        
Net change in unrealized gain (loss) on investments and cash equivalents $ (6,144) $ (24,071) $ (7,883) $ (22,618)
XML 18 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Changes In Net Assets - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Increase (decrease) in net assets resulting from operations:        
Net investment income $ 22,676 $ 20,294 $ 44,823 $ 33,772
Net realized gain (loss) 498 (105) 1,185 (75)
Net change in unrealized loss (4,179) (35,835) (20,189) (47,880)
Net increase (decrease) in net assets resulting from operations 18,995 (15,646) 25,819 (14,183)
Distributions to stockholders:        
From net investment income (22,588) (22,457) (44,735) (39,784)
From return of capital 220 0 0 0
Net distributions to stockholders (22,368) (22,457) (44,735) (39,784)
Capital transactions (see note 12):        
Issuance of common stock 0 226,839 0 226,839
Repurchases of common stock 0 0 (10) 0
Net capital transactions 0 226,839 (10) 226,839
Total increase (decrease) in net assets (3,373) 188,736 (18,926) 172,872
Net assets at beginning of period 984,178 826,417 999,731 842,281
Net assets at end of period $ 980,805 $ 1,015,153 $ 980,805 $ 1,015,153
Capital stock activity (see note 12):        
Issuance of common stock 0 12,511,825 0 12,511,825
Repurchases of common stock 0 0 (746) 0
Net capital stock activity 0 12,511,825 (746) 12,511,825
XML 19 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash Flows from Operating Activities    
Net increase (decrease) in net assets resulting from operations $ 25,819 $ (14,183)
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:    
Net realized (gain) loss on investments and cash equivalents (1,185) 75
Net change in unrealized loss on investments 20,189 47,880
(Increase) decrease in operating assets:    
Purchase of investments (368,924) (160,973)
Proceeds from disposition of investments 267,224 179,122
Net accretion of discount on investments (5,850) (4,769)
Capitalization of payment-in-kind income (6,206) (1,019)
Collections of payment-in-kind income 2 898
Receivable for investments sold (345) 293
Interest receivable (1,365) (1,863)
Dividends receivable 438 (1,615)
Prepaid expenses and other assets (218) (360)
Cash acquired in merger 0 2,313
Increase (decrease) in operating liabilities:    
Payable for investments and cash equivalents purchased (84,411) 28,871
Management fee payable (86) (519)
Performance-based incentive fee payable 91 1,512
Administrative services expense payable 678 (1,733)
Interest payable (1,006) 2,618
Other liabilities and accrued expenses (359) 1,619
Deferred financing costs/market discount 1,035 1,009
Net Cash Provided by (Used in) Operating Activities (154,479) 79,176
Cash Flows from Financing Activities:    
Cash distributions paid (52,216) (49,625)
Proceeds from unsecured borrowings 0 134,914
Repayment of unsecured borrowings (75,000) (150,000)
Proceeds from secured borrowings 400,000 338,404
Repayment of secured borrowings (199,000) (298,100)
Repurchase of common stock (10) 0
Net Cash Provided by (Used in) Financing Activities 73,774 (24,407)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (80,705) 54,769
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 428,333 322,935
CASH AND CASH EQUIVALENTS AT END OF PERIOD 347,628 377,704
Supplemental disclosure of cash flow information:    
Cash paid for interest 34,134 16,062
Issuance of shares in connection with the Mergers [1] $ 0 $ 226,839
[1] On April 1, 2022, in connection with the Merger (as defined in Note 1 “Organization”), the Company acquired net assets of $244,691 for the total stock consideration of $226,839.
XML 20 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Cash Flows (Parenthetical)
$ in Thousands
Apr. 01, 2022
USD ($)
Statement of Cash Flows [Abstract]  
Noncash or part noncash acquisition, value of assets acquired $ 244,691
Stock issued $ 226,839
XML 21 R8.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Schedule of Investments - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Schedule of Investments [Line Items]    
Cost $ 2,582,726 $ 2,552,177
Total Investments & Cash Equivalents 2,514,626 2,504,266
Liabilities in Excess of Other Assets (1,533,821) (1,504,535)
Total net assets $ 980,805 $ 999,731
Percentage of Total Investments (at fair value) 100.00% 100.00%
Senior Secured Loans — 134.4% [Member]    
Schedule of Investments [Line Items]    
Cost $ 1,351,873  
Fair Value 1,318,512  
Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Cost 964,165  
Fair Value 933,818  
Senior Secured Loans — 134.4% [Member] | Second Lien Asset-Based Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Cost 37,442  
Fair Value 37,926  
Senior Secured Loans — 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Cost 337,969  
Fair Value 339,519  
Senior Secured Loans — 124.6% [Member]    
Schedule of Investments [Line Items]    
Cost   $ 1,272,952
Fair Value   1,245,414
Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Cost   912,558
Fair Value   886,513
Senior Secured Loans — 124.6% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Cost   319,205
Fair Value   322,455
Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Cost 296,905  
Fair Value 271,333  
Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Cost   291,445
Fair Value   265,952
Common Equity/Equity Interests/Warrants—59.9% [Member]    
Schedule of Investments [Line Items]    
Cost 595,698  
Fair Value 587,780  
Common Equity/Equity Interests/Warrants—57.1% [Member]    
Schedule of Investments [Line Items]    
Cost   565,263
Fair Value   571,509
Total Investments [Member]    
Schedule of Investments [Line Items]    
Cost 2,249,526 [1] 2,134,587 [2]
Fair Value $ 2,181,426 [1] $ 2,086,676 [2]
Multi-Sector Holdings (includes Kingsbridge Holdings, LLC, SLR Equipment Finance, Equipment Operating Leases, LLC and Loyer Capital LLC) [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 16.60% 17.50%
Diversified Financial Services (includes SLR Credit Solutions, SLR Business Credit and SLR Healthcare ABL) [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 21.00% 22.10%
Health Care Providers & Services [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 10.70% 7.70%
Pharmaceuticals [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 5.50% 5.50%
Health Care Equipment & Supplies [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 6.60% 6.60%
Software [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 4.00% 4.30%
Biotechnology [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 3.80% 3.90%
Wireless Telecommunication Services [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 1.10% 1.10%
Capital Markets [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 2.00% 1.70%
Personal Products [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 1.40% 1.70%
Road & Rail [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 1.40% 1.70%
IT Services [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.50% 0.60%
Insurance [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 4.20% 4.20%
Diversified Consumer Services [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 3.60% 2.70%
Commercial Services & Supplies [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 1.70% 1.10%
Auto Parts & Equipment [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 1.20% 1.20%
Internet & Catalog Retail [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.70% 1.10%
Packaged Foods & Meats [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 1.10% 1.20%
Life Sciences Tools & Services [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 1.10% 1.30%
Communications Equipment [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.60% 0.70%
Specialty Retail [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.50% 0.50%
Auto Components [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.30% 0.40%
Airlines [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.20% 0.30%
Health Care Technology [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.70% 0.80%
Transportation Infrastructure [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.70% 0.70%
Machinery [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.20% 0.30%
Metals & Mining [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.20% 0.20%
Aerospace & Defense [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.30% 0.30%
Consumer Finance [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.10% 0.10%
Construction & Engineering [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.10% 0.00%
Hotels, Restaurants & Leisure [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.30% 0.30%
Oil, Gas & Consumable Fuels [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.30% 0.30%
Containers & Packaging [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.00% 0.00%
Energy Equipment & Services [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.00% 0.00%
Building Products [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.90% 0.90%
Internet Software & Services [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.90% 1.00%
Trading Companies and Distributors [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.60% 0.90%
Leisure Equipment and Products [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.50% 0.50%
Footwear [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.20% 0.30%
Water Utilities [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.10% 0.10%
Cash Equivalents — 41.8% [Member] | U.S. Treasury Bill [Member]    
Schedule of Investments [Line Items]    
Industry   Government
Acquisition Date   Dec. 30, 2022
Maturity Date   Feb. 23, 2023
Par Amount   $ 420,000
Cost   417,590
Fair Value   $ 417,590
Thrifts & Mortgage Finance [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 1.40% 1.30%
Media [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 1.40% 1.90%
Food Products [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.20% 0.40%
Food & Staples Retailing [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.10% 0.10%
Asset Management [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 1.00% 0.50%
Cash Equivalents — 34.0% [Member] | U.S. Treasury Bill [Member]    
Schedule of Investments [Line Items]    
Industry Government  
Acquisition Date Jun. 30, 2023  
Maturity Date Aug. 10, 2023  
Par Amount $ 335,000  
Cost 333,200  
Fair Value $ 333,200  
Aegis Toxicology Sciences Corporation [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Health Care Providers & Services  
Spread Above Index [3],[4] S+550  
Floor [3] 1.00%  
Interest Rate [3],[5] 10.84%  
Acquisition Date [3] May 07, 2018  
Maturity Date [3] May 09, 2025  
Par Amount [3] $ 13,480  
Cost [3] 13,249  
Fair Value [3] $ 13,480  
Aegis Toxicology Sciences Corporation [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Health Care Providers & Services
Spread Above Index [3],[4]   L+550
Floor [3]   1.00%
Interest Rate [3],[6]   10.09%
Acquisition Date [3]   May 07, 2018
Maturity Date [3]   May 09, 2025
Par Amount [3]   $ 17,103
Cost [3]   16,793
Fair Value [3]   $ 17,103
All State Ag Parts, LLC [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Trading Companies & Distributors  
Spread Above Index [3],[4] S+575  
Floor [3] 1.00%  
Interest Rate [3],[5] 11.25%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Sep. 01, 2026  
Par Amount [3] $ 4,494  
Cost [3] 4,393  
Fair Value [3] $ 4,494  
All State Ag Parts, LLC [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Trading Companies & Distributors
Spread Above Index [3],[4]   S+575
Floor [3]   1.00%
Interest Rate [3],[6]   10.19%
Acquisition Date [3]   Apr. 01, 2022
Maturity Date [3]   Sep. 01, 2026
Par Amount [3]   $ 4,197
Cost [3]   4,081
Fair Value [3]   $ 4,197
American Teleconferencing Services, Ltd. [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [7] Communications Equipment  
Spread Above Index [4],[7] L+650  
Floor [7] 1.00%  
Interest Rate [5],[7] 0.00%  
Acquisition Date [7] May 05, 2016  
Maturity Date [7] Sep. 09, 2021  
Par Amount [7] $ 36,135  
Cost [7] 25,926  
Fair Value [7] $ 0  
American Teleconferencing Services, Ltd. [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [7]   Communications Equipment
Spread Above Index [4],[7]   L+650
Floor [7]   1.00%
Interest Rate [6],[7]   0.00%
Acquisition Date [7]   May 05, 2016
Maturity Date [7]   Sep. 09, 2021
Par Amount [7]   $ 36,135
Cost [7]   25,926
Fair Value [7]   $ 0
American Teleconferencing Services, Ltd. [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [7] Communications Equipment  
Spread Above Index [4],[7] L+650  
Floor [7] 1.00%  
Interest Rate [5],[7] 0.00%  
Acquisition Date [7] Sep. 17, 2021  
Maturity Date [7] Apr. 07, 2023  
Par Amount [7] $ 6,115  
Cost [7] 5,971  
Fair Value [7] $ 0  
American Teleconferencing Services, Ltd. [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [7]   Communications Equipment
Spread Above Index [4],[7]   L+650
Floor [7]   1.00%
Interest Rate [6],[7]   0.00%
Acquisition Date [7]   Sep. 17, 2021
Maturity Date [7]   Jan. 31, 2023
Par Amount [7]   $ 6,405
Cost [7]   6,254
Fair Value [7]   $ 224
AmeriMark Intermediate Holdings, LLC [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [8],[9] Internet & Catalog Retail  
Spread Above Index [4],[8],[9] P+475  
Floor [8],[9] 1.00%  
Interest Rate [5],[8],[9] 13.00%  
Acquisition Date [8],[9] Jun. 16, 2023  
Maturity Date [8],[9] Aug. 04, 2023  
Par Amount [8],[9] $ 464  
Cost [8],[9] 464  
Fair Value [8],[9] $ 464  
AmeriMark Intermediate Holdings, LLC [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [10]   Internet & Catalog Retail
Spread Above Index [4],[10]   L+800
Floor [10]   1.00%
Interest Rate [6],[10]   14.77%
Acquisition Date [10]   Jul. 28, 2021
Maturity Date [10]   Oct. 15, 2026
Par Amount [10]   $ 24,087
Cost [10]   23,711
Fair Value [10]   $ 22,882
AmeriMark Intermediate Holdings, LLC [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [7],[8],[9] Internet & Catalog Retail  
Spread Above Index [4],[7],[8],[9] S+800  
Floor [7],[8],[9] 1.00%  
Interest Rate [5],[7],[8],[9] 0.00%  
Acquisition Date [7],[8],[9] Jul. 28, 2021  
Maturity Date [7],[8],[9] Oct. 15, 2026  
Par Amount [7],[8],[9] $ 18,743  
Cost [7],[8],[9] 17,071  
Fair Value [7],[8],[9] $ 5,134  
Apex Services Partners, LLC [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Diversified Consumer Services  
Spread Above Index [3],[4] S+525  
Floor [3] 1.00%  
Interest Rate [3],[5] 10.66%  
Acquisition Date [3] Aug. 31, 2022  
Maturity Date [3] Jul. 31, 2025  
Par Amount [3] $ 13,916  
Cost [3] 13,607  
Fair Value [3] $ 13,916  
Apex Services Partners, LLC [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Diversified Consumer Services
Spread Above Index [3],[4]   S+525
Floor [3]   1.00%
Interest Rate [3],[6]   9.80%
Acquisition Date [3]   Aug. 31, 2022
Maturity Date [3]   Jul. 31, 2025
Par Amount [3]   $ 14,021
Cost [3]   13,644
Fair Value [3]   $ 14,021
Atria Wealth Solutions, Inc. [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Diversified Financial Services  
Spread Above Index [3],[4] S+650  
Floor [3] 1.00%  
Interest Rate [3],[5] 12.00%  
Acquisition Date [3] Sep. 14, 2018  
Maturity Date [3] Feb. 29, 2024  
Par Amount [3] $ 8,098  
Cost [3] 8,074  
Fair Value [3] $ 8,098  
Atria Wealth Solutions, Inc. [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Diversified Financial Services
Spread Above Index [3],[4]   S+600
Floor [3]   1.00%
Interest Rate [3],[6]   10.84%
Acquisition Date [3]   Sep. 14, 2018
Maturity Date [3]   Feb. 29, 2024
Par Amount [3]   $ 8,149
Cost [3]   8,107
Fair Value [3]   $ 8,149
Basic Fun, Inc. [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Specialty Retail  
Spread Above Index [3],[4] S+650  
Floor [3] 1.00%  
Interest Rate [3],[5] 12.04%  
Acquisition Date [3] Oct. 30, 2020  
Maturity Date [3] Oct. 30, 2023  
Par Amount [3] $ 2,150  
Cost [3] 2,146  
Fair Value [3] $ 2,150  
Basic Fun, Inc. [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Specialty Retail
Spread Above Index [3],[4]   L+550
Floor [3]   1.00%
Interest Rate [3],[6]   10.27%
Acquisition Date [3]   Oct. 30, 2020
Maturity Date [3]   Oct. 30, 2023
Par Amount [3]   $ 2,162
Cost [3]   2,152
Fair Value [3]   $ 2,162
BayMark Health Services Inc [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Health Care Providers & Services  
Spread Above Index [3],[4] S+500  
Floor [3] 1.00%  
Interest Rate [3],[5] 10.50%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Jun. 11, 2027  
Par Amount [3] $ 8,308  
Cost [3] 8,026  
Fair Value [3] $ 8,308  
BayMark Health Services Inc [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Health Care Providers & Services
Spread Above Index [3],[4]   L+500
Floor [3]   1.00%
Interest Rate [3],[6]   9.73%
Acquisition Date [3]   Apr. 01, 2022
Maturity Date [3]   Jun. 11, 2027
Par Amount [3]   $ 9,432
Cost [3]   9,078
Fair Value [3]   $ 9,432
Bayside Opco, LLC [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [9] Healthcare Providers & Services  
Spread Above Index [4],[9],[11] S+700  
Floor [9] 1.00%  
Interest Rate [5],[9] 12.73%  
Acquisition Date [9] May 31, 2023  
Maturity Date [9] May 31, 2026  
Par Amount [9] $ 846  
Cost [9] 846  
Fair Value [9] $ 846  
Bayside Opco, LLC [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [9] Healthcare Providers & Services  
Spread Above Index [4],[9],[12] S+725  
Floor [9] 1.00%  
Interest Rate [5],[9] 12.64%  
Acquisition Date [9] May 31, 2023  
Maturity Date [9] May 31, 2026  
Par Amount [9] $ 18,224  
Cost [9] 18,224  
Fair Value [9] $ 18,224  
Bayside Parent, LLC [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [9] Healthcare Providers & Services  
Spread Above Index [4],[9],[12] S+1000  
Floor [9] 1.00%  
Interest Rate [5],[9] 15.39%  
Acquisition Date [9] May 31, 2023  
Maturity Date [9] May 31, 2026  
Par Amount [9] $ 4,773  
Cost [9] 4,773  
Fair Value [9] $ 4,773  
Bayside Parent, LLC [Member] | Common Equity/Equity Interests/Warrants—59.9% [Member]    
Schedule of Investments [Line Items]    
Industry [9],[13] Health Care Providers & Services  
Acquisition Date [9],[13] May 31, 2023  
Shares/Units [9],[13] 6,526  
Cost [9],[13] $ 11,411  
Fair Value [9],[13] $ 3,819  
CC SAG Holdings Corp. (Spectrum Automotive) [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Diversified Consumer Services  
Spread Above Index [3],[4] S+575  
Floor [3] 0.75%  
Interest Rate [3],[5] 11.25%  
Acquisition Date [3] Jun. 29, 2021  
Maturity Date [3] Jun. 29, 2028  
Par Amount [3] $ 39,680  
Cost [3] 39,053  
Fair Value [3] $ 39,680  
CC SAG Holdings Corp. (Spectrum Automotive) [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Diversified Consumer Services
Spread Above Index [3],[4]   L+575
Floor [3]   0.75%
Interest Rate [3],[6]   10.48%
Acquisition Date [3]   Jun. 29, 2021
Maturity Date [3]   Jun. 29, 2028
Par Amount [3]   $ 20,427
Cost [3]   20,057
Fair Value [3]   $ 20,427
Composite Technology Acquisition Corp. [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Building Products  
Spread Above Index [3],[4] S+450  
Floor [3] 1.00%  
Interest Rate [3],[5] 9.89%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Feb. 01, 2025  
Par Amount [3] $ 10,999  
Cost [3] 10,691  
Fair Value [3] $ 10,999  
Composite Technology Acquisition Corp. [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Building Products
Spread Above Index [3],[4]   L+475
Floor [3]   1.00%
Interest Rate [3],[6]   9.73%
Acquisition Date [3]   Apr. 01, 2022
Maturity Date [3]   Feb. 01, 2025
Par Amount [3]   $ 10,386
Cost [3]   9,983
Fair Value [3]   $ 10,386
Copper River Seafoods, Inc. [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Food Products  
Spread Above Index [4] P+275  
Floor 0.00%  
Interest Rate [5] 11.75%  
Acquisition Date Aug. 31, 2022  
Maturity Date Apr. 23, 2025  
Par Amount $ 3,842  
Cost 3,842  
Fair Value $ 3,842  
Copper River Seafoods, Inc. [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Food Products
Spread Above Index [4]   P+275
Floor   0.00%
Interest Rate [6]   10.25%
Acquisition Date   Aug. 31, 2022
Maturity Date   Apr. 23, 2025
Par Amount   $ 8,405
Cost   8,405
Fair Value   $ 8,405
CVAUSA Management, LLC,, [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Providers & Services  
Spread Above Index [4] S+650  
Floor 1.00%  
Interest Rate [5] 11.59%  
Acquisition Date May 22, 2023  
Maturity Date May 22, 2029  
Par Amount $ 14,260  
Cost 13,837  
Fair Value $ 13,832  
DeepIntent, Inc. [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Media  
Spread Above Index [4] P+175  
Floor 0.00%  
Interest Rate [5] 10.00%  
Acquisition Date Oct. 12, 2022  
Maturity Date Mar. 25, 2025  
Par Amount $ 18,075  
Cost 18,075  
Fair Value $ 18,075  
DeepIntent, Inc. [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Media
Spread Above Index [4]   P+175
Floor   0.00%
Interest Rate [6]   9.25%
Acquisition Date   Oct. 12, 2022
Maturity Date   Mar. 25, 2025
Par Amount   $ 16,951
Cost   16,951
Fair Value   $ 16,951
Enhanced Permanent Capital, LLC [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [14] Capital Markets  
Spread Above Index [4],[14] S+700  
Floor [14] 1.00%  
Interest Rate [5],[14] 11.93%  
Acquisition Date [14] Dec. 29, 2020  
Maturity Date [14] Dec. 29, 2025  
Par Amount [14] $ 43,435  
Cost [14] 42,618  
Fair Value [14] $ 43,435  
Enhanced Permanent Capital, LLC [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [15]   Capital Markets
Spread Above Index [4]   L+700
Floor [15]   1.00%
Interest Rate [6]   10.13%
Acquisition Date [15]   Dec. 29, 2020
Maturity Date [15]   Dec. 29, 2025
Par Amount [15]   $ 35,205
Cost [15]   34,496
Fair Value [15]   $ 35,205
Foundation Consumer Brands, LLC [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Personal Products  
Spread Above Index [3],[4] S+625  
Floor [3] 1.00%  
Interest Rate [3],[5] 11.47%  
Acquisition Date [3] Feb. 12, 2021  
Maturity Date [3] Feb. 12, 2027  
Par Amount [3] $ 30,088  
Cost [3] 29,411  
Fair Value [3] $ 30,088  
Foundation Consumer Brands, LLC [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Personal Products
Spread Above Index [3],[4]   L+550
Floor [3]   1.00%
Interest Rate [3],[6]   10.15%
Acquisition Date [3]   Feb. 12, 2021
Maturity Date [3]   Feb. 12, 2027
Par Amount [3]   $ 35,273
Cost [3]   34,421
Fair Value [3]   $ 35,273
iCIMS, Inc. [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Software  
Spread Above Index [4] S+725  
Floor 0.75%  
Interest Rate [5],[16] 12.38%  
Acquisition Date Aug. 18, 2022  
Maturity Date Aug. 18, 2028  
Par Amount $ 30,468  
Cost 30,016  
Fair Value $ 30,468  
iCIMS, Inc. [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Software
Spread Above Index [4]   S+725
Floor   0.75%
Interest Rate [6],[16]   11.52%
Acquisition Date   Aug. 18, 2022
Maturity Date   Aug. 18, 2028
Par Amount   $ 32,084
Cost   31,548
Fair Value   $ 31,522
Ivy Fertility Services, LLC [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Providers & Services
Spread Above Index [4]   L+625
Floor   1.00%
Interest Rate [6]   10.39%
Acquisition Date   Dec. 22, 2021
Maturity Date   Feb. 25, 2026
Par Amount   $ 30,092
Cost   29,415
Fair Value   $ 30,393
Kid Distro Holdings, LLC (Distro Kid) [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Software  
Spread Above Index [3],[4] S+575  
Floor [3] 1.00%  
Interest Rate [3],[5] 11.14%  
Acquisition Date [3] Sep. 24, 2021  
Maturity Date [3] Oct. 01, 2027  
Par Amount [3] $ 23,326  
Cost [3] 22,975  
Fair Value [3] $ 23,326  
Kid Distro Holdings, LLC (Distro Kid) [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Software
Spread Above Index [3],[4]   L+575
Floor [3]   1.00%
Interest Rate [3],[6]   10.48%
Acquisition Date [3]   Sep. 24, 2021
Maturity Date [3]   Oct. 01, 2027
Par Amount [3]   $ 26,452
Cost [3]   26,015
Fair Value [3]   $ 26,452
Kingsbridge Holdings, LLC [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [17] Multi-Sector Holdings  
Spread Above Index [4],[17] S+700  
Floor [17] 1.00%  
Interest Rate [5],[17] 12.22%  
Acquisition Date [17] Dec. 21, 2018  
Maturity Date [17] Dec. 21, 2024  
Par Amount [17] $ 80,000  
Cost [17] 79,847  
Fair Value [17] $ 80,000  
Kingsbridge Holdings, LLC [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [18]   Multi-Sector Holdings
Spread Above Index [4]   L+700
Floor [18]   1.00%
Interest Rate [6],[18]   10.75%
Acquisition Date [18]   Dec. 21, 2018
Maturity Date [18]   Dec. 21, 2024
Par Amount [18]   $ 80,000
Cost [18]   79,800
Fair Value [18]   $ 80,000
KORE Wireless Group, Inc. [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Wireless Telecommunication Services  
Spread Above Index [3],[4] S+550  
Floor [3] 0.00%  
Interest Rate [3],[5] 10.84%  
Acquisition Date [3] Dec. 21, 2018  
Maturity Date [3] Dec. 21, 2024  
Par Amount [3] $ 23,465  
Cost [3] 23,112  
Fair Value [3] $ 23,465  
KORE Wireless Group, Inc. [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Wireless Telecommunication Services
Spread Above Index [3],[4]   S+550
Floor [3]   0.00%
Interest Rate [3],[6]   10.08%
Acquisition Date [3]   Dec. 21, 2018
Maturity Date [3]   Dec. 21, 2024
Par Amount [3]   $ 23,588
Cost [3]   23,123
Fair Value [3]   $ 23,588
Logix Holding Company, LLC [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Communications Equipment  
Spread Above Index [3],[4] L+575  
Floor [3] 1.00%  
Interest Rate [3],[5] 11.48%  
Acquisition Date [3] Sep. 14, 2018  
Maturity Date [3] Dec. 22, 2024  
Par Amount [3] $ 14,009  
Cost [3] 13,423  
Fair Value [3] $ 13,729  
Logix Holding Company, LLC [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Communications Equipment
Spread Above Index [3],[4]   L+575
Floor [3]   1.00%
Interest Rate [3],[6]   10.13%
Acquisition Date [3]   Sep. 14, 2018
Maturity Date [3]   Dec. 22, 2024
Par Amount [3]   $ 14,009
Cost [3]   13,246
Fair Value [3]   $ 13,449
Maurices, Incorporated [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Specialty Retail  
Spread Above Index [3],[4] S+675  
Floor [3] 1.00%  
Interest Rate [3],[5] 9.78%  
Acquisition Date [3] Aug. 27, 2021  
Maturity Date [3] Jun. 01, 2024  
Par Amount [3] $ 8,343  
Cost [3] 8,262  
Fair Value [3] $ 8,343  
Maurices, Incorporated [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Specialty Retail
Spread Above Index [3],[4]   S+675
Floor [3]   1.00%
Interest Rate [3],[6]   8.74%
Acquisition Date [3]   Aug. 27, 2021
Maturity Date [3]   Jun. 01, 2024
Par Amount [3]   $ 7,808
Cost [3]   7,678
Fair Value [3]   $ 7,808
NAC Holdings Corporation (Jaguar) [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Insurance
Spread Above Index [3],[4]   S+525
Floor [3]   1.00%
Interest Rate [3],[6]   9.45%
Acquisition Date [3]   Jul. 30, 2021
Maturity Date [3]   Sep. 28, 2024
Par Amount [3]   $ 28,603
Cost [3]   28,214
Fair Value [3]   $ 28,603
One Touch Direct, LLC [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Commercial Services & Supplies  
Spread Above Index [4] P+75  
Floor 0.00%  
Interest Rate [5] 9.00%  
Acquisition Date Apr. 03, 2020  
Maturity Date Mar. 30, 2024  
Par Amount $ 3,929  
Cost 3,929  
Fair Value $ 3,929  
One Touch Direct, LLC [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Commercial Services & Supplies
Spread Above Index [4]   P+75
Floor   0.00%
Interest Rate [6]   8.25%
Acquisition Date   Apr. 03, 2020
Maturity Date   Mar. 30, 2024
Par Amount   $ 4,431
Cost   4,431
Fair Value   $ 4,431
PhyNet Dermatology LLC [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Providers & Services  
Spread Above Index [4] S+625  
Floor 1.00%  
Interest Rate [5] 11.45%  
Acquisition Date Sep. 05, 2018  
Maturity Date Aug. 16, 2024  
Par Amount $ 11,896  
Cost 11,873  
Fair Value $ 11,896  
PhyNet Dermatology LLC [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Providers & Services
Spread Above Index [4],[19]   S+625
Floor   1.00%
Interest Rate [6]   9.81%
Acquisition Date   Sep. 05, 2018
Maturity Date   Aug. 16, 2024
Par Amount   $ 14,458
Cost   14,420
Fair Value   $ 14,458
Pinnacle Treatment Centers, Inc. [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Health Care Providers & Services  
Spread Above Index [3],[4] S+675  
Floor [3] 1.00%  
Interest Rate [3],[5] 12.10%  
Acquisition Date [3] Jan. 22, 2020  
Maturity Date [3] Jan. 02, 2026  
Par Amount [3] $ 26,652  
Cost [3] 26,266  
Fair Value [3] $ 26,652  
Pinnacle Treatment Centers, Inc. [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Health Care Providers & Services
Spread Above Index [3],[4]   S+650
Floor [3]   1.00%
Interest Rate [3],[6]   10.57%
Acquisition Date [3]   Jan. 22, 2020
Maturity Date [3]   Jan. 02, 2026
Par Amount [3]   $ 27,997
Cost [3]   27,528
Fair Value [3]   $ 27,367
PPT Management Holdings, LLC [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Health Care Providers & Services
Spread Above Index [3],[4],[12]   L+850
Floor [3]   1.00%
Interest Rate [3],[6]   12.83%
Acquisition Date [3]   Sep. 14, 2018
Maturity Date [3]   Jan. 30, 2023
Par Amount [3]   $ 32,163
Cost [3]   31,987
Fair Value [3]   $ 25,827
RQM+ Corp. [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Life Sciences Tools & Services  
Spread Above Index [3],[4] S+575  
Floor [3] 1.00%  
Interest Rate [3],[5] 11.51%  
Acquisition Date [3] Aug. 20, 2021  
Maturity Date [3] Aug. 12, 2026  
Par Amount [3] $ 23,757  
Cost [3] 23,395  
Fair Value [3] $ 23,757  
RQM+ Corp. [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Life Sciences Tools & Services
Spread Above Index [3],[4]   S+575
Floor [3]   1.00%
Interest Rate [3],[6]   10.97%
Acquisition Date [3]   Aug. 20, 2021
Maturity Date [3]   Aug. 12, 2026
Par Amount [3]   $ 26,823
Cost [3]   26,455
Fair Value [3]   $ 26,823
SunMed Group Holdings, LLC [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Health Care Equipment & Supplies  
Spread Above Index [3],[4] S+575  
Floor [3] 0.75%  
Interest Rate [3],[5] 11.09%  
Acquisition Date [3] Jun. 16, 2021  
Maturity Date [3] Jun. 16, 2028  
Par Amount [3] $ 21,565  
Cost [3] 21,144  
Fair Value [3] $ 21,565  
SunMed Group Holdings, LLC [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Health Care Equipment & Supplies
Spread Above Index [3],[4]   L+575
Floor [3]   0.75%
Interest Rate [3],[6]   10.48%
Acquisition Date [3]   Jun. 16, 2021
Maturity Date [3]   Jun. 16, 2028
Par Amount [3]   $ 24,953
Cost [3]   24,446
Fair Value [3]   $ 24,953
Ultimate Baked Goods Midco LLC (Rise Baking) [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Packaged Foods & Meats  
Spread Above Index [3],[4] S+625  
Floor [3] 1.00%  
Interest Rate [3],[5] 11.45%  
Acquisition Date [3] Aug. 12, 2021  
Maturity Date [3] Aug. 13, 2027  
Par Amount [3] $ 23,895  
Cost [3] 23,244  
Fair Value [3] $ 23,895  
Ultimate Baked Goods Midco LLC (Rise Baking) [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Packaged Foods & Meats
Spread Above Index [3],[4]   L+650
Floor [3]   1.00%
Interest Rate [3],[6]   10.88%
Acquisition Date [3]   Aug. 12, 2021
Maturity Date [3]   Aug. 13, 2027
Par Amount [3]   $ 24,789
Cost [3]   24,038
Fair Value [3]   $ 24,789
ACRES Commercial Mortgage, LLC [Member] | Senior Secured Loans — 134.4% [Member] | Second Lien Asset-Based Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Diversified Financial Services  
Spread Above Index [4] S+705  
Floor 1.00%  
Interest Rate [5] 12.31%  
Acquisition Date Dec. 24, 2021  
Maturity Date Aug. 21, 2028  
Par Amount $ 29,925  
Cost 29,435  
Fair Value $ 29,925  
ACRES Commercial Mortgage, LLC [Member] | Senior Secured Loans — 124.6% [Member] | Second Lien Asset-Based Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Diversified Financial Services
Spread Above Index [4]   S+705
Floor   1.00%
Interest Rate [6]   11.38%
Acquisition Date   Dec. 24, 2021
Maturity Date   Aug. 21, 2028
Par Amount   $ 29,925
Cost   29,398
Fair Value   $ 29,925
FGI Worldwide LLC [Member] | Senior Secured Loans — 134.4% [Member] | Second Lien Asset-Based Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Diversified Financial Services  
Spread Above Index [4] S+650  
Floor 1.00%  
Interest Rate [5] 11.61%  
Acquisition Date Apr. 17, 2023  
Maturity Date Apr. 17, 2028  
Par Amount $ 8,206  
Cost 8,007  
Fair Value $ 8,001  
Alimera Sciences, Inc. [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Pharmaceuticals  
Spread Above Index [3],[4] S+515  
Floor [3] 4.60%  
Interest Rate [3],[5] 10.32%  
Acquisition Date [3] Dec. 31, 2019  
Maturity Date [3] May 01, 2028  
Par Amount [3] $ 34,738  
Cost [3] 34,769  
Fair Value [3] $ 34,738  
Alimera Sciences, Inc. [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Pharmaceuticals
Spread Above Index [3],[4]   L+765
Floor [3]   1.78%
Interest Rate [3],[6]   11.82%
Acquisition Date [3]   Dec. 31, 2019
Maturity Date [3]   Jul. 01, 2024
Par Amount [3]   $ 23,159
Cost [3]   23,894
Fair Value [3]   $ 24,433
Arcutis Biotherapeutics, Inc. [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [14] Pharamceuticals  
Spread Above Index [4],[14] L+745  
Floor [14] 0.10%  
Interest Rate [5],[14] 12.61%  
Acquisition Date [14] Dec. 22, 2021  
Maturity Date [14] Jan. 01, 2027  
Par Amount [14] $ 66,849  
Cost [14] 67,618  
Fair Value [14] $ 67,685  
Arcutis Biotherapeutics, Inc. [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [15]   Pharamceuticals
Spread Above Index [4],[15]   L+745
Floor [15]   0.10%
Interest Rate [6],[15]   11.62%
Acquisition Date [15]   Dec. 22, 2021
Maturity Date [15]   Jan. 01, 2027
Par Amount [15]   $ 66,849
Cost [15]   67,077
Fair Value [15]   $ 67,685
Ardelyx, Inc. [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [14] Pharmaceuticals  
Spread Above Index [4],[14] S+795  
Floor [14] 1.00%  
Interest Rate [5],[14] 13.15%  
Acquisition Date [14] Feb. 23, 2022  
Maturity Date [14] Mar. 01, 2027  
Par Amount [14] $ 9,475  
Cost [14] 9,496  
Fair Value [14] $ 9,570  
Ardelyx, Inc. [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [15]   Pharmaceuticals
Spread Above Index [4],[15]   L+795
Floor [15]   0.10%
Interest Rate [6],[15]   12.12%
Acquisition Date [15]   Feb. 23, 2022
Maturity Date [15]   Mar. 01, 2027
Par Amount [15]   $ 9,475
Cost [15]   9,437
Fair Value [15]   $ 9,499
BridgeBio Pharma, Inc. [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [14] Biotechnology  
Spread Above Index [4],[14] 0  
Floor [14] 0.00%  
Interest Rate [5],[14],[20] 9.00%  
Acquisition Date [14] Nov. 17, 2021  
Maturity Date [14] Nov. 17, 2026  
Par Amount [14] $ 40,446  
Cost [14] 40,101  
Fair Value [14] $ 40,446  
BridgeBio Pharma, Inc. [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [15]   Biotechnology
Spread Above Index [4],[15]   0
Floor [15]   0.00%
Interest Rate [6],[15],[20]   9.00%
Acquisition Date [15]   Nov. 17, 2021
Maturity Date [15]   Nov. 17, 2026
Par Amount [15]   $ 39,839
Cost [15]   39,340
Fair Value [15]   $ 39,839
Centrexion Therapeutics, Inc. [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Pharmaceuticals  
Spread Above Index [4] L+725  
Floor 2.45%  
Interest Rate [5] 12.41%  
Acquisition Date Jun. 28, 2019  
Maturity Date Jan. 01, 2024  
Par Amount $ 6,377  
Cost 7,018  
Fair Value $ 7,171  
Centrexion Therapeutics, Inc. [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Pharmaceuticals
Spread Above Index [4]   L+725
Floor   2.45%
Interest Rate [6]   11.42%
Acquisition Date   Jun. 28, 2019
Maturity Date   Jan. 01, 2024
Par Amount   $ 11,844
Cost   12,372
Fair Value   $ 12,555
Cerapedics, Inc. [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Biotechnology  
Spread Above Index [4] S+620  
Floor 2.75%  
Interest Rate [5] 11.37%  
Acquisition Date Dec. 27, 2022  
Maturity Date Jan. 01, 2028  
Par Amount $ 26,939  
Cost 26,958  
Fair Value $ 27,007  
Cerapedics, Inc. [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Biotechnology
Spread Above Index [4]   S+620
Floor   2.75%
Interest Rate [6]   10.52%
Acquisition Date   Dec. 27, 2022
Maturity Date   Jan. 01, 2028
Par Amount   $ 26,939
Cost   26,874
Fair Value   $ 26,872
Glooko, Inc. [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Health Care Technology  
Spread Above Index [3],[4] L+790  
Floor [3] 0.10%  
Interest Rate [3],[5] 13.06%  
Acquisition Date [3] Sep. 30, 2021  
Maturity Date [3] Oct. 01, 2026  
Par Amount [3] $ 15,883  
Cost [3] 15,941  
Fair Value [3] $ 16,002  
Glooko, Inc. [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Health Care Technology
Spread Above Index [3],[4]   L+790
Floor [3]   0.10%
Interest Rate [3],[6]   12.07%
Acquisition Date [3]   Sep. 30, 2021
Maturity Date [3]   Oct. 01, 2026
Par Amount [3]   $ 15,883
Cost [3]   15,867
Fair Value [3]   $ 15,922
Neuronetics, Inc. [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Health Care Equipment & Supplies  
Spread Above Index [3],[4] S+565  
Floor [3] 3.95%  
Interest Rate [3],[5] 10.82%  
Acquisition Date [3] Mar. 02, 2020  
Maturity Date [3] Mar. 29, 2028  
Par Amount [3] $ 19,299  
Cost [3] 19,201  
Fair Value [3] $ 19,347  
Neuronetics, Inc. [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Health Care Equipment & Supplies
Spread Above Index [3],[4]   L+765
Floor [3]   1.66%
Interest Rate [3],[6]   11.82%
Acquisition Date [3]   Mar. 02, 2020
Maturity Date [3]   Feb. 28, 2025
Par Amount [3]   $ 18,012
Cost [3]   18,450
Fair Value [3]   $ 19,003
OmniGuide Holdings, Inc. [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [21] Health Care Equipment & Supplies  
Spread Above Index [4],[21] S+1415  
Floor [21] 0.10%  
Interest Rate [5],[21],[22] 19.21%  
Acquisition Date [21] Jul. 30, 2018  
Maturity Date [21] Aug. 01, 2023  
Par Amount [21] $ 20,192  
Cost [21] 20,977  
Fair Value [21] $ 21,101  
OmniGuide Holdings, Inc. [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [21]   Health Care Equipment & Supplies
Spread Above Index [4],[21]   L+1405
Floor [21]   0.10%
Interest Rate [6],[21],[22]   18.22%
Acquisition Date [21]   Jul. 30, 2018
Maturity Date [21]   Jul. 01, 2023
Par Amount [21]   $ 19,201
Cost [21]   19,380
Fair Value [21]   $ 19,777
Vapotherm, Inc. [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Equipment & Supplies  
Spread Above Index [4] S+930  
Floor 1.00%  
Interest Rate [5],[23] 14.57%  
Acquisition Date Feb. 18, 2022  
Maturity Date Feb. 01, 2027  
Par Amount $ 35,992  
Cost 36,096  
Fair Value $ 36,441  
Vapotherm, Inc. [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Equipment & Supplies
Spread Above Index [4]   S+830
Floor   1.00%
Interest Rate [6],[24]   12.58%
Acquisition Date   Feb. 18, 2022
Maturity Date   Feb. 01, 2027
Par Amount   $ 34,455
Cost   34,270
Fair Value   $ 34,628
SOINT, LLC [Member] | Preferred Equity – 0.4% [Member]    
Schedule of Investments [Line Items]    
Industry [25] Aerospace & Defense [14],[17] Aerospace & Defense [15],[18]
Interest Rate [12],[25] 5.00% [5],[14],[17] 5.00% [6],[15],[18]
Acquisition Date [25] Jun. 08, 2012 [14],[17] Jun. 08, 2012 [15],[18]
Maturity Date [25] Jun. 30, 2025 [14],[17] Jun. 30, 2023 [15],[18]
Par Amount [25] $ 0 [14],[17] $ 49,273 [15],[18]
Cost [25] 5,050 [14],[17] 4,927 [15],[18]
Fair Value [25] $ 3,801 [14],[17] $ 3,801 [15],[18]
aTyr Pharma, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants—59.9% [Member]    
Schedule of Investments [Line Items]    
Industry [13] Pharmaceuticals  
Acquisition Date [13] Nov. 18, 2016  
Shares/Units [13] 6,347  
Cost [13] $ 106  
Fair Value [13] $ 0  
aTyr Pharma, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants—57.1% [Member]    
Schedule of Investments [Line Items]    
Industry [13]   Pharmaceuticals
Acquisition Date [13]   Nov. 18, 2016
Shares/Units [13]   6,347
Cost [13]   $ 106
Fair Value [13]   $ 0
CardioFocus, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants—59.9% [Member]    
Schedule of Investments [Line Items]    
Industry [13] Health Care Equipment & Supplies  
Acquisition Date [13] Mar. 31, 2017  
Shares/Units [13] 90  
Cost [13] $ 51  
Fair Value [13] $ 0  
CardioFocus, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants—57.1% [Member]    
Schedule of Investments [Line Items]    
Industry [13]   Health Care Equipment & Supplies
Acquisition Date [13]   Mar. 31, 2017
Shares/Units [13]   90
Cost [13]   $ 51
Fair Value [13]   $ 0
Centrexion Therapeutics, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants—59.9% [Member]    
Schedule of Investments [Line Items]    
Industry [13] Pharmaceuticals  
Acquisition Date [13] Jun. 28, 2019  
Shares/Units [13] 289,102  
Cost [13] $ 136  
Fair Value [13] $ 51  
Centrexion Therapeutics, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants—57.1% [Member]    
Schedule of Investments [Line Items]    
Industry [13]   Pharmaceuticals
Acquisition Date [13]   Jun. 28, 2019
Shares/Units [13]   289,102
Cost [13]   $ 136
Fair Value [13]   $ 82
Conventus Orthopaedics, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants—59.9% [Member]    
Schedule of Investments [Line Items]    
Industry [13] Health Care Equipment & Supplies  
Acquisition Date [13] Jun. 15, 2016  
Shares/Units [13] 157,500  
Cost [13] $ 65  
Fair Value [13] $ 0  
Conventus Orthopaedics, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants—57.1% [Member]    
Schedule of Investments [Line Items]    
Industry [13]   Health Care Equipment & Supplies
Acquisition Date [13]   Jun. 15, 2016
Shares/Units [13]   157,500
Cost [13]   $ 65
Fair Value [13]   $ 0
Delphinus Medical Technologies, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants—59.9% [Member]    
Schedule of Investments [Line Items]    
Industry [13] Health Care Equipment & Supplies  
Acquisition Date [13] Aug. 18, 2017  
Shares/Units [13] 444,388  
Cost [13] $ 74  
Fair Value [13] $ 82  
Delphinus Medical Technologies, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants—57.1% [Member]    
Schedule of Investments [Line Items]    
Industry [13]   Health Care Equipment & Supplies
Acquisition Date [13]   Aug. 18, 2017
Shares/Units [13]   444,388
Cost [13]   $ 74
Fair Value [13]   $ 103
Essence Group Holdings Corporation (Lumeris) Warrants [Member] | Common Equity/Equity Interests/Warrants—59.9% [Member]    
Schedule of Investments [Line Items]    
Industry [13] Health Care Technology  
Acquisition Date [13] Mar. 22, 2017  
Shares/Units [13] 260,000  
Cost [13] $ 129  
Fair Value [13] $ 341  
Essence Group Holdings Corporation (Lumeris) Warrants [Member] | Common Equity/Equity Interests/Warrants—57.1% [Member]    
Schedule of Investments [Line Items]    
Industry [13]   Health Care Technology
Acquisition Date [13]   Mar. 22, 2017
Shares/Units [13]   260,000
Cost [13]   $ 129
Fair Value [13]   $ 366
KBH Topco LLC (Kingsbridge) [Member] | Common Equity/Equity Interests/Warrants—59.9% [Member]    
Schedule of Investments [Line Items]    
Industry [17],[26],[27] Multi-Sector Holdings  
Acquisition Date [17],[26],[27] Nov. 03, 2020  
Shares/Units [17],[26],[27] 73,500,000  
Cost [17],[26],[27] $ 136,596  
Fair Value [17],[26],[27] $ 148,444  
KBH Topco LLC (Kingsbridge) [Member] | Common Equity/Equity Interests/Warrants—57.1% [Member]    
Schedule of Investments [Line Items]    
Industry [18],[26],[27]   Multi-Sector Holdings
Acquisition Date [18],[26],[27]   Nov. 03, 2020
Shares/Units [18],[26],[27]   73,500,000
Cost [18],[26],[27]   $ 136,596
Fair Value [18],[26],[27]   $ 148,444
RD Holdco Inc. (Rug Doctor) [Member] | Senior Secured Loans — 124.6% [Member] | Second Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [7],[18]   Diversified Consumer Services
Spread Above Index [4],[7],[12],[18]   S+975
Floor [7],[18]   1.00%
Interest Rate [6],[7],[18]   0.00%
Acquisition Date [7],[18]   Dec. 23, 2013
Maturity Date [7],[18]   Oct. 12, 2026
Par Amount [7],[18]   $ 13,043
Cost [7],[18]   11,791
Fair Value [7],[18]   $ 6,521
RD Holdco Inc. (Rug Doctor) [Member] | Common Equity/Equity Interests/Warrants—59.9% [Member]    
Schedule of Investments [Line Items]    
Industry [13],[17] Diversified Consumer Services  
Acquisition Date [13],[17] Dec. 23, 2013  
Shares/Units [13],[17] 231,177  
Cost [13],[17] $ 15,683  
Fair Value [13],[17] $ 0  
RD Holdco Inc. (Rug Doctor) [Member] | Common Equity/Equity Interests/Warrants—57.1% [Member]    
Schedule of Investments [Line Items]    
Industry [13],[18]   Diversified Consumer Services
Acquisition Date [13],[18]   Dec. 23, 2013
Shares/Units [13],[18]   231,177
Cost [13],[18]   $ 15,683
Fair Value [13],[18]   $ 0
RD Holdco Inc. (Rug Doctor, class B) [Member] | Common Equity/Equity Interests/Warrants—59.9% [Member]    
Schedule of Investments [Line Items]    
Industry [13],[17] Diversified Consumer Services  
Acquisition Date [13],[17] Dec. 23, 2013  
Shares/Units [13],[17] 522  
Cost [13],[17] $ 5,216  
Fair Value [13],[17] $ 0  
RD Holdco Inc. (Rug Doctor, class B) [Member] | Common Equity/Equity Interests/Warrants—57.1% [Member]    
Schedule of Investments [Line Items]    
Industry [13],[18]   Diversified Consumer Services
Acquisition Date [13],[18]   Dec. 23, 2013
Shares/Units [13],[18]   522
Cost [13],[18]   $ 5,216
Fair Value [13],[18]   $ 0
RD Holdco Inc. (Rug Doctor, Warrants) [Member] | Common Equity/Equity Interests/Warrants—59.9% [Member]    
Schedule of Investments [Line Items]    
Industry [13],[17] Diversified Consumer Services  
Acquisition Date [13],[17] Dec. 23, 2013  
Shares/Units [13],[17] 30,370  
Cost [13],[17] $ 381  
Fair Value [13],[17] $ 0  
RD Holdco Inc. (Rug Doctor, Warrants) [Member] | Common Equity/Equity Interests/Warrants—57.1% [Member]    
Schedule of Investments [Line Items]    
Industry [13],[18]   Diversified Consumer Services
Acquisition Date [13],[18]   Dec. 23, 2013
Shares/Units [13],[18]   30,370
Cost [13],[18]   $ 381
Fair Value [13],[18]   $ 0
Senseonics Holdings, Inc. [Member] | Common Equity/Equity Interests/Warrants—59.9% [Member]    
Schedule of Investments [Line Items]    
Industry [13],[14],[28] Health Care Equipment & Supplies  
Acquisition Date [13],[14],[28] Jul. 25, 2019  
Shares/Units [13],[14],[28] 469,353  
Cost [13],[14],[28] $ 235  
Fair Value [13],[14],[28] $ 358  
Senseonics Holdings, Inc. [Member] | Common Equity/Equity Interests/Warrants—57.1% [Member]    
Schedule of Investments [Line Items]    
Industry [13],[15],[28]   Health Care Equipment & Supplies
Acquisition Date [13],[15],[28]   Jul. 25, 2019
Shares/Units [13],[15],[28]   469,353
Cost [13],[15],[28]   $ 235
Fair Value [13],[15],[28]   $ 483
SLR Business Credit [Member] | Common Equity/Equity Interests/Warrants—59.9% [Member]    
Schedule of Investments [Line Items]    
Industry [14],[17],[29] Diversified Financial Services  
Acquisition Date [14],[17],[29] Apr. 01, 2022  
Shares/Units [14],[17],[29] 100  
Cost [14],[17],[29] $ 81,583  
Fair Value [14],[17],[29] $ 90,370  
SLR Business Credit [Member] | Common Equity/Equity Interests/Warrants—57.1% [Member]    
Schedule of Investments [Line Items]    
Industry [15],[18],[29]   Diversified Financial Services
Acquisition Date [15],[18],[29]   Apr. 01, 2022
Shares/Units [15],[18],[29]   100
Cost [15],[18],[29]   $ 81,583
Fair Value [15],[18],[29]   $ 89,370
SLR Credit Solutions [Member] | Common Equity/Equity Interests/Warrants—59.9% [Member]    
Schedule of Investments [Line Items]    
Industry [14],[17],[30] Diversified Financial Services  
Acquisition Date [14],[17],[30] Dec. 28, 2012  
Shares/Units [14],[17],[30] 280,303  
Cost [14],[17],[30] $ 280,737  
Fair Value [14],[17],[30] $ 279,000  
SLR Credit Solutions [Member] | Common Equity/Equity Interests/Warrants—57.1% [Member]    
Schedule of Investments [Line Items]    
Industry [15],[18],[30]   Diversified Financial Services
Acquisition Date [15],[18],[30]   Dec. 28, 2012
Shares/Units [15],[18],[30]   280,303
Cost [15],[18],[30]   $ 280,737
Fair Value [15],[18],[30]   $ 288,760
SLR Healthcare ABL [Member] | Common Equity/Equity Interests/Warrants—59.9% [Member]    
Schedule of Investments [Line Items]    
Industry [14],[17],[31] Diversified Financial Services  
Acquisition Date [14],[17],[31] Apr. 01, 2022  
Shares/Units [14],[17],[31] 32,839  
Cost [14],[17],[31] $ 34,335  
Fair Value [14],[17],[31] $ 34,850  
SLR Healthcare ABL [Member] | Common Equity/Equity Interests/Warrants—57.1% [Member]    
Schedule of Investments [Line Items]    
Industry [15],[18],[31]   Diversified Financial Services
Acquisition Date [15],[18],[31]   Apr. 01, 2022
Shares/Units [15],[18],[31]   32,839
Cost [15],[18],[31]   $ 34,335
Fair Value [15],[18],[31]   $ 34,350
Spectrum Pharmaceuticals, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants—59.9% [Member]    
Schedule of Investments [Line Items]    
Industry [13] Biotechnology  
Acquisition Date [13] Sep. 21, 2022  
Shares/Units [13] 159,470  
Cost [13] $ 51  
Fair Value [13] $ 80  
Spectrum Pharmaceuticals, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants—57.1% [Member]    
Schedule of Investments [Line Items]    
Industry [13]   Biotechnology
Acquisition Date [13]   Sep. 21, 2022
Shares/Units [13]   159,470
Cost [13]   $ 51
Fair Value [13]   $ 15
Vapotherm, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants—59.9% [Member]    
Schedule of Investments [Line Items]    
Industry [13] Health Care Equipment & Supplies  
Acquisition Date [13] Feb. 18, 2022  
Shares/Units [13] 207,117  
Cost [13] $ 262  
Fair Value [13] $ 20  
Vapotherm, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants—57.1% [Member]    
Schedule of Investments [Line Items]    
Industry [13]   Health Care Equipment & Supplies
Acquisition Date [13]   Feb. 18, 2022
Shares/Units [13]   36,996
Cost [13]   $ 210
Fair Value [13]   $ 87
Venus Concept Ltd. Warrants (f/k/a Restoration Robotics) [Member] | Common Equity/Equity Interests/Warrants—59.9% [Member]    
Schedule of Investments [Line Items]    
Industry [13] Health Care Equipment & Supplies  
Acquisition Date [13] May 10, 2018  
Shares/Units [13] 2,230  
Cost [13] $ 152  
Fair Value [13] $ 0  
Venus Concept Ltd. Warrants (f/k/a Restoration Robotics) [Member] | Common Equity/Equity Interests/Warrants—57.1% [Member]    
Schedule of Investments [Line Items]    
Industry [13]   Health Care Equipment & Supplies
Acquisition Date [13]   May 10, 2018
Shares/Units [13]   33,430
Cost [13]   $ 152
Fair Value [13]   $ 0
ENS Holdings III Corp. & ES Opco USA LLC (Bluefin) [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Trading Companies & Distributors  
Spread Above Index [3],[4] S+475  
Floor [3] 1.00%  
Interest Rate [3],[5] 10.09%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Dec. 31, 2025  
Par Amount [3] $ 4,640  
Cost [3] 4,504  
Fair Value [3] $ 4,640  
ENS Holdings III Corp. & ES Opco USA LLC (Bluefin) [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Trading Companies & Distributors
Spread Above Index [3],[4]   S+475
Floor [3]   1.00%
Interest Rate [3],[6]   9.43%
Acquisition Date [3]   Apr. 01, 2022
Maturity Date [3]   Dec. 31, 2025
Par Amount [3]   $ 4,978
Cost [3]   4,804
Fair Value [3]   $ 4,978
Enverus Holdings, Inc. (fka Drilling Info Holdings) [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] IT Services  
Spread Above Index [3],[4] S+450  
Floor [3] 0.00%  
Interest Rate [3],[5] 9.70%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Jul. 30, 2025  
Par Amount [3] $ 11,312  
Cost [3] 10,941  
Fair Value [3] $ 11,312  
Enverus Holdings, Inc. (fka Drilling Info Holdings) [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   IT Services
Spread Above Index [3],[4]   L+450
Floor [3]   0.00%
Interest Rate [3],[6]   8.88%
Acquisition Date [3]   Apr. 01, 2022
Maturity Date [3]   Jul. 30, 2025
Par Amount [3]   $ 11,598
Cost [3]   11,129
Fair Value [3]   $ 11,598
Erie Construction Mid-west, LLC [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Building Products  
Spread Above Index [3],[4] S+475  
Floor [3] 1.00%  
Interest Rate [3],[5] 10.34%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Jul. 30, 2027  
Par Amount [3] $ 8,686  
Cost [3] 8,391  
Fair Value [3] $ 8,686  
Erie Construction Mid-west, LLC [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Building Products
Spread Above Index [3],[4]   S+475
Floor [3]   1.00%
Interest Rate [3],[6]   9.79%
Acquisition Date [3]   Apr. 01, 2022
Maturity Date [3]   Jul. 30, 2027
Par Amount [3]   $ 8,915
Cost [3]   8,580
Fair Value [3]   $ 8,915
GSM Acquisition Corp [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Leisure Equipment & Products  
Spread Above Index [3],[4] S+500  
Floor [3] 1.00%  
Interest Rate [3],[5] 10.50%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Nov. 16, 2026  
Par Amount [3] $ 10,967  
Cost [3] 10,573  
Fair Value [3] $ 10,857  
GSM Acquisition Corp [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Leisure Equipment & Products
Spread Above Index [3],[4]   S+500
Floor [3]   1.00%
Interest Rate [3],[6]   9.03%
Acquisition Date [3]   Apr. 01, 2022
Maturity Date [3]   Nov. 16, 2026
Par Amount [3]   $ 11,022
Cost [3]   10,562
Fair Value [3]   $ 10,912
Higginbotham Insurance Agency, Inc [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Insurance  
Spread Above Index [3],[4] S+525  
Floor [3] 1.00%  
Interest Rate [3],[5] 10.45%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Nov. 25, 2026  
Par Amount [3] $ 4,898  
Cost [3] 4,724  
Fair Value [3] $ 4,898  
Higginbotham Insurance Agency, Inc [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Insurance
Spread Above Index [3],[4]   L+525
Floor [3]   0.75%
Interest Rate [3],[6]   9.63%
Acquisition Date [3]   Apr. 01, 2022
Maturity Date [3]   Nov. 25, 2026
Par Amount [3]   $ 6,223
Cost [3]   5,994
Fair Value [3]   $ 6,223
High Street Buyer, Inc [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Insurance  
Spread Above Index [3],[4] S+600  
Floor [3] 0.75%  
Interest Rate [3],[5] 11.39%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Apr. 16, 2028  
Par Amount [3] $ 5,162  
Cost [3] 4,897  
Fair Value [3] $ 5,162  
High Street Buyer, Inc [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Insurance
Spread Above Index [3],[4]   L+600
Floor [3]   0.75%
Interest Rate [3],[6]   10.73%
Acquisition Date [3]   Apr. 01, 2022
Maturity Date [3]   Apr. 16, 2028
Par Amount [3]   $ 5,188
Cost [3]   4,900
Fair Value [3]   $ 5,188
Human Interest Inc [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Internet Software & Services  
Spread Above Index [4] S+785  
Floor 1.00%  
Interest Rate [5] 13.01%  
Acquisition Date Jun. 30, 2022  
Maturity Date Jul. 01, 2027  
Par Amount $ 20,104  
Cost 19,863  
Fair Value $ 20,104  
Human Interest Inc [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Internet Software & Services
Spread Above Index [4]   S+785
Floor   1.00%
Interest Rate [6]   11.97%
Acquisition Date   Jun. 30, 2022
Maturity Date   Jul. 01, 2027
Par Amount   $ 20,104
Cost   19,783
Fair Value   $ 20,104
Kaseya, Inc [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Software  
Spread Above Index [3],[4] S+575  
Floor [3] 0.75%  
Interest Rate [3],[5],[32] 10.86%  
Acquisition Date [3] Jun. 22, 2022  
Maturity Date [3] Jun. 23, 2029  
Par Amount [3] $ 33,290  
Cost [3] 32,845  
Fair Value [3] $ 33,290  
Kaseya, Inc [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Software
Spread Above Index [3],[4]   S+575
Floor [3]   0.75%
Interest Rate [3],[6]   10.33%
Acquisition Date [3]   Jun. 22, 2022
Maturity Date [3]   Jun. 23, 2029
Par Amount [3]   $ 32,426
Cost [3]   31,966
Fair Value [3]   $ 32,426
National Spine and Pain Centers, LLC [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Providers & Services
Spread Above Index [4]   L+500
Floor   1.00%
Interest Rate [6]   7.31%
Acquisition Date   Apr. 01, 2022
Maturity Date   Jun. 02, 2024
Par Amount   $ 2,681
Cost   2,564
Fair Value   $ 2,547
Peter C. Foy & Associates Insurance Services, LLC [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Insurance  
Spread Above Index [4] S+600  
Floor 0.75%  
Interest Rate [5] 11.22%  
Acquisition Date Apr. 01, 2022  
Maturity Date Nov. 01, 2028  
Par Amount $ 11,888  
Cost 11,729  
Fair Value $ 11,888  
Peter C. Foy & Associates Insurance Services, LLC [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Insurance
Spread Above Index [4]   S+600
Floor   0.75%
Interest Rate [6]   10.44%
Acquisition Date   Apr. 01, 2022
Maturity Date   Nov. 01, 2028
Par Amount   $ 10,854
Cost   10,699
Fair Value   $ 10,854
Plastics Management, LLC [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Health Care Providers & Services  
Spread Above Index [3],[4] S+500  
Floor [3] 1.00%  
Interest Rate [3],[5] 10.44%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Aug. 18, 2027  
Par Amount [3] $ 17,225  
Cost [3] 16,500  
Fair Value [3] $ 17,225  
Plastics Management, LLC [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Health Care Providers & Services
Spread Above Index [3],[4]   S+500
Floor [3]   1.00%
Interest Rate [3],[6]   9.89%
Acquisition Date [3]   Apr. 01, 2022
Maturity Date [3]   Aug. 18, 2027
Par Amount [3]   $ 9,491
Cost [3]   9,161
Fair Value [3]   $ 9,491
RSC Acquisition, Inc [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Insurance  
Spread Above Index [3],[4] S+550  
Floor [3] 0.75%  
Interest Rate [3],[5] 10.64%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Nov. 01, 2026  
Par Amount [3] $ 21,841  
Cost [3] 21,664  
Fair Value [3] $ 21,841  
RSC Acquisition, Inc [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Insurance
Spread Above Index [3],[4]   S+550
Floor [3]   0.75%
Interest Rate [3],[6]   9.26%
Acquisition Date [3]   Apr. 01, 2022
Maturity Date [3]   Nov. 01, 2026
Par Amount [3]   $ 6,985
Cost [3]   6,813
Fair Value [3]   $ 6,985
RxSense Holdings LLC [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Diversified Consumer Services  
Spread Above Index [3],[4] S+500  
Floor [3] 1.00%  
Interest Rate [3],[5] 10.15%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Mar. 13, 2026  
Par Amount [3] $ 8,700  
Cost [3] 8,362  
Fair Value [3] $ 8,700  
RxSense Holdings LLC [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Diversified Consumer Services
Spread Above Index [3],[4]   L+500
Floor [3]   1.00%
Interest Rate [3],[6]   9.41%
Acquisition Date [3]   Apr. 01, 2022
Maturity Date [3]   Mar. 13, 2026
Par Amount [3]   $ 11,775
Cost [3]   11,357
Fair Value [3]   $ 11,775
SHO Holding I Corporation (Shoes for Crews) [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Footwear  
Spread Above Index [3],[4] S+523  
Floor [3] 1.00%  
Interest Rate [3],[5] 10.52%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Apr. 27, 2024  
Par Amount [3] $ 5,674  
Cost [3] 5,456  
Fair Value [3] $ 5,391  
SHO Holding I Corporation (Shoes for Crews) [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Footwear
Spread Above Index [3],[4]   L+523
Floor [3]   1.00%
Interest Rate [3],[6]   9.66%
Acquisition Date [3]   Apr. 01, 2022
Maturity Date [3]   Apr. 27, 2024
Par Amount [3]   $ 5,704
Cost [3]   5,361
Fair Value [3]   $ 5,419
Southern Orthodontic Partners Management, LLC [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Health Care Providers & Services  
Spread Above Index [3],[4] S+600  
Floor [3] 1.00%  
Interest Rate [3],[5] 11.50%  
Acquisition Date [3] Jun. 03, 2022  
Maturity Date [3] Jan. 27, 2026  
Par Amount [3] $ 2,791  
Cost [3] 2,767  
Fair Value [3] $ 2,791  
Southern Orthodontic Partners Management, LLC [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Health Care Providers & Services
Spread Above Index [3],[4]   S+600
Floor [3]   1.00%
Interest Rate [3],[6]   10.77%
Acquisition Date [3]   Jun. 03, 2022
Maturity Date [3]   Jan. 27, 2026
Par Amount [3]   $ 1,399
Cost [3]   1,387
Fair Value [3]   $ 1,399
TAUC Management, LLC [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Health Care Providers & Services  
Spread Above Index [3],[4] L+525  
Floor [3] 1.00%  
Interest Rate [3],[5] 10.59%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Feb. 12, 2027  
Par Amount [3] $ 6,895  
Cost [3] 6,615  
Fair Value [3] $ 6,550  
TAUC Management, LLC [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Health Care Providers & Services
Spread Above Index [3],[4]   L+525
Floor [3]   1.00%
Interest Rate [3],[6]   9.98%
Acquisition Date [3]   Apr. 01, 2022
Maturity Date [3]   Feb. 12, 2027
Par Amount [3]   $ 6,899
Cost [3]   6,585
Fair Value [3]   $ 6,864
Tilley Distribution, Inc [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Trading Companies & Distributors  
Spread Above Index [3],[4] S+600  
Floor [3] 1.00%  
Interest Rate [3],[5] 11.39%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Dec. 31, 2026  
Par Amount [3] $ 3,857  
Cost [3] 3,691  
Fair Value [3] $ 3,857  
Tilley Distribution, Inc [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Trading Companies & Distributors
Spread Above Index [3],[4]   S+550
Floor [3]   1.00%
Interest Rate [3],[6]   10.14%
Acquisition Date [3]   Apr. 01, 2022
Maturity Date [3]   Dec. 31, 2026
Par Amount [3]   $ 9,996
Cost [3]   9,527
Fair Value [3]   $ 9,996
Vessco Midco Holdings, LLC [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Water Utilities  
Spread Above Index [3],[4] L+450  
Floor [3] 1.00%  
Interest Rate [3],[5] 9.56%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Nov. 02, 2026  
Par Amount [3] $ 2,931  
Cost [3] 2,866  
Fair Value [3] $ 2,931  
Vessco Midco Holdings, LLC [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Water Utilities
Spread Above Index [3],[4]   L+450
Floor [3]   1.00%
Interest Rate [3],[6]   7.87%
Acquisition Date [3]   Apr. 01, 2022
Maturity Date [3]   Nov. 02, 2026
Par Amount [3]   $ 1,728
Cost [3]   1,668
Fair Value [3]   $ 1,728
World Insurance Associates, LLC [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Insurance  
Spread Above Index [3],[4] S+575  
Floor [3] 1.00%  
Interest Rate [3],[5] 10.81%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Apr. 01, 2026  
Par Amount [3] $ 48,371  
Cost [3] 47,337  
Fair Value [3] $ 48,371  
World Insurance Associates, LLC [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Insurance
Spread Above Index [3],[4]   S+575
Floor [3]   1.00%
Interest Rate [3],[6]   9.31%
Acquisition Date [3]   Apr. 01, 2022
Maturity Date [3]   Apr. 01, 2026
Par Amount [3]   $ 31,624
Cost [3]   30,785
Fair Value [3]   $ 30,359
Apeel Technology, Inc [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Biotechnology  
Spread Above Index [4] S+625  
Floor 1.00%  
Interest Rate [5] 8.75%  
Acquisition Date Jun. 29, 2022  
Maturity Date Jun. 01, 2027  
Par Amount $ 3,643  
Cost 3,634  
Fair Value $ 3,652  
Apeel Technology, Inc [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Biotechnology
Spread Above Index [4]   S+625
Floor   1.00%
Interest Rate [6]   8.75%
Acquisition Date   Jun. 29, 2022
Maturity Date   Jun. 01, 2027
Par Amount   $ 3,643
Cost   3,620
Fair Value   $ 3,643
Luxury Asset Capital, LLC [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Thrifts & Mortgage Finance  
Spread Above Index [3],[4] S+675  
Floor [3] 1.00%  
Interest Rate [3],[5] 12.02%  
Acquisition Date [3] Jul. 15, 2022  
Maturity Date [3] Jul. 15, 2027  
Par Amount [3] $ 30,500  
Cost [3] 29,978  
Fair Value [3] $ 30,500  
Luxury Asset Capital, LLC [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Thrifts & Mortgage Finance
Spread Above Index [3],[4]   S+675
Floor [3]   1.00%
Interest Rate [3],[6]   10.99%
Acquisition Date [3]   Jul. 15, 2022
Maturity Date [3]   Jul. 15, 2027
Par Amount [3]   $ 27,500
Cost [3]   26,991
Fair Value [3]   $ 27,500
Montefiore Nyack Hospital [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Providers & Services  
Spread Above Index [4] S+495  
Floor 0.00%  
Interest Rate [5] 10.60%  
Acquisition Date Aug. 09, 2022  
Maturity Date Nov. 15, 2025  
Par Amount $ 5,097  
Cost 5,097  
Fair Value $ 5,097  
Montefiore Nyack Hospital [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Health Care Providers & Services
Spread Above Index [3],[4]   L+495
Floor [3]   0.00%
Interest Rate [3],[6]   9.72%
Acquisition Date [3]   Aug. 09, 2022
Maturity Date [3]   Nov. 15, 2024
Par Amount [3]   $ 3,966
Cost [3]   3,966
Fair Value [3]   $ 3,966
Orthopedic Care Partners Management, LLC [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Providers & Services  
Spread Above Index [4] S+650  
Floor 1.00%  
Interest Rate [5] 11.83%  
Acquisition Date Aug. 17, 2022  
Maturity Date May 16, 2024  
Par Amount $ 4,176  
Cost 4,156  
Fair Value $ 4,176  
Orthopedic Care Partners Management, LLC [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Providers & Services
Spread Above Index [4]   S+650
Floor   1.00%
Interest Rate [6]   10.91%
Acquisition Date   Aug. 17, 2022
Maturity Date   May 16, 2024
Par Amount   $ 3,111
Cost   3,092
Fair Value   $ 3,111
Pediatric Home Respiratory Services, LLC [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Providers & Services  
Spread Above Index [4] S+625  
Floor 1.00%  
Interest Rate [5] 11.45%  
Acquisition Date Aug. 19, 2022  
Maturity Date Dec. 04, 2024  
Par Amount $ 1,976  
Cost 1,953  
Fair Value $ 1,976  
Pediatric Home Respiratory Services, LLC [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Providers & Services
Spread Above Index [4]   S+625
Floor   1.00%
Interest Rate [6]   10.67%
Acquisition Date   Aug. 19, 2022
Maturity Date   Dec. 04, 2024
Par Amount   $ 1,327
Cost   1,309
Fair Value   $ 1,313
SPAR Marketing Force, Inc. [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Media  
Spread Above Index [4] P+190  
Floor 0.00%  
Interest Rate [5] 10.15%  
Acquisition Date Jul. 18, 2022  
Maturity Date Oct. 10, 2024  
Par Amount $ 6,767  
Cost 6,767  
Fair Value $ 6,767  
SPAR Marketing Force, Inc. [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Media
Spread Above Index [4]   P+95
Floor   0.00%
Interest Rate [6]   8.45%
Acquisition Date   Jul. 18, 2022
Maturity Date   Oct. 10, 2024
Par Amount   $ 9,162
Cost   9,162
Fair Value   $ 9,162
Stryten Resources LLC [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Auto Parts & Equipment  
Spread Above Index [4] S+800  
Floor 1.00%  
Interest Rate [5] 13.50%  
Acquisition Date Aug. 11, 2021  
Maturity Date Oct. 12, 2026  
Par Amount $ 25,791  
Cost 25,423  
Fair Value $ 25,791  
Stryten Resources LLC [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Auto Parts & Equipment
Spread Above Index [4]   S+800
Floor   1.00%
Interest Rate [6]   12.44%
Acquisition Date   Aug. 11, 2021
Maturity Date   Oct. 12, 2026
Par Amount   $ 25,922
Cost   25,506
Fair Value   $ 25,922
BDG Media, Inc. [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Media  
Spread Above Index [4] L+900  
Floor 0.25%  
Interest Rate [5] 14.52%  
Acquisition Date Jul. 18, 2022  
Maturity Date Jul. 31, 2025  
Par Amount $ 6,461  
Cost 6,461  
Fair Value $ 6,461  
BDG Media, Inc. [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Media
Spread Above Index [4]   L+900
Floor   0.25%
Interest Rate [6]   13.17%
Acquisition Date   Jul. 18, 2022
Maturity Date   Apr. 27, 2023
Par Amount   $ 14,454
Cost   14,454
Fair Value   $ 14,454
RD Holdco, Inc. [Member] | Senior Secured Loans — 134.4% [Member] | Second Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [7],[17] Diversified Consumer Services  
Spread Above Index [4],[7],[12],[17] S+975  
Floor [7],[17] 1.00%  
Interest Rate [5],[7],[17] 0.00%  
Acquisition Date [7],[17] Dec. 23, 2013  
Maturity Date [7],[17] Oct. 12, 2026  
Par Amount [7],[17] $ 14,498  
Cost [7],[17] 12,297  
Fair Value [7],[17] $ 7,249  
Spectrum Pharmaceuticals, Inc. [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Biotechnology  
Spread Above Index [3],[4] S+570  
Floor [3] 2.30%  
Interest Rate [3],[5] 10.87%  
Acquisition Date [3] Sep. 21, 2022  
Maturity Date [3] Sep. 01, 2027  
Par Amount [3] $ 10,525  
Cost [3] 11,167  
Fair Value [3] $ 11,341  
Spectrum Pharmaceuticals, Inc. [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3]   Biotechnology
Spread Above Index [3],[4]   S+570
Floor [3]   2.30%
Interest Rate [3],[6]   9.88%
Acquisition Date [3]   Sep. 21, 2022
Maturity Date [3]   Sep. 01, 2027
Par Amount [3]   $ 10,525
Cost [3]   10,406
Fair Value [3]   $ 10,420
SCP Eye Care, LLC [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Providers & Services  
Spread Above Index [4] S+575  
Floor 1.00%  
Interest Rate [5] 10.93%  
Acquisition Date Oct. 06, 2022  
Maturity Date Oct. 05, 2029  
Par Amount $ 9,089  
Cost 8,814  
Fair Value $ 9,089  
SCP Eye Care, LLC [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Providers & Services
Spread Above Index [4]   S+575
Floor   1.00%
Interest Rate [6]   9.46%
Acquisition Date   Oct. 06, 2022
Maturity Date   Oct. 05, 2029
Par Amount   $ 8,314
Cost   8,050
Fair Value   $ 8,044
Meditrina, Inc. [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Equipment & Supplies  
Spread Above Index [4] S+550  
Floor 3.45%  
Interest Rate [5] 10.67%  
Acquisition Date Dec. 20, 2022  
Maturity Date Dec. 01, 2027  
Par Amount $ 3,367  
Cost 3,356  
Fair Value $ 3,367  
Meditrina, Inc. [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Equipment & Supplies
Spread Above Index [4]   S+550
Floor   3.45%
Interest Rate [6]   9.82%
Acquisition Date   Dec. 20, 2022
Maturity Date   Dec. 01, 2027
Par Amount   $ 3,367
Cost   3,338
Fair Value   $ 3,359
Outset Medical, Inc. [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [14] Health Care Equipment & Supplies  
Spread Above Index [4],[14] S+515  
Floor [14] 2.75%  
Interest Rate [5],[14] 10.32%  
Acquisition Date [14] Nov. 03, 2022  
Maturity Date [14] Nov. 01, 2027  
Par Amount [14] $ 35,084  
Cost [14] 35,067  
Fair Value [14] 35,084  
Outset Medical, Inc. [Member] | Senior Secured Loans — 124.6% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [15]   Health Care Equipment & Supplies
Spread Above Index [4],[15]   S+515
Floor [15]   2.75%
Interest Rate [6],[15]   9.33%
Acquisition Date [15]   Nov. 03, 2022
Maturity Date [15]   Nov. 01, 2027
Par Amount [15]   $ 35,084
Cost [15]   34,880
Fair Value [15]   34,820
SLR Senior Lending Program LLC [Member]    
Schedule of Investments [Line Items]    
Cost [33] 77,114 18,032
Fair Value [33],[34] 77,505 18,062
Total Investments & Cash Equivalents $ 1,906 $ 1,043
SLR Senior Lending Program LLC [Member] | Common Equity/Equity Interests/Warrants—59.9% [Member]    
Schedule of Investments [Line Items]    
Industry [14],[17],[35] Asset Management  
Acquisition Date [14],[17],[35] Dec. 01, 2022  
Shares/Units [14],[17],[35] 0  
Cost [14],[17],[35] $ 20,750  
Fair Value [14],[17],[35] $ 20,995  
SLR Senior Lending Program LLC [Member] | Common Equity/Equity Interests/Warrants—57.1% [Member]    
Schedule of Investments [Line Items]    
Industry [15],[18],[35]   Asset Management
Acquisition Date [15],[18],[35]   Dec. 01, 2022
Shares/Units [15],[18],[35]   0
Cost [15],[18],[35]   $ 9,500
Fair Value [15],[18],[35]   $ 9,426
Meditrina, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants—59.9% [Member]    
Schedule of Investments [Line Items]    
Industry [13] Health Care Equipment & Supplies  
Acquisition Date [13] Dec. 20, 2022  
Shares/Units [13] 29,366  
Cost [13] $ 23  
Fair Value [13] $ 19  
Meditrina, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants—57.1% [Member]    
Schedule of Investments [Line Items]    
Industry [13]   Health Care Equipment & Supplies
Acquisition Date [13]   Dec. 20, 2022
Shares/Units [13]   29,366
Cost [13]   $ 23
Fair Value [13]   $ 23
Fertility (ITC) Investment Holdco, LLC [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Providers & Services  
Spread Above Index [4] S+650  
Floor 1.00%  
Interest Rate [5] 11.63%  
Acquisition Date Jan. 04, 2023  
Maturity Date Jan. 03, 2029  
Par Amount $ 22,710  
Cost 22,068  
Fair Value $ 22,710  
Maxor Acquisition, Inc. [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Providers & Services  
Spread Above Index [4] S+675  
Floor 1.00%  
Interest Rate [5] 12.16%  
Acquisition Date Mar. 01, 2023  
Maturity Date Mar. 01, 2029  
Par Amount $ 23,843  
Cost 23,155  
Fair Value $ 23,128  
NSPC Intermediate Corp. (National Spine) [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Providers & Services  
Spread Above Index [4] S+850  
Floor 1.00%  
Interest Rate [5] 12.90%  
Acquisition Date Apr. 01, 2022  
Maturity Date Feb. 13, 2026  
Par Amount $ 2,216  
Cost 2,129  
Fair Value $ 2,216  
ONS MSO, LLC [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Providers & Services  
Spread Above Index [4] S+625  
Floor 1.00%  
Interest Rate [5] 11.32%  
Acquisition Date Feb. 10, 2023  
Maturity Date Jul. 08, 2025  
Par Amount $ 17,235  
Cost 16,791  
Fair Value $ 16,718  
United Digestive MSO Parent, LLC [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Providers & Services  
Spread Above Index [4] S+675  
Floor 1.00%  
Interest Rate [5] 11.99%  
Acquisition Date Mar. 30, 2023  
Maturity Date Mar. 30, 2029  
Par Amount $ 13,290  
Cost 12,903  
Fair Value $ 12,891  
Urology Management Holdings, Inc [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Providers & Services  
Spread Above Index [4] S+625  
Floor 1.00%  
Interest Rate [5] 11.36%  
Acquisition Date Feb. 07, 2023  
Maturity Date Jun. 15, 2026  
Par Amount $ 7,156  
Cost 6,962  
Fair Value $ 6,941  
A&A Crane and Rigging, LLC [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Commercial Services & Supplies  
Interest Rate [5],[36] 7.78%  
Acquisition Date [36] Mar. 27, 2023  
Maturity Date [36] Mar. 27, 2028  
Par Amount [36] $ 75  
Cost [36] 75  
Fair Value [36] $ 75  
Carolina's Contracting, LLC [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Diversified Consumer Services  
Acquisition Date [36] Mar. 07, 2023  
Par Amount [36] $ 3,850  
Cost [36] 3,887  
Fair Value [36] $ 3,850  
Carolina's Contracting, LLC [Member] | Equipment Financing — 27.7% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 8.40%  
Maturity Date [36] Mar. 07, 2028  
Carolina's Contracting, LLC [Member] | Equipment Financing — 27.7% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 8.72%  
Maturity Date [36] May 18, 2028  
Complete Equipment Rentals, LLC [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Commercial Services & Supplies  
Acquisition Date [36] Mar. 23, 2023  
Par Amount [36] $ 2,013  
Cost [36] 1,980  
Fair Value [36] $ 1,978  
Complete Equipment Rentals, LLC [Member] | Equipment Financing — 27.7% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 6.75%  
Maturity Date [36] Apr. 01, 2028  
Complete Equipment Rentals, LLC [Member] | Equipment Financing — 27.7% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 7.15%  
Maturity Date [36] Jun. 01, 2028  
Extreme Steel Crane & Rigging, LLC [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Commercial Services & Supplies  
Interest Rate [5],[36] 9.52%  
Acquisition Date [36] Mar. 03, 2023  
Maturity Date [36] Mar. 03, 2027  
Par Amount [36] $ 955  
Cost [36] 964  
Fair Value [36] $ 955  
NSPC Holdings, LLC (National Spine) [Member] | Common Equity/Equity Interests/Warrants—59.9% [Member]    
Schedule of Investments [Line Items]    
Industry [13] Health Care Providers & Services  
Acquisition Date [13] Feb. 13, 2023  
Shares/Units [13] 207,043  
Cost [13] $ 657  
Fair Value [13] $ 403  
Aero Operating LLC [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Commercial Services & Supplies  
Acquisition Date [36] Feb. 12, 2021  
Par Amount [36] $ 1,813  
Cost [36] 1,811  
Fair Value [36] $ 1,811  
Aero Operating LLC [Member] | Equipment Financing — 27.7% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 8.47%  
Maturity Date [36] Mar. 01, 2025  
Aero Operating LLC [Member] | Equipment Financing — 27.7% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 9.64%  
Maturity Date [36] Dec. 01, 2026  
Aero Operating LLC [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Commercial Services & Supplies
Acquisition Date [36]   Feb. 12, 2021
Par Amount [36]   $ 2,264
Cost [36]   2,262
Fair Value [36]   $ 2,262
Aero Operating LLC [Member] | Equipment Financing — 26.6% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   8.47%
Maturity Date [36]   Mar. 01, 2025
Aero Operating LLC [Member] | Equipment Financing — 26.6% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   9.64%
Maturity Date [36]   Dec. 01, 2026
AFG Dallas III, LLC [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Diversified Consumer Services  
Acquisition Date [36] Aug. 11, 2022  
Par Amount [36] $ 1,263  
Cost [36] 1,263  
Fair Value [36] $ 1,263  
AFG Dallas III, LLC [Member] | Equipment Financing — 27.7% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 10.00%  
Maturity Date [36] Aug. 11, 2026  
AFG Dallas III, LLC [Member] | Equipment Financing — 27.7% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 11.29%  
Maturity Date [36] Mar. 01, 2027  
AFG Dallas III, LLC [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Diversified Consumer Services
Interest Rate [6],[36]   10.00%
Acquisition Date [36]   Aug. 11, 2022
Par Amount [36]   $ 1,036
Cost [36]   1,036
Fair Value [36]   $ 1,036
AFG Dallas III, LLC [Member] | Equipment Financing — 26.6% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Maturity Date [36]   Aug. 11, 2026
AFG Dallas III, LLC [Member] | Equipment Financing — 26.6% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Maturity Date [36]   Aug. 29, 2026
Air Methods Corporation [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Airlines  
Acquisition Date [36] Nov. 03, 2021  
Par Amount [36] $ 3,356  
Cost [36] 3,405  
Fair Value [36] $ 3,356  
Air Methods Corporation [Member] | Equipment Financing — 27.7% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 7.08%  
Maturity Date [36] Nov. 03, 2026  
Air Methods Corporation [Member] | Equipment Financing — 27.7% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 7.13%  
Maturity Date [36] Nov. 23, 2026  
Air Methods Corporation [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Airlines
Acquisition Date [36]   Nov. 03, 2021
Par Amount [36]   $ 3,600
Cost [36]   3,660
Fair Value [36]   $ 3,600
Air Methods Corporation [Member] | Equipment Financing — 26.6% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   7.08%
Maturity Date [36]   Nov. 03, 2026
Air Methods Corporation [Member] | Equipment Financing — 26.6% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   7.13%
Maturity Date [36]   Nov. 23, 2026
AmeraMex International, Inc. [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Commercial Services & Supplies  
Interest Rate [5],[36] 10.00%  
Acquisition Date [36] Mar. 29, 2019  
Maturity Date [36] Apr. 15, 2025  
Par Amount [36] $ 720  
Cost [36] 720  
Fair Value [36] $ 727  
AmeraMex International, Inc. [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Commercial Services & Supplies
Interest Rate [6],[36]   10.00%
Acquisition Date [36]   Mar. 29, 2019
Maturity Date [36]   Sep. 15, 2024
Par Amount [36]   $ 1,059
Cost [36]   1,059
Fair Value [36]   $ 1,069
Bazzini, LLC [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Food & Staples Retailing  
Interest Rate [5],[36] 10.46%  
Acquisition Date [36] Dec. 23, 2022  
Maturity Date [36] Jan. 01, 2028  
Par Amount [36] $ 2,180  
Cost [36] 2,247  
Fair Value [36] $ 2,180  
Bazzini, LLC [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Food & Staples Retailing
Interest Rate [6],[36]   10.46%
Acquisition Date [36]   Dec. 23, 2022
Maturity Date [36]   Jan. 01, 2028
Par Amount [36]   $ 2,365
Cost [36]   2,440
Fair Value [36]   $ 2,365
Boart Longyear Company [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Metals & Mining  
Acquisition Date [36] May 28, 2020  
Par Amount [36] $ 3,283  
Cost [36] 3,283  
Fair Value [36] $ 3,283  
Boart Longyear Company [Member] | Equipment Financing — 27.7% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 8.31%  
Maturity Date [36] Jul. 01, 2024  
Boart Longyear Company [Member] | Equipment Financing — 27.7% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 10.44%  
Maturity Date [36] Oct. 07, 2026  
Boart Longyear Company [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Metals & Mining
Acquisition Date [36]   May 28, 2020
Par Amount [36]   $ 4,568
Cost [36]   4,568
Fair Value [36]   $ 4,568
Boart Longyear Company [Member] | Equipment Financing — 26.6% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   8.31%
Maturity Date [36]   Jul. 01, 2024
Boart Longyear Company [Member] | Equipment Financing — 26.6% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   10.44%
Maturity Date [36]   Oct. 07, 2026
Bowman Energy Solutions, LLC [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Commercial Services & Supplies  
Interest Rate [5],[36] 7.42%  
Acquisition Date [36] Jul. 01, 2022  
Maturity Date [36] Aug. 01, 2026  
Par Amount [36] $ 134  
Cost [36] 134  
Fair Value [36] $ 134  
Bowman Energy Solutions, LLC [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Commercial Services & Supplies
Interest Rate [6],[36]   7.42%
Acquisition Date [36]   Jul. 01, 2022
Maturity Date [36]   Aug. 01, 2026
Par Amount [36]   $ 153
Cost [36]   153
Fair Value [36]   $ 153
C-Port/Stone LLC [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Oil, Gas & Consumable Fuels  
Interest Rate [5],[36] 8.54%  
Acquisition Date [36] Oct. 07, 2022  
Maturity Date [36] Nov. 01, 2027  
Par Amount [36] $ 6,482  
Cost [36] 6,311  
Fair Value [36] $ 6,288  
C-Port/Stone LLC [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Oil, Gas & Consumable Fuels
Interest Rate [6],[36]   8.54%
Acquisition Date [36]   Oct. 07, 2022
Maturity Date [36]   Nov. 01, 2027
Par Amount [36]   $ 6,708
Cost [36]   6,514
Fair Value [36]   $ 6,507
Capital City Jet Center, Inc. [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Airlines  
Interest Rate [5],[36] 10.00%  
Acquisition Date [36] Apr. 04, 2018  
Par Amount [36] $ 1,777  
Cost [36] 1,777  
Fair Value [36] $ 1,762  
Capital City Jet Center, Inc. [Member] | Equipment Financing — 27.7% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Maturity Date [36] Oct. 04, 2023  
Capital City Jet Center, Inc. [Member] | Equipment Financing — 27.7% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Maturity Date [36] Jun. 22, 2026  
Capital City Jet Center, Inc. [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Airlines
Interest Rate [6],[36]   10.00%
Acquisition Date [36]   Apr. 04, 2018
Par Amount [36]   $ 2,241
Cost [36]   2,241
Fair Value [36]   $ 2,214
Capital City Jet Center, Inc. [Member] | Equipment Financing — 26.6% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Maturity Date [36]   Oct. 04, 2023
Capital City Jet Center, Inc. [Member] | Equipment Financing — 26.6% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Maturity Date [36]   Jun. 22, 2026
Champion Air, LLC [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Airlines
Interest Rate [6],[36]   10.00%
Acquisition Date [36]   Mar. 19, 2018
Maturity Date [36]   Jan. 01, 2023
Par Amount [36]   $ 1,055
Cost [36]   1,055
Fair Value [36]   $ 1,055
CKD Holdings, Inc. [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Road & Rail  
Acquisition Date [36] Sep. 22, 2022  
Par Amount [36] $ 3,285  
Cost [36] 3,285  
Fair Value [36] $ 3,285  
CKD Holdings, Inc. [Member] | Equipment Financing — 27.7% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 8.10%  
Maturity Date [36] Jun. 22, 2026  
CKD Holdings, Inc. [Member] | Equipment Financing — 27.7% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 8.60%  
Maturity Date [36] Sep. 22, 2027  
CKD Holdings, Inc. [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Road & Rail
Acquisition Date [36]   Sep. 22, 2022
Par Amount [36]   $ 3,690
Cost [36]   3,690
Fair Value [36]   $ 3,690
CKD Holdings, Inc. [Member] | Equipment Financing — 26.6% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   8.10%
Maturity Date [36]   Mar. 22, 2026
CKD Holdings, Inc. [Member] | Equipment Financing — 26.6% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   8.60%
Maturity Date [36]   Sep. 22, 2027
Clubcorp Holdings, Inc. [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Hotels, Restaurants & Leisure  
Acquisition Date [36] May 27, 2021  
Par Amount [36] $ 7,254  
Cost [36] 7,254  
Fair Value [36] $ 7,254  
Clubcorp Holdings, Inc. [Member] | Equipment Financing — 27.7% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 9.36%  
Maturity Date [36] Apr. 01, 2025  
Clubcorp Holdings, Inc. [Member] | Equipment Financing — 27.7% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 13.01%  
Maturity Date [36] May 01, 2028  
Clubcorp Holdings, Inc. [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Hotels, Restaurants & Leisure
Acquisition Date [36]   May 27, 2021
Par Amount [36]   $ 6,539
Cost [36]   6,539
Fair Value [36]   $ 6,539
Clubcorp Holdings, Inc. [Member] | Equipment Financing — 26.6% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   9.36%
Maturity Date [36]   Apr. 01, 2025
Clubcorp Holdings, Inc. [Member] | Equipment Financing — 26.6% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   13.01%
Maturity Date [36]   Jan. 01, 2028
Dongwon Autopart Technology Inc. [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Auto Components  
Interest Rate [5],[36] 7.96%  
Acquisition Date [36] Feb. 02, 2021  
Maturity Date [36] Jan. 01, 2026  
Par Amount [36] $ 1,553  
Cost [36] 1,568  
Fair Value [36] $ 1,553  
Dongwon Autopart Technology Inc. [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Auto Components
Interest Rate [6],[36]   7.96%
Acquisition Date [36]   Feb. 02, 2021
Maturity Date [36]   Jan. 01, 2026
Par Amount [36]   $ 1,828
Cost [36]   1,849
Fair Value [36]   $ 1,828
Drillers Choice, Inc [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Commercial Services & Supplies  
Acquisition Date [36] Oct. 31, 2022  
Par Amount [36] $ 2,050  
Cost [36] 2,053  
Fair Value [36] $ 2,050  
Drillers Choice, Inc [Member] | Equipment Financing — 27.7% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 8.00%  
Maturity Date [36] Nov. 01, 2027  
Drillers Choice, Inc [Member] | Equipment Financing — 27.7% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 10.08%  
Maturity Date [36] Jun. 01, 2029  
Drillers Choice, Inc [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Commercial Services & Supplies
Interest Rate [6],[36]   8.00%
Acquisition Date [36]   Oct. 31, 2022
Maturity Date [36]   Nov. 01, 2027
Par Amount [36]   $ 1,589
Cost [36]   1,589
Fair Value [36]   $ 1,589
EasyPak, LLC [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Containers & Packaging  
Interest Rate [5],[36] 9.01%  
Acquisition Date [36] Jan. 06, 2021  
Maturity Date [36] Jan. 01, 2024  
Par Amount [36] $ 94  
Cost [36] 94  
Fair Value [36] $ 94  
EasyPak, LLC [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Containers & Packaging
Interest Rate [6],[36]   9.01%
Acquisition Date [36]   Jan. 06, 2021
Maturity Date [36]   Jan. 01, 2024
Par Amount [36]   $ 276
Cost [36]   276
Fair Value [36]   $ 276
Energy Drilling Services, LLC [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Diversified Consumer Services  
Acquisition Date [36] Aug. 26, 2022  
Par Amount [36] $ 1,201  
Cost [36] 1,201  
Fair Value [36] $ 1,177  
Energy Drilling Services, LLC [Member] | Equipment Financing — 27.7% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 6.58%  
Maturity Date [36] Nov. 09, 2025  
Energy Drilling Services, LLC [Member] | Equipment Financing — 27.7% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 9.16%  
Maturity Date [36] Sep. 01, 2027  
Energy Drilling Services, LLC [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Diversified Consumer Services
Acquisition Date [36]   Aug. 26, 2022
Par Amount [36]   $ 1,321
Cost [36]   1,321
Fair Value [36]   $ 1,295
Energy Drilling Services, LLC [Member] | Equipment Financing — 26.6% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   6.58%
Maturity Date [36]   Dec. 09, 2025
Energy Drilling Services, LLC [Member] | Equipment Financing — 26.6% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   9.16%
Maturity Date [36]   Sep. 01, 2027
Environmental Protection & Improvement Company, LLC [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Road & Rail  
Interest Rate [5],[36] 8.25%  
Acquisition Date [36] Sep. 30, 2020  
Maturity Date [36] Oct. 01, 2027  
Par Amount [36] $ 4,925  
Cost [36] 4,949  
Fair Value [36] $ 4,925  
Environmental Protection & Improvement Company, LLC [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Road & Rail
Interest Rate [6],[36]   8.25%
Acquisition Date [36]   Sep. 30, 2020
Maturity Date [36]   Oct. 01, 2027
Par Amount [36]   $ 5,270
Cost [36]   5,300
Fair Value [36]   $ 5,270
Equipment Operating Leases, LLC [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [17],[37] Multi-Sector Holdings  
Interest Rate [5],[17],[37] 8.37%  
Acquisition Date [17],[37] Apr. 27, 2018  
Maturity Date [17],[37] Apr. 27, 2025  
Par Amount [17],[37] $ 3,614  
Cost [17],[37] 3,614  
Fair Value [17],[37] $ 3,523  
Equipment Operating Leases, LLC [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [18],[37]   Multi-Sector Holdings
Interest Rate [6],[18]   8.37%
Acquisition Date [18],[37]   Apr. 27, 2018
Maturity Date [18]   Apr. 27, 2025
Par Amount [18],[37]   $ 3,837
Cost [18],[37]   3,837
Fair Value [18],[37]   $ 3,741
First American Commercial Bancorp, Inc. [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Diversified Financial Services  
Acquisition Date [36] Oct. 28, 2021  
Par Amount [36] $ 2,615  
Cost [36] 2,617  
Fair Value [36] $ 2,615  
First American Commercial Bancorp, Inc. [Member] | Equipment Financing — 27.7% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 7.50%  
Maturity Date [36] Oct. 01, 2026  
First American Commercial Bancorp, Inc. [Member] | Equipment Financing — 27.7% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 9.02%  
Maturity Date [36] Mar. 01, 2027  
First American Commercial Bancorp, Inc. [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Diversified Financial Services
Acquisition Date [36]   Oct. 28, 2021
Par Amount [36]   $ 2,938
Cost [36]   2,941
Fair Value [36]   $ 2,938
First American Commercial Bancorp, Inc. [Member] | Equipment Financing — 26.6% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   7.50%
Maturity Date [36]   Oct. 01, 2026
First American Commercial Bancorp, Inc. [Member] | Equipment Financing — 26.6% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   9.02%
Maturity Date [36]   Mar. 01, 2027
First National Capital, LLC [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Diversified Financial Services  
Interest Rate [5],[36] 9.00%  
Acquisition Date [36] Nov. 05, 2021  
Maturity Date [36] Aug. 01, 2026  
Par Amount [36] $ 6,179  
Cost [36] 6,179  
Fair Value [36] $ 6,179  
First National Capital, LLC [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Diversified Financial Services
Interest Rate [6],[36]   9.00%
Acquisition Date [36]   Nov. 05, 2021
Maturity Date [36]   Aug. 01, 2026
Par Amount [36]   $ 7,116
Cost [36]   7,116
Fair Value [36]   $ 7,116
Freightsol LLC [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Road & Rail  
Acquisition Date [36] Apr. 09, 2019  
Maturity Date [36] Nov. 01, 2023  
Par Amount [36] $ 457  
Cost [36] 459  
Fair Value [36] $ 457  
Freightsol LLC [Member] | Equipment Financing — 27.7% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 12.51%  
Freightsol LLC [Member] | Equipment Financing — 27.7% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 12.89%  
Freightsol LLC [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Road & Rail
Acquisition Date [36]   Apr. 09, 2019
Maturity Date [36]   Nov. 01, 2023
Par Amount [36]   $ 779
Cost [36]   784
Fair Value [36]   $ 779
Freightsol LLC [Member] | Equipment Financing — 26.6% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   12.51%
Freightsol LLC [Member] | Equipment Financing — 26.6% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   12.89%
Garda CL Technical Services, Inc. [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Commercial Services & Supplies  
Interest Rate [5],[36] 8.31%  
Acquisition Date [36] Mar. 22, 2018  
Maturity Date [36] Oct. 05, 2023  
Par Amount [36] $ 55  
Cost [36] 55  
Fair Value [36] $ 55  
Garda CL Technical Services, Inc. [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Commercial Services & Supplies
Acquisition Date [36]   Mar. 22, 2018
Par Amount [36]   $ 469
Cost [36]   469
Fair Value [36]   $ 468
Garda CL Technical Services, Inc. [Member] | Equipment Financing — 26.6% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   8.30%
Maturity Date [36]   Jun. 05, 2023
Garda CL Technical Services, Inc. [Member] | Equipment Financing — 26.6% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   8.77%
Maturity Date [36]   Oct. 05, 2023
Georgia Jet, Inc. [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Airlines  
Interest Rate [5],[36] 8.00%  
Acquisition Date [36] Dec. 04, 2017  
Maturity Date [36] Jan. 04, 2024  
Par Amount [36] $ 229  
Cost [36] 229  
Fair Value [36] $ 229  
Georgia Jet, Inc. [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Airlines
Interest Rate [6],[36]   8.00%
Acquisition Date [36]   Dec. 04, 2017
Maturity Date [36]   Jan. 04, 2024
Par Amount [36]   $ 425
Cost [36]   425
Fair Value [36]   $ 425
GMT Corporation [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Machinery  
Interest Rate [5],[36] 10.71%  
Acquisition Date [36] Oct. 23, 2018  
Maturity Date [36] Jan. 01, 2026  
Par Amount [36] $ 4,320  
Cost [36] 4,324  
Fair Value [36] $ 4,320  
GMT Corporation [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Machinery
Interest Rate [6],[36]   10.71%
Acquisition Date [36]   Oct. 23, 2018
Maturity Date [36]   Jan. 01, 2026
Par Amount [36]   $ 4,801
Cost [36]   4,806
Fair Value [36]   $ 4,801
Hawkeye Contracting Company, LLC [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Construction & Engineering  
Interest Rate [5],[36] 10.50%  
Acquisition Date [36] Oct. 08, 2021  
Maturity Date [36] Nov. 01, 2025  
Par Amount [36] $ 847  
Cost [36] 847  
Fair Value [36] $ 847  
Hawkeye Contracting Company, LLC [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Construction & Engineering
Interest Rate [6],[36]   10.50%
Acquisition Date [36]   Oct. 08, 2021
Maturity Date [36]   Nov. 01, 2025
Par Amount [36]   $ 997
Cost [36]   997
Fair Value [36]   $ 997
HTI Logistics Corporation [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Commercial Services & Supplies  
Acquisition Date [36] Nov. 15, 2018  
Par Amount [36] $ 223  
Cost [36] 223  
Fair Value [36] $ 218  
HTI Logistics Corporation [Member] | Equipment Financing — 27.7% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 9.69%  
Maturity Date [36] May 01, 2024  
HTI Logistics Corporation [Member] | Equipment Financing — 27.7% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 9.94%  
Maturity Date [36] Sep. 01, 2025  
HTI Logistics Corporation [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Commercial Services & Supplies
Acquisition Date [36]   Nov. 15, 2018
Par Amount [36]   $ 290
Cost [36]   290
Fair Value [36]   $ 283
HTI Logistics Corporation [Member] | Equipment Financing — 26.6% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   9.69%
Maturity Date [36]   May 01, 2024
HTI Logistics Corporation [Member] | Equipment Financing — 26.6% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   9.94%
Maturity Date [36]   Sep. 01, 2025
International Automotive Components Group, North America, Inc. [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Auto Components  
Interest Rate [5],[36] 7.95%  
Acquisition Date [36] Jun. 23, 2021  
Maturity Date [36] Jun. 23, 2025  
Par Amount [36] $ 4,952  
Cost [36] 4,976  
Fair Value [36] $ 4,853  
International Automotive Components Group, North America, Inc. [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Auto Components
Interest Rate [6],[36]   7.95%
Acquisition Date [36]   Jun. 23, 2021
Maturity Date [36]   Jun. 23, 2025
Par Amount [36]   $ 6,072
Cost [36]   6,109
Fair Value [36]   $ 5,951
Kool Pak, LLC [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Road & Rail  
Interest Rate [5],[36] 8.58%  
Acquisition Date [36] Feb. 05, 2018  
Maturity Date [36] Mar. 01, 2024  
Par Amount [36] $ 113  
Cost [36] 113  
Fair Value [36] $ 113  
Kool Pak, LLC [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Road & Rail
Interest Rate [6],[36]   8.58%
Acquisition Date [36]   Feb. 05, 2018
Maturity Date [36]   Mar. 01, 2024
Par Amount [36]   $ 194
Cost [36]   194
Fair Value [36]   $ 194
Loc Performance Products, LLC [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Machinery  
Interest Rate [5],[36] 10.50%  
Acquisition Date [36] Dec. 29, 2022  
Maturity Date [36] Jun. 01, 2027  
Par Amount [36] $ 709  
Cost [36] 709  
Fair Value [36] $ 709  
Loc Performance Products, LLC [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Machinery
Interest Rate [6],[36]   10.50%
Acquisition Date [36]   Dec. 29, 2022
Maturity Date [36]   Jun. 01, 2027
Par Amount [36]   $ 767
Cost [36]   767
Fair Value [36]   $ 767
Loyer Capital LLC [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [17],[37] Multi-Sector Holdings  
Acquisition Date [17],[37] May 16, 2019  
Par Amount [17],[37] $ 7,500  
Cost [17],[37] 7,500  
Fair Value [17],[37] $ 7,361  
Loyer Capital LLC [Member] | Equipment Financing — 27.7% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[17],[37] 8.73%  
Maturity Date [17],[37] May 16, 2024  
Loyer Capital LLC [Member] | Equipment Financing — 27.7% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[17],[37] 11.52%  
Maturity Date [17],[37] Sep. 25, 2024  
Loyer Capital LLC [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [18],[37]   Multi-Sector Holdings
Acquisition Date [18],[37]   May 16, 2019
Par Amount [18],[37]   $ 7,500
Cost [18],[37]   7,500
Fair Value [18],[37]   $ 7,361
Loyer Capital LLC [Member] | Equipment Financing — 26.6% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[18],[37]   8.73%
Maturity Date [18],[37]   May 16, 2024
Loyer Capital LLC [Member] | Equipment Financing — 26.6% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[18],[37]   11.52%
Maturity Date [18],[37]   Sep. 25, 2024
Lux Credit Consultants, LLC [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Road & Rail  
Acquisition Date [36] Jun. 17, 2021  
Par Amount [36] $ 13,260  
Cost [36] 13,260  
Fair Value [36] $ 13,260  
Lux Credit Consultants, LLC [Member] | Equipment Financing — 27.7% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 8.28%  
Maturity Date [36] Dec. 01, 2024  
Lux Credit Consultants, LLC [Member] | Equipment Financing — 27.7% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 12.09%  
Maturity Date [36] Dec. 01, 2026  
Lux Credit Consultants, LLC [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Road & Rail
Acquisition Date [36]   Jun. 17, 2021
Par Amount [36]   $ 16,411
Cost [36]   16,411
Fair Value [36]   $ 16,411
Lux Credit Consultants, LLC [Member] | Equipment Financing — 26.6% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   8.28%
Maturity Date [36]   Dec. 01, 2024
Lux Credit Consultants, LLC [Member] | Equipment Financing — 26.6% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   12.09%
Maturity Date [36]   Dec. 01, 2026
Lux Vending, LLC [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Consumer Finance  
Acquisition Date [36] Aug. 20, 2021  
Par Amount [36] $ 1,151  
Cost [36] 1,163  
Fair Value [36] $ 1,151  
Lux Vending, LLC [Member] | Equipment Financing — 27.7% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 12.46%  
Maturity Date [36] Jul. 20, 2024  
Lux Vending, LLC [Member] | Equipment Financing — 27.7% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 13.26%  
Maturity Date [36] Oct. 01, 2024  
Lux Vending, LLC [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Consumer Finance
Acquisition Date [36]   Aug. 20, 2021
Par Amount [36]   $ 1,638
Cost [36]   1,663
Fair Value [36]   $ 1,638
Lux Vending, LLC [Member] | Equipment Financing — 26.6% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   12.46%
Maturity Date [36]   Aug. 20, 2024
Lux Vending, LLC [Member] | Equipment Financing — 26.6% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   13.26%
Maturity Date [36]   Oct. 01, 2024
Miranda Logistics Enterprise, Inc [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Construction & Engineering  
Interest Rate [5],[36] 7.69%  
Acquisition Date [36] Apr. 14, 2023  
Maturity Date [36] Apr. 14, 2028  
Par Amount [36] $ 862  
Cost [36] 862  
Fair Value [36] $ 862  
Mountain Air Helicopters, Inc. [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Commercial Services & Supplies  
Interest Rate [5],[36] 10.00%  
Acquisition Date [36] Jul. 31, 2017  
Maturity Date [36] Feb. 28, 2025  
Par Amount [36] $ 310  
Cost [36] 309  
Fair Value [36] $ 310  
Mountain Air Helicopters, Inc. [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Commercial Services & Supplies
Interest Rate [6],[36]   10.00%
Acquisition Date [36]   Jul. 31, 2017
Maturity Date [36]   Feb. 28, 2025
Par Amount [36]   $ 369
Cost [36]   368
Fair Value [36]   $ 369
No Limit Construction Services, LLC [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Commercial Services & Supplies  
Interest Rate [5],[36] 7.73%  
Acquisition Date [36] May 05, 2023  
Maturity Date [36] Jun. 01, 2028  
Par Amount [36] $ 129  
Cost [36] 129  
Fair Value [36] $ 129  
Ozzies, Inc. [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Commercial Services & Supplies  
Interest Rate [5],[36] 10.72%  
Acquisition Date [36] Dec. 23, 2022  
Maturity Date [36] Jan. 01, 2027  
Par Amount [36] $ 1,837  
Cost [36] 1,895  
Fair Value [36] $ 1,837  
Ozzies, Inc. [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Commercial Services & Supplies
Interest Rate [6],[36]   10.72%
Acquisition Date [36]   Dec. 23, 2022
Maturity Date [36]   Jan. 01, 2027
Par Amount [36]   $ 2,005
Cost [36]   2,072
Fair Value [36]   $ 2,005
PCX Aerostructures LLC [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Aerospace & Defense  
Interest Rate [5],[36] 9.32%  
Acquisition Date [36] Nov. 23, 2022  
Maturity Date [36] Dec. 01, 2028  
Par Amount [36] $ 2,489  
Cost [36] 2,489  
Fair Value [36] $ 2,489  
PCX Aerostructures LLC [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Aerospace & Defense
Interest Rate [6],[36]   9.32%
Acquisition Date [36]   Nov. 23, 2022
Maturity Date [36]   Dec. 01, 2028
Par Amount [36]   $ 2,658
Cost [36]   2,658
Fair Value [36]   $ 2,658
Rane Light Metal Castings Inc. [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Machinery  
Interest Rate [5],[36] 10.00%  
Acquisition Date [36] Jun. 01, 2020  
Maturity Date [36] Jun. 01, 2024  
Par Amount [36] $ 109  
Cost [36] 109  
Fair Value [36] $ 109  
Rane Light Metal Castings Inc. [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Machinery
Interest Rate [6],[36]   10.00%
Acquisition Date [36]   Jun. 01, 2020
Maturity Date [36]   Jun. 01, 2024
Par Amount [36]   $ 159
Cost [36]   159
Fair Value [36]   $ 159
Rango, Inc. [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Commercial Services & Supplies  
Acquisition Date [36] Sep. 24, 2019  
Par Amount [36] $ 1,023  
Cost [36] 1,038  
Fair Value [36] $ 1,004  
Rango, Inc. [Member] | Equipment Financing — 27.7% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 9.33%  
Maturity Date [36] Aug. 01, 2023  
Rango, Inc. [Member] | Equipment Financing — 27.7% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 9.79%  
Maturity Date [36] Nov. 01, 2024  
Rango, Inc. [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Commercial Services & Supplies
Acquisition Date [36]   Sep. 24, 2019
Par Amount [36]   $ 1,940
Cost [36]   1,960
Fair Value [36]   $ 1,904
Rango, Inc. [Member] | Equipment Financing — 26.6% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   9.33%
Maturity Date [36]   Apr. 01, 2023
Rango, Inc. [Member] | Equipment Financing — 26.6% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   9.79%
Maturity Date [36]   Nov. 01, 2024
Rayzor's Edge LLC [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Diversified Consumer Services  
Acquisition Date [36] May 19, 2023  
Par Amount [36] $ 753  
Cost [36] 753  
Fair Value [36] $ 753  
Rayzor's Edge LLC [Member] | Equipment Financing — 27.7% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 7.69%  
Maturity Date [36] May 18, 2030  
Rayzor's Edge LLC [Member] | Equipment Financing — 27.7% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 8.27%  
Maturity Date [36] Jun. 30, 2030  
RH Land Construction, LLC Harbor Dredging LA, Inc [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Construction & Engineering  
Interest Rate [5],[36] 8.08%  
Acquisition Date [36] May 10, 2023  
Maturity Date [36] May 10, 2026  
Par Amount [36] $ 135  
Cost [36] 135  
Fair Value [36] $ 135  
Royal Coach Lines, Inc.[Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Road & Rail  
Interest Rate [5],[36] 9.56%  
Acquisition Date [36] Nov. 21, 2019  
Maturity Date [36] Aug. 01, 2025  
Par Amount [36] $ 718  
Cost [36] 718  
Fair Value [36] $ 655  
Royal Coach Lines, Inc.[Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Road & Rail
Interest Rate [6],[36]   9.56%
Acquisition Date [36]   Nov. 21, 2019
Maturity Date [36]   Aug. 01, 2025
Par Amount [36]   $ 849
Cost [36]   849
Fair Value [36]   $ 775
Royal Express Inc. [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Road & Rail  
Interest Rate [5],[36] 9.53%  
Acquisition Date [36] Jan. 17, 2019  
Maturity Date [36] Feb. 01, 2024  
Par Amount [36] $ 291  
Cost [36] 292  
Fair Value [36] $ 291  
Royal Express Inc. [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Road & Rail
Interest Rate [6],[36]   9.53%
Acquisition Date [36]   Jan. 17, 2019
Maturity Date [36]   Feb. 01, 2024
Par Amount [36]   $ 428
Cost [36]   431
Fair Value [36]   $ 428
Rotten Rock Hardscaping & Tree Service [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Diversified Consumer Services  
Interest Rate [5],[36] 8.21%  
Acquisition Date [36] Dec. 06, 2022  
Maturity Date [36] Dec. 06, 2027  
Par Amount [36] $ 225  
Cost [36] 225  
Fair Value [36] $ 225  
Rotten Rock Hardscaping & Tree Service [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Diversified Consumer Services
Interest Rate [6],[36]   8.21%
Acquisition Date [36]   Dec. 06, 2022
Maturity Date [36]   Dec. 06, 2027
Par Amount [36]   $ 245
Cost [36]   245
Fair Value [36]   $ 245
Signet Marine Corporation [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Transportation Infrastructure  
Interest Rate [5],[36] 8.50%  
Acquisition Date [36] Oct. 31, 2022  
Maturity Date [36] Nov. 01, 2029  
Par Amount [36] $ 13,275  
Cost [36] 13,320  
Fair Value [36] $ 13,275  
Signet Marine Corporation [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Transportation Infrastructure
Interest Rate [6],[36]   8.50%
Acquisition Date [36]   Oct. 31, 2022
Maturity Date [36]   Jul. 01, 2029
Par Amount [36]   $ 14,102
Cost [36]   14,152
Fair Value [36]   $ 14,102
SLR Equipment Finance [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [17] Multi-Sector Holdings  
Interest Rate [5],[17] 8.50%  
Acquisition Date [17] Jan. 24, 2022  
Maturity Date [17] Jan. 27, 2024  
Par Amount [17] $ 2,500  
Cost [17] 2,500  
Fair Value [17] $ 2,500  
SLR Equipment Finance [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [17]   Multi-Sector Holdings
Interest Rate [6],[36]   8.50%
Acquisition Date [17]   Jan. 24, 2022
Maturity Date   Jan. 24, 2023
Par Amount [17]   $ 5,000
Cost [17]   5,000
Fair Value [17]   $ 5,000
Smiley Lifting Solutions, LLC [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Commercial Services & Supplies  
Acquisition Date [36] Jun. 30, 2022  
Par Amount [36] $ 6,297  
Cost [36] 6,297  
Fair Value [36] $ 6,297  
Smiley Lifting Solutions, LLC [Member] | Equipment Financing — 27.7% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 7.82%  
Maturity Date [36] Sep. 15, 2026  
Smiley Lifting Solutions, LLC [Member] | Equipment Financing — 27.7% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 8.61%  
Maturity Date [36] Jun. 27, 2030  
Smiley Lifting Solutions, LLC [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Commercial Services & Supplies
Acquisition Date [36]   Jun. 30, 2022
Par Amount [36]   $ 4,139
Cost [36]   4,139
Fair Value [36]   $ 4,139
Smiley Lifting Solutions, LLC [Member] | Equipment Financing — 26.6% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   7.82%
Maturity Date [36]   Sep. 15, 2026
Smiley Lifting Solutions, LLC [Member] | Equipment Financing — 26.6% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   8.28%
Maturity Date [36]   Dec. 29, 2029
ST Coaches, LLC [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Road & Rail  
Acquisition Date [36] Jul. 31, 2017  
Par Amount [36] $ 1,442  
Cost [36] 1,442  
Fair Value [36] $ 1,383  
ST Coaches, LLC [Member] | Equipment Financing — 27.7% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 8.47%  
Maturity Date [36] Jul. 01, 2023  
ST Coaches, LLC [Member] | Equipment Financing — 27.7% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 8.58%  
Maturity Date [36] Jan. 25, 2025  
ST Coaches, LLC [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Road & Rail
Acquisition Date [36]   Jul. 31, 2017
Par Amount [36]   $ 1,521
Cost [36]   1,521
Fair Value [36]   $ 1,459
ST Coaches, LLC [Member] | Equipment Financing — 26.6% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   8.47%
Maturity Date [36]   Jul. 01, 2023
ST Coaches, LLC [Member] | Equipment Financing — 26.6% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   8.58%
Maturity Date [36]   Jan. 25, 2025
Star Coaches Inc. [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Road & Rail  
Interest Rate [5],[36] 8.42%  
Acquisition Date [36] Mar. 09, 2018  
Maturity Date [36] Apr. 01, 2025  
Par Amount [36] $ 2,613  
Cost [36] 2,613  
Fair Value [36] $ 2,345  
Star Coaches Inc. [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Road & Rail
Interest Rate [6],[36]   8.42%
Acquisition Date [36]   Mar. 09, 2018
Maturity Date [36]   Apr. 01, 2025
Par Amount [36]   $ 2,887
Cost [36]   2,887
Fair Value [36]   $ 2,591
Superior Transportation, Inc. [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Road & Rail  
Acquisition Date [36] Jul. 31, 2017  
Maturity Date [36] Jan. 01, 2026  
Par Amount [36] $ 2,800  
Cost [36] 2,800  
Fair Value [36] $ 2,800  
Superior Transportation, Inc. [Member] | Equipment Financing — 27.7% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 10.22%  
Superior Transportation, Inc. [Member] | Equipment Financing — 27.7% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 10.69%  
Superior Transportation, Inc. [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Road & Rail
Acquisition Date [36]   Jul. 31, 2017
Maturity Date [36]   Jan. 01, 2026
Par Amount [36]   $ 3,369
Cost [36]   3,369
Fair Value [36]   $ 3,369
Superior Transportation, Inc. [Member] | Equipment Financing — 26.6% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   10.22%
Superior Transportation, Inc. [Member] | Equipment Financing — 26.6% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   10.63%
The Smedley Company & Smedley Services, Inc. [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Commercial Services & Supplies  
Interest Rate [5],[36] 4.07%  
Acquisition Date [36] Jul. 31, 2017  
Maturity Date [36] Jan. 15, 2028  
Par Amount [36] $ 1,553  
Cost [36] 1,553  
Fair Value [36] $ 1,553  
The Smedley Company & Smedley Services, Inc. [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Commercial Services & Supplies
Interest Rate [6],[36]   4.07%
Acquisition Date [36]   Jul. 31, 2017
Maturity Date [36]   Jan. 15, 2028
Par Amount [36]   $ 1,706
Cost [36]   1,706
Fair Value [36]   $ 1,706
Trinity Equipment Rentals, Inc. [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Commercial Services & Supplies  
Acquisition Date [36] Oct. 08, 2021  
Par Amount [36] $ 1,939  
Cost [36] 1,939  
Fair Value [36] $ 1,939  
Trinity Equipment Rentals, Inc. [Member] | Equipment Financing — 27.7% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 7.94%  
Maturity Date [36] Nov. 01, 2024  
Trinity Equipment Rentals, Inc. [Member] | Equipment Financing — 27.7% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 8.93%  
Maturity Date [36] Dec. 01, 2026  
Trinity Equipment Rentals, Inc. [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Commercial Services & Supplies
Acquisition Date [36]   Oct. 08, 2021
Par Amount [36]   $ 577
Cost [36]   577
Fair Value [36]   $ 577
Trinity Equipment Rentals, Inc. [Member] | Equipment Financing — 26.6% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   7.94%
Maturity Date [36]   Nov. 01, 2024
Trinity Equipment Rentals, Inc. [Member] | Equipment Financing — 26.6% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   8.75%
Maturity Date [36]   Dec. 01, 2026
U.S. Crane & Rigging, LLC [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Commercial Services & Supplies  
Interest Rate [5],[36] 10.92%  
Acquisition Date [36] Dec. 23, 2022  
Maturity Date [36] Mar. 01, 2027  
Par Amount [36] $ 1,848  
Cost [36] 1,848  
Fair Value [36] $ 1,848  
U.S. Crane & Rigging, LLC [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Commercial Services & Supplies
Interest Rate [6],[36]   10.92%
Acquisition Date [36]   Dec. 23, 2022
Maturity Date [36]   Mar. 01, 2027
Par Amount [36]   $ 2,005
Cost [36]   2,005
Fair Value [36]   $ 2,005
Up Trucking Services, LLC [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Road & Rail  
Interest Rate [5],[36] 11.21%  
Acquisition Date [36] Mar. 23, 2018  
Maturity Date [36] Aug. 01, 2024  
Par Amount [36] $ 329  
Cost [36] 331  
Fair Value [36] $ 329  
Up Trucking Services, LLC [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Road & Rail
Interest Rate [6],[36]   11.21%
Acquisition Date [36]   Mar. 23, 2018
Maturity Date [36]   Aug. 01, 2024
Par Amount [36]   $ 469
Cost [36]   473
Fair Value [36]   $ 469
Waste Pro of Florida, Inc. Waste Pro USA, Inc [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Commercial Services & Supplies  
Interest Rate [5],[36] 9.17%  
Acquisition Date [36] Apr. 18, 2023  
Maturity Date [36] Apr. 18, 2028  
Par Amount [36] $ 9,735  
Cost [36] 9,904  
Fair Value [36] $ 9,735  
Wind River Environmental, LLC [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Diversified Consumer Services  
Acquisition Date [36] Jul. 31, 2019  
Par Amount [36] $ 461  
Cost [36] 462  
Fair Value [36] $ 461  
Wind River Environmental, LLC [Member] | Equipment Financing — 27.7% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 8.43%  
Maturity Date [36] Aug. 01, 2024  
Wind River Environmental, LLC [Member] | Equipment Financing — 27.7% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 10.00%  
Maturity Date [36] Oct. 05, 2025  
Wind River Environmental, LLC [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Diversified Consumer Services
Acquisition Date [36]   Jul. 31, 2019
Par Amount [36]   $ 604
Cost [36]   605
Fair Value [36]   $ 604
Wind River Environmental, LLC [Member] | Equipment Financing — 26.6% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   8.43%
Maturity Date [36]   Aug. 01, 2024
Wind River Environmental, LLC [Member] | Equipment Financing — 26.6% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   10.00%
Maturity Date [36]   Oct. 05, 2025
Womble Company, Inc. [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Energy Equipment & Services  
Interest Rate [5],[36] 9.11%  
Acquisition Date [36] Dec. 27, 2019  
Maturity Date [36] Jan. 01, 2025  
Par Amount [36] $ 300  
Cost [36] 300  
Fair Value [36] $ 289  
Womble Company, Inc. [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Energy Equipment & Services
Interest Rate [6],[36]   9.11%
Acquisition Date [36]   Dec. 27, 2019
Maturity Date [36]   Jan. 01, 2025
Par Amount [36]   $ 386
Cost [36]   386
Fair Value [36]   $ 371
Worldwide Flight Services, Inc. [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Transportation Infrastructure  
Acquisition Date [36] Sep. 23, 2022  
Par Amount [36] $ 2,426  
Cost [36] 2,463  
Fair Value [36] $ 2,426  
Worldwide Flight Services, Inc. [Member] | Equipment Financing — 27.7% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 8.32%  
Maturity Date [36] Sep. 23, 2027  
Worldwide Flight Services, Inc. [Member] | Equipment Financing — 27.7% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [5],[36] 9.93%  
Maturity Date [36] Jun. 23, 2028  
Worldwide Flight Services, Inc. [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Transportation Infrastructure
Acquisition Date [36]   Sep. 23, 2022
Par Amount [36]   $ 304
Cost [36]   308
Fair Value [36]   $ 304
Worldwide Flight Services, Inc. [Member] | Equipment Financing — 26.6% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   8.32%
Maturity Date [36]   Sep. 23, 2027
Worldwide Flight Services, Inc. [Member] | Equipment Financing — 26.6% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[36]   9.36%
Maturity Date [36]   Oct. 28, 2027
Zamborelli Enterprises Pacific Souther Foundation [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [36] Diversified Consumer Services  
Interest Rate [5],[36] 8.91%  
Acquisition Date [36] Dec. 07, 2022  
Maturity Date [36] Jan. 01, 2027  
Par Amount [36] $ 644  
Cost [36] 650  
Fair Value [36] $ 644  
Zamborelli Enterprises Pacific Souther Foundation [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [36]   Diversified Consumer Services
Interest Rate [6],[36]   8.91%
Acquisition Date [36]   Dec. 07, 2022
Maturity Date [36]   Jan. 01, 2027
Par Amount [36]   $ 707
Cost [36]   714
Fair Value [36]   $ 707
SLR Equipment Finance Equity Interests [Member] | Equipment Financing — 27.7% [Member]    
Schedule of Investments [Line Items]    
Industry [13],[17],[38],[39] Multi-Sector Holdings  
Acquisition Date [13],[17],[38],[39] Jul. 31, 2017  
Shares/Units [13],[17],[38],[39] 200  
Cost [13],[17],[38],[39] $ 145,000  
Fair Value [13],[17],[38],[39] $ 120,820  
SLR Equipment Finance Equity Interests [Member] | Equipment Financing — 26.6% [Member]    
Schedule of Investments [Line Items]    
Industry [13],[18],[38],[39]   Multi-Sector Holdings
Acquisition Date [13],[18],[38],[39]   Jul. 31, 2017
Shares/Units [13],[18],[38],[39]   200
Cost [13],[18],[38],[39]   $ 145,000
Fair Value [13],[18],[38],[39]   $ 120,820
Vertos Medical, Inc. [Member] | Senior Secured Loans — 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Equipment & Supplies  
Spread Above Index [4] S+515  
Floor 4.75%  
Interest Rate [5] 10.25%  
Acquisition Date Jun. 14, 2023  
Maturity Date Jul. 01, 2028  
Par Amount $ 6,651  
Cost 6,570  
Fair Value $ 6,567  
SLRAMI Topco Blocker, LLC [Member] | Common Equity/Equity Interests/Warrants—59.9% [Member]    
Schedule of Investments [Line Items]    
Industry [9],[13],[40] Internet & Catalog Retail  
Acquisition Date [9],[13],[40] Jun. 16, 2023  
Shares/Units [9],[13],[40] 0  
Cost [9],[13],[40] $ 7,014  
Fair Value [9],[13],[40] $ 8,897  
Vertos Medical, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants—59.9% [Member]    
Schedule of Investments [Line Items]    
Industry [13] Health Care Equipment & Supplies  
Acquisition Date [13] Jun. 14, 2023  
Shares/Units [13] 161,761  
Cost [13] $ 51  
Fair Value [13] $ 51  
[1] Aggregate net unrealized depreciation for U.S. federal income tax purposes is $3,002; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $154,967 and $157,969, respectively, based on a tax cost of $2,184,428. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.
[2] Aggregate net unrealized appreciation for U.S. federal income tax purposes is $17,187; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $161,053 and $143,866, respectively, based on a tax cost of $2,069,489. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.
[3] Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SUNS SPV LLC (the “SUNS SPV”). Such investments are pledged as collateral under the Senior Secured Revolving SPV Credit Facility (the “SPV Credit Facility”) (see Note 7 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company.
[4] Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR, SOFR or PRIME rate. These instruments are often subject to a LIBOR, SOFR or PRIME rate floor.
[5] Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR” or “L”), the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of June 30, 2023.
[6] Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR” or “L”), the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of December 31, 2022.
[7] Investment is on non-accrual status.
[8] AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each co-Borrowers.
[9] Denotes investments in which we are an “Affiliated Person” but not exercising a controlling influence, as defined in the 1940 Act, due to beneficially owning, either directly or through one or more controlled companies, more than 5% but less than 25% of the outstanding voting securities of the investment. Transactions during the six months ended June 30, 2023 (beginning with the date at which the Company became an Affiliated Person) in these affiliated investments are as follows:
[10] AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each co-Borrowers. Amerimark may elect to defer up to 8.00% of the coupon as PIK.
[11] Spread is 1.00% Cash / 6.00% PIK.
[12] Interest is paid in kind (“PIK”).
[13] Non-income producing security.
[14] Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of June 30, 2023, on a fair value basis, non-qualifying assets in the portfolio represented 24.5% of the total assets of the Company.
[15] Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2022, on a fair value basis, non-qualifying assets in the portfolio represented 24.2% of the total assets of the Company.
[16] iCIMS, Inc. may elect to defer up to 3.875% of the coupon as PIK.
[17] Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (the “1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the six months ended June 30, 2023 in these controlled investments are as follows:
[18] Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (“1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2022 in these controlled investments are as follows:
[19] Spread is 5.75% Cash / 0.50% PIK.
[20] BridgeBio Pharma, Inc. may elect to defer up to 3.00% of the coupon as PIK.
[21] OmniGuide Holdings, Inc., Domain Surgical, Inc. and OmniGuide, Inc. are co-borrowers.
[22] OmniGuide Holdings, Inc. may elect to defer up to 10.00% of the coupon as PIK.
[23] Vapotherm, Inc. may elect to defer up to 9.00% of the coupon as PIK.
[24] Vapotherm, Inc. may elect to defer up to 8.00% of the coupon as PIK.
[25] The Company’s investment in SOINT, LLC includes a one dollar investment in common shares.
[26] Kingsbridge Holdings, LLC is held through KBH Topco LLC, a Delaware corporation.
[27] See note 13 to the consolidated financial statements.
[28] Denotes a Level 1 investment.
[29] See note 15 to the consolidated financial statements.
[30] See note 9 to the consolidated financial statements.
[31] See note 14 to the consolidated financial statements.
[32] Kaseya, Inc. may elect to defer up to 2.50% of the coupon as PIK.
[33] The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
[34] Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
[35] See note 17 to the consolidated financial statements.
[36] Indicates an investment that is wholly held by the Company through NEFPASS LLC.
[37] Denotes a subsidiary of SLR Equipment Finance.
[38] SLR Equipment Finance is held through NEFCORP LLC, a wholly-owned consolidated taxable subsidiary and NEFPASS LLC, a wholly-owned consolidated subsidiary.
[39] See note 11 to the consolidated financial statements.
[40] Through this entity and other intermediate entities, the Company owns approximately 7.3% of the underlying common units of ASC Holdco, LLC, a joint venture which owns certain assets of the former Amerimark Interactive, LLC.
XML 22 R9.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Schedule of Investments (Parenthetical) - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Percentage representing senior secured loans in investments owned 134.40% 124.60%
Percentage representing equipment financing in investments owned 27.70% 26.60%
Percentage representing preferred equity in investments owned 0.40% 0.40%
Percentage representing common equity or equity interests or warrants owned 59.90% 57.10%
Percentage representing total investments in investments owned 222.40% 208.70%
Percentage representing cash equivalents in investments owned 34.00% 41.80%
Percentage representing total investments and cash equivalents in investments owned 256.40% 250.50%
Percentage representing liabilities in excess of other assets in investments owned (156.40%) (150.50%)
Percentage representing net assets in investments owned 100.00% 100.00%
Percentage of outstanding voting securities of the investment 25.00% 25.00%
Percentage of non-qualifying assets in the portfolio of total assets 24.50% 24.20%
Tax Basis of Investments, Unrealized Appreciation (Depreciation), Net $ 3,002 $ 17,187
Tax Basis of Investments, Gross, Unrealized Appreciation 154,967 161,053
Tax Basis of Investments, Gross, Unrealized Depreciation 157,969 143,866
Investment Owned tax costs $ 2,184,428 $ 2,069,489
Spread One [Member]    
Percentage spread as cash 1.00% 5.75%
Percentage spread as paid in kind 6.00% 0.50%
Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance $ 797,594 $ 706,203
Gross Additions 14,380 131,369
Gross Reductions 5,224 20,722
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) (7,883) (18,630)
Interest/Dividend Income 27,935 53,898
Ending balance 798,913 797,594
Companies more than 5% less than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 44,909  
Gross Additions 464  
Gross Reductions 0  
Net realized gain (loss) 0  
Net change in unrealized gain (loss) (3,216)  
Interest/Dividend Income 265  
Ending balance 42,157 44,909
Equipment Operating Leases LLC [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 3,741 18,939
Gross Additions 0 0
Gross Reductions 224 15,833
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 6 635
Interest/Dividend Income 156 749
Ending balance 3,523 3,741
Kingsbridge Holdings, LLC [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 80,000 80,000
Gross Additions 0 0
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) (46) (87)
Interest/Dividend Income 4,875 7,402
Ending balance 80,000 80,000
KBH Topco LLC (Kingsbridge) [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 148,444 145,996
Gross Additions 0 0
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 0 2,448
Interest/Dividend Income 7,000 15,225
Ending balance 148,444 148,444
Loyer Capital LLC [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 7,361 10,725
Gross Additions 0 0
Gross Reductions 0 3,500
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 0 136
Interest/Dividend Income 374 1,003
Ending balance 7,361 7,361
RD Holdco Inc Common Equity [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 0 0
Gross Additions 0 0
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 0 0
Interest/Dividend Income 0 0
Ending balance 0 0
RD Holdco Inc Class B [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 0 5,216
Gross Additions 0 0
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 0 (5,216)
Interest/Dividend Income 0 0
Ending balance 0 0
RD Holdco Inc Warrants [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 0 0
Gross Additions 0 0
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 0 0
Interest/Dividend Income 0 0
Ending balance 0 0
RD Holdco Inc Debt [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 6,521 11,829
Gross Additions 507 685
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 221 (5,280)
Interest/Dividend Income 0 (18)
Ending balance 7,249 6,521
SLR Business Credit [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 89,370 0
Gross Additions 0 81,583
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 1,000 7,787
Interest/Dividend Income 3,500 5,150
Ending balance 90,370 89,370
SLR Credit Solutions [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 288,760 298,766
Gross Additions 0 0
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) (9,760) (10,006)
Interest/Dividend Income 10,000 20,500
Ending balance 279,000 288,760
SLR Equipment Finance Equity [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 120,820 129,102
Gross Additions 0 0
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 0 (8,282)
Interest/Dividend Income 0 0
Ending balance 120,820 120,820
SLR Equipment Finance Debt [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 5,000 0
Gross Additions 2,500 5,000
Gross Reductions 5,000 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 0 0
Interest/Dividend Income 120 379
Ending balance 2,500 5,000
SLR Healthcare ABL [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 34,350 0
Gross Additions 0 34,335
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 500 15
Interest/Dividend Income 1,730 2,595
Ending balance 34,850 34,350
SLR Senior Lending Program LLC [Member]    
Investment Company Change in Net Assets    
Beginning balance [1],[2] 18,062  
Ending balance [1],[2] 77,505 18,062
SLR Senior Lending Program LLC [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 9,426 0
Gross Additions 11,250 9,500
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 319 (74)
Interest/Dividend Income 57 0
Ending balance 20,995 9,426
SOAGG LLC [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 0 1,121
Gross Additions   0
Gross Reductions   447
Net realized gain (loss)   0
Net change in unrealized gain (loss)   (674)
Interest/Dividend Income   647
Ending balance   0
SOINT LLC [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 3,801 4,509
Gross Additions 123 266
Gross Reductions 0 942
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) (123) (32)
Interest/Dividend Income 123 266
Ending balance $ 3,801 $ 3,801
Amerimark [Member]    
Investment interest rate, Paid in kind   8.00%
Bridge Bio Pharma, Inc [Member]    
Investment interest rate, Paid in kind 3.00% 3.00%
Omni Guide Holdings, Inc [Member]    
Investment interest rate, Paid in kind 10.00% 10.00%
Vapotherm, Inc. [Member]    
Investment interest rate, Paid in kind 9.00% 8.00%
iCIMS, Inc. [Member]    
Investment interest rate, Paid in kind 3.875% 3.875%
AmeriMark Intermediate Holdings LLC [Member] | Companies more than 5% less than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance $ 0  
Gross Additions 464  
Gross Reductions 0  
Net realized gain (loss) 0  
Net change in unrealized gain (loss) 0  
Interest/Dividend Income 0  
Ending balance 464 $ 0
AmeriMark Intermediate Holdings LLC [Member] | Companies more than 5% less than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 9,371  
Gross Additions 0  
Gross Reductions 0  
Net realized gain (loss) 0  
Net change in unrealized gain (loss) (4,237)  
Interest/Dividend Income 0  
Ending balance 5,134 9,371
Bayside Opco LLC [Member] | Companies more than 5% less than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 846  
Gross Additions 0  
Gross Reductions 0  
Net realized gain (loss) 0  
Net change in unrealized gain (loss) 0  
Interest/Dividend Income 9  
Ending balance 846 846
Bayside Opco LLC [Member] | Companies more than 5% less than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 18,224  
Gross Additions 0  
Gross Reductions 0  
Net realized gain (loss) 0  
Net change in unrealized gain (loss) 0  
Interest/Dividend Income 194  
Ending balance 18,224 18,224
Bayside Parent, LLC (loan) [Member] | Companies more than 5% less than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 4,773  
Gross Additions 0  
Gross Reductions 0  
Net realized gain (loss) 0  
Net change in unrealized gain (loss) 0  
Interest/Dividend Income 62  
Ending balance 4,773 4,773
Bayside Parent, LLC (equity) [Member] | Companies more than 5% less than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 4,681  
Gross Additions 0  
Gross Reductions 0  
Net realized gain (loss) 0  
Net change in unrealized gain (loss) (862)  
Interest/Dividend Income 0  
Ending balance 3,819 4,681
SLRAMI Topco Blocker, LLC [Member] | Companies more than 5% less than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 7,014  
Gross Additions 0  
Gross Reductions 0  
Net realized gain (loss) 0  
Net change in unrealized gain (loss) 1,883  
Interest/Dividend Income 0  
Ending balance $ 8,897 $ 7,014
ASC Holdco LLC [Member]    
Investment Company Change in Net Assets    
Investment company percentage of holding 7.30%  
Kaseya, Inc. [Member]    
Investment interest rate, Paid in kind 2.50%  
[1] Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
[2] The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
XML 23 R10.htm IDEA: XBRL DOCUMENT v3.23.2
Insider Trading Arrangements
3 Months Ended
Jun. 30, 2023
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 24 R11.htm IDEA: XBRL DOCUMENT v3.23.2
N-2 - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2022
Jun. 30, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cover [Abstract]                        
Entity Central Index Key 0001418076                      
Amendment Flag false                      
Securities Act File Number 814-00754                      
Document Type 10-Q                      
Entity Registrant Name SLR INVESTMENT CORP.                      
Entity Address, Address Line One 500 Park Avenue                      
Entity Address, City or Town New York                      
Entity Address, State or Province NY                      
Entity Address, Postal Zip Code 10022                      
City Area Code 212                      
Local Phone Number 993-1670                      
Entity Emerging Growth Company false                      
Financial Highlights [Abstract]                        
Senior Securities [Table Text Block]
Information about our senior securities is shown in the following table (in thousands) as of the quarter ended June 30, 2023 and each year ended December 31 for the past ten years, unless otherwise noted. The “—” indicates information which the SEC expressly does not require to be disclosed for certain types of senior securities.
 
Class and Year
  
Total Amount

Outstanding(1)
    
Asset

Coverage

Per Unit(2)
    
Involuntary

Liquidating

Preference

Per Unit(3)
    
Average

Market Value

Per Unit(4)
 
Credit Facility
           
Fiscal 2023 (through June 30, 2023)
   $ 482,000      $ 713        —          N/A  
Fiscal 2022
     293,000        513        —          N/A  
Fiscal 2021
     222,500        552        —          N/A  
Fiscal 2020
     126,000        421        —          N/A  
Fiscal 2019
     42,900        182        —          N/A  
Fiscal 2018
     96,400        593        —          N/A  
Fiscal 2017
     245,600        1,225        —          N/A  
Fiscal 2016
     115,200        990        —          N/A  
Fiscal 2015
     207,900        1,459        —          N/A  
Fiscal 2014
     —          —          —          N/A  
Fiscal 2013
     —          —          —          N/A  
SPV Credit Facility
           
Fiscal 2023 (through June 30, 2023)
     167,200        247        —          N/A  
Fiscal 2022
     155,200        272        —          N/A  
2022 Unsecured Notes
           
Fiscal 2022
     —          —          —          N/A  
Fiscal 2021
     150,000        372        —          N/A  
Fiscal 2020
     150,000        501        —          N/A  
Fiscal 2019
     150,000        638        —          N/A  
Fiscal 2018
     150,000        923        —          N/A  
Fiscal 2017
     150,000        748        —          N/A  
Fiscal 2016
     50,000        430        —          N/A  
2022 Tranche C Notes
           
Fiscal 2022
     —          —          —          N/A  
Fiscal 2021
     21,000        52        —          N/A  
Fiscal 2020
     21,000        70        —          N/A  
Fiscal 2019
     21,000        89        —          N/A  
Fiscal 2018
     21,000        129        —          N/A  
Fiscal 2017
     21,000        105        —          N/A  
2023 Unsecured Notes
           
Fiscal 2023 (through June 30, 2023)
     —          —          —          N/A  
Fiscal 2022
     75,000        131        —          N/A  
Fiscal 2021
     75,000        186        —          N/A  
Fiscal 2020
     75,000        250        —          N/A  
Fiscal 2019
     75,000        319        —          N/A  
Fiscal 2018
     75,000        461        —          N/A  
Fiscal 2017
     75,000        374        —          N/A  
2024 Unsecured Notes
           
Fiscal 2023 (through June 30, 2023)
     125,000        185        —          N/A  
Fiscal 2022
     125,000        219        —          N/A  
Fiscal 2021
     125,000        309        —          N/A  
Fiscal 2020
     125,000        417        —          N/A  
Fiscal 2019
     125,000        531        —          N/A  
2025 Unsecured Notes
           
Fiscal 2023 (through June 30, 2023)
     85,000        126        —          N/A  
Fiscal 2022
     85,000        149        —          N/A  
2026 Unsecured Notes
           
 
Class and Year
  
Total Amount

Outstanding(1)
    
Asset

Coverage

Per Unit(2)
    
Involuntary

Liquidating

Preference

Per Unit(3)
    
Average

Market Value

Per Unit(4)
 
Fiscal 2023 (through June 30, 2023)
     75,000        111        —          N/A  
Fiscal 2022
     75,000        131        —          N/A  
Fiscal 2021
     75,000        186        —          N/A  
Fiscal 2020
     75,000        250        —          N/A  
Fiscal 2019
     75,000        319        —          N/A  
2027 Unsecured Notes
           
Fiscal 2023 (through June 30, 2023)
     50,000        74        —          N/A  
Fiscal 2022
     50,000        88        —          N/A  
Fiscal 2021
     50,000        124        —          N/A  
2027 Series F Unsecured Notes
           
Fiscal 2023 (through June 30, 2023)
     135,000        200        —          N/A  
Fiscal 2022
     135,000        237        —          N/A  
2042 Unsecured Notes
           
Fiscal 2017
     —          —          —          N/A  
Fiscal 2016
     100,000        859        —        $ 1,002  
Fiscal 2015
     100,000        702        —          982  
Fiscal 2014
     100,000        2,294        —          943  
Fiscal 2013
     100,000        2,411        —          934  
Senior Secured Notes
           
Fiscal 2017
     —          —          —          N/A  
Fiscal 2016
     75,000        645        —          N/A  
Fiscal 2015
     75,000        527        —          N/A  
Fiscal 2014
     75,000        1,721        —          N/A  
Fiscal 2013
     75,000        1,808        —          N/A  
Term Loans
           
Fiscal 2023 (through June 30, 2023)
     100,000        148        —          N/A  
Fiscal 2022
     100,000        175        —          N/A  
Fiscal 2021
     100,000        248        —          N/A  
Fiscal 2020
     75,000        250        —          N/A  
Fiscal 2019
     75,000        319        —          N/A  
Fiscal 2018
     50,000        308        —          N/A  
Fiscal 2017
     50,000        250        —          N/A  
Fiscal 2016
     50,000        430        —          N/A  
Fiscal 2015
     50,000        351        —          N/A  
Fiscal 2014
     50,000        1,147        —          N/A  
Fiscal 2013
     50,000        1,206        —          N/A  
NEFPASS Facility
           
Fiscal 2021
     —          —          —          N/A  
Fiscal 2020
     30,000        100        —          N/A  
Fiscal 2019
     30,000        128        —          N/A  
Fiscal 2018
     30,000        185        —          N/A  
SSLP Facility
           
Fiscal 2019
     —          —          —          N/A  
Fiscal 2018
     53,785        331        —          N/A  
Total Senior Securities
           
Fiscal 2023 (through June 30, 2023)
   $ 1,219,200      $ 1,804        —          N/A  
Fiscal 2022
     1,093,200        1,915        —          N/A  
Fiscal 2021
     818,500        2,029        —          N/A  
Fiscal 2020
     677,000        2,259        —          N/A  
Fiscal 2019
     593,900        2,525        —          N/A  
Fiscal 2018
     476,185        2,930        —          N/A  
Fiscal 2017
     541,600        2,702        —          N/A  
Fiscal 2016
     390,200        3,354        —          N/A  
Fiscal 2015
     432,900        3,039        —          N/A  
Fiscal 2014
     225,000        5,162        —          N/A  
Fiscal 2013
     225,000        5,425        —          N/A  
 
(1)
Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented.
(2)
The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of June 30, 2023, asset coverage was 180.4%.
(3)
The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it.
(4)
Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014 and 2013 periods was $100,175, $98,196, $94,301 and $93,392, respectively.
                     
Senior Securities Amount [1] $ 1,219,200 $ 390,200 $ 432,900 $ 225,000 $ 225,000 $ 1,093,200   $ 818,500 $ 677,000 $ 593,900 $ 476,185 $ 541,600
Senior Securities Coverage per Unit [2] $ 1,804 $ 3,354 $ 3,039 $ 5,162 $ 5,425 $ 1,915   $ 2,029 $ 2,259 $ 2,525 $ 2,930 $ 2,702
Preferred Stock Liquidating Preference [3] $ 0 $ 0 $ 0 $ 0 $ 0 0   0 $ 0 $ 0 $ 0 $ 0
Senior Securities, Note [Text Block]
Senior Securities
Information about our senior securities is shown in the following table (in thousands) as of the quarter ended June 30, 2023 and each year ended December 31 for the past ten years, unless otherwise noted. The “—” indicates information which the SEC expressly does not require to be disclosed for certain types of senior securities.
 
Class and Year
  
Total Amount

Outstanding(1)
    
Asset

Coverage

Per Unit(2)
    
Involuntary

Liquidating

Preference

Per Unit(3)
    
Average

Market Value

Per Unit(4)
 
Credit Facility
           
Fiscal 2023 (through June 30, 2023)
   $ 482,000      $ 713        —          N/A  
Fiscal 2022
     293,000        513        —          N/A  
Fiscal 2021
     222,500        552        —          N/A  
Fiscal 2020
     126,000        421        —          N/A  
Fiscal 2019
     42,900        182        —          N/A  
Fiscal 2018
     96,400        593        —          N/A  
Fiscal 2017
     245,600        1,225        —          N/A  
Fiscal 2016
     115,200        990        —          N/A  
Fiscal 2015
     207,900        1,459        —          N/A  
Fiscal 2014
     —          —          —          N/A  
Fiscal 2013
     —          —          —          N/A  
SPV Credit Facility
           
Fiscal 2023 (through June 30, 2023)
     167,200        247        —          N/A  
Fiscal 2022
     155,200        272        —          N/A  
2022 Unsecured Notes
           
Fiscal 2022
     —          —          —          N/A  
Fiscal 2021
     150,000        372        —          N/A  
Fiscal 2020
     150,000        501        —          N/A  
Fiscal 2019
     150,000        638        —          N/A  
Fiscal 2018
     150,000        923        —          N/A  
Fiscal 2017
     150,000        748        —          N/A  
Fiscal 2016
     50,000        430        —          N/A  
2022 Tranche C Notes
           
Fiscal 2022
     —          —          —          N/A  
Fiscal 2021
     21,000        52        —          N/A  
Fiscal 2020
     21,000        70        —          N/A  
Fiscal 2019
     21,000        89        —          N/A  
Fiscal 2018
     21,000        129        —          N/A  
Fiscal 2017
     21,000        105        —          N/A  
2023 Unsecured Notes
           
Fiscal 2023 (through June 30, 2023)
     —          —          —          N/A  
Fiscal 2022
     75,000        131        —          N/A  
Fiscal 2021
     75,000        186        —          N/A  
Fiscal 2020
     75,000        250        —          N/A  
Fiscal 2019
     75,000        319        —          N/A  
Fiscal 2018
     75,000        461        —          N/A  
Fiscal 2017
     75,000        374        —          N/A  
2024 Unsecured Notes
           
Fiscal 2023 (through June 30, 2023)
     125,000        185        —          N/A  
Fiscal 2022
     125,000        219        —          N/A  
Fiscal 2021
     125,000        309        —          N/A  
Fiscal 2020
     125,000        417        —          N/A  
Fiscal 2019
     125,000        531        —          N/A  
2025 Unsecured Notes
           
Fiscal 2023 (through June 30, 2023)
     85,000        126        —          N/A  
Fiscal 2022
     85,000        149        —          N/A  
2026 Unsecured Notes
           
 
Class and Year
  
Total Amount

Outstanding(1)
    
Asset

Coverage

Per Unit(2)
    
Involuntary

Liquidating

Preference

Per Unit(3)
    
Average

Market Value

Per Unit(4)
 
Fiscal 2023 (through June 30, 2023)
     75,000        111        —          N/A  
Fiscal 2022
     75,000        131        —          N/A  
Fiscal 2021
     75,000        186        —          N/A  
Fiscal 2020
     75,000        250        —          N/A  
Fiscal 2019
     75,000        319        —          N/A  
2027 Unsecured Notes
           
Fiscal 2023 (through June 30, 2023)
     50,000        74        —          N/A  
Fiscal 2022
     50,000        88        —          N/A  
Fiscal 2021
     50,000        124        —          N/A  
2027 Series F Unsecured Notes
           
Fiscal 2023 (through June 30, 2023)
     135,000        200        —          N/A  
Fiscal 2022
     135,000        237        —          N/A  
2042 Unsecured Notes
           
Fiscal 2017
     —          —          —          N/A  
Fiscal 2016
     100,000        859        —        $ 1,002  
Fiscal 2015
     100,000        702        —          982  
Fiscal 2014
     100,000        2,294        —          943  
Fiscal 2013
     100,000        2,411        —          934  
Senior Secured Notes
           
Fiscal 2017
     —          —          —          N/A  
Fiscal 2016
     75,000        645        —          N/A  
Fiscal 2015
     75,000        527        —          N/A  
Fiscal 2014
     75,000        1,721        —          N/A  
Fiscal 2013
     75,000        1,808        —          N/A  
Term Loans
           
Fiscal 2023 (through June 30, 2023)
     100,000        148        —          N/A  
Fiscal 2022
     100,000        175        —          N/A  
Fiscal 2021
     100,000        248        —          N/A  
Fiscal 2020
     75,000        250        —          N/A  
Fiscal 2019
     75,000        319        —          N/A  
Fiscal 2018
     50,000        308        —          N/A  
Fiscal 2017
     50,000        250        —          N/A  
Fiscal 2016
     50,000        430        —          N/A  
Fiscal 2015
     50,000        351        —          N/A  
Fiscal 2014
     50,000        1,147        —          N/A  
Fiscal 2013
     50,000        1,206        —          N/A  
NEFPASS Facility
           
Fiscal 2021
     —          —          —          N/A  
Fiscal 2020
     30,000        100        —          N/A  
Fiscal 2019
     30,000        128        —          N/A  
Fiscal 2018
     30,000        185        —          N/A  
SSLP Facility
           
Fiscal 2019
     —          —          —          N/A  
Fiscal 2018
     53,785        331        —          N/A  
Total Senior Securities
           
Fiscal 2023 (through June 30, 2023)
   $ 1,219,200      $ 1,804        —          N/A  
Fiscal 2022
     1,093,200        1,915        —          N/A  
Fiscal 2021
     818,500        2,029        —          N/A  
Fiscal 2020
     677,000        2,259        —          N/A  
Fiscal 2019
     593,900        2,525        —          N/A  
Fiscal 2018
     476,185        2,930        —          N/A  
Fiscal 2017
     541,600        2,702        —          N/A  
Fiscal 2016
     390,200        3,354        —          N/A  
Fiscal 2015
     432,900        3,039        —          N/A  
Fiscal 2014
     225,000        5,162        —          N/A  
Fiscal 2013
     225,000        5,425        —          N/A  
 
(1)
Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented.
(2)
The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of June 30, 2023, asset coverage was 180.4%.
(3)
The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it.
(4)
Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014 and 2013 periods was $100,175, $98,196, $94,301 and $93,392, respectively.
                     
General Description of Registrant [Abstract]                        
Investment Objectives and Practices [Text Block]
Portfolio and Investment Activity
During the three months ended June 30, 2023, we invested approximately $212.9 million across 44 portfolio companies. This compares to investing, exclusive of assets acquired through the Merger, approximately $94.7 million in 29 portfolio companies for the three months ended June 30, 2022. Investments sold, prepaid or repaid during the three months ended June 30, 2023 totaled approximately $122.4 million versus approximately $78.5 million for the three months ended June 30, 2022.
At June 30, 2023, our portfolio consisted of 156 portfolio companies and was invested 33.7% in cash flow senior secured loans, 27.8% in asset-based senior secured loans / SLR Credit Solutions (“SLR Credit”) / SLR Healthcare ABL / SLR Business Credit, 22.9% in equipment senior secured financings / SLR Equipment Finance (“SLR Equipment”) / Kingsbridge Holdings, LLC (“KBH”) and 15.6% in life science senior secured loans, in each case, measured at fair value, versus 127 portfolio companies invested 30.0% in cash flow senior secured loans, 30.9% in asset-based senior secured loans / SLR Credit, 24.3% in equipment senior secured financings / SLR Equipment / KBH, and 14.8% in life science senior secured loans, in each case, measured at fair value, at June 30, 2022.
At June 30, 2023, 78.0% or $1.68 billion of our income producing investment portfolio
*
is floating rate and 22.0% or $473.9 million is fixed rate, measured at fair value. At June 30, 2022, 77.1% or $1.53 billion of our income producing investment portfolio
*
is floating rate and 22.9% or $453.7 million is fixed rate, measured at fair value. As of June 30, 2023 and 2022, we had three and two issuers, respectively, on
non-accrual
status.
 
*
 
We have included SLR Credit Solutions, SLR Equipment Finance, SLR Healthcare ABL, SLR Business Credit and Kingsbridge Holdings, LLC within our income producing investment portfolio.
                     
Risk Factors [Table Text Block]
Item 1A.
Risk Factors
In addition to the other information set forth in this report, you should carefully consider the factors discussed in “Risk Factors” in the February 28, 2023 filing of our Annual Report on
Form 10-K, which
could materially affect our business, financial condition and/or operating results. The risks described in our Annual Report are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially and adversely affect our business, financial condition and/or operating results. Other than the risk factors set forth below, there have been no material changes during the period ended June 30, 2023 to the risk factors discussed in “Risk Factors” in the February 28, 2023 filing of our Annual Report on Form
10-K.
Adverse developments affecting the financial services industry, such as actual events or concerns involving liquidity, defaults or
non-performance
by financial institutions or transactional counterparties could have a material adverse effect on us, the Investment Adviser and our portfolio companies.
Cash not held in custody accounts and held by us, our Investment Adviser and by our portfolio companies in
non-interest-bearing
and interest-bearing operating accounts could, at times, exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limits. If such banking institutions were to fail, we, our Investment Adviser, or our portfolio companies could lose all or a portion of those amounts held in excess of such insurance limits. In addition, actual events involving limited liquidity, defaults,
non-performance
or other adverse developments that affect financial institutions, transactional counterparties or other companies in the financial services industry or the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems, which could adversely affect our, our Investment Adviser’s and our portfolio companies’ business, financial condition, results of operations, or prospects.
Although we and our Investment Adviser assess our and our portfolio companies’ banking and financing relationships as we believe necessary or appropriate, our and our portfolio companies’ access to funding sources and other credit arrangements in amounts adequate to finance or capitalize current and projected future business operations could be significantly impaired by factors that affect the financial institutions with which we, our Investment Adviser or our portfolio companies have arrangements directly or the financial services industry or economy in general. These factors could include, among others, events such as liquidity constraints or failures, the ability to perform obligations under various types of financial, credit or liquidity agreements or arrangements, disruptions or instability in the financial services industry or financial markets, or concerns or negative expectations about the prospects for companies in the financial services industry. These factors could involve financial institutions or financial services industry companies with which we, our Investment Adviser or our portfolio companies have financial or business relationships, but could also include factors involving financial markets or the financial services industry generally.
In addition, investor concerns regarding the U.S. or international financial systems could result in less favorable commercial financing terms, including higher interest rates or costs and tighter financial and operating covenants, or systemic limitations on access to credit and liquidity sources, thereby making it more difficult for us, our Investment Adviser, or our portfolio companies to acquire financing on acceptable terms or at all.
Our stock repurchase program could affect the price of our common stock and increase volatility and may be suspended or terminated at any time, which may result in a decrease in the trading price of our common stock.
 
On May 9, 2023, the Board most recently extended our share repurchase program (the “Program”), under which we can repurchase up to $50 million of our outstanding common stock. Under the Program, purchases can be made at management’s discretion from time to time in open-market transactions, in accordance with all applicable securities laws and regulations, at prices below the Company’s NAV as reported in its most recently published consolidated financial statements. We have in the past, and could in the future, enter into a plan to repurchase shares of our common stock pursuant to the Program in a manner intended to comply with the requirements of Rule
10b5-1
under the Exchange Act.
The Program is discretionary and whether purchases will be made under the Program and how much will be purchased at any time is uncertain and dependent on prevailing market prices and trading volumes, all of which we cannot predict. These activities could have the effect of maintaining the market price of our common stock or retarding a decline in the market price of the common stock, and, as a result, the price of our common stock could be higher than the price that otherwise might exist in the open market. Repurchases pursuant to the Program could affect the price of our common stock and increase its volatility. The existence of the Program could also cause the price of our common stock to be higher than it would be in the absence of such a program and could potentially reduce the market liquidity for our common stock. There can be no assurance that any stock repurchases will enhance stockholder value because the market price of our common stock could decline below the levels at which we repurchased such shares. Any failure to repurchase shares after we have announced our intention to do so could negatively impact our reputation and investor confidence in us and could negatively impact our stock price. Although the Program is intended to enhance long-term stockholder value, short-term stock price fluctuations could reduce the Program’s
effectiveness.
The alternative reference rates that have replaced LIBOR in our credit arrangements and other financial instruments may not yield the same or similar economic results as LIBOR over the life of such transactions.
The London Interbank Offered Rate (“LIBOR”) is an index rate that historically was widely used in lending transactions and was a common reference rate for setting the floating interest rate on private loans. LIBOR was typically the reference rate used in floating-rate loans extended to our portfolio companies.
The ICE Benchmark Administration (“IBA”) (the entity that is responsible for calculating LIBOR) ceased providing overnight, one, three, six and twelve months USD LIBOR tenors on June 30, 2023. In addition, the United Kingdom’s Financial Conduct Authority (“FCA”), which oversees the IBA, now prohibits entities supervised by the FCA from using LIBORs, including USD LIBOR, except in very limited circumstances.
In the United States, the Secured Overnight Financing Rate (“SOFR”) is the preferred alternative rate for LIBOR. SOFR is a measure of the cost of borrowing cash overnight, collateralized by U.S. Treasury securities, and is based on directly observable U.S. Treasury-backed repurchase transactions. SOFR is published by the Federal Reserve Bank of New York each U.S. Government Securities Business Day, for transactions made on the immediately preceding U.S. Government Securities Business Day. Alternative reference rates that may replace LIBOR, including SOFR for USD transactions, may not yield the same or similar economic results as LIBOR over the lives of such transactions.
As of the filing date of this Quarterly Report on Form 10-Q, many of our loans that referenced LIBOR have been amended to reference the forward-looking term rate published by CME Group Benchmark Administration Limited based on SOFR (“CME Term SOFR”) or CME Term SOFR plus a fixed spread adjustment. CME Term SOFR rates are forward-looking rates that are derived by compounding projected overnight SOFR rates over one, three, and six months taking into account the values of multiple consecutive, executed, one-month and three-month CME Group traded SOFR futures contracts and, in some cases, over-the-counter SOFR Overnight Indexed Swaps as an indicator of CME Term SOFR reference rate values. CME Term SOFR and the inputs on which it is based are derived from SOFR. Since CME Term SOFR is a relatively new market rate, there will likely be no established trading market for credit agreements or other financial instruments when they are issued, and an established market may never develop or may not be liquid. Market terms for instruments referencing CME Term SOFR rates may be lower than those of later-issued CME Term SOFR indexed instruments. Similarly, if CME Term SOFR does not prove to be widely used, the trading price of instruments referencing CME Term SOFR may be lower than those of instruments indexed to indices that are more widely used. Further, the composition and characteristics of SOFR and CME Term SOFR are not the same as those of LIBOR. Even with the application of a fixed spread adjustment, LIBOR and CME Term SOFR will not have the same composition and characteristics, and there can be no assurance that the replacement rate, as so adjusted, will be a direct substitute for LIBOR.
There can be no guarantee that SOFR will not be discontinued or fundamentally altered in a manner that is materially adverse to the interests of investors in loans referencing SOFR. If the manner in which SOFR or CME Term SOFR is calculated is changed, that change may result in a reduction of the amount of interest payable on such loans and the trading prices of the SOFR Loans. In addition, there can be no guarantee that loans referencing SOFR or CME Term SOFR will continue to reference those rates until maturity or that, in the future, our loans will reference benchmark rates other than CME Term SOFR. Should any of these events occur, our loans, and the yield generated thereby, could be affected. Specifically, the anticipated yield on our loans may not be fully realized and our loans may be subject to increased pricing volatility and market risk.
                     
NAV Per Share $ 17.98         $ 18.33 $ 18.53 $ 19.93        
Credit Facility [Member]                        
Financial Highlights [Abstract]                        
Senior Securities Amount [1] $ 482,000 $ 115,200 $ 207,900 $ 0 $ 0 $ 293,000   $ 222,500 $ 126,000 $ 42,900 $ 96,400 $ 245,600
Senior Securities Coverage per Unit [2] $ 713 $ 990 $ 1,459 $ 0 $ 0 $ 513   $ 552 $ 421 $ 182 $ 593 $ 1,225
Preferred Stock Liquidating Preference [3] $ 0 $ 0 $ 0 $ 0 $ 0 $ 0   $ 0 $ 0 $ 0 $ 0 $ 0
SPV Credit Facility [Member]                        
Financial Highlights [Abstract]                        
Senior Securities Amount [1] $ 167,200         $ 155,200            
Senior Securities Coverage per Unit [2] $ 247         $ 272            
Preferred Stock Liquidating Preference [3] $ 0         $ 0            
2022 Unsecured Notes [Member]                        
Financial Highlights [Abstract]                        
Senior Securities Amount [1]   $ 50,000       $ 0   $ 150,000 $ 150,000 $ 150,000 $ 150,000 $ 150,000
Senior Securities Coverage per Unit [2]   $ 430       $ 0   $ 372 $ 501 $ 638 $ 923 $ 748
Preferred Stock Liquidating Preference [3]   $ 0       $ 0   $ 0 $ 0 $ 0 $ 0 $ 0
2022 Tranche C Notes [Member]                        
Financial Highlights [Abstract]                        
Senior Securities Amount [1]           $ 0   $ 21,000 $ 21,000 $ 21,000 $ 21,000 $ 21,000
Senior Securities Coverage per Unit [2]           $ 0   $ 52 $ 70 $ 89 $ 129 $ 105
Preferred Stock Liquidating Preference [3]           $ 0   $ 0 $ 0 $ 0 $ 0 $ 0
2023 Unsecured Notes [Member]                        
Financial Highlights [Abstract]                        
Senior Securities Amount [1] $ 0         $ 75,000   $ 75,000 $ 75,000 $ 75,000 $ 75,000 $ 75,000
Senior Securities Coverage per Unit [2] $ 0         $ 131   $ 186 $ 250 $ 319 $ 461 $ 374
Preferred Stock Liquidating Preference [3] $ 0         $ 0   $ 0 $ 0 $ 0 $ 0 $ 0
2024 Unsecured Notes [Member]                        
Financial Highlights [Abstract]                        
Senior Securities Amount [1] $ 125,000         $ 125,000   $ 125,000 $ 125,000 $ 125,000    
Senior Securities Coverage per Unit [2] $ 185         $ 219   $ 309 $ 417 $ 531    
Preferred Stock Liquidating Preference [3] $ 0         $ 0   $ 0 $ 0 $ 0    
2025 Unsecured Notes [Member]                        
Financial Highlights [Abstract]                        
Senior Securities Amount [1] $ 85,000         $ 85,000            
Senior Securities Coverage per Unit [2] $ 126         $ 149            
Preferred Stock Liquidating Preference [3] $ 0         $ 0            
2026 Unsecured Notes [Member]                        
Financial Highlights [Abstract]                        
Senior Securities Amount [1] $ 75,000         $ 75,000   $ 75,000 $ 75,000 $ 75,000    
Senior Securities Coverage per Unit [2] $ 111         $ 131   $ 186 $ 250 $ 319    
Preferred Stock Liquidating Preference [3] $ 0         $ 0   $ 0 $ 0 $ 0    
2027 Unsecured Notes [Member]                        
Financial Highlights [Abstract]                        
Senior Securities Amount [1] $ 50,000         $ 50,000   $ 50,000        
Senior Securities Coverage per Unit [2] $ 74         $ 88   $ 124        
Preferred Stock Liquidating Preference [3] $ 0         $ 0   $ 0        
2027 Series F Unsecured Notes [Member]                        
Financial Highlights [Abstract]                        
Senior Securities Amount [1] $ 135,000         $ 135,000            
Senior Securities Coverage per Unit [2] $ 200         $ 237            
Preferred Stock Liquidating Preference [3] $ 0         $ 0            
2042 Unsecured Notes [Member]                        
Financial Highlights [Abstract]                        
Senior Securities Amount [1]   $ 100,000 $ 100,000 $ 100,000 $ 100,000             $ 0
Senior Securities Coverage per Unit [2]   $ 859 $ 702 $ 2,294 $ 2,411             $ 0
Preferred Stock Liquidating Preference [3]   0 0 0 0             $ 0
Senior Securities Average Market Value per Unit [4]   $ 1,002 $ 982 $ 943 $ 934              
Senior Secured Notes [Member]                        
Financial Highlights [Abstract]                        
Senior Securities Amount [1]   $ 75,000 $ 75,000 $ 75,000 $ 75,000             $ 0
Senior Securities Coverage per Unit [2]   $ 645 $ 527 $ 1,721 $ 1,808             $ 0
Preferred Stock Liquidating Preference [3]   $ 0 $ 0 $ 0 $ 0             $ 0
Term Loans [Member]                        
Financial Highlights [Abstract]                        
Senior Securities Amount [1] $ 100,000 $ 50,000 $ 50,000 $ 50,000 $ 50,000 $ 100,000   $ 100,000 $ 75,000 $ 75,000 $ 50,000 $ 50,000
Senior Securities Coverage per Unit [2] $ 148 $ 430 $ 351 $ 1,147 $ 1,206 $ 175   $ 248 $ 250 $ 319 $ 308 $ 250
Preferred Stock Liquidating Preference [3] $ 0 $ 0 $ 0 $ 0 $ 0 $ 0   $ 0 $ 0 $ 0 $ 0 $ 0
NEFPASS Facility [Member]                        
Financial Highlights [Abstract]                        
Senior Securities Amount [1]               $ 0 $ 30,000 $ 30,000 $ 30,000  
Senior Securities Coverage per Unit [2]               $ 0 $ 100 $ 128 $ 185  
Preferred Stock Liquidating Preference [3]               $ 0 $ 0 $ 0 $ 0  
SSLP Facility [Member]                        
Financial Highlights [Abstract]                        
Senior Securities Amount [1]                   $ 0 $ 53,785  
Senior Securities Coverage per Unit [2]                   $ 0 $ 331  
Preferred Stock Liquidating Preference [3]                   $ 0 $ 0  
[1] Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented.
[2] The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of June 30, 2023, asset coverage was 180.4%.
[3] The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it.
[4] Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014 and 2013 periods was $100,175, $98,196, $94,301 and $93,392, respectively.
XML 25 R12.htm IDEA: XBRL DOCUMENT v3.23.2
Organization
6 Months Ended
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization
Note 1. Organization
SLR Investment Corp. (the “Company”, “SLRC”, “we”, “us” or “our”), a Maryland corporation formed in November 2007, is a
closed-end,
externally managed,
non-diversified
management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). Furthermore, as the Company is an investment company, it continues to apply the guidance in FASB Accounting Standards Codification (“ASC”) Topic 946. In addition, for U.S. federal income tax purposes, the Company has elected to be treated, and intends to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).
On February 9, 2010, the Company priced its initial public offering, selling 5.68 million shares of common stock, including the underwriters’ over-allotment, at a price of $18.50 per share. Concurrent with this offering, the Company’s senior management purchased an additional 600,000 shares through a private placement, also at $18.50 per share.
The Company’s investment objective is to maximize both current income and capital appreciation through debt and equity investments. The Company directly and indirectly invests primarily in leveraged middle market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. From time to time, we may also invest in public companies that are thinly traded.
On April 1, 2022, we acquired SLR Senior Investment Corp., a Maryland corporation (“SUNS”) pursuant to that certain Agreement and Plan of Merger (the “Merger Agreement”), dated as of December 1, 2021, by and among us, SUNS, Solstice Merger Sub, Inc., a Maryland corporation and our wholly-owned subsidiary (“Merger Sub”), and, solely for the limited purposes set forth therein, SLR Capital Partners, LLC (the “Investment Adviser”). Pursuant to the Merger Agreement, Merger Sub merged with and into SUNS, with SUNS continuing as the surviving company and as SUNS’s wholly-owned subsidiary (the “Merger”) and, immediately thereafter, SUNS merged with and into us, with us continuing as the surviving company (together with the Merger, the “Mergers”). In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each outstanding share of SUNS’s common stock was converted into the right to receive 0.7796 shares of our common stock (with SUNS’s stockholders receiving cash in lieu of fractional shares of our common stock). As a result of the Mergers, we issued an aggregate of 12,511,825 shares of our common stock to former SUNS stockholders.
XML 26 R13.htm IDEA: XBRL DOCUMENT v3.23.2
Significant Accounting Policies
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
Significant Accounting Policies
Note 2. Significant Accounting Policies
The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“GAAP”), and include the accounts of the Company and certain wholly-owned subsidiaries. The consolidated financial statements reflect all adjustments and reclassifications which, in the opinion of management, are necessary for the fair presentation of the results of the operations and financial condition for the periods presented. All significant intercompany balances and transactions have been eliminated. Certain prior period amounts may have been reclassified to conform to the current period presentation.
Interim consolidated financial statements are prepared in accordance with GAAP for interim financial information and pursuant to the requirements for reporting on Form
10-Q
and Regulation
S-X,
as appropriate. Accordingly, they may not include all of the information and notes required by GAAP for annual consolidated financial statements. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reported periods. Changes in the economic environment, financial markets and any other parameters used in determining these estimates could cause actual results to differ materially. The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the fiscal year ending on December 31, 2023.
 
 
In the opinion of management, all adjustments, which are of a normal recurring nature, considered necessary for the fair presentation of financial statements, have been included.
The significant accounting policies consistently followed by the Company are:
 
  (a)
Investment transactions are accounted for on the trade date;
 
  (b)
Under procedures established by the board of directors (the “Board”), we value investments, including certain senior secured debt, subordinated debt and other debt securities with maturities greater than 60 days, for which market quotations are readily available and deemed to represent fair value under GAAP, at such market quotations (unless they are deemed not to represent fair value). A market quotation is readily available for a security only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. If the Company anticipates using a market quotation for a security, it will also monitor for circumstances that may necessitate the use of fair value, such as significant events that may cause concern over the reliability of a market quotation. We attempt to obtain market quotations from at least two brokers or dealers (if available, otherwise from a principal market maker or a primary market dealer or other independent pricing service). We utilize
mid-market
pricing as a practical expedient for fair value unless a different point within the range is more representative. If and when market quotations are deemed not to represent fair value, we may utilize independent third-party valuation firms to assist us in determining the fair value of material assets. Accordingly, such investments go through our multi-step valuation process as described below. In each such case, independent valuation firms, that may from time to time be engaged by the Board, consider observable market inputs together with significant unobservable inputs in arriving at their valuation recommendations. Debt investments with maturities of 60 days or less shall each be valued at cost plus accreted discount, or minus amortized premium, which is expected to approximate fair value, unless such valuation, in the judgment of the Investment Adviser, does not represent fair value, in which case such investments shall be valued at fair value as determined in good faith by or under the direction of the Board. Investments that are not publicly traded or whose market quotations are not readily available are valued at fair value as determined in good faith by or under the direction of the Board. Such determination of fair values involves subjective judgments and estimates.
With respect to investments for which market quotations are not readily available or when such market quotations are deemed not to represent fair value under GAAP, the Board has approved a multi-step valuation process each quarter, as described below:
 
  (1)
our quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of the Investment Adviser responsible for the portfolio investment;
 
  (2)
preliminary valuation conclusions are then documented and discussed with senior management of the Investment Adviser;
 
  (3)
independent valuation firms engaged by the Board conduct independent appraisals and review the Investment Adviser’s preliminary valuations and make their own independent assessment for all material assets;
 
  (4)
the audit committee of the Board reviews the preliminary valuation of the Investment Adviser and that of the independent valuation firm and responds to the valuation recommendation of the independent valuation firm, if any, to reflect any comments; and
 
  (5)
the Board discusses valuations and determines the fair value of each investment in our portfolio in good faith based on the input of the Investment Adviser, the respective independent valuation firm, if any, and the audit committee.
The valuation principles set forth above may be modified from time to time, in whole or in part, as determined by the Board in its sole discretion. The Board will also (1) periodically assess and manage valuation risks; (2) establish and apply fair value methodologies; (3) test fair value methodologies; (4) oversee and evaluate third-party pricing services, as applicable; (5) oversee the reporting required by Rule
2a-5
under the 1940 Act; and (6) maintain recordkeeping requirements under Rule
2a-5.
 
 
Investments in all asset classes are valued utilizing a market approach, an income approach, or both approaches, as appropriate. However, in accordance with ASC
820-10,
certain investments that qualify as investment companies in accordance with ASC 946, may be valued using net asset value as a practical expedient for fair value. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities (including a business). The income approach uses valuation approaches to convert future amounts (for example, cash flows or earnings) to a single present amount (discounted). The measurement is based on the value indicated by current market expectations about those future amounts. In following these approaches, the types of factors that we may take into account in fair value pricing our investments include, as relevant: available current market data, including relevant and applicable market trading and transaction comparables, applicable market yields and multiples, security covenants, call protection provisions, the nature and realizable value of any collateral, the portfolio company’s ability to make payments, its earnings and discounted cash flows, the markets in which the portfolio company does business, comparisons of financial ratios of peer companies that are public, M&A comparables, our principal market (as the reporting entity) and enterprise values, among other factors. When available, broker quotations and/or quotations provided by pricing services are considered as an input in the valuation process. For the six months ended June 30, 2023, there has been no change to the Company’s valuation approaches or techniques and the nature of the related inputs considered in the valuation process.
ASC Topic 820 classifies the inputs used to measure these fair values into the following hierarchy:
Level
 1
: Unadjusted quoted prices in active markets for identical assets or liabilities, accessible by the Company at the measurement date.
Level
 2
: Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or other observable inputs other than quoted prices.
Level
 3
: Unobservable inputs for the asset or liability.
In all cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each investment. The exercise of judgment is based in part on our knowledge of the asset class and our prior experience.
 
  (c)
Gains or losses on investments are calculated by using the specific identification method.
 
  (d)
The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Loan origination fees, original issue discount, and market discounts are capitalized and we amortize such amounts into income using the effective interest method. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record call premiums received on loans repaid as interest income when we receive such amounts. Capital structuring fees, amendment fees, consent fees, and any other
non-recurring
fee income as well as a management fee and other fee income for services rendered, if any, are recorded as other income when earned.
 
  (e)
The Company intends to comply with the applicable provisions of the Code pertaining to
RICs
to make distributions of taxable income sufficient to relieve it of substantially all U.S. federal income taxes. The Company, at its discretion, may carry forward taxable income in excess of calendar year distributions and pay a 4% excise tax on this income. The Company will accrue excise tax on such estimated excess taxable income as appropriate.
 
  (f)
Book and tax basis differences relating to stockholder distributions and other permanent book and tax differences are typically reclassified among the Company’s capital accounts annually. In addition, the character of income and gains to be distributed is determined in accordance with income tax regulations that may differ from GAAP.
 
  (g)
Distributions to common stockholders are recorded as of the record date. The amount to be paid out as a distribution is determined by the Board. Net realized capital gains, if any, are generally distributed or deemed distributed at least annually.
 
  (h)
In accordance with Regulation
S-X
and ASC Topic 810—
Consolidation
, the Company consolidates its interest in controlled investment company subsidiaries, financing subsidiaries and certain wholly-owned holding companies that serve to facilitate investment in portfolio companies. In addition, the Company may also consolidate any controlled operating companies substantially all of whose business consists of providing services to the Company.
 
 
  (i)
The accounting records of the Company are maintained in U.S. dollars. Any assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the rate of exchange of such currencies against U.S. dollars on the date of valuation. The Company will not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. Such fluctuations would be included with the net unrealized gain or loss from investments. The Company’s investments in foreign securities, if any, may involve certain risks, including without limitation: foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments in terms of U.S. dollars and therefore the earnings of the Company.
 
  (j)
In accordance with ASC
835-30,
the Company reports origination and other expenses related to certain debt issuances as a direct deduction from the carrying amount of the debt liability. Applicable expenses are deferred and amortized using either the effective interest method or the straight-line method over the stated life. The straight-line method may be used on revolving facilities and/or when it approximates the effective yield method.
 
  (k)
The Company may enter into forward exchange contracts in order to hedge against foreign currency risk. These contracts are
marked-to-market
by recognizing the difference between the contract exchange rate and the current market rate as unrealized appreciation or depreciation. Realized gains or losses are recognized when contracts are settled.
 
  (l)
The Company records expenses related to shelf registration statements and applicable equity offering costs as prepaid assets. These expenses are typically charged as a reduction of capital upon the sale of shares or expensed, in accordance with ASC
946-20-25.
 
  (m)
Investments that are expected to pay regularly scheduled interest in cash are generally placed on
non-accrual
status when principal or interest cash payments are past due 30 days or more (90 days or more for equipment financing) and/or when it is no longer probable that principal or interest cash payments will be collected. Such
non-accrual
investments are restored to accrual status if past due principal and interest are paid in cash, and in management’s judgment, are likely to continue timely payment of their remaining principal and interest obligations. Cash interest payments received on such investments may be recognized as income or applied to principal depending on management’s judgment.
 
  (n)
The Company defines cash equivalents as securities that are readily convertible into known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only securities with a maturity of three months or less would qualify, with limited exceptions. The Company believes that certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities would qualify as cash equivalents.
XML 27 R14.htm IDEA: XBRL DOCUMENT v3.23.2
Agreements
6 Months Ended
Jun. 30, 2023
Agreements [Abstract]  
Agreements
Note 3. Agreements
The Company has an investment advisory and management agreement (the “Advisory Agreement”) with the Investment Adviser, under which the Investment Adviser manages the
day-to-day
operations of, and provides investment advisory services to the Company. For providing these services, the Investment Adviser receives a fee from the Company, consisting of two components—a base management fee and a performance-based incentive fee. The base management fee is determined by taking the average value of the Company’s gross assets at the end of the two most recently completed calendar quarters calculated at an annual rate of 1.50% on gross assets up to 200% of the Company’s total net assets as of the immediately preceding quarter end and 1.00% on gross assets that exceed 200% of the Company’s total net assets as of the immediately preceding quarter end. For purposes of computing the base management fee, gross assets exclude temporary assets acquired at the end of each fiscal quarter for purposes of preserving investment flexibility in the next fiscal quarter. Temporary assets include, but are not limited to, U.S. treasury bills, other short-term U.S. government or government agency securities, repurchase agreements or cash borrowings.
The performance-based incentive fee has two parts, as follows: one part is calculated and payable quarterly in arrears based on the Company’s
pre-incentive
fee net investment income for the immediately preceding calendar quarter. For this purpose,
pre-incentive
fee net investment income means interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that we receive from portfolio companies) accrued during the calendar quarter, minus the Company’s operating expenses for the quarter (including the base management fee, any expenses payable under the Administration Agreement, and any interest expense and distributions paid on any issued and outstanding preferred stock, but excluding the performance-based incentive fee).
Pre-incentive
fee net investment income does not include any realized capital gains or losses, or unrealized capital appreciation or depreciation.
Pre-incentive
fee net investment income, expressed as a rate of return on the value of the Company’s net assets at the end of the immediately preceding calendar quarter, is compared to the hurdle rate of 1.75% per quarter (7% annualized). The Company pays the Investment Adviser a performance-based incentive fee with respect to the Company’s
pre-incentive
fee net investment income in each calendar quarter as follows: (1) no performance-based incentive fee in any calendar quarter in which the Company’s
pre-incentive
fee net investment income does not exceed the hurdle rate; (2) 100% of the Company’s
pre-incentive
fee net investment income with respect to that portion of such
pre-incentive
fee net investment income, if any, that exceeds the hurdle rate but is less than
2.1875
% in any calendar quarter; and (3) 20% of the amount of the Company’s
pre-incentive
fee net investment income, if any, that exceeds
2.1875
% in any calendar quarter. These calculations are appropriately
pro-rated
for any period of less than three months.
The second part of the performance-based incentive fee is determined and payable in arrears as of the end of each calendar year (or upon termination of the Advisory Agreement, as of the termination date), and will equal 20% of the Company’s cumulative realized capital gains less cumulative realized capital losses, unrealized capital depreciation (unrealized depreciation on a gross
investment-by-investment
basis at the end of each calendar year) and all net capital gains upon which prior performance-based capital gains incentive fee payments were previously made to the Investment Adviser. For financial statement purposes, the second part of the performance-based incentive fee is accrued based upon 20% of cumulative net realized gains and net unrealized capital appreciation. No accrual was required for the three and six months ended June 30, 2023 and 2022.
For the three and six months ended June 30, 2023, the Company recognized $7,878 and $15,584, respectively, in base management fees and $5,638 and $11,147, respectively, in performance-based incentive fees. For the three and six months ended June 30, 2023, $125 and $235, respectively, of such performance-based incentive fees were waived. For the three and six months ended June 30, 2022, the Company recognized $6,913 and $14,129, respectively, in base management fees and $4,734 and $4,734, respectively, in gross performance-based incentive fees. For the three and six months ended June 30, 2022, $1,358 and $1,358 of such performance-based incentive fees were waived. The Investment Adviser has agreed to waive incentive fees resulting from income earned due to the accretion of purchase discount allocated to investments acquired as a result of the Mergers. Fees waived pursuant to the above are not subject to recoupment by the Investment Adviser.
The Company has also entered into an Administration Agreement with SLR Capital Management, LLC (the “Administrator”) under which the Administrator provides administrative services to the Company. For providing these services, facilities and personnel, the Company reimburses the Administrator for the Company’s allocable portion of overhead and other expenses incurred by the Administrator in performing its obligations under the Administration Agreement, including rent. The Administrator will also provide, on the Company’s behalf, managerial assistance to those portfolio companies to which the Company is required to provide such assistance. The Company typically reimburses the Administrator on a quarterly basis.
For the three and six months ended June 30, 2023, the Company recognized expenses under the Administration Agreement of $1,480 and $2,988 respectively. For the three and six months ended June 30, 2022, the Company recognized expenses under the Administration Agreement of $1,369 and $2,552 respectively. No managerial assistance fees were accrued or collected for the three and six months ended June 30, 2023 and 2022.
 
XML 28 R15.htm IDEA: XBRL DOCUMENT v3.23.2
Net Asset Value Per Share
6 Months Ended
Jun. 30, 2023
Net Asset Value Per Share [Abstract]  
Net Asset Value Per Share
Note 4. Net Asset Value Per Share
At June 30, 2023, the Company’s total net assets and net asset value per share were $980,805 and $17.98, respectively. This compares to total net assets and net asset value per share at December 31, 2022 of $999,731 and $18.33, respectively.
XML 29 R16.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings Per Share
6 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
Earnings Per Share
Note 5. Earnings Per Share
The following table sets forth the computation of basic and diluted net increase in net assets per share resulting from operations, pursuant to ASC
260-10,
for the three and six months ended June 30, 2023 and 2022:
 
    
Three months ended June 30,
    
Six months ended June 30,
 
    
2023
    
2022
    
2023
    
2022
 
Earnings (loss) per share (basic & diluted)
           
Numerator - net increase (decrease) in net assets resulting from operations:
   $ 18,995      $ (15,646    $ 25,819      $ (14,183
Denominator - weighted average shares:
     54,554,634        54,772,651        54,554,642        48,551,302  
Earnings (loss) per share:
   $ 0.35      ($ 0.29    $ 0.47      ($ 0.29
XML 30 R17.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value
6 Months Ended
Jun. 30, 2023
Fair Value Disclosures [Abstract]  
Fair Value
Note 6. Fair Value
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a framework for measuring fair value that includes a hierarchy used to classify the inputs used in measuring fair value. The hierarchy prioritizes the inputs to valuations used to measure fair value into three levels. The level in the fair value hierarchy within which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The levels of the fair value hierarchy are as follows:
Level
 1.
 Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company has the ability to access.
Level
 2.
 Financial assets and liabilities whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 2 inputs include the following:
 
  a)
Quoted prices for similar assets or liabilities in active markets;
 
  b)
Quoted prices for identical or similar assets or liabilities in
non-active
markets;
 
  c)
Pricing models whose inputs are observable for substantially the full term of the asset or liability; and
 
  d)
Pricing models whose inputs are derived principally from or corroborated by observable market data through correlation or other means for substantially the full term of the asset or liability.
Level
 3.
Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s and, if applicable, an independent third-party valuation firm’s own assumptions about the assumptions a market participant would use in pricing the asset or liability.
When the inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3).
Gains and losses for assets and liabilities categorized within the Level 3 table below may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3).
A review of fair value hierarchy classifications is conducted on a quarterly basis. Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. Such reclassifications involving Level 3 assets and liabilities are reported as transfers in/out of Level 3 as of the end of the quarter in which the reclassifications occur. Within the fair value hierarchy tables below, cash and cash equivalents are excluded but could be classified as Level 1.
 
 
The following tables present the balances of assets measured at fair value on a recurring basis, as of June 30, 2023 and December 31, 2022:
Fair Value Measurements
As of June 30, 2023
 
    
Level 1
    
Level 2
    
Level 3
    
Measured at
Net Asset Value*
    
Total
 
Assets:
              
Senior Secured Loans
   $ —      $ —        $ 1,318,512      $ —        $ 1,318,512  
Equipment Financing
     —          —          271,333        —          271,333  
Preferred Equity
     —          —          3,801        —          3,801  
Common Equity/Equity Interests/Warrants
     358        —          566,427        20,995        587,780  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
   $ 358    $ —        $ 2,160,073      $ 20,995      $ 2,181,426  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Fair Value Measurements
As of December 31, 2022
 
    
Level 1
    
Level 2
    
Level 3
    
Measured at
Net Asset Value*
    
Total
 
Assets:
              
Senior Secured Loans
   $ —      $ —        $ 1,245,414      $ —        $ 1,245,414  
Equipment Financing
     —          —          265,952        —          265,952  
Preferred Equity
     —          —          3,801        —          3,801  
Common Equity/Equity Interests/Warrants
     483        —          561,600        9,426        571,509  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
   $ 483    $      $ 2,076,767      $ 9,426      $ 2,086,676  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
*
In accordance with ASC
820-10,
certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The portfolio investment in this category is SSLP. See Note 17 for more information on this investment, including its investment strategy and the Company’s unfunded equity commitment to SSLP. This investment is not redeemable by the Company absent an election by the members of the entity to liquidate all investments and distribute the proceeds to the members.
 
 
The following tables provide a summary of the changes in fair value of Level 3 assets for the three and six months ended June 30, 2023, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at June 30, 2023:
Fair Value Measurements Using Level 3 Inputs
 
    
Senior Secured

Loans
   
Equipment

Financing
   
Preferred Equity
   
Common Equity/

Equity

Interests/

Warrants
   
Total
 
Fair value, March
 31, 2023
   $ 1,256,830     $ 258,044     $ 3,801     $ 559,919     $ 2,078,594  
Total gains or losses included in earnings:
          
Net realized gain
     333       —         —         —         333  
Net change in unrealized gain (loss)
     7,647       (138     (62     (11,998     (4,551
Purchase of investment securities
     166,766       22,739       62       18,506       208,073  
Proceeds from dispositions of investment securities
     (113,064     (9,312     —         —         (122,376
Transfers in/out of Level 3
     —         —         —         —         —    
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Fair value, June
 30, 2023
   $ 1,318,512     $ 271,333     $ 3,801     $ 566,427     $ 2,160,073  
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
          
Net change in unrealized gain (loss)
   $ 1,207     $ (138   $ (62   $ (11,998   $ (10,991
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
    
Senior Secured

Loans
   
Equipment

Financing
   
Preferred Equity
   
Common Equity/

Equity

Interests/

Warrants
   
Total
 
Fair value, December
 31, 2022
   $ 1,245,414     $ 265,952     $ 3,801     $ 561,600     $ 2,076,767  
Total gains or losses included in earnings:
          
Net realized gain
     1,157       —         —         —         1,157  
Net change in unrealized loss
     (5,823     (78     (123     (14,358     (20,382
Purchase of investment securities
     320,336       30,084       123       19,185       369,728  
Proceeds from dispositions of investment securities
     (242,572     (24,625     —         —         (267,197
Transfers in/out of Level 3
     —         —         —         —         —    
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Fair value, June
 30, 2023
   $ 1,318,512     $ 271,333     $ 3,801     $ 566,427     $ 2,160,073  
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
          
Net change in unrealized loss.
   $ (11,594   $ (78   $ (123   $ (14,358   $ (26,153
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
While the Company has not made an election to apply the fair value option of accounting to any of its current debt obligations, if the Company’s debt obligations were carried at fair value at June 30, 2023, the fair value of the Credit Facility, SPV Credit Facility, 2024 Unsecured Notes, 2025 Unsecured Notes, 2026 Unsecured Notes, 2027 Unsecured Notes and 2027 Series F Unsecured Notes would be $582,000, $167,200, $119,688, $80,325, $68,250, $43,125 and $118,463, respectively.
 
 
The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2022, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2022:
Fair Value Measurements Using Level 3 Inputs
 
    
Senior Secured

Loans
   
Equipment

Financing
   
Preferred Equity
   
Common Equity/

Equity

Interests/

Warrants
   
Total
 
Fair value, December
 31, 2021
   $ 939,690     $ 273,795     $ 5,630     $ 450,381     $ 1,669,496  
Total gains or losses included in earnings:
          
Net realized gain (loss)
     (36,244     —         —         6       (36,238
Net change in unrealized loss
     (8,065     (6,924     (706     (5,048     (20,743
Purchase of investment securities(1)
     796,389       84,168       266       116,272       997,095  
Proceeds from dispositions of investment securities
     (446,356     (85,087     (1,389     (11     (532,843
Transfers in/out of Level 3
     —         —         —         —         —    
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Fair value, December
 31, 2022
   $ 1,245,414     $ 265,952     $ 3,801     $ 561,600     $ 2,076,767  
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
          
Net change in unrealized loss
   $ (8,920   $ (6,924   $ (706   $ (5,048   $ (21,598
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
(1)
Includes positions acquired from SUNS as a result of the Mergers.
The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the year ended December 31, 2022:
 
2022 Unsecured Notes
  
For the year ended
December 31, 2022
 
Beginning fair value
   $ 150,000  
Net realized (gain) loss
     —    
Net change in unrealized (gain) loss
     —    
Borrowings
     —    
Repayments
     (150,000
Transfers in/out of Level 3
     —    
  
 
 
 
Ending fair value
   $ —    
  
 
 
 
The Company made an election to apply the fair value option of accounting to the 2022 Unsecured Notes, in accordance with ASC
825-10.
On May 8, 2022, the borrowings were repaid in full. While the Company has not made an election to apply the fair value option of accounting to any of its other debt obligations, if the Company’s debt obligations were carried at fair value at December 31, 2022, the fair value of the Credit Facility, SPV Credit Facility, 2023 Unsecured Notes, 2024 Unsecured Notes, 2025 Unsecured Notes, 2026 Unsecured Notes, 2027 Unsecured Notes and 2027 Series F Unsecured Notes would be $393,000, $155,200, $75,000, $118,750, $79,688, $68,250, $42,875 and $118,125, respectively.
 
 
Quantitative Information about Level 3 Fair Value Measurements
The Company typically determines the fair value of its performing debt investments utilizing a yield analysis. In a yield analysis, a price is ascribed for each investment based upon an assessment of current and expected market yields for similar investments and risk profiles. Additional consideration is given to current contractual interest rates, relative maturities and other key terms and risks associated with an investment. Among other factors, a significant determinant of risk is the amount of leverage used by the portfolio company relative to the total enterprise value of the company, and the rights and remedies of our investment within each portfolio company.
Significant unobservable quantitative inputs typically used in the fair value measurement of the Company’s Level 3 assets and liabilities primarily reflect current market yields, including indices, and readily available quotes from brokers, dealers, and pricing services as indicated by comparable assets and liabilities, as well as enterprise values, returns on equity and earnings before income taxes, depreciation and amortization (“EBITDA”) multiples of similar companies, and comparable market transactions for equity securities.
Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of June 30, 2023 is summarized in the table below:
 
    
Asset or
Liability
  
Fair Value at

June 30, 2023
    
Principal Valuation
Technique/Methodology
  
Unobservable Input
  
Range (Weighted

Average)
Senior Secured Loans
   Asset   
$
$
1,306,129
12,383
 
 
  
Income Approach
Recovery Analysis
  
Market Yield
Recoverable Amount
   9.9% – 20.8% (12.8%)
N/A
Equipment Financing
   Asset    $
$
150,513
120,820
 
 
  
Income Approach
Market Multiple
(1)
  
Market Yield
Comparable Multiple
   8.5% – 9.7% (9.6%)
1.1x-1.4x (1.2x)
Preferred Equity
   Asset    $ 3,801      Income Approach    Market Yield    5.0% – 5.0% (5.0%)
Common Equity/Equity Interests/Warrants
   Asset    $
$
162,207
404,220
 
 
  
Market Multiple
(2)
Market Approach
  
Comparable Multiple
Return on Equity
   6.3x – 11.5x (8.7x)
4.7% – 32.4% (10.7%)
 
(1)
Includes $120,820 of investments valued using an implied multiple.
(2)
Includes $1,047 of investments valued using a Black-Scholes model and $161,160 of investments valued using an EBITDA multiple.
Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of December 31, 2022 is summarized in the table below:
 
    
Asset or
Liability
  
Fair Value at

December 31, 2022
    
Principal Valuation
Technique/Methodology
  
Unobservable Input
  
Range (Weighted

Average)
Senior Secured Loans
   Asset    $
$
1,212,842
32,572
 
 
  
Income Approach
Market Multiple
(1)
  
Market Yield
Comparable Multiple
   9.4% – 18.2% (12.0%)
0.1x-21.4x (12.4x)
Equipment Financing
   Asset    $
$
145,132
120,820
 
 
  
Income Approach
Market Multiple
(2)
  
Market Yield
Comparable Multiple
   8.5% – 9.7% (9.7%)
1.1x-1.4x (1.2x)
Preferred Equity
   Asset    $ 3,801      Income Approach    Market Yield    5.0% – 5.0% (5.0%)
Common Equity/Equity Interests/Warrants
   Asset    $
$
149,120
412,480
 
 
  
Market Multiple
(3)
Market Approach
  
Comparable Multiple
Return on Equity
   7.8x – 9.8x (8.8x)
6.6% – 35.2% (9.2%)
 
(1)
Investments are valued using a
sum-of-the
parts analysis, using expected revenue multiples for certain segments of the businesses and expected EBITDA multiples for certain segments of the businesses.
(2)
Includes $120,820 of investments valued using an implied multiple.
(3)
Includes $676 of investments valued using a Black-Scholes model and $148,444 of investments valued using an EBITDA multiple.
Significant increases or decreases in any of the above unobservable inputs in isolation, including unobservable inputs used in deriving
bid-ask
spreads, if applicable, could result in significantly lower or higher fair value measurements for such assets and liabilities. Generally, an increase in market yields or decrease in EBITDA multiples may result in a decrease in the fair value of certain of the Company’s investments.
XML 31 R18.htm IDEA: XBRL DOCUMENT v3.23.2
Debt
6 Months Ended
Jun. 30, 2023
Debt Instruments [Abstract]  
Debt
Note 7. Debt
Our debt obligations consisted of the following as of June 30, 2023 and December 31, 2022:
 
    
June 30, 2023
   
December 31, 2022
 
Facility
  
Face Amount
    
Carrying Value
   
Face Amount
    
Carrying Value
 
Credit Facility
   $ 582,000      $ 577,843
(1)
 
  $ 393,000      $ 388,254
(1)
 
SPV Credit Facility
     167,200        166,433
(2)
 
    155,200        154,302
(2)
 
2023 Unsecured Notes
     —          —         75,000        74,979
(3)
 
2024 Unsecured Notes
     125,000        124,563
(4)
 
    125,000        124,421
(4)
 
2025 Unsecured Notes
     85,000        84,696
(5)
 
    85,000        84,613
(5)
 
2026 Unsecured Notes
     75,000        74,556
(6)
 
    75,000        74,498
(6)
 
2027 Unsecured Notes
     50,000        49,959
(7)
 
    50,000        49,953
(7)
 
2027 Series F Unsecured Notes
     135,000        134,983
(8)
 
    135,000        134,978
(8)
 
    
 
 
    
 
 
   
 
 
    
 
 
 
     $ 1,219,200      $ 1,213,033     $ 1,093,200      $ 1,085,998  
    
 
 
    
 
 
   
 
 
    
 
 
 
 
(1)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $4,157 and $4,746 as of June 30, 2023 and December 31, 2022, respectively.
(2)
Carrying Value equals the Face Amount net of unamortized market discount of $767 and $898 as of June 30, 2023 and December 31, 2022, respectively.
(3)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $21 as of December 31, 2022.
(4)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $437 and $579 as of June 30, 2023 and December 31, 2022, respectively.
(5)
Carrying Value equals the Face Amount net of unamortized market discount of $304 and $387 as of June 30, 2023 and December 31, 2022, respectively.
(6)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $444 and $502 as of June 30, 2023 and December 31, 2022, respectively.
(7)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $41 and $47 as of June 30, 2023 and December 31, 2022, respectively.
(8)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $17 and $22 as of June 30, 2023 and December 31, 2022, respectively.
Unsecured Notes
On April 1, 2022, the Company entered into an assumption agreement (the “Note Assumption Agreement”), effective as of the closing of the Mergers. The Note Assumption Agreement relates to the Company’s assumption of $85,000 in aggregate principal amount of five-year, 3.90% senior unsecured notes, due March 31, 2025 (the “2025 Unsecured Notes”) and other obligations of SUNS under the Note Purchase Agreement, dated as of March 31, 2020 (the “Note Purchase Agreement”), among SUNS and certain institutional investors. Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30. Pursuant to the Note Assumption Agreement, the Company expressly assumed on behalf of SUNS the due and punctual payment of the principal of (and premium, if any) and interest on all the 2025 Unsecured Notes outstanding, and the due and punctual performance and observance of every covenant and every condition of the Note Purchase Agreement, to be performed or observed by SUNS.
On January 6, 2022, the Company closed a private offering of $135,000 of the 2027 Series F Unsecured Notes with a fixed interest rate of 3.33% and a maturity date of January 6, 2027. Interest on the 2027 Series F Unsecured Notes is due semi-annually on January 6 and July 6. The 2027 Series F Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On September 14, 2021, the Company closed a private offering of $50,000 of the 2027 Unsecured Notes with a fixed interest rate of 2.95% and a maturity date of March 14, 2027. Interest on the 2027 Unsecured Notes is due semi-annually on March 14 and September 14. The 2027 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 18, 2019, the Company closed a private offering of $125,000 of the 2024 Unsecured Notes with a fixed interest rate of 4.20% and a maturity date of December 15, 2024. Interest on the 2024 Unsecured Notes is due semi-annually on June 15 and December 15. The 2024 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
 
 
On December 18, 2019, the Company closed a private offering of $75,000 of the 2026 Unsecured Notes with a fixed interest rate of 4.375% and a maturity date of December 15, 2026. Interest on the 2026 Unsecured Notes is due semi-annually on June 15 and December 15. The 2026 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On November 22, 2017, we issued $75,000 in aggregate principal amount of publicly registered 2023 Unsecured Notes for net proceeds of $73,846. Interest on the 2023 Unsecured Notes is paid semi-annually on January 20 and July 20, at a fixed rate of 4.50% per year, commencing on January 20, 2018. The 2023 Unsecured Notes were repaid in full on the maturity date, January 20, 2023.
Revolving and Term Loan Facilities
On April 1, 2022, the Company entered into an assumption agreement (the “CF Assumption Agreement”), effective as of the closing of the Mergers. The CF Assumption Agreement relates to the Company’s assumption of the Revolving Credit Facility, originally entered into on August 26, 2011 (as amended from time to time, the “SPV Credit Facility”), by and among SUNS SPV LLC (the “SUNS SPV”), a wholly-owned subsidiary of SUNS, acting as borrower, Citibank, N.A., acting as administrative agent and collateral agent, and the other parties thereto. Currently, the commitment under the SPV Credit Facility is $225,000; however, the commitment can also be expanded up to $600,000. The stated interest rate on the SPV Credit Facility is
SOFR
plus
2.00%-2.50%
with no
SOFR
floor requirement and the current final maturity date is June 1, 2026. The SPV Credit Facility is secured by all of the assets held by SUNS SPV. Under the terms of the SPV Credit Facility and related transaction documents, the Company as successor to SUNS, and SUNS SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SPV Credit Facility also includes usual and customary events of default for credit facilities of this nature. At June 30, 2023, outstanding USD equivalent borrowings under the SPV Credit Facility totaled $167,200.
On December 28, 2021, the Company closed on Amendment No. 1 to its August 28, 2019 senior secured credit agreement (the “Credit Facility”). Following the amendment and a November 2022 upsizing, the Credit Facility is composed of $625,000 of revolving credit and $100,000 of term loans. Borrowings generally bear interest at a rate per annum equal to the base rate plus a range of
1.75%-2.00%
or the alternate base rate plus
0.75%-1.00%.
The Credit Facility has a 0% floor and matures in December 2026 and includes ratable amortization in the final year. The Credit Facility may be increased up to $800,000 with additional new lenders or an increase in commitments from current lenders. The Credit Facility contains certain customary affirmative and negative covenants and events of default. In addition, the Credit Facility contains certain financial covenants that among other things, requires the Company to maintain a minimum shareholder’s equity and a minimum asset coverage ratio. At June 30, 2023, outstanding USD equivalent borrowings under the Credit Facility totaled $582,000, composed of $482,000 of revolving credit and $100,000 of term loans.
Certain covenants on our issued debt may restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our status as a RIC under Subchapter M of the Code.
The average annualized interest cost for all borrowings for the six months ended June 30, 2023 and the year ended December 31, 2022 was 5.60% and 4.09%, respectively. These costs are exclusive of other credit facility expenses such as unused fees, agency fees and other prepaid expenses related to establishing and/or amending the Credit Facility, the SPV Credit Facility, the 2023 Unsecured Notes, the 2024 Unsecured Notes, the 2025 Unsecured Notes, the 2026 Unsecured Notes, the 2027 Unsecured Notes and the 2027 Series F Unsecured Notes (collectively the “Debt Instruments”), if any. The maximum amounts borrowed on the Debt Instruments during the six months ended June 30, 2023 and the year ended December 31, 2022 were $1,219,200 and $1,164,200, respectively.
XML 32 R19.htm IDEA: XBRL DOCUMENT v3.23.2
Financial Highlights
6 Months Ended
Jun. 30, 2023
Investment Company, Financial Highlights [Abstract]  
Financial Highlights
Note 8. Financial Highlights
The following is a schedule of financial highlights for the six months ended June 30, 2023 and 2022:
 
    
Six months ended

June 30, 2023
   
Six months ended

June 30, 2022
 
Per Share Data: (a)
    
Net asset value, beginning of year
   $ 18.33     $ 19.93  
  
 
 
   
 
 
 
Net investment income
     0.82       0.70  
Net realized and unrealized loss
     (0.35     (0.97 )* 
  
 
 
   
 
 
 
Net increase (decrease) in net assets resulting from operations
     0.47       (0.27
Issuance of common stock in connection with the Merger
     —         (0.31
Distributions to stockholders:
    
From distributable earnings
     (0.82     (0.82
From return of capital
     —         —    
  
 
 
   
 
 
 
Net asset value, end of period
   $ 17.98     $ 18.53  
  
 
 
   
 
 
 
Per share market value, end of period
   $ 14.27     $ 14.63  
Total Return (b)(c)
     8.41     (19.85 %) 
Net assets, end of period
   $ 980,805     $ 1,015,153  
Shares outstanding, end of period
     54,554,634       54,772,651  
Ratios to average net assets (c):
    
Net investment income
     4.52     3.53
  
 
 
   
 
 
 
Operating expenses
     3.22 %**      2.44 %** 
Interest and other credit facility expenses
     3.34     1.95
  
 
 
   
 
 
 
Total expenses
     6.56 %**      4.39 %** 
  
 
 
   
 
 
 
Average debt outstanding
   $ 1,125,576     $ 880,327  
Portfolio turnover ratio
     12.6     9.0
 
(a)
Calculated using the average shares outstanding method, except for the issuance of common stock in connection with the Merger, which reflects the actual amount per share for the applicable period.
(b)
Total return is based on the change in market price per share during the period and takes into account distributions, if any, reinvested in accordance with the dividend reinvestment plan. The market price per share as of December 31, 2022 and December 31, 2021 was $13.91 and $18.43, respectively. Total return does not include a sales load.
(c)
Not annualized for periods less than one year.
*
The amount shown may not correspond with the aggregate amount for the period as it includes the effect of the timing of the Merger.
**
The ratio of operating expenses to average net assets and the ratio of total expenses to average net assets is shown net of the performance-based incentive fee waiver (see note 3). For the six months ended June 30, 2023, the ratios of operating expenses to average net assets and total expenses to average net assets would be 3.24% and 6.58%, respectively, without the performance-based incentive fee waiver. For the six months ended June 30, 2022, the ratios of operating expenses to average net assets and total expenses to average net assets would be 2.58% and 4.53%, respectively, without the performance-based incentive fee waiver.
XML 33 R20.htm IDEA: XBRL DOCUMENT v3.23.2
SLR Credit Solutions
6 Months Ended
Jun. 30, 2023
Line of Credit Facility [Abstract]  
SLR Credit Solutions
Note 9. SLR Credit Solutions
On December 28, 2012, we acquired an equity interest in Crystal Capital Financial Holdings LLC (“Crystal Financial”) for $275,000 in cash. Crystal Financial owned approximately 98% of the outstanding ownership interest in SLR Credit Solutions (“SLR Credit”), f/k/a Crystal Financial LLC. The remaining financial interest was held by various employees of SLR Credit, through their investment in Crystal Management LP. SLR Credit had a diversified portfolio of 23 loans having a total par value of approximately $400,000 at November 30, 2012 and a $275,000 committed revolving credit facility. On July 28, 2016, the Company purchased Crystal Management LP’s approximately 2% equity interest in SLR Credit for approximately $5,737. Upon the closing of this transaction, the Company holds 100% of the equity interest in SLR Credit. On September 30, 2016, Crystal Capital Financial Holdings LLC was dissolved. As of June 30, 2023, total commitments to the revolving credit facility are $300,000.
As of June 30, 2023 SLR Credit had 29 funded commitments to 25 different issuers with total funded loans of approximately $425,019 on total assets of $443,024. As of December 31, 2022 SLR Credit had 29 funded commitments to 25 different issuers with total funded loans of approximately $439,484 on total assets of $460,683. As of June 30, 2023 and December 31, 2022, the largest loan outstanding totaled $30,000 and $33,420, respectively. For the same periods, the average exposure per issuer was $17,001 and $17,579, respectively. SLR Credit’s credit facility, which is
non-recourse
to the Company, had approximately $216,947 and $224,325 of borrowings outstanding at June 30, 2023 and December 31, 2022, respectively. For the three months ended June 30, 2023 and 2022, SLR Credit had net income of $6,767 and $1,880, respectively, on gross income of $13,897 and $6,882, respectively. For the six months ended June 30, 2023 and 2022, SLR Credit had net income (loss) of ($2,905) and $4,660, respectively, on gross income of $28,452 and $13,575, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions.
XML 34 R21.htm IDEA: XBRL DOCUMENT v3.23.2
Commitments and Contingencies
6 Months Ended
Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
Note 10. Commitments and Contingencies
Off-Balance
Sheet Arrangements
The Company had unfunded debt and equity commitments to various revolving and delayed-draw term loans as well as to SLR Credit and SLR Healthcare. The total amount of these unfunded commitments as of June 30, 2023 and December 31, 2022 is $325,858 and $323,663, respectively, comprised of the following:
 
    
June 30, 2023
    
December 31, 2022
 
SLR Credit Solutions*
   $ 44,263      $ 44,263  
Outset Medical, Inc.
     35,084        35,084  
Apeel Technology, Inc.
     32,786        32,786  
CVAUSA Management, LLC
     22,882        —    
Human Interest, Inc
     20,104        20,104  
Glooko, Inc.
     17,868        17,868  
BDG Media, Inc.
     11,539        3,546  
ONS MSO, LLC
     10,961        —    
iCIMS, Inc
     10,800        11,435  
Arcutis Biotherapeutics, Inc.
     8,356        8,356  
Atria Wealth Solutions, Inc.
     8,215        8,215  
Copper River Seafoods, Inc.
     8,158        3,595  
Ardelyx, Inc
     7,752        7,752  
Cerapedics, Inc.
     6,735        6,735  
United Digestive MSO Parent, LLC
     5,259        —    
Luxury Asset Capital, LLC
     4,500        7,500  
Kaseya, Inc.
     3,768        3,936  
SPAR Marketing Force, Inc.
     3,733        1,338  
Urology Management Holdings, Inc.
     3,596        —    
One Touch Direct, LLC
     3,571        3,069  
Spectrum Pharmaceuticals, Inc.
     3,508        8,771  
SLR Equipment Finance
     3,500        1,000  
Meditrina, Inc.
     3,367        3,367  
Vertos Medical, Inc.
     3,325        —    
Foundation Consumer Brands, LLC
     3,009        3,009  
Vessco Midco Holdings, LLC
     2,677        3,892  
Kid Distro Holdings, LLC
     2,650        2,650  
RSC Acquisition, Inc.
     2,487        7,498  
Erie Construction
Mid-west,
LLC
     2,403        1,248  
Ultimate Baked Goods Midco LLC
     2,361        1,636  
Maurices, Incorporated
     2,353        4,314  
Basic Fun, Inc.
     2,150        2,675  
SCP Eye Care, LLC
     1,955        2,771  
DeepIntent, Inc.
     1,925        3,049  
SunMed Group Holdings, LLC
     1,621        843  
SLR Healthcare ABL*
     1,400        1,400  
American Teleconferencing Services, Ltd
     1,380        1,090  
Montefiore Nyack Hospital
     1,301        1,034  
Pinnacle Treatment Centers, Inc.
     1,286        1,745  
RxSense Holdings LLC
     1,250        1,250  
Bayside Opco, LLC
     1,247        —    
Enverus Holdings, Inc.
     1,233        1,004  
Tilley Distribution, Inc.
     1,158        525  
Pediatric Home Respiratory Services, LLC
     1,147        1,805  
GSM Acquisition Corp
     862        784  
Composite Technology Acquisition Corp
     825        1,537  
High Street Buyer, Inc.
     631        327  
CC SAG Holdings Corp. (Spectrum Automotive)
     548        20,670  
Orthopedic Care Partners Management, LLC
     536        1,620  
Southern Orthodontic Partners Management, LLC
     519        1,918  
ENS Holdings III Corp, LLC
     461        144  
World Insurance Associates, LLC
     295        17,117  
TAUC Management, LLC
     294        294  
AmeriMark Intermediate Holdings, LLC
     221        —    
All State Ag Parts, LLC
     43        135  
Plastics Management, LLC
     —          2,424  
Ivy Fertility Services, LLC
     —          1,571  
NAC Holdings Corporation
     —          1,479  
Peter C. Foy & Associates Insurance Services, LLC
     —          1,094  
BayMark Health Services, Inc.
     —          391  
  
 
 
    
 
 
 
Total Commitments
   $ 325,858      $ 323,663  
  
 
 
    
 
 
 
 
*
The Company controls the funding of the SLR Credit Solutions and SLR Healthcare ABL commitments and may cancel them at its discretion.
 
In addition to the above, please see Note 17. SLR Senior Lending Program LLC herein, which describes that the Company has an equity commitment of $29,250 in SSLP and that the Company also controls such funding. The credit agreements of the above loan commitments contain customary lending provisions and/or are subject to the portfolio company’s achievement of certain milestones that allow relief to the Company from funding obligations for previously made commitments in instances where the underlying company experiences materially adverse events that affect the financial condition or business outlook for the company. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company. As of June 30, 2023 and December 31, 2022, the Company had sufficient cash available and/or liquid securities available to fund its commitments and had reviewed them for any appropriate fair value adjustment.
XML 35 R22.htm IDEA: XBRL DOCUMENT v3.23.2
SLR Equipment Finance
6 Months Ended
Jun. 30, 2023
Schedule of Equity Method Investments [Line Items]  
SLR Equipment Finance
Note 13. Kingsbridge Holdings, LLC
On November 3, 2020, the Company acquired 87.5% of the equity securities of Kingsbridge Holdings, LLC (“KBH”) through KBH Topco LLC (“KBHT”), a Delaware corporation. KBH is a residual focused independent
mid-ticket
lessor of equipment primarily to U.S. investment grade companies. The Company invested $216,596 to effect the transaction, of which $136,596 was invested to acquire 87.5% of KBHT’s equity and $80,000 in KBH’s debt. The existing management team of KBH committed to continuing to lead KBH after the transaction. Following the transaction, the Company owns 87.5% of KBHT equity and the KBH management team owns the remaining 12.5% of KBHT’s equity.
As of June 30, 2023 and December 31, 2022, KBHT had total assets of $797,930 and $777,151, respectively. For the same periods, debt recourse to KBHT totaled $246,294 and $222,094, respectively, and
non-recourse
debt totaled $356,929 and $353,128, respectively. None of the debt is recourse to the Company. For the three months ended June 30, 2023 and 2022, KBHT had net income of $3,287 and $3,657, respectively, on gross income of $75,500 and $77,316, respectively. For the six months ended June 30, 2023 and 2022, KBHT had net income of $5,914 and $7,066, respectively, on gross income of $143,507 and $143,741, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in KBHT’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that KBHT will be able to maintain consistent dividend payments to us.
SLR Equipment Finance [Member]  
Schedule of Equity Method Investments [Line Items]  
SLR Equipment Finance
Note 11. SLR Equipment Finance
On July 31, 2017, we acquired a 100% equity interest in NEF Holdings, LLC, which conducts its business through its wholly-owned subsidiary Nations Equipment Finance, LLC. Effective February 25, 2021, Nations Equipment Finance, LLC and its related companies are doing business as SLR Equipment Finance (“SLR Equipment”). SLR Equipment is an independent equipment finance company that provides senior secured loans and leases primarily to U.S. based companies. We invested $209,866 in cash to effect the transaction, of which $145,000 was invested in the equity of SLR Equipment through our wholly-owned consolidated taxable subsidiary NEFCORP LLC and our wholly-owned consolidated subsidiary NEFPASS LLC and $64,866 was used to purchase certain leases and loans held by SLR Equipment through NEFPASS LLC. Concurrent with the transaction, SLR Equipment refinanced its existing senior secured credit facility into a $150,000
non-recourse
facility with an accordion feature to expand up to $250,000. In September 2019, SLR Equipment amended the facility, increasing commitments to $213,957 with an accordion feature to expand up to $313,957 and extended the maturity date of the facility to July 31, 2023. In June 2023, the facility was amended to extend the maturity date to January 31, 2024, with updated commitments totaling $152,147, effective August 1, 2023.
As of June 30, 2023, SLR Equipment had 129 funded equipment-backed leases and loans to 54 different customers with a total net investment in leases and loans of approximately $197,694 on total assets of $246,528. As of December 31, 2022, SLR Equipment had 131 funded equipment-backed leases and loans to 59 different customers with a total net investment in leases and loans of approximately $190,830 on total assets of $241,813. As of June 30, 2023 and December 31, 2022, the largest position outstanding totaled $18,243 and $19,259, respectively. For the same periods, the average exposure per customer was $3,661 and $3,234, respectively. SLR Equipment’s credit facility, which is
non-recourse
to the Company, had approximately $124,732 and $114,977 of borrowings outstanding at June 30, 2023 and December 31, 2022, respectively. For the three months ended June 30, 2023 and June 30, 2022, SLR Equipment had net loss of $2,055 and $1,753, respectively, on gross income of $4,054 and $4,045, respectively. For the six months ended June 30, 2023 and June 30, 2022, SLR Equipment had net loss of $1,017 and $1,159, respectively, on gross income of $10,391 and $9,218, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions.
XML 36 R23.htm IDEA: XBRL DOCUMENT v3.23.2
Capital Share Transactions
6 Months Ended
Jun. 30, 2023
Stockholders' Equity Note [Abstract]  
Capital Share Transactions
Note 12. Capital Share Transactions
As of June 30, 2023 and June 30, 2022, 200,000,000 shares of $0.01 par value capital stock were authorized.
Transactions in capital stock were as follows:
 
    
Shares
    
Amount
 
    
Three months ended
June 30, 2023
    
Three months ended
June 30, 2022
    
Three months ended
June 30, 2023
    
Three months ended
June 30, 2022
 
Shares issued in connection with the Mergers
     —          12,511,825      $ —        $ 226,839  
    
 
 
    
 
 
    
 
 
    
 
 
 
Net increase
     —          12,511,825      $ —        $ 226,839  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
    
Shares
    
Amount
 
    
  Six months ended  
June 30, 2023
    
  Six months ended  
June 30, 2022
    
   Six months ended   
June 30, 2023
    
  Six months ended  
June 30, 2022
 
Shares issued in connection with the Mergers
     —          12,511,825      $ —        $ 226,839  
Shares repurchased
     (746      —        $ (10    $ —    
    
 
 
    
 
 
    
 
 
    
 
 
 
Net increase
     (746      12,511,825      $ (10    $ 226,839  
    
 
 
    
 
 
    
 
 
    
 
 
 
XML 37 R24.htm IDEA: XBRL DOCUMENT v3.23.2
Kingsbridge Holdings, LLC
6 Months Ended
Jun. 30, 2023
Equity Method Investments and Joint Ventures [Abstract]  
Kingsbridge Holdings, LLC
Note 13. Kingsbridge Holdings, LLC
On November 3, 2020, the Company acquired 87.5% of the equity securities of Kingsbridge Holdings, LLC (“KBH”) through KBH Topco LLC (“KBHT”), a Delaware corporation. KBH is a residual focused independent
mid-ticket
lessor of equipment primarily to U.S. investment grade companies. The Company invested $216,596 to effect the transaction, of which $136,596 was invested to acquire 87.5% of KBHT’s equity and $80,000 in KBH’s debt. The existing management team of KBH committed to continuing to lead KBH after the transaction. Following the transaction, the Company owns 87.5% of KBHT equity and the KBH management team owns the remaining 12.5% of KBHT’s equity.
As of June 30, 2023 and December 31, 2022, KBHT had total assets of $797,930 and $777,151, respectively. For the same periods, debt recourse to KBHT totaled $246,294 and $222,094, respectively, and
non-recourse
debt totaled $356,929 and $353,128, respectively. None of the debt is recourse to the Company. For the three months ended June 30, 2023 and 2022, KBHT had net income of $3,287 and $3,657, respectively, on gross income of $75,500 and $77,316, respectively. For the six months ended June 30, 2023 and 2022, KBHT had net income of $5,914 and $7,066, respectively, on gross income of $143,507 and $143,741, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in KBHT’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that KBHT will be able to maintain consistent dividend payments to us.
XML 38 R25.htm IDEA: XBRL DOCUMENT v3.23.2
SLR Healthcare ABL
6 Months Ended
Jun. 30, 2023
Equity Method Investments and Joint Ventures [Abstract]  
SLR Healthcare ABL
Note 14. SLR Healthcare ABL
SUNS acquired an equity interest in SLR Healthcare ABL, f/k/a Gemino Healthcare Finance, LLC (“SLR Healthcare”) on September 30, 2013. SLR Healthcare is a commercial finance company that originates, underwrites, and manages primarily secured, asset-based loans for small and
mid-sized
companies operating in the healthcare industry. SUNS initial investment in SLR Healthcare ABL was $32,839. The management team of SLR Healthcare
co-invested
in the transaction and continues to lead SLR Healthcare. As of June 30, 2023, SLR Healthcare’s management team and the Company own approximately 7% and 93% of the equity in SLR Healthcare, respectively. SLRC acquired SLR Healthcare in connection with the Mergers on April 1, 2022.
Concurrent with the closing of the transaction, SLR Healthcare entered into a new, four-year,
non-recourse,
$100,000 credit facility with
non-affiliates,
which was expandable to $150,000 under its accordion feature. Effective March 31, 2014, the credit facility was expanded to $105,000 and again on June 27, 2014 to $110,000. On May 27, 2016, SLR Healthcare entered into a new $125,000 credit facility which replaced the previously existing facility. The new facility has similar terms as compared to the previous facility and includes an accordion feature increase to $200,000 and had a maturity date of May 27, 2020. On June 28, 2019, this $125,000 facility was amended, extending the maturity date to June 28, 2023. On March 31, 2023, the facility was again amended, adjusting capacity to $100,000 and extending the maturity date to March 31, 2026.
SLR Healthcare currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of June 30, 2023, the portfolio totaled approximately $261,600 of commitments with a total net investment in loans of $99,555 on total assets of $106,837. As of December 31, 2022, the portfolio totaled approximately $242,106 of commitments with a total net investment in loans of $92,383 on total assets of $108,705. At June 30, 2023, the portfolio consisted of 40 issuers with an average balance of approximately $2,489 versus 41 issuers with an average balance of approximately $2,253 at December 31, 2022. All of the commitments in SLR Healthcare’s portfolio are floating-rate, senior-secured,
cash-pay
loans. SLR Healthcare’s credit facility, which is
non-recourse
to us, had approximately $74,900 and $77,000 of borrowings outstanding at June 30, 2023 and December 31, 2022, respectively. For the three months ended June 30, 2023 and 2022, SLR Healthcare had net income of $1,273 and $847, respectively, on gross income of $4,439 and $2,487, respectively. For the six months ended June 30, 2023 and 2022, SLR Healthcare had net income of $2,393 and $1,721, respectively, on gross income of $8,276 and $4,878, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions.
XML 39 R26.htm IDEA: XBRL DOCUMENT v3.23.2
SLR Business Credit
6 Months Ended
Jun. 30, 2023
Equity Method Investments and Joint Ventures [Abstract]  
SLR Business Credit
Note 15. SLR Business Credit
SUNS acquired 100% of the equity interests of North Mill Capital LLC (“NMC”) on October 20, 2017. NMC is a leading asset-backed lending commercial finance company that provides senior secured asset-backed financings to U.S. based
small-to-medium-sized
businesses primarily in the manufacturing, services and distribution industries. SUNS invested approximately $51,000 to effect the transaction. Subsequently, SUNS contributed 1% of its equity interest in NMC to ESP SSC Corporation. Immediately thereafter, SUNS and ESP SSC Corporation contributed their equity interests to NorthMill LLC (“North Mill”). On May 1, 2018, North Mill merged with and into NMC, with NMC being the surviving company. SUNS and ESP SSC Corporation then owned 99% and 1% of the equity interests of NMC, respectively. The management team of NMC continues to lead NMC. On June 28, 2019, North Mill Holdco LLC (“NM Holdco”), a newly formed entity and ESP SSC Corporation acquired 100% of Summit Financial Resources, a Salt Lake City-based provider of asset-backed financing to small and
medium-sized
businesses. As part of this transaction, SUNS 99% interest in the equity of NMC was contributed to NM Holdco. This approximately $15,500 transaction was financed with borrowings on NMC’s credit facility. Effective February 25, 2021, NMC and its related companies are doing business as SLR Business Credit. On June 3, 2021, NMC acquired 100% of Fast Pay Partners LLC, a Los Angeles-based provider of asset-backed financing to digital media companies. The transaction purchase price of $66,671 was financed with equity from SUNS of $19,000 and borrowings on NMC’s credit facility of $47,671. SLRC acquired SLR Business Credit in connection with the Mergers on April 1, 2022.
SLR Business Credit currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of June 30, 2023, the portfolio totaled approximately $620,232 of commitments, of which $255,169 were funded, on total assets of $300,645. As of December 31, 2022, the portfolio totaled approximately $603,432 of commitments, of which $286,006 were funded, on total assets of $332,247. At June 30, 2023, the portfolio consisted of 101 issuers with an average balance of approximately $2,526 versus 108 issuers with an average balance of approximately $2,648 at December 31, 2022. NMC has a senior credit facility with a bank lending group for $285,307 which expires on November 13, 2025. Borrowings are secured by substantially all of NMC’s assets. NMC’s credit facility, which is
non-recourse
to us, had approximately $198,571 and $214,425 of borrowings outstanding at June 30, 2023 and December 31, 2022, respectively. For the three months ended June 30, 2023 and 2022, SLR Business Credit had net income of $1,414 and $1,857 respectively, on gross income of $8,827 and $6,626, respectively. For the six months ended June 30, 2023 and 2022, SLR Business Credit had net income of $3,431 and $3,726 respectively, on gross income of $11,067 and $12,772, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Business Credit’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Business Credit will be able to maintain consistent dividend payments to us.
XML 40 R27.htm IDEA: XBRL DOCUMENT v3.23.2
Stock Repurchase Program
6 Months Ended
Jun. 30, 2023
Stockholders' Equity Note [Abstract]  
Stock Repurchase Program
Note 16. Stock Repurchase Program
On May 9, 2023, our Board authorized an extension of a program for the purpose of repurchasing up to $50,000 of our outstanding shares of common stock. Under the repurchase program, we may, but are not obligated to, repurchase shares of our outstanding common stock in the open market from time to time provided that we comply with our code of ethics and the guidelines specified in Rule
10b-18
of the Exchange Act, including certain price, market volume and timing constraints. In addition, any repurchases will be conducted in accordance with the 1940 Act. Unless further amended or extended by our Board, we expect the repurchase program to be in place until the earlier of May 10, 2024 or until $50,000 of our outstanding shares of common stock have been repurchased. The timing and number of additional shares to be repurchased will depend on a number of factors, including market conditions. There are no assurances that we will engage in any repurchases beyond what is reported herein. For the six months ended June 30, 2023, the Company repurchased 746 shares at an average price of approximately $14.02 per share, inclusive of commissions. The total dollar amount of shares repurchased for the six months ended June 30, 2023 was $10. During the fiscal year ended December 31, 2022, the Company repurchased 217,271 shares at an average price of approximately $13.98 per share, inclusive of commissions. The total dollar amount of shares repurchased for the fiscal year ended December 31, 2022 was $3,038.
XML 41 R28.htm IDEA: XBRL DOCUMENT v3.23.2
SLR Senior Lending Program LLC
6 Months Ended
Jun. 30, 2023
Investments, Debt and Equity Securities [Abstract]  
SLR Senior Lending Program LLC
Note 17. SLR Senior Lending Program LLC
On October 12, 2022, the Company entered into an amended and restated limited liability company agreement with Sunstone Senior Credit L.P. (the “Investor”) to create a joint venture vehicle, SLR Senior Lending Program LLC (“SSLP”). SSLP is expected to invest primarily in senior secured cash flow loans. The Company and the Investor each have made initial equity commitments of $50,000, resulting in a total equity commitment of $100,000. Investment decisions and all material decisions in respect of SSLP must be approved by representatives of the Company and the Investor.
On December 1, 2022, SSLP commenced operations. On December 12, 2022, SSLP as servicer and SLR Senior Lending Program SPV LLC (“SSLP SPV”), a newly formed wholly owned subsidiary of SSLP, as borrower entered into a $100,000 senior secured revolving credit facility (the “SSLP Facility”) with Goldman Sachs Bank USA acting as administrative agent. The SSLP Facility is scheduled to mature on December 12, 2027. The SSLP Facility generally bears interest at a rate of SOFR plus 3.25%. SSLP and SSLP SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SSLP Facility also includes usual and customary events of default for credit facilities of this nature. At June 30, 2023, there were $38,400 of borrowings outstanding on the SSLP Facility.
As of June 30, 2023, the Company and the Investor had contributed combined equity capital in the amount of $41,500. As of June 30, 2023, the Company and the Investors’ remaining commitments to SSLP totaled $29,250 and $29,250, respectively. The Company, along with the Investor, controls the funding of SSLP and SSLP may not call the unfunded commitments of the Company or the Investor without the approval of both the Company and the Investor.
As of June 30, 2023 and December 31, 2022, SSLP had total assets of $79,411 and $19,105, respectively. For the same periods, SSLP’s portfolio consisted of floating rate senior secured loans to 20 and 7 different borrowers, respectively. For the three months ended June 30, 2023, SSLP invested $32,557 in 9 portfolio companies. Investments prepaid totaled $182 for the three months ended June 30, 2023. For the period December 1, 2022 (commencement of operations) through December 31, 2022, SSLP invested $18,100 in 7 portfolio companies. Investments prepaid totaled $68 for the period December 1, 2022 (commencement of operations) through December 31, 2022.
 
SSLP Portfolio as of June 30, 2023
 
Description
  
Industry
  
Spread
Above
Index
(1)
    
Floor
   
Interest
Rate
(2)
   
Maturity
Date
    
Par
Amount
    
Cost
    
Fair
Value
(3)
 
Aegis Toxicology Sciences Corporation
(4)
  
Health Care Providers & Services
     S+550        1.00     10.84     5/9/25      $ 2,974      $ 2,974      $ 2,974  
Atria Wealth Solutions, Inc.
(4)
  
Diversified Financial Services
     S+650        1.00     12.00     2/29/24        2,481        2,481        2,481  
BayMark Health Services, Inc.
(4)
  
Health Care Providers & Services
     S+500        1.00     10.50     6/11/27        4,054        4,054        4,054  
ENS Holdings III Corp. & ES Opco USA LLC
(4)
  
Trading Companies & Distributors
     S+475        1.00     10.09     12/31/25        1,091        1,091        1,091  
Fertility (ITC) Investment Holdco, LLC
(4)
  
Health Care Providers & Services
     S+650        1.00     11.63     1/3/29        5,985        5,809        5,985  
Foundation Consumer Brands, LLC
(4)
  
Personal Products
     S+625        1.00     11.47     2/12/27        6,863        6,863        6,863  
Higginbotham Insurance Agency, Inc.
(4)
  
Insurance
     S+525        1.00     10.45     11/25/26        1,293        1,293        1,293  
High Street Buyer, Inc.
(4)
  
Insurance
     S+600        0.75     11.39     4/16/28        2,481        2,481        2,481  
iCIMS, Inc.
(4)
  
Software
     S+725        0.75     12.38     8/18/28        3,029        2,991        3,029  
Kid Distro Holdings, LLC
(4)
  
Software
     S+575        1.00     11.14     10/1/27        5,970        5,970        5,970  
ONS MSO, LLC
(4)
  
Health Care Providers & Services
     S+625        1.00     11.32     7/8/25        5,951        5,774        5,773  
PhyNet Dermatology LLC
(4)
  
Health Care Providers & Services
     S+625        1.00     11.45     8/16/24        2,481        2,481        2,481  
Pinnacle Treatment Centers, Inc.
(4)
  
Health Care Providers & Services
     S+675        1.00     12.10     1/2/26        2,487        2,487        2,487  
Plastics Management, LLC
(4)
  
Health Care Providers & Services
     S+500        1.00     10.44     8/18/27        5,666        5,481        5,666  
RQM+ Corp.
(4)
  
Life Sciences Tools & Services
     S+575        1.00     11.51     8/12/26        5,985        5,985        5,985  
RSC Acquisition, Inc.
(4)
  
Insurance
     S+550        0.75     10.64     11/1/26        5,045        5,045        5,045  
RxSense Holdings LLC
(4)
  
Diversified Consumer Services
     S+500        1.00     10.15     3/13/26        2,985        2,985        2,985  
SunMed Group Holdings, LLC
(4)
  
Health Care Equipment & Supplies
     S+575        0.75     11.09     6/16/28        2,487        2,487        2,487  
Tilley Distribution, Inc.
(4)
  
Trading Companies & Distributors
     S+550        1.00     11.39     12/31/26        5,978        5,978        5,978  
Urology Management Holdings, Inc.
(4)
  
Health Care Providers & Services
     S+625        1.00     11.36     6/15/26        2,471        2,404        2,397  
                                                    
 
 
    
 
 
 
                                                     $ 77,114      $ 77,505  
                                                    
 
 
    
 
 
 
 
(1)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR. These instruments are typically subject to a SOFR floor.
(2)
Floating rate debt investments typically bear interest at a rate determined by reference to the SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of June 30, 2023.
(3)
Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
(4)
The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
 
 
SSLP Portfolio as of December 31, 2022
 
Description
  
Industry
  
Spread
Above
Index
(1)
    
Floor
   
Interest
Rate
(2)
   
Maturity
Date
    
Par
Amount
    
Cost
    
Fair
Value
(3)
 
Atria Wealth Solutions, Inc.
(4)
  
Diversified Financial Services
     S+600        1.00     10.84     2/29/24      $ 2,494      $ 2,494      $ 2,494  
BayMark Health Services, Inc.
(4)
  
Health Care Providers & Services
     L+500        1.00     9.73     6/11/27        2,992        2,992        2,992  
ENS Holdings III Corp. & ES Opco USA LLC
(4)
  
Trading Companies & Distributors
     L+475        1.00     9.43     12/31/25        1,097        1,097        1,097  
Foundation Consumer Brands, LLC
(4)
  
Personal Products
     L+550        1.00     10.15     2/12/27        2,963        2,963        2,963  
High Street Buyer, Inc.
(4)
  
Insurance
     L+600        0.75     10.73     4/16/28        2,494        2,494        2,494  
Ivy Fertility Services, LLC
(4)
  
Health Care Providers & Services
     L+625        1.00     10.39     2/25/26        3,000        3,000        3,030  
Kid Distro Holdings, LLC
(4)
  
Software
     L+575        1.00     10.48     10/1/27        2,992        2,992        2,992  
                                                    
 
 
    
 
 
 
                                                     $ 18,032      $ 18,062  
                                                    
 
 
    
 
 
 
 
(1)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or SOFR. These instruments are typically subject to a LIBOR or SOFR floor.
(2)
Floating rate debt investments typically bear interest at a rate determined by reference to either the LIBOR (“L”) or SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2022.
(3)
Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
(4)
The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
Below is certain summarized financial information for SSLP as of June 30, 2023 and December 31, 2022 and for the three and six months ended June 30, 2023 and for the period December 1, 2022 (commencement of operations) through December 31, 2022:
 

 
  
June 30, 2023
 
  
December 31,

2022
 
Selected Balance Sheet Information for SSLP:
                 
Investments at fair value (cost $77,114 and $18,032, respectively)
   $ 77,505      $ 18,062  
Cash and other assets
     1,906        1,043  
    
 
 
    
 
 
 
Total assets
   $ 79,411      $ 19,105  
    
 
 
    
 
 
 
Debt outstanding
   $ 36,944      $ —    
Interest payable and other credit facility related expenses
     345        165  
Accrued expenses and other payables
     131        89  
    
 
 
    
 
 
 
Total liabilities
   $ 37,420      $ 254  
    
 
 
    
 
 
 
Members’ equity
   $ 41,991      $ 18,851  
    
 
 
    
 
 
 
Total liabilities and members’ equity
   $ 79,411      $ 19,105  
    
 
 
    
 
 
 
 
 

 
  
For the three

months ended June

30, 2023
 
  
For the six
months ended June

30, 2023
 
  
For the period
December 1, 2022
(commencement
of operations) to
December 31,
2022
 
Selected Income Statement Information
for SSLP:
                          
Interest income
   $ 1,605      $ 2,614      $ 152  
    
 
 
    
 
 
    
 
 
 
Service fees*
     38        57      $ 4  
Interest and other credit facility expenses
     1,447        2,252        166  
Organizational costs
     —          —          73  
Other general and administrative expenses
     19        57        88  
    
 
 
    
 
 
    
 
 
 
Total expenses
     1,504        2,366        331  
    
 
 
    
 
 
    
 
 
 
Net investment income (loss)
   $ 101      $ 248      $ (179
    
 
 
    
 
 
    
 
 
 
Realized gain on investments
     —          30        —    
Net change in unrealized gain on investments
     321        361        30  
    
 
 
    
 
 
    
 
 
 
Net realized and unrealized gain on investments
   $ 321      $ 391        30  
    
 
 
    
 
 
    
 
 
 
Net income (loss)
   $ 422      $ 639      $ (149
    
 
 
    
 
 
    
 
 
 
 
*
Service fees are included within the Company’s Consolidated Statements of Operations as other income.
XML 42 R29.htm IDEA: XBRL DOCUMENT v3.23.2
Subsequent Events
6 Months Ended
Jun. 30, 2023
Subsequent Events [Abstract]  
Subsequent Events
Note 18. Subsequent Events
The Company has evaluated the need for disclosures and/or adjustments resulting from subsequent events through the date the consolidated financial statements were issued.
On July 5, 2023, the Board declared a monthly distribution of $0.136667 per share payable on August 1, 2023 to holders of record as of July 20, 2023.
On August 8, 2023, the Board declared a monthly distribution of $0.136667 per share payable on August 30, 2023 to holders of record as of August 18, 2023
.
Timing of Future Distributions
Effective with the fourth quarter of 2023, SLRC’s board of directors intends to adjust the timing of declaring and paying distributions to SLRC’s shareholders from monthly to quarterly. As a result, SLRC’s management anticipates that the last monthly distribution, if declared by SLRC’s board of directors, will be for September 2023 and the next distribution after that, if declared by SLRC’s board of directors, will be a quarterly distribution for the fourth quarter of 2023. The amount and timing of past distributions are not a guarantee of any future distributions or the amount thereof. The payment, timing and amount of any future distributions will be determined by SLRC’s board of directors.
XML 43 R30.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings Per Share (Tables)
6 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
Summary of Computation of Basic And Diluted Net
The following table sets forth the computation of basic and diluted net increase in net assets per share resulting from operations, pursuant to ASC
260-10,
for the three and six months ended June 30, 2023 and 2022:
 
    
Three months ended June 30,
    
Six months ended June 30,
 
    
2023
    
2022
    
2023
    
2022
 
Earnings (loss) per share (basic & diluted)
           
Numerator - net increase (decrease) in net assets resulting from operations:
   $ 18,995      $ (15,646    $ 25,819      $ (14,183
Denominator - weighted average shares:
     54,554,634        54,772,651        54,554,642        48,551,302  
Earnings (loss) per share:
   $ 0.35      ($ 0.29    $ 0.47      ($ 0.29
XML 44 R31.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value (Tables)
6 Months Ended
Jun. 30, 2023
Fair Value Disclosures [Abstract]  
Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following tables present the balances of assets measured at fair value on a recurring basis, as of June 30, 2023 and December 31, 2022:
Fair Value Measurements
As of June 30, 2023
 
    
Level 1
    
Level 2
    
Level 3
    
Measured at
Net Asset Value*
    
Total
 
Assets:
              
Senior Secured Loans
   $ —      $ —        $ 1,318,512      $ —        $ 1,318,512  
Equipment Financing
     —          —          271,333        —          271,333  
Preferred Equity
     —          —          3,801        —          3,801  
Common Equity/Equity Interests/Warrants
     358        —          566,427        20,995        587,780  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
   $ 358    $ —        $ 2,160,073      $ 20,995      $ 2,181,426  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Fair Value Measurements
As of December 31, 2022
 
    
Level 1
    
Level 2
    
Level 3
    
Measured at
Net Asset Value*
    
Total
 
Assets:
              
Senior Secured Loans
   $ —      $ —        $ 1,245,414      $ —        $ 1,245,414  
Equipment Financing
     —          —          265,952        —          265,952  
Preferred Equity
     —          —          3,801        —          3,801  
Common Equity/Equity Interests/Warrants
     483        —          561,600        9,426        571,509  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
   $ 483    $      $ 2,076,767      $ 9,426      $ 2,086,676  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
*
In accordance with ASC
820-10,
certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The portfolio investment in this category is SSLP. See Note 17 for more information on this investment, including its investment strategy and the Company’s unfunded equity commitment to SSLP. This investment is not redeemable by the Company absent an election by the members of the entity to liquidate all investments and distribute the proceeds to the members.
Summary of Changes in Fair Value of Level 3 Assets and Liabilities
The following tables provide a summary of the changes in fair value of Level 3 assets for the three and six months ended June 30, 2023, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at June 30, 2023:
Fair Value Measurements Using Level 3 Inputs
 
    
Senior Secured

Loans
   
Equipment

Financing
   
Preferred Equity
   
Common Equity/

Equity

Interests/

Warrants
   
Total
 
Fair value, March
 31, 2023
   $ 1,256,830     $ 258,044     $ 3,801     $ 559,919     $ 2,078,594  
Total gains or losses included in earnings:
          
Net realized gain
     333       —         —         —         333  
Net change in unrealized gain (loss)
     7,647       (138     (62     (11,998     (4,551
Purchase of investment securities
     166,766       22,739       62       18,506       208,073  
Proceeds from dispositions of investment securities
     (113,064     (9,312     —         —         (122,376
Transfers in/out of Level 3
     —         —         —         —         —    
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Fair value, June
 30, 2023
   $ 1,318,512     $ 271,333     $ 3,801     $ 566,427     $ 2,160,073  
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
          
Net change in unrealized gain (loss)
   $ 1,207     $ (138   $ (62   $ (11,998   $ (10,991
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
    
Senior Secured

Loans
   
Equipment

Financing
   
Preferred Equity
   
Common Equity/

Equity

Interests/

Warrants
   
Total
 
Fair value, December
 31, 2022
   $ 1,245,414     $ 265,952     $ 3,801     $ 561,600     $ 2,076,767  
Total gains or losses included in earnings:
          
Net realized gain
     1,157       —         —         —         1,157  
Net change in unrealized loss
     (5,823     (78     (123     (14,358     (20,382
Purchase of investment securities
     320,336       30,084       123       19,185       369,728  
Proceeds from dispositions of investment securities
     (242,572     (24,625     —         —         (267,197
Transfers in/out of Level 3
     —         —         —         —         —    
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Fair value, June
 30, 2023
   $ 1,318,512     $ 271,333     $ 3,801     $ 566,427     $ 2,160,073  
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
          
Net change in unrealized loss.
   $ (11,594   $ (78   $ (123   $ (14,358   $ (26,153
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
While the Company has not made an election to apply the fair value option of accounting to any of its current debt obligations, if the Company’s debt obligations were carried at fair value at June 30, 2023, the fair value of the Credit Facility, SPV Credit Facility, 2024 Unsecured Notes, 2025 Unsecured Notes, 2026 Unsecured Notes, 2027 Unsecured Notes and 2027 Series F Unsecured Notes would be $582,000, $167,200, $119,688, $80,325, $68,250, $43,125 and $118,463, respectively.
 
 
The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2022, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2022:
Fair Value Measurements Using Level 3 Inputs
 
    
Senior Secured

Loans
   
Equipment

Financing
   
Preferred Equity
   
Common Equity/

Equity

Interests/

Warrants
   
Total
 
Fair value, December
 31, 2021
   $ 939,690     $ 273,795     $ 5,630     $ 450,381     $ 1,669,496  
Total gains or losses included in earnings:
          
Net realized gain (loss)
     (36,244     —         —         6       (36,238
Net change in unrealized loss
     (8,065     (6,924     (706     (5,048     (20,743
Purchase of investment securities(1)
     796,389       84,168       266       116,272       997,095  
Proceeds from dispositions of investment securities
     (446,356     (85,087     (1,389     (11     (532,843
Transfers in/out of Level 3
     —         —         —         —         —    
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Fair value, December
 31, 2022
   $ 1,245,414     $ 265,952     $ 3,801     $ 561,600     $ 2,076,767  
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
          
Net change in unrealized loss
   $ (8,920   $ (6,924   $ (706   $ (5,048   $ (21,598
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
(1)
Includes positions acquired from SUNS as a result of the Mergers.
Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3)
The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the year ended December 31, 2022:
 
2022 Unsecured Notes
  
For the year ended
December 31, 2022
 
Beginning fair value
   $ 150,000  
Net realized (gain) loss
     —    
Net change in unrealized (gain) loss
     —    
Borrowings
     —    
Repayments
     (150,000
Transfers in/out of Level 3
     —    
  
 
 
 
Ending fair value
   $ —    
  
 
 
 
Summary of Quantitative Information about the Company's Level 3 Asset and Liability
Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of June 30, 2023 is summarized in the table below:
 
    
Asset or
Liability
  
Fair Value at

June 30, 2023
    
Principal Valuation
Technique/Methodology
  
Unobservable Input
  
Range (Weighted

Average)
Senior Secured Loans
   Asset   
$
$
1,306,129
12,383
 
 
  
Income Approach
Recovery Analysis
  
Market Yield
Recoverable Amount
   9.9% – 20.8% (12.8%)
N/A
Equipment Financing
   Asset    $
$
150,513
120,820
 
 
  
Income Approach
Market Multiple
(1)
  
Market Yield
Comparable Multiple
   8.5% – 9.7% (9.6%)
1.1x-1.4x (1.2x)
Preferred Equity
   Asset    $ 3,801      Income Approach    Market Yield    5.0% – 5.0% (5.0%)
Common Equity/Equity Interests/Warrants
   Asset    $
$
162,207
404,220
 
 
  
Market Multiple
(2)
Market Approach
  
Comparable Multiple
Return on Equity
   6.3x – 11.5x (8.7x)
4.7% – 32.4% (10.7%)
 
(1)
Includes $120,820 of investments valued using an implied multiple.
(2)
Includes $1,047 of investments valued using a Black-Scholes model and $161,160 of investments valued using an EBITDA multiple.
Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of December 31, 2022 is summarized in the table below:
 
    
Asset or
Liability
  
Fair Value at

December 31, 2022
    
Principal Valuation
Technique/Methodology
  
Unobservable Input
  
Range (Weighted

Average)
Senior Secured Loans
   Asset    $
$
1,212,842
32,572
 
 
  
Income Approach
Market Multiple
(1)
  
Market Yield
Comparable Multiple
   9.4% – 18.2% (12.0%)
0.1x-21.4x (12.4x)
Equipment Financing
   Asset    $
$
145,132
120,820
 
 
  
Income Approach
Market Multiple
(2)
  
Market Yield
Comparable Multiple
   8.5% – 9.7% (9.7%)
1.1x-1.4x (1.2x)
Preferred Equity
   Asset    $ 3,801      Income Approach    Market Yield    5.0% – 5.0% (5.0%)
Common Equity/Equity Interests/Warrants
   Asset    $
$
149,120
412,480
 
 
  
Market Multiple
(3)
Market Approach
  
Comparable Multiple
Return on Equity
   7.8x – 9.8x (8.8x)
6.6% – 35.2% (9.2%)
 
(1)
Investments are valued using a
sum-of-the
parts analysis, using expected revenue multiples for certain segments of the businesses and expected EBITDA multiples for certain segments of the businesses.
(2)
Includes $120,820 of investments valued using an implied multiple.
(3)
Includes $676 of investments valued using a Black-Scholes model and $148,444 of investments valued using an EBITDA multiple.
XML 45 R32.htm IDEA: XBRL DOCUMENT v3.23.2
Debt (Tables)
6 Months Ended
Jun. 30, 2023
Debt Instruments [Abstract]  
Schedule of Long-term Debt Instruments
Our debt obligations consisted of the following as of June 30, 2023 and December 31, 2022:
 
    
June 30, 2023
   
December 31, 2022
 
Facility
  
Face Amount
    
Carrying Value
   
Face Amount
    
Carrying Value
 
Credit Facility
   $ 582,000      $ 577,843
(1)
 
  $ 393,000      $ 388,254
(1)
 
SPV Credit Facility
     167,200        166,433
(2)
 
    155,200        154,302
(2)
 
2023 Unsecured Notes
     —          —         75,000        74,979
(3)
 
2024 Unsecured Notes
     125,000        124,563
(4)
 
    125,000        124,421
(4)
 
2025 Unsecured Notes
     85,000        84,696
(5)
 
    85,000        84,613
(5)
 
2026 Unsecured Notes
     75,000        74,556
(6)
 
    75,000        74,498
(6)
 
2027 Unsecured Notes
     50,000        49,959
(7)
 
    50,000        49,953
(7)
 
2027 Series F Unsecured Notes
     135,000        134,983
(8)
 
    135,000        134,978
(8)
 
    
 
 
    
 
 
   
 
 
    
 
 
 
     $ 1,219,200      $ 1,213,033     $ 1,093,200      $ 1,085,998  
    
 
 
    
 
 
   
 
 
    
 
 
 
 
(1)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $4,157 and $4,746 as of June 30, 2023 and December 31, 2022, respectively.
(2)
Carrying Value equals the Face Amount net of unamortized market discount of $767 and $898 as of June 30, 2023 and December 31, 2022, respectively.
(3)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $21 as of December 31, 2022.
(4)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $437 and $579 as of June 30, 2023 and December 31, 2022, respectively.
(5)
Carrying Value equals the Face Amount net of unamortized market discount of $304 and $387 as of June 30, 2023 and December 31, 2022, respectively.
(6)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $444 and $502 as of June 30, 2023 and December 31, 2022, respectively.
(7)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $41 and $47 as of June 30, 2023 and December 31, 2022, respectively.
(8)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $17 and $22 as of June 30, 2023 and December 31, 2022, respectively.
XML 46 R33.htm IDEA: XBRL DOCUMENT v3.23.2
Financial Highlights (Tables)
6 Months Ended
Jun. 30, 2023
Investment Company, Financial Highlights [Abstract]  
Schedule of financial highlights
The following is a schedule of financial highlights for the six months ended June 30, 2023 and 2022:
 
    
Six months ended

June 30, 2023
   
Six months ended

June 30, 2022
 
Per Share Data: (a)
    
Net asset value, beginning of year
   $ 18.33     $ 19.93  
  
 
 
   
 
 
 
Net investment income
     0.82       0.70  
Net realized and unrealized loss
     (0.35     (0.97 )* 
  
 
 
   
 
 
 
Net increase (decrease) in net assets resulting from operations
     0.47       (0.27
Issuance of common stock in connection with the Merger
     —         (0.31
Distributions to stockholders:
    
From distributable earnings
     (0.82     (0.82
From return of capital
     —         —    
  
 
 
   
 
 
 
Net asset value, end of period
   $ 17.98     $ 18.53  
  
 
 
   
 
 
 
Per share market value, end of period
   $ 14.27     $ 14.63  
Total Return (b)(c)
     8.41     (19.85 %) 
Net assets, end of period
   $ 980,805     $ 1,015,153  
Shares outstanding, end of period
     54,554,634       54,772,651  
Ratios to average net assets (c):
    
Net investment income
     4.52     3.53
  
 
 
   
 
 
 
Operating expenses
     3.22 %**      2.44 %** 
Interest and other credit facility expenses
     3.34     1.95
  
 
 
   
 
 
 
Total expenses
     6.56 %**      4.39 %** 
  
 
 
   
 
 
 
Average debt outstanding
   $ 1,125,576     $ 880,327  
Portfolio turnover ratio
     12.6     9.0
 
(a)
Calculated using the average shares outstanding method, except for the issuance of common stock in connection with the Merger, which reflects the actual amount per share for the applicable period.
(b)
Total return is based on the change in market price per share during the period and takes into account distributions, if any, reinvested in accordance with the dividend reinvestment plan. The market price per share as of December 31, 2022 and December 31, 2021 was $13.91 and $18.43, respectively. Total return does not include a sales load.
(c)
Not annualized for periods less than one year.
*
The amount shown may not correspond with the aggregate amount for the period as it includes the effect of the timing of the Merger.
**
The ratio of operating expenses to average net assets and the ratio of total expenses to average net assets is shown net of the performance-based incentive fee waiver (see note 3). For the six months ended June 30, 2023, the ratios of operating expenses to average net assets and total expenses to average net assets would be 3.24% and 6.58%, respectively, without the performance-based incentive fee waiver. For the six months ended June 30, 2022, the ratios of operating expenses to average net assets and total expenses to average net assets would be 2.58% and 4.53%, respectively, without the performance-based incentive fee waiver.
XML 47 R34.htm IDEA: XBRL DOCUMENT v3.23.2
Commitments and Contingencies (Tables)
6 Months Ended
Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
Summary of unfunded debt and equity commitments The total amount of these unfunded commitments as of June 30, 2023 and December 31, 2022 is $325,858 and $323,663, respectively, comprised of the following:
 
    
June 30, 2023
    
December 31, 2022
 
SLR Credit Solutions*
   $ 44,263      $ 44,263  
Outset Medical, Inc.
     35,084        35,084  
Apeel Technology, Inc.
     32,786        32,786  
CVAUSA Management, LLC
     22,882        —    
Human Interest, Inc
     20,104        20,104  
Glooko, Inc.
     17,868        17,868  
BDG Media, Inc.
     11,539        3,546  
ONS MSO, LLC
     10,961        —    
iCIMS, Inc
     10,800        11,435  
Arcutis Biotherapeutics, Inc.
     8,356        8,356  
Atria Wealth Solutions, Inc.
     8,215        8,215  
Copper River Seafoods, Inc.
     8,158        3,595  
Ardelyx, Inc
     7,752        7,752  
Cerapedics, Inc.
     6,735        6,735  
United Digestive MSO Parent, LLC
     5,259        —    
Luxury Asset Capital, LLC
     4,500        7,500  
Kaseya, Inc.
     3,768        3,936  
SPAR Marketing Force, Inc.
     3,733        1,338  
Urology Management Holdings, Inc.
     3,596        —    
One Touch Direct, LLC
     3,571        3,069  
Spectrum Pharmaceuticals, Inc.
     3,508        8,771  
SLR Equipment Finance
     3,500        1,000  
Meditrina, Inc.
     3,367        3,367  
Vertos Medical, Inc.
     3,325        —    
Foundation Consumer Brands, LLC
     3,009        3,009  
Vessco Midco Holdings, LLC
     2,677        3,892  
Kid Distro Holdings, LLC
     2,650        2,650  
RSC Acquisition, Inc.
     2,487        7,498  
Erie Construction
Mid-west,
LLC
     2,403        1,248  
Ultimate Baked Goods Midco LLC
     2,361        1,636  
Maurices, Incorporated
     2,353        4,314  
Basic Fun, Inc.
     2,150        2,675  
SCP Eye Care, LLC
     1,955        2,771  
DeepIntent, Inc.
     1,925        3,049  
SunMed Group Holdings, LLC
     1,621        843  
SLR Healthcare ABL*
     1,400        1,400  
American Teleconferencing Services, Ltd
     1,380        1,090  
Montefiore Nyack Hospital
     1,301        1,034  
Pinnacle Treatment Centers, Inc.
     1,286        1,745  
RxSense Holdings LLC
     1,250        1,250  
Bayside Opco, LLC
     1,247        —    
Enverus Holdings, Inc.
     1,233        1,004  
Tilley Distribution, Inc.
     1,158        525  
Pediatric Home Respiratory Services, LLC
     1,147        1,805  
GSM Acquisition Corp
     862        784  
Composite Technology Acquisition Corp
     825        1,537  
High Street Buyer, Inc.
     631        327  
CC SAG Holdings Corp. (Spectrum Automotive)
     548        20,670  
Orthopedic Care Partners Management, LLC
     536        1,620  
Southern Orthodontic Partners Management, LLC
     519        1,918  
ENS Holdings III Corp, LLC
     461        144  
World Insurance Associates, LLC
     295        17,117  
TAUC Management, LLC
     294        294  
AmeriMark Intermediate Holdings, LLC
     221        —    
All State Ag Parts, LLC
     43        135  
Plastics Management, LLC
     —          2,424  
Ivy Fertility Services, LLC
     —          1,571  
NAC Holdings Corporation
     —          1,479  
Peter C. Foy & Associates Insurance Services, LLC
     —          1,094  
BayMark Health Services, Inc.
     —          391  
  
 
 
    
 
 
 
Total Commitments
   $ 325,858      $ 323,663  
  
 
 
    
 
 
 
 
*
The Company controls the funding of the SLR Credit Solutions and SLR Healthcare ABL commitments and may cancel them at its discretion.
XML 48 R35.htm IDEA: XBRL DOCUMENT v3.23.2
Capital Share Transactions (Tables)
6 Months Ended
Jun. 30, 2023
Stockholders' Equity Note [Abstract]  
Schedule of Stockholders Equity
Transactions in capital stock were as follows:
 
    
Shares
    
Amount
 
    
Three months ended
June 30, 2023
    
Three months ended
June 30, 2022
    
Three months ended
June 30, 2023
    
Three months ended
June 30, 2022
 
Shares issued in connection with the Mergers
     —          12,511,825      $ —        $ 226,839  
    
 
 
    
 
 
    
 
 
    
 
 
 
Net increase
     —          12,511,825      $ —        $ 226,839  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
    
Shares
    
Amount
 
    
  Six months ended  
June 30, 2023
    
  Six months ended  
June 30, 2022
    
   Six months ended   
June 30, 2023
    
  Six months ended  
June 30, 2022
 
Shares issued in connection with the Mergers
     —          12,511,825      $ —        $ 226,839  
Shares repurchased
     (746      —        $ (10    $ —    
    
 
 
    
 
 
    
 
 
    
 
 
 
Net increase
     (746      12,511,825      $ (10    $ 226,839  
    
 
 
    
 
 
    
 
 
    
 
 
 
XML 49 R36.htm IDEA: XBRL DOCUMENT v3.23.2
SLR Senior Lending Program LLC (Tables)
6 Months Ended
Jun. 30, 2023
Investments, Debt and Equity Securities [Abstract]  
SSLP Portfolio
SSLP Portfolio as of June 30, 2023
 
Description
  
Industry
  
Spread
Above
Index
(1)
    
Floor
   
Interest
Rate
(2)
   
Maturity
Date
    
Par
Amount
    
Cost
    
Fair
Value
(3)
 
Aegis Toxicology Sciences Corporation
(4)
  
Health Care Providers & Services
     S+550        1.00     10.84     5/9/25      $ 2,974      $ 2,974      $ 2,974  
Atria Wealth Solutions, Inc.
(4)
  
Diversified Financial Services
     S+650        1.00     12.00     2/29/24        2,481        2,481        2,481  
BayMark Health Services, Inc.
(4)
  
Health Care Providers & Services
     S+500        1.00     10.50     6/11/27        4,054        4,054        4,054  
ENS Holdings III Corp. & ES Opco USA LLC
(4)
  
Trading Companies & Distributors
     S+475        1.00     10.09     12/31/25        1,091        1,091        1,091  
Fertility (ITC) Investment Holdco, LLC
(4)
  
Health Care Providers & Services
     S+650        1.00     11.63     1/3/29        5,985        5,809        5,985  
Foundation Consumer Brands, LLC
(4)
  
Personal Products
     S+625        1.00     11.47     2/12/27        6,863        6,863        6,863  
Higginbotham Insurance Agency, Inc.
(4)
  
Insurance
     S+525        1.00     10.45     11/25/26        1,293        1,293        1,293  
High Street Buyer, Inc.
(4)
  
Insurance
     S+600        0.75     11.39     4/16/28        2,481        2,481        2,481  
iCIMS, Inc.
(4)
  
Software
     S+725        0.75     12.38     8/18/28        3,029        2,991        3,029  
Kid Distro Holdings, LLC
(4)
  
Software
     S+575        1.00     11.14     10/1/27        5,970        5,970        5,970  
ONS MSO, LLC
(4)
  
Health Care Providers & Services
     S+625        1.00     11.32     7/8/25        5,951        5,774        5,773  
PhyNet Dermatology LLC
(4)
  
Health Care Providers & Services
     S+625        1.00     11.45     8/16/24        2,481        2,481        2,481  
Pinnacle Treatment Centers, Inc.
(4)
  
Health Care Providers & Services
     S+675        1.00     12.10     1/2/26        2,487        2,487        2,487  
Plastics Management, LLC
(4)
  
Health Care Providers & Services
     S+500        1.00     10.44     8/18/27        5,666        5,481        5,666  
RQM+ Corp.
(4)
  
Life Sciences Tools & Services
     S+575        1.00     11.51     8/12/26        5,985        5,985        5,985  
RSC Acquisition, Inc.
(4)
  
Insurance
     S+550        0.75     10.64     11/1/26        5,045        5,045        5,045  
RxSense Holdings LLC
(4)
  
Diversified Consumer Services
     S+500        1.00     10.15     3/13/26        2,985        2,985        2,985  
SunMed Group Holdings, LLC
(4)
  
Health Care Equipment & Supplies
     S+575        0.75     11.09     6/16/28        2,487        2,487        2,487  
Tilley Distribution, Inc.
(4)
  
Trading Companies & Distributors
     S+550        1.00     11.39     12/31/26        5,978        5,978        5,978  
Urology Management Holdings, Inc.
(4)
  
Health Care Providers & Services
     S+625        1.00     11.36     6/15/26        2,471        2,404        2,397  
                                                    
 
 
    
 
 
 
                                                     $ 77,114      $ 77,505  
                                                    
 
 
    
 
 
 
 
(1)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR. These instruments are typically subject to a SOFR floor.
(2)
Floating rate debt investments typically bear interest at a rate determined by reference to the SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of June 30, 2023.
(3)
Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
(4)
The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
 
 
SSLP Portfolio as of December 31, 2022
 
Description
  
Industry
  
Spread
Above
Index
(1)
    
Floor
   
Interest
Rate
(2)
   
Maturity
Date
    
Par
Amount
    
Cost
    
Fair
Value
(3)
 
Atria Wealth Solutions, Inc.
(4)
  
Diversified Financial Services
     S+600        1.00     10.84     2/29/24      $ 2,494      $ 2,494      $ 2,494  
BayMark Health Services, Inc.
(4)
  
Health Care Providers & Services
     L+500        1.00     9.73     6/11/27        2,992        2,992        2,992  
ENS Holdings III Corp. & ES Opco USA LLC
(4)
  
Trading Companies & Distributors
     L+475        1.00     9.43     12/31/25        1,097        1,097        1,097  
Foundation Consumer Brands, LLC
(4)
  
Personal Products
     L+550        1.00     10.15     2/12/27        2,963        2,963        2,963  
High Street Buyer, Inc.
(4)
  
Insurance
     L+600        0.75     10.73     4/16/28        2,494        2,494        2,494  
Ivy Fertility Services, LLC
(4)
  
Health Care Providers & Services
     L+625        1.00     10.39     2/25/26        3,000        3,000        3,030  
Kid Distro Holdings, LLC
(4)
  
Software
     L+575        1.00     10.48     10/1/27        2,992        2,992        2,992  
                                                    
 
 
    
 
 
 
                                                     $ 18,032      $ 18,062  
                                                    
 
 
    
 
 
 
 
(1)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or SOFR. These instruments are typically subject to a LIBOR or SOFR floor.
(2)
Floating rate debt investments typically bear interest at a rate determined by reference to either the LIBOR (“L”) or SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2022.
(3)
Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
(4)
The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
Summary financial information for SSLP
Below is certain summarized financial information for SSLP as of June 30, 2023 and December 31, 2022 and for the three and six months ended June 30, 2023 and for the period December 1, 2022 (commencement of operations) through December 31, 2022:
 

 
  
June 30, 2023
 
  
December 31,

2022
 
Selected Balance Sheet Information for SSLP:
                 
Investments at fair value (cost $77,114 and $18,032, respectively)
   $ 77,505      $ 18,062  
Cash and other assets
     1,906        1,043  
    
 
 
    
 
 
 
Total assets
   $ 79,411      $ 19,105  
    
 
 
    
 
 
 
Debt outstanding
   $ 36,944      $ —    
Interest payable and other credit facility related expenses
     345        165  
Accrued expenses and other payables
     131        89  
    
 
 
    
 
 
 
Total liabilities
   $ 37,420      $ 254  
    
 
 
    
 
 
 
Members’ equity
   $ 41,991      $ 18,851  
    
 
 
    
 
 
 
Total liabilities and members’ equity
   $ 79,411      $ 19,105  
    
 
 
    
 
 
 
 
 

 
  
For the three

months ended June

30, 2023
 
  
For the six
months ended June

30, 2023
 
  
For the period
December 1, 2022
(commencement
of operations) to
December 31,
2022
 
Selected Income Statement Information
for SSLP:
                          
Interest income
   $ 1,605      $ 2,614      $ 152  
    
 
 
    
 
 
    
 
 
 
Service fees*
     38        57      $ 4  
Interest and other credit facility expenses
     1,447        2,252        166  
Organizational costs
     —          —          73  
Other general and administrative expenses
     19        57        88  
    
 
 
    
 
 
    
 
 
 
Total expenses
     1,504        2,366        331  
    
 
 
    
 
 
    
 
 
 
Net investment income (loss)
   $ 101      $ 248      $ (179
    
 
 
    
 
 
    
 
 
 
Realized gain on investments
     —          30        —    
Net change in unrealized gain on investments
     321        361        30  
    
 
 
    
 
 
    
 
 
 
Net realized and unrealized gain on investments
   $ 321      $ 391        30  
    
 
 
    
 
 
    
 
 
 
Net income (loss)
   $ 422      $ 639      $ (149
    
 
 
    
 
 
    
 
 
 
 
*
Service fees are included within the Company’s Consolidated Statements of Operations as other income.
XML 50 R37.htm IDEA: XBRL DOCUMENT v3.23.2
Organization - Additional Information (Details) - $ / shares
3 Months Ended 6 Months Ended
Apr. 01, 2022
Feb. 10, 2010
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Stock issued during period, shares     0 12,511,825 0 12,511,825  
Shares issued, price per share     $ 14.02   $ 14.02   $ 13.98
IPO [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Stock issued during period, shares   5,680,000          
Over-Allotment Option [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Share price   $ 18.5          
Private Placement [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Stock issued during period, shares   600,000          
Share price   $ 18.5          
Common Stock [Member] | SUNS Company Merger [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Shares issued, price per share $ 0.7796            
Stock issued during period, shares, acquisitions 12,511,825            
XML 51 R38.htm IDEA: XBRL DOCUMENT v3.23.2
Significant Accounting Policies - Additional Information (Details)
6 Months Ended
Jun. 30, 2023
Property, Plant and Equipment [Line Items]  
Percentage of excise tax 4.00%
Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Debt instrument term 60 days
Restricted investment term 90 days
Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Debt instrument term 60 days
Restricted investment term 30 days
XML 52 R39.htm IDEA: XBRL DOCUMENT v3.23.2
Agreements - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Agreement [Line Items]        
Management fees $ 7,878 $ 6,913 $ 15,584 $ 14,129
Administrative fees expense 1,480 1,369 2,988 2,552
Performance Based Incentive Fees Waiver 125 1,358 $ 235 1,358
Advisory Agreement [Member]        
Agreement [Line Items]        
Pre-incentive fee net investment income Quarter hurdle rate     1.75%  
Pre-incentive fee net investment income Annual hurdle rate     (7.00%)  
Percentage of cumulative realized capital gain loss     20.00%  
Percentage of cumulative net realized gain and unrealized capital appreciation     20.00%  
Management fees 7,878 6,913 $ 15,584 14,129
Performance based incentive fees 5,638 4,734 11,147 4,734
Administrative fees expense $ 1,480 $ 1,369 $ 2,988 $ 2,552
Advisory Agreement [Member] | Minimum [Member]        
Agreement [Line Items]        
Percentage of gross assets     1.00%  
Percentage of total net assets     200.00%  
Percentage of pre-incentive fee net investment income     100.00%  
Advisory Agreement [Member] | Maximum [Member]        
Agreement [Line Items]        
Percentage of gross assets     1.50%  
Percentage of total net assets     200.00%  
Percentage of pre-incentive fee net investment income     20.00%  
XML 53 R40.htm IDEA: XBRL DOCUMENT v3.23.2
Net Asset Value Per Share - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Net Asset Value Per Share [Abstract]            
Net assets $ 980,805 $ 984,178 $ 999,731 $ 1,015,153 $ 826,417 $ 842,281
Net asset value per share $ 17.98   $ 18.33 $ 18.53   $ 19.93
XML 54 R41.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings Per Share - Summary of Computation of Basic and Diluted Net (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Earnings per share (basic & diluted)        
Numerator - net increase in net assets resulting from operations: $ 18,995 $ (15,646) $ 25,819 $ (14,183)
Denominator - weighted average shares, Basic 54,554,634 54,772,651 54,554,642 48,551,302
Denominator - weighted average shares, Diluted 54,554,634 54,772,651 54,554,642 48,551,302
Earnings per share, Basic $ 0.35 $ (0.29) $ 0.47 $ (0.29)
Earnings per share, Diluted $ 0.35 $ (0.29) $ 0.47 $ (0.29)
XML 55 R42.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - Recurring Fair Value [Member] - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets $ 2,181,426 $ 2,086,676
Measured at Net Asset Value [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets [1] 20,995 9,426
Senior Secured Loans [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 1,318,512 1,245,414
Senior Secured Loans [Member] | Measured at Net Asset Value [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets [1] 0 0
Equipment Financing [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 271,333 265,952
Equipment Financing [Member] | Measured at Net Asset Value [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets [1] 0 0
Preferred Equity [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 3,801 3,801
Preferred Equity [Member] | Measured at Net Asset Value [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets [1] 0 0
Common Equity/Equity Interests/Warrants [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 587,780 571,509
Common Equity/Equity Interests/Warrants [Member] | Measured at Net Asset Value [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets [1] 20,995 9,426
Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 358 483
Level 1 [Member] | Senior Secured Loans [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Level 1 [Member] | Equipment Financing [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Level 1 [Member] | Preferred Equity [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Level 1 [Member] | Common Equity/Equity Interests/Warrants [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 358 483
Level 2 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Level 2 [Member] | Senior Secured Loans [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Level 2 [Member] | Equipment Financing [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Level 2 [Member] | Preferred Equity [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Level 2 [Member] | Common Equity/Equity Interests/Warrants [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Level 3 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 2,160,073 2,076,767
Level 3 [Member] | Senior Secured Loans [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 1,318,512 1,245,414
Level 3 [Member] | Equipment Financing [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 271,333 265,952
Level 3 [Member] | Preferred Equity [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 3,801 3,801
Level 3 [Member] | Common Equity/Equity Interests/Warrants [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets $ 566,427 $ 561,600
[1] In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The portfolio investment in this category is SSLP. See Note 17 for more information on this investment, including its investment strategy and the Company’s unfunded equity commitment to SSLP. This investment is not redeemable by the Company absent an election by the members of the entity to liquidate all investments and distribute the proceeds to the members.
XML 56 R43.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value - Summary of Changes in Fair Value of Level 3 Assets and Liabilities (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2023
Dec. 31, 2022
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Opening balance $ 2,078,594 $ 2,076,767 $ 1,669,496
Net realized gain (loss) 333 1,157 (36,238)
Net change in unrealized gain (loss) (4,551) (20,382) $ (20,743)
Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]     Unrealized Gain (Loss) on Investments
Purchase of investment securities 208,073 369,728 $ 997,095
Proceeds from dispositions of investment securities (122,376) (267,197) (532,843)
Transfers in/out of Level 3 0 0 0
Closing balance 2,160,073 2,160,073 2,076,767
Net change in unrealized gain (loss) (10,991) (26,153) $ (21,598)
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]     Unrealized Gain (Loss) on Investments
Senior Secured Loans [Member]      
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Opening balance 1,256,830 1,245,414 $ 939,690
Net realized gain (loss) 333 1,157 (36,244)
Net change in unrealized gain (loss) 7,647 (5,823) (8,065)
Purchase of investment securities 166,766 320,336 796,389
Proceeds from dispositions of investment securities (113,064) (242,572) (446,356)
Transfers in/out of Level 3 0 0 0
Closing balance 1,318,512 1,318,512 1,245,414
Net change in unrealized gain (loss) 1,207 (11,594) (8,920)
Equipment Financing [Member]      
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Opening balance 258,044 265,952 273,795
Net realized gain (loss) 0 0 0
Net change in unrealized gain (loss) (138) (78) (6,924)
Purchase of investment securities 22,739 30,084 84,168
Proceeds from dispositions of investment securities (9,312) (24,625) (85,087)
Transfers in/out of Level 3 0 0 0
Closing balance 271,333 271,333 265,952
Net change in unrealized gain (loss) (138) (78) (6,924)
Preferred Equity [Member]      
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Opening balance 3,801 3,801 5,630
Net realized gain (loss) 0 0 0
Net change in unrealized gain (loss) (62) (123) (706)
Purchase of investment securities 62 123 266
Proceeds from dispositions of investment securities 0 0 (1,389)
Transfers in/out of Level 3 0 0 0
Closing balance 3,801 3,801 3,801
Net change in unrealized gain (loss) (62) (123) (706)
Common Equity/Equity Interests/Warrants [Member]      
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Opening balance 559,919 561,600 450,381
Net realized gain (loss) 0 0 6
Net change in unrealized gain (loss) (11,998) (14,358) (5,048)
Purchase of investment securities 18,506 19,185 116,272
Proceeds from dispositions of investment securities 0 0 (11)
Transfers in/out of Level 3 0 0 0
Closing balance 566,427 566,427 561,600
Net change in unrealized gain (loss) $ (11,998) $ (14,358) $ (5,048)
XML 57 R44.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Details) - 2022 Unsecured Notes [Member]
$ in Thousands
12 Months Ended
Dec. 31, 2022
USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Beginning fair value $ 150,000
Net realized (gain) loss 0
Net change in unrealized (gain) loss 0
Borrowings 0
Repayments (150,000)
Transfers in/out of Level 3 0
Ending fair value $ 0
XML 58 R45.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Parenthetical) (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
SLRCTerm Loan And Credit Facility [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Debt Instrument, Fair Value Disclosure $ 582,000 $ 393,000
SPV Credit Facility [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Debt Instrument, Fair Value Disclosure 167,200 155,200
2023 Unsecured Notes [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Debt Instrument, Fair Value Disclosure   75,000
2024 Unsecured Notes [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Debt Instrument, Fair Value Disclosure 119,688 118,750
2025 Unsecured Notes [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Debt Instrument, Fair Value Disclosure 80,325 79,688
2026 Unsecured Notes [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Debt Instrument, Fair Value Disclosure 68,250 68,250
2027 Unsecured Notes [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Debt Instrument, Fair Value Disclosure 43,125 42,875
2027 Series F Unsecured Notes [Member]    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Debt Instrument, Fair Value Disclosure $ 118,463 $ 118,125
XML 59 R46.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Details) - Level 3 [Member] - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Senior Secured Loans [Member] | Income Approach [Member] | Market Yield [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Assets $ 1,306,129 $ 1,212,842
Principal Valuation Technique/Methodology Income Approach Income Approach
Unobservable Input Market Yield Market Yield
Senior Secured Loans [Member] | Market Multiple [Member] | Comparable Multiple [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Assets   $ 32,572
Principal Valuation Technique/Methodology   Market Multiple
Unobservable Input   Comparable Multiple
Senior Secured Loans [Member] | Recovery Analysis [Member] | Recoverable Amount [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Assets $ 12,383  
Principal Valuation Technique/Methodology Recovery Analysis  
Unobservable Input Recoverable Amount  
Equipment Financing [Member] | Income Approach [Member] | Market Yield [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Assets $ 150,513 $ 145,132
Principal Valuation Technique/Methodology Income Approach Income Approach
Unobservable Input Market Yield Market Yield
Equipment Financing [Member] | Market Multiple [Member] | Comparable Multiple [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Assets $ 120,820 $ 120,820
Principal Valuation Technique/Methodology Market Multiple Market Multiple
Unobservable Input Comparable Multiple Comparable Multiple
Preferred Equity [Member] | Income Approach [Member] | Market Yield [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Assets $ 3,801 $ 3,801
Principal Valuation Technique/Methodology Income Approach Income Approach
Unobservable Input Market Yield Market Yield
Common Equity/Equity Interests/Warrants [Member] | Market Multiple [Member] | Comparable Multiple [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Assets $ 162,207 $ 149,120
Principal Valuation Technique/Methodology Market Multiple Market Multiple
Unobservable Input Comparable Multiple Comparable Multiple
Common Equity/Equity Interests/Warrants [Member] | Market Approach [Member] | Return on Equity [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Assets $ 404,220 $ 412,480
Principal Valuation Technique/Methodology Market Approach Market Approach
Unobservable Input Return on Equity Return on Equity
XML 60 R47.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Parenthetical) (Details)
$ in Thousands
Jun. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
Measurement Input, EBITDA Multiple [Member] | Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value $ 161,160 $ 148,444
Black Scholes Pricing Model [Member] | Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value 1,047 676
Senior Secured Loans [Member] | Income Approach [Member] | Market Yield [Member] | Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value $ 1,306,129 $ 1,212,842
Senior Secured Loans [Member] | Income Approach [Member] | Market Yield [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 9.9 9.4
Senior Secured Loans [Member] | Income Approach [Member] | Market Yield [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 20.8 18.2
Senior Secured Loans [Member] | Income Approach [Member] | Market Yield [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 12.8 12
Senior Secured Loans [Member] | Market Multiple [Member] | Comparable Multiple [Member] | Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value   $ 32,572
Senior Secured Loans [Member] | Market Multiple [Member] | Comparable Multiple [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input   0.1
Senior Secured Loans [Member] | Market Multiple [Member] | Comparable Multiple [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input   21.4
Senior Secured Loans [Member] | Market Multiple [Member] | Comparable Multiple [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input   12.4
Equipment Financing [Member] | Income Approach [Member] | Market Yield [Member] | Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value $ 150,513 $ 145,132
Equipment Financing [Member] | Income Approach [Member] | Market Yield [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 8.5 8.5
Equipment Financing [Member] | Income Approach [Member] | Market Yield [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 9.7 9.7
Equipment Financing [Member] | Income Approach [Member] | Market Yield [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 9.6 9.7
Equipment Financing [Member] | Market Multiple [Member] | Comparable Multiple [Member] | Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value $ 120,820 $ 120,820
Equipment Financing [Member] | Market Multiple [Member] | Comparable Multiple [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 1.1 1.1
Equipment Financing [Member] | Market Multiple [Member] | Comparable Multiple [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 1.4 1.4
Equipment Financing [Member] | Market Multiple [Member] | Comparable Multiple [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 1.2 1.2
Preferred Equity [Member] | Income Approach [Member] | Market Yield [Member] | Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value $ 3,801 $ 3,801
Preferred Equity [Member] | Income Approach [Member] | Market Yield [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 5 5
Preferred Equity [Member] | Income Approach [Member] | Market Yield [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 5 5
Preferred Equity [Member] | Income Approach [Member] | Market Yield [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 5 5
Common Equity/Equity Interests/Warrants [Member] | Market Multiple [Member] | Comparable Multiple [Member] | Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value $ 162,207 $ 149,120
Common Equity/Equity Interests/Warrants [Member] | Market Multiple [Member] | Comparable Multiple [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 6.3 7.8
Common Equity/Equity Interests/Warrants [Member] | Market Multiple [Member] | Comparable Multiple [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 11.5 9.8
Common Equity/Equity Interests/Warrants [Member] | Market Multiple [Member] | Comparable Multiple [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 8.7 8.8
Common Equity/Equity Interests/Warrants [Member] | Market Approach [Member] | Return on Equity [Member] | Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value $ 404,220 $ 412,480
Common Equity/Equity Interests/Warrants [Member] | Market Approach [Member] | Return on Equity [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 4.7 6.6
Common Equity/Equity Interests/Warrants [Member] | Market Approach [Member] | Return on Equity [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 32.4 35.2
Common Equity/Equity Interests/Warrants [Member] | Market Approach [Member] | Return on Equity [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 10.7 9.2
XML 61 R48.htm IDEA: XBRL DOCUMENT v3.23.2
Debt - Schedule of Long-term Debt Instruments (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2021
Debt Instrument [Line Items]    
Face Amount $ 1,219,200 $ 1,093,200
Total 1,213,033 1,085,998
Credit Facility [Member]    
Debt Instrument [Line Items]    
Face Amount 582,000 393,000
Credit Facility, Carrying Value 577,843 388,254
SPV Credit Facility [Member]    
Debt Instrument [Line Items]    
Face Amount 167,200 155,200
SPV Credit Facility, Carrying Value 166,433 154,302
2023 Unsecured Notes [Member]    
Debt Instrument [Line Items]    
Face Amount 0 75,000
Unsecured Debt 0 74,979
2024 Unsecured Notes [Member]    
Debt Instrument [Line Items]    
Face Amount 125,000 125,000
Unsecured Debt 124,563 124,421
2025 Unsecured Notes [Member]    
Debt Instrument [Line Items]    
Face Amount 85,000 85,000
Unsecured Debt 84,696 84,613
2026 Unsecured Notes [Member]    
Debt Instrument [Line Items]    
Face Amount 75,000 75,000
Unsecured Debt 74,556 74,498
2027 Unsecured Notes [Member]    
Debt Instrument [Line Items]    
Face Amount 50,000 50,000
Unsecured Debt 49,959 49,953
2027 Series F Unsecured Notes [Member]    
Debt Instrument [Line Items]    
Face Amount 135,000 135,000
Unsecured Debt $ 134,983 $ 134,978
XML 62 R49.htm IDEA: XBRL DOCUMENT v3.23.2
Debt - Schedule of Long-term Debt Instruments (Parenthetical) (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Credit Facility [Member]    
Debt Instrument [Line Items]    
Long term debt unamortized debt issuance costs $ 4,157 $ 4,746
SPV Credit Facility [Member]    
Debt Instrument [Line Items]    
Debt Instrument, Unamortized Discount 767 898
2022 Tranche C Notes [Member]    
Debt Instrument [Line Items]    
Long term debt unamortized debt issuance costs   21
2023 Unsecured Notes [Member]    
Debt Instrument [Line Items]    
Long term debt unamortized debt issuance costs 437 579
2024 Unsecured Notes [Member]    
Debt Instrument [Line Items]    
Long term debt unamortized debt issuance costs 304 387
2025 Unsecured Notes [Member]    
Debt Instrument [Line Items]    
Long term debt unamortized debt issuance costs 444 502
2026 Unsecured Notes [Member]    
Debt Instrument [Line Items]    
Long term debt unamortized debt issuance costs 41 47
2027 Unsecured Notes [Member]    
Debt Instrument [Line Items]    
Long term debt unamortized debt issuance costs $ 17 $ 22
XML 63 R50.htm IDEA: XBRL DOCUMENT v3.23.2
Debt - Additional Information (Details) - USD ($)
4 Months Ended 6 Months Ended 12 Months Ended 49 Months Ended
Dec. 31, 2021
Dec. 18, 2019
Dec. 31, 2011
Jun. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 12, 2022
Apr. 01, 2022
Jan. 06, 2022
Dec. 28, 2021
Sep. 14, 2021
Nov. 22, 2017
Aug. 26, 2011
Debt Instrument [Line Items]                          
Debt instrument face value       $ 1,219,200,000 $ 1,093,200,000                
Debt instrument maturity date   Dec. 15, 2024                      
Long term debt weighted average interest over a period of time       5.60% 4.09%                
Long term debt maximum amount borrowed during the period       $ 1,219,200,000 $ 1,164,200,000                
Credit Facility [Member]                          
Debt Instrument [Line Items]                          
Debt instrument face value       $ 85,000,000                  
Long term debt term       5 years                  
Debt instrument maturity date       Mar. 31, 2025                  
Debt instrument payment terms       Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30                  
Credit Facility One [Member]                          
Debt Instrument [Line Items]                          
Debt instrument face value               $ 85,000,000          
Debt instrument stated interest rate percentage       3.90%                  
Line of credit $ 154,302,000     $ 166,433,000   $ 154,302,000              
Two Thousand And Twenty Seven Series F Unsecured Notes [Member]                          
Debt Instrument [Line Items]                          
Debt instrument face value       $ 135,000,000         $ 135,000,000        
Debt instrument maturity date       Jan. 06, 2027                  
Debt instrument payment terms       Interest on the 2027 Series F Unsecured Notes is due semi-annually on January 6 and July 6                  
Debt instrument stated interest rate percentage       3.33%                  
Two Thousand And Twenty Four Unsecured Notes [Member]                          
Debt Instrument [Line Items]                          
Debt instrument face value   $ 125,000,000   $ 125,000,000 125,000,000                
Debt instrument payment terms       Interest on the 2024 Unsecured Notes is due semi-annually on June 15 and December 15                  
Debt instrument stated interest rate percentage       4.20%                  
Two Thousand And Twenty Six Unsecured Notes [Member]                          
Debt Instrument [Line Items]                          
Debt instrument face value   $ 75,000,000   $ 75,000,000 $ 75,000,000                
Debt instrument stated interest rate percentage       4.375% 4.375%                
Two Thousand And Twenty Two Tranche C Notes [Member]                          
Debt Instrument [Line Items]                          
Debt instrument maturity date   Dec. 15, 2026                      
Two Thousand And Twenty Three Unsecured Notes [Member]                          
Debt Instrument [Line Items]                          
Debt instrument face value       $ 75,000,000     $ 75,000,000         $ 75,000,000  
Debt instrument maturity date           Jan. 20, 2023              
Debt instrument payment terms           semi-annually on January 20 and July 20              
Debt instrument stated interest rate percentage       4.50% 4.50%                
Proceeds from net debt           $ 73,846,000              
Term Loan And Credit Facility [Member]                          
Debt Instrument [Line Items]                          
Line of credit and term loan outstanding $ 388,254,000     $ 577,843,000   $ 388,254,000              
Term Loan And Credit Facility [Member] | SPV LLC [Member] | Citi Bank NA [Member]                          
Debt Instrument [Line Items]                          
Debt instrument maturity date       Jun. 01, 2026                  
Line of credit and term loan outstanding       $ 167,200,000                  
Line of credit maximum borrowing capacity and debt instrument face value                   $ 800,000,000      
Term Loan And Credit Facility [Member] | SPV LLC [Member] | Citi Bank NA [Member] | Line of Credit [Member]                          
Debt Instrument [Line Items]                          
Line of credit facility, maximum borrowing capacity                   625,000,000      
Other long term debt       482,000,000                  
Term Loan And Credit Facility [Member] | SPV LLC [Member] | Citi Bank NA [Member] | Term Loan [Member]                          
Debt Instrument [Line Items]                          
Debt instrument face value                   $ 100,000,000      
Line of credit       100,000,000                  
Term Loan And Credit Facility [Member] | Credit Facility [Member] | Citi Bank NA [Member]                          
Debt Instrument [Line Items]                          
Line of credit and term loan outstanding       $ 582,000,000                  
Term Loan And Credit Facility [Member] | Maximum [Member] | SPV LLC [Member] | Citi Bank NA [Member]                          
Debt Instrument [Line Items]                          
Line of credit facility, maximum borrowing capacity                         $ 600,000,000
Debt instrument variable interest rate spread (1.00%)                        
Term Loan And Credit Facility [Member] | Maximum [Member] | London Interbank Offered Rate [Member] | Citi Bank NA [Member]                          
Debt Instrument [Line Items]                          
Debt instrument variable interest rate spread       (2.00%)                  
Term Loan And Credit Facility [Member] | Maximum [Member] | Secured Overnight Financing Rate [Member] | Citi Bank NA [Member]                          
Debt Instrument [Line Items]                          
Debt instrument variable interest rate spread     (2.50%)                    
Term Loan And Credit Facility [Member] | Minimum [Member] | SPV LLC [Member] | Citi Bank NA [Member]                          
Debt Instrument [Line Items]                          
Line of credit facility, maximum borrowing capacity                         $ 225,000,000
Debt instrument variable interest rate spread 0.75%     1.75%                  
Term Loan And Credit Facility [Member] | Minimum [Member] | Secured Overnight Financing Rate [Member] | Citi Bank NA [Member]                          
Debt Instrument [Line Items]                          
Debt instrument variable interest rate spread     2.00%                    
Two Thousand And Twenty Seven Unsecured Notes [Member]                          
Debt Instrument [Line Items]                          
Debt instrument face value       $ 50,000,000             $ 50,000,000    
Debt instrument stated interest rate percentage       2.95%             2.95%    
XML 64 R51.htm IDEA: XBRL DOCUMENT v3.23.2
Financial Highlights - Schedule of Financial Highlights (Details) - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Mar. 31, 2023
Dec. 31, 2022
Mar. 31, 2022
Dec. 31, 2021
Per Share Data:            
Net asset value, beginning of year $ 18.33 $ 19.93        
Net investment income 0.82 0.7        
Net realized and unrealized loss (0.35) (0.97)        
Net increase (decrease) in net assets resulting from operations 0.47 (0.27)        
Issuance of common stock in connection with the Merger   (0.31)        
From distributable earnings (0.82) (0.82)        
From return of capital 0 0        
Net asset value, end of period 17.98 18.53        
Per share market value, end of period $ 14.27 $ 14.63   $ 13.91   $ 18.43
Total Return 8.41% (19.85%)        
Net assets, end of period $ 980,805 $ 1,015,153 $ 984,178 $ 999,731 $ 826,417 $ 842,281
Shares outstanding, end of period 54,554,634 54,772,651   54,555,380    
Ratios to average net assets:            
Net investment income 4.52% 3.53%        
Operating expenses 3.22% 2.44%        
Interest and other credit facility expenses 3.34% 1.95%        
Total expenses 6.56% 4.39%        
Average debt outstanding $ 1,125,576 $ 880,327        
Portfolio turnover ratio 12.60% 9.00%        
XML 65 R52.htm IDEA: XBRL DOCUMENT v3.23.2
Financial Highlights - Schedule of Financial Highlights (Parentheticals) (Details) - $ / shares
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Investment Company, Financial Highlights [Abstract]        
Fair value of common stock per share $ 14.27 $ 14.63 $ 13.91 $ 18.43
Investment company, expense ratio excluding incentive fee 6.58% 4.53%    
Investment Company Operating Expense Ratio Excluding Incentive Fee 3.24% 2.58%    
XML 66 R53.htm IDEA: XBRL DOCUMENT v3.23.2
SLR Credit Solutions - Additional Information (Details)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jul. 28, 2016
USD ($)
Dec. 28, 2012
USD ($)
Nov. 30, 2012
USD ($)
loans
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Jun. 30, 2023
USD ($)
fund
issuers
Jun. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
fund
issuers
Dec. 12, 2022
USD ($)
Dec. 31, 2021
USD ($)
Number of issuers in business credit | issuers           101   108    
Assets       $ 2,553,230   $ 2,553,230   $ 2,537,695    
Non-recourse debt       1,213,033   1,213,033       $ 1,085,998
Revolving Credit Facility [Member]                    
Line of credit facility, maximum borrowing capacity   $ 275,000                
Crystal Financial [Member]                    
Line of credit facility, maximum borrowing capacity     $ 400,000              
SLR Business Credit Facility [Member]                    
Line of credit facility, maximum borrowing capacity       30,000   $ 30,000   $ 33,420    
Business combination, consideration transferred $ 5,737                  
Number of funded commitments | fund           29   29    
Number of issuers in business credit | issuers           25   25    
Long-term line of credit       425,019   $ 425,019     $ 439,484  
Assets       443,024   443,024     $ 460,683  
Line of credit facility average outstanding amount           17,001   $ 17,579    
Net income (loss)       6,767 $ 1,880 2,905 $ 4,660      
Gross income       13,897 $ 6,882 28,452 $ 13,575      
Non-recourse debt       $ 216,947   216,947   $ 224,325    
SLR Business Credit Facility [Member] | Revolving Credit Facility [Member]                    
Line of credit facility commitments amount           $ 300,000        
SLR Business Credit Facility [Member] | Crystal Financial [Member]                    
Payment to acquire business   $ 275,000                
Equity method investment, ownership percentage 2.00% 98.00%                
Number of loans in business credit | loans     23              
SLR Business Credit Facility [Member] | Crystal Capital Financial Holdings LLC [Member]                    
Equity method investment, ownership percentage 100.00%                  
XML 67 R54.htm IDEA: XBRL DOCUMENT v3.23.2
Commitments and Contingencies - Additional Information (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Other Commitments [Line Items]    
Other Commitment $ 325,858 $ 323,663
XML 68 R55.htm IDEA: XBRL DOCUMENT v3.23.2
Commitments and Contingencies - Summary of Unfunded Debt and Equity Commitments (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Other Commitments [Line Items]    
Other Commitment $ 325,858 $ 323,663
Unfunded Debt and Equity Commitments [Member]    
Other Commitments [Line Items]    
Other Commitment 325,858 323,663
Unfunded Debt and Equity Commitments [Member] | SLR Credit Solutions [Member]    
Other Commitments [Line Items]    
Other Commitment [1] 44,263 44,263
Unfunded Debt and Equity Commitments [Member] | Outset Medical, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 35,084 35,084
Unfunded Debt and Equity Commitments [Member] | Apeel Technology, Inc [Member]    
Other Commitments [Line Items]    
Other Commitment 32,786 32,786
Unfunded Debt and Equity Commitments [Member] | CVAUSA Management, LLC,, [Member]    
Other Commitments [Line Items]    
Other Commitment 22,882 0
Unfunded Debt and Equity Commitments [Member] | Human Interest, Inc [Member]    
Other Commitments [Line Items]    
Other Commitment 20,104 20,104
Unfunded Debt and Equity Commitments [Member] | Glooko, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 17,868 17,868
Unfunded Debt and Equity Commitments [Member] | BDG Media, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 11,539 3,546
Unfunded Debt and Equity Commitments [Member] | ONS MSO, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 10,961 0
Unfunded Debt and Equity Commitments [Member] | iCIMS, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 10,800 11,435
Unfunded Debt and Equity Commitments [Member] | Arcutis Biotherapeutics, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 8,356 8,356
Unfunded Debt and Equity Commitments [Member] | Atria Wealth Solutions, Inc [Member]    
Other Commitments [Line Items]    
Other Commitment 8,215 8,215
Unfunded Debt and Equity Commitments [Member] | Copper River Seafoods, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 8,158 3,595
Unfunded Debt and Equity Commitments [Member] | Ardelyx, Inc [Member]    
Other Commitments [Line Items]    
Other Commitment 7,752 7,752
Unfunded Debt and Equity Commitments [Member] | Cerapedics, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 6,735 6,735
Unfunded Debt and Equity Commitments [Member] | United Digestive MSO Parent, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 5,259 0
Unfunded Debt and Equity Commitments [Member] | Luxury Asset Capital, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 4,500 7,500
Unfunded Debt and Equity Commitments [Member] | Kaseya, Inc [Member]    
Other Commitments [Line Items]    
Other Commitment 3,768 3,936
Unfunded Debt and Equity Commitments [Member] | SPAR Marketing Force, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 3,733 1,338
Unfunded Debt and Equity Commitments [Member] | Urology Management Holdings, Inc [Member]    
Other Commitments [Line Items]    
Other Commitment 3,596 0
Unfunded Debt and Equity Commitments [Member] | One Touch Direct, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 3,571 3,069
Unfunded Debt and Equity Commitments [Member] | Spectrum Pharmaceuticals, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 3,508 8,771
Unfunded Debt and Equity Commitments [Member] | SLR Equipment Finance [Member]    
Other Commitments [Line Items]    
Other Commitment 3,500 1,000
Unfunded Debt and Equity Commitments [Member] | Meditrina, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 3,367 3,367
Unfunded Debt and Equity Commitments [Member] | Vertos Medical, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 3,325 0
Unfunded Debt and Equity Commitments [Member] | Foundation Consumer Brands, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 3,009 3,009
Unfunded Debt and Equity Commitments [Member] | Vessco Midco Holdings, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 2,677 3,892
Unfunded Debt and Equity Commitments [Member] | Kid Distro Holdings, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 2,650 2,650
Unfunded Debt and Equity Commitments [Member] | RSC Acquisition, Inc [Member]    
Other Commitments [Line Items]    
Other Commitment 2,487 7,498
Unfunded Debt and Equity Commitments [Member] | Erie Construction Mid-west, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 2,403 1,248
Unfunded Debt and Equity Commitments [Member] | Ultimate Baked Goods Midco LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 2,361 1,636
Unfunded Debt and Equity Commitments [Member] | Maurices, Incorporated [Member]    
Other Commitments [Line Items]    
Other Commitment 2,353 4,314
Unfunded Debt and Equity Commitments [Member] | Basic Fun, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 2,150 2,675
Unfunded Debt and Equity Commitments [Member] | SCP Eye Care, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 1,955 2,771
Unfunded Debt and Equity Commitments [Member] | DeepIntent, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 1,925 3,049
Unfunded Debt and Equity Commitments [Member] | SunMed Group Holdings, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 1,621 843
Unfunded Debt and Equity Commitments [Member] | SLR Healthcare ABL [Member]    
Other Commitments [Line Items]    
Other Commitment [1] 1,400 1,400
Unfunded Debt and Equity Commitments [Member] | American Teleconferencing Services, Ltd. [Member]    
Other Commitments [Line Items]    
Other Commitment 1,380 1,090
Unfunded Debt and Equity Commitments [Member] | Montefiore Nyack Hospital [Member]    
Other Commitments [Line Items]    
Other Commitment 1,301 1,034
Unfunded Debt and Equity Commitments [Member] | Pinnacle Treatment Centers, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 1,286 1,745
Unfunded Debt and Equity Commitments [Member] | RxSense Holdings LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 1,250 1,250
Unfunded Debt and Equity Commitments [Member] | Bayside Opco LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 1,247 0
Unfunded Debt and Equity Commitments [Member] | Enverus Holdings, Inc [Member]    
Other Commitments [Line Items]    
Other Commitment 1,233 1,004
Unfunded Debt and Equity Commitments [Member] | Tilley Distribution Inc [Member]    
Other Commitments [Line Items]    
Other Commitment 1,158 525
Unfunded Debt and Equity Commitments [Member] | Pediatric Home Respiratory Services, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 1,147 1,805
Unfunded Debt and Equity Commitments [Member] | GSM Acquisition Corp [Member]    
Other Commitments [Line Items]    
Other Commitment 862 784
Unfunded Debt and Equity Commitments [Member] | Composite Technology Acquisition Corp [Member]    
Other Commitments [Line Items]    
Other Commitment 825 1,537
Unfunded Debt and Equity Commitments [Member] | High Street Buyer Inc [Member]    
Other Commitments [Line Items]    
Other Commitment 631 327
Unfunded Debt and Equity Commitments [Member] | CC SAG Holdings Corp. (Spectrum Automotive) [Member]    
Other Commitments [Line Items]    
Other Commitment 548 20,670
Unfunded Debt and Equity Commitments [Member] | Orthopedic Care Partners Management, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 536 1,620
Unfunded Debt and Equity Commitments [Member] | Southern Orthodontic Partners Management LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 519 1,918
Unfunded Debt and Equity Commitments [Member] | ENS Holdings III Corp, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 461 144
Unfunded Debt and Equity Commitments [Member] | World Insurance Associates, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 295 17,117
Unfunded Debt and Equity Commitments [Member] | TAUC Management, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 294 294
Unfunded Debt and Equity Commitments [Member] | AmeriMark Intermediate Holdings, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 221 0
Unfunded Debt and Equity Commitments [Member] | All State Ag Parts, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 43 135
Unfunded Debt and Equity Commitments [Member] | Plastics Management, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 0 2,424
Unfunded Debt and Equity Commitments [Member] | Ivy Fertility Services, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 0 1,571
Unfunded Debt and Equity Commitments [Member] | NAC Holdings Corporation [Member]    
Other Commitments [Line Items]    
Other Commitment 0 1,479
Unfunded Debt and Equity Commitments [Member] | Peter C. Foy & Associates Insurance Services, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 0 1,094
Unfunded Debt and Equity Commitments [Member] | BayMark Health Services, Inc [Member]    
Other Commitments [Line Items]    
Other Commitment $ 0 $ 391
[1] The Company controls the funding of the SLR Credit Solutions and SLR Healthcare ABL commitments and may cancel them at its discretion.
XML 69 R56.htm IDEA: XBRL DOCUMENT v3.23.2
SLR Equipment Finance - Additional Information (Details)
$ in Thousands
3 Months Ended 6 Months Ended
Sep. 30, 2019
USD ($)
Jun. 30, 2023
USD ($)
Customers
Jun. 30, 2022
USD ($)
Jun. 30, 2023
USD ($)
Customers
Jun. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
Customers
Dec. 31, 2021
USD ($)
Jul. 31, 2017
USD ($)
Schedule of Equity Method Investments [Line Items]                
Non-recourse debt   $ 1,213,033   $ 1,213,033     $ 1,085,998  
Line of credit facility, expiration date       Nov. 13, 2025        
SLR Equipment Finance [Member]                
Schedule of Equity Method Investments [Line Items]                
Equity method investment, ownership percentage               100.00%
Equity method investment, aggregate cost               $ 209,866
Equity method investment aggregate equity investment               145,000
Equity method investment aggregate investment in investee leases and loans held               64,866
Line of credit facility, maximum borrowing capacity $ 213,957 $ 152,147   $ 152,147       150,000
Line of credit facility maximum borrowing capacity with accordion feature $ 313,957             $ 250,000
Number of funded equipment-backed leases and loans   129   129   131    
Number of Customers | Customers   54   54   59    
Net investment in lease   $ 197,694   $ 197,694   $ 190,830    
Assets under lease   246,528   246,528   241,813    
Equipment backed leases and loans largest position outstanding   18,243   18,243   19,259    
Equipment backed leases and loans average exposure per customer   3,661   3,661   3,234    
Non-recourse debt   124,732   124,732   $ 114,977    
Net income   2,055 $ 1,753 1,017 $ 1,159      
Gross income   $ 4,054 $ 4,045 $ 10,391 $ 9,218      
Line of credit facility, expiration date Jan. 31, 2024     Aug. 01, 2023        
XML 70 R57.htm IDEA: XBRL DOCUMENT v3.23.2
Capital Share Transactions - Additional Information (Details) - $ / shares
Jun. 30, 2023
Dec. 31, 2022
Dec. 12, 2022
Jun. 30, 2022
Stockholders' Equity Note [Abstract]        
Shares authorized 200,000,000 200,000,000   200,000,000
Par value $ 0.01 $ 0.01 $ 0.01 $ 0.01
XML 71 R58.htm IDEA: XBRL DOCUMENT v3.23.2
Capital Share Transactions - Summary of Transactions In Capital Stock (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Shares repurchased, Shares 0 0 (746) 0 (217,271)
Shares repurchased, Value $ 0 $ 0 $ (10) $ 0 $ (3,038)
Net increase, Shares 0 12,511,825 (746) 12,511,825  
Net increase, Value $ 0 $ 226,839 $ (10) $ 226,839  
Shares issued in connection with the Mergers [Member]          
Shares 0 12,511,825 0 12,511,825  
Amount $ 0 $ 226,839 $ 0 $ 226,839  
XML 72 R59.htm IDEA: XBRL DOCUMENT v3.23.2
Kingsbridge Holdings, LLC - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Nov. 03, 2020
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Proceeds from unsecured borrowings       $ 0 $ 134,914    
Total assets   $ 2,553,230   2,553,230   $ 2,537,695  
Non-recourse debt   1,213,033   1,213,033     $ 1,085,998
KBHT [Member]              
Total assets   797,930   797,930   777,151  
Kingsbridge Holdings, LLC [Member]              
Equity method investments $ 216,596            
Payments to acquire investments 136,596            
Proceeds from unsecured borrowings $ 80,000            
Recourse debt   246,294   246,294   222,094  
Non-recourse debt   356,929   356,929   $ 353,128  
Net income (loss)   3,287 $ 3,657 5,914 7,066    
Gross income   $ 75,500 $ 77,316 $ 143,507 $ 143,741    
Maximum [Member] | Kingsbridge Holdings, LLC [Member]              
Equity method investment, ownership percentage 87.50%            
Minimum [Member] | Kingsbridge Holdings, LLC [Member]              
Equity method investment, ownership percentage 12.50%            
XML 73 R60.htm IDEA: XBRL DOCUMENT v3.23.2
SLR Healthcare ABL - Additional Information (Details)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 28, 2019
USD ($)
May 27, 2016
USD ($)
Sep. 30, 2013
USD ($)
Jun. 30, 2023
USD ($)
Mar. 31, 2023
USD ($)
Jun. 30, 2022
USD ($)
Jun. 30, 2023
USD ($)
issuers
Jun. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
issuers
Sep. 30, 2022
Dec. 31, 2021
USD ($)
Jun. 27, 2014
USD ($)
Mar. 31, 2014
USD ($)
Line of credit facility, expiration date             Nov. 13, 2025            
Commitments and contingencies                    
Total assets       2,553,230     $ 2,553,230   $ 2,537,695        
Number of issuers in business credit | issuers             101   108        
Long term debt       1,213,033     $ 1,213,033       $ 1,085,998    
SLR Healthcare ABL Credit [Member]                          
Line of credit facility, maximum borrowing capacity $ 125,000       $ 100,000             $ 110,000  
Debt instrument term     4 years                    
Line of credit facility, expiration date Jun. 28, 2023 May 27, 2020     Mar. 31, 2026                
Total assets       106,837     $ 106,837   $ 108,705        
Number of issuers in business credit | issuers             40   41        
Long-term line of credit       2,489     $ 2,489   $ 2,253        
Net income (loss)       1,273   $ 847 2,393 $ 1,721          
Gross income       4,439   $ 2,487 8,276 $ 4,878          
Long term debt       74,900     74,900   77,000        
Senior Secured Commitments [Member]                          
Commitments and contingencies       261,600     261,600   242,106        
Commitment funded amount       $ 99,555     $ 99,555            
Senior Secured Commitments [Member] | SLR Healthcare ABL Credit [Member]                          
Commitment funded amount                 $ 92,383        
Maximum [Member]                          
Debt instrument term             60 days            
Maximum [Member] | SLR Healthcare ABL Credit [Member]                          
Line of credit facility, maximum borrowing capacity   $ 200,000 $ 150,000                    
Minimum [Member]                          
Debt instrument term             60 days            
Minimum [Member] | SLR Healthcare ABL Credit [Member]                          
Line of credit facility, maximum borrowing capacity   $ 125,000 100,000                   $ 105,000
SLR Healthcare ABL [Member]                          
Equity method investments     $ 32,839                    
SLR Healthcare ABL [Member] | Maximum [Member]                          
Equity method investment, ownership percentage                   93.00%      
SLR Healthcare ABL [Member] | Minimum [Member]                          
Equity method investment, ownership percentage                   7.00%      
XML 74 R61.htm IDEA: XBRL DOCUMENT v3.23.2
SLR Business Credit - Additional Information (Details)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 03, 2021
USD ($)
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Jun. 30, 2023
USD ($)
issuers
Jun. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
issuers
Jun. 28, 2019
USD ($)
May 01, 2018
Oct. 20, 2017
USD ($)
SLR Business Credit [Line Items]                  
Commitments and contingencies            
Assets   2,553,230   $ 2,553,230   $ 2,537,695      
Number of issuers in business credit | issuers       101   108      
Line of credit facility, expiration date       Nov. 13, 2025          
SLR Business Credit [Member]                  
SLR Business Credit [Line Items]                  
Long-term line of credit   2,526   $ 2,526   $ 2,648      
Net income   1,414 $ 1,857 3,431 $ 3,726        
Gross income   8,827 $ 6,626 11,067 $ 12,772        
Senior Secured Commitments [Member]                  
SLR Business Credit [Line Items]                  
Commitments and contingencies   261,600   261,600   242,106      
Commitment funded amount   99,555   99,555          
Senior Secured Commitments [Member] | SLR Business Credit [Member]                  
SLR Business Credit [Line Items]                  
Commitments and contingencies   620,232   620,232   603,432      
Commitment funded amount   255,169   255,169   286,006      
Assets   300,645   300,645   332,247      
Fast Pay Partners LLC [Member]                  
SLR Business Credit [Line Items]                  
Percentage of voting interests acquired 100.00%                
Business combination, consideration transferred $ 66,671                
NMCs Credit Facility [Member]                  
SLR Business Credit [Line Items]                  
Line of credit facility, maximum borrowing capacity 47,671           $ 15,500    
SUNS [Member]                  
SLR Business Credit [Line Items]                  
Line of credit facility, maximum borrowing capacity $ 19,000                
NMC Senior Credit Facility [Member]                  
SLR Business Credit [Line Items]                  
Line of credit facility, maximum borrowing capacity   285,307   285,307          
Long-term line of credit   $ 198,571   $ 198,571   $ 214,425      
NM Holdco [Member]                  
SLR Business Credit [Line Items]                  
Percentage of equity interest contributed to another entity             99.00%    
North Mill Capital LLC [Member]                  
SLR Business Credit [Line Items]                  
Equity method investment, ownership percentage               99.00% 100.00%
Equity method investments                 $ 51,000
ESP SSC Corporation [Member]                  
SLR Business Credit [Line Items]                  
Equity method investment, ownership percentage               1.00% 1.00%
Summit Financial Resources [Member]                  
SLR Business Credit [Line Items]                  
Equity method investment, ownership percentage             100.00%    
XML 75 R62.htm IDEA: XBRL DOCUMENT v3.23.2
Stock Repurchase Program - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
May 09, 2023
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Stockholders' Equity Note [Abstract]            
Stock repurchase program, authorized amount $ 50,000          
Stock repurchase program expiration date May 10, 2024          
Stock Repurchased During Period, Shares   0 0 746 0 217,271
Shares Issued, Price Per Share   $ 14.02   $ 14.02   $ 13.98
Stock Repurchased During Period, Value   $ 0 $ 0 $ 10 $ 0 $ 3,038
XML 76 R63.htm IDEA: XBRL DOCUMENT v3.23.2
SLR Senior Lending Program LLC - Summary of SSLP's portfolio (Details) - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Summary of Investment Holdings [Line Items]    
Cost $ 2,582,726 $ 2,552,177
SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Cost [1] 77,114 18,032
Fair Value [1],[2] $ 77,505 $ 18,062
Health Care Providers & Services [Member] | Aegis Toxicology Sciences Corporation [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [1],[3] S+550  
Floor [1] 1.00%  
Interest Rate [1],[4] 10.84%  
Maturity Date [1] May 09, 2025  
Par Amount [1] $ 2,974  
Cost [1] 2,974  
Fair Value [1],[2] $ 2,974  
Health Care Providers & Services [Member] | BayMark Health Services Inc [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [1],[3] S+500 L+500
Floor [1] 1.00% 1.00%
Interest Rate [1],[4] 10.50% 9.73%
Maturity Date [1] Jun. 11, 2027 Jun. 11, 2027
Par Amount [1] $ 4,054 $ 2,992
Cost [1] 4,054 2,992
Fair Value [1],[2] $ 4,054 $ 2,992
Health Care Providers & Services [Member] | Fertility (ITC) Investment Holdco, LLC [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [1],[3] S+650  
Floor [1] 1.00%  
Interest Rate [1],[4] 11.63%  
Maturity Date [1] Jan. 03, 2029  
Par Amount [1] $ 5,985  
Cost [1] 5,809  
Fair Value [1],[2] $ 5,985  
Health Care Providers & Services [Member] | ONS MSO, LLC [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [1],[3] S+625  
Floor [1] 1.00%  
Interest Rate [1],[4] 11.32%  
Maturity Date [1] Jul. 08, 2025  
Par Amount [1] $ 5,951  
Cost [1] 5,774  
Fair Value [1],[2] $ 5,773  
Health Care Providers & Services [Member] | PhyNet Dermatology LLC [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [1],[3] S+625  
Floor [1] 1.00%  
Interest Rate [1],[4] 11.45%  
Maturity Date [1] Aug. 16, 2024  
Par Amount [1] $ 2,481  
Cost [1] 2,481  
Fair Value [1],[2] $ 2,481  
Health Care Providers & Services [Member] | Pinnacle Treatment Centers, Inc [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [1],[3] S+675  
Floor [1] 1.00%  
Interest Rate [1],[4] 12.10%  
Maturity Date [1] Jan. 02, 2026  
Par Amount [1] $ 2,487  
Cost [1] 2,487  
Fair Value [1],[2] $ 2,487  
Health Care Providers & Services [Member] | Plastics Management LLC [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [1],[3] S+500  
Floor [1] 1.00%  
Interest Rate [1],[4] 10.44%  
Maturity Date [1] Aug. 18, 2027  
Par Amount [1] $ 5,666  
Cost [1] 5,481  
Fair Value [1],[2] $ 5,666  
Health Care Providers & Services [Member] | Urology Management Holdings, Inc [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [1],[3] S+625  
Floor [1] 1.00%  
Interest Rate [1],[4] 11.36%  
Maturity Date [1] Jun. 15, 2026  
Par Amount [1] $ 2,471  
Cost [1] 2,404  
Fair Value [1],[2] $ 2,397  
Health Care Providers & Services [Member] | Ivy Fertility Services, LLC [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [1],[3]   L+625
Floor [1]   1.00%
Interest Rate [1],[4]   10.39%
Maturity Date [1]   Feb. 25, 2026
Par Amount [1]   $ 3,000
Cost [1]   3,000
Fair Value [1],[2]   $ 3,030
Diversified Financial Services [Member] | Atria Wealth Solutions, Inc [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [1],[3] S+650 S+600
Floor [1] 1.00% 1.00%
Interest Rate [1],[4] 12.00% 10.84%
Maturity Date [1] Feb. 29, 2024 Feb. 29, 2024
Par Amount [1] $ 2,481 $ 2,494
Cost [1] 2,481 2,494
Fair Value [1],[2] $ 2,481 $ 2,494
Trading Companies & Distributors [Member] | ENS Holdings III Corp. ES Opco USA LLC [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [1],[3] S+475 L+475
Floor [1] 1.00% 1.00%
Interest Rate [1],[4] 10.09% 9.43%
Maturity Date [1] Dec. 31, 2025 Dec. 31, 2025
Par Amount [1] $ 1,091 $ 1,097
Cost [1] 1,091 1,097
Fair Value [1],[2] $ 1,091 $ 1,097
Trading Companies & Distributors [Member] | Tilley Distribution Inc [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [1],[3] S+550  
Floor [1] 1.00%  
Interest Rate [1],[4] 11.39%  
Maturity Date [1] Dec. 31, 2026  
Par Amount [1] $ 5,978  
Cost [1] 5,978  
Fair Value [1],[2] $ 5,978  
Personal Products [Member] | Foundation Consumer Brands, LLC [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [1],[3] S+625 L+550
Floor [1] 1.00% 1.00%
Interest Rate [1],[4] 11.47% 10.15%
Maturity Date [1] Feb. 12, 2027 Feb. 12, 2027
Par Amount [1] $ 6,863 $ 2,963
Cost [1] 6,863 2,963
Fair Value [1],[2] $ 6,863 $ 2,963
Insurance [Member] | Higginbotham Insurance Agency Inc [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [1],[3] S+525  
Floor [1] 1.00%  
Interest Rate [1],[4] 10.45%  
Maturity Date [1] Nov. 25, 2026  
Par Amount [1] $ 1,293  
Cost [1] 1,293  
Fair Value [1],[2] $ 1,293  
Insurance [Member] | High Street Buyer Inc [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [1],[3] S+600 L+600
Floor [1] 0.75% 0.75%
Interest Rate [1],[4] 11.39% 10.73%
Maturity Date [1] Apr. 16, 2028 Apr. 16, 2028
Par Amount [1] $ 2,481 $ 2,494
Cost [1] 2,481 2,494
Fair Value [1],[2] $ 2,481 $ 2,494
Insurance [Member] | RSC Acquisition Inc [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [1],[3] S+550  
Floor [1] 0.75%  
Interest Rate [1],[4] 10.64%  
Maturity Date [1] Nov. 01, 2026  
Par Amount [1] $ 5,045  
Cost [1] 5,045  
Fair Value [1],[2] $ 5,045  
Software [Member] | ICIMS, Inc [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [1],[3] S+725  
Floor [1] 0.75%  
Interest Rate [1],[4] 12.38%  
Maturity Date [1] Aug. 18, 2028  
Par Amount [1] $ 3,029  
Cost [1] 2,991  
Fair Value [1],[2] $ 3,029  
Software [Member] | Kid Distro Holdings, LLC [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [1],[3] S+575  
Floor [1] 1.00%  
Interest Rate [1],[4] 11.14%  
Maturity Date [1] Oct. 01, 2027  
Par Amount [1] $ 5,970  
Cost [1] 5,970  
Fair Value [1],[2] $ 5,970  
Software [Member] | Kid Distro Holdings, LLC (Distro Kid) [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [1],[3]   L+575
Floor [1]   1.00%
Interest Rate [1],[4]   10.48%
Maturity Date [1]   Oct. 01, 2027
Par Amount [1]   $ 2,992
Cost [1]   2,992
Fair Value [1],[2]   $ 2,992
Life Sciences Tools and Services [Member] | RQM+ Corp [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [1],[3] S+575  
Floor [1] 1.00%  
Interest Rate [1],[4] 11.51%  
Maturity Date [1] Aug. 12, 2026  
Par Amount [1] $ 5,985  
Cost [1] 5,985  
Fair Value [1],[2] $ 5,985  
Diversified Consumer Services [Member] | RxSense Holdings LLC [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [1],[3] S+500  
Floor [1] 1.00%  
Interest Rate [1],[4] 10.15%  
Maturity Date [1] Mar. 13, 2026  
Par Amount [1] $ 2,985  
Cost [1] 2,985  
Fair Value [1],[2] $ 2,985  
Health Care Equipment and Supplies [Member] | SunMed Group Holdings, LLC [Member] | SLR Senior Lending Program LLC [Member]    
Summary of Investment Holdings [Line Items]    
Spread Above Index [1],[3] S+575  
Floor [1] 0.75%  
Interest Rate [1],[4] 11.09%  
Maturity Date [1] Jun. 16, 2028  
Par Amount [1] $ 2,487  
Cost [1] 2,487  
Fair Value [1],[2] $ 2,487  
[1] The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
[2] Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
[3] Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR. These instruments are typically subject to a SOFR floor.
[4] Floating rate debt investments typically bear interest at a rate determined by reference to the SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of June 30, 2023.
XML 77 R64.htm IDEA: XBRL DOCUMENT v3.23.2
SLR Senior Lending Program LLC - Summary financial information for SSLP (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Dec. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Condensed Financial Statements, Captions [Line Items]          
Cash and other assets $ 2,504,266 $ 2,514,626   $ 2,514,626  
Total assets 2,537,695 2,553,230   2,553,230  
Debt outstanding 1,085,998 1,213,033   1,213,033  
Total liabilities 1,537,964 1,572,425   1,572,425  
Organizational costs   1,480 $ 1,369 2,988 $ 2,552
Other general and administrative expenses   948 476 2,449 3,277
Total expenses   33,786 23,844 65,296 43,372
Net investment income (loss)   22,676 20,294 44,823 33,772
Realized gain on investments   498 (105) 1,185 (75)
Net change in unrealized gain on investments   (4,179) (35,835) (20,189) (47,880)
Net realized and unrealized gain on investments   (3,681) (35,940) (19,004) (47,955)
Net income (loss)   18,995 $ (15,646) 25,819 $ (14,183)
SLR Senior Lending Program LLC [Member]          
Condensed Financial Statements, Captions [Line Items]          
Investments at fair value (cost $77,114 and $18,032, respectively) [1],[2] 18,062 77,505   77,505  
Cash and other assets 1,043 1,906   1,906  
Total assets 19,105 79,411   79,411  
Debt outstanding 0 36,944   36,944  
Interest payable and other credit facility related expenses 165 345   345  
Accrued expenses and other payables 89 131   131  
Total liabilities 254 37,420   37,420  
Members' equity 18,851 41,991   41,991  
Total liabilities and members' equity 19,105 79,411   79,411  
Interest income 152 1,605   2,614  
Service fees [3] 4 38   57  
Interest and other credit facility expenses 166 1,447   2,252  
Organizational costs 73 0   0  
Other general and administrative expenses 88 19   57  
Total expenses 331 1,504   2,366  
Net investment income (loss) (179) 101   248  
Realized gain on investments 0 0   30  
Net change in unrealized gain on investments 30 321   361  
Net realized and unrealized gain on investments 30 321   391  
Net income (loss) $ (149) $ 422   $ 639  
[1] Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
[2] The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
[3] Service fees are included within the Company’s Consolidated Statements of Operations as other income.
XML 78 R65.htm IDEA: XBRL DOCUMENT v3.23.2
SLR Senior Lending Program LLC - Summary financial information for SSLP (Parenthetical) (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Condensed Financial Statements, Captions [Line Items]    
Cost $ 2,582,726 $ 2,552,177
SLR Senior Lending Program LLC [Member]    
Condensed Financial Statements, Captions [Line Items]    
Cost [1] $ 77,114 $ 18,032
[1] The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
XML 79 R66.htm IDEA: XBRL DOCUMENT v3.23.2
SLR Senior Lending Program LLC - Additional Information (Details) - USD ($)
$ in Thousands
1 Months Ended 6 Months Ended
Dec. 12, 2022
Dec. 18, 2019
Dec. 31, 2022
Jun. 30, 2023
Oct. 12, 2022
Summary of Investment Holdings [Line Items]          
Other Commitment     $ 323,663 $ 325,858  
Debt Instrument, Maturity Date   Dec. 15, 2024      
total assets     2,537,695 2,553,230  
Unfunded Debt and Equity Commitments [Member]          
Summary of Investment Holdings [Line Items]          
Other Commitment     323,663 325,858  
SLR Senior Lending Program LLC [Member]          
Summary of Investment Holdings [Line Items]          
Other Ownership Interests, Contributed Capital       41,500  
total assets     19,105 79,411  
Payments to Acquire Investments     18,100 32,557  
Prepaid Expense     $ 68 182  
SLR Senior Lending Program LLC [Member] | Unfunded Debt and Equity Commitments [Member]          
Summary of Investment Holdings [Line Items]          
Other Commitment         $ 100,000
SLR Senior Lending Program LLC [Member] | Senior Secured Revolving Credit Facility [Member] | SLR Senior Lending Program SPV LLC [Member]          
Summary of Investment Holdings [Line Items]          
Long-term Line of Credit $ 100,000     38,400  
Debt Instrument, Maturity Date Dec. 12, 2027        
SLR Senior Lending Program LLC [Member] | Senior Secured Revolving Credit Facility [Member] | SLR Senior Lending Program SPV LLC [Member] | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]          
Summary of Investment Holdings [Line Items]          
Line of Credit Facility, Interest Rate During Period 3.25%        
SLR Senior Lending Program LLC [Member] | Investor [Member] | Unfunded Debt and Equity Commitments [Member]          
Summary of Investment Holdings [Line Items]          
Other Commitment       29,250 50,000
SLR Senior Lending Program LLC [Member] | Management [Member] | Unfunded Debt and Equity Commitments [Member]          
Summary of Investment Holdings [Line Items]          
Other Commitment       $ 29,250 $ 50,000
XML 80 R67.htm IDEA: XBRL DOCUMENT v3.23.2
Subsequent Events - Additional Information (Details) - $ / shares
Aug. 08, 2023
Jul. 05, 2023
Subsequent Event [Member] | Board [Member]    
Subsequent Event [Line Items]    
Dividends payable, amount per share $ 0.136667 $ 0.136667
XML 81 d518171d10q_htm.xml IDEA: XBRL DOCUMENT 0001418076 2023-01-01 2023-06-30 0001418076 2023-04-01 2023-06-30 0001418076 2022-04-01 2022-06-30 0001418076 2022-01-01 2022-06-30 0001418076 2023-06-30 0001418076 2022-12-31 0001418076 2022-06-30 0001418076 2023-08-04 0001418076 2023-05-09 0001418076 2023-05-09 2023-05-09 0001418076 2022-01-01 2022-12-31 0001418076 2021-12-31 0001418076 2022-12-12 0001418076 2019-12-18 2019-12-18 0001418076 2022-04-01 2022-04-01 0001418076 2013-12-31 0001418076 2015-12-31 0001418076 2014-12-31 0001418076 2017-12-31 0001418076 2016-12-31 0001418076 2019-12-31 0001418076 2018-12-31 0001418076 2020-12-31 0001418076 2022-03-31 0001418076 2023-03-31 0001418076 slrc:CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember 2023-06-30 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:SlramiTopcoBlockerLlcMember 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:VertosMedicalInc.WarrantsMember 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:BaysideParentLLCMember 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:CardioFocusIncMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:SlrEquipmentFinanceEquityInterestsMember 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:SlrHealthcareAblMember 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:AtyrPharmaIncMember 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:DelphinusMedicalTechnologiesIncMember 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:EssenceGroupHoldingsCorporationLumerisMember 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:KbhTopcoLlcKingsbridgeMember 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:RdHoldcoIncClassBMember 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:VenusConceptLtdMember 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:SlrCreditSolutionsMember 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:VapothermIncMember 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:SpectrumPharmaceuticalsInc.WarrantsMember 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:RdHoldcoIncWarrantsMember 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:SenseonicsHoldingsIncMember 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:SlrBusinessCreditMember 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:NspcHoldingsLlcNationalSpineMember 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:RdHoldcoIncMember 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:MeditrinaIncWarrantsMember 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:ConventusOrthopaedicsIncMember 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:CentrexionTherapeuticsIncMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:PinnacleTreatmentCentersInc.Member 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:PediatricHomeRespiratoryServicesLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:TilleyDistributionIncMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SunmedGroupHoldingsLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:BasicFunInc.Member 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AmericanTeleconferencingServicesLtd.Member 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:NspcIntermediateCorpMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FertilityInvestmentHoldcoLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:WorldInsuranceAssociatesLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:UrologyManagementHoldingsIncMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:VesscoMidcoHoldingsLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcBluefinMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:DeepintentInc.Member 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SouthernOrthodonticPartnersManagementLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:RxsenseHoldingsLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:PhynetDermatologyLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:PlasticsManagementLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:UnitedDigestiveMsoParentLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AllStateAgPartsLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CompositeTechnologyAcquisitionCorp.Member 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:EnhancedPermanentCapitalLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:BaymarkHealthServicesIncMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:KaseyaIncMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:HigginbothamInsuranceAgencyIncMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:RscAcquisitionIncMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:KingsbridgeHoldingsLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:LogixHoldingCompanyLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:MontefioreNyackHospitalMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:OneTouchDirectLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AmericanTeleconferencingServicesLtdOneMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:OrthopedicCarePartnersManagementLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:UltimateBakedGoodsMidcoLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:StrytenResourcesLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:TaucManagementLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ShoHoldingICorporationShoesForCrewsMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SparMarketingForceInc.Member 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ScpEyeCareLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:RqmCorp.Member 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:MaxorAcquisitionInc.Member 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:OnsMsoLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:PeterCFoyandAssociatesInsuranceServicesLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:LuxuryAssetCapitalLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:MauricesIncorporatedMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:KidDistroHoldingsLlcDistroKidMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:KoreWirelessGroupInc.Member 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:IcimsInc.Member 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:HighStreetBuyerIncMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:HumanInterestIncMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FoundationConsumerBrandsLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:GsmAcquisitionCorpMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:EnverusHoldingsIncFkaDrillingInfoHoldingsMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ErieConstructionMidwestLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CopperRiverSeafoodsInc.Member 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:BdgMediaInc.Member 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ApexServicesPartnersLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AtriaWealthSolutionsIncMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AmerimarkIntermediateHoldingsLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AegisToxicologySciencesCorporationMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:BaysideParentLLCMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CVAUSAManagementLLCMember 2023-06-30 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FgiWorldwideLlcMember 2023-06-30 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AcresCommercialMortgageLlcMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AmeriMarkIntermediateHoldingsLLCOneMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:BaysideOpcoLLCMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:BaysideOpcoLLCOneMember 2023-06-30 0001418076 slrc:SecondLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:RdHoldcoInc.Member 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:GmtCorporationMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:EasyPakLlcMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:ExtremeSteelCraneRiggingLlcMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:BazziniLlcMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:FreightsolLlcMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:RottenRockHardscapingAndTreeServiceMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:LuxVendingLlcMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:DrillersChoiceIncMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:CarolinasContractingLlcMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:SuperiorTransportationIncMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:CapitalCityJetCenterIncMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:UpTruckingServicesLlcMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:AfgDallasIiiLlcMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:StCoachesLlcMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:SignetMarineCorporationMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:EquipmentOperatingLeasesLlcMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:FirstNationalCapitalLlcMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:GardaClTechnicalServicesIncMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:ClubcorpHoldingsIncMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:CompleteEquipmentRentalsLlcMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:LocPerformanceProductsLlcMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:HtiLogisticsCorporationMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:U.s.CraneAndRiggingLlcMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:WindRiverEnvironmentalLlcMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:WorldwideFlightServicesInc.Member 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:WombleCompanyIncMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:TheSmedleyCompanySmedleyServicesIncMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:SmileyLiftingSolutionsLlcMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:ZamborelliEnterprisesPacificSoutherFoundationMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:TrinityEquipmentRentalsIncMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:SlrEquipmentFinanceMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:StarCoachesIncMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:RangoIncMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:RaneLightMetalCastingsIncMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:PcxAerostructuresLlcMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:RoyalExpressIncMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:RoyalCoachLinesIncMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:MountainAirHelicoptersIncMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:LuxCreditConsultantsLlcMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:KoolPakLlcMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:OzziesIncMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:LoyerCapitalLlcMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:GeorgiaJetIncMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:HawkeyeContractingCompanyLlcMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:InternationalAutomotiveComponentsGroupNorthAmericaIncMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:FirstAmericanCommercialBancorpIncMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:EnergyDrillingServicesLlcMember 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ArcutisBiotherapeuticsInc.Member 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SpectrumPharmaceuticalsInc.Member 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:EnvironmentalProtectionImprovementCompanyLlcMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:CPortStoneLlcMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:CkdHoldingsInc.Member 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:BowmanEnergySolutionsLlcMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:RhLandConstructionLlcHarborDredgingLaIncMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:WasteProOfFloridaInc.WasteProUsaIncMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:NoLimitConstructionServicesLlcMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:RayzorsEdgeLlcMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:MirandaLogisticsEnterpriseIncMember 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:VertosMedicalInc.Member 2023-06-30 0001418076 slrc:U.s.TreasuryBillMember slrc:CashEquivalentsThirtyFourPointZeroPercentMember 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:OmniguideHoldingsInc.Member 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:OutsetMedicalInc.Member 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:VapothermInc.Member 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:BridgebioPharmaInc.Member 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CentrexionTherapeuticsInc.Member 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:MeditrinaInc.Member 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:NeuroneticsInc.Member 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:DongwonAutopartTechnologyIncMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:AaCraneAndRiggingLlcMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:AeroOperatingLlcMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:AirMethodsCorporationMember 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CerapedicsInc.Member 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:GlookoInc.Member 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:AmeraMexInternationalIncMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:BoartLongyearCompanyMember 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AlimeraSciencesInc.Member 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ApeelTechnologyIncMember 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ArdelyxInc.Member 2023-06-30 0001418076 slrc:PreferredEquityzeroPointFourPercentMember slrc:SointLlcMember 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember 2023-06-30 0001418076 slrc:TotalInvestmentMember 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-06-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-06-30 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2023-06-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2023-06-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2023-06-30 0001418076 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2023-06-30 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 slrc:PreferredEquityMember us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2023-06-30 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 slrc:PreferredEquityMember us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2023-06-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-06-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputRecoverableAmountMember slrc:ValuationTechniqueRecoveryApproachMember 2023-06-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-06-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2023-06-30 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-06-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2023-06-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2023-06-30 0001418076 srt:MinimumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-06-30 0001418076 srt:MaximumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-06-30 0001418076 srt:WeightedAverageMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-06-30 0001418076 srt:WeightedAverageMember slrc:EquipmentFinancingMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2023-06-30 0001418076 srt:WeightedAverageMember slrc:EquipmentFinancingMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2023-06-30 0001418076 srt:MinimumMember slrc:PreferredEquityMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-06-30 0001418076 srt:MaximumMember slrc:PreferredEquityMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-06-30 0001418076 srt:WeightedAverageMember slrc:PreferredEquityMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-06-30 0001418076 srt:MinimumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2023-06-30 0001418076 srt:MaximumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2023-06-30 0001418076 srt:WeightedAverageMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2023-06-30 0001418076 srt:MinimumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2023-06-30 0001418076 srt:MaximumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2023-06-30 0001418076 srt:WeightedAverageMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2023-06-30 0001418076 us-gaap:FairValueInputsLevel3Member slrc:BlackScholesPricingModelMember 2023-06-30 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember 2023-06-30 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2023-06-30 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2023-06-30 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2023-06-30 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2023-06-30 0001418076 slrc:CreditFacilityOneMember 2023-06-30 0001418076 slrc:TermLoanAndCreditFacilityMember 2023-06-30 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2023-06-30 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2023-06-30 0001418076 slrc:NmcSeniorCreditFacilityMember 2023-06-30 0001418076 slrc:SlrBusinessCreditMember slrc:SeniorSecuredCommitmentsMember 2023-06-30 0001418076 slrc:SlrBusinessCreditMember 2023-06-30 0001418076 slrc:KbhtMember 2023-06-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2023-06-30 0001418076 slrc:CreditFacilityMember 2023-06-30 0001418076 slrc:SeniorSecuredCommitmentsMember 2023-06-30 0001418076 slrc:SlrHealthcareAblCreditMember 2023-06-30 0001418076 slrc:BridgeBioPharmaIncMember 2023-06-30 0001418076 slrc:OmniGuideHoldingsIncMember 2023-06-30 0001418076 slrc:VapothermInc.Member 2023-06-30 0001418076 slrc:IcimsInc.Member 2023-06-30 0001418076 slrc:KaseyaIncMember 2023-06-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2023-06-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:CreditFacilityMember slrc:CitiBankNaMember 2023-06-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember us-gaap:LineOfCreditMember 2023-06-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember slrc:TermLoanMember 2023-06-30 0001418076 slrc:SlrBusinessCreditFacilityMember 2023-06-30 0001418076 slrc:SlrEquipmentFinanceMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CVAUSAManagementLLCMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:VertosMedicalInc.Member 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BaysideOpcoLLCMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AmerimarkIntermediateHoldingsLlcMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MontefioreNyackHospitalMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ErieConstructionMidwestLlcMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CompositeTechnologyAcquisitionCorpMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:GsmAcquisitionCorpMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:EnsHoldingsIiiCorpLlcMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ApeelTechnologyIncMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:GlookoInc.Member 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:IcimsInc.Member 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CopperRiverSeafoodsInc.Member 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ArdelyxIncMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CerapedicsInc.Member 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:UnitedDigestiveMsoParentLlcMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SparMarketingForceInc.Member 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:UrologyManagementHoldingsIncMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OneTouchDirectLlcMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SpectrumPharmaceuticalsInc.Member 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrEquipmentFinanceMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:KidDistroHoldingsLlcDistroKidMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:RscAcquisitionIncMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MauricesIncorporatedMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BasicFunInc.Member 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:DeepintentInc.Member 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrHealthcareAblMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AmericanTeleconferencingServicesLtd.Member 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PinnacleTreatmentCentersInc.Member 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:RxsenseHoldingsLlcMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:EnverusHoldingsIncMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:TilleyDistributionIncMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PediatricHomeRespiratoryServicesLlcMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:HighStreetBuyerIncMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:TaucManagementLlcMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:IvyFertilityServicesLlcMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BaymarkHealthServicesIncMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrCreditSolutionsMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BdgMediaInc.Member 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ArcutisBiotherapeuticsInc.Member 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:VesscoMidcoHoldingsLlcMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:FoundationConsumerBrandsLlcMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AllStateAgPartsLlcMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:NacHoldingsCorporationMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OnsMsoLlcMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ScpEyeCareLlcMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SouthernOrthodonticPartnersManagementLlcMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OrthopedicCarePartnersManagementLlcMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SunmedGroupHoldingsLlcMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OutsetMedicalInc.Member 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:HumanInterestIncMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:WorldInsuranceAssociatesLlcMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AtriaWealthSolutionsIncMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:LuxuryAssetCapitalLlcMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:KaseyaIncMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MeditrinaInc.Member 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PlasticsManagementLlcMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PeterC.FoyAssociatesInsuranceServicesLlcMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:UltimateBakedGoodsMidcoLlcMember 2023-06-30 0001418076 slrc:FootwearMember 2023-06-30 0001418076 slrc:FoodAndStaplesRetailingMember 2023-06-30 0001418076 slrc:ConstructionAndEngineeringMember 2023-06-30 0001418076 slrc:DiversifiedConsumerServicesMember 2023-06-30 0001418076 slrc:LifeSciencesToolsAndServicesMember 2023-06-30 0001418076 slrc:InternetSoftwareServicesMember 2023-06-30 0001418076 slrc:HealthCareTechnologyMember 2023-06-30 0001418076 slrc:InternetAndCatalogRetailMember 2023-06-30 0001418076 slrc:SpecialtyRetailMember 2023-06-30 0001418076 slrc:AirlinesMember 2023-06-30 0001418076 slrc:FoodProductsMember 2023-06-30 0001418076 slrc:WaterUtilitiesMember 2023-06-30 0001418076 slrc:EnergyEquipmentAndServicesMember 2023-06-30 0001418076 slrc:HealthCareProvidersAndServicesMember 2023-06-30 0001418076 slrc:SoftwareMember 2023-06-30 0001418076 slrc:MediaMember 2023-06-30 0001418076 slrc:AutoPartsAndEquipmentMember 2023-06-30 0001418076 slrc:CommercialServicesAndSuppliesMember 2023-06-30 0001418076 slrc:BuildingProductsMember 2023-06-30 0001418076 slrc:TransportationInfrastructureMember 2023-06-30 0001418076 slrc:AutoComponentsMember 2023-06-30 0001418076 slrc:MachineryMember 2023-06-30 0001418076 slrc:MetalsAndMiningMember 2023-06-30 0001418076 slrc:ConsumerFinanceMember 2023-06-30 0001418076 slrc:ContainersAndPackagingMember 2023-06-30 0001418076 slrc:DiversifiedFinancialServicesMember 2023-06-30 0001418076 slrc:HealthCareEquipmentAndSuppliesMember 2023-06-30 0001418076 slrc:TradingCompaniesAndDistributorsMember 2023-06-30 0001418076 slrc:ItServicesMember 2023-06-30 0001418076 slrc:LeisureEquipmentAndProductsMember 2023-06-30 0001418076 slrc:HotelsRestaurantsAndLeisureMember 2023-06-30 0001418076 slrc:AerospaceAndDefenseMember 2023-06-30 0001418076 slrc:OilGasAndConsumableFuelsMember 2023-06-30 0001418076 slrc:PersonalProductsMember 2023-06-30 0001418076 slrc:RoadAndRailMember 2023-06-30 0001418076 slrc:PackagedFoodsAndMeatsMember 2023-06-30 0001418076 slrc:WirelessTelecommunicationServicesMember 2023-06-30 0001418076 us-gaap:AssetManagement1Member 2023-06-30 0001418076 slrc:CommunicationsEquipmentMember 2023-06-30 0001418076 slrc:MultiSectorHoldingsMember 2023-06-30 0001418076 slrc:PharmaceuticalsMember 2023-06-30 0001418076 slrc:InsuranceMember 2023-06-30 0001418076 slrc:BiotechnologyMember 2023-06-30 0001418076 slrc:CapitalMarketsMember 2023-06-30 0001418076 slrc:ThriftsMortgageFinanceMember 2023-06-30 0001418076 slrc:CreditFacilityMember 2023-06-30 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2023-06-30 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2023-06-30 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2023-06-30 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2023-06-30 0001418076 slrc:CreditFacilityOneMember 2023-06-30 0001418076 slrc:TermLoansMember 2023-06-30 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2023-06-30 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2023-06-30 0001418076 slrc:RscAcquisitionIncMember slrc:InsuranceMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:PlasticsManagementLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:KidDistroHoldingsLlcMember us-gaap:TechnologySectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:PersonalProductsMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:HighStreetBuyerIncMember slrc:InsuranceMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:BaymarkHealthServicesIncMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:TilleyDistributionIncMember slrc:TradingCompaniesDistributorsMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:RxsenseHoldingsLlcMember slrc:DiversifiedConsumerServicesMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:PhynetDermatologyLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:IcimsIncMember us-gaap:TechnologySectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:HigginbothamInsuranceAgencyIncMember slrc:InsuranceMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:AegisToxicologySciencesCorporationMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:PinnacleTreatmentCentersIncMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:RqmCorpMember slrc:LifeSciencesToolsAndServicesMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:UrologyManagementHoldingsIncMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:SunmedGroupHoldingsLlcMember slrc:HealthCareEquipmentAndSuppliesMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:AtriaWealthSolutionsIncMember us-gaap:FinancialServicesSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcMember slrc:TradingCompaniesDistributorsMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:OnsMsoLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:FertilityItcInvestmentHoldcoLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember us-gaap:InvestorMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember srt:ManagementMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:SeniorSecuredRevolvingCreditFacilityMember slrc:SlrSeniorLendingProgramSpvLlcMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:ASCHoldcoLLCMember 2023-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SpectrumPharmaceuticalsInc.WarrantsMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SlrCreditSolutionsMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SlrHealthcareAblMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SenseonicsHoldingsIncMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SlrBusinessCreditMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:RdHoldcoIncClassBMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:RdHoldcoIncWarrantsMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:MeditrinaIncWarrantsMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:RdHoldcoIncMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:EssenceGroupHoldingsCorporationLumerisMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:KbhTopcoLlcKingsbridgeMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:ConventusOrthopaedicsIncMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:DelphinusMedicalTechnologiesIncMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:CardioFocusIncMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:CentrexionTherapeuticsIncMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:AtyrPharmaIncMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:VapothermIncMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:VenusConceptLtdMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SlrEquipmentFinanceEquityInterestsMember 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ArdelyxInc.Member 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:BridgebioPharmaInc.Member 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:GlookoInc.Member 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:MeditrinaInc.Member 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:NeuroneticsInc.Member 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:VapothermInc.Member 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ApeelTechnologyIncMember 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:CentrexionTherapeuticsInc.Member 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:OmniguideHoldingsInc.Member 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:OutsetMedicalInc.Member 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AlimeraSciencesInc.Member 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ArcutisBiotherapeuticsInc.Member 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:CerapedicsInc.Member 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:SpectrumPharmaceuticalsInc.Member 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AfgDallasIiiLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AmeraMexInternationalIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:BowmanEnergySolutionsLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:CPortStoneLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:ChampionAirLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:CkdHoldingsInc.Member 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:DongwonAutopartTechnologyIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:EquipmentOperatingLeasesLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:FirstNationalCapitalLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:FreightsolLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:GardaClTechnicalServicesIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:GmtCorporationMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:HtiLogisticsCorporationMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LocPerformanceProductsLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LuxVendingLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:MountainAirHelicoptersIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RoyalExpressIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RottenRockHardscapingAndTreeServiceMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SlrEquipmentFinanceMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:StarCoachesIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:U.s.CraneAndRiggingLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:WindRiverEnvironmentalLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:WorldwideFlightServicesInc.Member 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:InternationalAutomotiveComponentsGroupNorthAmericaIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:KoolPakLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:PcxAerostructuresLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RaneLightMetalCastingsIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RangoIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AeroOperatingLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AirMethodsCorporationMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:BoartLongyearCompanyMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:CapitalCityJetCenterIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:DrillersChoiceIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:EnvironmentalProtectionImprovementCompanyLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:FirstAmericanCommercialBancorpIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SmileyLiftingSolutionsLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SuperiorTransportationIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:TrinityEquipmentRentalsIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:WombleCompanyIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SignetMarineCorporationMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:StCoachesLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:TheSmedleyCompanySmedleyServicesIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:UpTruckingServicesLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:ZamborelliEnterprisesPacificSoutherFoundationMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LoyerCapitalLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LuxCreditConsultantsLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:OzziesIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RoyalCoachLinesIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:EnergyDrillingServicesLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:GeorgiaJetIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:HawkeyeContractingCompanyLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:BazziniLlcMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:ClubcorpHoldingsIncMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:EasyPakLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:KoreWirelessGroupInc.Member 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:MontefioreNyackHospitalMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:EnverusHoldingsIncFkaDrillingInfoHoldingsMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FoundationConsumerBrandsLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:HumanInterestIncMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AmericanTeleconferencingServicesLtd.Member 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AmerimarkIntermediateHoldingsLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:OneTouchDirectLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:PeterCFoyandAssociatesInsuranceServicesLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:PlasticsManagementLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ScpEyeCareLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ShoHoldingICorporationShoesForCrewsMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:CompositeTechnologyAcquisitionCorp.Member 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AtriaWealthSolutionsIncMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:BasicFunInc.Member 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:BaymarkHealthServicesIncMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AegisToxicologySciencesCorporationMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AllStateAgPartsLlcMember 2022-12-31 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AcresCommercialMortgageLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:KingsbridgeHoldingsLlcMember 2022-12-31 0001418076 slrc:SecondLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:RdHoldcoIncMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:IvyFertilityServicesLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AmericanTeleconferencingServicesLtdOneMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:HighStreetBuyerIncMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:PediatricHomeRespiratoryServicesLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcBluefinMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:GsmAcquisitionCorpMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:SparMarketingForceInc.Member 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:DeepintentInc.Member 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:PinnacleTreatmentCentersInc.Member 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:PptManagementHoldingsLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:RscAcquisitionIncMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:TaucManagementLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:WorldInsuranceAssociatesLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:VesscoMidcoHoldingsLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:TilleyDistributionIncMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:UltimateBakedGoodsMidcoLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:SouthernOrthodonticPartnersManagementLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:StrytenResourcesLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:SunmedGroupHoldingsLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:RqmCorp.Member 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:RxsenseHoldingsLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:PhynetDermatologyLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:NationalSpineAndPainCentersLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:OrthopedicCarePartnersManagementLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:LuxuryAssetCapitalLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:MauricesIncorporatedMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:NacHoldingsCorporationJaguarMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:LogixHoldingCompanyLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:KaseyaIncMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:KidDistroHoldingsLlcDistroKidMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:IcimsInc.Member 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:HigginbothamInsuranceAgencyIncMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ErieConstructionMidwestLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:BdgMediaInc.Member 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:EnhancedPermanentCapitalLlcMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:CopperRiverSeafoodsInc.Member 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ApexServicesPartnersLlcMember 2022-12-31 0001418076 slrc:PreferredEquityzeroPointFourPercentMember slrc:SointLlcMember 2022-12-31 0001418076 slrc:U.s.TreasuryBillMember slrc:CashEquivalentsAtFortyOnePointEightMember 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember 2022-12-31 0001418076 slrc:TotalInvestmentMember 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember 2022-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2022-12-31 0001418076 srt:MinimumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 srt:MaximumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 srt:WeightedAverageMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 srt:MinimumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 srt:MaximumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 srt:WeightedAverageMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 srt:WeightedAverageMember slrc:EquipmentFinancingMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 srt:WeightedAverageMember slrc:EquipmentFinancingMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 srt:MinimumMember slrc:PreferredEquityMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 srt:MaximumMember slrc:PreferredEquityMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 srt:WeightedAverageMember slrc:PreferredEquityMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 srt:MinimumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 srt:MaximumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 srt:WeightedAverageMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 srt:MinimumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2022-12-31 0001418076 srt:MaximumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2022-12-31 0001418076 srt:WeightedAverageMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel3Member slrc:BlackScholesPricingModelMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember 2022-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2022-12-31 0001418076 slrc:SlrBusinessCreditMember slrc:SeniorSecuredCommitmentsMember 2022-12-31 0001418076 slrc:NmcSeniorCreditFacilityMember 2022-12-31 0001418076 slrc:SlrBusinessCreditMember 2022-12-31 0001418076 slrc:KbhtMember 2022-12-31 0001418076 slrc:KingsbridgeHoldingsLlcMember 2022-12-31 0001418076 slrc:SeniorSecuredCommitmentsMember 2022-12-31 0001418076 slrc:SlrHealthcareAblCreditMember slrc:SeniorSecuredCommitmentsMember 2022-12-31 0001418076 slrc:SlrHealthcareAblCreditMember 2022-12-31 0001418076 slrc:AmerimarkMember 2022-12-31 0001418076 slrc:BridgeBioPharmaIncMember 2022-12-31 0001418076 slrc:OmniGuideHoldingsIncMember 2022-12-31 0001418076 slrc:VapothermInc.Member 2022-12-31 0001418076 slrc:IcimsInc.Member 2022-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember 2022-12-31 0001418076 slrc:SlrEquipmentFinanceMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CVAUSAManagementLLCMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:VertosMedicalInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BaysideOpcoLLCMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AmerimarkIntermediateHoldingsLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PediatricHomeRespiratoryServicesLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrHealthcareAblMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PinnacleTreatmentCentersInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:TilleyDistributionIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrCreditSolutionsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:HumanInterestIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BdgMediaInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OnsMsoLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:IcimsInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ArcutisBiotherapeuticsInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ArdelyxIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:LuxuryAssetCapitalLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MeditrinaInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:FoundationConsumerBrandsLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:VesscoMidcoHoldingsLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:RscAcquisitionIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ErieConstructionMidwestLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BasicFunInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ScpEyeCareLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:DeepintentInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SunmedGroupHoldingsLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:RxsenseHoldingsLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:EnverusHoldingsIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:HighStreetBuyerIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OrthopedicCarePartnersManagementLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SouthernOrthodonticPartnersManagementLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AllStateAgPartsLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:NacHoldingsCorporationMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PeterC.FoyAssociatesInsuranceServicesLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OutsetMedicalInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:GlookoInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:WorldInsuranceAssociatesLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AtriaWealthSolutionsIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CerapedicsInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:KaseyaIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MauricesIncorporatedMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:EnsHoldingsIiiCorpLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PlasticsManagementLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:UnitedDigestiveMsoParentLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:KidDistroHoldingsLlcDistroKidMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:UltimateBakedGoodsMidcoLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MontefioreNyackHospitalMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AmericanTeleconferencingServicesLtd.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CompositeTechnologyAcquisitionCorpMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:GsmAcquisitionCorpMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ApeelTechnologyIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SpectrumPharmaceuticalsInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CopperRiverSeafoodsInc.Member 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrEquipmentFinanceMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OneTouchDirectLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:TaucManagementLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:IvyFertilityServicesLlcMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BaymarkHealthServicesIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:UrologyManagementHoldingsIncMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SparMarketingForceInc.Member 2022-12-31 0001418076 slrc:DiversifiedFinancialServicesMember 2022-12-31 0001418076 slrc:HealthCareProvidersAndServicesMember 2022-12-31 0001418076 slrc:HealthCareEquipmentAndSuppliesMember 2022-12-31 0001418076 slrc:InsuranceMember 2022-12-31 0001418076 slrc:RoadAndRailMember 2022-12-31 0001418076 slrc:PersonalProductsMember 2022-12-31 0001418076 slrc:AirlinesMember 2022-12-31 0001418076 slrc:MachineryMember 2022-12-31 0001418076 slrc:ConsumerFinanceMember 2022-12-31 0001418076 slrc:FoodAndStaplesRetailingMember 2022-12-31 0001418076 slrc:PharmaceuticalsMember 2022-12-31 0001418076 slrc:MediaMember 2022-12-31 0001418076 slrc:LifeSciencesToolsAndServicesMember 2022-12-31 0001418076 slrc:CommercialServicesAndSuppliesMember 2022-12-31 0001418076 slrc:PackagedFoodsAndMeatsMember 2022-12-31 0001418076 slrc:LeisureEquipmentAndProductsMember 2022-12-31 0001418076 slrc:TransportationInfrastructureMember 2022-12-31 0001418076 us-gaap:AssetManagement1Member 2022-12-31 0001418076 slrc:HotelsRestaurantsAndLeisureMember 2022-12-31 0001418076 slrc:AutoComponentsMember 2022-12-31 0001418076 slrc:OilGasAndConsumableFuelsMember 2022-12-31 0001418076 slrc:ConstructionAndEngineeringMember 2022-12-31 0001418076 slrc:MultiSectorHoldingsMember 2022-12-31 0001418076 slrc:BiotechnologyMember 2022-12-31 0001418076 slrc:SoftwareMember 2022-12-31 0001418076 slrc:DiversifiedConsumerServicesMember 2022-12-31 0001418076 slrc:ThriftsMortgageFinanceMember 2022-12-31 0001418076 slrc:InternetAndCatalogRetailMember 2022-12-31 0001418076 slrc:FootwearMember 2022-12-31 0001418076 slrc:MetalsAndMiningMember 2022-12-31 0001418076 slrc:WaterUtilitiesMember 2022-12-31 0001418076 slrc:EnergyEquipmentAndServicesMember 2022-12-31 0001418076 slrc:ContainersAndPackagingMember 2022-12-31 0001418076 slrc:HealthCareTechnologyMember 2022-12-31 0001418076 slrc:CommunicationsEquipmentMember 2022-12-31 0001418076 slrc:ItServicesMember 2022-12-31 0001418076 slrc:SpecialtyRetailMember 2022-12-31 0001418076 slrc:FoodProductsMember 2022-12-31 0001418076 slrc:AerospaceAndDefenseMember 2022-12-31 0001418076 slrc:CapitalMarketsMember 2022-12-31 0001418076 slrc:AutoPartsAndEquipmentMember 2022-12-31 0001418076 slrc:WirelessTelecommunicationServicesMember 2022-12-31 0001418076 slrc:InternetSoftwareServicesMember 2022-12-31 0001418076 slrc:BuildingProductsMember 2022-12-31 0001418076 slrc:TradingCompaniesAndDistributorsMember 2022-12-31 0001418076 slrc:CreditFacilityOneMember 2022-12-31 0001418076 slrc:CreditFacilityMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2022-12-31 0001418076 slrc:CreditFacilityOneMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-12-31 0001418076 slrc:TermLoansMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-12-31 0001418076 slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcMember slrc:TradingCompaniesDistributorsMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:HighStreetBuyerIncMember slrc:InsuranceMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:KidDistroHoldingsLlcDistroKidMember us-gaap:TechnologySectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:AtriaWealthSolutionsIncMember us-gaap:FinancialServicesSectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:BaymarkHealthServicesIncMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:IvyFertilityServicesLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:PersonalProductsMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2023-04-01 2023-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember 2023-04-01 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-04-01 2023-06-30 0001418076 slrc:AdvisoryAgreementMember 2023-04-01 2023-06-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2023-04-01 2023-06-30 0001418076 us-gaap:EquitySecuritiesMember 2023-04-01 2023-06-30 0001418076 slrc:EquipmentFinancingMember 2023-04-01 2023-06-30 0001418076 slrc:PreferredEquityMember 2023-04-01 2023-06-30 0001418076 slrc:SlrBusinessCreditMember 2023-04-01 2023-06-30 0001418076 slrc:SharesIssuedInConnectionWithTheMergersMember 2023-04-01 2023-06-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2023-04-01 2023-06-30 0001418076 slrc:SlrHealthcareAblCreditMember 2023-04-01 2023-06-30 0001418076 slrc:SlrEquipmentFinanceMember 2023-04-01 2023-06-30 0001418076 slrc:SlrBusinessCreditFacilityMember 2023-04-01 2023-06-30 0001418076 slrc:SlrSeniorLendingProgramLlcMember 2023-04-01 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-04-01 2022-06-30 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2022-04-01 2022-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember 2022-04-01 2022-06-30 0001418076 slrc:AdvisoryAgreementMember 2022-04-01 2022-06-30 0001418076 slrc:SlrBusinessCreditMember 2022-04-01 2022-06-30 0001418076 slrc:SharesIssuedInConnectionWithTheMergersMember 2022-04-01 2022-06-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2022-04-01 2022-06-30 0001418076 slrc:SlrHealthcareAblCreditMember 2022-04-01 2022-06-30 0001418076 slrc:SlrEquipmentFinanceMember 2022-04-01 2022-06-30 0001418076 slrc:SlrBusinessCreditFacilityMember 2022-04-01 2022-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember 2022-01-01 2022-06-30 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2022-01-01 2022-06-30 0001418076 slrc:AdvisoryAgreementMember 2022-01-01 2022-06-30 0001418076 slrc:SlrBusinessCreditMember 2022-01-01 2022-06-30 0001418076 slrc:SharesIssuedInConnectionWithTheMergersMember 2022-01-01 2022-06-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2022-01-01 2022-06-30 0001418076 slrc:SlrHealthcareAblCreditMember 2022-01-01 2022-06-30 0001418076 slrc:SlrEquipmentFinanceMember 2022-01-01 2022-06-30 0001418076 slrc:SlrBusinessCreditFacilityMember 2022-01-01 2022-06-30 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AmericanTeleconferencingServicesLtd.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AmericanTeleconferencingServicesLtdOneMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ApexServicesPartnersLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AtriaWealthSolutionsIncMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:BdgMediaInc.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CompositeTechnologyAcquisitionCorp.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:DeepintentInc.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:EnhancedPermanentCapitalLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ErieConstructionMidwestLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FoundationConsumerBrandsLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:HighStreetBuyerIncMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:KaseyaIncMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:KidDistroHoldingsLlcDistroKidMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:KoreWirelessGroupInc.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:PeterCFoyandAssociatesInsuranceServicesLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:RxsenseHoldingsLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:VesscoMidcoHoldingsLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:WorldInsuranceAssociatesLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SparMarketingForceInc.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CopperRiverSeafoodsInc.Member 2023-01-01 2023-06-30 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AcresCommercialMortgageLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:LogixHoldingCompanyLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:HigginbothamInsuranceAgencyIncMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:BasicFunInc.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:RscAcquisitionIncMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ShoHoldingICorporationShoesForCrewsMember 2023-01-01 2023-06-30 0001418076 slrc:SecondLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:RdHoldcoInc.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:IcimsInc.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:KingsbridgeHoldingsLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:EnverusHoldingsIncFkaDrillingInfoHoldingsMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:HumanInterestIncMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:LuxuryAssetCapitalLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:MaxorAcquisitionInc.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:MontefioreNyackHospitalMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:NspcIntermediateCorpMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:OneTouchDirectLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:OnsMsoLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:OrthopedicCarePartnersManagementLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:PediatricHomeRespiratoryServicesLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:PhynetDermatologyLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:PinnacleTreatmentCentersInc.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:PlasticsManagementLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:RqmCorp.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ScpEyeCareLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SouthernOrthodonticPartnersManagementLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:StrytenResourcesLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SunmedGroupHoldingsLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:TaucManagementLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:TilleyDistributionIncMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:UltimateBakedGoodsMidcoLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:UnitedDigestiveMsoParentLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:UrologyManagementHoldingsIncMember 2023-01-01 2023-06-30 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FgiWorldwideLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AegisToxicologySciencesCorporationMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AllStateAgPartsLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AmerimarkIntermediateHoldingsLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AmeriMarkIntermediateHoldingsLLCOneMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:BaymarkHealthServicesIncMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:BaysideOpcoLLCMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:BaysideOpcoLLCOneMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:BaysideParentLLCMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CVAUSAManagementLLCMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcBluefinMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FertilityInvestmentHoldcoLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:GsmAcquisitionCorpMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:MauricesIncorporatedMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ApeelTechnologyIncMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:BridgebioPharmaInc.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CentrexionTherapeuticsInc.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SpectrumPharmaceuticalsInc.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AlimeraSciencesInc.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ArcutisBiotherapeuticsInc.Member 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:RoyalExpressIncMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:SmileyLiftingSolutionsLlcMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:StCoachesLlcMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:StarCoachesIncMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:SuperiorTransportationIncMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:TheSmedleyCompanySmedleyServicesIncMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:OzziesIncMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:PcxAerostructuresLlcMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:RangoIncMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:RayzorsEdgeLlcMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:RhLandConstructionLlcHarborDredgingLaIncMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:RoyalCoachLinesIncMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:HtiLogisticsCorporationMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:KoolPakLlcMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:LuxCreditConsultantsLlcMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:MirandaLogisticsEnterpriseIncMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:MountainAirHelicoptersIncMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:NoLimitConstructionServicesLlcMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:EasyPakLlcMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:EnvironmentalProtectionImprovementCompanyLlcMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:ExtremeSteelCraneRiggingLlcMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:FreightsolLlcMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:GardaClTechnicalServicesIncMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:HawkeyeContractingCompanyLlcMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:BowmanEnergySolutionsLlcMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:CPortStoneLlcMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:CkdHoldingsInc.Member 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:ClubcorpHoldingsIncMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:CompleteEquipmentRentalsLlcMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:DrillersChoiceIncMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:VertosMedicalInc.Member 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:AaCraneAndRiggingLlcMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:AeroOperatingLlcMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:AmeraMexInternationalIncMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:BazziniLlcMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:BoartLongyearCompanyMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:EnergyDrillingServicesLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:MeditrinaInc.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:NeuroneticsInc.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:OmniguideHoldingsInc.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:OutsetMedicalInc.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:VapothermInc.Member 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:ZamborelliEnterprisesPacificSoutherFoundationMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:AirMethodsCorporationMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:LoyerCapitalLlcMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:LuxVendingLlcMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:RottenRockHardscapingAndTreeServiceMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:CapitalCityJetCenterIncMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:SignetMarineCorporationMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:SlrEquipmentFinanceMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:WindRiverEnvironmentalLlcMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:WorldwideFlightServicesInc.Member 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:EquipmentOperatingLeasesLlcMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:FirstNationalCapitalLlcMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:FirstAmericanCommercialBancorpIncMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:GeorgiaJetIncMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:GmtCorporationMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:InternationalAutomotiveComponentsGroupNorthAmericaIncMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:LocPerformanceProductsLlcMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:RaneLightMetalCastingsIncMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CerapedicsInc.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ArdelyxInc.Member 2023-01-01 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:GlookoInc.Member 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:AfgDallasIiiLlcMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:CarolinasContractingLlcMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:DongwonAutopartTechnologyIncMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:EssenceGroupHoldingsCorporationLumerisMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:KbhTopcoLlcKingsbridgeMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:RdHoldcoIncMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:RdHoldcoIncWarrantsMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:SlrBusinessCreditMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:AtyrPharmaIncMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:TrinityEquipmentRentalsIncMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:U.s.CraneAndRiggingLlcMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:UpTruckingServicesLlcMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:WasteProOfFloridaInc.WasteProUsaIncMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:WombleCompanyIncMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:BaysideParentLLCMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:CardioFocusIncMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:ConventusOrthopaedicsIncMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:CentrexionTherapeuticsIncMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:SlrCreditSolutionsMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:SpectrumPharmaceuticalsInc.WarrantsMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:RdHoldcoIncClassBMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:SlrHealthcareAblMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:DelphinusMedicalTechnologiesIncMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:MeditrinaIncWarrantsMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:NspcHoldingsLlcNationalSpineMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:SenseonicsHoldingsIncMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:SlramiTopcoBlockerLlcMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:VapothermIncMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:SlrEquipmentFinanceEquityInterestsMember 2023-01-01 2023-06-30 0001418076 slrc:PreferredEquityzeroPointFourPercentMember slrc:SointLlcMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:VenusConceptLtdMember 2023-01-01 2023-06-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember slrc:VertosMedicalInc.WarrantsMember 2023-01-01 2023-06-30 0001418076 slrc:U.s.TreasuryBillMember slrc:CashEquivalentsThirtyFourPointZeroPercentMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:AeroOperatingLlcMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:AeroOperatingLlcMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:AfgDallasIiiLlcMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:AfgDallasIiiLlcMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:FreightsolLlcMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:FreightsolLlcMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:HtiLogisticsCorporationMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:DrillersChoiceIncMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:DrillersChoiceIncMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:EnergyDrillingServicesLlcMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:EnergyDrillingServicesLlcMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:FirstAmericanCommercialBancorpIncMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:FirstAmericanCommercialBancorpIncMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:CkdHoldingsInc.Member 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:CkdHoldingsInc.Member 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:ClubcorpHoldingsIncMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:ClubcorpHoldingsIncMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:CompleteEquipmentRentalsLlcMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:CompleteEquipmentRentalsLlcMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:AirMethodsCorporationMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:AirMethodsCorporationMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:BoartLongyearCompanyMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:BoartLongyearCompanyMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:CarolinasContractingLlcMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:CarolinasContractingLlcMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:SuperiorTransportationIncMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:SuperiorTransportationIncMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:TrinityEquipmentRentalsIncMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:TrinityEquipmentRentalsIncMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:WindRiverEnvironmentalLlcMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:WindRiverEnvironmentalLlcMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:RayzorsEdgeLlcMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:RayzorsEdgeLlcMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:SmileyLiftingSolutionsLlcMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:SmileyLiftingSolutionsLlcMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:StCoachesLlcMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:StCoachesLlcMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:LuxCreditConsultantsLlcMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:LuxCreditConsultantsLlcMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:LuxVendingLlcMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:LuxVendingLlcMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:RangoIncMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:RangoIncMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:WorldwideFlightServicesInc.Member 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:WorldwideFlightServicesInc.Member 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:HtiLogisticsCorporationMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:LoyerCapitalLlcMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:LoyerCapitalLlcMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:CapitalCityJetCenterIncMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySevenPointSevenPercentMember slrc:CapitalCityJetCenterIncMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:AdvisoryAgreementMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:AdvisoryAgreementMember 2023-01-01 2023-06-30 0001418076 slrc:AdvisoryAgreementMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingMember 2023-01-01 2023-06-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2023-01-01 2023-06-30 0001418076 us-gaap:EquitySecuritiesMember 2023-01-01 2023-06-30 0001418076 slrc:PreferredEquityMember 2023-01-01 2023-06-30 0001418076 slrc:SpreadOneMember 2023-01-01 2023-06-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-01-01 2023-06-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputRecoverableAmountMember slrc:ValuationTechniqueRecoveryApproachMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-01-01 2023-06-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2023-01-01 2023-06-30 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-01-01 2023-06-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2023-01-01 2023-06-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2023-01-01 2023-06-30 0001418076 slrc:SlrBusinessCreditMember 2023-01-01 2023-06-30 0001418076 slrc:SharesIssuedInConnectionWithTheMergersMember 2023-01-01 2023-06-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2023-01-01 2023-06-30 0001418076 slrc:CreditFacilityMember 2023-01-01 2023-06-30 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2023-01-01 2023-06-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2023-01-01 2023-06-30 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2023-01-01 2023-06-30 0001418076 slrc:SlrHealthcareAblCreditMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrBusinessCreditMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncDebtMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrHealthcareAblMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideOpcoLLCMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:AmeriMarkIntermediateHoldingsOneLLCMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:AmerimarkIntermediateHoldingsLlcMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:SlramiTopcoBlockerLlcMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideParentLlcEquityMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideOpcoLLCOneMember 2023-01-01 2023-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideParentLlcLoanMember 2023-01-01 2023-06-30 0001418076 srt:MaximumMember slrc:TermLoanAndCreditFacilityMember slrc:LondonInterbankOfferedRateMember slrc:CitiBankNaMember 2023-01-01 2023-06-30 0001418076 srt:MinimumMember slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2023-01-01 2023-06-30 0001418076 slrc:SlrEquipmentFinanceMember 2023-01-01 2023-06-30 0001418076 us-gaap:RevolvingCreditFacilityMember slrc:SlrBusinessCreditFacilityMember 2023-01-01 2023-06-30 0001418076 slrc:SlrBusinessCreditFacilityMember 2023-01-01 2023-06-30 0001418076 slrc:FertilityItcInvestmentHoldcoLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:OnsMsoLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:TilleyDistributionIncMember slrc:TradingCompaniesDistributorsMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:PersonalProductsMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:HighStreetBuyerIncMember slrc:InsuranceMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:RscAcquisitionIncMember slrc:InsuranceMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:SunmedGroupHoldingsLlcMember slrc:HealthCareEquipmentAndSuppliesMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:AtriaWealthSolutionsIncMember us-gaap:FinancialServicesSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:KidDistroHoldingsLlcMember us-gaap:TechnologySectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:PinnacleTreatmentCentersIncMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:UrologyManagementHoldingsIncMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:AegisToxicologySciencesCorporationMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:BaymarkHealthServicesIncMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcMember slrc:TradingCompaniesDistributorsMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:HigginbothamInsuranceAgencyIncMember slrc:InsuranceMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:IcimsIncMember us-gaap:TechnologySectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:PhynetDermatologyLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:PlasticsManagementLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:RqmCorpMember slrc:LifeSciencesToolsAndServicesMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:RxsenseHoldingsLlcMember slrc:DiversifiedConsumerServicesMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-06-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ArcutisBiotherapeuticsInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ArdelyxInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:BridgebioPharmaInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:GlookoInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AlimeraSciencesInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ApeelTechnologyIncMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:CentrexionTherapeuticsInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:CerapedicsInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:SpectrumPharmaceuticalsInc.Member 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:CapitalCityJetCenterIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:EquipmentOperatingLeasesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:FirstNationalCapitalLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:GeorgiaJetIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LoyerCapitalLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LuxVendingLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SlrEquipmentFinanceMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:WindRiverEnvironmentalLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:WorldwideFlightServicesInc.Member 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SlrEquipmentFinanceEquityInterestsMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:InternationalAutomotiveComponentsGroupNorthAmericaIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LocPerformanceProductsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SignetMarineCorporationMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:DongwonAutopartTechnologyIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:ZamborelliEnterprisesPacificSoutherFoundationMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RaneLightMetalCastingsIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RottenRockHardscapingAndTreeServiceMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:EnergyDrillingServicesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:FirstAmericanCommercialBancorpIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:GmtCorporationMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AfgDallasIiiLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AirMethodsCorporationMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:ChampionAirLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AeroOperatingLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AmeraMexInternationalIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:BazziniLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:BoartLongyearCompanyMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:BowmanEnergySolutionsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:CPortStoneLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:CkdHoldingsInc.Member 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:ClubcorpHoldingsIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:DrillersChoiceIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:EasyPakLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:EnvironmentalProtectionImprovementCompanyLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:FreightsolLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:GardaClTechnicalServicesIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:HawkeyeContractingCompanyLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:HtiLogisticsCorporationMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:KoolPakLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LuxCreditConsultantsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:MountainAirHelicoptersIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:OzziesIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:PcxAerostructuresLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RangoIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RoyalCoachLinesIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RoyalExpressIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SmileyLiftingSolutionsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:StCoachesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:StarCoachesIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SuperiorTransportationIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:TheSmedleyCompanySmedleyServicesIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:TrinityEquipmentRentalsIncMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:U.s.CraneAndRiggingLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:UpTruckingServicesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:WombleCompanyIncMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:MeditrinaInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:NeuroneticsInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:OmniguideHoldingsInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:OutsetMedicalInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:VapothermInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AmericanTeleconferencingServicesLtd.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AmericanTeleconferencingServicesLtdOneMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ApexServicesPartnersLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AtriaWealthSolutionsIncMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:BdgMediaInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:SouthernOrthodonticPartnersManagementLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:StrytenResourcesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:SunmedGroupHoldingsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:TaucManagementLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:TilleyDistributionIncMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:UltimateBakedGoodsMidcoLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:PhynetDermatologyLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:PinnacleTreatmentCentersInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:PlasticsManagementLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:PptManagementHoldingsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:RqmCorp.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ScpEyeCareLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:LuxuryAssetCapitalLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:MontefioreNyackHospitalMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:NationalSpineAndPainCentersLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:OneTouchDirectLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:OrthopedicCarePartnersManagementLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:PediatricHomeRespiratoryServicesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AmerimarkIntermediateHoldingsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:BaymarkHealthServicesIncMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcBluefinMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:GsmAcquisitionCorpMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:HumanInterestIncMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:IvyFertilityServicesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AegisToxicologySciencesCorporationMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AllStateAgPartsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:KingsbridgeHoldingsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:AcresCommercialMortgageLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:KoreWirelessGroupInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:LogixHoldingCompanyLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ShoHoldingICorporationShoesForCrewsMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:CopperRiverSeafoodsInc.Member 2022-01-01 2022-12-31 0001418076 slrc:SecondLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:RdHoldcoIncMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:WorldInsuranceAssociatesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:DeepintentInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:EnverusHoldingsIncFkaDrillingInfoHoldingsMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:MauricesIncorporatedMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:HighStreetBuyerIncMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:NacHoldingsCorporationJaguarMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:PeterCFoyandAssociatesInsuranceServicesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:RscAcquisitionIncMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:RxsenseHoldingsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:SparMarketingForceInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:VesscoMidcoHoldingsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:CompositeTechnologyAcquisitionCorp.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:EnhancedPermanentCapitalLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:ErieConstructionMidwestLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:IcimsInc.Member 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:KaseyaIncMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:KidDistroHoldingsLlcDistroKidMember 2022-01-01 2022-12-31 0001418076 slrc:U.s.TreasuryBillMember slrc:CashEquivalentsAtFortyOnePointEightMember 2022-01-01 2022-12-31 0001418076 slrc:PreferredEquityzeroPointFourPercentMember slrc:SointLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:AtyrPharmaIncMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:CardioFocusIncMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:CentrexionTherapeuticsIncMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:ConventusOrthopaedicsIncMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:FoundationConsumerBrandsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:HigginbothamInsuranceAgencyIncMember 2022-01-01 2022-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember slrc:BasicFunInc.Member 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:RdHoldcoIncWarrantsMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SenseonicsHoldingsIncMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SlrBusinessCreditMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SlrCreditSolutionsMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SlrHealthcareAblMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:DelphinusMedicalTechnologiesIncMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:EssenceGroupHoldingsCorporationLumerisMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:KbhTopcoLlcKingsbridgeMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:MeditrinaIncWarrantsMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:RdHoldcoIncMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:RdHoldcoIncClassBMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:SpectrumPharmaceuticalsInc.WarrantsMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:VapothermIncMember 2022-01-01 2022-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember slrc:VenusConceptLtdMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AeroOperatingLlcMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AeroOperatingLlcMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AirMethodsCorporationMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AirMethodsCorporationMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:BoartLongyearCompanyMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:BoartLongyearCompanyMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:CkdHoldingsInc.Member 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:CkdHoldingsInc.Member 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:ClubcorpHoldingsIncMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:ClubcorpHoldingsIncMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:EnergyDrillingServicesLlcMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:EnergyDrillingServicesLlcMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:FirstAmericanCommercialBancorpIncMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:FirstAmericanCommercialBancorpIncMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:FreightsolLlcMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:FreightsolLlcMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:GardaClTechnicalServicesIncMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:GardaClTechnicalServicesIncMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:HtiLogisticsCorporationMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:HtiLogisticsCorporationMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LoyerCapitalLlcMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LoyerCapitalLlcMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LuxCreditConsultantsLlcMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LuxCreditConsultantsLlcMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LuxVendingLlcMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:LuxVendingLlcMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RangoIncMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:RangoIncMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SmileyLiftingSolutionsLlcMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SmileyLiftingSolutionsLlcMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:StCoachesLlcMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:StCoachesLlcMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SuperiorTransportationIncMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:SuperiorTransportationIncMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:TrinityEquipmentRentalsIncMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:TrinityEquipmentRentalsIncMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:WindRiverEnvironmentalLlcMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:WindRiverEnvironmentalLlcMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:WorldwideFlightServicesInc.Member 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:WorldwideFlightServicesInc.Member 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AfgDallasIiiLlcMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:AfgDallasIiiLlcMember 2022-01-01 2022-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:CapitalCityJetCenterIncMember 2022-01-01 2022-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentySixPointSixPercentMember slrc:CapitalCityJetCenterIncMember 2022-01-01 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember 2022-01-01 2022-12-31 0001418076 slrc:PreferredEquityMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingMember 2022-01-01 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-01-01 2022-12-31 0001418076 slrc:SpreadOneMember 2022-01-01 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-01-01 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-01-01 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-01-01 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-01-01 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2022-01-01 2022-12-31 0001418076 slrc:SlrHealthcareAblCreditMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncDebtMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SoaggLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrHealthcareAblMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrBusinessCreditMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2022-01-01 2022-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember 2022-01-01 2022-12-31 0001418076 slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcMember slrc:TradingCompaniesDistributorsMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:HighStreetBuyerIncMember slrc:InsuranceMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:PersonalProductsMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:BaymarkHealthServicesIncMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:IvyFertilityServicesLlcMember us-gaap:HealthcareSectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:KidDistroHoldingsLlcDistroKidMember us-gaap:TechnologySectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:AtriaWealthSolutionsIncMember us-gaap:FinancialServicesSectorMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 us-gaap:IPOMember 2010-02-10 2010-02-10 0001418076 us-gaap:PrivatePlacementMember 2010-02-10 2010-02-10 0001418076 us-gaap:OverAllotmentOptionMember 2010-02-10 0001418076 us-gaap:PrivatePlacementMember 2010-02-10 0001418076 slrc:SunsCompanyMergerMember us-gaap:CommonStockMember 2022-04-01 2022-04-01 0001418076 slrc:CreditFacilityOneMember 2022-04-01 0001418076 slrc:SunsCompanyMergerMember us-gaap:CommonStockMember 2022-04-01 0001418076 slrc:SlrHealthcareAblCreditMember 2023-01-01 2023-03-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2021-12-31 0001418076 slrc:CreditFacilityOneMember 2021-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2021-12-31 0001418076 slrc:CreditFacilityMember 2021-12-31 0001418076 slrc:NefpassFacilityMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-12-31 0001418076 slrc:TermLoansMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-01-06 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2021-09-14 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2019-12-18 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2019-12-18 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2017-11-22 2021-12-31 0001418076 srt:MinimumMember slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2011-08-26 0001418076 srt:MaximumMember slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2011-08-26 0001418076 srt:MinimumMember slrc:TermLoanAndCreditFacilityMember slrc:SecuredOvernightFinancingRateMember slrc:CitiBankNaMember 2011-08-26 2011-12-31 0001418076 srt:MaximumMember slrc:TermLoanAndCreditFacilityMember slrc:SecuredOvernightFinancingRateMember slrc:CitiBankNaMember 2011-08-26 2011-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember slrc:TermLoanMember 2021-12-28 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember us-gaap:LineOfCreditMember 2021-12-28 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2021-12-28 0001418076 srt:MaximumMember slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2021-12-28 2021-12-31 0001418076 srt:MinimumMember slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2021-12-28 2021-12-31 0001418076 slrc:CrystalFinancialMember slrc:SlrBusinessCreditFacilityMember 2012-11-30 2012-11-30 0001418076 slrc:CrystalFinancialMember 2012-11-30 0001418076 slrc:CrystalFinancialMember slrc:SlrBusinessCreditFacilityMember 2012-12-28 2012-12-28 0001418076 slrc:CrystalFinancialMember slrc:SlrBusinessCreditFacilityMember 2012-12-28 0001418076 us-gaap:RevolvingCreditFacilityMember 2012-12-28 0001418076 slrc:SlrBusinessCreditFacilityMember 2016-07-28 2016-07-28 0001418076 slrc:CrystalFinancialMember slrc:SlrBusinessCreditFacilityMember 2016-07-28 0001418076 slrc:CrystalCapitalFinancialHoldingsLlcMember slrc:SlrBusinessCreditFacilityMember 2016-07-28 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2022-12-12 0001418076 slrc:SlrBusinessCreditFacilityMember 2022-12-12 0001418076 slrc:SeniorSecuredRevolvingCreditFacilityMember slrc:SlrSeniorLendingProgramSpvLlcMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-12 0001418076 slrc:SlrEquipmentFinanceMember 2017-07-31 0001418076 slrc:SlrEquipmentFinanceMember 2019-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2020-11-03 2020-11-03 0001418076 srt:MaximumMember slrc:KingsbridgeHoldingsLlcMember 2020-11-03 0001418076 srt:MinimumMember slrc:KingsbridgeHoldingsLlcMember 2020-11-03 0001418076 slrc:KingsbridgeHoldingsLlcMember 2020-11-03 0001418076 slrc:SlrHealthcareAblMember 2013-09-30 0001418076 srt:MaximumMember slrc:SlrHealthcareAblCreditMember 2013-09-30 0001418076 srt:MinimumMember slrc:SlrHealthcareAblCreditMember 2013-09-30 0001418076 srt:MinimumMember slrc:SlrHealthcareAblMember 2022-09-30 0001418076 srt:MaximumMember slrc:SlrHealthcareAblMember 2022-09-30 0001418076 srt:MinimumMember slrc:SlrHealthcareAblCreditMember 2014-03-31 0001418076 slrc:SlrHealthcareAblCreditMember 2014-06-27 0001418076 srt:MinimumMember slrc:SlrHealthcareAblCreditMember 2016-05-27 0001418076 srt:MaximumMember slrc:SlrHealthcareAblCreditMember 2016-05-27 0001418076 slrc:EspSscCorporationMember 2017-10-20 0001418076 slrc:NorthMillCapitalLlcMember 2017-10-20 0001418076 slrc:EspSscCorporationMember 2018-05-01 0001418076 slrc:NorthMillCapitalLlcMember 2018-05-01 0001418076 slrc:SummitFinancialResourcesMember 2019-06-28 0001418076 slrc:NmHoldcoMember 2019-06-28 0001418076 slrc:NmcsCreditFacilityMember 2019-06-28 0001418076 slrc:SlrHealthcareAblCreditMember 2019-06-28 0001418076 slrc:FastPayPartnersLlcMember 2021-06-03 2021-06-03 0001418076 slrc:SunsMember 2021-06-03 0001418076 slrc:NmcsCreditFacilityMember 2021-06-03 0001418076 slrc:FastPayPartnersLlcMember 2021-06-03 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrSeniorLendingProgramLlcMember 2022-10-12 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember us-gaap:InvestorMember slrc:SlrSeniorLendingProgramLlcMember 2022-10-12 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember srt:ManagementMember slrc:SlrSeniorLendingProgramLlcMember 2022-10-12 0001418076 slrc:SeniorSecuredRevolvingCreditFacilityMember slrc:SlrSeniorLendingProgramSpvLlcMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-12 2022-12-12 0001418076 slrc:SeniorSecuredRevolvingCreditFacilityMember slrc:SlrSeniorLendingProgramSpvLlcMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-12 2022-12-12 0001418076 slrc:SlrSeniorLendingProgramLlcMember 2022-12-01 2022-12-31 0001418076 slrc:BoardMember us-gaap:SubsequentEventMember 2023-08-08 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2013-01-01 2013-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2014-01-01 2014-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2015-01-01 2015-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2016-01-01 2016-12-31 0001418076 slrc:BoardMember us-gaap:SubsequentEventMember 2023-07-05 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2019-12-18 2019-12-18 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2017-11-22 0001418076 slrc:SlrEquipmentFinanceMember 2019-09-30 2019-09-30 0001418076 slrc:SlrHealthcareAblCreditMember 2016-05-27 2016-05-27 0001418076 slrc:SlrHealthcareAblCreditMember 2019-06-28 2019-06-28 0001418076 slrc:SlrHealthcareAblCreditMember 2023-03-31 0001418076 slrc:SlrHealthcareAblCreditMember 2013-09-30 2013-09-30 0001418076 slrc:TermLoansMember 2013-12-31 0001418076 slrc:CreditFacilityMember 2013-12-31 0001418076 slrc:SeniorSecuredNotesMember 2013-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2013-12-31 0001418076 slrc:CreditFacilityMember 2014-12-31 0001418076 slrc:TermLoansMember 2014-12-31 0001418076 slrc:SeniorSecuredNotesMember 2014-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2014-12-31 0001418076 slrc:CreditFacilityMember 2015-12-31 0001418076 slrc:TermLoansMember 2015-12-31 0001418076 slrc:SeniorSecuredNotesMember 2015-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2015-12-31 0001418076 slrc:CreditFacilityMember 2016-12-31 0001418076 slrc:TermLoansMember 2016-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2016-12-31 0001418076 slrc:SeniorSecuredNotesMember 2016-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2016-12-31 0001418076 slrc:CreditFacilityMember 2017-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2017-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2017-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2017-12-31 0001418076 slrc:TermLoansMember 2017-12-31 0001418076 slrc:SeniorSecuredNotesMember 2017-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2017-12-31 0001418076 slrc:CreditFacilityMember 2018-12-31 0001418076 slrc:SslpFacilityMember 2018-12-31 0001418076 slrc:NefpassFacilityMember 2018-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2018-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2018-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2018-12-31 0001418076 slrc:TermLoansMember 2018-12-31 0001418076 slrc:CreditFacilityMember 2019-12-31 0001418076 slrc:SslpFacilityMember 2019-12-31 0001418076 slrc:NefpassFacilityMember 2019-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2019-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2019-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2019-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2019-12-31 0001418076 slrc:TermLoansMember 2019-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2019-12-31 0001418076 slrc:CreditFacilityMember 2020-12-31 0001418076 slrc:NefpassFacilityMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2020-12-31 0001418076 slrc:TermLoansMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2020-12-31 0001418076 slrc:EquipmentFinancingMember 2023-03-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2023-03-31 0001418076 us-gaap:EquitySecuritiesMember 2023-03-31 0001418076 slrc:PreferredEquityMember 2023-03-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2023-06-30 0001418076 us-gaap:EquitySecuritiesMember 2023-06-30 0001418076 slrc:EquipmentFinancingMember 2023-06-30 0001418076 slrc:PreferredEquityMember 2023-06-30 0001418076 slrc:PreferredEquityMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncDebtMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrHealthcareAblMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrBusinessCreditMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:AmeriMarkIntermediateHoldingsOneLLCMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:AmerimarkIntermediateHoldingsLlcMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideOpcoLLCMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideParentLlcEquityMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:SlramiTopcoBlockerLlcMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideOpcoLLCOneMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideParentLlcLoanMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrHealthcareAblMember 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrBusinessCreditMember 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrSeniorLendingProgramLlcMember 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncDebtMember 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2023-06-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2023-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2023-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideOpcoLLCOneMember 2023-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideParentLlcLoanMember 2023-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideParentLlcEquityMember 2023-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:SlramiTopcoBlockerLlcMember 2023-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideOpcoLLCMember 2023-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:AmerimarkIntermediateHoldingsLlcMember 2023-06-30 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:AmeriMarkIntermediateHoldingsOneLLCMember 2023-06-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember 2021-12-31 0001418076 slrc:PreferredEquityMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrBusinessCreditMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrSeniorLendingProgramLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrHealthcareAblMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SoaggLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncDebtMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SoaggLlcMember 2022-12-31 iso4217:USD shares pure utr:Day utr:Year iso4217:USD shares slrc:issuers slrc:loans slrc:fund slrc:Customers false Q2 0001418076 --12-31 NY http://fasb.org/us-gaap/2023#UnrealizedGainLossOnInvestments http://fasb.org/us-gaap/2023#UnrealizedGainLossOnInvestments 10-Q true 2023-06-30 2023 false 814-00754 SLR INVESTMENT CORP. MD 26-1381340 500 Park Avenue New York 10022 212 993-1670 Common Stock, par value $0.01 per share SLRC NASDAQ Yes Yes Large Accelerated Filer false false false 54554634 1358634 1312701 1340356000 1289082000 59803 0 42157000 0 831089 821886 798913000 797594000 14428000 10743000 333200000 417590000 333200000 417590000 10754000 11192000 11071000 9706000 1469000 1124000 882000 664000 2553230000 2537695000 1219200000 1093200000 6167000 7202000 1213033000 1085998000 333200000 417611000 0 7481000 7878000 7964000 5513000 5422000 6937000 7943000 2166000 1488000 3698000 4057000 1572425000 1537964000 0.01 0.01 200000000 200000000 54554634 54554634 54555380 54555380 546000 546000 1162559000 1162569000 -182300000 -163384000 980805000 999731000 17.98 18.33 41267000 28855000 78605000 49517000 265000 0 265000 0 2814000 1922000 5525000 4483000 11177000 11083000 22353000 20798000 757000 925000 3079000 988000 57000 -5000 57000 0 56337000 42780000 109884000 75786000 7878000 6913000 15584000 14129000 5638000 4734000 11147000 4734000 17842000 10352000 33128000 18680000 1480000 1369000 2988000 2552000 948000 476000 2449000 3277000 33786000 23844000 65296000 43372000 -125000 -1358000 -235000 -1358000 33661000 22486000 65061000 42014000 22676000 20294000 44823000 33772000 498000 -105000 1185000 -75000 5181000 -11764000 -9090000 -25262000 -3216000 0 -3216000 0 -6144000 -24071000 -7883000 -22618000 -4179000 -35835000 -20189000 -47880000 -3681000 -35940000 -19004000 -47955000 18995000 -15646000 25819000 -14183000 0.35 0.35 -0.29 -0.29 0.47 0.47 -0.29 -0.29 22676000 20294000 44823000 33772000 498000 -105000 1185000 -75000 -4179000 -35835000 -20189000 -47880000 18995000 -15646000 25819000 -14183000 22588000 22457000 44735000 39784000 -220000 0 0 0 22368000 22457000 44735000 39784000 0 226839000 0 226839000 0 0 10000 0 0 226839000 -10000 226839000 -3373000 188736000 -18926000 172872000 984178000 826417000 999731000 842281000 980805000 1015153000 980805000 1015153000 0 12511825 0 12511825 0 0 746 0 0 12511825 -746 12511825 -25819000 14183000 1185000 -75000 -20189000 -47880000 -368924000 -160973000 267224000 179122000 -5850000 -4769000 -6206000 -1019000 2000 898000 -345000 293000 1365000 1863000 -438000 1615000 218000 360000 0 -2313000 -84411000 28871000 -86000 -519000 91000 1512000 678000 -1733000 -1006000 2618000 -359000 1619000 1035000 1009000 -154479000 79176000 52216000 49625000 0 134914000 75000000 150000000 400000000 338404000 199000000 298100000 10000 0 73774000 -24407000 -80705000 54769000 428333000 322935000 347628000 377704000 34134000 16062000 0 226839000 244691000 226839000 1.344 Health Care Providers & Services S+550 0.01 0.1084 2018-05-07 2025-05-09 13480000 13249000 13480000 Trading Companies & Distributors S+575 0.01 0.1125 2022-04-01 2026-09-01 4494000 4393000 4494000 Communications Equipment L+650 0.01 0 2016-05-05 2021-09-09 36135000 25926000 0 Communications Equipment L+650 0.01 0 2021-09-17 2023-04-07 6115000 5971000 0 Internet & Catalog Retail P+475 0.01 0.13 2023-06-16 2023-08-04 464000 464000 464000 Internet & Catalog Retail S+800 0.01 0 2021-07-28 2026-10-15 18743000 17071000 5134000 Diversified Consumer Services S+525 0.01 0.1066 2022-08-31 2025-07-31 13916000 13607000 13916000 Diversified Financial Services S+650 0.01 0.12 2018-09-14 2024-02-29 8098000 8074000 8098000 Specialty Retail S+650 0.01 0.1204 2020-10-30 2023-10-30 2150000 2146000 2150000 Health Care Providers & Services S+500 0.01 0.105 2022-04-01 2027-06-11 8308000 8026000 8308000 Healthcare Providers & Services S+700 0.01 0.1273 2023-05-31 2026-05-31 846000 846000 846000 Healthcare Providers & Services S+725 0.01 0.1264 2023-05-31 2026-05-31 18224000 18224000 18224000 Healthcare Providers & Services S+1000 0.01 0.1539 2023-05-31 2026-05-31 4773000 4773000 4773000 Media L+900 0.0025 0.1452 2022-07-18 2025-07-31 6461000 6461000 6461000 Diversified Consumer Services S+575 0.0075 0.1125 2021-06-29 2028-06-29 39680000 39053000 39680000 Building Products S+450 0.01 0.0989 2022-04-01 2025-02-01 10999000 10691000 10999000 Food Products P+275 0 0.1175 2022-08-31 2025-04-23 3842000 3842000 3842000 Health Care Providers & Services S+650 0.01 0.1159 2023-05-22 2029-05-22 14260000 13837000 13832000 Media P+175 0 0.10 2022-10-12 2025-03-25 18075000 18075000 18075000 Capital Markets S+700 0.01 0.1193 2020-12-29 2025-12-29 43435000 42618000 43435000 Trading Companies & Distributors S+475 0.01 0.1009 2022-04-01 2025-12-31 4640000 4504000 4640000 IT Services S+450 0 0.097 2022-04-01 2025-07-30 11312000 10941000 11312000 Building Products S+475 0.01 0.1034 2022-04-01 2027-07-30 8686000 8391000 8686000 Health Care Providers & Services S+650 0.01 0.1163 2023-01-04 2029-01-03 22710000 22068000 22710000 Personal Products S+625 0.01 0.1147 2021-02-12 2027-02-12 30088000 29411000 30088000 Leisure Equipment & Products S+500 0.01 0.105 2022-04-01 2026-11-16 10967000 10573000 10857000 Insurance S+525 0.01 0.1045 2022-04-01 2026-11-25 4898000 4724000 4898000 Insurance S+600 0.0075 0.1139 2022-04-01 2028-04-16 5162000 4897000 5162000 Internet Software & Services S+785 0.01 0.1301 2022-06-30 2027-07-01 20104000 19863000 20104000 Software S+725 0.0075 0.1238 2022-08-18 2028-08-18 30468000 30016000 30468000 Software S+575 0.0075 0.1086 2022-06-22 2029-06-23 33290000 32845000 33290000 Software S+575 0.01 0.1114 2021-09-24 2027-10-01 23326000 22975000 23326000 Multi-Sector Holdings S+700 0.01 0.1222 2018-12-21 2024-12-21 80000000 79847000 80000000 Wireless Telecommunication Services S+550 0 0.1084 2018-12-21 2024-12-21 23465000 23112000 23465000 Communications Equipment L+575 0.01 0.1148 2018-09-14 2024-12-22 14009000 13423000 13729000 Thrifts & Mortgage Finance S+675 0.01 0.1202 2022-07-15 2027-07-15 30500000 29978000 30500000 Specialty Retail S+675 0.01 0.0978 2021-08-27 2024-06-01 8343000 8262000 8343000 Health Care Providers & Services S+675 0.01 0.1216 2023-03-01 2029-03-01 23843000 23155000 23128000 Health Care Providers & Services S+495 0 0.106 2022-08-09 2025-11-15 5097000 5097000 5097000 Health Care Providers & Services S+850 0.01 0.129 2022-04-01 2026-02-13 2216000 2129000 2216000 Commercial Services & Supplies P+75 0 0.09 2020-04-03 2024-03-30 3929000 3929000 3929000 Health Care Providers & Services S+625 0.01 0.1132 2023-02-10 2025-07-08 17235000 16791000 16718000 Health Care Providers & Services S+650 0.01 0.1183 2022-08-17 2024-05-16 4176000 4156000 4176000 Health Care Providers & Services S+625 0.01 0.1145 2022-08-19 2024-12-04 1976000 1953000 1976000 Insurance S+600 0.0075 0.1122 2022-04-01 2028-11-01 11888000 11729000 11888000 Health Care Providers & Services S+625 0.01 0.1145 2018-09-05 2024-08-16 11896000 11873000 11896000 Health Care Providers & Services S+675 0.01 0.121 2020-01-22 2026-01-02 26652000 26266000 26652000 Health Care Providers & Services S+500 0.01 0.1044 2022-04-01 2027-08-18 17225000 16500000 17225000 Life Sciences Tools & Services S+575 0.01 0.1151 2021-08-20 2026-08-12 23757000 23395000 23757000 Insurance S+550 0.0075 0.1064 2022-04-01 2026-11-01 21841000 21664000 21841000 Diversified Consumer Services S+500 0.01 0.1015 2022-04-01 2026-03-13 8700000 8362000 8700000 Health Care Providers & Services S+575 0.01 0.1093 2022-10-06 2029-10-05 9089000 8814000 9089000 Footwear S+523 0.01 0.1052 2022-04-01 2024-04-27 5674000 5456000 5391000 Health Care Providers & Services S+600 0.01 0.115 2022-06-03 2026-01-27 2791000 2767000 2791000 Media P+190 0 0.1015 2022-07-18 2024-10-10 6767000 6767000 6767000 Auto Parts & Equipment S+800 0.01 0.135 2021-08-11 2026-10-12 25791000 25423000 25791000 Health Care Equipment & Supplies S+575 0.0075 0.1109 2021-06-16 2028-06-16 21565000 21144000 21565000 Health Care Providers & Services L+525 0.01 0.1059 2022-04-01 2027-02-12 6895000 6615000 6550000 Trading Companies & Distributors S+600 0.01 0.1139 2022-04-01 2026-12-31 3857000 3691000 3857000 Packaged Foods & Meats S+625 0.01 0.1145 2021-08-12 2027-08-13 23895000 23244000 23895000 Health Care Providers & Services S+675 0.01 0.1199 2023-03-30 2029-03-30 13290000 12903000 12891000 Health Care Providers & Services S+625 0.01 0.1136 2023-02-07 2026-06-15 7156000 6962000 6941000 Water Utilities L+450 0.01 0.0956 2022-04-01 2026-11-02 2931000 2866000 2931000 Insurance S+575 0.01 0.1081 2022-04-01 2026-04-01 48371000 47337000 48371000 964165000 933818000 Diversified Financial Services S+705 0.01 0.1231 2021-12-24 2028-08-21 29925000 29435000 29925000 Diversified Financial Services S+650 0.01 0.1161 2023-04-17 2028-04-17 8206000 8007000 8001000 37442000 37926000 Diversified Consumer Services S+975 0.01 0 2013-12-23 2026-10-12 14498000 12297000 7249000 Pharmaceuticals S+515 0.046 0.1032 2019-12-31 2028-05-01 34738000 34769000 34738000 Biotechnology S+625 0.01 0.0875 2022-06-29 2027-06-01 3643000 3634000 3652000 Pharamceuticals L+745 0.001 0.1261 2021-12-22 2027-01-01 66849000 67618000 67685000 Pharmaceuticals S+795 0.01 0.1315 2022-02-23 2027-03-01 9475000 9496000 9570000 Biotechnology 0 0 0.09 2021-11-17 2026-11-17 40446000 40101000 40446000 Pharmaceuticals L+725 0.0245 0.1241 2019-06-28 2024-01-01 6377000 7018000 7171000 Biotechnology S+620 0.0275 0.1137 2022-12-27 2028-01-01 26939000 26958000 27007000 Health Care Technology L+790 0.001 0.1306 2021-09-30 2026-10-01 15883000 15941000 16002000 Health Care Equipment & Supplies S+550 0.0345 0.1067 2022-12-20 2027-12-01 3367000 3356000 3367000 Health Care Equipment & Supplies S+565 0.0395 0.1082 2020-03-02 2028-03-29 19299000 19201000 19347000 Health Care Equipment & Supplies S+1415 0.001 0.1921 2018-07-30 2023-08-01 20192000 20977000 21101000 Health Care Equipment & Supplies S+515 0.0275 0.1032 2022-11-03 2027-11-01 35084000 35067000 35084000 Biotechnology S+570 0.023 0.1087 2022-09-21 2027-09-01 10525000 11167000 11341000 Health Care Equipment & Supplies S+930 0.01 0.1457 2022-02-18 2027-02-01 35992000 36096000 36441000 Health Care Equipment & Supplies S+515 0.0475 0.1025 2023-06-14 2028-07-01 6651000 6570000 6567000 337969000 339519000 1351873000 1318512000 0.277 Commercial Services & Supplies 0.0778 2023-03-27 2028-03-27 75000 75000 75000 Commercial Services & Supplies 0.0847 0.0964 2021-02-12 2025-03-01 2026-12-01 1813000 1811000 1811000 Diversified Consumer Services 0.10 0.1129 2022-08-11 2026-08-11 2027-03-01 1263000 1263000 1263000 Airlines 0.0708 0.0713 2021-11-03 2026-11-03 2026-11-23 3356000 3405000 3356000 Commercial Services & Supplies 0.10 2019-03-29 2025-04-15 720000 720000 727000 Food & Staples Retailing 0.1046 2022-12-23 2028-01-01 2180000 2247000 2180000 Metals & Mining 0.0831 0.1044 2020-05-28 2024-07-01 2026-10-07 3283000 3283000 3283000 Commercial Services & Supplies 0.0742 2022-07-01 2026-08-01 134000 134000 134000 Oil, Gas & Consumable Fuels 0.0854 2022-10-07 2027-11-01 6482000 6311000 6288000 Airlines 0.10 2018-04-04 2023-10-04 2026-06-22 1777000 1777000 1762000 Diversified Consumer Services 0.084 0.0872 2023-03-07 2028-03-07 2028-05-18 3850000 3887000 3850000 Road & Rail 0.081 0.086 2022-09-22 2026-06-22 2027-09-22 3285000 3285000 3285000 Hotels, Restaurants & Leisure 0.0936 0.1301 2021-05-27 2025-04-01 2028-05-01 7254000 7254000 7254000 Commercial Services & Supplies 0.0675 0.0715 2023-03-23 2028-04-01 2028-06-01 2013000 1980000 1978000 Auto Components 0.0796 2021-02-02 2026-01-01 1553000 1568000 1553000 Commercial Services & Supplies 0.08 0.1008 2022-10-31 2027-11-01 2029-06-01 2050000 2053000 2050000 Containers & Packaging 0.0901 2021-01-06 2024-01-01 94000 94000 94000 Diversified Consumer Services 0.0658 0.0916 2022-08-26 2025-11-09 2027-09-01 1201000 1201000 1177000 Road & Rail 0.0825 2020-09-30 2027-10-01 4925000 4949000 4925000 Multi-Sector Holdings 0.0837 2018-04-27 2025-04-27 3614000 3614000 3523000 Commercial Services & Supplies 0.0952 2023-03-03 2027-03-03 955000 964000 955000 Diversified Financial Services 0.075 0.0902 2021-10-28 2026-10-01 2027-03-01 2615000 2617000 2615000 Diversified Financial Services 0.09 2021-11-05 2026-08-01 6179000 6179000 6179000 Road & Rail 0.1251 0.1289 2019-04-09 2023-11-01 457000 459000 457000 Commercial Services & Supplies 0.0831 2018-03-22 2023-10-05 55000 55000 55000 Airlines 0.08 2017-12-04 2024-01-04 229000 229000 229000 Machinery 0.1071 2018-10-23 2026-01-01 4320000 4324000 4320000 Construction & Engineering 0.105 2021-10-08 2025-11-01 847000 847000 847000 Commercial Services & Supplies 0.0969 0.0994 2018-11-15 2024-05-01 2025-09-01 223000 223000 218000 Auto Components 0.0795 2021-06-23 2025-06-23 4952000 4976000 4853000 Road & Rail 0.0858 2018-02-05 2024-03-01 113000 113000 113000 Machinery 0.105 2022-12-29 2027-06-01 709000 709000 709000 Multi-Sector Holdings 0.0873 0.1152 2019-05-16 2024-05-16 2024-09-25 7500000 7500000 7361000 Road & Rail 0.0828 0.1209 2021-06-17 2024-12-01 2026-12-01 13260000 13260000 13260000 Consumer Finance 0.1246 0.1326 2021-08-20 2024-07-20 2024-10-01 1151000 1163000 1151000 Construction & Engineering 0.0769 2023-04-14 2028-04-14 862000 862000 862000 Commercial Services & Supplies 0.10 2017-07-31 2025-02-28 310000 309000 310000 Commercial Services & Supplies 0.0773 2023-05-05 2028-06-01 129000 129000 129000 Commercial Services & Supplies 0.1072 2022-12-23 2027-01-01 1837000 1895000 1837000 Aerospace & Defense 0.0932 2022-11-23 2028-12-01 2489000 2489000 2489000 Machinery 0.10 2020-06-01 2024-06-01 109000 109000 109000 Commercial Services & Supplies 0.0933 0.0979 2019-09-24 2023-08-01 2024-11-01 1023000 1038000 1004000 Diversified Consumer Services 0.0769 0.0827 2023-05-19 2030-05-18 2030-06-30 753000 753000 753000 Construction & Engineering 0.0808 2023-05-10 2026-05-10 135000 135000 135000 Road & Rail 0.0956 2019-11-21 2025-08-01 718000 718000 655000 Road & Rail 0.0953 2019-01-17 2024-02-01 291000 292000 291000 Diversified Consumer Services 0.0821 2022-12-06 2027-12-06 225000 225000 225000 Transportation Infrastructure 0.085 2022-10-31 2029-11-01 13275000 13320000 13275000 Multi-Sector Holdings 0.085 2022-01-24 2024-01-27 2500000 2500000 2500000 Commercial Services & Supplies 0.0782 0.0861 2022-06-30 2026-09-15 2030-06-27 6297000 6297000 6297000 Road & Rail 0.0847 0.0858 2017-07-31 2023-07-01 2025-01-25 1442000 1442000 1383000 Road & Rail 0.0842 2018-03-09 2025-04-01 2613000 2613000 2345000 Road & Rail 0.1022 0.1069 2017-07-31 2026-01-01 2800000 2800000 2800000 Commercial Services & Supplies 0.0407 2017-07-31 2028-01-15 1553000 1553000 1553000 Commercial Services & Supplies 0.0794 0.0893 2021-10-08 2024-11-01 2026-12-01 1939000 1939000 1939000 Commercial Services & Supplies 0.1092 2022-12-23 2027-03-01 1848000 1848000 1848000 Road & Rail 0.1121 2018-03-23 2024-08-01 329000 331000 329000 Commercial Services & Supplies 0.0917 2023-04-18 2028-04-18 9735000 9904000 9735000 Diversified Consumer Services 0.0843 0.10 2019-07-31 2024-08-01 2025-10-05 461000 462000 461000 Energy Equipment & Services 0.0911 2019-12-27 2025-01-01 300000 300000 289000 Transportation Infrastructure 0.0832 0.0993 2022-09-23 2027-09-23 2028-06-23 2426000 2463000 2426000 Diversified Consumer Services 0.0891 2022-12-07 2027-01-01 644000 650000 644000 Multi-Sector Holdings 2017-07-31 200 145000000 120820000 296905000 271333000 0.004 Aerospace & Defense 0.05 2012-06-08 2025-06-30 0 5050000 3801000 0.599 Pharmaceuticals 2016-11-18 6347 106000 0 Health Care Providers & Services 2023-05-31 6526 11411000 3819000 Health Care Equipment & Supplies 2017-03-31 90 51000 0 Pharmaceuticals 2019-06-28 289102 136000 51000 Health Care Equipment & Supplies 2016-06-15 157500 65000 0 Health Care Equipment & Supplies 2017-08-18 444388 74000 82000 Health Care Technology 2017-03-22 260000 129000 341000 Multi-Sector Holdings 2020-11-03 73500000 136596000 148444000 Health Care Equipment & Supplies 2022-12-20 29366 23000 19000 Health Care Providers & Services 2023-02-13 207043 657000 403000 Diversified Consumer Services 2013-12-23 231177 15683000 0 Diversified Consumer Services 2013-12-23 522 5216000 0 Diversified Consumer Services 2013-12-23 30370 381000 0 Health Care Equipment & Supplies 2019-07-25 469353 235000 358000 Internet & Catalog Retail 2023-06-16 0 7014000 8897000 Diversified Financial Services 2022-04-01 100 81583000 90370000 Diversified Financial Services 2012-12-28 280303 280737000 279000000 Diversified Financial Services 2022-04-01 32839 34335000 34850000 Asset Management 2022-12-01 0 20750000 20995000 Biotechnology 2022-09-21 159470 51000 80000 Health Care Equipment & Supplies 2022-02-18 207117 262000 20000 Health Care Equipment & Supplies 2018-05-10 2230 152000 0 Health Care Equipment & Supplies 2023-06-14 161761 51000 51000 595698000 587780000 2.224 2249526000 2181426000 0.34 Government 2023-06-30 2023-08-10 335000000 333200000 333200000 2.564 2582726000 2514626000 -1.564 1533821000 1 980805000 0.25 3741000 0 -224000 0 -6000 -156000 3523000 80000000 0 0 0 46000 -4875000 80000000 148444000 0 0 0 0 -7000000 148444000 7361000 0 0 0 0 -374000 7361000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6521000 507000 0 0 -221000 0 7249000 89370000 0 0 0 -1000000 -3500000 90370000 288760000 0 0 0 9760000 -10000000 279000000 120820000 0 0 0 0 0 120820000 5000000 2500000 -5000000 0 0 -120000 2500000 34350000 0 0 0 -500000 -1730000 34850000 9426000 11250000 0 0 -319000 -57000 20995000 3801000 123000 0 0 123000 -123000 3801000 797594000 14380000 -5224000 0 7883000 -27935000 798913000 0.245 3002000 154967000 157969000 2184428000 0.01 0.06 0.03 0.10 0.09 0.03875 0 464000 0 0 0 0 464000 9371000 0 0 0 4237000 0 5134000 846000 0 0 0 0 -9000 846000 18224000 0 0 0 0 -194000 18224000 4773000 0 0 0 0 -62000 4773000 4681000 0 0 0 862000 0 3819000 7014000 0 0 0 -1883000 0 8897000 44909000 464000 0 0 3216000 -265000 42157000 0.073 0.025 0.21 0.166 0.107 0.066 0.055 0.042 0.04 0.038 0.036 0.02 0.017 0.014 0.014 0.014 0.014 0.012 0.011 0.011 0.011 0.01 0.009 0.009 0.007 0.007 0.007 0.006 0.006 0.005 0.005 0.005 0.003 0.003 0.003 0.003 0.002 0.002 0.002 0.002 0.002 0.001 0.001 0.001 0.001 0 0 1 1.246 Health Care Providers & Services L+550 0.01 0.1009 2018-05-07 2025-05-09 17103000 16793000 17103000 Trading Companies & Distributors S+575 0.01 0.1019 2022-04-01 2026-09-01 4197000 4081000 4197000 Communications Equipment L+650 0.01 0 2016-05-05 2021-09-09 36135000 25926000 0 Communications Equipment L+650 0.01 0 2021-09-17 2023-01-31 6405000 6254000 224000 Internet & Catalog Retail L+800 0.01 0.1477 2021-07-28 2026-10-15 24087000 23711000 22882000 Diversified Consumer Services S+525 0.01 0.098 2022-08-31 2025-07-31 14021000 13644000 14021000 Diversified Financial Services S+600 0.01 0.1084 2018-09-14 2024-02-29 8149000 8107000 8149000 Specialty Retail L+550 0.01 0.1027 2020-10-30 2023-10-30 2162000 2152000 2162000 Health Care Providers & Services L+500 0.01 0.0973 2022-04-01 2027-06-11 9432000 9078000 9432000 Media L+900 0.0025 0.1317 2022-07-18 2023-04-27 14454000 14454000 14454000 Diversified Consumer Services L+575 0.0075 0.1048 2021-06-29 2028-06-29 20427000 20057000 20427000 Building Products L+475 0.01 0.0973 2022-04-01 2025-02-01 10386000 9983000 10386000 Food Products P+275 0 0.1025 2022-08-31 2025-04-23 8405000 8405000 8405000 Media P+175 0 0.0925 2022-10-12 2025-03-25 16951000 16951000 16951000 Capital Markets L+700 0.01 0.1013 2020-12-29 2025-12-29 35205000 34496000 35205000 Trading Companies & Distributors S+475 0.01 0.0943 2022-04-01 2025-12-31 4978000 4804000 4978000 IT Services L+450 0 0.0888 2022-04-01 2025-07-30 11598000 11129000 11598000 Building Products S+475 0.01 0.0979 2022-04-01 2027-07-30 8915000 8580000 8915000 Personal Products L+550 0.01 0.1015 2021-02-12 2027-02-12 35273000 34421000 35273000 Leisure Equipment & Products S+500 0.01 0.0903 2022-04-01 2026-11-16 11022000 10562000 10912000 Insurance L+525 0.0075 0.0963 2022-04-01 2026-11-25 6223000 5994000 6223000 Insurance L+600 0.0075 0.1073 2022-04-01 2028-04-16 5188000 4900000 5188000 Internet Software & Services S+785 0.01 0.1197 2022-06-30 2027-07-01 20104000 19783000 20104000 Software S+725 0.0075 0.1152 2022-08-18 2028-08-18 32084000 31548000 31522000 Health Care Providers & Services L+625 0.01 0.1039 2021-12-22 2026-02-25 30092000 29415000 30393000 Software S+575 0.0075 0.1033 2022-06-22 2029-06-23 32426000 31966000 32426000 Software L+575 0.01 0.1048 2021-09-24 2027-10-01 26452000 26015000 26452000 Multi-Sector Holdings L+700 0.01 0.1075 2018-12-21 2024-12-21 80000000 79800000 80000000 Wireless Telecommunication Services S+550 0 0.1008 2018-12-21 2024-12-21 23588000 23123000 23588000 Communications Equipment L+575 0.01 0.1013 2018-09-14 2024-12-22 14009000 13246000 13449000 Thrifts & Mortgage Finance S+675 0.01 0.1099 2022-07-15 2027-07-15 27500000 26991000 27500000 Specialty Retail S+675 0.01 0.0874 2021-08-27 2024-06-01 7808000 7678000 7808000 Health Care Providers & Services L+495 0 0.0972 2022-08-09 2024-11-15 3966000 3966000 3966000 Insurance S+525 0.01 0.0945 2021-07-30 2024-09-28 28603000 28214000 28603000 Health Care Providers & Services L+500 0.01 0.0731 2022-04-01 2024-06-02 2681000 2564000 2547000 Commercial Services & Supplies P+75 0 0.0825 2020-04-03 2024-03-30 4431000 4431000 4431000 Health Care Providers & Services S+650 0.01 0.1091 2022-08-17 2024-05-16 3111000 3092000 3111000 Health Care Providers & Services S+625 0.01 0.1067 2022-08-19 2024-12-04 1327000 1309000 1313000 Insurance S+600 0.0075 0.1044 2022-04-01 2028-11-01 10854000 10699000 10854000 Health Care Providers & Services S+625 0.01 0.0981 2018-09-05 2024-08-16 14458000 14420000 14458000 Health Care Providers & Services S+650 0.01 0.1057 2020-01-22 2026-01-02 27997000 27528000 27367000 Health Care Providers & Services S+500 0.01 0.0989 2022-04-01 2027-08-18 9491000 9161000 9491000 Health Care Providers & Services L+850 0.01 0.1283 2018-09-14 2023-01-30 32163000 31987000 25827000 Life Sciences Tools & Services S+575 0.01 0.1097 2021-08-20 2026-08-12 26823000 26455000 26823000 Insurance S+550 0.0075 0.0926 2022-04-01 2026-11-01 6985000 6813000 6985000 Diversified Consumer Services L+500 0.01 0.0941 2022-04-01 2026-03-13 11775000 11357000 11775000 Health Care Providers & Services S+575 0.01 0.0946 2022-10-06 2029-10-05 8314000 8050000 8044000 Footwear L+523 0.01 0.0966 2022-04-01 2024-04-27 5704000 5361000 5419000 Health Care Providers & Services S+600 0.01 0.1077 2022-06-03 2026-01-27 1399000 1387000 1399000 Media P+95 0 0.0845 2022-07-18 2024-10-10 9162000 9162000 9162000 Auto Parts & Equipment S+800 0.01 0.1244 2021-08-11 2026-10-12 25922000 25506000 25922000 Health Care Equipment & Supplies L+575 0.0075 0.1048 2021-06-16 2028-06-16 24953000 24446000 24953000 Health Care Providers & Services L+525 0.01 0.0998 2022-04-01 2027-02-12 6899000 6585000 6864000 Trading Companies & Distributors S+550 0.01 0.1014 2022-04-01 2026-12-31 9996000 9527000 9996000 Packaged Foods & Meats L+650 0.01 0.1088 2021-08-12 2027-08-13 24789000 24038000 24789000 Water Utilities L+450 0.01 0.0787 2022-04-01 2026-11-02 1728000 1668000 1728000 Insurance S+575 0.01 0.0931 2022-04-01 2026-04-01 31624000 30785000 30359000 912558000 886513000 Diversified Financial Services S+705 0.01 0.1138 2021-12-24 2028-08-21 29925000 29398000 29925000 Diversified Consumer Services S+975 0.01 0 2013-12-23 2026-10-12 13043000 11791000 6521000 Pharmaceuticals L+765 0.0178 0.1182 2019-12-31 2024-07-01 23159000 23894000 24433000 Biotechnology S+625 0.01 0.0875 2022-06-29 2027-06-01 3643000 3620000 3643000 Pharamceuticals L+745 0.001 0.1162 2021-12-22 2027-01-01 66849000 67077000 67685000 Pharmaceuticals L+795 0.001 0.1212 2022-02-23 2027-03-01 9475000 9437000 9499000 Biotechnology 0 0 0.09 2021-11-17 2026-11-17 39839000 39340000 39839000 Pharmaceuticals L+725 0.0245 0.1142 2019-06-28 2024-01-01 11844000 12372000 12555000 Biotechnology S+620 0.0275 0.1052 2022-12-27 2028-01-01 26939000 26874000 26872000 Health Care Technology L+790 0.001 0.1207 2021-09-30 2026-10-01 15883000 15867000 15922000 Health Care Equipment & Supplies S+550 0.0345 0.0982 2022-12-20 2027-12-01 3367000 3338000 3359000 Health Care Equipment & Supplies L+765 0.0166 0.1182 2020-03-02 2025-02-28 18012000 18450000 19003000 Health Care Equipment & Supplies L+1405 0.001 0.1822 2018-07-30 2023-07-01 19201000 19380000 19777000 Health Care Equipment & Supplies S+515 0.0275 0.0933 2022-11-03 2027-11-01 35084000 34880000 34820000 Biotechnology S+570 0.023 0.0988 2022-09-21 2027-09-01 10525000 10406000 10420000 Health Care Equipment & Supplies S+830 0.01 0.1258 2022-02-18 2027-02-01 34455000 34270000 34628000 319205000 322455000 1272952000 1245414000 0.266 Commercial Services & Supplies 0.0847 0.0964 2021-02-12 2025-03-01 2026-12-01 2264000 2262000 2262000 Diversified Consumer Services 0.10 2022-08-11 2026-08-11 2026-08-29 1036000 1036000 1036000 Airlines 0.0708 0.0713 2021-11-03 2026-11-03 2026-11-23 3600000 3660000 3600000 Commercial Services & Supplies 0.10 2019-03-29 2024-09-15 1059000 1059000 1069000 Food & Staples Retailing 0.1046 2022-12-23 2028-01-01 2365000 2440000 2365000 Metals & Mining 0.0831 0.1044 2020-05-28 2024-07-01 2026-10-07 4568000 4568000 4568000 Commercial Services & Supplies 0.0742 2022-07-01 2026-08-01 153000 153000 153000 Oil, Gas & Consumable Fuels 0.0854 2022-10-07 2027-11-01 6708000 6514000 6507000 Airlines 0.10 2018-04-04 2023-10-04 2026-06-22 2241000 2241000 2214000 Airlines 0.10 2018-03-19 2023-01-01 1055000 1055000 1055000 Road & Rail 0.081 0.086 2022-09-22 2026-03-22 2027-09-22 3690000 3690000 3690000 Hotels, Restaurants & Leisure 0.0936 0.1301 2021-05-27 2025-04-01 2028-01-01 6539000 6539000 6539000 Auto Components 0.0796 2021-02-02 2026-01-01 1828000 1849000 1828000 Commercial Services & Supplies 0.08 2022-10-31 2027-11-01 1589000 1589000 1589000 Containers & Packaging 0.0901 2021-01-06 2024-01-01 276000 276000 276000 Diversified Consumer Services 0.0658 0.0916 2022-08-26 2025-12-09 2027-09-01 1321000 1321000 1295000 Road & Rail 0.0825 2020-09-30 2027-10-01 5270000 5300000 5270000 Multi-Sector Holdings 0.0837 2018-04-27 2025-04-27 3837000 3837000 3741000 Diversified Financial Services 0.075 0.0902 2021-10-28 2026-10-01 2027-03-01 2938000 2941000 2938000 Diversified Financial Services 0.09 2021-11-05 2026-08-01 7116000 7116000 7116000 Road & Rail 0.1251 0.1289 2019-04-09 2023-11-01 779000 784000 779000 Commercial Services & Supplies 0.083 0.0877 2018-03-22 2023-06-05 2023-10-05 469000 469000 468000 Airlines 0.08 2017-12-04 2024-01-04 425000 425000 425000 Machinery 0.1071 2018-10-23 2026-01-01 4801000 4806000 4801000 Construction & Engineering 0.105 2021-10-08 2025-11-01 997000 997000 997000 Commercial Services & Supplies 0.0969 0.0994 2018-11-15 2024-05-01 2025-09-01 290000 290000 283000 Auto Components 0.0795 2021-06-23 2025-06-23 6072000 6109000 5951000 Road & Rail 0.0858 2018-02-05 2024-03-01 194000 194000 194000 Machinery 0.105 2022-12-29 2027-06-01 767000 767000 767000 Multi-Sector Holdings 0.0873 0.1152 2019-05-16 2024-05-16 2024-09-25 7500000 7500000 7361000 Road & Rail 0.0828 0.1209 2021-06-17 2024-12-01 2026-12-01 16411000 16411000 16411000 Consumer Finance 0.1246 0.1326 2021-08-20 2024-08-20 2024-10-01 1638000 1663000 1638000 Commercial Services & Supplies 0.10 2017-07-31 2025-02-28 369000 368000 369000 Commercial Services & Supplies 0.1072 2022-12-23 2027-01-01 2005000 2072000 2005000 Aerospace & Defense 0.0932 2022-11-23 2028-12-01 2658000 2658000 2658000 Machinery 0.10 2020-06-01 2024-06-01 159000 159000 159000 Commercial Services & Supplies 0.0933 0.0979 2019-09-24 2023-04-01 2024-11-01 1940000 1960000 1904000 Road & Rail 0.0956 2019-11-21 2025-08-01 849000 849000 775000 Road & Rail 0.0953 2019-01-17 2024-02-01 428000 431000 428000 Diversified Consumer Services 0.0821 2022-12-06 2027-12-06 245000 245000 245000 Transportation Infrastructure 0.085 2022-10-31 2029-07-01 14102000 14152000 14102000 Multi-Sector Holdings 0.085 2022-01-24 2023-01-24 5000000 5000000 5000000 Commercial Services & Supplies 0.0782 0.0828 2022-06-30 2026-09-15 2029-12-29 4139000 4139000 4139000 Road & Rail 0.0847 0.0858 2017-07-31 2023-07-01 2025-01-25 1521000 1521000 1459000 Road & Rail 0.0842 2018-03-09 2025-04-01 2887000 2887000 2591000 Road & Rail 0.1022 0.1063 2017-07-31 2026-01-01 3369000 3369000 3369000 Commercial Services & Supplies 0.0407 2017-07-31 2028-01-15 1706000 1706000 1706000 Commercial Services & Supplies 0.0794 0.0875 2021-10-08 2024-11-01 2026-12-01 577000 577000 577000 Commercial Services & Supplies 0.1092 2022-12-23 2027-03-01 2005000 2005000 2005000 Road & Rail 0.1121 2018-03-23 2024-08-01 469000 473000 469000 Diversified Consumer Services 0.0843 0.10 2019-07-31 2024-08-01 2025-10-05 604000 605000 604000 Energy Equipment & Services 0.0911 2019-12-27 2025-01-01 386000 386000 371000 Transportation Infrastructure 0.0832 0.0936 2022-09-23 2027-09-23 2027-10-28 304000 308000 304000 Diversified Consumer Services 0.0891 2022-12-07 2027-01-01 707000 714000 707000 Multi-Sector Holdings 2017-07-31 200 145000000 120820000 291445000 265952000 0.004 Aerospace & Defense 0.05 2012-06-08 2023-06-30 49273000 4927000 3801000 0.571 Pharmaceuticals 2016-11-18 6347 106000 0 Health Care Equipment & Supplies 2017-03-31 90 51000 0 Pharmaceuticals 2019-06-28 289102 136000 82000 Health Care Equipment & Supplies 2016-06-15 157500 65000 0 Health Care Equipment & Supplies 2017-08-18 444388 74000 103000 Health Care Technology 2017-03-22 260000 129000 366000 Multi-Sector Holdings 2020-11-03 73500000 136596000 148444000 Health Care Equipment & Supplies 2022-12-20 29366 23000 23000 Diversified Consumer Services 2013-12-23 231177 15683000 0 Diversified Consumer Services 2013-12-23 522 5216000 0 Diversified Consumer Services 2013-12-23 30370 381000 0 Health Care Equipment & Supplies 2019-07-25 469353 235000 483000 Diversified Financial Services 2022-04-01 100 81583000 89370000 Diversified Financial Services 2012-12-28 280303 280737000 288760000 Diversified Financial Services 2022-04-01 32839 34335000 34350000 Asset Management 2022-12-01 0 9500000 9426000 Biotechnology 2022-09-21 159470 51000 15000 Health Care Equipment & Supplies 2022-02-18 36996 210000 87000 Health Care Equipment & Supplies 2018-05-10 33430 152000 0 565263000 571509000 2.087 2134587000 2086676000 0.418 Government 2022-12-30 2023-02-23 420000000 417590000 417590000 2.505 2552177000 2504266000 -1.505 1504535000 1 999731000 0.25 18939000 0 -15833000 0 -635000 -749000 3741000 80000000 0 0 0 87000 -7402000 80000000 145996000 0 0 0 -2448000 -15225000 148444000 10725000 0 -3500000 0 -136000 -1003000 7361000 0 0 0 0 0 0 0 5216000 0 0 0 5216000 0 0 0 0 0 0 0 0 0 11829000 685000 0 0 5280000 18000 6521000 0 81583000 0 0 -7787000 -5150000 89370000 298766000 0 0 0 10006000 -20500000 288760000 129102000 0 0 0 8282000 0 120820000 0 5000000 0 0 0 -379000 5000000 0 34335000 0 0 -15000 -2595000 34350000 0 9500000 0 0 74000 0 9426000 1121000 0 -447000 0 674000 -647000 0 4509000 266000 -942000 0 32000 -266000 3801000 706203000 131369000 -20722000 0 18630000 -53898000 797594000 0.242 17187000 161053000 143866000 2069489000 0.08 0.0575 0.005 0.03 0.10 0.08 0.03875 0.221 0.175 0.077 0.066 0.055 0.043 0.042 0.039 0.027 0.019 0.017 0.017 0.017 0.013 0.013 0.012 0.012 0.011 0.011 0.011 0.01 0.009 0.009 0.008 0.007 0.007 0.006 0.005 0.005 0.005 0.004 0.004 0.003 0.003 0.003 0.003 0.003 0.003 0.002 0.001 0.001 0.001 0 0 0 1 <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 1. Organization </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SLR Investment Corp. (the “Company”, “SLRC”, “we”, “us” or “our”), a Maryland corporation formed in November 2007, is a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">closed-end,</div> externally managed, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-diversified</div> management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). Furthermore, as the Company is an investment company, it continues to apply the guidance in FASB Accounting Standards Codification (“ASC”) Topic 946. In addition, for U.S. federal income tax purposes, the Company has elected to be treated, and intends to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February 9, 2010, the Company priced its initial public offering, selling 5.68 million shares of common stock, including the underwriters’ over-allotment, at a price of $18.50 per share. Concurrent with this offering, the Company’s senior management purchased an additional 600,000 shares through a private placement, also at $18.50 per share. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company’s investment objective is to maximize both current income and capital appreciation through debt and equity investments. The Company directly and indirectly invests primarily in leveraged middle market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. From time to time, we may also invest in public companies that are thinly traded. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On April 1, 2022, we acquired SLR Senior Investment Corp., a Maryland corporation (“SUNS”) pursuant to that certain Agreement and Plan of Merger (the “Merger Agreement”), dated as of December 1, 2021, by and among us, SUNS, Solstice Merger Sub, Inc., a Maryland corporation and our wholly-owned subsidiary (“Merger Sub”), and, solely for the limited purposes set forth therein, SLR Capital Partners, LLC (the “Investment Adviser”). Pursuant to the Merger Agreement, Merger Sub merged with and into SUNS, with SUNS continuing as the surviving company and as SUNS’s wholly-owned subsidiary (the “Merger”) and, immediately thereafter, SUNS merged with and into us, with us continuing as the surviving company (together with the Merger, the “Mergers”). In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each outstanding share of SUNS’s common stock was converted into the right to receive 0.7796 shares of our common stock (with SUNS’s stockholders receiving cash in lieu of fractional shares of our common stock). As a result of the Mergers, we issued an aggregate of 12,511,825 shares of our common stock to former SUNS stockholders. </div> 5680000 18.5 600000 18.5 0.7796 12511825 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 2. Significant Accounting Policies </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“GAAP”), and include the accounts of the Company and certain wholly-owned subsidiaries. The consolidated financial statements reflect all adjustments and reclassifications which, in the opinion of management, are necessary for the fair presentation of the results of the operations and financial condition for the periods presented. All significant intercompany balances and transactions have been eliminated. Certain prior period amounts may have been reclassified to conform to the current period presentation. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interim consolidated financial statements are prepared in accordance with GAAP for interim financial information and pursuant to the requirements for reporting on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-Q</div> and Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-X,</div> as appropriate. Accordingly, they may not include all of the information and notes required by GAAP for annual consolidated financial statements. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reported periods. Changes in the economic environment, financial markets and any other parameters used in determining these estimates could cause actual results to differ materially. The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the fiscal year ending on December 31, 2023. </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the opinion of management, all adjustments, which are of a normal recurring nature, considered necessary for the fair presentation of financial statements, have been included. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The significant accounting policies consistently followed by the Company are: </div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(a)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Investment transactions are accounted for on the trade date; </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(b)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Under procedures established by the board of directors (the “Board”), we value investments, including certain senior secured debt, subordinated debt and other debt securities with maturities greater than 60 days, for which market quotations are readily available and deemed to represent fair value under GAAP, at such market quotations (unless they are deemed not to represent fair value). A market quotation is readily available for a security only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. If the Company anticipates using a market quotation for a security, it will also monitor for circumstances that may necessitate the use of fair value, such as significant events that may cause concern over the reliability of a market quotation. We attempt to obtain market quotations from at least two brokers or dealers (if available, otherwise from a principal market maker or a primary market dealer or other independent pricing service). We utilize <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">mid-market</div> pricing as a practical expedient for fair value unless a different point within the range is more representative. If and when market quotations are deemed not to represent fair value, we may utilize independent third-party valuation firms to assist us in determining the fair value of material assets. Accordingly, such investments go through our multi-step valuation process as described below. In each such case, independent valuation firms, that may from time to time be engaged by the Board, consider observable market inputs together with significant unobservable inputs in arriving at their valuation recommendations. Debt investments with maturities of 60 days or less shall each be valued at cost plus accreted discount, or minus amortized premium, which is expected to approximate fair value, unless such valuation, in the judgment of the Investment Adviser, does not represent fair value, in which case such investments shall be valued at fair value as determined in good faith by or under the direction of the Board. Investments that are not publicly traded or whose market quotations are not readily available are valued at fair value as determined in good faith by or under the direction of the Board. Such determination of fair values involves subjective judgments and estimates. </div> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">With respect to investments for which market quotations are not readily available or when such market quotations are deemed not to represent fair value under GAAP, the Board has approved a multi-step valuation process each quarter, as described below: </div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:13%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">our quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of the Investment Adviser responsible for the portfolio investment; </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:13%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">preliminary valuation conclusions are then documented and discussed with senior management of the Investment Adviser; </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:13%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(3)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">independent valuation firms engaged by the Board conduct independent appraisals and review the Investment Adviser’s preliminary valuations and make their own independent assessment for all material assets; </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:13%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(4)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">the audit committee of the Board reviews the preliminary valuation of the Investment Adviser and that of the independent valuation firm and responds to the valuation recommendation of the independent valuation firm, if any, to reflect any comments; and </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:13%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(5)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">the Board discusses valuations and determines the fair value of each investment in our portfolio in good faith based on the input of the Investment Adviser, the respective independent valuation firm, if any, and the audit committee. </div> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The valuation principles set forth above may be modified from time to time, in whole or in part, as determined by the Board in its sole discretion. The Board will also (1) periodically assess and manage valuation risks; (2) establish and apply fair value methodologies; (3) test fair value methodologies; (4) oversee and evaluate third-party pricing services, as applicable; (5) oversee the reporting required by Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2a-5</div> under the 1940 Act; and (6) maintain recordkeeping requirements under Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2a-5.</div> </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Investments in all asset classes are valued utilizing a market approach, an income approach, or both approaches, as appropriate. However, in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">820-10,</div> certain investments that qualify as investment companies in accordance with ASC 946, may be valued using net asset value as a practical expedient for fair value. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities (including a business). The income approach uses valuation approaches to convert future amounts (for example, cash flows or earnings) to a single present amount (discounted). The measurement is based on the value indicated by current market expectations about those future amounts. In following these approaches, the types of factors that we may take into account in fair value pricing our investments include, as relevant: available current market data, including relevant and applicable market trading and transaction comparables, applicable market yields and multiples, security covenants, call protection provisions, the nature and realizable value of any collateral, the portfolio company’s ability to make payments, its earnings and discounted cash flows, the markets in which the portfolio company does business, comparisons of financial ratios of peer companies that are public, M&amp;A comparables, our principal market (as the reporting entity) and enterprise values, among other factors. When available, broker quotations and/or quotations provided by pricing services are considered as an input in the valuation process. For the six months ended June 30, 2023, there has been no change to the Company’s valuation approaches or techniques and the nature of the related inputs considered in the valuation process. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">ASC Topic 820 classifies the inputs used to measure these fair values into the following hierarchy: </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Level</div><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"> 1</div>: Unadjusted quoted prices in active markets for identical assets or liabilities, accessible by the Company at the measurement date. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Level</div><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"> 2</div>: Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or other observable inputs other than quoted prices. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Level</div><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"></div><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"> 3</div>: Unobservable inputs for the asset or liability. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">In all cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each investment. The exercise of judgment is based in part on our knowledge of the asset class and our prior experience. </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(c)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Gains or losses on investments are calculated by using the specific identification method. </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(d)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Loan origination fees, original issue discount, and market discounts are capitalized and we amortize such amounts into income using the effective interest method. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record call premiums received on loans repaid as interest income when we receive such amounts. Capital structuring fees, amendment fees, consent fees, and any other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recurring</div> fee income as well as a management fee and other fee income for services rendered, if any, are recorded as other income when earned. </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(e)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company intends to comply with the applicable provisions of the Code pertaining to <div style="display:inline;">RICs</div> to make distributions of taxable income sufficient to relieve it of substantially all U.S. federal income taxes. The Company, at its discretion, may carry forward taxable income in excess of calendar year distributions and pay a 4% excise tax on this income. The Company will accrue excise tax on such estimated excess taxable income as appropriate. </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(f)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Book and tax basis differences relating to stockholder distributions and other permanent book and tax differences are typically reclassified among the Company’s capital accounts annually. In addition, the character of income and gains to be distributed is determined in accordance with income tax regulations that may differ from GAAP. </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(g)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Distributions to common stockholders are recorded as of the record date. The amount to be paid out as a distribution is determined by the Board. Net realized capital gains, if any, are generally distributed or deemed distributed at least annually. </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(h)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">In accordance with Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-X</div> and ASC Topic 810—<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Consolidation</div></div>, the Company consolidates its interest in controlled investment company subsidiaries, financing subsidiaries and certain wholly-owned holding companies that serve to facilitate investment in portfolio companies. In addition, the Company may also consolidate any controlled operating companies substantially all of whose business consists of providing services to the Company. </div> </td> </tr> </table> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(i)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The accounting records of the Company are maintained in U.S. dollars. Any assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the rate of exchange of such currencies against U.S. dollars on the date of valuation. The Company will not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. Such fluctuations would be included with the net unrealized gain or loss from investments. The Company’s investments in foreign securities, if any, may involve certain risks, including without limitation: foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments in terms of U.S. dollars and therefore the earnings of the Company. </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(j)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">In accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">835-30,</div> the Company reports origination and other expenses related to certain debt issuances as a direct deduction from the carrying amount of the debt liability. Applicable expenses are deferred and amortized using either the effective interest method or the straight-line method over the stated life. The straight-line method may be used on revolving facilities and/or when it approximates the effective yield method. </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(k)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company may enter into forward exchange contracts in order to hedge against foreign currency risk. These contracts are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">marked-to-market</div></div> by recognizing the difference between the contract exchange rate and the current market rate as unrealized appreciation or depreciation. Realized gains or losses are recognized when contracts are settled. </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(l)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company records expenses related to shelf registration statements and applicable equity offering costs as prepaid assets. These expenses are typically charged as a reduction of capital upon the sale of shares or expensed, in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">946-20-25.</div></div> </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(m)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Investments that are expected to pay regularly scheduled interest in cash are generally placed on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-accrual</div> status when principal or interest cash payments are past due 30 days or more (90 days or more for equipment financing) and/or when it is no longer probable that principal or interest cash payments will be collected. Such <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-accrual</div> investments are restored to accrual status if past due principal and interest are paid in cash, and in management’s judgment, are likely to continue timely payment of their remaining principal and interest obligations. Cash interest payments received on such investments may be recognized as income or applied to principal depending on management’s judgment. </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">(n)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company defines cash equivalents as securities that are readily convertible into known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only securities with a maturity of three months or less would qualify, with limited exceptions. The Company believes that certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities would qualify as cash equivalents. </div> </td> </tr> </table> P60D P60D 0.04 P30D P90D <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 3. Agreements </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has an investment advisory and management agreement (the “Advisory Agreement”) with the Investment Adviser, under which the Investment Adviser manages the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">day-to-day</div></div> operations of, and provides investment advisory services to the Company. For providing these services, the Investment Adviser receives a fee from the Company, consisting of two components—a base management fee and a performance-based incentive fee. The base management fee is determined by taking the average value of the Company’s gross assets at the end of the two most recently completed calendar quarters calculated at an annual rate of 1.50% on gross assets up to 200% of the Company’s total net assets as of the immediately preceding quarter end and 1.00% on gross assets that exceed 200% of the Company’s total net assets as of the immediately preceding quarter end. For purposes of computing the base management fee, gross assets exclude temporary assets acquired at the end of each fiscal quarter for purposes of preserving investment flexibility in the next fiscal quarter. Temporary assets include, but are not limited to, U.S. treasury bills, other short-term U.S. government or government agency securities, repurchase agreements or cash borrowings. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The performance-based incentive fee has two parts, as follows: one part is calculated and payable quarterly in arrears based on the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income for the immediately preceding calendar quarter. For this purpose, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income means interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that we receive from portfolio companies) accrued during the calendar quarter, minus the Company’s operating expenses for the quarter (including the base management fee, any expenses payable under the Administration Agreement, and any interest expense and distributions paid on any issued and outstanding preferred stock, but excluding the performance-based incentive fee). <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-incentive</div> fee net investment income does not include any realized capital gains or losses, or unrealized capital appreciation or depreciation. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-incentive</div> fee net investment income, expressed as a rate of return on the value of the Company’s net assets at the end of the immediately preceding calendar quarter, is compared to the hurdle rate of 1.75% per quarter (7% annualized). The Company pays the Investment Adviser a performance-based incentive fee with respect to the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income in each calendar quarter as follows: (1) no performance-based incentive fee in any calendar quarter in which the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income does not exceed the hurdle rate; (2) 100% of the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income with respect to that portion of such <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income, if any, that exceeds the hurdle rate but is less than <div style="display:inline;">2.1875</div>% in any calendar quarter; and (3) 20% of the amount of the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income, if any, that exceeds <div style="display:inline;">2.1875</div>% in any calendar quarter. These calculations are appropriately <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pro-rated</div> for any period of less than three months. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The second part of the performance-based incentive fee is determined and payable in arrears as of the end of each calendar year (or upon termination of the Advisory Agreement, as of the termination date), and will equal 20% of the Company’s cumulative realized capital gains less cumulative realized capital losses, unrealized capital depreciation (unrealized depreciation on a gross <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">investment-by-investment</div></div> basis at the end of each calendar year) and all net capital gains upon which prior performance-based capital gains incentive fee payments were previously made to the Investment Adviser. For financial statement purposes, the second part of the performance-based incentive fee is accrued based upon 20% of cumulative net realized gains and net unrealized capital appreciation. No accrual was required for the three and six months ended June 30, 2023 and 2022. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the three and six months ended June 30, 2023, the Company recognized $7,878 and $15,584, respectively, in base management fees and $5,638 and $11,147, respectively, in performance-based incentive fees. For the three and six months ended June 30, 2023, $125 and $235, respectively, of such performance-based incentive fees were waived. For the three and six months ended June 30, 2022, the Company recognized $6,913 and $14,129, respectively, in base management fees and $4,734 and $4,734, respectively, in gross performance-based incentive fees. For the three and six months ended June 30, 2022, $1,358 and $1,358 of such performance-based incentive fees were waived. The Investment Adviser has agreed to waive incentive fees resulting from income earned due to the accretion of purchase discount allocated to investments acquired as a result of the Mergers. Fees waived pursuant to the above are not subject to recoupment by the Investment Adviser. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has also entered into an Administration Agreement with SLR Capital Management, LLC (the “Administrator”) under which the Administrator provides administrative services to the Company. For providing these services, facilities and personnel, the Company reimburses the Administrator for the Company’s allocable portion of overhead and other expenses incurred by the Administrator in performing its obligations under the Administration Agreement, including rent. The Administrator will also provide, on the Company’s behalf, managerial assistance to those portfolio companies to which the Company is required to provide such assistance. The Company typically reimburses the Administrator on a quarterly basis. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the three and six months ended June 30, 2023, the Company recognized expenses under the Administration Agreement of $1,480 and $2,988 respectively. For the three and six months ended June 30, 2022, the Company recognized expenses under the Administration Agreement of $1,369 and $2,552 respectively. No managerial assistance fees were accrued or collected for the three and six months ended June 30, 2023 and 2022. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> 0.015 2 0.01 2 0.0175 -0.07 1 0.20 0.20 0.20 7878000 15584000 5638000 11147000 125000 235000 6913000 14129000 4734000 4734000 1358000 1358000 1480000 2988000 1369000 2552000 <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 4. Net Asset Value Per Share </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At June 30, 2023, the Company’s total net assets and net asset value per share were $980,805 and $17.98, respectively. This compares to total net assets and net asset value per share at December 31, 2022 of $999,731 and $18.33, respectively. </div> 980805000 17.98 999731000 18.33 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 5. Earnings Per Share </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table sets forth the computation of basic and diluted net increase in net assets per share resulting from operations, pursuant to ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">260-10,</div> for the three and six months ended June 30, 2023 and 2022: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:51%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three months ended June 30,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six months ended June 30,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Earnings (loss) per share (basic &amp; diluted)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Numerator - net increase (decrease) in net assets resulting from operations:</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,995</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(15,646</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25,819</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(14,183</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Denominator - weighted average shares:</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,554,634</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,772,651</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,554,642</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">48,551,302</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Earnings (loss) per share:</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.35</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">($</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.29</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.47</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">($</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.29</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table sets forth the computation of basic and diluted net increase in net assets per share resulting from operations, pursuant to ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">260-10,</div> for the three and six months ended June 30, 2023 and 2022: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:51%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three months ended June 30,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six months ended June 30,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Earnings (loss) per share (basic &amp; diluted)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Numerator - net increase (decrease) in net assets resulting from operations:</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,995</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(15,646</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25,819</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(14,183</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Denominator - weighted average shares:</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,554,634</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,772,651</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,554,642</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">48,551,302</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Earnings (loss) per share:</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.35</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">($</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.29</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.47</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">($</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.29</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr></table> 18995000 -15646000 25819000 -14183000 54554634 54554634 54772651 54772651 54554642 54554642 48551302 48551302 0.35 0.35 -0.29 -0.29 0.47 0.47 -0.29 -0.29 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 6. Fair Value </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a framework for measuring fair value that includes a hierarchy used to classify the inputs used in measuring fair value. The hierarchy prioritizes the inputs to valuations used to measure fair value into three levels. The level in the fair value hierarchy within which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The levels of the fair value hierarchy are as follows: </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 1.</div></div> Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company has the ability to access. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 2.</div></div> Financial assets and liabilities whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 2 inputs include the following: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">a)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Quoted prices for similar assets or liabilities in active markets; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">b)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Quoted prices for identical or similar assets or liabilities in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-active</div> markets; </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">c)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Pricing models whose inputs are observable for substantially the full term of the asset or liability; and </div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%"> </td> <td style="width:5%;vertical-align:top;text-align:left;">d)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Pricing models whose inputs are derived principally from or corroborated by observable market data through correlation or other means for substantially the full term of the asset or liability. </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 3. </div></div>Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s and, if applicable, an independent third-party valuation firm’s own assumptions about the assumptions a market participant would use in pricing the asset or liability. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">When the inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3). </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Gains and losses for assets and liabilities categorized within the Level 3 table below may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3). </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A review of fair value hierarchy classifications is conducted on a quarterly basis. Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. Such reclassifications involving Level 3 assets and liabilities are reported as transfers in/out of Level 3 as of the end of the quarter in which the reclassifications occur. Within the fair value hierarchy tables below, cash and cash equivalents are excluded but could be classified as Level 1. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div></div><div><div style="line-height:normal;background-color:white;display: inline;"></div></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following tables present the balances of assets measured at fair value on a recurring basis, as of June 30, 2023 and December 31, 2022: </div><div style="margin-top: 24pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Fair Value Measurements </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">As of June 30, 2023 </div></div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:60%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Measured at<br/> Net Asset Value*</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets:</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,318,512</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,318,512</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equipment Financing</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">271,333</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">271,333</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Equity</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Equity/Equity Interests/Warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">358</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">566,427</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">20,995</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">587,780</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">358</td> <td style="white-space:nowrap;vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,160,073</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,995</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,181,426</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top: 24pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Fair Value Measurements </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2022 </div></div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Measured at<br/> Net Asset Value*</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets:</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,245,414</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,245,414</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equipment Financing</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">265,952</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">265,952</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Equity</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Equity/Equity Interests/Warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">483</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">561,600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">9,426</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">571,509</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">483</td> <td style="white-space:nowrap;vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,076,767</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,426</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,086,676</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">*</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">In accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">820-10,</div> certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The portfolio investment in this category is SSLP. See Note 17 for more information on this investment, including its investment strategy and the Company’s unfunded equity commitment to SSLP. This investment is not redeemable by the Company absent an election by the members of the entity to liquidate all investments and distribute the proceeds to the members. </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following tables provide a summary of the changes in fair value of Level 3 assets for the three and six months ended June 30, 2023, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at June 30, 2023: </div><div style="margin-top: 24pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Fair Value Measurements Using Level 3 Inputs </div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:52%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Senior Secured</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Loans</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equipment</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financing</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preferred Equity</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common Equity/</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equity</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Interests/</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, March</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 31, 2023</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,256,830</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">258,044</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">559,919</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,078,594</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total gains or losses included in earnings:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized gain</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">333</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">333</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized gain (loss)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,647</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(138</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(62</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(11,998</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,551</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Purchase of investment securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">166,766</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22,739</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">62</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,506</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">208,073</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from dispositions of investment securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(113,064</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(9,312</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(122,376</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transfers in/out of Level 3</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, June</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 30, 2023</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,318,512</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">271,333</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">566,427</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,160,073</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized gain (loss)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,207</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(138</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(62</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(11,998</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,991</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:52%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Senior Secured</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Loans</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equipment</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financing</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preferred Equity</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common Equity/</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equity</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Interests/</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, December</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 31, 2022</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,245,414</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">265,952</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">561,600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,076,767</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total gains or losses included in earnings:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized gain</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,157</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,157</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,823</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(78</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(123</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(14,358</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(20,382</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Purchase of investment securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">320,336</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,084</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">123</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,185</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">369,728</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from dispositions of investment securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(242,572</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(24,625</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(267,197</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transfers in/out of Level 3</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, June</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 30, 2023</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,318,512</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">271,333</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">566,427</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,160,073</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized loss.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(11,594</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(78</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(123</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(14,358</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(26,153</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While the Company has not made an election to apply the fair value option of accounting to any of its current debt obligations, if the Company’s debt obligations were carried at fair value at June 30, 2023, the fair value of the Credit Facility, SPV Credit Facility, 2024 Unsecured Notes, 2025 Unsecured Notes, 2026 Unsecured Notes, 2027 Unsecured Notes and 2027 Series F Unsecured Notes would be $582,000, $167,200, $119,688, $80,325, $68,250, $43,125 and $118,463, respectively. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2022, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2022: </div><div style="margin-top: 24pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Fair Value Measurements Using Level 3 Inputs </div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:52%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Senior Secured</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Loans</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equipment</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financing</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preferred Equity</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common Equity/</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equity</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Interests/</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, December</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 31, 2021</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">939,690</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">273,795</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,630</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">450,381</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,669,496</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total gains or losses included in earnings:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized gain (loss)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(36,244</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(36,238</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><span style="-sec-ix-hidden:hidden85540990">Net</span> change in unrealized loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8,065</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,924</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(706</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,048</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(20,743</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Purchase of investment securities(1)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">796,389</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">84,168</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">266</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">116,272</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">997,095</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from dispositions of investment securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(446,356</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(85,087</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,389</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(11</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(532,843</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transfers in/out of Level 3</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, December</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 31, 2022</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,245,414</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">265,952</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">561,600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,076,767</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><span style="-sec-ix-hidden:hidden85540991">Net</span> change in unrealized loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8,920</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,924</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(706</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,048</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(21,598</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes positions acquired from SUNS as a result of the Mergers. </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the year ended December 31, 2022: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:12%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2022 Unsecured Notes</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the year ended<br/> December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Beginning fair value</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized (gain) loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized (gain) loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Borrowings</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Repayments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(150,000</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transfers in/out of Level 3</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ending fair value</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company made an election to apply the fair value option of accounting to the 2022 Unsecured Notes, in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">825-10.</div> On May 8, 2022, the borrowings were repaid in full. While the Company has not made an election to apply the fair value option of accounting to any of its other debt obligations, if the Company’s debt obligations were carried at fair value at December 31, 2022, the fair value of the Credit Facility, SPV Credit Facility, 2023 Unsecured Notes, 2024 Unsecured Notes, 2025 Unsecured Notes, 2026 Unsecured Notes, 2027 Unsecured Notes and 2027 Series F Unsecured Notes would be $393,000, $155,200, $75,000, $118,750, $79,688, $68,250, $42,875 and $118,125, respectively. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Quantitative Information about Level 3 Fair Value Measurements </div></div></div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company typically determines the fair value of its performing debt investments utilizing a yield analysis. In a yield analysis, a price is ascribed for each investment based upon an assessment of current and expected market yields for similar investments and risk profiles. Additional consideration is given to current contractual interest rates, relative maturities and other key terms and risks associated with an investment. Among other factors, a significant determinant of risk is the amount of leverage used by the portfolio company relative to the total enterprise value of the company, and the rights and remedies of our investment within each portfolio company. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Significant unobservable quantitative inputs typically used in the fair value measurement of the Company’s Level 3 assets and liabilities primarily reflect current market yields, including indices, and readily available quotes from brokers, dealers, and pricing services as indicated by comparable assets and liabilities, as well as enterprise values, returns on equity and earnings before income taxes, depreciation and amortization (“EBITDA”) multiples of similar companies, and comparable market transactions for equity securities. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of June 30, 2023 is summarized in the table below: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:27%"></td> <td style="vertical-align:bottom;width:3%"></td> <td style="width:5%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td style="width:23%"></td> <td style="vertical-align:bottom;width:3%"></td> <td style="width:22%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Asset or</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Liability</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value at</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Principal Valuation</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Technique/Methodology</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Unobservable Input</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Range (Weighted</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average)</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">Asset</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="display:inline;">$</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,306,129 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">12,383</div> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="display:inline;"> </div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Income Approach</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Recovery Analysis</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Yield</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Recoverable Amount</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">9.9% – 20.8% (12.8%) <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">N/A</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equipment Financing</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">Asset</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,513 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">120,820</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Income Approach</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Multiple<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Yield</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Comparable Multiple</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">8.5% – 9.7% (9.6%) <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1.1x-1.4x (1.2x)</div></div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Equity</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Asset</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Income Approach</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Yield</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">5.0% – 5.0% (5.0%)</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Equity/Equity Interests/Warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">Asset</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">162,207 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">404,220</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Multiple<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Approach</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Comparable Multiple</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Return on Equity</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">6.3x – 11.5x (8.7x) <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">4.7% – 32.4% (10.7%)</div> </td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes $120,820 of investments valued using an implied multiple. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes $1,047 of investments valued using a Black-Scholes model and $161,160 of investments valued using an EBITDA multiple. </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of December 31, 2022 is summarized in the table below: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:24%"></td> <td style="vertical-align:bottom;width:4%"></td> <td style="width:5%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td style="width:22%"></td> <td style="vertical-align:bottom;width:4%"></td> <td style="width:21%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Asset or</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Liability</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value at</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Principal Valuation</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Technique/Methodology</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Unobservable Input</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Range (Weighted</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average)</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">Asset</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,212,842 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">32,572</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Income Approach</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Multiple<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Yield</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Comparable Multiple</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">9.4% – 18.2% (12.0%) <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">0.1x-21.4x (12.4x)</div></div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equipment Financing</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">Asset</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">145,132 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">120,820</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Income Approach</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Multiple<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Yield</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Comparable Multiple</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">8.5% – 9.7% (9.7%) <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1.1x-1.4x (1.2x)</div></div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Equity</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">Asset</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Income Approach</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Yield</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">5.0% – 5.0% (5.0%)</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Equity/Equity Interests/Warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">Asset</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">149,120 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">412,480</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Multiple<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(3)</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Approach</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Comparable Multiple</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Return on Equity</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">7.8x – 9.8x (8.8x) <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">6.6% – 35.2% (9.2%)</div> </td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Investments are valued using a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">sum-of-the</div></div> parts analysis, using expected revenue multiples for certain segments of the businesses and expected EBITDA multiples for certain segments of the businesses. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes $120,820 of investments valued using an implied multiple. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(3)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes $676 of investments valued using a Black-Scholes model and $148,444 of investments valued using an EBITDA multiple. </div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Significant increases or decreases in any of the above unobservable inputs in isolation, including unobservable inputs used in deriving <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">bid-ask</div> spreads, if applicable, could result in significantly lower or higher fair value measurements for such assets and liabilities. Generally, an increase in market yields or decrease in EBITDA multiples may result in a decrease in the fair value of certain of the Company’s investments. </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following tables present the balances of assets measured at fair value on a recurring basis, as of June 30, 2023 and December 31, 2022: </div><div style="margin-top: 24pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Fair Value Measurements </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">As of June 30, 2023 </div></div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:60%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Measured at<br/> Net Asset Value*</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets:</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,318,512</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,318,512</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equipment Financing</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">271,333</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">271,333</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Equity</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Equity/Equity Interests/Warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">358</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">566,427</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">20,995</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">587,780</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">358</td> <td style="white-space:nowrap;vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,160,073</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,995</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,181,426</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top: 24pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Fair Value Measurements </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2022 </div></div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Measured at<br/> Net Asset Value*</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets:</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,245,414</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,245,414</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equipment Financing</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">265,952</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">265,952</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Equity</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Equity/Equity Interests/Warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">483</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">561,600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">9,426</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom;text-align:right;">571,509</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Investments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">483</td> <td style="white-space:nowrap;vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,076,767</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,426</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,086,676</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">*</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">In accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">820-10,</div> certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The portfolio investment in this category is SSLP. See Note 17 for more information on this investment, including its investment strategy and the Company’s unfunded equity commitment to SSLP. This investment is not redeemable by the Company absent an election by the members of the entity to liquidate all investments and distribute the proceeds to the members. </div></td></tr></table> 0 0 1318512000 0 1318512000 0 0 271333000 0 271333000 0 0 3801000 0 3801000 358000 0 566427000 20995000 587780000 358000 0 2160073000 20995000 2181426000 0 0 1245414000 0 1245414000 0 0 265952000 0 265952000 0 0 3801000 0 3801000 483000 0 561600000 9426000 571509000 483000 0 2076767000 9426000 2086676000 <div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following tables provide a summary of the changes in fair value of Level 3 assets for the three and six months ended June 30, 2023, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at June 30, 2023: </div><div style="margin-top: 24pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Fair Value Measurements Using Level 3 Inputs </div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:52%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Senior Secured</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Loans</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equipment</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financing</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preferred Equity</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common Equity/</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equity</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Interests/</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, March</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 31, 2023</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,256,830</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">258,044</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">559,919</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,078,594</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total gains or losses included in earnings:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized gain</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">333</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">333</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized gain (loss)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,647</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(138</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(62</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(11,998</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,551</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Purchase of investment securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">166,766</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22,739</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">62</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,506</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">208,073</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from dispositions of investment securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(113,064</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(9,312</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(122,376</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transfers in/out of Level 3</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, June</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 30, 2023</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,318,512</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">271,333</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">566,427</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,160,073</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized gain (loss)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,207</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(138</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(62</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(11,998</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,991</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:52%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Senior Secured</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Loans</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equipment</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financing</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preferred Equity</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common Equity/</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equity</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Interests/</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, December</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 31, 2022</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,245,414</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">265,952</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">561,600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,076,767</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total gains or losses included in earnings:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized gain</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,157</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,157</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,823</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(78</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(123</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(14,358</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(20,382</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Purchase of investment securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">320,336</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,084</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">123</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,185</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">369,728</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from dispositions of investment securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(242,572</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(24,625</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(267,197</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transfers in/out of Level 3</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, June</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 30, 2023</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,318,512</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">271,333</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">566,427</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,160,073</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized loss.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(11,594</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(78</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(123</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(14,358</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(26,153</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While the Company has not made an election to apply the fair value option of accounting to any of its current debt obligations, if the Company’s debt obligations were carried at fair value at June 30, 2023, the fair value of the Credit Facility, SPV Credit Facility, 2024 Unsecured Notes, 2025 Unsecured Notes, 2026 Unsecured Notes, 2027 Unsecured Notes and 2027 Series F Unsecured Notes would be $582,000, $167,200, $119,688, $80,325, $68,250, $43,125 and $118,463, respectively. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2022, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2022: </div><div style="margin-top: 24pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Fair Value Measurements Using Level 3 Inputs </div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:52%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Senior Secured</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Loans</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equipment</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financing</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preferred Equity</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common Equity/</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equity</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Interests/</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, December</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 31, 2021</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">939,690</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">273,795</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,630</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">450,381</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,669,496</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total gains or losses included in earnings:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized gain (loss)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(36,244</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(36,238</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><span style="-sec-ix-hidden:hidden85540990">Net</span> change in unrealized loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8,065</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,924</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(706</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,048</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(20,743</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Purchase of investment securities(1)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">796,389</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">84,168</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">266</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">116,272</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">997,095</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from dispositions of investment securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(446,356</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(85,087</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,389</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(11</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(532,843</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transfers in/out of Level 3</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, December</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 31, 2022</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,245,414</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">265,952</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">561,600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,076,767</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><span style="-sec-ix-hidden:hidden85540991">Net</span> change in unrealized loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8,920</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,924</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(706</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(5,048</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(21,598</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes positions acquired from SUNS as a result of the Mergers. </div></td></tr></table> 1256830000 258044000 3801000 559919000 2078594000 333000 0 0 0 333000 7647000 -138000 -62000 -11998000 -4551000 166766000 22739000 62000 18506000 208073000 -113064000 -9312000 0 0 -122376000 0 0 0 0 0 1318512000 271333000 3801000 566427000 2160073000 1207000 -138000 -62000 -11998000 -10991000 1245414000 265952000 3801000 561600000 2076767000 1157000 0 0 0 1157000 -5823000 -78000 -123000 -14358000 -20382000 320336000 30084000 123000 19185000 369728000 -242572000 -24625000 0 0 -267197000 0 0 0 0 0 1318512000 271333000 3801000 566427000 2160073000 -11594000 -78000 -123000 -14358000 -26153000 582000000 167200000 119688000 80325000 68250000 43125000 118463000 939690000 273795000 5630000 450381000 1669496000 -36244000 0 0 6000 -36238000 -8065000 -6924000 -706000 -5048000 -20743000 796389000 84168000 266000 116272000 997095000 -446356000 -85087000 -1389000 -11000 -532843000 0 0 0 0 0 1245414000 265952000 3801000 561600000 2076767000 -8920000 -6924000 -706000 -5048000 -21598000 <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the year ended December 31, 2022: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:80%"></td> <td style="vertical-align:bottom;width:12%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2022 Unsecured Notes</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the year ended<br/> December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Beginning fair value</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized (gain) loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized (gain) loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Borrowings</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Repayments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(150,000</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transfers in/out of Level 3</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ending fair value</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 150000000 0 0 0 -150000000 0 0 393000000 155200000 75000000 118750000 79688000 68250000 42875000 118125000 <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of June 30, 2023 is summarized in the table below: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:27%"></td> <td style="vertical-align:bottom;width:3%"></td> <td style="width:5%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td style="width:23%"></td> <td style="vertical-align:bottom;width:3%"></td> <td style="width:22%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Asset or</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Liability</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value at</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Principal Valuation</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Technique/Methodology</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Unobservable Input</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Range (Weighted</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average)</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">Asset</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="display:inline;">$</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,306,129 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">12,383</div> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="display:inline;"> </div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Income Approach</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Recovery Analysis</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Yield</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Recoverable Amount</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">9.9% – 20.8% (12.8%) <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">N/A</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equipment Financing</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">Asset</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,513 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">120,820</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Income Approach</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Multiple<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Yield</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Comparable Multiple</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">8.5% – 9.7% (9.6%) <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1.1x-1.4x (1.2x)</div></div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Equity</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Asset</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Income Approach</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Yield</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">5.0% – 5.0% (5.0%)</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Equity/Equity Interests/Warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">Asset</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">162,207 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">404,220</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Multiple<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Approach</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Comparable Multiple</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Return on Equity</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">6.3x – 11.5x (8.7x) <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">4.7% – 32.4% (10.7%)</div> </td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes $120,820 of investments valued using an implied multiple. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes $1,047 of investments valued using a Black-Scholes model and $161,160 of investments valued using an EBITDA multiple. </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of December 31, 2022 is summarized in the table below: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:24%"></td> <td style="vertical-align:bottom;width:4%"></td> <td style="width:5%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td style="width:22%"></td> <td style="vertical-align:bottom;width:4%"></td> <td style="width:21%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Asset or</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Liability</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value at</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Principal Valuation</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Technique/Methodology</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Unobservable Input</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Range (Weighted</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average)</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">Asset</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,212,842 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">32,572</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Income Approach</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Multiple<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Yield</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Comparable Multiple</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">9.4% – 18.2% (12.0%) <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">0.1x-21.4x (12.4x)</div></div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Equipment Financing</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">Asset</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">145,132 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">120,820</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Income Approach</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Multiple<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Yield</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Comparable Multiple</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">8.5% – 9.7% (9.7%) <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1.1x-1.4x (1.2x)</div></div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Equity</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">Asset</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,801</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Income Approach</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">Market Yield</td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">5.0% – 5.0% (5.0%)</td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Equity/Equity Interests/Warrants</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">Asset</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$ <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">$</div> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">149,120 <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right; line-height: normal;">412,480</div> </td> <td style="white-space:nowrap;vertical-align:bottom">  <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Multiple<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(3)</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Market Approach</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Comparable Multiple</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Return on Equity</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap;text-align:center;">7.8x – 9.8x (8.8x) <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">6.6% – 35.2% (9.2%)</div> </td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Investments are valued using a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">sum-of-the</div></div> parts analysis, using expected revenue multiples for certain segments of the businesses and expected EBITDA multiples for certain segments of the businesses. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes $120,820 of investments valued using an implied multiple. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(3)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Includes $676 of investments valued using a Black-Scholes model and $148,444 of investments valued using an EBITDA multiple. </div></td></tr></table> 1306129000 12383000 Income Approach Recovery Analysis Market Yield Recoverable Amount 9.9 20.8 12.8 150513000 120820000 Income Approach Market Multiple Market Yield Comparable Multiple 8.5 9.7 9.6 1.1 1.4 1.2 3801000 Income Approach Market Yield 5 5 5 162207000 404220000 Market Multiple Market Approach Comparable Multiple Return on Equity 6.3 11.5 8.7 4.7 32.4 10.7 120820000 1047000 161160000 1212842000 32572000 Income Approach Market Multiple Market Yield Comparable Multiple 9.4 18.2 12 0.1 21.4 12.4 145132000 120820000 Income Approach Market Multiple Market Yield Comparable Multiple 8.5 9.7 9.7 1.1 1.4 1.2 3801000 Income Approach Market Yield 5 5 5 149120000 412480000 Market Multiple Market Approach Comparable Multiple Return on Equity 7.8 9.8 8.8 6.6 35.2 9.2 120820000 676000 148444000 <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 7. Debt </div></div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Our debt obligations consisted of the following as of June 30, 2023 and December 31, 2022: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:55%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Facility</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Face Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Face Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Credit Facility</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">582,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">577,843</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">393,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">388,254</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SPV Credit Facility</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">167,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">166,433</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">155,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">154,302</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023 Unsecured Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,979</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(3)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024 Unsecured Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">124,563</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">124,421</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025 Unsecured Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">85,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">84,696</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">85,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">84,613</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026 Unsecured Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,556</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(6)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,498</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(6)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027 Unsecured Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">49,959</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(7)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">49,953</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(7)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027 Series F Unsecured Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">135,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">134,983</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(8)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">135,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">134,978</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(8)</div> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,219,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,213,033</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,093,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,085,998</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $4,157 and $4,746 as of June 30, 2023 and December 31, 2022, respectively. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized market discount of $767 and $898 as of June 30, 2023 and December 31, 2022, respectively. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(3)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $21 as of December 31, 2022. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(4)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $437 and $579 as of June 30, 2023 and December 31, 2022, respectively. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(5)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized market discount of $304 and $387 as of June 30, 2023 and December 31, 2022, respectively. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(6)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $444 and $502 as of June 30, 2023 and December 31, 2022, respectively. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(7)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $41 and $47 as of June 30, 2023 and December 31, 2022, respectively. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(8)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $17 and $22 as of June 30, 2023 and December 31, 2022, respectively. </div></td></tr></table> <div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Unsecured Notes </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On April 1, 2022, the Company entered into an assumption agreement (the “Note Assumption Agreement”), effective as of the closing of the Mergers. The Note Assumption Agreement relates to the Company’s assumption of $85,000 in aggregate principal amount of five-year, 3.90% senior unsecured notes, due March 31, 2025 (the “2025 Unsecured Notes”) and other obligations of SUNS under the Note Purchase Agreement, dated as of March 31, 2020 (the “Note Purchase Agreement”), among SUNS and certain institutional investors. Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30. Pursuant to the Note Assumption Agreement, the Company expressly assumed on behalf of SUNS the due and punctual payment of the principal of (and premium, if any) and interest on all the 2025 Unsecured Notes outstanding, and the due and punctual performance and observance of every covenant and every condition of the Note Purchase Agreement, to be performed or observed by SUNS. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January 6, 2022, the Company closed a private offering of $135,000 of the 2027 Series F Unsecured Notes with a fixed interest rate of 3.33% and a maturity date of January 6, 2027. Interest on the 2027 Series F Unsecured Notes is due semi-annually on January 6 and July 6. The 2027 Series F Unsecured Notes were issued in a private placement only to qualified institutional buyers. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September 14, 2021, the Company closed a private offering of $50,000 of the 2027 Unsecured Notes with a fixed interest rate of 2.95% and a maturity date of March 14, 2027. Interest on the 2027 Unsecured Notes is due semi-annually on March 14 and September 14. The 2027 Unsecured Notes were issued in a private placement only to qualified institutional buyers. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December 18, 2019, the Company closed a private offering of $125,000 of the 2024 Unsecured Notes with a fixed interest rate of 4.20% and a maturity date of December 15, 2024. Interest on the 2024 Unsecured Notes is due semi-annually on June 15 and December 15. The 2024 Unsecured Notes were issued in a private placement only to qualified institutional buyers. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;;text-indent: 0px;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December 18, 2019, the Company closed a private offering of $75,000 of the 2026 Unsecured Notes with a fixed interest rate of 4.375% and a maturity date of December 15, 2026. Interest on the 2026 Unsecured Notes is due semi-annually on June 15 and December 15. The 2026 Unsecured Notes were issued in a private placement only to qualified institutional buyers. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November 22, 2017, we issued $75,000 in aggregate principal amount of publicly registered 2023 Unsecured Notes for net proceeds of $73,846. Interest on the 2023 Unsecured Notes is paid semi-annually on January 20 and July 20, at a fixed rate of 4.50% per year, commencing on January 20, 2018. The 2023 Unsecured Notes were repaid in full on the maturity date, January 20, 2023. </div> <div style="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman;text-indent: 0px;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Revolving and Term Loan Facilities </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On April 1, 2022, the Company entered into an assumption agreement (the “CF Assumption Agreement”), effective as of the closing of the Mergers. The CF Assumption Agreement relates to the Company’s assumption of the Revolving Credit Facility, originally entered into on August 26, 2011 (as amended from time to time, the “SPV Credit Facility”), by and among SUNS SPV LLC (the “SUNS SPV”), a wholly-owned subsidiary of SUNS, acting as borrower, Citibank, N.A., acting as administrative agent and collateral agent, and the other parties thereto. Currently, the commitment under the SPV Credit Facility is $225,000; however, the commitment can also be expanded up to $600,000. The stated interest rate on the SPV Credit Facility is <div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">SOFR</div></div> plus <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2.00%-2.50%</div> with no <div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">SOFR</div></div> floor requirement and the current final maturity date is June 1, 2026. The SPV Credit Facility is secured by all of the assets held by SUNS SPV. Under the terms of the SPV Credit Facility and related transaction documents, the Company as successor to SUNS, and SUNS SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SPV Credit Facility also includes usual and customary events of default for credit facilities of this nature. At June 30, 2023, outstanding USD equivalent borrowings under the SPV Credit Facility totaled $167,200. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December 28, 2021, the Company closed on Amendment No. 1 to its August 28, 2019 senior secured credit agreement (the “Credit Facility”). Following the amendment and a November 2022 upsizing, the Credit Facility is composed of $625,000 of revolving credit and $100,000 of term loans. Borrowings generally bear interest at a rate per annum equal to the base rate plus a range of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1.75%-2.00%</div> or the alternate base rate plus <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">0.75%-1.00%.</div> The Credit Facility has a 0% floor and matures in December 2026 and includes ratable amortization in the final year. The Credit Facility may be increased up to $800,000 with additional new lenders or an increase in commitments from current lenders. The Credit Facility contains certain customary affirmative and negative covenants and events of default. In addition, the Credit Facility contains certain financial covenants that among other things, requires the Company to maintain a minimum shareholder’s equity and a minimum asset coverage ratio. At June 30, 2023, outstanding USD equivalent borrowings under the Credit Facility totaled $582,000, composed of $482,000 of revolving credit and $100,000 of term loans. </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain covenants on our issued debt may restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our status as a RIC under Subchapter M of the Code. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The average annualized interest cost for all borrowings for the six months ended June 30, 2023 and the year ended December 31, 2022 was 5.60% and 4.09%, respectively. These costs are exclusive of other credit facility expenses such as unused fees, agency fees and other prepaid expenses related to establishing and/or amending the Credit Facility, the SPV Credit Facility, the 2023 Unsecured Notes, the 2024 Unsecured Notes, the 2025 Unsecured Notes, the 2026 Unsecured Notes, the 2027 Unsecured Notes and the 2027 Series F Unsecured Notes (collectively the “Debt Instruments”), if any. The maximum amounts borrowed on the Debt Instruments during the six months ended June 30, 2023 and the year ended December 31, 2022 were $1,219,200 and $1,164,200, respectively. </div> <div style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Our debt obligations consisted of the following as of June 30, 2023 and December 31, 2022: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:55%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Facility</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Face Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Face Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Credit Facility</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">582,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">577,843</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">393,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">388,254</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SPV Credit Facility</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">167,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">166,433</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">155,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">154,302</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2023 Unsecured Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,979</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(3)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2024 Unsecured Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">124,563</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">124,421</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2025 Unsecured Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">85,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">84,696</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">85,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">84,613</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2026 Unsecured Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,556</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(6)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,498</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(6)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027 Unsecured Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">49,959</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(7)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">49,953</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(7)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">2027 Series F Unsecured Notes</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">135,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">134,983</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(8)</div> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">135,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">134,978</td> <td style="white-space:nowrap;vertical-align:bottom"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(8)</div> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,219,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,213,033</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,093,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,085,998</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $4,157 and $4,746 as of June 30, 2023 and December 31, 2022, respectively. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized market discount of $767 and $898 as of June 30, 2023 and December 31, 2022, respectively. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(3)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $21 as of December 31, 2022. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(4)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $437 and $579 as of June 30, 2023 and December 31, 2022, respectively. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(5)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized market discount of $304 and $387 as of June 30, 2023 and December 31, 2022, respectively. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(6)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $444 and $502 as of June 30, 2023 and December 31, 2022, respectively. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(7)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $41 and $47 as of June 30, 2023 and December 31, 2022, respectively. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(8)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $17 and $22 as of June 30, 2023 and December 31, 2022, respectively. </div></td></tr></table> 582000000 577843000 393000000 388254000 167200000 166433000 155200000 154302000 0 0 75000000 74979000 125000000 124563000 125000000 124421000 85000000 84696000 85000000 84613000 75000000 74556000 75000000 74498000 50000000 49959000 50000000 49953000 135000000 134983000 135000000 134978000 1219200000 1213033000 1093200000 1085998000 4157000 4746000 767000 898000 21000 437000 579000 304000 387000 444000 502000 41000 47000 17000 22000 85000000 85000000 P5Y 0.039 2025-03-31 Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30 135000000 135000000 0.0333 2027-01-06 Interest on the 2027 Series F Unsecured Notes is due semi-annually on January 6 and July 6 50000000 50000000 0.0295 0.0295 125000000 125000000 125000000 0.042 2024-12-15 Interest on the 2024 Unsecured Notes is due semi-annually on June 15 and December 15 75000000 75000000 75000000 0.04375 0.04375 2026-12-15 75000000 75000000 75000000 73846000 semi-annually on January 20 and July 20 0.045 0.045 2023-01-20 225000000 600000000 0.02 -0.025 2026-06-01 167200000 625000000 100000000 0.0175 -0.02 0.0075 -0.01 800000000 582000000 482000000 100000000 0.056 0.0409 1219200000 1164200000 <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 8. Financial Highlights </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a schedule of financial highlights for the six months ended June 30, 2023 and 2022: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:67%"></td> <td style="vertical-align:bottom;width:11%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six months ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six months ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Per Share Data: (a)</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net asset value, beginning of year</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18.33</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19.93</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net investment income</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.82</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.70</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized and unrealized loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.35</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.97</td> <td style="white-space:nowrap;vertical-align:bottom">)* </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net increase (decrease) in net assets resulting from operations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.47</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.27</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of common stock in connection with the Merger</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.31</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Distributions to stockholders:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">From distributable earnings</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.82</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.82</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">From return of capital</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net asset value, end of period</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17.98</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18.53</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Per share market value, end of period</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14.27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14.63</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Return (b)(c)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8.41</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(19.85</td> <td style="white-space:nowrap;vertical-align:bottom">%) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net assets, end of period</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">980,805</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,015,153</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares outstanding, end of period</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,554,634</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,772,651</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ratios to average net assets (c):</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net investment income</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.52</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.53</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.22</td> <td style="white-space:nowrap;vertical-align:bottom">%** </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.44</td> <td style="white-space:nowrap;vertical-align:bottom">%** </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest and other credit facility expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.34</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.95</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.56</td> <td style="white-space:nowrap;vertical-align:bottom">%** </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.39</td> <td style="white-space:nowrap;vertical-align:bottom">%** </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Average debt outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,125,576</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">880,327</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Portfolio turnover ratio</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12.6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table><div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(a)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Calculated using the average shares outstanding method, except for the issuance of common stock in connection with the Merger, which reflects the actual amount per share for the applicable period. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(b)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Total return is based on the change in market price per share during the period and takes into account distributions, if any, reinvested in accordance with the dividend reinvestment plan. The market price per share as of December 31, 2022 and December 31, 2021 was $13.91 and $18.43, respectively. Total return does not include a sales load. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(c)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Not annualized for periods less than one year. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">*</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The amount shown may not correspond with the aggregate amount for the period as it includes the effect of the timing of the Merger. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">**</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The ratio of operating expenses to average net assets and the ratio of total expenses to average net assets is shown net of the performance-based incentive fee waiver (see note 3). For the six months ended June 30, 2023, the ratios of operating expenses to average net assets and total expenses to average net assets would be 3.24% and 6.58%, respectively, without the performance-based incentive fee waiver. For the six months ended June 30, 2022, the ratios of operating expenses to average net assets and total expenses to average net assets would be 2.58% and 4.53%, respectively, without the performance-based incentive fee waiver. </div></td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a schedule of financial highlights for the six months ended June 30, 2023 and 2022: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:67%"></td> <td style="vertical-align:bottom;width:11%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six months ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six months ended</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Per Share Data: (a)</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net asset value, beginning of year</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18.33</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19.93</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net investment income</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.82</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.70</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized and unrealized loss</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.35</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.97</td> <td style="white-space:nowrap;vertical-align:bottom">)* </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net increase (decrease) in net assets resulting from operations</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.47</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.27</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of common stock in connection with the Merger</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.31</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Distributions to stockholders:</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">From distributable earnings</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.82</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.82</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">From return of capital</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net asset value, end of period</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17.98</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18.53</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Per share market value, end of period</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14.27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14.63</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Return (b)(c)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8.41</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(19.85</td> <td style="white-space:nowrap;vertical-align:bottom">%) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net assets, end of period</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">980,805</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,015,153</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares outstanding, end of period</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,554,634</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,772,651</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ratios to average net assets (c):</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net investment income</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.52</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.53</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Operating expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.22</td> <td style="white-space:nowrap;vertical-align:bottom">%** </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.44</td> <td style="white-space:nowrap;vertical-align:bottom">%** </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest and other credit facility expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.34</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.95</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total expenses</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.56</td> <td style="white-space:nowrap;vertical-align:bottom">%** </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.39</td> <td style="white-space:nowrap;vertical-align:bottom">%** </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Average debt outstanding</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,125,576</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">880,327</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Portfolio turnover ratio</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12.6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td></tr></table><div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(a)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Calculated using the average shares outstanding method, except for the issuance of common stock in connection with the Merger, which reflects the actual amount per share for the applicable period. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(b)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Total return is based on the change in market price per share during the period and takes into account distributions, if any, reinvested in accordance with the dividend reinvestment plan. The market price per share as of December 31, 2022 and December 31, 2021 was $13.91 and $18.43, respectively. Total return does not include a sales load. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(c)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Not annualized for periods less than one year. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">*</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The amount shown may not correspond with the aggregate amount for the period as it includes the effect of the timing of the Merger. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">**</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The ratio of operating expenses to average net assets and the ratio of total expenses to average net assets is shown net of the performance-based incentive fee waiver (see note 3). For the six months ended June 30, 2023, the ratios of operating expenses to average net assets and total expenses to average net assets would be 3.24% and 6.58%, respectively, without the performance-based incentive fee waiver. For the six months ended June 30, 2022, the ratios of operating expenses to average net assets and total expenses to average net assets would be 2.58% and 4.53%, respectively, without the performance-based incentive fee waiver. </div></td></tr></table> 18.33 19.93 0.82 0.7 -0.35 -0.97 0.47 -0.27 -0.31 0.82 0.82 0 0 17.98 18.53 14.27 14.63 0.0841 -0.1985 980805000 1015153000 54554634 54772651 0.0452 0.0353 0.0322 0.0244 0.0334 0.0195 0.0656 0.0439 1125576000 880327000 0.126 0.09 13.91 18.43 0.0324 0.0658 0.0258 0.0453 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 9. SLR Credit Solutions </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December 28, 2012, we acquired an equity interest in Crystal Capital Financial Holdings LLC (“Crystal Financial”) for $275,000 in cash. Crystal Financial owned approximately 98% of the outstanding ownership interest in SLR Credit Solutions (“SLR Credit”), f/k/a Crystal Financial LLC. The remaining financial interest was held by various employees of SLR Credit, through their investment in Crystal Management LP. SLR Credit had a diversified portfolio of 23 loans having a total par value of approximately $400,000 at November 30, 2012 and a $275,000 committed revolving credit facility. On July 28, 2016, the Company purchased Crystal Management LP’s approximately 2% equity interest in SLR Credit for approximately $5,737. Upon the closing of this transaction, the Company holds 100% of the equity interest in SLR Credit. On September 30, 2016, Crystal Capital Financial Holdings LLC was dissolved. As of June 30, 2023, total commitments to the revolving credit facility are $300,000. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of June 30, 2023 SLR Credit had 29 funded commitments to 25 different issuers with total funded loans of approximately $425,019 on total assets of $443,024. As of December 31, 2022 SLR Credit had 29 funded commitments to 25 different issuers with total funded loans of approximately $439,484 on total assets of $460,683. As of June 30, 2023 and December 31, 2022, the largest loan outstanding totaled $30,000 and $33,420, respectively. For the same periods, the average exposure per issuer was $17,001 and $17,579, respectively. SLR Credit’s credit facility, which is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recourse</div> to the Company, had approximately $216,947 and $224,325 of borrowings outstanding at June 30, 2023 and December 31, 2022, respectively. For the three months ended June 30, 2023 and 2022, SLR Credit had net income of $6,767 and $1,880, respectively, on gross income of $13,897 and $6,882, respectively. For the six months ended June 30, 2023 and 2022, SLR Credit had net income (loss) of ($2,905) and $4,660, respectively, on gross income of $28,452 and $13,575, respectively. Due to timing and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> items, there may be material differences between GAAP net income and cash available for distributions. </div> 275000000 0.98 23 400000000 275000000 0.02 5737000 1 300000000 29 25 425019000 443024000 29 25 439484000 460683000 30000000 33420000 17001000 17579000 216947000 224325000 6767000 1880000 13897000 6882000 2905000 4660000 28452000 13575000 <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 10. Commitments and Contingencies </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Off-Balance</div> Sheet Arrangements </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company had unfunded debt and equity commitments to various revolving and delayed-draw term loans as well as to SLR Credit and SLR Healthcare. The total amount of these unfunded commitments as of June 30, 2023 and December 31, 2022 is $325,858 and $323,663, respectively, comprised of the following: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:68%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SLR Credit Solutions*</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">44,263</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">44,263</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outset Medical, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">35,084</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">35,084</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Apeel Technology, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32,786</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32,786</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">CVAUSA Management, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22,882</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Human Interest, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,104</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,104</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Glooko, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,868</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,868</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">BDG Media, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,539</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,546</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ONS MSO, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,961</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">iCIMS, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,800</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,435</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Arcutis Biotherapeutics, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,356</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,356</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Atria Wealth Solutions, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,215</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,215</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Copper River Seafoods, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,158</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,595</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ardelyx, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,752</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,752</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cerapedics, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,735</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,735</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">United Digestive MSO Parent, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,259</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Luxury Asset Capital, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Kaseya, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,768</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,936</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SPAR Marketing Force, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,733</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,338</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Urology Management Holdings, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,596</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">One Touch Direct, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,571</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,069</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Spectrum Pharmaceuticals, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,508</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,771</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SLR Equipment Finance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Meditrina, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,367</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,367</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vertos Medical, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,325</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foundation Consumer Brands, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,009</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,009</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vessco Midco Holdings, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,677</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,892</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Kid Distro Holdings, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,650</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,650</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">RSC Acquisition, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,487</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,498</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Erie Construction <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Mid-west,</div> LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,403</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,248</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ultimate Baked Goods Midco LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,361</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,636</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Maurices, Incorporated</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,353</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic Fun, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,150</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,675</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SCP Eye Care, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,955</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,771</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">DeepIntent, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,925</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,049</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SunMed Group Holdings, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,621</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">843</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SLR Healthcare ABL*</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,400</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,400</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">American Teleconferencing Services, Ltd</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,380</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,090</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Montefiore Nyack Hospital</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,301</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,034</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Pinnacle Treatment Centers, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,286</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,745</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">RxSense Holdings LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Bayside Opco, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,247</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Enverus Holdings, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,233</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,004</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Tilley Distribution, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,158</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">525</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Pediatric Home Respiratory Services, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,147</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,805</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">GSM Acquisition Corp</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">862</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">784</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Composite Technology Acquisition Corp</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">825</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,537</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">High Street Buyer, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">631</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">327</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">CC SAG Holdings Corp. (Spectrum Automotive)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">548</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,670</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Orthopedic Care Partners Management, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">536</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,620</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Southern Orthodontic Partners Management, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">519</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,918</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ENS Holdings III Corp, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">461</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">144</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">World Insurance Associates, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">295</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,117</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TAUC Management, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">294</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">294</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">AmeriMark Intermediate Holdings, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">221</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">All State Ag Parts, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">43</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">135</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Plastics Management, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,424</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ivy Fertility Services, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,571</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NAC Holdings Corporation</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,479</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Peter C. Foy &amp; Associates Insurance Services, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,094</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">BayMark Health Services, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">391</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Commitments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">325,858</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">323,663</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">*</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company controls the funding of the SLR Credit Solutions and SLR Healthcare ABL commitments and may cancel them at its discretion. </div></td></tr></table><div></div><div><div style="line-height:normal;background-color:white;display: inline;"></div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition to the above, please see Note 17. SLR Senior Lending Program LLC herein, which describes that the Company has an equity commitment of $29,250 in SSLP and that the Company also controls such funding. The credit agreements of the above loan commitments contain customary lending provisions and/or are subject to the portfolio company’s achievement of certain milestones that allow relief to the Company from funding obligations for previously made commitments in instances where the underlying company experiences materially adverse events that affect the financial condition or business outlook for the company. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company. As of June 30, 2023 and December 31, 2022, the Company had sufficient cash available and/or liquid securities available to fund its commitments and had reviewed them for any appropriate fair value adjustment. </div></div></div> The total amount of these unfunded commitments as of June 30, 2023 and December 31, 2022 is $325,858 and $323,663, respectively, comprised of the following: <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:68%"></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:8%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SLR Credit Solutions*</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">44,263</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">44,263</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Outset Medical, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">35,084</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">35,084</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Apeel Technology, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32,786</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32,786</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">CVAUSA Management, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22,882</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Human Interest, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,104</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,104</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Glooko, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,868</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,868</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">BDG Media, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,539</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,546</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ONS MSO, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,961</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">iCIMS, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,800</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,435</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Arcutis Biotherapeutics, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,356</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,356</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Atria Wealth Solutions, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,215</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,215</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Copper River Seafoods, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,158</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,595</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ardelyx, Inc</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,752</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,752</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cerapedics, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,735</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,735</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">United Digestive MSO Parent, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,259</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Luxury Asset Capital, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Kaseya, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,768</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,936</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SPAR Marketing Force, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,733</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,338</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Urology Management Holdings, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,596</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">One Touch Direct, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,571</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,069</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Spectrum Pharmaceuticals, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,508</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,771</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SLR Equipment Finance</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Meditrina, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,367</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,367</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vertos Medical, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,325</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foundation Consumer Brands, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,009</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,009</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Vessco Midco Holdings, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,677</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,892</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Kid Distro Holdings, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,650</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,650</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">RSC Acquisition, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,487</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,498</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Erie Construction <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Mid-west,</div> LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,403</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,248</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ultimate Baked Goods Midco LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,361</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,636</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Maurices, Incorporated</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,353</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic Fun, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,150</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,675</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SCP Eye Care, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,955</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,771</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">DeepIntent, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,925</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,049</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SunMed Group Holdings, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,621</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">843</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SLR Healthcare ABL*</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,400</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,400</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">American Teleconferencing Services, Ltd</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,380</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,090</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Montefiore Nyack Hospital</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,301</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,034</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Pinnacle Treatment Centers, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,286</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,745</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">RxSense Holdings LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Bayside Opco, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,247</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Enverus Holdings, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,233</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,004</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Tilley Distribution, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,158</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">525</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Pediatric Home Respiratory Services, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,147</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,805</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">GSM Acquisition Corp</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">862</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">784</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Composite Technology Acquisition Corp</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">825</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,537</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">High Street Buyer, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">631</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">327</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">CC SAG Holdings Corp. (Spectrum Automotive)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">548</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,670</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Orthopedic Care Partners Management, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">536</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,620</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Southern Orthodontic Partners Management, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">519</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,918</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ENS Holdings III Corp, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">461</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">144</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">World Insurance Associates, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">295</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,117</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TAUC Management, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">294</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">294</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">AmeriMark Intermediate Holdings, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">221</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">All State Ag Parts, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">43</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">135</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Plastics Management, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,424</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ivy Fertility Services, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,571</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NAC Holdings Corporation</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,479</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Peter C. Foy &amp; Associates Insurance Services, LLC</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,094</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">BayMark Health Services, Inc.</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">391</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total Commitments</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">325,858</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">323,663</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">*</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company controls the funding of the SLR Credit Solutions and SLR Healthcare ABL commitments and may cancel them at its discretion. </div></td></tr></table> 325858000 323663000 44263000 44263000 35084000 35084000 32786000 32786000 22882000 0 20104000 20104000 17868000 17868000 11539000 3546000 10961000 0 10800000 11435000 8356000 8356000 8215000 8215000 8158000 3595000 7752000 7752000 6735000 6735000 5259000 0 4500000 7500000 3768000 3936000 3733000 1338000 3596000 0 3571000 3069000 3508000 8771000 3500000 1000000 3367000 3367000 3325000 0 3009000 3009000 2677000 3892000 2650000 2650000 2487000 7498000 2403000 1248000 2361000 1636000 2353000 4314000 2150000 2675000 1955000 2771000 1925000 3049000 1621000 843000 1400000 1400000 1380000 1090000 1301000 1034000 1286000 1745000 1250000 1250000 1247000 0 1233000 1004000 1158000 525000 1147000 1805000 862000 784000 825000 1537000 631000 327000 548000 20670000 536000 1620000 519000 1918000 461000 144000 295000 17117000 294000 294000 221000 0 43000 135000 0 2424000 0 1571000 0 1479000 0 1094000 0 391000 325858000 323663000 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 11. SLR Equipment Finance </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July 31, 2017, we acquired a 100% equity interest in NEF Holdings, LLC, which conducts its business through its wholly-owned subsidiary Nations Equipment Finance, LLC. Effective February 25, 2021, Nations Equipment Finance, LLC and its related companies are doing business as SLR Equipment Finance (“SLR Equipment”). SLR Equipment is an independent equipment finance company that provides senior secured loans and leases primarily to U.S. based companies. We invested $209,866 in cash to effect the transaction, of which $145,000 was invested in the equity of SLR Equipment through our wholly-owned consolidated taxable subsidiary NEFCORP LLC and our wholly-owned consolidated subsidiary NEFPASS LLC and $64,866 was used to purchase certain leases and loans held by SLR Equipment through NEFPASS LLC. Concurrent with the transaction, SLR Equipment refinanced its existing senior secured credit facility into a $150,000 <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recourse</div> facility with an accordion feature to expand up to $250,000. In September 2019, SLR Equipment amended the facility, increasing commitments to $213,957 with an accordion feature to expand up to $313,957 and extended the maturity date of the facility to July 31, 2023. In June 2023, the facility was amended to extend the maturity date to January 31, 2024, with updated commitments totaling $152,147, effective August 1, 2023. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of June 30, 2023, SLR Equipment had 129 funded equipment-backed leases and loans to 54 different customers with a total net investment in leases and loans of approximately $197,694 on total assets of $246,528. As of December 31, 2022, SLR Equipment had 131 funded equipment-backed leases and loans to 59 different customers with a total net investment in leases and loans of approximately $190,830 on total assets of $241,813. As of June 30, 2023 and December 31, 2022, the largest position outstanding totaled $18,243 and $19,259, respectively. For the same periods, the average exposure per customer was $3,661 and $3,234, respectively. SLR Equipment’s credit facility, which is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recourse</div> to the Company, had approximately $124,732 and $114,977 of borrowings outstanding at June 30, 2023 and December 31, 2022, respectively. For the three months ended June 30, 2023 and June 30, 2022, SLR Equipment had net loss of $2,055 and $1,753, respectively, on gross income of $4,054 and $4,045, respectively. For the six months ended June 30, 2023 and June 30, 2022, SLR Equipment had net loss of $1,017 and $1,159, respectively, on gross income of $10,391 and $9,218, respectively. Due to timing and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> items, there may be material differences between GAAP net income and cash available for distributions. </div> 1 209866000 145000000 64866000 150000000 250000000 213957000 313957000 2024-01-31 152147000 2023-08-01 129 54 197694000 246528000 131 59 190830000 241813000 18243000 19259000 3661000 3234000 124732000 114977000 2055000 1753000 4054000 4045000 1017000 1159000 10391000 9218000 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 12. Capital Share Transactions </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of June 30, 2023 and June 30, 2022, 200,000,000 shares of $0.01 par value capital stock were authorized. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Transactions in capital stock were as follows: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:39%"></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three months ended<br/> June 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three months ended<br/> June 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three months ended<br/> June 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three months ended<br/> June 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares issued in connection with the Mergers</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,511,825</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">226,839</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net increase</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,511,825</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">226,839</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:36%"></td> <td style="vertical-align:bottom;width:11%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:11%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  Six months ended  <br/> June 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  Six months ended  <br/> June 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">   Six months ended   <br/> June 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  Six months ended  <br/> June 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares issued in connection with the Mergers</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,511,825</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">226,839</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares repurchased</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(746</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net increase</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(746</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,511,825</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">226,839</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 200000000 200000000 0.01 0.01 <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Transactions in capital stock were as follows: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:39%"></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three months ended<br/> June 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three months ended<br/> June 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three months ended<br/> June 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three months ended<br/> June 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares issued in connection with the Mergers</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,511,825</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">226,839</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net increase</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,511,825</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">226,839</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:36%"></td> <td style="vertical-align:bottom;width:11%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:11%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:10%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  Six months ended  <br/> June 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  Six months ended  <br/> June 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">   Six months ended   <br/> June 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">  Six months ended  <br/> June 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares issued in connection with the Mergers</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,511,825</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">226,839</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares repurchased</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(746</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net increase</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(746</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,511,825</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">226,839</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 0 12511825 0 226839000 0 12511825 0 226839000 0 12511825 0 226839000 746 0 10000 0 -746 12511825 -10000 226839000 <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 13. Kingsbridge Holdings, LLC </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November 3, 2020, the Company acquired 87.5% of the equity securities of Kingsbridge Holdings, LLC (“KBH”) through KBH Topco LLC (“KBHT”), a Delaware corporation. KBH is a residual focused independent <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">mid-ticket</div> lessor of equipment primarily to U.S. investment grade companies. The Company invested $216,596 to effect the transaction, of which $136,596 was invested to acquire 87.5% of KBHT’s equity and $80,000 in KBH’s debt. The existing management team of KBH committed to continuing to lead KBH after the transaction. Following the transaction, the Company owns 87.5% of KBHT equity and the KBH management team owns the remaining 12.5% of KBHT’s equity. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of June 30, 2023 and December 31, 2022, KBHT had total assets of $797,930 and $777,151, respectively. For the same periods, debt recourse to KBHT totaled $246,294 and $222,094, respectively, and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recourse</div> debt totaled $356,929 and $353,128, respectively. None of the debt is recourse to the Company. For the three months ended June 30, 2023 and 2022, KBHT had net income of $3,287 and $3,657, respectively, on gross income of $75,500 and $77,316, respectively. For the six months ended June 30, 2023 and 2022, KBHT had net income of $5,914 and $7,066, respectively, on gross income of $143,507 and $143,741, respectively. Due to timing and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in KBHT’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that KBHT will be able to maintain consistent dividend payments to us. </div> 0.875 216596000 136596000 0.875 80000000 0.875 0.125 797930000 777151000 246294000 222094000 356929000 353128000 3287000 3657000 75500000 77316000 5914000 7066000 143507000 143741000 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 14. SLR Healthcare ABL </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SUNS acquired an equity interest in SLR Healthcare ABL, f/k/a Gemino Healthcare Finance, LLC (“SLR Healthcare”) on September 30, 2013. SLR Healthcare is a commercial finance company that originates, underwrites, and manages primarily secured, asset-based loans for small and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">mid-sized</div> companies operating in the healthcare industry. SUNS initial investment in SLR Healthcare ABL was $32,839. The management team of SLR Healthcare <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">co-invested</div> in the transaction and continues to lead SLR Healthcare. As of June 30, 2023, SLR Healthcare’s management team and the Company own approximately 7% and 93% of the equity in SLR Healthcare, respectively. SLRC acquired SLR Healthcare in connection with the Mergers on April 1, 2022. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Concurrent with the closing of the transaction, SLR Healthcare entered into a new, four-year, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recourse,</div> $100,000 credit facility with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-affiliates,</div> which was expandable to $150,000 under its accordion feature. Effective March 31, 2014, the credit facility was expanded to $105,000 and again on June 27, 2014 to $110,000. On May 27, 2016, SLR Healthcare entered into a new $125,000 credit facility which replaced the previously existing facility. The new facility has similar terms as compared to the previous facility and includes an accordion feature increase to $200,000 and had a maturity date of May 27, 2020. On June 28, 2019, this $125,000 facility was amended, extending the maturity date to June 28, 2023. On March 31, 2023, the facility was again amended, adjusting capacity to $100,000 and extending the maturity date to March 31, 2026. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SLR Healthcare currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of June 30, 2023, the portfolio totaled approximately $261,600 of commitments with a total net investment in loans of $99,555 on total assets of $106,837. As of December 31, 2022, the portfolio totaled approximately $242,106 of commitments with a total net investment in loans of $92,383 on total assets of $108,705. At June 30, 2023, the portfolio consisted of 40 issuers with an average balance of approximately $2,489 versus 41 issuers with an average balance of approximately $2,253 at December 31, 2022. All of the commitments in SLR Healthcare’s portfolio are floating-rate, senior-secured, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">cash-pay</div> loans. SLR Healthcare’s credit facility, which is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recourse</div> to us, had approximately $74,900 and $77,000 of borrowings outstanding at June 30, 2023 and December 31, 2022, respectively. For the three months ended June 30, 2023 and 2022, SLR Healthcare had net income of $1,273 and $847, respectively, on gross income of $4,439 and $2,487, respectively. For the six months ended June 30, 2023 and 2022, SLR Healthcare had net income of $2,393 and $1,721, respectively, on gross income of $8,276 and $4,878, respectively. Due to timing and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> items, there may be material differences between GAAP net income and cash available for distributions. </div> 32839000 0.07 0.93 P4Y 100000000 150000000 105000000 110000000 125000000 200000000 2020-05-27 125000000 2023-06-28 100000000 2026-03-31 261600000 99555000 106837000 242106000 92383000 108705000 40 2489000 41 2253000 74900000 77000000 1273000 847000 4439000 2487000 2393000 1721000 8276000 4878000 <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 15. SLR Business Credit </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SUNS acquired 100% of the equity interests of North Mill Capital LLC (“NMC”) on October 20, 2017. NMC is a leading asset-backed lending commercial finance company that provides senior secured asset-backed financings to U.S. based <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">small-to-medium-sized</div></div></div> businesses primarily in the manufacturing, services and distribution industries. SUNS invested approximately $51,000 to effect the transaction. Subsequently, SUNS contributed 1% of its equity interest in NMC to ESP SSC Corporation. Immediately thereafter, SUNS and ESP SSC Corporation contributed their equity interests to NorthMill LLC (“North Mill”). On May 1, 2018, North Mill merged with and into NMC, with NMC being the surviving company. SUNS and ESP SSC Corporation then owned 99% and 1% of the equity interests of NMC, respectively. The management team of NMC continues to lead NMC. On June 28, 2019, North Mill Holdco LLC (“NM Holdco”), a newly formed entity and ESP SSC Corporation acquired 100% of Summit Financial Resources, a Salt Lake City-based provider of asset-backed financing to small and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">medium-sized</div> businesses. As part of this transaction, SUNS 99% interest in the equity of NMC was contributed to NM Holdco. This approximately $15,500 transaction was financed with borrowings on NMC’s credit facility. Effective February 25, 2021, NMC and its related companies are doing business as SLR Business Credit. On June 3, 2021, NMC acquired 100% of Fast Pay Partners LLC, a Los Angeles-based provider of asset-backed financing to digital media companies. The transaction purchase price of $66,671 was financed with equity from SUNS of $19,000 and borrowings on NMC’s credit facility of $47,671. SLRC acquired SLR Business Credit in connection with the Mergers on April 1, 2022. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SLR Business Credit currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of June 30, 2023, the portfolio totaled approximately $620,232 of commitments, of which $255,169 were funded, on total assets of $300,645. As of December 31, 2022, the portfolio totaled approximately $603,432 of commitments, of which $286,006 were funded, on total assets of $332,247. At June 30, 2023, the portfolio consisted of 101 issuers with an average balance of approximately $2,526 versus 108 issuers with an average balance of approximately $2,648 at December 31, 2022. NMC has a senior credit facility with a bank lending group for $285,307 which expires on November 13, 2025. Borrowings are secured by substantially all of NMC’s assets. NMC’s credit facility, which is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recourse</div> to us, had approximately $198,571 and $214,425 of borrowings outstanding at June 30, 2023 and December 31, 2022, respectively. For the three months ended June 30, 2023 and 2022, SLR Business Credit had net income of $1,414 and $1,857 respectively, on gross income of $8,827 and $6,626, respectively. For the six months ended June 30, 2023 and 2022, SLR Business Credit had net income of $3,431 and $3,726 respectively, on gross income of $11,067 and $12,772, respectively. Due to timing and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Business Credit’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Business Credit will be able to maintain consistent dividend payments to us. </div> 1 51000000 0.01 0.99 0.01 1 0.99 15500000 1 66671000 19000000 47671000 620232000 255169000 300645000 603432000 286006000 332247000 101 2526000 108 2648000 285307000 2025-11-13 198571000 214425000 1414000 1857000 8827000 6626000 3431000 3726000 11067000 12772000 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 16. Stock Repurchase Program </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On May 9, 2023, our Board authorized an extension of a program for the purpose of repurchasing up to $50,000 of our outstanding shares of common stock. Under the repurchase program, we may, but are not obligated to, repurchase shares of our outstanding common stock in the open market from time to time provided that we comply with our code of ethics and the guidelines specified in Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10b-18</div> of the Exchange Act, including certain price, market volume and timing constraints. In addition, any repurchases will be conducted in accordance with the 1940 Act. Unless further amended or extended by our Board, we expect the repurchase program to be in place until the earlier of May 10, 2024 or until $50,000 of our outstanding shares of common stock have been repurchased. The timing and number of additional shares to be repurchased will depend on a number of factors, including market conditions. There are no assurances that we will engage in any repurchases beyond what is reported herein. For the six months ended June 30, 2023, the Company repurchased 746 shares at an average price of approximately $14.02 per share, inclusive of commissions. The total dollar amount of shares repurchased for the six months ended June 30, 2023 was $10. During the fiscal year ended December 31, 2022, the Company repurchased 217,271 shares at an average price of approximately $13.98 per share, inclusive of commissions. The total dollar amount of shares repurchased for the fiscal year ended December 31, 2022 was $3,038. </div> 50000000 2024-05-10 746 14.02 10000 217271 13.98 3038000 <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 17. SLR Senior Lending Program LLC </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October 12, 2022, the Company entered into an amended and restated limited liability company agreement with Sunstone Senior Credit L.P. (the “Investor”) to create a joint venture vehicle, SLR Senior Lending Program LLC (“SSLP”). SSLP is expected to invest primarily in senior secured cash flow loans. The Company and the Investor each have made initial equity commitments of $50,000, resulting in a total equity commitment of $100,000. Investment decisions and all material decisions in respect of SSLP must be approved by representatives of the Company and the Investor. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December 1, 2022, SSLP commenced operations. On December 12, 2022, SSLP as servicer and SLR Senior Lending Program SPV LLC (“SSLP SPV”), a newly formed wholly owned subsidiary of SSLP, as borrower entered into a $100,000 senior secured revolving credit facility (the “SSLP Facility”) with Goldman Sachs Bank USA acting as administrative agent. The SSLP Facility is scheduled to mature on December 12, 2027. The SSLP Facility generally bears interest at a rate of SOFR plus 3.25%. SSLP and SSLP SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SSLP Facility also includes usual and customary events of default for credit facilities of this nature. At June 30, 2023, there were $38,400 of borrowings outstanding on the SSLP Facility. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of June 30, 2023, the Company and the Investor had contributed combined equity capital in the amount of $41,500. As of June 30, 2023, the Company and the Investors’ remaining commitments to SSLP totaled $29,250 and $29,250, respectively. The Company, along with the Investor, controls the funding of SSLP and SSLP may not call the unfunded commitments of the Company or the Investor without the approval of both the Company and the Investor. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of June 30, 2023 and December 31, 2022, SSLP had total assets of $79,411 and $19,105, respectively. For the same periods, SSLP’s portfolio consisted of floating rate senior secured loans to 20 and 7 different borrowers, respectively. For the three months ended June 30, 2023, SSLP invested $32,557 in 9 portfolio companies. Investments prepaid totaled $182 for the three months ended June 30, 2023. For the period December 1, 2022 (commencement of operations) through December 31, 2022, SSLP invested $18,100 in 7 portfolio companies. Investments prepaid totaled $68 for the period December 1, 2022 (commencement of operations) through December 31, 2022. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">SSLP Portfolio as of June 30, 2023 </div></div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:31%"></td> <td style="vertical-align:bottom;width:1%"></td> <td style="width:28%"></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Description</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Industry</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Spread<br/> Above<br/> Index<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(1)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Floor</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Interest<br/> Rate<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(2)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Maturity<br/> Date</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Par<br/> Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair<br/> Value<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(3)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Aegis Toxicology Sciences Corporation<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Health Care Providers &amp; Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+550</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.84</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5/9/25</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,974</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,974</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,974</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Atria Wealth Solutions, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Diversified Financial Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+650</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2/29/24</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">BayMark Health Services, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Health Care Providers &amp; Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.50</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6/11/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,054</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,054</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,054</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ENS Holdings III Corp. &amp; ES Opco USA LLC <div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Trading Companies &amp; Distributors</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+475</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.09</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12/31/25</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,091</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,091</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,091</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fertility (ITC) Investment Holdco, LLC <div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Health Care Providers &amp; Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+650</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.63</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1/3/29</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,985</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,809</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,985</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foundation Consumer Brands, LLC <div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Personal Products</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.47</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2/12/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,863</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,863</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,863</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Higginbotham Insurance Agency, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Insurance</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+525</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.45</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11/25/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,293</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,293</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,293</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">High Street Buyer, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Insurance</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.75</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.39</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4/16/28</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">iCIMS, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Software</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+725</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.75</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12.38</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8/18/28</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,029</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,991</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,029</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Kid Distro Holdings, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Software</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+575</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.14</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10/1/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,970</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,970</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,970</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ONS MSO, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Health Care Providers &amp; Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.32</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7/8/25</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,951</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,774</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,773</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PhyNet Dermatology LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Health Care Providers &amp; Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.45</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8/16/24</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Pinnacle Treatment Centers, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Health Care Providers &amp; Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+675</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12.10</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1/2/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,487</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,487</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,487</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Plastics Management, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Health Care Providers &amp; Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.44</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8/18/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,666</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,666</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">RQM+ Corp.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Life Sciences Tools &amp; Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+575</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.51</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8/12/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,985</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,985</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,985</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">RSC Acquisition, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Insurance</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+550</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.75</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.64</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11/1/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,045</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,045</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,045</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">RxSense Holdings LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Diversified Consumer Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.15</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3/13/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,985</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,985</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,985</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SunMed Group Holdings, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Health Care Equipment &amp; Supplies</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+575</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.75</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.09</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6/16/28</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,487</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,487</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,487</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Tilley Distribution, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Trading Companies &amp; Distributors</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+550</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.39</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12/31/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,978</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,978</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,978</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Urology Management Holdings, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Health Care Providers &amp; Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.36</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6/15/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,471</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,404</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,397</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">77,114</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">77,505</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR. These instruments are typically subject to a SOFR floor. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Floating rate debt investments typically bear interest at a rate determined by reference to the SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of June 30, 2023. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(3)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(4)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company also holds this security on its Consolidated Statements of Assets and Liabilities. </div> </td> </tr> </table> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">SSLP Portfolio as of December 31, 2022</div></div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:31%"></td> <td style="vertical-align:bottom;width:1%"></td> <td style="width:28%"></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Description</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Industry</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Spread<br/> Above<br/> Index<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(1)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Floor</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Interest<br/> Rate<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(2)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Maturity<br/> Date</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Par<br/> Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair<br/> Value<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(3)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Atria Wealth Solutions, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Diversified Financial Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.84</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2/29/24</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">BayMark Health Services, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Health Care Providers &amp; Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.73</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6/11/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ENS Holdings III Corp. &amp; ES Opco USA LLC <div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Trading Companies &amp; Distributors</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+475</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.43</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12/31/25</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,097</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,097</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,097</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foundation Consumer Brands, LLC <div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Personal Products</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+550</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.15</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2/12/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,963</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,963</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,963</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">High Street Buyer, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Insurance</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.75</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.73</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4/16/28</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ivy Fertility Services, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Health Care Providers &amp; Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.39</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2/25/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,030</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Kid Distro Holdings, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Software</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+575</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.48</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10/1/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,032</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,062</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or SOFR. These instruments are typically subject to a LIBOR or SOFR floor. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Floating rate debt investments typically bear interest at a rate determined by reference to either the LIBOR (“L”) or SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2022. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(3)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(4)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company also holds this security on its Consolidated Statements of Assets and Liabilities. </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Below is certain summarized financial information for SSLP as of June 30, 2023 and December 31, 2022 and for the three and six months ended June 30, 2023 and for the period December 1, 2022 (commencement of operations) through December 31, 2022: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 74%;"></td> <td style="width: 7%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 7%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2023</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Selected Balance Sheet Information for SSLP:</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Investments at fair value (cost $77,114 and $18,032, respectively)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">77,505</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,062</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash and other assets</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,906</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,043</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total assets</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">79,411</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,105</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Debt outstanding</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">36,944</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest payable and other credit facility related expenses</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">345</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">165</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued expenses and other payables</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">131</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">89</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total liabilities</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">37,420</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">254</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Members’ equity</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">41,991</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,851</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total liabilities and members’ equity</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">79,411</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,105</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div></div><div> <div style="line-height:normal;background-color:white;display: inline;"> </div> </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;;text-indent: 0px;"> <div style="display:inline;"></div><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 50%;"></td> <td style="width: 12%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 12%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 12%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the three</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">months ended June</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">30, 2023</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the six<br/>months ended June</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">30, 2023</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the period<br/>December 1, 2022<br/>(commencement<br/>of operations) to<br/>December 31,<br/>2022 </div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> </tr> <tr style="font-size: 0px;"> <td style="width:50%"></td> <td style="vertical-align:bottom;width:12%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:12%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:12%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Selected Income Statement Information <br/>for SSLP:</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest income</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,605</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,614</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service fees*</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">38</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">57</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest and other credit facility expenses</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,447</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,252</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">166</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Organizational costs</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">73</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other general and administrative expenses</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">57</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">88</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total expenses</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,504</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,366</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">331</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net investment income (loss)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">101</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">248</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(179</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Realized gain on investments</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized gain on investments</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">321</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">361</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized and unrealized gain on investments</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">321</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">391</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net income (loss)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">422</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">639</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(149</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%;text-indent: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">*</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Service fees are included within the Company’s Consolidated Statements of Operations as other income. </div> </td> </tr> </table> 50000000 50000000 100000000 100000000 2027-12-12 0.0325 38400000 41500000 29250000 29250000 79411000 19105000 32557000 182000 18100000 68000 <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">SSLP Portfolio as of June 30, 2023 </div></div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:31%"></td> <td style="vertical-align:bottom;width:1%"></td> <td style="width:28%"></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Description</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Industry</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Spread<br/> Above<br/> Index<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(1)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Floor</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Interest<br/> Rate<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(2)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Maturity<br/> Date</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Par<br/> Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair<br/> Value<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(3)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Aegis Toxicology Sciences Corporation<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Health Care Providers &amp; Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+550</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.84</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5/9/25</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,974</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,974</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,974</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Atria Wealth Solutions, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Diversified Financial Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+650</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2/29/24</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">BayMark Health Services, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Health Care Providers &amp; Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.50</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6/11/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,054</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,054</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,054</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ENS Holdings III Corp. &amp; ES Opco USA LLC <div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Trading Companies &amp; Distributors</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+475</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.09</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12/31/25</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,091</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,091</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,091</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fertility (ITC) Investment Holdco, LLC <div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Health Care Providers &amp; Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+650</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.63</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1/3/29</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,985</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,809</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,985</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foundation Consumer Brands, LLC <div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Personal Products</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.47</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2/12/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,863</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,863</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,863</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Higginbotham Insurance Agency, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Insurance</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+525</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.45</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11/25/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,293</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,293</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,293</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">High Street Buyer, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Insurance</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.75</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.39</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4/16/28</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">iCIMS, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Software</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+725</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.75</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12.38</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8/18/28</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,029</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,991</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,029</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Kid Distro Holdings, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Software</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+575</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.14</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10/1/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,970</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,970</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,970</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ONS MSO, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Health Care Providers &amp; Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.32</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7/8/25</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,951</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,774</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,773</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PhyNet Dermatology LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Health Care Providers &amp; Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.45</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8/16/24</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Pinnacle Treatment Centers, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Health Care Providers &amp; Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+675</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12.10</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1/2/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,487</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,487</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,487</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Plastics Management, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Health Care Providers &amp; Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.44</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8/18/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,666</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,481</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,666</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">RQM+ Corp.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Life Sciences Tools &amp; Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+575</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.51</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8/12/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,985</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,985</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,985</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">RSC Acquisition, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Insurance</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+550</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.75</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.64</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11/1/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,045</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,045</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,045</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">RxSense Holdings LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Diversified Consumer Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.15</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3/13/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,985</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,985</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,985</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SunMed Group Holdings, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Health Care Equipment &amp; Supplies</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+575</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.75</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.09</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6/16/28</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,487</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,487</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,487</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Tilley Distribution, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Trading Companies &amp; Distributors</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+550</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.39</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12/31/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,978</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,978</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,978</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Urology Management Holdings, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Health Care Providers &amp; Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.36</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6/15/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,471</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,404</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,397</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">77,114</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">77,505</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR. These instruments are typically subject to a SOFR floor. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Floating rate debt investments typically bear interest at a rate determined by reference to the SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of June 30, 2023. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(3)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(4)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company also holds this security on its Consolidated Statements of Assets and Liabilities. </div> </td> </tr> </table> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">SSLP Portfolio as of December 31, 2022</div></div></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%; border: 0px; margin: 0px auto; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width:31%"></td> <td style="vertical-align:bottom;width:1%"></td> <td style="width:28%"></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Description</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Industry</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Spread<br/> Above<br/> Index<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(1)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Floor</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Interest<br/> Rate<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(2)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Maturity<br/> Date</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Par<br/> Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Cost</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair<br/> Value<div style="font-size:75%; vertical-align:top;display:inline;;font-size:6.6px">(3)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Atria Wealth Solutions, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Diversified Financial Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">S+600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.84</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2/29/24</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">BayMark Health Services, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Health Care Providers &amp; Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.73</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6/11/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">ENS Holdings III Corp. &amp; ES Opco USA LLC <div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Trading Companies &amp; Distributors</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+475</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.43</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12/31/25</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,097</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,097</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,097</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Foundation Consumer Brands, LLC <div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Personal Products</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+550</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.15</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2/12/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,963</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,963</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,963</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">High Street Buyer, Inc.<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px"> (4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Insurance</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.75</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.73</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4/16/28</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,494</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Ivy Fertility Services, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Health Care Providers &amp; Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.39</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2/25/26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,030</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Kid Distro Holdings, LLC<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Software</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">L+575</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.00</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10.48</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10/1/27</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,032</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,062</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or SOFR. These instruments are typically subject to a LIBOR or SOFR floor. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Floating rate debt investments typically bear interest at a rate determined by reference to either the LIBOR (“L”) or SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2022. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(3)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border: 0px; width: 100%; border-spacing: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(4)</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The Company also holds this security on its Consolidated Statements of Assets and Liabilities. </div> </td> </tr> </table> S+550 0.01 0.1084 2025-05-09 2974000 2974000 2974000 S+650 0.01 0.12 2024-02-29 2481000 2481000 2481000 S+500 0.01 0.105 2027-06-11 4054000 4054000 4054000 S+475 0.01 0.1009 2025-12-31 1091000 1091000 1091000 S+650 0.01 0.1163 2029-01-03 5985000 5809000 5985000 S+625 0.01 0.1147 2027-02-12 6863000 6863000 6863000 S+525 0.01 0.1045 2026-11-25 1293000 1293000 1293000 S+600 0.0075 0.1139 2028-04-16 2481000 2481000 2481000 S+725 0.0075 0.1238 2028-08-18 3029000 2991000 3029000 S+575 0.01 0.1114 2027-10-01 5970000 5970000 5970000 S+625 0.01 0.1132 2025-07-08 5951000 5774000 5773000 S+625 0.01 0.1145 2024-08-16 2481000 2481000 2481000 S+675 0.01 0.121 2026-01-02 2487000 2487000 2487000 S+500 0.01 0.1044 2027-08-18 5666000 5481000 5666000 S+575 0.01 0.1151 2026-08-12 5985000 5985000 5985000 S+550 0.0075 0.1064 2026-11-01 5045000 5045000 5045000 S+500 0.01 0.1015 2026-03-13 2985000 2985000 2985000 S+575 0.0075 0.1109 2028-06-16 2487000 2487000 2487000 S+550 0.01 0.1139 2026-12-31 5978000 5978000 5978000 S+625 0.01 0.1136 2026-06-15 2471000 2404000 2397000 77114000 77505000 S+600 0.01 0.1084 2024-02-29 2494000 2494000 2494000 L+500 0.01 0.0973 2027-06-11 2992000 2992000 2992000 L+475 0.01 0.0943 2025-12-31 1097000 1097000 1097000 L+550 0.01 0.1015 2027-02-12 2963000 2963000 2963000 L+600 0.0075 0.1073 2028-04-16 2494000 2494000 2494000 L+625 0.01 0.1039 2026-02-25 3000000 3000000 3030000 L+575 0.01 0.1048 2027-10-01 2992000 2992000 2992000 18032000 18062000 <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Below is certain summarized financial information for SSLP as of June 30, 2023 and December 31, 2022 and for the three and six months ended June 30, 2023 and for the period December 1, 2022 (commencement of operations) through December 31, 2022: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> <div style="letter-spacing: 0px; top: 0px;;display:inline;"></div><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 74%;"></td> <td style="width: 7%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 7%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2023</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Selected Balance Sheet Information for SSLP:</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Investments at fair value (cost $77,114 and $18,032, respectively)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">77,505</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,062</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash and other assets</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,906</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,043</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total assets</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">79,411</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,105</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Debt outstanding</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">36,944</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest payable and other credit facility related expenses</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">345</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">165</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued expenses and other payables</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">131</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">89</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total liabilities</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">37,420</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">254</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Members’ equity</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">41,991</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18,851</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total liabilities and members’ equity</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">79,411</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,105</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div></div><div> <div style="line-height:normal;background-color:white;display: inline;"> </div> </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;;text-indent: 0px;"> <div style="display:inline;"></div><br/></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 84%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 50%;"></td> <td style="width: 12%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 12%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 12%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the three</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">months ended June</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">30, 2023</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the six<br/>months ended June</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">30, 2023</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the period<br/>December 1, 2022<br/>(commencement<br/>of operations) to<br/>December 31,<br/>2022 </div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> </tr> <tr style="font-size: 0px;"> <td style="width:50%"></td> <td style="vertical-align:bottom;width:12%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:12%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:12%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Selected Income Statement Information <br/>for SSLP:</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest income</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,605</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,614</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">152</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service fees*</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">38</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">57</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Interest and other credit facility expenses</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,447</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,252</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">166</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Organizational costs</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">73</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other general and administrative expenses</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">57</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">88</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total expenses</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,504</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,366</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">331</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net investment income (loss)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">101</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">248</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(179</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Realized gain on investments</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net change in unrealized gain on investments</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">321</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">361</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized and unrealized gain on investments</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">321</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">391</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net income (loss)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">422</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">639</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(149</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"></div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%;text-indent: 0px;"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">*</td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Service fees are included within the Company’s Consolidated Statements of Operations as other income. </div> </td> </tr> </table> 77114000 18032000 77505000 18062000 1906000 1043000 79411000 19105000 36944000 0 345000 165000 131000 89000 37420000 254000 41991000 18851000 79411000 19105000 1605000 2614000 152000 38000 57000 4000 1447000 2252000 166000 0 0 73000 19000 57000 88000 1504000 2366000 331000 101000 248000 -179000 0 30000 0 321000 361000 30000 321000 391000 30000 422000 639000 -149000 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;">Note 18. Subsequent Events </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company has evaluated the need for disclosures and/or adjustments resulting from subsequent events through the date the consolidated financial statements were issued. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July 5, 2023, the Board declared a monthly distribution of $0.136667 per share payable on August 1, 2023 to holders of record as of July 20, 2023. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On August 8, 2023, the Board declared a monthly distribution of $0.136667 per share payable on August 30, 2023 to holders of record as of August 18, 2023<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">.</div></div></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Timing of Future Distributions</div></div></div></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin-top: 6pt; margin-bottom: 0pt; text-indent: 4%; font-size: 10pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Effective with the fourth quarter of 2023, SLRC’s board of directors intends to adjust the timing of declaring and paying distributions to SLRC’s shareholders from monthly to quarterly. As a result, SLRC’s management anticipates that the last monthly distribution, if declared by SLRC’s board of directors, will be for September 2023 and the next distribution after that, if declared by SLRC’s board of directors, will be a quarterly distribution for the fourth quarter of 2023. The amount and timing of past distributions are not a guarantee of any future distributions or the amount thereof. The payment, timing and amount of any future distributions will be determined by SLRC’s board of directors.</div></div></div> 0.136667 0.136667 <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Portfolio and Investment Activity </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the three months ended June 30, 2023, we invested approximately $212.9 million across 44 portfolio companies. This compares to investing, exclusive of assets acquired through the Merger, approximately $94.7 million in 29 portfolio companies for the three months ended June 30, 2022. Investments sold, prepaid or repaid during the three months ended June 30, 2023 totaled approximately $122.4 million versus approximately $78.5 million for the three months ended June 30, 2022. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At June 30, 2023, our portfolio consisted of 156 portfolio companies and was invested 33.7% in cash flow senior secured loans, 27.8% in asset-based senior secured loans / SLR Credit Solutions (“SLR Credit”) / SLR Healthcare ABL / SLR Business Credit, 22.9% in equipment senior secured financings / SLR Equipment Finance (“SLR Equipment”) / Kingsbridge Holdings, LLC (“KBH”) and 15.6% in life science senior secured loans, in each case, measured at fair value, versus 127 portfolio companies invested 30.0% in cash flow senior secured loans, 30.9% in asset-based senior secured loans / SLR Credit, 24.3% in equipment senior secured financings / SLR Equipment / KBH, and 14.8% in life science senior secured loans, in each case, measured at fair value, at June 30, 2022. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At June 30, 2023, 78.0% or $1.68 billion of our income producing investment portfolio<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">*</div> is floating rate and 22.0% or $473.9 million is fixed rate, measured at fair value. At June 30, 2022, 77.1% or $1.53 billion of our income producing investment portfolio<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">*</div> is floating rate and 22.9% or $453.7 million is fixed rate, measured at fair value. As of June 30, 2023 and 2022, we had three and two issuers, respectively, on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-accrual</div> status. </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">*</div> </td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">We have included SLR Credit Solutions, SLR Equipment Finance, SLR Healthcare ABL, SLR Business Credit and Kingsbridge Holdings, LLC within our income producing investment portfolio. </div></td></tr></table> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Senior Securities </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Information about our senior securities is shown in the following table (in thousands) as of the quarter ended June 30, 2023 and each year ended December 31 for the past ten years, unless otherwise noted. The “—” indicates information which the SEC expressly does not require to be disclosed for certain types of senior securities. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:59%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Class and Year</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total Amount</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Outstanding(1)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Asset</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Coverage</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Per Unit(2)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Involuntary</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Liquidating</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preference</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Per Unit(3)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Market Value</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Per Unit(4)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Credit Facility</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through June 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">482,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">713</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">293,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">513</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">222,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">552</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">126,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">421</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,900</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">182</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">96,400</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">593</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">245,600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,225</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">115,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">990</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2015</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">207,900</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,459</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2014</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2013</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">SPV Credit Facility</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through June 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">167,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">247</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">155,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">272</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2022 Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">372</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">501</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">638</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">923</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">748</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">430</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2022 Tranche C Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">52</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">70</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">89</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">129</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">105</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2023 Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through June 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">131</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">186</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">319</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">461</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">374</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2024 Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through June 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">185</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">219</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">309</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">417</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">531</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2025 Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through June 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">85,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">126</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">85,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">149</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2026 Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:57%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Class and Year</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total Amount</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Outstanding(1)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Asset</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Coverage</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Per Unit(2)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Involuntary</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Liquidating</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preference</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Per Unit(3)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Market Value</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Per Unit(4)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through June 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">111</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">131</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">186</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">319</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2027 Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through June 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">88</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">124</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2027 Series F Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through June 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">135,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">135,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">237</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2042 Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">859</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,002</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2015</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">702</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">982</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2014</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,294</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">943</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2013</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,411</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">934</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Senior Secured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">645</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2015</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">527</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2014</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,721</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2013</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,808</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Term Loans</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through June 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">148</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">175</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">248</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">319</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">308</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">430</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2015</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">351</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2014</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,147</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2013</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,206</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">NEFPASS Facility</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">128</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">185</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">SSLP Facility</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">53,785</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">331</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Total Senior Securities</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through June 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,219,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,804</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,093,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,915</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">818,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,029</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">677,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,259</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">593,900</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,525</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">476,185</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,930</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">541,600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,702</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">390,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,354</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2015</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">432,900</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,039</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2014</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">225,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,162</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2013</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">225,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,425</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table><div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of June 30, 2023, asset coverage was 180.4%. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(3)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(4)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014 and 2013 periods was $100,175, $98,196, $94,301 and $93,392, respectively. </div></td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Information about our senior securities is shown in the following table (in thousands) as of the quarter ended June 30, 2023 and each year ended December 31 for the past ten years, unless otherwise noted. The “—” indicates information which the SEC expressly does not require to be disclosed for certain types of senior securities. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:59%"></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:7%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Class and Year</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total Amount</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Outstanding(1)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Asset</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Coverage</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Per Unit(2)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Involuntary</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Liquidating</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preference</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Per Unit(3)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Market Value</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Per Unit(4)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Credit Facility</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through June 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">482,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">713</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">293,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">513</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">222,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">552</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">126,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">421</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,900</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">182</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">96,400</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">593</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">245,600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,225</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">115,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">990</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2015</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">207,900</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,459</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2014</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2013</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">SPV Credit Facility</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through June 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">167,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">247</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">155,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">272</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2022 Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">372</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">501</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">638</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">923</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">748</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">430</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2022 Tranche C Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">52</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">70</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">89</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">129</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">105</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2023 Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through June 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">131</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">186</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">319</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">461</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">374</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2024 Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through June 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">185</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">219</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">309</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">417</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">125,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">531</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2025 Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through June 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">85,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">126</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">85,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">149</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2026 Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:57%"></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:6%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Class and Year</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total Amount</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Outstanding(1)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Asset</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Coverage</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Per Unit(2)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Involuntary</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Liquidating</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preference</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Per Unit(3)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Market Value</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Per Unit(4)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through June 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">111</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">131</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">186</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">319</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2027 Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through June 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">88</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">124</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2027 Series F Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through June 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">135,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">135,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">237</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">2042 Unsecured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">859</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,002</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2015</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">702</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">982</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2014</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,294</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">943</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2013</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,411</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">934</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Senior Secured Notes</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">645</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2015</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">527</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2014</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,721</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2013</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,808</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Term Loans</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through June 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">148</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">175</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">248</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">75,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">319</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">308</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">250</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">430</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2015</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">351</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2014</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,147</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2013</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">50,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,206</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">NEFPASS Facility</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">128</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">30,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">185</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">SSLP Facility</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">53,785</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">331</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Total Senior Securities</div></div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2023 (through June 30, 2023)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,219,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,804</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2022</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,093,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,915</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2021</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">818,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,029</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2020</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">677,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,259</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2019</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">593,900</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,525</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2018</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">476,185</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,930</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2017</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">541,600</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,702</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2016</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">390,200</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,354</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2015</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">432,900</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,039</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2014</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">225,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,162</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fiscal 2013</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">225,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,425</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">N/A</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr></table><div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(1)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(2)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of June 30, 2023, asset coverage was 180.4%. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(3)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it. </div></td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;">(4)</td> <td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014 and 2013 periods was $100,175, $98,196, $94,301 and $93,392, respectively. </div></td></tr></table> 482000000 713 0 293000000 513 0 222500000 552 0 126000000 421 0 42900000 182 0 96400000 593 0 245600000 1225 0 115200000 990 0 207900000 1459 0 0 0 0 0 0 0 167200000 247 0 155200000 272 0 0 0 0 150000000 372 0 150000000 501 0 150000000 638 0 150000000 923 0 150000000 748 0 50000000 430 0 0 0 0 21000000 52 0 21000000 70 0 21000000 89 0 21000000 129 0 21000000 105 0 0 0 0 75000000 131 0 75000000 186 0 75000000 250 0 75000000 319 0 75000000 461 0 75000000 374 0 125000000 185 0 125000000 219 0 125000000 309 0 125000000 417 0 125000000 531 0 85000000 126 0 85000000 149 0 75000000 111 0 75000000 131 0 75000000 186 0 75000000 250 0 75000000 319 0 50000000 74 0 50000000 88 0 50000000 124 0 135000000 200 0 135000000 237 0 0 0 0 100000000 859 0 1002 100000000 702 0 982 100000000 2294 0 943 100000000 2411 0 934 0 0 0 75000000 645 0 75000000 527 0 75000000 1721 0 75000000 1808 0 100000000 148 0 100000000 175 0 100000000 248 0 75000000 250 0 75000000 319 0 50000000 308 0 50000000 250 0 50000000 430 0 50000000 351 0 50000000 1147 0 50000000 1206 0 0 0 0 30000000 100 0 30000000 128 0 30000000 185 0 0 0 0 53785000 331 0 1219200000 1804 0 1093200000 1915 0 818500000 2029 0 677000000 2259 0 593900000 2525 0 476185000 2930 0 541600000 2702 0 390200000 3354 0 432900000 3039 0 225000000 5162 0 225000000 5425 0 <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td id="tx518171_16" style="width:10%;vertical-align:top;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Item 1A.</div></div></td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">Risk Factors </div></div> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;">In addition to the other information set forth in this report, you should carefully consider the factors discussed in “Risk Factors” in the February 28, 2023 filing of our Annual Report on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Form 10-K, which</div> could materially affect our business, financial condition and/or operating results. The risks described in our Annual Report are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially and adversely affect our business, financial condition and/or operating results. Other than the risk factors set forth below, there have been no material changes during the period ended June 30, 2023 to the risk factors discussed in “Risk Factors” in the February 28, 2023 filing of our Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K.</div> </div></div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"></div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Adverse developments affecting the financial services industry, such as actual events or concerns involving liquidity, defaults or <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-performance</div> by financial institutions or transactional counterparties could have a material adverse effect on us, the Investment Adviser and our portfolio companies. </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cash not held in custody accounts and held by us, our Investment Adviser and by our portfolio companies in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-interest-bearing</div> and interest-bearing operating accounts could, at times, exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limits. If such banking institutions were to fail, we, our Investment Adviser, or our portfolio companies could lose all or a portion of those amounts held in excess of such insurance limits. In addition, actual events involving limited liquidity, defaults, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-performance</div> or other adverse developments that affect financial institutions, transactional counterparties or other companies in the financial services industry or the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems, which could adversely affect our, our Investment Adviser’s and our portfolio companies’ business, financial condition, results of operations, or prospects. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although we and our Investment Adviser assess our and our portfolio companies’ banking and financing relationships as we believe necessary or appropriate, our and our portfolio companies’ access to funding sources and other credit arrangements in amounts adequate to finance or capitalize current and projected future business operations could be significantly impaired by factors that affect the financial institutions with which we, our Investment Adviser or our portfolio companies have arrangements directly or the financial services industry or economy in general. These factors could include, among others, events such as liquidity constraints or failures, the ability to perform obligations under various types of financial, credit or liquidity agreements or arrangements, disruptions or instability in the financial services industry or financial markets, or concerns or negative expectations about the prospects for companies in the financial services industry. These factors could involve financial institutions or financial services industry companies with which we, our Investment Adviser or our portfolio companies have financial or business relationships, but could also include factors involving financial markets or the financial services industry generally. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, investor concerns regarding the U.S. or international financial systems could result in less favorable commercial financing terms, including higher interest rates or costs and tighter financial and operating covenants, or systemic limitations on access to credit and liquidity sources, thereby making it more difficult for us, our Investment Adviser, or our portfolio companies to acquire financing on acceptable terms or at all. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our stock repurchase program could affect the price of our common stock and increase volatility and may be suspended or terminated at any time, which may result in a decrease in the trading price of our common stock. </div></div></div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On May 9, 2023, the Board most recently extended our share repurchase program (the “Program”), under which we can repurchase up to $50 million of our outstanding common stock. Under the Program, purchases can be made at management’s discretion from time to time in open-market transactions, in accordance with all applicable securities laws and regulations, at prices below the Company’s NAV as reported in its most recently published consolidated financial statements. We have in the past, and could in the future, enter into a plan to repurchase shares of our common stock pursuant to the Program in a manner intended to comply with the requirements of Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10b5-1</div> under the Exchange Act. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Program is discretionary and whether purchases will be made under the Program and how much will be purchased at any time is uncertain and dependent on prevailing market prices and trading volumes, all of which we cannot predict. These activities could have the effect of maintaining the market price of our common stock or retarding a decline in the market price of the common stock, and, as a result, the price of our common stock could be higher than the price that otherwise might exist in the open market. Repurchases pursuant to the Program could affect the price of our common stock and increase its volatility. The existence of the Program could also cause the price of our common stock to be higher than it would be in the absence of such a program and could potentially reduce the market liquidity for our common stock. There can be no assurance that any stock repurchases will enhance stockholder value because the market price of our common stock could decline below the levels at which we repurchased such shares. Any failure to repurchase shares after we have announced our intention to do so could negatively impact our reputation and investor confidence in us and could negatively impact our stock price. Although the Program is intended to enhance long-term stockholder value, short-term stock price fluctuations could reduce the Program’s <div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">effectiveness. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">The alternative reference rates that have replaced LIBOR in our credit arrangements and other financial instruments may not yield the same or similar economic results as LIBOR over the life of such transactions.</div></div></div></div> </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The London Interbank Offered Rate (“LIBOR”) is an index rate that historically was widely used in lending transactions and was a common reference rate for setting the floating interest rate on private loans. LIBOR was typically the reference rate used in floating-rate loans extended to our portfolio companies. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The ICE Benchmark Administration (“IBA”) (the entity that is responsible for calculating LIBOR) ceased providing overnight, one, three, six and twelve months USD LIBOR tenors on June 30, 2023. In addition, the United Kingdom’s Financial Conduct Authority (“FCA”), which oversees the IBA, now prohibits entities supervised by the FCA from using LIBORs, including USD LIBOR, except in very limited circumstances. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In the United States, the Secured Overnight Financing Rate (“SOFR”) is the preferred alternative rate for LIBOR. SOFR is a measure of the cost of borrowing cash overnight, collateralized by U.S. Treasury securities, and is based on directly observable U.S. Treasury-backed repurchase transactions. SOFR is published by the Federal Reserve Bank of New York each U.S. Government Securities Business Day, for transactions made on the immediately preceding U.S. Government Securities Business Day. Alternative reference rates that may replace LIBOR, including SOFR for USD transactions, may not yield the same or similar economic results as LIBOR over the lives of such transactions. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of the filing date of this Quarterly Report on Form 10-Q, many of our loans that referenced LIBOR have been amended to reference the forward-looking term rate published by CME Group Benchmark Administration Limited based on SOFR (“CME Term SOFR”) or CME Term SOFR plus a fixed spread adjustment. CME Term SOFR rates are forward-looking rates that are derived by compounding projected overnight SOFR rates over one, three, and six months taking into account the values of multiple consecutive, executed, one-month and three-month CME Group traded SOFR futures contracts and, in some cases, over-the-counter SOFR Overnight Indexed Swaps as an indicator of CME Term SOFR reference rate values. CME Term SOFR and the inputs on which it is based are derived from SOFR. Since CME Term SOFR is a relatively new market rate, there will likely be no established trading market for credit agreements or other financial instruments when they are issued, and an established market may never develop or may not be liquid. Market terms for instruments referencing CME Term SOFR rates may be lower than those of later-issued CME Term SOFR indexed instruments. Similarly, if CME Term SOFR does not prove to be widely used, the trading price of instruments referencing CME Term SOFR may be lower than those of instruments indexed to indices that are more widely used. Further, the composition and characteristics of SOFR and CME Term SOFR are not the same as those of LIBOR. Even with the application of a fixed spread adjustment, LIBOR and CME Term SOFR will not have the same composition and characteristics, and there can be no assurance that the replacement rate, as so adjusted, will be a direct substitute for LIBOR. </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">There can be no guarantee that SOFR will not be discontinued or fundamentally altered in a manner that is materially adverse to the interests of investors in loans referencing SOFR. If the manner in which SOFR or CME Term SOFR is calculated is changed, that change may result in a reduction of the amount of interest payable on such loans and the trading prices of the SOFR Loans. In addition, there can be no guarantee that loans referencing SOFR or CME Term SOFR will continue to reference those rates until maturity or that, in the future, our loans will reference benchmark rates other than CME Term SOFR. Should any of these events occur, our loans, and the yield generated thereby, could be affected. Specifically, the anticipated yield on our loans may not be fully realized and our loans may be subject to increased pricing volatility and market risk. </div></div></div> false false false false Investment is on non-accrual status. Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SUNS SPV LLC (the “SUNS SPV”). Such investments are pledged as collateral under the Senior Secured Revolving SPV Credit Facility (the “SPV Credit Facility”) (see Note 7 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company. Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of June 30, 2023, on a fair value basis, non-qualifying assets in the portfolio represented 24.5% of the total assets of the Company. Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (the “1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the six months ended June 30, 2023 in these controlled investments are as follows: Indicates an investment that is wholly held by the Company through NEFPASS LLC. Denotes a subsidiary of SLR Equipment Finance. Non-income producing security. See note 13 to the consolidated financial statements. Kingsbridge Holdings, LLC is held through KBH Topco LLC, a Delaware corporation. See note 15 to the consolidated financial statements. See note 9 to the consolidated financial statements. See note 14 to the consolidated financial statements. See note 17 to the consolidated financial statements. Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2022, on a fair value basis, non-qualifying assets in the portfolio represented 24.2% of the total assets of the Company. Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (“1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2022 in these controlled investments are as follows: SLR Equipment Finance is held through NEFCORP LLC, a wholly-owned consolidated taxable subsidiary and NEFPASS LLC, a wholly-owned consolidated subsidiary. See note 11 to the consolidated financial statements. Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR” or “L”), the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of June 30, 2023. Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR, SOFR or PRIME rate. These instruments are often subject to a LIBOR, SOFR or PRIME rate floor. Denotes investments in which we are an “Affiliated Person” but not exercising a controlling influence, as defined in the 1940 Act, due to beneficially owning, either directly or through one or more controlled companies, more than 5% but less than 25% of the outstanding voting securities of the investment. Transactions during the six months ended June 30, 2023 (beginning with the date at which the Company became an Affiliated Person) in these affiliated investments are as follows: AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each co-Borrowers. Kaseya, Inc. may elect to defer up to 2.50% of the coupon as PIK. Interest is paid in kind (“PIK”). iCIMS, Inc. may elect to defer up to 3.875% of the coupon as PIK. BridgeBio Pharma, Inc. may elect to defer up to 3.00% of the coupon as PIK. OmniGuide Holdings, Inc., Domain Surgical, Inc. and OmniGuide, Inc. are co-borrowers. OmniGuide Holdings, Inc. may elect to defer up to 10.00% of the coupon as PIK. Vapotherm, Inc. may elect to defer up to 9.00% of the coupon as PIK. The Company’s investment in SOINT, LLC includes a one dollar investment in common shares. Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR” or “L”), the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of December 31, 2022. AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each co-Borrowers. Amerimark may elect to defer up to 8.00% of the coupon as PIK. Spread is 5.75% Cash / 0.50% PIK. Vapotherm, Inc. may elect to defer up to 8.00% of the coupon as PIK. Spread is 1.00% Cash / 6.00% PIK. Denotes a Level 1 investment. Through this entity and other intermediate entities, the Company owns approximately 7.3% of the underlying common units of ASC Holdco, LLC, a joint venture which owns certain assets of the former Amerimark Interactive, LLC. Aggregate net unrealized depreciation for U.S. federal income tax purposes is $3,002; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $154,967 and $157,969, respectively, based on a tax cost of $2,184,428. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated. In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The portfolio investment in this category is SSLP. See Note 17 for more information on this investment, including its investment strategy and the Company’s unfunded equity commitment to SSLP. This investment is not redeemable by the Company absent an election by the members of the entity to liquidate all investments and distribute the proceeds to the members. Aggregate net unrealized appreciation for U.S. federal income tax purposes is $17,187; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $161,053 and $143,866, respectively, based on a tax cost of $2,069,489. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated. The Company controls the funding of the SLR Credit Solutions and SLR Healthcare ABL commitments and may cancel them at its discretion. On April 1, 2022, in connection with the Merger (as defined in Note 1 “Organization”), the Company acquired net assets of $244,691 for the total stock consideration of $226,839. The Company also holds this security on its Consolidated Statements of Assets and Liabilities. Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR. These instruments are typically subject to a SOFR floor. Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein. Floating rate debt investments typically bear interest at a rate determined by reference to the SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of June 30, 2023. Service fees are included within the Company’s Consolidated Statements of Operations as other income. Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented. The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of June 30, 2023, asset coverage was 180.4%. The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it. Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014 and 2013 periods was $100,175, $98,196, $94,301 and $93,392, respectively. EXCEL 82 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( /& "%<'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " #Q@ A7_2KLH>\ K @ $0 &1O8U!R;W!S+V-O&ULS9+/ M2L0P$(=?17)O)VUUD=#MQ65/"H(+BK>0S.X&FS\D(^V^O6G=[2+Z $(NF?GE MFV\@K0I"^8C/T0>,9##=C+9W2:BP9D>B( "2.J*5JGR9URV, M2R2=POPJ&4&G@&MVF?S:/&QV6];5O&X*?I_/KN:"K\3=[?OD^L/O*FR]-GOS MCXTO@ET+O_Y%]P502P,$% @ \8 (5YE&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R M> +]O6N[!3+ MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,! M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2 MBW A(5M>5 TR M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$ MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH] M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZKR2.FJW"$2M"/F(9 M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+ MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+ M.7\N?<^E[[GT/:'2MSAD6R4)RU3393>* M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.WF)&Y M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_# M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0 MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYNTB42%(JP# 4A M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.' MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_ M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]! MU4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04 M" #Q@ A75S_$'=L% #A'@ & 'AL+W=OSL&_^.G$'FRY>)$KQA1ZC:-$7K562JT_=CK27[&8RC.^ M9HF^L^ BIDJ?BF5'K@6C02:*HPYQG'XGIF'2&@ZR:U,Q'/!416'"I@+)-(ZI M>+MF$=]>M7!K=^$Q7*Z4N= 9#M9TR69,_;&>"GW6*5V",&:)#'F"!%M^!*RK=P[1@;EF?,72*"B8'':6- MS>V.7YA+!^ERS/D=&WR=\5QRY?D9GYNC=\-]U/==!4:)WG',0WP[WO]%!HK%LM_ M;*\LM^S:+4WO_"C7U&=7+=W])!,;UAK^\!WN.S_;>+^1V3OZ;DG?A=PK^OG; MFME(83EVVI]M2*"J(5*O1.J!91IIGB!CNHOHTL8$ZQF+UI$+ M]JKC U4-^2Y*OHO_Q5=49RTA[/:9V/A 34.^RY+O$BS1;:)"]88>V3*42E - M.J&QM97"/K/[1S2>?+F=S1]N)W/D?7J&K-BIYE<'+B7S4Q&JD$DT M\DV=1@Q-TOB9">L\"YM=X&[;<O:!SHYALN0C^? M*0%/GJY"H4>?L8YTK^AW]F8EA*TL&NW,6F[V IZBJB#JZR#X;!2SB>?4RH4$Y$9>]=<*"LE[*5$ M:LT]L*PI8I5\\)'11W=*_869C3H (VQ6&^Y@75/(*O9@.*OL.F;1;G.^; 12 M5-FCP0'')^O'G@>KFG)6\0?#B:7@-#.E0)[NC4LN[*,/['-/A?ZJ'?D^TT;: M)L@MK<2GR$.X"D3XJ$0T3G3OS->FVS0%+J*/P2.++O6NV*Z]4)UVG#)!]8UQ:NB#X'3RCQ4^HN2+Q F M/S[_A(K/33LA[*3?3:QSTTQQ_^4#6NLXO*%1RM#WSIF#T5I/QMGZL/4=G"(9 MD2H9$3C'[*#1[:N_HHF>]>M6% X834:SFY%UM1(6-B6L,A$Y*A.5/==$/EWK M DT%WX2);X>%/2=/5M!31"%212%R5!0J0;/(H#GG?)M8&6&["=NB)RY>K*2G M"$-N%89<.,M\33KE4ND8\5>XKDU'!QRQXQ!K/H)U34FK?.0>M3(T3GPN]#=+ MMBBTUX0]GB9*O-53P^X/-U;D4T0FMXI,[E&1Z?V0.LNVU]"G5.F:3LSBD17W M&X6AXCWD;KW,S>SI;H:];J_7[;O=06>SS]C9VT0T22C;6Y7(-[63[R>65\O] MVU&V:]FI'L\W?Q^H"5(216RAI<[9N?YYD>^GYB>*K[,MR6>N%(^SPQ6C 1/F M 7U_P;G:G9@?*'>UA_\!4$L#!!0 ( /& "%?OE8>*XP8 -T> 8 M>&PO=V]R:W-H965T&ULK5EM;]LV$/XKA)<-+>#$(JG7+#&0 M)AC68=V"INT^#/M 2W0L5!)=D4K2_?H=9<5ZHY@8\X?$DGUW?(X\WO-0NG@4 MY5>YX5RAISPKY.5LH]3V?+&0\8;G3)Z)+2_@E[4HWY?)"5"I+"WY;(EGE.2N_O^.9>+R%NL8^2I#DO9"H*5/+UY>P*GU]33SO4%E]2_B@[UTBGLA+B MJ[YYGUS.'(V(9SQ6.@2#CP=^S;-,1P(9-0#3 6F:S_H\?&UIFAN))*Y(TS(,C38O?) MGIJ)Z#A@=\*!- [DM0ZT<:!UHCMD=5HW3+'E12D>4:FM(9J^J.>F]H9LTD(O MXYTJX=<4_-3R6A129&G"%$_0G8(/6",ED5BC*RDY7%T5"?H]9:LT2U7*)3I% MG^]NT)N3M^@$I07ZM!&59$4B+Q8*\.BHB[@9^]UN;#(Q]F]5<8:H,T?$(=3@ M?FUWO^$QN./:G?3=%S +^ZD@^ZD@=3PZ$>]]\<"EVJ7/%%JSM$0/+*OXN2FU M72S7'$MOOG.Y93&_G,'NDKQ\X+/E3S]@W_G9E.B1@O72IONTJ2WZ\IK)C2G! MG9=?>^EF\+#$KDO"B\5#%[G!R@E!,+J<[1 M":5T#@T*0;VA$Q<'.; 09[@($5X,<]+@3,!6VGW:G0O1(3V& ,UO6C M 5:#$2:N&6NXQQI:L=Z6?,O2!/$GH%H)#5,7JU ;7B)6=U03VG $) S) .S8 MQOA6&:!%8V&))Y'"1WN'),=#?S(,\/#3LM.CK4G=XC'R"_. M,;OPL:+U<^TP,;8W"KY2P*MX3G#4=CD\=Z)=TUO#T(CEHH*R[S<]?;<5I:;P M I0?<'=5@&&ITG_AJT3'3:6L6 $!=">MZ?W$GV,_V T2P "D'_,,W7&."J&@ M@OW:*C#VUB:IWAXBF#J4#FK$9.B$7A2%$T72\C:V\N/REGTWM@8-.AY2R;8J MXPWH/F/3: 9ZD2D,=D 5/L83J;1<@MAR,[:3\P=6@+[7,XS64"$-1O1&-N6"J+E.QNP:A,%03IBLHJDNAUL* MQG8.ON5E?>*!#7"J17\"=1)#!E#IAR4QIE_/PZ-*-UBY9(*C<4O2^)4L/48[ ML37'5.Q'-!BB'5L%T92"PRUC8SME7R5P6M'5S.I9UNTRC;E\_52/N9E@WQ^" M-]%\.-516@K'=@[_LZ;KK'/JT;V$Q7%9\9;9C;#'+$W]:%3F8RO7\8()V"V; MX]?0>?8"9X[)&GL!<8DW!&DRI-/;D;2L3JQ,"H?./$^[35K 5BSN>1'KJ6XK M SO&TK!'-_,T,AZ[_G^@_@RT7$^P5=?\ 31]-2F[B%4H''RX/%*T?JJ=4[6= MG?5BBP)))>*O<]C^S:$:G3AG#D9;V&=RPTJNC_'.W-G]U571O8^;(-H2:J92 M&U%J<3/40=K/<^<>_/G4;6^].0V=9W>MA6 ;U[J\4E+!!51?/Y1Q6<:L[[G# MCO2"47\26UU [+K@%DX4IVD! J: M,NP%4AVH% [$+AETGU2"G#T=-B.ZSCRAT0F?81TUV4130"25&6D% [()@WT30 MEWI'@5K#WP MH>MVK&C]:6B5"K4KEL2-%ZT]!JS>H>\QBM8J7@U,_4K1^ZJUB MH7;%\'5MZGA:;Y-?@X9P&$*'?O4GUS_- P ( X !@ !X;"]W;W)K>'.IUNRH4NJ/V^?)#RYC4K&2LH5$QQ)NIXY#_A^@4/C8"W^ M9'2O6O?(A+(2XMD\O,]FCF>(:$%3;20(7'9T08O"* ''EX.HTWS3.+;O7]1_ ML\%#,"NBZ$(4?[%,YS,G<5!&UZ0J]">Q_YT> K* J2B4_47[VC:.')162HOR MX P$)>/UE7P])*+E #K]#O[!P;_6(3@X!#;0FLR&]4@TF4^EV"-IK$'-W-C< M6&^(AG%3QJ66\"\#/SU?"*Y$P3*B:8:6&BY0(ZV06*,'I2C(M^09^7C^C-CV^GK@8@(^NFAX^_JS_N7_CXAXK?H< ; M(=_S@Q[WQ;#[(TW!'5MW_]3=A30TN?";7/A6;WQ![SW?4:5-_$CL.)'_N1YWE3=]>.HL\T]'$KN48Q^'$NX@[;G#'@[B/=*41XTK+RF1YA-8D MI8B4HN*]R.,."/;QI)>YQ]2;G(=W ATVT.$5T$I5A .LR:[J8PT[18YP%'=! MNW8Q#-^+E%%#&0V/!%&6L"K">I$^C]"62"1@L=9V6L/@J"C:4GB1P]SMHZ_% MXQ:5=^?A,_3O&)UPQPUW? WWLN:V?#"**YT+R?ZC61]KW"EU7>9NKJ^Q/*%. M&NKDAFS7U",[2/J1DPY(. [#<12,SXC[#<,@N0 \:8 G_P,8VCH,$9XQONFC MGEQ+W6]XF1I[Q^[D?8][2[AI.P55"NF<[6%U6?FP.Y'4;FCSOSG'W#D_=K;AUY)[30+K1Z-7Z\Q';3:*PP.PJ1;M5Y# M[,>7IC0^]E$\W$B/58-::8'\ZTHV*'ISR5Y)[30%Q\:,ASOS;27K=MQPDGC! M><&Z9I!)@ M+YF&PO=V]R:W-H965T&ULQ5M=;^,V%OTKA+>[ M2( Z%DE]IHF!Q&+;%!,G.YZ9+G:Q#QJ+L87*DBO)R;2_OI3L6!9Y13LMBWE) M;/GP4/?PBKR'DJY>\N*7!0WC5;IB%B6.UI%23887S7''HOQ5;ZITB3CCP4J-ZM55/QV MR]/\Y7J !Z\'WB>+954?&(VOUM&"SWCU_U)_N8NO!U9]1CSE\ZJFB,2_9S[A:5HSB?/X M=4N /4,R?HDU:O<]??N2[@)R: M;YZG9?,7O>RPU@#--V65KW:-Q1FLDFS[/_JR$^*@@>"!&Y!= R(WL'L:T%T# M>FH/]JZ!?6H/SJY!$_IH&WLC7!A5T?BJR%]04:,%6_VA4;]I+?1*LCI19E4A M?DU$NVH\R;,R3Y,XJGB,9I7X)[*@*E'^A![6O(CJT2S1$'VCLFW/T#4HR M]&&9;\HHB\NK427.H68:S7?]W6[[(SW]472?9]6R1"R+>0RT#_7M74W[D8A] M+P!Y%>"6: E_VF07B%K?(F(1"IS/Y/3F! KGK_7._G3O'3'H/AMHPT=[^.ZF MG]CLPSV;?D!WT\G#/;N$1GC+8<,<]B*FKY,4S'XS_]0_L6M]! M\IHD"TV2,4-DG8&P]P-AZ]C''_(J2L6E]LS+JKX@Q<=YON+0:&R)W(:H7A:> MQXY+J7CZ46479Q/.M+BI44=@*?-_NPI@*\QS/=_>H3LC./F1'FWOL/X]L M.F,S,.48G.2LY1EE<*<)=5 M7.13A<22CO)JR0LT+WBC\'R;2(( *(LZ M$BI4491B(HG+ "[?/9C9.I($>TD"K20WL:BUDK*J"R"1"O6UELQ%^#L=CJ9% M "2K/-M. !!U TD$%43$C"QI ("< SD[$F"K+0TMK0@/32HL>";JP+1)CJ@K MRVM6@&6@I9Q38,L7!@"R/5=2 1VY9T8@"*$L_KT>"@/,8G+,3:0#&0IH>K MX2Y4%4:H;\NS !S'1*X-/@?%W72S'JL((L>4T"0&8 MZU@R&P-@-K%PST* V[(3Z^O..MB3JLX=3S<<5[YV)Q#,(H&2]2K,MGU"Y:A5 MF$CZWJQO*T^L+SW?LYMW=_]E(;J9ANCC=/_UAYN[*3I[]S";G:.'*6K=T:Q! M3FYF/R+V[X]WGV[>U0?!RA4;+5V-LH5&V9@IMNX@MN4KUM>O=>H6/$J3W\7\ MM(B2#)VE>5F>HSP[2.FR6?K*$O$#)?RLD35,LJ0 M\T^4OV0\AFU&_K7^QI4[]6;2Z" M7?!Z8V>3_5D%X=S7%M]OSGV3;*%1-F:*K3N*;0&/]16\J5$$!U$ML(]Q6]EA?VG?FB5H$PW*IM?B0NKY2#D P M)[#E'1D(AP/+DMTQA+.]P.F9($AK HC>!&PK N$'H]KVQ'S[Z;S.LTS\%)4E M%^J(I-ZD59(MT%.1KU"^WSJ&)-KUV-EF\H- K@X!V! [KBV73 "..#Z6$PJD ML[%/>Q1J+0+16P06%9F(O'Q-'%%#H]DR*OBWZ#8JDSDHP9;2.S@9ZT*^5B8 M:FA=$-DB@F3*SL%1LF[XK64@>LN@"3],TDT%[O+?[DB/":"B0 $@,E6 8V1= M 5J#0/0&8:(I'=#_[OGJ,R_^#VI@="/=*%MHE(V98NN.4.MJB&W@M@;16J,W M#X=)MM H&S/%UAV.UFX1K1/8[S>"@^"H-RJP,);RQ*#"B.\[,AD/'>D6>PK<$W%E#P" 9)-\"@_3\G2# M:[T/)5]OZ:-:W_7F%#7)%AIE8Z;8NJ-X\-#3\3L\?]?21]4;-4-*L'R?!( I M27X2$],R=05J_1/5WQ5J5[Q57O"MPSUMU=,3OSF'C7HJHVS,%%MWB%I/1?6W ML$Y<]8S>C#+*%AIE8Z;8NL/1.C^J=W[:54]U8<3'MCPC #>% B(_(@.@'$=V MAPQ V7;?QB=MC1_5/SP5)L])S'L> Z;@\TR>[&Y!F.7+CX@!,$*H(]\@AF#" M!O=87-J:(ZHW1\>,/ 4,CA(IX$=D&W\"#P,P?1-\:VEH\!7K&*/.QRA;:)2- MF6+K/C+<.A_[^*V:OZN.L8&[)RZ6'U^:0#!B6Y[D]4,(Y_GR9<] .N)B^8(> M';P L>+%HGGSI$3S?)-5VZ??]T?W;[?<-.]T2,=O\>4$ \=#?,FV[ZZT]-M7 M:>ZC8I%D]=[_D^C*NO#$A5ELWT[9?JGR=?/ZQ>>\JO)5\W')HY@7-4#\_I3G MU>N7NH/].T+C/P!02P,$% @ \8 (5Y;O0^.5!0 A!L !@ !X;"]W M;W)KU3M5SPO2QR1C]52.S+,JF^W]*"/]_,\.S'A<_Y9BOUA?ERL4LV])[* MK[M/E3J;MRQ97E(FTH*G4%(GZ>J(K6A2:2=W'/P?263NG'GAZ_(/]?2U>B7E(!%WQXN\\D]N; M63!#&5TG^T)^YL\?Z$&0J_E27HCZ$STW6-^9H70O)"\/@]4=E#EKOI-OAT"< M#% \\ !R&$#, 2_-8!\&V.?.X!P&..?.X!X&U-+GC?8Z<%$BD^6BXL^HTFC% MI@_JZ->C5;QRI@OE7E;JUUR-D\L59X(7>99(FJ%[J;Y4%4B!^!JMM@G;4('N M&/I35>P[(:CZX0I]O8_0Q9M+] ;E#'W9\KU(6"86NV>MU1O:HRB_Q?U;LV:E-$ M%P47XA*2W#"YI[<9!H;@/N8*6ZZAMP_".#! ,<#DN[!8KQ7KC8I-ZXZLE^&> MM<*U9$BQU[\'!_NAH1E V6Y@FZH!&+%P8+#%T)Q^$%BP=+^5[I]1US_=CJ#@ M^/TL!F%HJ%[U45?8]1QCH41]&'$#;,8&(G-P8,.Q"=K8!(-M.LJ%K/*'?:T4 M28Z48T@?M[S(: 4WXF#*1CPE630E63P162)QJJ[DHPG& MPR[X,]WM*^64!!5GJ7;&58]"(@"BO*,I>8BGJ_9H@?&X!TZ!10A*[=O2GM0^ M!$XPZ)5-O:-D7=%'*XR'O? 7KN6.6D(P!I#AM7W;C$,?AH/ MTWK!]$I)TD\ M,Q0 GT^"EYZ \-$:XW%O?## B40/=),SICVPJGQE@',._:]RB_M>- S4PT%O M&^KC N(IH!D%@"\,?1N;40#X'$("_$(4CB88#]HY(PJ492/Z@][C:!A8@?FL MMP)PV,(N=FTS .<1QF<0=B-P=)PX/&LCKOM<\_=K+K^?LQ4/6ME7;\53LD63 MLL53L77_6SPZ8S+LC%^S%9-13[L"()BX& ?$?'8?)XO/(>O*/OID,NR37[D= MD[Y3[2D?A40 Y,HWG]OC0:*NW*,A)H.&KK,?=]:M0TFI3O\X1*H-[)IO_D=NK[2NC=_6+$N/Z+;Y>8>!ZA*_CYH70D;YY M/_4QJ=1&)E!!UVHJZZVO;K=J7ODT)Y+OZG<:#UQ*7M:'6YJHQRX-4+^ON>IY MAQ,]0?OB;?D?4$L#!!0 ( /& "%?^E!?"?P@ .DC 8 >&PO=V]R M:W-H965T&ULK5IM<^(X$OXK*G9J*ZD*@R49OV02JAC"[')U MD^22F;T/5_=!,0)T,19KF62ROWY;LK'!EDVFCB^);5KMIUNM?KIE7;W*]%FM M.,_0CW6*LLVEX.!BE9\S=1'N>$)_+*0Z9IE<)LN!VJ3)GO?'+(5?!8S+1A.9*!F+.*)7-U-<@ @]8TB(KW3?+WD9;W>>BK3+*50M-D MSN>'XP> O32 [ R8D$Z%_]@F'Q%U+A!Q"+7@N7G_<-(!AY;^I$8?;?-GY;1% M*M?H;L-3EHEDB<8ZPD4FN-5KN5;7KE4O_DNU81&_[L'J5CQ]X;W1K[]@S_ED M,_E$R@XWM#95L&%2,YWPC"6E:%S M:?//\)2QA 0.AK7 :4KY0WO0^*4=_E$[HA5+EER'PS8I;;(88\/M M-Q 1!P?U@&]*N7X0.';H00D]Z(SWLUFRB^1=3&L;]F+1!+8U#H-3QN&)E!TX M(2R=$';.W_TVA>D#RX$%CTQ5V PQZ@4A<6N399$#L*'?DIZP4_&WTXTUE1'G M\X)NYD)MI!*FI#H.OE!]$&B>3QK@+7+8#[$F3"OXO>(#'UTH+((PVP$&_)'< M)MD[%DFA^L"EPV#HU+%;Q%S?"UN@DPHZZ80^81N1Z67-=M@W[$V#[8ND_RP2 MG<,CN>96Z*2)R2..5X=N$<,.;H->E2BXLP" FB\NRF[UD[AI,U[JF)LB01BT M(*YJ"MQ=5#SPB$.B?P+>A5;G@ N@>IU;L;J6E>G6<[]%BH1M:[*J&7 G2XYF M2<8A*VDRV^&V0AQ:YI=Z#8PVLYFVQNABPZHXH_!;!*D2X,Z2!O7 M>KB%2''%I+B;2N]3OF%BCO@/Z'05S[E?9BN>%DQD1=RDQC[!#<@6*>JU\">N M"!1W4E/> ; (*I/4%')HS=,E3ZTX@P:"1OIJBA"*V^:^(C@<=M+\S%ZY5C0? M"_8DXO::$W2(QS*WJRYQ59GHDU1'%BS#FDR93]P78QK MTVJ1(T'@8_N\DHI023>A?F4)6YH6'BTXUZF];543"R\&=0:R"0W;"(A4W$FZ MN?.>IV;'*HEX7V_:&,X!S.*%'X7=Y,2PX=RF#![BEF*%5+1)NFES/%^+1*A, MKQ JL-01)"1BM34B;K)BIY?ST<6H3[V:I7XK;@LWTF&]4[)( 3>UA7%%H.0( M@?(%3W627X@$8EFGS4BJ3 W6+'V&RG97S%J!-_D2.[1._58IIPUX1:KD>']J M:.I^?^/A^V[CX;U[5L1"H'CHNG[#_TU!:!]\K\6.BFI)=[-:WVS[4L[#N'O' MA)RT53V5MD,O5%Q.NKM5XX6Y3DSB:9M7];IDLMIM:4.'A.#&.K?(N:%'6LHY M6C$M_9EN=0O+.MKJ%?0D4] %,V??'&VR9;U.LHA@ZH;8;4%<,2KM9M0'7O1' MNE5Z-V +;_I#QVF@MLAA+==2A=**8ND1BCUP]#M1-WG3=1P+ZJ8OOMT6J'I6$-'-^I M4[!%;MB^?T0K#J;='-P*%HV_H<_3WV:WM[/;W]#=%W0_?9C=W5AML&P!DX#N ME8R%#4TY2DA(V])Y1<#T2*_;9<04GG?#;_:V%%Q+ZH6Q3<[W_=9\4S$G[>Z" M'[>;36RZ)1:;:BV6"G*.6<9ZI2R@M(#%D7]=!V*UUA+TI)WPJ;0=?KNK^-GM MYF>3(,R&2]X+YYV#]:-B9;>;EF=*;77_:)AB MQ0"EWK^(9)(4!PI>1;9"T%>@KV;[Q9;+/A]YQW_P?ZV6X\:7QGK^MH@0X@6T M)6NXFM8/GU2_+9G+BH M/9_@RQML>3YVR>7$M8T =\,OYC#&H'IU?@CF*TN7 JKKF"\ AO/1AZA.\W,E M^4TF-^:DQ9/,,KDVERO.P&PM +\O)+BZN-$O*$_WC/X&4$L#!!0 ( /& M"%?4(O[J0@( -@$ 8 >&PO=V]R:W-H965T&UL?51? M3]LP$/\JIPQ-(*$F=4,'+(T$16@\;*KHV!ZF/;C)M;%P[.!S6O;M9SLAZECA M)?;9OM^?^,[93IM'JA M/-=2T2RJK&TNXYB*"FM.(]V@1F2:AFS))G&-1%>[&IK%^( M\ZSA&URB?6@6QD7Q@%**&A4)K<#@>A9=C2^O4W\^'/@A<$=[<_!.5EH_^N"N MG$6)%X02"^L1N!NV.$[W[@KV?,X]7:$GA"[ON[/0B@J(EJ^L^V2FHA>I&_MS_A[T$QMY( M8'T""[H[HJ#RAEN>9T;OP/C3#LU/@M60[<0)Y2]E:8W;%2[/YG.M2$M1<..6*[2BX/($CD H^%[IEK@J*8NM4^+QXJ)G MO>Y8V1NL5XT903(^!98P!@_+&S@^.OD7)G9&!C=L<,,"[N0-W,' *_V_KE9D MC:N WX>T=ICI84S?%9?4\ )GD2M[0K/%*/_X83Q-/K^C>#(HGKR'GG_3JO Z MM8&&&PNJCWGQU H2OG)/81[;\*0O?NAAV4253U_[6M",Y0M"23%J](VP^,?8!F6B1",\!< $-+ M$??#WP8᠟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�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

+$L2GKE@A>GM?-V\]2$:QP.7A1% $7#BP$Z M-KJ],T,'1P 81R**=0#CS ",*@&,%^78Z!KDL2QCN@=%'FM$R\!2P-$BDA=;0-=50)B501<'0,X%@6)8>M(+I.@IA+VF,"CO*5CAR8 M7,?2 (X24H;[&>'G>;1'*:-FL+(9^ M[?+CWN,.,-FZ?VK"Q/9NU>R#!@J^RAW@I7[WU!!""=HD'(XJUADTIF*Q,6B> M*SHQG1*VJ(I^? !R!@"D9^+4#^=6+9(&"@8@9TT (*>F],\1W*E'I(HU .3, M7/!7"H!4!V?LYCA%_F)_N %*:CYFW[R0!\9S:N9;J?D:H\48+7LR6FX?O-NI M%P66.[YPQ["^6J"10CQ8FRVTS]1S R\" EP.#ESW31='@!6NZ-TVCNF. EW)1 MRFKPTFJ:J@*5 B\5Q"BF?UU^LZKR8Y16LV4PRF$QRK[IHEB,TFJV:^?]SL 0 MQU':W96)4M9A%'-S6"F,\I(<+*8+7G[+J^< 7KH&O!P8O.R9+HH&+UA;OFV: MYAT#O)2+4M:!%U-ROE+@I8H8Q?32R^V:]1PPRJG!* ?&*'NFBZ(QRJ!V?MHU M#I9C8)1R4NL9@)=6$P,4#'8Y'';9,UD4C%U: MK=IYMV.(XQC8I5R4L@:[M$SZ8:6P2W4@RB\42;CU+7S2%$DP\ZW@?(V] M8XHD["5B?V5"LY2HET>MD=!JF0B64M9(*(0Z"L2R)MN]+ ;0\Z$9TW;#V#\E MARRF0L(N^H(QX GI:*3=?#$ M%-&O%#QY4:X64QQAE]3F,N&6,X-;#HM;]DL5!>.6=K-V?FI(XQBXI51TL@:W MM$WM_4KAE@K"$U,78:>LYA+!DW;;P)/#!K[MERJ*AB>=VOG@S)!&F6HBE V> MF)O"2L&3E^16,241=DIH+A-NZ1G<AU.0CW=3]E^1R\7Y=9IU^NR- ML81B*-/L_]EI8@A+)Q_*3'W.R]&2N=4QP2M',(H.1R %PEU3/>/8)M*S)!N3 MSVRLI.>*>$P!A>W3G0\-:C:Y\#K=VOEISWAX#Q?8OW?"*-C)V\&>WAW3]? 8 MP?UEHY5U",:4Y:\4@JDB4#%E$[9/?"X=4#DU0.6P0&7OA%$T4,'^W8.^(8_R M5$\H)5 QM?DK!51>E*O%%%#8/@6Z; BFVS0(YK (9N^$43""Z;9JY^V>(8]C M()BRTW3HTL'5,X,4#DL4-D[810,5'K-VGGG MM&O(HSPU%LH(5'HF0[%20.4%N%IV+K/0-646S'PK/5]C]9@R"PAO#*+G"FY,186M MDZ%+AU]Z!K\<.,Q_WX11-'ZA'N F>.X84?XE(Y5U^,74]:\4?JDB3#'U%+9. MA2X=3!D8F')@F+)OPB@:IIS5SCM- U.. 5-*1BIK8$K?E/>O%$QY46X64TUA MZT3HLN&7?LO@EP/CEWT31L'XI=^NG7-']Q=&%T7;0Q288*KX MERBZ_UBDLLX>,D7\C3WT7+&-B>[?/C*W9/#EM&G@2RF"^\L*7TXQ+J%KHN9* M%-Q?0OAR:BKX5PJ^5 >E[.RU[1NOK9EOI>=+,@/^L88.7\7&R'MI)H9WF,Z? M Y02:D'$&ZM'8DM#+=E+:Z63)D)'("RX+Q0O?QPYT9B?]\1MLWK)%*\*1?0M MFG'?'N6\UO@:/D(];+L1Z6?2;[?PU!ON<%)C0M$UNSVAL.&+?'P19KYT,9]S M=QQ_]<]6;8>1^]N/W%9 M?6?UR6C*K3'HP$$D1\5 WS7ZI\E[XKB2MW7=Q4AYP7,L-O41T/T%0%[M_!89 MFGD3=HF(T@U![A6]MPXB_Q+TYQX^"F(YBQ!UG;HW' MMGM'8!I?([Y3K^7:/ES_^/CIQ\GE]=75Q?>;3^_4'[LYG,0.G;5?O1]Z_IC[ M[YIR&]XUY0ZD8*)&BTU@H S@$X/U3E]MK5OD\_NI7VS\\R4.N0?(/MB$V)F< M*].-#":M#"9I-('KC=X\?/\+$%]07OQ>"R!#X#FP$O]N^+I99_A_;]ZS6!(0 MFYP@6Z20_^#PP)^L98%FP-9F_\,M?R?<'V_PJKU< 0!!0,)AN+_7VK$X2&]B MJ]%LQMOXER;];[.A*41H9A<<'L*;)U("";YG\D ?WR_OR6X[>.N%EL,N9B#W MP]36#?VW0GD<9A[741B$<(8P].O6FWTDAMC[Z]X=E2ACS_.168,15W0,5QQ) M0A]?/GZU_)\\%'O\3\N)RD&1W?U1I(DU,'&498FCO+$?2Q6'8%KTEB*,LC"R M*#H, ?,.6R:KK#Q1E,>BE'51"*8]KXE"*#E^,;&26PFG)(,J@;2#*82'*GLFB:(C2 MJ9VW>X8XC@%1RD4IZR"*:9)9*8CRDMPKIBSR]B5-RX9=>@:['!2[[)LLBL8N M_=IYQW3(/ 9V*1FEK,,NID%FI;!+=2#*SC4T3DT-#3/?2L_7V#LFE+\TH?S\ MGKNE,H<&M?->TYA#1P_F+XXPBC:(,!ZA:ZBC/-'\1R.5-1;1F>G%:RRBDH,8 M$\^_?3ANV7#*6#@:&.\H3TEQ*GF)Z[E<(I+\H+8X+Z MMX_)+1V Z1H 4XJP_O("F!YVGS*>EA(%]I<2P9AVO)5",-4!*K]P]WS#?9#G M[+.YA#;SK?1\C?EC+J%+=0DM)._G4IE(5)7#Q.:6XS*Z4 (IVE0:('XP5%*R M2^ECDLPZB\DT[#464\FQC;F;WNU>J7SP!?21@2_EN:,N,7QI-UL 7SJGADK* M=5==3O@"!6-84_2F+)?1\:,:T"C'VSW/%,GV#998E M3[\$6&:CCZY?.V\U3<#N 4',?LFB:!_N:>U\T#-UHHZ!7$I%*.N02W4[B/QV M--5R3\UP14-::D6;+UF:K3^;@EANO7(2SD8)U\RQKBDMH9Q/0/C MEL5P[QG N%;3P+@#P[C]DD7!0K;5JIV?[D_$5I,V"H)QI2*4-3"N92[@2X+E M>AJ6*Q7U;!0SG=KYV>"Y(;D7Y:GK&HBW+**[SP'B=0W$.S#$VR]9%"U[>[7S M=KU]9C+KCP'R2D4JZT">2:LO"Z7$<@.#Y0Z,Y?9+%D6+V#/$X82CI+_4TH(8IK"5PJ"5!%IF#R6W#CTTB&-@4$:ATY: M*2_2.*N=]]JF6N1Q4E3*B#0ZYGZ[4DCC13D[3)Y%;I1TV2!(IV4@R*&3*DH+ M03IM+$5PVC9A=\=)H2@E"#%W*MW18HVNPQJ&#_LN+-; - M $.C]WBU&^Y/V-7GN6:Z'0SWVK-UY@KIL'Q M/AL<@^0DP7ED$^;4)"X?QH8I\NR+-ETP>[UK#)<#&BY'I(9U]HKI.&SLE>>* M0DPKXORVH>4 &EU3T/C SM(BSKY@H-%M 1&6)8BK=+@B8[!$P?&$P6,+TV*X4G M7I3CHFF QK)X:98&:/1-D-=A<48!1U\TSC@%G-$S!' ,G'%X:EB',ZK;&?-% MXHP*PHG6F8$3R_&A9Z6!$V<&3APV9KR HR\83O2:M?-.R_3@/D:@^.&I80V< MZ+4,G*@2G'A);HO6P.",9?$R* O.Z+5KYSUS/7) G%' T1>-,SJ ,TQ"VE%P MQN&I81W.,%6&*X4SJ@@G3(N#W*+E98$3/0,G#@LG"CCZHN%$W]R"' M.')X: MUL$)4S&X4G#B1;DM3-."W,KD9<$9 X,S#HLS"CCZHG'&6>V\VS$$< R<<7AJ M6(,S^J9><*5P1A7AA.E,D%M^O"1PHM\R<.*P<** HR\83O3;M?-.SY0 /@:< M.#PUK(,3IO)OI>#$BW);F/8#N17&RX(SN@9G'!9G%'#T1>,,*@#GAW5(P]3]K132J"*@,#T&1108!ARO7E5^DJ%\#H&X!QV-O8P@B@:("!_3+;IJ3.,6YDCT43ZP"&J0=< M*8#QDEP;IH!??MVN^ \8:AMRG4[3=.US@(RQ'+/_Q_?*XMUX(J$=H!9:HA;0/UGABS7PK,5]C!6V= M\M)AK\,I"."[*?NOR.7B_#K-.GWVYD@FTF_ELHZ:_3\[38QZ[^S/UA'E7UIG M]78UHC^.=H1K+9VU)UFTW7*&1SIH=JMPG,_%- MXW,YH:V]-]5^UD(]T#SK5$6U/P-/9NYQ%JS?S]IXKFRB ->I]_- MW7:E]'L5U;BIG)57$6=_:KQ;.Q^T!O6>4>*'4N)YAUFT$N_5SMOU9OO,G.DQ MZE?M5XF;POR54N(ORD@WI:CRJL[L3[N?UL[[IZ MT>['T.X%'/ Z[6ZJY%=*NU=0B9MLIMQ]* MO--LH1+OM8V?_2B91?M4XIVF22FLE!)_22:Z22#*S1C8GW;OU,Z[I_VZJ8MS MN'R@ VCW+FKWLXY!;$?)[]FO=C<5F2NEW:NHQ$^-$E\6"Z?[4^)],-&[K7K? MF.B'4N)YAUFT$C]%)7[:;)LS/8(2+^" UREQ4_6X4DK\19GH?:/=E^5%?W_: M'0L8GS5-H/OAM'O>81:LW5M-.-5ZIV<2V8ZAW0LXX#7:O64J"U=*NU=1B?>, M$E\6"[V]*?%6NW;>[;3-+?KAE'C>81:MQ+%M9KW9,:%PQU#B!1SP.B5NJFU6 M2HF_*!.]:[3[LKSH[D^[8\)3NV<"W0^GW?,.LVCMCM[Y8^ZK=UKS1Q9X#JC_ MOS3I?^\?['$X?==JO4IF@%H1%X&/9R/N.'-K/+;=.Z(=?(W+4:_ES#Y<__CX MZOP*@".J9ELS+W)#YDT8MT93-L*"]_@J$-6T M@UB3,"\*@]!R\8#9:]MEX=2+ G@=O&%6"*\XX^X8?XI_@FRQO3&;^QP&"OFX MP300E2+;%T5 [4H1$)PS4 L/0?' (F"_&!5S1[7!K'6DY'-)&$A+B..'0"(N MAZ_; 8.M&$6.!>_ Z$!U/NHUDD7T7BC(%I\;U&%^\"/+<6"*UA#[..#P0)3I M45TO3)X)8PP7RY.J,]AB.&;Z%$?<8=H-=CN%F>=N!KP_BYS0GCNV&-MS>BG1]: ?SKN?0[)3):CR 0B&S:,A_-)9 ML-"WQ@ALD'XOI*3Z:OD_07+]TW*BM!35E!JH@-#ZB0(3'S>V8&',DK\?.5Z MG\Q]&PAS#/0HOR;Q%*H,4E,D;T,:ZP&X8'$RL>_A!Y[C6'Z WV8!6G;T ZE^ M%FHLT&'PSGI59)&]*.>!P\5?0V5L!R$\E#W8X72UPB*^EN_.Q+[S3KUS MUJ[CXD =AK ;SF(U\Y*9BN:R[4:6]$(LO9-/NLO6$[S#=,(=H!M4MY'6C,26 MAEIB^;7R0:/Y$6(;OW;>:[.\SC=J(CEOK# <)<,LW=>2J1IWX6&Y[7VT99)[ M-K-,?$L35$,.- &"RGFP%D%-S6T:RS1Y3WQ&_WLOI]>9/^I2\.UR,R(A1AJ# M#CPNF1 #R=+HGR;OB4DE;^N-C!AU,H(I66SJH_?D+Z$W IU%D@.4RB6Z7-PP M^.M;*V^_Z5_VU[UN=0X)Z!^++1HT>K:[))]3GG4K"CWUCB\6CV\=5(8_I:.4 M>"K^#1L%H-8>[=Y)*K5QFD>&29?,S@->3R8G'RS' IPAB>%FRD$27OB^Y=Y1 MC[D@CUWSM[R_0F+H]R&@TW>1(+7SSSX0?PCOH@:@_PK[B62T($P0^I$?$,$/ M(U!08/((Z^'2F\T1.\TL_/^?'+3&!!MY@9JPYG@(\,O9S [%.F%\4*H^J@Y0 M 7/?4Z*:S3T_G(")Y^'W842PMD"!+.:(+YS%\K.L.Y_3?&$0--I <\&V\_') MV+<>&"HQYGB6"^C1KQ.^(T,15!-L%#P>U03@Q'O4B/@]G X'L C@3YLOJ;!@ MPYJ$S$*-CN 3'S4:"2R;3)E\HZ?O XE(\3&D2:U@"AH2 !)$U2+ %]Y0"/7 MM3VA\Q#(%>B"^P%:>Z2DZO29!\\25C)LA>BG!I._@(GX"!2R&SBUQD+_ EKP M'G /UJ\PS+'1Z+D?^8B:)LJ/6O111@>_8\L4K9%G>Y-KLIE5IL?!W4**GO9? M)0A:\<4E?&4-YH( -/.\HUW 4)39S3. M4[359EV98F+Q!W+R3OT1S6D4=1I+LC,^D?;>3N08_*MNK0ZWLT5C0KSK@&UP M4*N^R&WHK?"*+$-;'7YSXL_;B[85\NUA'NY MSJZN+BO$5^UVX\SPU528]A1SNXO-Y538$WC2TS$3[?<3%8= M7KKP1U%H!^R#31&&UIS#RU%0->X:%$919B>, GLRTX6^;;%_<"=,#KK5_D,ZQ?P,?MHW_& MTE._WERS[Y9?P6BJWK,,LC?._$KIM:OH,?(7JI*(2$&N&J-US15T#!A+?@7] M C3I!6^-*.C*769BAHO> M":.[-G#3/V'J7E#9 E7F*OJYNCI>@";[C(L3O60N/3>(9MQG'WQL?U8];XC) M[RQZ)XQJVZC:@F#DL:_V&/Y-G/G5XJRVN45[+O?3+T"C_% MM_ "3'KR@+4<90.OJJE(X\A\)I%=U>':/YS0GEDA9Q^LGWS,_H9YV-+V,]Q5 M5>XRN=C'9KNO5H3]?$4DB>?//1\;$AMVJR"[F;8QARN;:@7VB'V.*FCIF5K? MS\1[\@*4U\WE=_9I <:>Y?/J^2G-E9O:"1,)>2"&^LCY_(LKVF%72W&U3%U] M$\]?&CZ[B=ROZ.2 1]-6G'G_W'>BN%+-1H-M$":/%?KF.XXS[,'67W7*'CSQWPGWNX@4:N^'^O? J7H55V!^KLVP*$"@#&@.IA58JQ3*"_25$K"\=]MUW7&CF< MW<)>A905>LFQ?6?U$JX-XR4[47*'?G7XZ\?C#7<#'GL^*N?X,-7VGTG\U M0 M9A^L!>X.NYZ/O.JY& VG/=/\T.HPV"<7)A\%E:TW9YC,V&;EX;9;VW'X0F2I MV<,H3J>IEE%F.$[=G)4\GZ8ZC/4=V[P#3XU DU;H>"C MB694.U'R&^H7H-G^=O-53Q)EEYX_KQ"S-4T$E@D'.7Q[S]G< W[B[):/IJZH M$5YI)C/M+I1&*SER? $:[>_PFMV$/N-:C&;*3,B4V*:9;^L?@':[=H/IQ[U MWJ4$-.P&&KK<#[0>-.0P,2Q8118L??&"ZC#:C1>%4^Z[C#AN#*,!RZWB-L-L ME60V4QORV%SXZ=M- CF_?/E"L-.P7%59KFD"_ _%6?_R?&?,OKA!Y&/G&6QZ M[8UL*ZS>A5MQ3H+GOA.MT[+SUPM0:;<7?UQ6&C\:;C/.R6,DA6+O:X:%1/P9 M197PRA8Y:)I0K><:@?P"%-R%X[";$/GOXHX\)A7D/U,FRQALAPZ5=*P YEYE MW^/^I/ESWYGB"LH:O?:K#/CE?L$^X_0=.ZQN>++A07/Y=G16^W9QF8XTP0KA MMN<:/GL1?&:"*(_-@-]YR'UVV6"?O86D%6LV?Z_=$FA7!RE56*7 $\.CJWG4 MV'V'*Z5 GDU18%)CMHI%-1MF6^UDV9_QIW'-_'$]TZCQ"MK35:/ORI5#SQ]S M7WP)UL "SP%AX=\-7S?K#/_OS2K.4C/;B86./K]B*;NLJRS[_"H-,UL'NPOW M0LL! V\VLZGB77 D??9;L0*[T^X]R[S3PK>AL\>,@6IIK@[(I+$7#1U>4J%9 MR 3+K[M>WCD09\$_%@R9FEK"8'V8A#;19O)23I,,+OU1^!0-=\_V.-P"N\U M7]6V4LP9\2%^WGV5E4NP>%W.H;*$+?Z_&P\^_W<[D\$3U*_V=$:/7Z60I]C% M>#:WW 4;P>B^YP0LA##2YV,[9#>>0P61 F:Y8Y9IA3!* M5#M]/+-@7'0:.3C,C%DAL^&CL1V,?(ZC-)A&JRM)- ;HUD@DQH+1&_S1Y3TPJ>9M^^R"I:.@Y8Z1K MBTU]/OF]]I?0&P%)D1P NKGTJ,D38#SK/&='1%-K?6(ZT8K=S'"-6!(;-'JV MFT?C?^WXN*EA^W:0OR+ MRU 64Q&*T"-.MH;>/:^SN<.M@+. <_;-"SEKG3:(EV^X:WL^N^*"_;_[WIUO MS=#1RZ;(IB""1TO9U& HO49"*EEW/N="[DB1 M10MEC@_=VX&2;&]A%U"B!='PWWP4JNV; M>WXX 5L2YT03)#?6Z7OXS6AJ\WNN%CH"E8#/@45R>)*K-LIR'.^!^=RQ^40- MJM8Z\8'78LD[!-*VA*0%$0#3X_>V%P7. DALG!:U-FYB$**@#>!\X*!H7!B) M^\X"1Y.S9?QQSGV;TQ>Q$[9OPX1@E\>@PH >8 $XGICI9$(+1VU@NS V?!6W M3](33&D8!4!G 6QY%#J>]Y/FB=^73P.2LO'" -X*TA-&O0!3L6&B#W8XA=^S M(<=YCGWKP671' ON12[N!1^G?CGV0'N%S.6P@L#R@8E@,V%O MSW211&J(6L M8 KO OWYBB9\]1FW?!V3@EFHMU;]D.R45)68X-DX/O\5'DPW;"821? M :+ =9.BS.I3'!SI@#_PL="HN #BDSG0[]RG.-B)9?OLWG(B>-[XWT#H.$"# MK5)(18K 5GNE# 1AA/LDL >L+$*"@[U65 22A0,9WP.[X'F%/E(Y4/8]G#+0 MO4:$2.M^E$89I"_@$]@]]0,Q%C&D-0KM>['12&\IM:/;ITP:J#M+6F\R.1E: M#G*@U&S!%"N2^';P4XE,G";P@Q/!NN#8'BQ_C/\%;8KBR,>^-A*%P72#!OL; M=[F/[%F7')2_ \ODKQ$-;,<\\D=3%/:PJ0' <>9AHNNJ[0Q9,.,]($G=E7-1TA6.@,3.F*-<)I8ZZ)8+(3B$[9Q:[ATG"8G$!X3Y$[XB M> /V XB0!2!D@PE2"$HUH3QTX2MDU8@+CF/6S(M@KWT^\NY=IJQ1\M?URNP!GFX>J_"K%\V/(> !] '( AD+F%Q _1V0$\+ MLXVTS3BU::#O@3$0RGB"3E$\P)\ 2D:)Q@X?/#;S J)K$B5@H0%O+T!=!A*8 M<2FD4A^B@$&*?[=2N^B+;C\!,>M#[+IO::_(KS@LQ!QI?&E82.<#O2,WAFRQ M]TR9*4O4MQMQ2"\0#.I8\P#>5G_%'Z767UOE+M4^S7@\6*^YRQ3S'*IRH Z, MDW&",.DH?MKXS_3'9EO,MJS]\8K[C6WT%*GV9<W2L(+'7B"0GN5B_.)>.>7EKJK?OH(&E3H*+ P M'=#5XSRHL\'K')_MJF-<<;L":@4FZOY>:]6CE;A M2#K<]\M^U,Q1/!EFKCWT'X#E_;$\ #B*?6R[.;Z]'=]W:X&6ECF_9WI^%V11 M[^W0GJ!J!1!?J6O94L0.G4:[V:VS=F< __1Z;S9I9+PL7',EH47B/-TML$,X MT);*]#!V[V=A<*(?]I?(9,?(@MW!*%LRMU[@0\PNFUU^#@_9GT)X=J*^4SI1 M?Q'=18'$G+;0WJX@^QZ(/.^!EN5Z=9E>W*B]45KLMAV4ZWV&0N)PZ@@LU'5 M$*E&6!8@+%4,6.LE"$NU6",LM]RG,[-/U9"5!GX>2*)^M20@:S6K+U'CQ;:[ M1E!L(U -]JR(/#62\NE>T+EO.^*PNM47E=IJ#?K<3J>87:J&K#38\U A!'SH M1Y:O^.<%7"U]M?S15"ZW8^3%5NK'0/6*R%4C,8N6F-47F.D%M_I5N5X^A(8Q MQGM%!*Z7K)<3=B\ (=H:L'MOA$8VVJBME%$91&PDN&7$VI-1'#5'V)V MN<2[?- *P4_)C%+K^B4U7X$U&NO_R2E7]/?!*K"(DLW+V-3D7Y7N(6:7R[S+ M!PO];S6:9YU.)Z=YF4'#+X% S2Y7YB''0<,[EAQ_GG"X)(LT3MT#H>9#%RIH M&Z!873:[_!P>8APD);Z_2]<"%]=9AQ7Z![Z42B^XK=U*MC%W M]*HO/U/KE3ED1A)LH6H,BJ^2Y#0 ]4#R]8;/PY>%4+,K;AK!L8M.ZAJ55 T1 M:X3GTXL;: 7G7H#DS)1X-7)@6QUCK/HJ"4Z#30]>Y/4%7$II15Y;1K1NIX3: M9J.J(5*-L"Q 6,:-OE^"L(R+EW:,#-A&J?3,-E5#5!KT>>@:KR] GB;U;,^, MG-A*[9AMJH8X-8+RZ5[0;-6Y2HM*O<2K,=2WT2D&H5=$5AKH>3#HF2E'5VF) MJJ_6W"IMIWJ,YEDG4[NM_7G\!#C'2GQ75TZ"UW<=1]6Z!^W8$E?K=C<1&U5..MYW]GMI7#6(:[K#'I^ M/B)53_%Y 0(U6Y"@8R3JEK4(>F:GGK]8-0*SN%2%7O6EY5+JEV'_3?G$9IN> MOY0TX/,XS<*[U9>HR_&W1E9L3/TP^V3B;XVOV^QR=1]BXF^KO49CW3^38((X M[M;$$I3W(6:7R[S+)N"VO&=3&>(TNUR9AYB VZHO9SSP_Y&+8*INJ-?DX]!XX#?N6RS[#/ M\/BS,V9-8#@63CGC[A@'Q#_A].&5Y;,%;$2#?8["R.=L!C.?.HOTX^K,ADFX MBWK\W#&'$6=P%&,V7-!P'SS+'S?8O^ 9CW,^"N%-*V1>Y&=FGITHC7C'7>[# M*A'S';O>1#.8/_ASY$WXW7Q/?P,3!,']GH,2YIC M@AN[L\!089[/]"/,4\@[XW77@T.T'I&:!)' PV'?7-Q4^?1DLZR 6?.Y WP& M7V^PHU$5G,G4NH>#<>!)O8 @6PN[3N0!Q /E$09@<.&= L!G\-Y9\Q6.A[\$ M@6&[EK^0!PE[-4Z.$,\SF )-GR"!94X4'LT?1SP@IDC]Q/'- M<'^WW_H@&DVS@@=IRL)-II]/A) :\Y$]YKCEP'U(D/3+],1QP$1HY'&?QDZ# M;?T)>;N=C%" $LM*!ZF?Y3W%4P3$#DLZC.^CU\W--!LM=O75J]39^J?-^]K;U>= M?*O3: _PQZF)-OJG.7.5;[^GGS_()P]!$^(T+3;U^>3WVE] /2(40+8 MKGT M4,"$P5_?6ML12?I Y6('C9X-%*)_'7UB\0Q],16N/'>Z+>*AU9 M_HLGBLYRV?_YRZ#=;K[WY@AF0GK5>@]2ZAXD$"DN#9G 0"X)'E1SH-L 3*7 M3H-=H+KU>1 Y(8G,!Q)FC@5"S4J)OCK*N_2O\=FM4R!2*YBN@(-X5C.+D#U( M5S4W4$-VHL= 0@8 ,7F@]+$^T3K@ >E/3Q]P0( "2<20^4?H53A3L.Y"(P.ZHB&,,BM^"J1+F&T8!T#N<]!@GYY::)=BDIF#2&U6QA#&](])>F_IC: MCR;BCX4FD(7A?(1+Q)/*H\FGF-[\D!M_ F0&UGUPCV0 M.6%\GA!1\'04EPG-+'FA5NOU@JY]6X/MSUO";4+;FVWHPU#'#RX\7-\M/\2M M7V\)%0I5M-_LFN@7XQK %W;Q(@C[CASA SNW>^U9HU> MRW'IM9R!<,S3^,I;1>;M>Y:R?Y]PQ-+U#Z,ZUCR M]5?\4>IY=;2MYW;AI7( MV?9>K0EKE-_IP'KRHE#TVURR>G$DL%_ZJX=JK1AJ^]#*%0]>9;P+:WS?X3#Y M%S&YO(>L _JKA7/\&;N M31WNBSD>?&9U1A^SZ]BTU*<\Q+L4P&DH^NJDCV'_K#O\FG@SH*\!Z+-37DZT MA28@(LG*1SND3M^CLYT C' !"3@",2 &!F[%(6TZ]8 07WET:;,E'@7_V'] MFW-USKB@S_%CXI7>HIT+]J-8VPT?H=,6: J&O2>$(BS$_)^3.V75G+2+OX+N M^8S@-X+_!0G^6Y+Q,]M%#&^%P&KD31G#\2*;".\-V0AH!20_1,F& M[ S?"IC+\;X(.3Q$L\(=@]'R#'P)8VL!>W@"_TFY$:3S#RVU>>0'D24L991X MVL[!YXF.I%MPG]NS8>1+!U]ZDY5,0^>A<,RA'89CH*$-]#3EUICV6%AT>*/N M!AP%-#$T7;K;(1/^+!AM1G(<)+@W!**2TQ5NLLS34Q/5D;%/KPD?H0!@UC;HOYZ2C\+KFO]->%; [GSX M)CP*?>'[B=/ACR#; I 3=16JXRTL)UR<3& U\=K('2^$M'QK3"[:0%UXW5Q? M7?Q0UUTHAM3[5^K=?0B@0P6HYPI>(.LSR,7H(20M4 ,CSSQ[J/ LT!%]E MD##I]'9T.T)[O"6_!L=[<_D=C$#['F:C[J&^"%_FAX^7[.KJ$O45WGO:=%6* M;]*<)]XH0NWGN7)@NNGQ;=A(F^)^E $6@'&'7(,7 2EOTW["SWQ+7>1*NJ9+ MOY.A%:@YT,9.;#\(@::YJR8&%,O^?KEZU7 HP FP0E"]<]"]M ',#L1U)>X M&]L^Z%Z,W*&CBU^NV P-PXSY$ $+^K"%]SEVN.QP]7=2.*+1J*0 M! >8R FG(Z0D>' $ RT$T,!E9^."JM M)6L"@WRSN,-N&JR,SHXZ^^!' *Z.Z^:@.:WP=,C#F]J^];]L&S\"\3E1FA D M&/ %\R1[!!'U%GR>YH#-U--@*P2D?NN2E3KH+XL=T@$)QSA<5DK#U(]L"A/U M/6 \G 0N)9(LC*$DKK@UI$M O'!$'M7D,9$E7?OQ>SKW,0?(3>+'$XPCKY[% M%3M&\8D[PF32,8^FIF&-P%0)5LI?=#SAS=[:A3YPC!F,G+&2'^4W Y%]3H:+ M$_QORA 4^DD_#?T0+MQ%=F.3L)R9-8:ONT+4T>WQ8TCN.MRK,!3VG!:FX5@/ M4L#"U$'1$4O-O< 6AIV\=[[Y)"@8CX$LH;IR[04H[=:C-1E,%$@;E PT./P1 M'X/\@_52(:K6,C(.TG.1[P%ZA0,5&&XZB<=QU'$!"ZB,Q#8N!A^DK/- MG*0^"<<.5U1D7'.[Y1O!?VQOCV2041 21QCC0(5_X$B M1KNZU_7L'*T0%Q\9P P7D2!$&-)4J]Q^A+87N.Q26C[AF)J]%.S MT;&@ EE\#C0MQ0S]C$26)<\U0B'MS=&W$;D@?&24B?9.$K@FJ) KV*+XQ WI M6R3TM-V4NT6SP>_-O"#,/1']64-.]^7J277I0\==H%@\BMD!.HT93/\QPH[L M T@* 'F[)!;$7//.7LVVCEL%WP8; ED4[.VB_O.=B4#BD:-$KHJC>8PYEXPB-&X3?: M33">D8 4/,8ETIT4U"62]>15BKI6D2>_YK+!!)"7)F2@US,!Y"L#R-6#W,AQ MWJ>\"<(5MR:^G/2P_F^GM^*Q8?%AL!64*PLQ\+C98Q*QG M/6C+P>G+(>QYCSMHO'K9 HQ0(0/BTK .P75O-,+P6REVA7UT(RSA*VE$?/>] M.]^:)?;3BL]OOO\S^8XPI.KL$R@5$5FAN71>K>.&K+H,VRL%3*"Z0"JZVQ M-R<$@P!8T-:8*(N'4TSB)2/H#J_VW$#>C(E[4943*7$)470,3< ,6_F9\,\" M_A?Y;V1>Q &FD0!X,S UA'&);F?ZJ'76;;*+41A?T7VU_(6#+_XF&4];"0%?4.WAD%Y&FFWP]:?6$3R.*WKV5^QY>TKV_;6C8GK+'L,_/W8 M:PU:IZT_6^W:$NK9_I)MZR-]+R&?R9+SC3S$&([5VG>[REN%:8YZ ME[<;&Y4Q*OJ_T5$!2HS4+XHF>,-1KS_: 8:^HY>*70PQ'^*KN#3X80<_5]H# M3!PR7_N+C?2Y10$K\A;W1\.)S4U=AH M:KEWP@FAX@_IK@5TWA^N]+V1?V@Y?0+&TL,6Q<]P[(F("\?(([P=)!JIBT?C M<]0P6% #_1X.W5]F,O'^:-PTQ%W5B-L4'DD.K;'WX (\$YE6\?=&XKY #+A M,'FP #R\(%SE_WQT[?0%8XD_",* ML2X9B$O1B?@_"=(3@@_QS\(U[9&)D) MV 4=P#"A/(OT?OAX>K(AZ]N8#.;K,7=<'+#2'>&'>@_QKOWF87E1>CN#3"" M10X;X3I&AP[&AMJNR"E<^B:A%?U0&^P#'UEXA?Y (4"(@?1HIE3:D(PI \WE M4P2^O#7++?!!]R+*G22+C& 6$QPZ1@VI32:*L$3"D@@Z>% ^KW@[ECX7$\BD MXR+(Q^Q4%UU:+F:M @4E26!6ZC@$_>)1R,U(DZ/PQV&ZG8"'\4;&Z83BB- C MN'('Q(TCPP33U.B,N_>V[[G9$"Y<"H)*N?577SY<_Q FTO7G'WB:_\M]F8^Y M8B-#*D<8/TP>! A&5UR8QI_@6_1(4<]!;73F]S* + E;TX<8PA@XA&.+NRE; M7B$-1=@8,C Z:6E)Q(?Q-J5G1]SCH0M#T&G6&:E^NY3%VT#7A_RN].WGB9;T M;JL\2<+P O$Q="%[P+LYW]3V63"7/E-=\/A\&+^17NT247RD##":06 _BHH] M ?E^Q]J=3:=)9:P[]9Q[RD#E[XJ-GL(AV>GHC20O;&IIM^%942V,[?1E>8K; MD:.2D D1HH 7[^H7@D;1_$02)3**PP)$WF*DHB]1F+@RT1D#>.2Z16VC.-P( M[T4P!1I#3^7QY#(H\'Z<#X_''R IQ?G7^AI$]+SCD3UVJ_O$T0";TJ4,R%>1 MD"D4@A8H&T>_:"6.EG8!%X_"*(@HIA)DCU*/,M)49:,&4PXKL6@SEH^:]@]^ M[(*&E[G2 4K.G"0_4!5LNIBC8X. +FVMS(W&'&Q!ET E&2'BY=%-^OPUD:"S M]@.1?SST:K$/$R;L12[K "<%!HI(9Z>Z!10@*]PX@+@8""_G7E%#B38Q9N[B M-S$>>NTFTF7^HXV*QWG2EO[=>^#W>"&D\HGY^ YC K',3H:M8!68H6JMJ%N MTXI(O 4AAH?Y8QI,2)8D,DC)6!%BAAAA+N]+@P>5JL&9^WD_ MQV>4U)Q,?K;-W\MQX44,+5P#1^WOL]D'M>Y>J[SUU,OBI_BB].;KCQ*&O%G6 MSBM]1[O73UTA6-+B9=NA5Q24WN)YA3PIKR#VVF>_;C6:S4,L\M6;7UOFX?:N MQ*=TL$-:7N0>!:X1I4<2I=]XJ-^(R_#K[UA8ENP,_.M_N.572QY[>=7$^*.\L9#>SR^N"L_WA(N=RTA9;4VZ+V?E4+%;2-RIY#A]XOK,R=Z( MU'2Z2HJGB[=:;!ON@KICI^IG'!%R7X3N8 M/Y6-'L$ARG9@L,U4WWJ4@SNA.#$JE(#5FP'9C.MB.B*")8AF&/_POS+(*F[9 MI-4V()PL!@U4N7CQ-)GH&R< ^I'#XQO061SR!?.7V&)!-_75)_SI%9J6SVNDI%?* U8F,I6!Q5:\=<5LN7M:?D=B>' MJUT[8PL:2<&23#?30%U;5E)3>ZS2[Q>K?^=2T!L:&E.8-.7="ID@MU!(!6HV MY2JR$KG=N:2%P8;41B">.PR&2Y432!*#Y5EJ\U:%U#!TYH'B3!*JQ&SQ!:5D M_CL:W\FK_^P^C;P@/)$7S*FRN7$9@+AP_8K]2)M0*?F0QGF/.:KG,:6P!O,P M8[^L&BX'-=);R6"MY+74E5E5F9-AUNNS&'3E_2>%RI*W]I,!IRTW)R=Q14JB MR$A,4%Z2D2B>_)R_%#4*2?L3-_/A%JK8&;*4R>P(/4%MD+Y MR64AI.SWZT^;>4.791G_2+>6QQ4K:^H?D"V^7_RX95^^--CU[=\__6!?OGV^ M_O'UXO;+];?5^FA]R<9\_9311[OZT#Y<__CXZ+W)\K?![]3)^+W1[9=Q"Z!5:[_,ZE%NKE7%K;7)HY<_\D#(^ MIXG:9G?6YBVYPIZ(PHW QV10[.8HVK>P_9>PI$3DJAMXCCTF'!Q$0Z!(&V"J M3(]&,9RTQ]3",E$@QWD0U )2($VQ7(3>?EU9)3_!XG0PT+1.=LRZ7U(\.'Q( M"%V&:T;4_G7M7!OL<_:J@NXR-B]29BE8*JO>BP,WEQ:E-$_<\W0YYSS51TK[ MI<#KN#Q5"P X1:NN==S2._^*$?6Q*"4FFPXCTV"BN0PN35187)U(M/00C==P MX7%!YK1NV^Y.9RL]\%?[$="]^RV:P21'S+5F"+'YY!WF&'X6994(W]X"0WUP MO-'/&FT_O/J!"/A[L_4G_!\B@5NOV?^STZ2_:XP'(VN.H->/>"U.M!I?A+_7 M<*@;ZM +2_MST.MU6\WN::TR2JG_K)32A=%*LH (9M5*DM]1(97 MZW5:E!B M5)652OQDF"X$KZ@YEN[2KK.%%ZGZA5@J8Q(A+*0EE' M3=\Z53]8JH//?.B#Q; 0U-8>2(_[1&:<"NE^01T)IC'Q[F+A5TRM6 M6().C1QL]*N)%:<#2JM(S^627T(E'L5YQ*BTTZ@$X84K6S%Z?ERL,OG"F/.9 M]/[:LR1Y4]1$7J2VA%HAI',.G[1!UT2A5%=.ICO_C.DLH=4A=[P'E;1*6G6( M69QN8D+&:22:N2KO<%8E"VHIUC\/2]M(BGNX*0&R;J1\>CF(H9@ZI.L=I&4P MJH_L:[J0&51:O]E 2]%-9[3'S4224L\J*TQV[J1JM\2\>$E$=75L5P4/.?9_ M(H#KB$[C'#YO#_>16(];-L- ;[\D@N%"6PF:(W8H>SVBJ$DJ4XD25%3C5?;_ M$_)V<\IXM+HNKS)?*2? K)PP"I)[D1FK*NJZZI K_:1)L[CQ=&9UBE^#W<&P_70 M))*R&EOM3 MI?'%E$=WHA@X9]F.N*K/W^2ZLIOS=EB0)]Z$XIV>J(RAU7H0M:E5XV%UVKA< M<;\N;RB7YJT7U$ISM\[1HO%T#F?OH=9Z/E_'E>"L/%$FKA8%B^:S?WT]\\?# MITAZ@UQ4+8?7?25./:^GQ"6:U=&,2HE1'1UTLBBIJCP"V%59FYD*L93E7&3/ M!X$L+%EP8[EON(/=C,BWC8GX)P]X8QJ?([H(P'3 JVR1Q"^(+ ]1K:+9I);U M:MDGO[,>E-7S_0RT;3!-RKK-]SKHUWDY83Y6*32.ZM#DV#(][>7E^^EY_RT>"&,0)HN2)1!9Q +\8 M<;W&KPSUM7P?\6HE7_4.OD%5$\R?%R?0RYEI*H'8$A-79;]I"- K72?RKU/^!/MW1 +&0D, M)0LG20"BY[8+>9G3@DQ%P(>+.2?6BE=25VE>*4\G0:WUFK^BYW(=W@^5G$:+6))4O*Y$;2_M]D[ZZC"B-H4_1$J&3A%) MF%)<]XL(3]9P)TVNK681A*#,Y.X(=<+H9B! U\4]8#H1;C.;<9]^D0AB*CZO M7P=,P9KC?K8&!$TN4%67T.!+7?UJH8O4GP_XVG(EF8O9V2,!IU1A'5>3TDH6 MNQK44B*['A04XD-=&@5SX5A"'J<%&\@E_D?"&E:HX1/&0V.-* M=-O*G\_NINSSB%'#FR?J6S?FY[W3O[[57B;A:JG;J6S(&GPH[Y5D%.AXY=W2 MF@NHBSD>9?S5/UOIJ14:"HMZ?^(^QC+!U*G41HS4.4ZJ<,6=:)4$8&Q4P"O M+["%%A;,U6$DYIHGX;&K;Y#.F&B M?P6/YV'*10^OF+Q3'>2B+",(QSF0U0RM=O5=]>L4\A)]N^*F9MA)@/H$4C01 M)C)P[!*(S"=909(MV1@2C0'LB\B#3<[?28K1T;\O0X24E:M5U=/N-9+,*QP" MNQ?@C)1YI3\\E^(H%BB4!AD!1SQD1=+9GXLDB.3GQ 4B1T4O^[OF>;&G2-IB M\;6L^(F("\9#>P #A\VHRB)_M*DPHFPBQE6-X ;>=\9'NXIW?A64H\Q(@+FX M9Z>9<#?9C,Q#T'@7Q9O7/TA'\U).:W2A;IQ<&'F2UI)G!L3C)0?T>')AFOK!I+B'C_Y7GCCV9[H1W8IB]2CGM/_":25VWT_XG]^V!:-L\YH^B6JX@ M%!OEJ2Q8CCF:>+GI8!2# /*.[.Z5ZD=&4(\PB%0N:1HDY1? LN*PF-SRZP*V MB<;5LD&YH!@<6FNN/LW2>#PY->Y)TN0\L0*7B@NO#R,QU!53UY?+3^P#[/84 MX02[T+K):;$<7SYS&4O-AH%E.OL4Y^G9H$$(S7RWJS/VX^2GJ! \=+&T]T?&8J%C 3 MF$&7'R[%8/P#'C;V$@VRJYF%Q$@!!_7$\>N7%XD?@(!DCRZX>>BEP+L M!R: /.!RIO80P2SM"%H/033'.Z(@Z0,"HPEC7E03IW6D;D[BU8EPFSG!<7C> M(@XD&=G^*)JARV%D2'I#OSOM[&_"N-@YNT'O![QWK>A.40(<0$J28EU=79 * M8P.%$OX\I8V5_*/#:XAZ^2AZV0RH'2%S;-4%9$#&K62 0X*IS@)4;2K$BT3* M_ ?*H;N[6Y\&6FB^&^$;@:?$G1F2J_ X,F)HEK'$))BML2%J0=P.DA+Z8= M:P7AH7L>Y ,BP\TKN?DBKG0C [+'!"5DGZC_%FG,0"Z9R.Q6\^2_J:;&0MG% M BX0&<2TH:!R$HX.QZK01$)!]'11P._$\;R?ZNY;<'^*8RZ_?F)_\[UHOEJC M7DF!'C,O$9X2/3C +8Z=DD% ::D/V-Q!(QCVY!'-=> 5"T/0_AV)^^M&YMN" M!=!#GEV&QASX,; Z4"FM!.&3)T.@DABE6%[I Q.)ZQJ<&M4GK7Y">?M.'EL1 M9DI[2E8UG2]559R+LAZ!+-]2EVW0*0'=Y20_&A8V1$3"$?H:*G3O$]@(B)9UY7"F:&[E=0-X@#P#!!B$ MV. /GA23;H:8M8PGTHC4:$S.3B*B3_= &/$%BKR+4A'8*R587>MRD'YFNE%= M_.0-BXA;#:[SQPK3D^"!J,-$' 1K"CPY-3Q+=6UA2=1%N=84_I9"@D:EK[$Y M4Z=P!TK< ODK3R%]RK*:F8HNH.A"T$JHIT.1SH:@3_@'XBL\993J66\R!%Y> M7BC/1)#T(!*!@!(GZ/PHI.^7B72YRTM"*;=%@ZRL>K:#V #FA-3%S1U) BMN MQIB-*DIU0R1NH8AB,47I29E;"Q'$((L4B^G&_0QU&1,C)YK2E7"Y9&WD=2>1 MOQ7+JZ7#TKMPZM )I8&0QK 4&^,JP\B7!9+Q*?7L]6X"UFC<9*QAC*@D[$CR M#E/S 6$MI *<"]B.67)18P=K"=7:JH@#CQ E+P; MB20%.BI7-7T_UWS_9__LG^?[@^O\,;8U0 M-Y8C1-XG0([ &YJ; -GD#X%*9+V:;-%;T5;+/S]6I9JQ/1852=P[2]3_BO2U M!6IM6@"/EB6MJGFM2I/>6^&12G#^X#EQ?L=P/F[(1Y4E_0<6XKGAKHT]>1/F M*!%W?_-<;AAP'0.>/2<&S+8U>*$,^!4#BFZL"0=-FY28+QGCA5KLJV'!-2S8 M;CXG%NP9%J14*;)_OVB5H7Z-^586JWHY66<'B..^E:Z9[P[:^<^EV<9A7(1+ MCLLC1MU66"LNMD\A'XW> T9 $\,!:%[Y_,?;F(1]_=JR[ M;*'$;GZA1,&#O]?LQ_ =N;1AHYR BQR;W$?JS[OU9VZXW\=E5GB )^YI0^%9 M?#FE<+?7:$FO)7O1N .]^Q1IA)=]LOU'7L.45M\Z:;V>O%F1J_&&66+Y@@@] M7_PWR3@5K^,N#]:(G*)XMS-2]40?P*X)N2O2728R)ST.YA'4Q$,(<%RR!E<8\WC!/N!CRI)K+WC);7(]4!)G^C*%,:=J'PQ\N[=:R2 M@^O;5TVUE+Q7KG@M\%85GDN3$.(:UFT.8'?H .)T+'9S\H]*];,8I-,GUV

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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 84 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 85 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 1576 313 1 true 375 0 false 10 false false R1.htm 1001 - Document - Cover Page Sheet http://www.slrinvestments.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1002 - Statement - Consolidated Statements of Assets And Liabilities Sheet http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities Consolidated Statements of Assets And Liabilities Statements 2 false false R3.htm 1003 - Statement - Consolidated Statements of Assets And Liabilities (Parenthetical) Sheet http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical Consolidated Statements of Assets And Liabilities (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - Consolidated Statements of Operations Sheet http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 1005 - Statement - Consolidated Statements of Changes In Net Assets Sheet http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets Consolidated Statements of Changes In Net Assets Statements 5 false false R6.htm 1006 - Statement - Consolidated Statements of Cash Flows Sheet http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 1007 - Statement - Consolidated Statements of Cash Flows (Parenthetical) Sheet http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlowsParenthetical Consolidated Statements of Cash Flows (Parenthetical) Statements 7 false false R8.htm 1008 - Statement - Consolidated Schedule of Investments Sheet http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments Consolidated Schedule of Investments Statements 8 false false R9.htm 1009 - Statement - Consolidated Schedule of Investments (Parenthetical) Sheet http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical Consolidated Schedule of Investments (Parenthetical) Statements 9 false false R10.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 10 false false R11.htm 995470 - Disclosure - N-2 Sheet http://xbrl.sec.gov/cef/role/N2 N-2 Notes 11 false false R12.htm 999001 - Disclosure - Organization Sheet http://www.slrinvestments.com/role/Organization Organization Notes 12 false false R13.htm 999002 - Disclosure - Significant Accounting Policies Sheet http://www.slrinvestments.com/role/SignificantAccountingPolicies Significant Accounting Policies Notes 13 false false R14.htm 999003 - Disclosure - Agreements Sheet http://www.slrinvestments.com/role/Agreements Agreements Notes 14 false false R15.htm 999004 - Disclosure - Net Asset Value Per Share Sheet http://www.slrinvestments.com/role/NetAssetValuePerShare Net Asset Value Per Share Notes 15 false false R16.htm 999005 - Disclosure - Earnings Per Share Sheet http://www.slrinvestments.com/role/EarningsPerShare Earnings Per Share Notes 16 false false R17.htm 999006 - Disclosure - Fair Value Sheet http://www.slrinvestments.com/role/FairValue Fair Value Notes 17 false false R18.htm 999007 - Disclosure - Debt Sheet http://www.slrinvestments.com/role/Debt Debt Notes 18 false false R19.htm 999008 - Disclosure - Financial Highlights Sheet http://www.slrinvestments.com/role/FinancialHighlights Financial Highlights Notes 19 false false R20.htm 999009 - Disclosure - SLR Credit Solutions Sheet http://www.slrinvestments.com/role/SlrCreditSolutions SLR Credit Solutions Notes 20 false false R21.htm 999010 - Disclosure - Commitments and Contingencies Sheet http://www.slrinvestments.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 21 false false R22.htm 999011 - Disclosure - SLR Equipment Finance Sheet http://www.slrinvestments.com/role/SlrEquipmentFinance SLR Equipment Finance Notes 22 false false R23.htm 999012 - Disclosure - Capital Share Transactions Sheet http://www.slrinvestments.com/role/CapitalShareTransactions Capital Share Transactions Notes 23 false false R24.htm 999013 - Disclosure - Kingsbridge Holdings, LLC Sheet http://www.slrinvestments.com/role/KingsbridgeHoldingsLlc Kingsbridge Holdings, LLC Notes 24 false false R25.htm 999014 - Disclosure - SLR Healthcare ABL Sheet http://www.slrinvestments.com/role/SlrHealthcareAbl SLR Healthcare ABL Notes 25 false false R26.htm 999015 - Disclosure - SLR Business Credit Sheet http://www.slrinvestments.com/role/SlrBusinessCredit SLR Business Credit Notes 26 false false R27.htm 999016 - Disclosure - Stock Repurchase Program Sheet http://www.slrinvestments.com/role/StockRepurchaseProgram Stock Repurchase Program Notes 27 false false R28.htm 999017 - Disclosure - SLR Senior Lending Program LLC Sheet http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlc SLR Senior Lending Program LLC Notes 28 false false R29.htm 999018 - Disclosure - Subsequent Events Sheet http://www.slrinvestments.com/role/SubsequentEvents Subsequent Events Notes 29 false false R30.htm 999019 - Disclosure - Earnings Per Share (Tables) Sheet http://www.slrinvestments.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.slrinvestments.com/role/EarningsPerShare 30 false false R31.htm 999020 - Disclosure - Fair Value (Tables) Sheet http://www.slrinvestments.com/role/FairValueTables Fair Value (Tables) Tables http://www.slrinvestments.com/role/FairValue 31 false false R32.htm 999021 - Disclosure - Debt (Tables) Sheet http://www.slrinvestments.com/role/DebtTables Debt (Tables) Tables http://www.slrinvestments.com/role/Debt 32 false false R33.htm 999022 - Disclosure - Financial Highlights (Tables) Sheet http://www.slrinvestments.com/role/FinancialHighlightsTables Financial Highlights (Tables) Tables http://www.slrinvestments.com/role/FinancialHighlights 33 false false R34.htm 999023 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.slrinvestments.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.slrinvestments.com/role/CommitmentsAndContingencies 34 false false R35.htm 999024 - Disclosure - Capital Share Transactions (Tables) Sheet http://www.slrinvestments.com/role/CapitalShareTransactionsTables Capital Share Transactions (Tables) Tables http://www.slrinvestments.com/role/CapitalShareTransactions 35 false false R36.htm 999025 - Disclosure - SLR Senior Lending Program LLC (Tables) Sheet http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcTables SLR Senior Lending Program LLC (Tables) Tables http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlc 36 false false R37.htm 999026 - Disclosure - Organization - Additional Information (Details) Sheet http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails Organization - Additional Information (Details) Details 37 false false R38.htm 999027 - Disclosure - Significant Accounting Policies - Additional Information (Details) Sheet http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails Significant Accounting Policies - Additional Information (Details) Details 38 false false R39.htm 999028 - Disclosure - Agreements - Additional Information (Details) Sheet http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails Agreements - Additional Information (Details) Details 39 false false R40.htm 999029 - Disclosure - Net Asset Value Per Share - Additional Information (Details) Sheet http://www.slrinvestments.com/role/NetAssetValuePerShareAdditionalInformationDetails Net Asset Value Per Share - Additional Information (Details) Details 40 false false R41.htm 999030 - Disclosure - Earnings Per Share - Summary of Computation of Basic and Diluted Net (Details) Sheet http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetails Earnings Per Share - Summary of Computation of Basic and Diluted Net (Details) Details 41 false false R42.htm 999031 - Disclosure - Fair Value - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails Fair Value - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Details 42 false false R43.htm 999032 - Disclosure - Fair Value - Summary of Changes in Fair Value of Level 3 Assets and Liabilities (Details) Sheet http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails Fair Value - Summary of Changes in Fair Value of Level 3 Assets and Liabilities (Details) Details 43 false false R44.htm 999033 - Disclosure - Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Details) Sheet http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Details) Details 44 false false R45.htm 999034 - Disclosure - Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Parenthetical) (Details) Sheet http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Parenthetical) (Details) Details 45 false false R46.htm 999035 - Disclosure - Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Details) Sheet http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Details) Details 46 false false R47.htm 999036 - Disclosure - Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Parenthetical) (Details) Sheet http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Parenthetical) (Details) Details 47 false false R48.htm 999037 - Disclosure - Debt - Schedule of Long-term Debt Instruments (Details) Sheet http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails Debt - Schedule of Long-term Debt Instruments (Details) Details 48 false false R49.htm 999038 - Disclosure - Debt - Schedule of Long-term Debt Instruments (Parenthetical) (Details) Sheet http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails Debt - Schedule of Long-term Debt Instruments (Parenthetical) (Details) Details 49 false false R50.htm 999039 - Disclosure - Debt - Additional Information (Details) Sheet http://www.slrinvestments.com/role/DebtAdditionalInformationDetails Debt - Additional Information (Details) Details 50 false false R51.htm 999040 - Disclosure - Financial Highlights - Schedule of Financial Highlights (Details) Sheet http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails Financial Highlights - Schedule of Financial Highlights (Details) Details 51 false false R52.htm 999041 - Disclosure - Financial Highlights - Schedule of Financial Highlights (Parentheticals) (Details) Sheet http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsParentheticalsDetails Financial Highlights - Schedule of Financial Highlights (Parentheticals) (Details) Details 52 false false R53.htm 999042 - Disclosure - SLR Credit Solutions - Additional Information (Details) Sheet http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails SLR Credit Solutions - Additional Information (Details) Details 53 false false R54.htm 999043 - Disclosure - Commitments and Contingencies - Additional Information (Details) Sheet http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails Commitments and Contingencies - Additional Information (Details) Details 54 false false R55.htm 999044 - Disclosure - Commitments and Contingencies - Summary of Unfunded Debt and Equity Commitments (Details) Sheet http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails Commitments and Contingencies - Summary of Unfunded Debt and Equity Commitments (Details) Details 55 false false R56.htm 999045 - Disclosure - SLR Equipment Finance - Additional Information (Details) Sheet http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails SLR Equipment Finance - Additional Information (Details) Details 56 false false R57.htm 999046 - Disclosure - Capital Share Transactions - Additional Information (Details) Sheet http://www.slrinvestments.com/role/CapitalShareTransactionsAdditionalInformationDetails Capital Share Transactions - Additional Information (Details) Details 57 false false R58.htm 999047 - Disclosure - Capital Share Transactions - Summary of Transactions In Capital Stock (Details) Sheet http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails Capital Share Transactions - Summary of Transactions In Capital Stock (Details) Details 58 false false R59.htm 999048 - Disclosure - Kingsbridge Holdings, LLC - Additional Information (Details) Sheet http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails Kingsbridge Holdings, LLC - Additional Information (Details) Details 59 false false R60.htm 999049 - Disclosure - SLR Healthcare ABL - Additional Information (Details) Sheet http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails SLR Healthcare ABL - Additional Information (Details) Details 60 false false R61.htm 999050 - Disclosure - SLR Business Credit - Additional Information (Details) Sheet http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails SLR Business Credit - Additional Information (Details) Details 61 false false R62.htm 999051 - Disclosure - Stock Repurchase Program - Additional Information (Details) Sheet http://www.slrinvestments.com/role/StockRepurchaseProgramAdditionalInformationDetails Stock Repurchase Program - Additional Information (Details) Details 62 false false R63.htm 999052 - Disclosure - SLR Senior Lending Program LLC - Summary of SSLP's portfolio (Details) Sheet http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails SLR Senior Lending Program LLC - Summary of SSLP's portfolio (Details) Details 63 false false R64.htm 999053 - Disclosure - SLR Senior Lending Program LLC - Summary financial information for SSLP (Details) Sheet http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails SLR Senior Lending Program LLC - Summary financial information for SSLP (Details) Details 64 false false R65.htm 999054 - Disclosure - SLR Senior Lending Program LLC - Summary financial information for SSLP (Parenthetical) (Details) Sheet http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpParentheticalDetails SLR Senior Lending Program LLC - Summary financial information for SSLP (Parenthetical) (Details) Details 65 false false R66.htm 999055 - Disclosure - SLR Senior Lending Program LLC - Additional Information (Details) Sheet http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails SLR Senior Lending Program LLC - Additional Information (Details) Details 66 false false R67.htm 999056 - Disclosure - Subsequent Events - Additional Information (Details) Sheet http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails Subsequent Events - Additional Information (Details) Details 67 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityAddressStateOrProvince - d518171d10q.htm 7 d518171d10q.htm d518171dex231.htm d518171dex311.htm d518171dex312.htm d518171dex313.htm d518171dex321.htm d518171dex322.htm d518171dex323.htm slrc-20230630.xsd slrc-20230630_cal.xml slrc-20230630_def.xml slrc-20230630_lab.xml slrc-20230630_pre.xml http://fasb.org/srt/2023 http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/cef/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 88 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d518171d10q.htm": { "axisCustom": 6, "axisStandard": 24, "baseTaxonomies": { "http://fasb.org/srt/2023": 1, "http://fasb.org/us-gaap/2023": 2710, "http://xbrl.sec.gov/cef/2023": 184, "http://xbrl.sec.gov/dei/2023": 29, "http://xbrl.sec.gov/ecd/2023": 4 }, "contextCount": 1576, "dts": { "calculationLink": { "local": [ "slrc-20230630_cal.xml" ] }, "definitionLink": { "local": [ "slrc-20230630_def.xml" ] }, "inline": { "local": [ "d518171d10q.htm" ] }, "labelLink": { "local": [ "slrc-20230630_lab.xml" ] }, "presentationLink": { "local": [ "slrc-20230630_pre.xml" ] }, "schema": { "local": [ "slrc-20230630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/2006/xbrldi-2006.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/cef/2023/cef-2023.xsd", "https://xbrl.sec.gov/cef/2023/cef-2023_pre.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023_lab.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-sub-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] } }, "elementCount": 1052, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2023": 2, "http://xbrl.sec.gov/dei/2023": 5, "total": 7 }, "keyCustom": 96, "keyStandard": 217, "memberCustom": 315, "memberStandard": 25, "nsprefix": "slrc", "nsuri": "http://www.slrinvestments.com/20230630", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "1001 - Document - Cover Page", "menuCat": "Cover", "order": "1", "role": "http://www.slrinvestments.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "lang": "en-US", "name": "dei:DocumentPeriodEndDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "ecd:NonRule10b51ArrTrmntdFlag", "ecd:Rule10b51ArrTrmntdFlag", "ecd:NonRule10b51ArrAdoptedFlag", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P04_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "ecd:Rule10b51ArrAdoptedFlag", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "995445 - Disclosure - Insider Trading Arrangements", "menuCat": "Notes", "order": "10", "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "shortName": "Insider Trading Arrangements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "ecd:NonRule10b51ArrTrmntdFlag", "ecd:Rule10b51ArrTrmntdFlag", "ecd:NonRule10b51ArrAdoptedFlag", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P04_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "ecd:Rule10b51ArrAdoptedFlag", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityFileNumber", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "995470 - Disclosure - N-2", "menuCat": "Notes", "order": "11", "role": "http://xbrl.sec.gov/cef/role/N2", "shortName": "N-2", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "cef:SeniorSecuritiesNoteTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "lang": "en-US", "name": "cef:SeniorSecuritiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999001 - Disclosure - Organization", "menuCat": "Notes", "order": "12", "role": "http://www.slrinvestments.com/role/Organization", "shortName": "Organization", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999002 - Disclosure - Significant Accounting Policies", "menuCat": "Notes", "order": "13", "role": "http://www.slrinvestments.com/role/SignificantAccountingPolicies", "shortName": "Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:AgreementsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999003 - Disclosure - Agreements", "menuCat": "Notes", "order": "14", "role": "http://www.slrinvestments.com/role/Agreements", "shortName": "Agreements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:AgreementsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:NetAssetValuePerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999004 - Disclosure - Net Asset Value Per Share", "menuCat": "Notes", "order": "15", "role": "http://www.slrinvestments.com/role/NetAssetValuePerShare", "shortName": "Net Asset Value Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:NetAssetValuePerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999005 - Disclosure - Earnings Per Share", "menuCat": "Notes", "order": "16", "role": "http://www.slrinvestments.com/role/EarningsPerShare", "shortName": "Earnings Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999006 - Disclosure - Fair Value", "menuCat": "Notes", "order": "17", "role": "http://www.slrinvestments.com/role/FairValue", "shortName": "Fair Value", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999007 - Disclosure - Debt", "menuCat": "Notes", "order": "18", "role": "http://www.slrinvestments.com/role/Debt", "shortName": "Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999008 - Disclosure - Financial Highlights", "menuCat": "Notes", "order": "19", "role": "http://www.slrinvestments.com/role/FinancialHighlights", "shortName": "Financial Highlights", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002 - Statement - Consolidated Statements of Assets And Liabilities", "menuCat": "Statements", "order": "2", "role": "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "shortName": "Consolidated Statements of Assets And Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:SlrCreditSolutionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999009 - Disclosure - SLR Credit Solutions", "menuCat": "Notes", "order": "20", "role": "http://www.slrinvestments.com/role/SlrCreditSolutions", "shortName": "SLR Credit Solutions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:SlrCreditSolutionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999010 - Disclosure - Commitments and Contingencies", "menuCat": "Notes", "order": "21", "role": "http://www.slrinvestments.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999011 - Disclosure - SLR Equipment Finance", "menuCat": "Notes", "order": "22", "role": "http://www.slrinvestments.com/role/SlrEquipmentFinance", "shortName": "SLR Equipment Finance", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023_SlrEquipmentFinanceMembersrtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "decimals": null, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:CapitalShareTransactionsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999012 - Disclosure - Capital Share Transactions", "menuCat": "Notes", "order": "23", "role": "http://www.slrinvestments.com/role/CapitalShareTransactions", "shortName": "Capital Share Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:CapitalShareTransactionsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999013 - Disclosure - Kingsbridge Holdings, LLC", "menuCat": "Notes", "order": "24", "role": "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlc", "shortName": "Kingsbridge Holdings, LLC", "subGroupType": "", "uniqueAnchor": null }, "R25": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:SlrHealthcareAblTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999014 - Disclosure - SLR Healthcare ABL", "menuCat": "Notes", "order": "25", "role": "http://www.slrinvestments.com/role/SlrHealthcareAbl", "shortName": "SLR Healthcare ABL", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:SlrHealthcareAblTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:SlrBusinessCreditDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999015 - Disclosure - SLR Business Credit", "menuCat": "Notes", "order": "26", "role": "http://www.slrinvestments.com/role/SlrBusinessCredit", "shortName": "SLR Business Credit", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:SlrBusinessCreditDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999016 - Disclosure - Stock Repurchase Program", "menuCat": "Notes", "order": "27", "role": "http://www.slrinvestments.com/role/StockRepurchaseProgram", "shortName": "Stock Repurchase Program", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999017 - Disclosure - SLR Senior Lending Program LLC", "menuCat": "Notes", "order": "28", "role": "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlc", "shortName": "SLR Senior Lending Program LLC", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999018 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "29", "role": "http://www.slrinvestments.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtCost", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003 - Statement - Consolidated Statements of Assets And Liabilities (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "shortName": "Consolidated Statements of Assets And Liabilities (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "-3", "lang": null, "name": "slrc:CashEquivalentsAtCost", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999019 - Disclosure - Earnings Per Share (Tables)", "menuCat": "Tables", "order": "30", "role": "http://www.slrinvestments.com/role/EarningsPerShareTables", "shortName": "Earnings Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999020 - Disclosure - Fair Value (Tables)", "menuCat": "Tables", "order": "31", "role": "http://www.slrinvestments.com/role/FairValueTables", "shortName": "Fair Value (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999021 - Disclosure - Debt (Tables)", "menuCat": "Tables", "order": "32", "role": "http://www.slrinvestments.com/role/DebtTables", "shortName": "Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999022 - Disclosure - Financial Highlights (Tables)", "menuCat": "Tables", "order": "33", "role": "http://www.slrinvestments.com/role/FinancialHighlightsTables", "shortName": "Financial Highlights (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCommitmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999023 - Disclosure - Commitments and Contingencies (Tables)", "menuCat": "Tables", "order": "34", "role": "http://www.slrinvestments.com/role/CommitmentsAndContingenciesTables", "shortName": "Commitments and Contingencies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCommitmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "slrc:CapitalShareTransactionsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999024 - Disclosure - Capital Share Transactions (Tables)", "menuCat": "Tables", "order": "35", "role": "http://www.slrinvestments.com/role/CapitalShareTransactionsTables", "shortName": "Capital Share Transactions (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "slrc:CapitalShareTransactionsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999025 - Disclosure - SLR Senior Lending Program LLC (Tables)", "menuCat": "Tables", "order": "36", "role": "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcTables", "shortName": "SLR Senior Lending Program LLC (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P04_01_2023To06_30_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999026 - Disclosure - Organization - Additional Information (Details)", "menuCat": "Details", "order": "37", "role": "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails", "shortName": "Organization - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P02_10_2010To02_10_2010_IPOMemberusgaapSubsidiarySaleOfStockAxis", "decimals": "-4", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": "2", "first": true, "lang": null, "name": "slrc:PercentageOfExciseTax", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999027 - Disclosure - Significant Accounting Policies - Additional Information (Details)", "menuCat": "Details", "order": "38", "role": "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "shortName": "Significant Accounting Policies - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": "2", "first": true, "lang": null, "name": "slrc:PercentageOfExciseTax", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P04_01_2023To06_30_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ManagementFeeExpense", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999028 - Disclosure - Agreements - Additional Information (Details)", "menuCat": "Details", "order": "39", "role": "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "shortName": "Agreements - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "slrc:AgreementsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P04_01_2023To06_30_2023", "decimals": "-3", "lang": null, "name": "slrc:PerformanceBasedIncentiveFeesWaiver", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P04_01_2023To06_30_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GrossInvestmentIncomeOperating", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004 - Statement - Consolidated Statements of Operations", "menuCat": "Statements", "order": "4", "role": "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P04_01_2023To06_30_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GrossInvestmentIncomeOperating", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AssetsNet", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999029 - Disclosure - Net Asset Value Per Share - Additional Information (Details)", "menuCat": "Details", "order": "40", "role": "http://www.slrinvestments.com/role/NetAssetValuePerShareAdditionalInformationDetails", "shortName": "Net Asset Value Per Share - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R41": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P04_01_2023To06_30_2023", "decimals": "-3", "first": true, "lang": null, "name": "slrc:IncreaseDecreaseInNetAssetsFromOperation", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999030 - Disclosure - Earnings Per Share - Summary of Computation of Basic and Diluted Net (Details)", "menuCat": "Details", "order": "41", "role": "http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetails", "shortName": "Earnings Per Share - Summary of Computation of Basic and Diluted Net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P04_01_2023To06_30_2023", "decimals": "-3", "first": true, "lang": null, "name": "slrc:IncreaseDecreaseInNetAssetsFromOperation", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999031 - Disclosure - Fair Value - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)", "menuCat": "Details", "order": "42", "role": "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "shortName": "Fair Value - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_30_2023_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999032 - Disclosure - Fair Value - Summary of Changes in Fair Value of Level 3 Assets and Liabilities (Details)", "menuCat": "Details", "order": "43", "role": "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails", "shortName": "Fair Value - Summary of Changes in Fair Value of Level 3 Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn12_31_2021_TwoThousandAndTwentyTwoUnsecuredNotesMemberusgaapFairValueByLiabilityClassAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999033 - Disclosure - Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Details)", "menuCat": "Details", "order": "44", "role": "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details", "shortName": "Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn12_31_2021_TwoThousandAndTwentyTwoUnsecuredNotesMemberusgaapFairValueByLiabilityClassAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_30_2023_TermLoanAndCreditFacilityMemberusgaapLongtermDebtTypeAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFairValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999034 - Disclosure - Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Parenthetical) (Details)", "menuCat": "Details", "order": "45", "role": "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "shortName": "Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Parenthetical) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_30_2023_TermLoanAndCreditFacilityMemberusgaapLongtermDebtTypeAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFairValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_IncomeApproachValuationTechniqueMemberusgaapValuationTechniqueAxis_InvestmentInSeniorSecuredLoansMemberusgaapFairValueByAssetClassAxis_MeasurementInputMarketYieldMemberusgaapMeasurementInputTypeAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999035 - Disclosure - Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Details)", "menuCat": "Details", "order": "46", "role": "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "shortName": "Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_IncomeApproachValuationTechniqueMemberusgaapValuationTechniqueAxis_InvestmentInSeniorSecuredLoansMemberusgaapFairValueByAssetClassAxis_MeasurementInputMarketYieldMemberusgaapMeasurementInputTypeAxis", "decimals": null, "lang": "en-US", "name": "slrc:DescriptionOfFairValueMeasurementValuationProcess", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputEbitdaMultipleMemberSLRCMeasurementInputTypeOneAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999036 - Disclosure - Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Parenthetical) (Details)", "menuCat": "Details", "order": "47", "role": "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails", "shortName": "Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Parenthetical) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_30_2023_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputEbitdaMultipleMemberSLRCMeasurementInputTypeOneAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999037 - Disclosure - Debt - Schedule of Long-term Debt Instruments (Details)", "menuCat": "Details", "order": "48", "role": "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "shortName": "Debt - Schedule of Long-term Debt Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_30_2023_TermLoanAndCreditFacilityMemberusgaapLongtermDebtTypeAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredFinanceCostsNet", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999038 - Disclosure - Debt - Schedule of Long-term Debt Instruments (Parenthetical) (Details)", "menuCat": "Details", "order": "49", "role": "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "shortName": "Debt - Schedule of Long-term Debt Instruments (Parenthetical) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_30_2023_TermLoanAndCreditFacilityMemberusgaapLongtermDebtTypeAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredFinanceCostsNet", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P04_01_2023To06_30_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentIncomeNet", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005 - Statement - Consolidated Statements of Changes In Net Assets", "menuCat": "Statements", "order": "5", "role": "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "shortName": "Consolidated Statements of Changes In Net Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P04_01_2023To06_30_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentIncomeNet", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999039 - Disclosure - Debt - Additional Information (Details)", "menuCat": "Details", "order": "50", "role": "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "shortName": "Debt - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": "4", "lang": null, "name": "us-gaap:LongTermDebtWeightedAverageInterestRateOverTime", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "div", "slrc:NetAssetValuePerShareTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn12_31_2022", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NetAssetValuePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999040 - Disclosure - Financial Highlights - Schedule of Financial Highlights (Details)", "menuCat": "Details", "order": "51", "role": "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails", "shortName": "Financial Highlights - Schedule of Financial Highlights (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock", "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": "2", "lang": null, "name": "us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock", "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "2", "first": true, "lang": null, "name": "slrc:FairValueOfCommonStockPerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999041 - Disclosure - Financial Highlights - Schedule of Financial Highlights (Parentheticals) (Details)", "menuCat": "Details", "order": "52", "role": "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsParentheticalsDetails", "shortName": "Financial Highlights - Schedule of Financial Highlights (Parentheticals) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock", "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": "4", "lang": null, "name": "us-gaap:InvestmentCompanyExpenseRatioExcludingIncentiveFee", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "div", "slrc:SlrBusinessCreditDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": "0", "first": true, "lang": null, "name": "slrc:NumberOfIssuerInBusinessCredit", "reportCount": 1, "unitRef": "Unit_issuers", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999042 - Disclosure - SLR Credit Solutions - Additional Information (Details)", "menuCat": "Details", "order": "53", "role": "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "shortName": "SLR Credit Solutions - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "slrc:SlrCreditSolutionTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn12_28_2012_RevolvingCreditFacilityMemberusgaapCreditFacilityAxis", "decimals": "-3", "lang": null, "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "us-gaap:OtherCommitmentsTableTextBlock", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OtherCommitment", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999043 - Disclosure - Commitments and Contingencies - Additional Information (Details)", "menuCat": "Details", "order": "54", "role": "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "shortName": "Commitments and Contingencies - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R55": { "firstAnchor": { "ancestors": [ "us-gaap:OtherCommitmentsTableTextBlock", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OtherCommitment", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999044 - Disclosure - Commitments and Contingencies - Summary of Unfunded Debt and Equity Commitments (Details)", "menuCat": "Details", "order": "55", "role": "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "shortName": "Commitments and Contingencies - Summary of Unfunded Debt and Equity Commitments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_30_2023_SlrCreditSolutionsMemberdeiLegalEntityAxis_UnfundedDebtAndEquityCommitmentsMemberusgaapOtherCommitmentsAxis", "decimals": "-3", "lang": null, "name": "us-gaap:OtherCommitment", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebt", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999045 - Disclosure - SLR Equipment Finance - Additional Information (Details)", "menuCat": "Details", "order": "56", "role": "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "shortName": "SLR Equipment Finance - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn07_31_2017_SlrEquipmentFinanceMembersrtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "decimals": "2", "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999046 - Disclosure - Capital Share Transactions - Additional Information (Details)", "menuCat": "Details", "order": "57", "role": "http://www.slrinvestments.com/role/CapitalShareTransactionsAdditionalInformationDetails", "shortName": "Capital Share Transactions - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:CommonStockSharesAuthorized", "div", "slrc:CapitalShareTransactionsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_30_2022", "decimals": "INF", "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P04_01_2023To06_30_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockRepurchasedDuringPeriodShares", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999047 - Disclosure - Capital Share Transactions - Summary of Transactions In Capital Stock (Details)", "menuCat": "Details", "order": "58", "role": "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "shortName": "Capital Share Transactions - Summary of Transactions In Capital Stock (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "slrc:CapitalShareTransactionsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P04_01_2023To06_30_2023", "decimals": "-3", "lang": null, "name": "us-gaap:InvestmentCompanyIncreaseDecreaseFromShareTransaction", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfUnsecuredDebt", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999048 - Disclosure - Kingsbridge Holdings, LLC - Additional Information (Details)", "menuCat": "Details", "order": "59", "role": "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "shortName": "Kingsbridge Holdings, LLC - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn12_31_2022_KbhtMemberdeiLegalEntityAxis", "decimals": "-3", "lang": null, "name": "us-gaap:Assets", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": "-3", "first": true, "lang": null, "name": "slrc:NetIncreaseInNetAssetsResultingFromoperations", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006 - Statement - Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "6", "role": "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": "-3", "first": true, "lang": null, "name": "slrc:NetIncreaseInNetAssetsResultingFromoperations", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "div", "slrc:SlrBusinessCreditDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LineOfCreditFacilityExpirationDate1", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999049 - Disclosure - SLR Healthcare ABL - Additional Information (Details)", "menuCat": "Details", "order": "60", "role": "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "shortName": "SLR Healthcare ABL - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "slrc:SlrHealthcareAblTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_28_2019_SlrHealthcareAblCreditMemberusgaapLineOfCreditFacilityAxis", "decimals": "-3", "lang": null, "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": null, "first": true, "lang": null, "name": "us-gaap:CommitmentsAndContingencies", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "true" }, "groupType": "disclosure", "isDefault": "false", "longName": "999050 - Disclosure - SLR Business Credit - Additional Information (Details)", "menuCat": "Details", "order": "61", "role": "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "shortName": "SLR Business Credit - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "slrc:SlrBusinessCreditDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn12_31_2022_SlrBusinessCreditMemberusgaapLineOfCreditFacilityAxis", "decimals": "-3", "lang": null, "name": "us-gaap:LineOfCredit", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn05_09_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999051 - Disclosure - Stock Repurchase Program - Additional Information (Details)", "menuCat": "Details", "order": "62", "role": "http://www.slrinvestments.com/role/StockRepurchaseProgramAdditionalInformationDetails", "shortName": "Stock Repurchase Program - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn05_09_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtCost", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999052 - Disclosure - SLR Senior Lending Program LLC - Summary of SSLP's portfolio (Details)", "menuCat": "Details", "order": "63", "role": "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails", "shortName": "SLR Senior Lending Program LLC - Summary of SSLP's portfolio (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023_AegisToxicologySciencesCorporationMembersrtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_HealthcareSectorMemberusgaapEquitySecuritiesByIndustryAxis_SlrSeniorLendingProgramLlcMemberdeiLegalEntityAxis", "decimals": null, "lang": "en-US", "name": "slrc:InvestmentsOwnedSpreadAboveIndexRate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashCashEquivalentsAndShortTermInvestments", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999053 - Disclosure - SLR Senior Lending Program LLC - Summary financial information for SSLP (Details)", "menuCat": "Details", "order": "64", "role": "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails", "shortName": "SLR Senior Lending Program LLC - Summary financial information for SSLP (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "srt:ScheduleOfCondensedFinancialStatementsTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn12_31_2022_SlrSeniorLendingProgramLlcMemberdeiLegalEntityAxis", "decimals": "-3", "lang": null, "name": "us-gaap:DebtLongtermAndShorttermCombinedAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtCost", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999054 - Disclosure - SLR Senior Lending Program LLC - Summary financial information for SSLP (Parenthetical) (Details)", "menuCat": "Details", "order": "65", "role": "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpParentheticalDetails", "shortName": "SLR Senior Lending Program LLC - Summary financial information for SSLP (Parenthetical) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R66": { "firstAnchor": { "ancestors": [ "us-gaap:OtherCommitmentsTableTextBlock", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn12_31_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OtherCommitment", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999055 - Disclosure - SLR Senior Lending Program LLC - Additional Information (Details)", "menuCat": "Details", "order": "66", "role": "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails", "shortName": "SLR Senior Lending Program LLC - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_30_2023_SlrSeniorLendingProgramLlcMemberdeiLegalEntityAxis", "decimals": "-3", "lang": null, "name": "us-gaap:OtherOwnershipInterestsValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "div", "us-gaap:SubsequentEventsTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn08_08_2023_BoardMembersrtTitleOfIndividualAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis", "decimals": "6", "first": true, "lang": null, "name": "us-gaap:DividendsPayableAmountPerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999056 - Disclosure - Subsequent Events - Additional Information (Details)", "menuCat": "Details", "order": "67", "role": "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails", "shortName": "Subsequent Events - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:SubsequentEventsTextBlock", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn08_08_2023_BoardMembersrtTitleOfIndividualAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis", "decimals": "6", "first": true, "lang": null, "name": "us-gaap:DividendsPayableAmountPerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P04_01_2022To04_01_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1007 - Statement - Consolidated Statements of Cash Flows (Parenthetical)", "menuCat": "Statements", "order": "7", "role": "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlowsParenthetical", "shortName": "Consolidated Statements of Cash Flows (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P04_01_2022To04_01_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtCost", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1008 - Statement - Consolidated Schedule of Investments", "menuCat": "Statements", "order": "8", "role": "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "shortName": "Consolidated Schedule of Investments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "-3", "lang": null, "name": "slrc:LiabilitiesInExcessOfOtherAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": "3", "first": true, "lang": null, "name": "slrc:PercentageRepresentingSeniorSecuredLoansInInvestmentsOwned", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1009 - Statement - Consolidated Schedule of Investments (Parenthetical)", "menuCat": "Statements", "order": "9", "role": "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "shortName": "Consolidated Schedule of Investments (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d518171d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": "3", "first": true, "lang": null, "name": "slrc:PercentageRepresentingSeniorSecuredLoansInInvestmentsOwned", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } } }, "segmentCount": 375, "tag": { "cef_AcquiredFundFeesAndExpensesNoteTextBlock": { "auth_ref": [ "r735" ], "lang": { "en-us": { "role": { "label": "Acquired Fund Fees and Expenses, Note [Text Block]" } } }, "localname": "AcquiredFundFeesAndExpensesNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_AcquiredFundFeesAndExpensesPercent": { "auth_ref": [ "r736" ], "lang": { "en-us": { "role": { "label": "Acquired Fund Fees and Expenses [Percent]" } } }, "localname": "AcquiredFundFeesAndExpensesPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_AcquiredFundFeesEstimatedNoteTextBlock": { "auth_ref": [ "r737" ], "lang": { "en-us": { "role": { "label": "Acquired Fund Fees Estimated, Note [Text Block]" } } }, "localname": "AcquiredFundFeesEstimatedNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_AcquiredFundIncentiveAllocationNoteTextBlock": { "auth_ref": [ "r738" ], "lang": { "en-us": { "role": { "label": "Acquired Fund Incentive Allocation, Note [Text Block]" } } }, "localname": "AcquiredFundIncentiveAllocationNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_AcquiredFundTotalAnnualExpensesNoteTextBlock": { "auth_ref": [ "r739" ], "lang": { "en-us": { "role": { "label": "Acquired Fund Total Annual Expenses, Note [Text Block]" } } }, "localname": "AcquiredFundTotalAnnualExpensesNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_AllRisksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "All Risks:" } } }, "localname": "AllRisksMember", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "cef_AnnualCoverageReturnRatePercent": { "auth_ref": [ "r765" ], "lang": { "en-us": { "role": { "label": "Annual Coverage Return Rate [Percent]" } } }, "localname": "AnnualCoverageReturnRatePercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_AnnualDividendPayment": { "auth_ref": [ "r764" ], "lang": { "en-us": { "role": { "label": "Annual Dividend Payment" } } }, "localname": "AnnualDividendPayment", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_AnnualDividendPaymentCurrent": { "auth_ref": [ "r764" ], "lang": { "en-us": { "role": { "label": "Annual Dividend Payment, Current" } } }, "localname": "AnnualDividendPaymentCurrent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_AnnualDividendPaymentInitial": { "auth_ref": [ "r764" ], "lang": { "en-us": { "role": { "label": "Annual Dividend Payment, Initial" } } }, "localname": "AnnualDividendPaymentInitial", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_AnnualExpensesTableTextBlock": { "auth_ref": [ "r743" ], "lang": { "en-us": { "role": { "label": "Annual Expenses [Table Text Block]" } } }, "localname": "AnnualExpensesTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_AnnualInterestRateCurrentPercent": { "auth_ref": [ "r764" ], "lang": { "en-us": { "role": { "label": "Annual Interest Rate, Current [Percent]" } } }, "localname": "AnnualInterestRateCurrentPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_AnnualInterestRateInitialPercent": { "auth_ref": [ "r764" ], "lang": { "en-us": { "role": { "label": "Annual Interest Rate, Initial [Percent]" } } }, "localname": "AnnualInterestRateInitialPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_AnnualInterestRatePercent": { "auth_ref": [ "r764" ], "lang": { "en-us": { "role": { "label": "Annual Interest Rate [Percent]" } } }, "localname": "AnnualInterestRatePercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_BasisOfTransactionFeesNoteTextBlock": { "auth_ref": [ "r741" ], "lang": { "en-us": { "role": { "label": "Basis of Transaction Fees, Note [Text Block]" } } }, "localname": "BasisOfTransactionFeesNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_BdcFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BDC File Number" } } }, "localname": "BdcFileNumber", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "fileNumberItemType" }, "cef_BusinessDevelopmentCompanyFlag": { "auth_ref": [ "r708" ], "lang": { "en-us": { "role": { "label": "Business Development Company [Flag]" } } }, "localname": "BusinessDevelopmentCompanyFlag", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract": { "auth_ref": [ "r709" ], "lang": { "en-us": { "role": { "label": "Capital Stock, Long-Term Debt, and Other Securities [Abstract]" } } }, "localname": "CapitalStockLongTermDebtAndOtherSecuritiesAbstract", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_CapitalStockTableTextBlock": { "auth_ref": [ "r710" ], "lang": { "en-us": { "role": { "label": "Capital Stock [Table Text Block]" } } }, "localname": "CapitalStockTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_DistributionServicingFeesPercent": { "auth_ref": [ "r747" ], "lang": { "en-us": { "role": { "label": "Distribution/Servicing Fees [Percent]" } } }, "localname": "DistributionServicingFeesPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_DistributionsMayReducePrincipalTextBlock": { "auth_ref": [ "r717" ], "lang": { "en-us": { "role": { "label": "Distributions May Reduce Principal [Text Block]" } } }, "localname": "DistributionsMayReducePrincipalTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_DividendAndInterestExpensesOnShortSalesPercent": { "auth_ref": [ "r747" ], "lang": { "en-us": { "role": { "label": "Dividend and Interest Expenses on Short Sales [Percent]" } } }, "localname": "DividendAndInterestExpensesOnShortSalesPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_DividendExpenseOnPreferredSharesPercent": { "auth_ref": [ "r747" ], "lang": { "en-us": { "role": { "label": "Dividend Expenses on Preferred Shares [Percent]" } } }, "localname": "DividendExpenseOnPreferredSharesPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_DividendReinvestmentAndCashPurchaseFees": { "auth_ref": [ "r733" ], "lang": { "en-us": { "role": { "label": "Dividend Reinvestment and Cash Purchase Fees" } } }, "localname": "DividendReinvestmentAndCashPurchaseFees", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_EffectsOfLeveragePurposeTextBlock": { "auth_ref": [ "r766" ], "lang": { "en-us": { "role": { "label": "Effects of Leverage, Purpose [Text Block]" } } }, "localname": "EffectsOfLeveragePurposeTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_EffectsOfLeverageTableTextBlock": { "auth_ref": [ "r766" ], "lang": { "en-us": { "role": { "label": "Effects of Leverage [Table Text Block]" } } }, "localname": "EffectsOfLeverageTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_EffectsOfLeverageTextBlock": { "auth_ref": [ "r763" ], "lang": { "en-us": { "role": { "label": "Effects of Leverage [Text Block]" } } }, "localname": "EffectsOfLeverageTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_ExpenseExampleTableTextBlock": { "auth_ref": [ "r733" ], "lang": { "en-us": { "role": { "label": "Expense Example [Table Text Block]" } } }, "localname": "ExpenseExampleTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_ExpenseExampleYear01": { "auth_ref": [ "r740" ], "lang": { "en-us": { "role": { "label": "Expense Example, Year 01" } } }, "localname": "ExpenseExampleYear01", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_ExpenseExampleYears1to10": { "auth_ref": [ "r740" ], "lang": { "en-us": { "role": { "label": "Expense Example, Years 1 to 10" } } }, "localname": "ExpenseExampleYears1to10", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_ExpenseExampleYears1to3": { "auth_ref": [ "r740" ], "lang": { "en-us": { "role": { "label": "Expense Example, Years 1 to 3" } } }, "localname": "ExpenseExampleYears1to3", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_ExpenseExampleYears1to5": { "auth_ref": [ "r740" ], "lang": { "en-us": { "role": { "label": "Expense Example, Years 1 to 5" } } }, "localname": "ExpenseExampleYears1to5", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_FeeTableAbstract": { "auth_ref": [ "r733" ], "lang": { "en-us": { "role": { "label": "Fee Table [Abstract]" } } }, "localname": "FeeTableAbstract", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_FinancialHighlightsAbstract": { "auth_ref": [ "r748" ], "lang": { "en-us": { "role": { "label": "Financial Highlights [Abstract]" } } }, "localname": "FinancialHighlightsAbstract", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_GeneralDescriptionOfRegistrantAbstract": { "auth_ref": [ "r760" ], "lang": { "en-us": { "role": { "label": "General Description of Registrant [Abstract]" } } }, "localname": "GeneralDescriptionOfRegistrantAbstract", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_HighestPriceOrBid": { "auth_ref": [ "r767" ], "lang": { "en-us": { "role": { "label": "Highest Price or Bid" } } }, "localname": "HighestPriceOrBid", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_HighestPriceOrBidNav": { "auth_ref": [ "r771" ], "lang": { "en-us": { "role": { "label": "Highest Price or Bid, NAV" } } }, "localname": "HighestPriceOrBidNav", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_HighestPriceOrBidPremiumDiscountToNavPercent": { "auth_ref": [ "r772" ], "lang": { "en-us": { "role": { "label": "Highest Price or Bid, Premium (Discount) to NAV [Percent]" } } }, "localname": "HighestPriceOrBidPremiumDiscountToNavPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_IncentiveAllocationMaximumPercent": { "auth_ref": [ "r738" ], "lang": { "en-us": { "role": { "label": "Incentive Allocation Maximum [Percent]" } } }, "localname": "IncentiveAllocationMaximumPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_IncentiveAllocationMinimumPercent": { "auth_ref": [ "r738" ], "lang": { "en-us": { "role": { "label": "Incentive Allocation Minimum [Percent]" } } }, "localname": "IncentiveAllocationMinimumPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_IncentiveAllocationPercent": { "auth_ref": [ "r738" ], "lang": { "en-us": { "role": { "label": "Incentive Allocation [Percent]" } } }, "localname": "IncentiveAllocationPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_IncentiveFeesPercent": { "auth_ref": [ "r747" ], "lang": { "en-us": { "role": { "label": "Incentive Fees [Percent]" } } }, "localname": "IncentiveFeesPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_InterestExpensesOnBorrowingsPercent": { "auth_ref": [ "r746" ], "lang": { "en-us": { "role": { "label": "Interest Expenses on Borrowings [Percent]" } } }, "localname": "InterestExpensesOnBorrowingsPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_IntervalFundFlag": { "auth_ref": [ "r708" ], "lang": { "en-us": { "role": { "label": "Interval Fund [Flag]" } } }, "localname": "IntervalFundFlag", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "cef_InvestmentObjectivesAndPracticesTextBlock": { "auth_ref": [ "r761" ], "lang": { "en-us": { "role": { "label": "Investment Objectives and Practices [Text Block]" } } }, "localname": "InvestmentObjectivesAndPracticesTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_LatestNav": { "auth_ref": [ "r773" ], "lang": { "en-us": { "role": { "label": "Latest NAV (Deprecated 2023-01-31)" } } }, "localname": "LatestNav", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_LatestPremiumDiscountToNavPercent": { "auth_ref": [ "r773" ], "lang": { "en-us": { "role": { "label": "Latest Premium (Discount) to NAV [Percent]" } } }, "localname": "LatestPremiumDiscountToNavPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_LatestSharePrice": { "auth_ref": [ "r773" ], "lang": { "en-us": { "role": { "label": "Latest Share Price (Deprecated 2023-01-31)" } } }, "localname": "LatestSharePrice", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_LoanServicingFeesPercent": { "auth_ref": [ "r747" ], "lang": { "en-us": { "role": { "label": "Loan Servicing Fees [Percent]" } } }, "localname": "LoanServicingFeesPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_LongTermDebtDividendsAndCovenantsTextBlock": { "auth_ref": [ "r724" ], "lang": { "en-us": { "role": { "label": "Long Term Debt, Dividends and Covenants [Text Block]" } } }, "localname": "LongTermDebtDividendsAndCovenantsTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_LongTermDebtIssuanceAndSubstitutionTextBlock": { "auth_ref": [ "r725" ], "lang": { "en-us": { "role": { "label": "Long Term Debt, Issuance and Substitution [Text Block]" } } }, "localname": "LongTermDebtIssuanceAndSubstitutionTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_LongTermDebtPrincipal": { "auth_ref": [ "r722" ], "lang": { "en-us": { "role": { "label": "Long Term Debt, Principal" } } }, "localname": "LongTermDebtPrincipal", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_LongTermDebtRightsLimitedByOtherSecuritiesTextBlock": { "auth_ref": [ "r726" ], "lang": { "en-us": { "role": { "label": "Long Term Debt, Rights Limited by Other Securities [Text Block]" } } }, "localname": "LongTermDebtRightsLimitedByOtherSecuritiesTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_LongTermDebtStructuringTextBlock": { "auth_ref": [ "r723" ], "lang": { "en-us": { "role": { "label": "Long Term Debt, Structuring [Text Block]" } } }, "localname": "LongTermDebtStructuringTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_LongTermDebtTableTextBlock": { "auth_ref": [ "r722" ], "lang": { "en-us": { "role": { "label": "Long Term Debt [Table Text Block]" } } }, "localname": "LongTermDebtTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_LongTermDebtTitleTextBlock": { "auth_ref": [ "r722" ], "lang": { "en-us": { "role": { "label": "Long Term Debt, Title [Text Block]" } } }, "localname": "LongTermDebtTitleTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_LowestPriceOrBid": { "auth_ref": [ "r767" ], "lang": { "en-us": { "role": { "label": "Lowest Price or Bid" } } }, "localname": "LowestPriceOrBid", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_LowestPriceOrBidNav": { "auth_ref": [ "r771" ], "lang": { "en-us": { "role": { "label": "Lowest Price or Bid, NAV" } } }, "localname": "LowestPriceOrBidNav", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_LowestPriceOrBidPremiumDiscountToNavPercent": { "auth_ref": [ "r772" ], "lang": { "en-us": { "role": { "label": "Lowest Price or Bid, Premium (Discount) to NAV [Percent]" } } }, "localname": "LowestPriceOrBidPremiumDiscountToNavPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock": { "auth_ref": [ "r745" ], "lang": { "en-us": { "role": { "label": "Management Fee not based on Net Assets, Note [Text Block]" } } }, "localname": "ManagementFeeNotBasedOnNetAssetsNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_ManagementFeesPercent": { "auth_ref": [ "r744" ], "lang": { "en-us": { "role": { "label": "Management Fees [Percent]" } } }, "localname": "ManagementFeesPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_NetExpenseOverAssetsPercent": { "auth_ref": [ "r747" ], "lang": { "en-us": { "role": { "label": "Net Expense over Assets [Percent]" } } }, "localname": "NetExpenseOverAssetsPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_NewCefOrBdcRegistrantFlag": { "auth_ref": [ "r708" ], "lang": { "en-us": { "role": { "label": "New CEF or BDC Registrant [Flag]" } } }, "localname": "NewCefOrBdcRegistrantFlag", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "cef_NoPublicTradingTextBlock": { "auth_ref": [ "r770" ], "lang": { "en-us": { "role": { "label": "No Public Trading [Text Block]" } } }, "localname": "NoPublicTradingTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_NoTradingHistoryTextBlock": { "auth_ref": [ "r774" ], "lang": { "en-us": { "role": { "label": "No Trading History [Text Block]" } } }, "localname": "NoTradingHistoryTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OtherAnnualExpense1Percent": { "auth_ref": [ "r747" ], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Ae": { "order": 1.0, "parentTag": "cef_OtherAnnualExpensesPercent", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Other Annual Expense 1 [Percent]" } } }, "localname": "OtherAnnualExpense1Percent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherAnnualExpense2Percent": { "auth_ref": [ "r747" ], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Ae": { "order": 2.0, "parentTag": "cef_OtherAnnualExpensesPercent", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Other Annual Expense 2 [Percent]" } } }, "localname": "OtherAnnualExpense2Percent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherAnnualExpense3Percent": { "auth_ref": [ "r747" ], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Ae": { "order": 3.0, "parentTag": "cef_OtherAnnualExpensesPercent", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Other Annual Expense 3 [Percent]" } } }, "localname": "OtherAnnualExpense3Percent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherAnnualExpensesAbstract": { "auth_ref": [ "r747" ], "lang": { "en-us": { "role": { "label": "Other Annual Expenses [Abstract]" } } }, "localname": "OtherAnnualExpensesAbstract", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_OtherAnnualExpensesPercent": { "auth_ref": [ "r747" ], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Ae": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "label": "Other Annual Expenses [Percent]" } } }, "localname": "OtherAnnualExpensesPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherExpensesNoteTextBlock": { "auth_ref": [ "r743" ], "lang": { "en-us": { "role": { "label": "Other Expenses, Note [Text Block]" } } }, "localname": "OtherExpensesNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OtherFeederFundExpensesPercent": { "auth_ref": [ "r747" ], "lang": { "en-us": { "role": { "label": "Other Feeder Fund Expenses [Percent]" } } }, "localname": "OtherFeederFundExpensesPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherMasterFundExpensesPercent": { "auth_ref": [ "r747" ], "lang": { "en-us": { "role": { "label": "Other Master Fund Expenses [Percent]" } } }, "localname": "OtherMasterFundExpensesPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherSecuritiesTableTextBlock": { "auth_ref": [ "r727" ], "lang": { "en-us": { "role": { "label": "Other Securities [Table Text Block]" } } }, "localname": "OtherSecuritiesTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OtherSecurityDescriptionTextBlock": { "auth_ref": [ "r727" ], "lang": { "en-us": { "role": { "label": "Other Security, Description [Text Block]" } } }, "localname": "OtherSecurityDescriptionTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OtherSecurityTitleTextBlock": { "auth_ref": [ "r727" ], "lang": { "en-us": { "role": { "label": "Other Security, Title [Text Block]" } } }, "localname": "OtherSecurityTitleTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OtherTransactionExpense1Percent": { "auth_ref": [ "r742" ], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Te": { "order": 1.0, "parentTag": "cef_OtherTransactionExpensesPercent", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Other Transaction Expense 1 [Percent]" } } }, "localname": "OtherTransactionExpense1Percent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherTransactionExpense2Percent": { "auth_ref": [ "r742" ], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Te": { "order": 2.0, "parentTag": "cef_OtherTransactionExpensesPercent", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Other Transaction Expense 2 [Percent]" } } }, "localname": "OtherTransactionExpense2Percent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherTransactionExpense3Percent": { "auth_ref": [ "r742" ], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Te": { "order": 3.0, "parentTag": "cef_OtherTransactionExpensesPercent", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Other Transaction Expense 3 [Percent]" } } }, "localname": "OtherTransactionExpense3Percent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherTransactionExpensesAbstract": { "auth_ref": [ "r742" ], "lang": { "en-us": { "role": { "label": "Other Transaction Expenses [Abstract]" } } }, "localname": "OtherTransactionExpensesAbstract", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_OtherTransactionExpensesPercent": { "auth_ref": [ "r742" ], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Te": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "label": "Other Transaction Expenses [Percent]" } } }, "localname": "OtherTransactionExpensesPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherTransactionFeesBasisMaximum": { "auth_ref": [ "r742" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fees Basis, Maximum" } } }, "localname": "OtherTransactionFeesBasisMaximum", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_OtherTransactionFeesBasisMaximumPercent": { "auth_ref": [ "r742" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fees Basis, Maximum [Percent]" } } }, "localname": "OtherTransactionFeesBasisMaximumPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherTransactionFeesBasisNoteTextBlock": { "auth_ref": [ "r742" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fees Basis, Note [Text Block]" } } }, "localname": "OtherTransactionFeesBasisNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OtherTransactionFeesNoteTextBlock": { "auth_ref": [ "r742" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fees, Note [Text Block]" } } }, "localname": "OtherTransactionFeesNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OutstandingSecuritiesTableTextBlock": { "auth_ref": [ "r728" ], "lang": { "en-us": { "role": { "label": "Outstanding Securities [Table Text Block]" } } }, "localname": "OutstandingSecuritiesTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OutstandingSecurityAuthorizedShares": { "auth_ref": [ "r730" ], "lang": { "en-us": { "role": { "label": "Outstanding Security, Authorized [Shares]" } } }, "localname": "OutstandingSecurityAuthorizedShares", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "sharesItemType" }, "cef_OutstandingSecurityHeldShares": { "auth_ref": [ "r731" ], "lang": { "en-us": { "role": { "label": "Outstanding Security, Held [Shares]" } } }, "localname": "OutstandingSecurityHeldShares", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "sharesItemType" }, "cef_OutstandingSecurityNotHeldShares": { "auth_ref": [ "r732" ], "lang": { "en-us": { "role": { "label": "Outstanding Security, Not Held [Shares]" } } }, "localname": "OutstandingSecurityNotHeldShares", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "sharesItemType" }, "cef_OutstandingSecurityTitleTextBlock": { "auth_ref": [ "r729" ], "lang": { "en-us": { "role": { "label": "Outstanding Security, Title [Text Block]" } } }, "localname": "OutstandingSecurityTitleTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_PreferredStockRestrictionsArrearageTextBlock": { "auth_ref": [ "r718" ], "lang": { "en-us": { "role": { "label": "Preferred Stock Restrictions, Arrearage [Text Block]" } } }, "localname": "PreferredStockRestrictionsArrearageTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_PreferredStockRestrictionsOtherTextBlock": { "auth_ref": [ "r719" ], "lang": { "en-us": { "role": { "label": "Preferred Stock Restrictions, Other [Text Block]" } } }, "localname": "PreferredStockRestrictionsOtherTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_PrimaryShelfFlag": { "auth_ref": [ "r708" ], "lang": { "en-us": { "role": { "label": "Primary Shelf [Flag]" } } }, "localname": "PrimaryShelfFlag", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "cef_PrimaryShelfQualifiedFlag": { "auth_ref": [ "r708" ], "lang": { "en-us": { "role": { "label": "Primary Shelf Qualified [Flag]" } } }, "localname": "PrimaryShelfQualifiedFlag", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "cef_ProspectusLineItems": { "auth_ref": [ "r708" ], "lang": { "en-us": { "role": { "label": "Prospectus [Line Items]" } } }, "localname": "ProspectusLineItems", "nsuri": "http://xbrl.sec.gov/cef/2023", "xbrltype": "stringItemType" }, "cef_ProspectusTable": { "auth_ref": [ "r708" ], "lang": { "en-us": { "role": { "label": "Prospectus:" } } }, "localname": "ProspectusTable", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_PurposeOfFeeTableNoteTextBlock": { "auth_ref": [ "r734" ], "lang": { "en-us": { "role": { "label": "Purpose of Fee Table , Note [Text Block]" } } }, "localname": "PurposeOfFeeTableNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_RegisteredClosedEndFundFlag": { "auth_ref": [ "r708" ], "lang": { "en-us": { "role": { "label": "Registered Closed-End Fund [Flag]" } } }, "localname": "RegisteredClosedEndFundFlag", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "cef_ReturnAtMinusFivePercent": { "auth_ref": [ "r766" ], "lang": { "en-us": { "role": { "label": "Return at Minus Five [Percent]" } } }, "localname": "ReturnAtMinusFivePercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_ReturnAtMinusTenPercent": { "auth_ref": [ "r766" ], "lang": { "en-us": { "role": { "label": "Return at Minus Ten [Percent]" } } }, "localname": "ReturnAtMinusTenPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_ReturnAtPlusFivePercent": { "auth_ref": [ "r766" ], "lang": { "en-us": { "role": { "label": "Return at Plus Five [Percent]" } } }, "localname": "ReturnAtPlusFivePercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_ReturnAtPlusTenPercent": { "auth_ref": [ "r766" ], "lang": { "en-us": { "role": { "label": "Return at Plus Ten [Percent]" } } }, "localname": "ReturnAtPlusTenPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_ReturnAtZeroPercent": { "auth_ref": [ "r766" ], "lang": { "en-us": { "role": { "label": "Return at Zero [Percent]" } } }, "localname": "ReturnAtZeroPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_RightsLimitedByOtherSecuritiesTextBlock": { "auth_ref": [ "r721" ], "lang": { "en-us": { "role": { "label": "Rights Limited by Other Securities [Text Block]" } } }, "localname": "RightsLimitedByOtherSecuritiesTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_RightsSubjectToOtherThanMajorityVoteTextBlock": { "auth_ref": [ "r720" ], "lang": { "en-us": { "role": { "label": "Rights Subject to Other than Majority Vote [Text Block]" } } }, "localname": "RightsSubjectToOtherThanMajorityVoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_RiskAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risk [Axis]" } } }, "localname": "RiskAxis", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_RiskFactorsTableTextBlock": { "auth_ref": [ "r762" ], "lang": { "en-us": { "role": { "label": "Risk Factors [Table Text Block]" } } }, "localname": "RiskFactorsTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_RiskTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risk [Text Block]" } } }, "localname": "RiskTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SalesLoadPercent": { "auth_ref": [ "r733" ], "lang": { "en-us": { "role": { "label": "Sales Load [Percent]" } } }, "localname": "SalesLoadPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_SecurityDividendsTextBlock": { "auth_ref": [ "r711" ], "lang": { "en-us": { "role": { "label": "Security Dividends [Text Block]" } } }, "localname": "SecurityDividendsTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SecurityLiabilitiesTextBlock": { "auth_ref": [ "r714" ], "lang": { "en-us": { "role": { "label": "Security Liabilities [Text Block]" } } }, "localname": "SecurityLiabilitiesTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SecurityLiquidationRightsTextBlock": { "auth_ref": [ "r713" ], "lang": { "en-us": { "role": { "label": "Security Liquidation Rights [Text Block]" } } }, "localname": "SecurityLiquidationRightsTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SecurityObligationsOfOwnershipTextBlock": { "auth_ref": [ "r716" ], "lang": { "en-us": { "role": { "label": "Security Obligations of Ownership [Text Block]" } } }, "localname": "SecurityObligationsOfOwnershipTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SecurityPreemptiveAndOtherRightsTextBlock": { "auth_ref": [ "r715" ], "lang": { "en-us": { "role": { "label": "Security Preemptive and Other Rights [Text Block]" } } }, "localname": "SecurityPreemptiveAndOtherRightsTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SecurityTitleTextBlock": { "auth_ref": [ "r710" ], "lang": { "en-us": { "role": { "label": "Security Title [Text Block]" } } }, "localname": "SecurityTitleTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SecurityVotingRightsTextBlock": { "auth_ref": [ "r712" ], "lang": { "en-us": { "role": { "label": "Security Voting Rights [Text Block]" } } }, "localname": "SecurityVotingRightsTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SeniorSecuritiesAmount": { "auth_ref": [ "r753" ], "lang": { "en-us": { "role": { "label": "Senior Securities Amount (Deprecated 2023-01-31)" } } }, "localname": "SeniorSecuritiesAmount", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_SeniorSecuritiesAmt": { "auth_ref": [ "r753" ], "lang": { "en-us": { "role": { "label": "Senior Securities Amount" } } }, "localname": "SeniorSecuritiesAmt", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_SeniorSecuritiesAverageMarketValuePerUnit": { "auth_ref": [ "r756" ], "lang": { "en-us": { "role": { "label": "Senior Securities Average Market Value per Unit" } } }, "localname": "SeniorSecuritiesAverageMarketValuePerUnit", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_SeniorSecuritiesAveragingMethodNoteTextBlock": { "auth_ref": [ "r758" ], "lang": { "en-us": { "role": { "label": "Senior Securities Averaging Method, Note [Text Block]" } } }, "localname": "SeniorSecuritiesAveragingMethodNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SeniorSecuritiesCoveragePerUnit": { "auth_ref": [ "r754" ], "lang": { "en-us": { "role": { "label": "Senior Securities Coverage per Unit (Deprecated 2023-01-31)" } } }, "localname": "SeniorSecuritiesCoveragePerUnit", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_SeniorSecuritiesCvgPerUnit": { "auth_ref": [ "r754" ], "lang": { "en-us": { "role": { "label": "Senior Securities Coverage per Unit" } } }, "localname": "SeniorSecuritiesCvgPerUnit", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_SeniorSecuritiesHeadingsNoteTextBlock": { "auth_ref": [ "r759" ], "lang": { "en-us": { "role": { "label": "Senior Securities Headings, Note [Text Block]" } } }, "localname": "SeniorSecuritiesHeadingsNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SeniorSecuritiesHighlightsAnnualizedNoteTextBlock": { "auth_ref": [ "r750", "r757" ], "lang": { "en-us": { "role": { "label": "Senior Securities Highlights Annualized, Note [Text Block]" } } }, "localname": "SeniorSecuritiesHighlightsAnnualizedNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SeniorSecuritiesHighlightsAuditedNoteTextBlock": { "auth_ref": [ "r751", "r757" ], "lang": { "en-us": { "role": { "label": "Senior Securities Highlights Audited, Note [Text Block]" } } }, "localname": "SeniorSecuritiesHighlightsAuditedNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit": { "auth_ref": [ "r755" ], "lang": { "en-us": { "role": { "label": "Senior Securities Involuntary Liquidating Preference per Unit (Deprecated 2023-01-31)" } } }, "localname": "SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_SeniorSecuritiesNoteTextBlock": { "auth_ref": [ "r749", "r757" ], "lang": { "en-us": { "role": { "label": "Senior Securities, Note [Text Block]" } } }, "localname": "SeniorSecuritiesNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SeniorSecuritiesTableTextBlock": { "auth_ref": [ "r752" ], "lang": { "en-us": { "role": { "label": "Senior Securities [Table Text Block]" } } }, "localname": "SeniorSecuritiesTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SharePriceTableTextBlock": { "auth_ref": [ "r768" ], "lang": { "en-us": { "role": { "label": "Share Price [Table Text Block]" } } }, "localname": "SharePriceTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SharePricesNotActualTransactionsTextBlock": { "auth_ref": [ "r769" ], "lang": { "en-us": { "role": { "label": "Share Prices Not Actual Transactions [Text Block]" } } }, "localname": "SharePricesNotActualTransactionsTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_ShareholderTransactionExpensesTableTextBlock": { "auth_ref": [ "r733" ], "lang": { "en-us": { "role": { "label": "Shareholder Transaction Expenses [Table Text Block]" } } }, "localname": "ShareholderTransactionExpensesTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_TotalAnnualExpensesPercent": { "auth_ref": [ "r746" ], "lang": { "en-us": { "role": { "label": "Total Annual Expenses [Percent]" } } }, "localname": "TotalAnnualExpensesPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_UnderwritersCompensationPercent": { "auth_ref": [ "r742" ], "lang": { "en-us": { "role": { "label": "Underwriters Compensation [Percent]" } } }, "localname": "UnderwritersCompensationPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_WaiversAndReimbursementsOfFeesPercent": { "auth_ref": [ "r747" ], "lang": { "en-us": { "role": { "label": "Waivers and Reimbursements of Fees [Percent]" } } }, "localname": "WaiversAndReimbursementsOfFeesPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_WarrantsOrRightsCalledAmount": { "auth_ref": [ "r727" ], "lang": { "en-us": { "role": { "label": "Warrants or Rights, Called Amount" } } }, "localname": "WarrantsOrRightsCalledAmount", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_WarrantsOrRightsCalledPeriodDate": { "auth_ref": [ "r727" ], "lang": { "en-us": { "role": { "label": "Warrants or Rights, Called Period [Date]" } } }, "localname": "WarrantsOrRightsCalledPeriodDate", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "dateItemType" }, "cef_WarrantsOrRightsCalledTitleTextBlock": { "auth_ref": [ "r727" ], "lang": { "en-us": { "role": { "label": "Warrants or Rights, Called Title" } } }, "localname": "WarrantsOrRightsCalledTitleTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_WarrantsOrRightsExercisePrice": { "auth_ref": [ "r727" ], "lang": { "en-us": { "role": { "label": "Warrants or Rights, Exercise Price" } } }, "localname": "WarrantsOrRightsExercisePrice", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "dei_AdditionalSecurities462b": { "auth_ref": [ "r833" ], "lang": { "en-us": { "role": { "label": "Additional Securities. 462(b)" } } }, "localname": "AdditionalSecurities462b", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_AdditionalSecurities462bFileNumber": { "auth_ref": [ "r833" ], "lang": { "en-us": { "role": { "label": "Additional Securities, 462(b), File Number" } } }, "localname": "AdditionalSecurities462bFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "fileNumberItemType" }, "dei_AdditionalSecuritiesEffective413b": { "auth_ref": [ "r832" ], "lang": { "en-us": { "role": { "label": "Additional Securities Effective, 413(b)" } } }, "localname": "AdditionalSecuritiesEffective413b", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_AddressTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.", "label": "Address Type [Domain]" } } }, "localname": "AddressTypeDomain", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings.", "label": "Approximate Date of Commencement of Proposed Sale to Public" } } }, "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "dateOrAsapItemType" }, "dei_BusinessContactMember": { "auth_ref": [ "r683", "r696" ], "lang": { "en-us": { "role": { "documentation": "Business contact for the entity", "label": "Business Contact [Member]" } } }, "localname": "BusinessContactMember", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_ContactPersonnelName": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of contact personnel", "label": "Contact Personnel Name" } } }, "localname": "ContactPersonnelName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DelayedOrContinuousOffering": { "auth_ref": [ "r707", "r708", "r788" ], "lang": { "en-us": { "role": { "label": "Delayed or Continuous Offering" } } }, "localname": "DelayedOrContinuousOffering", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_DividendOrInterestReinvestmentPlanOnly": { "auth_ref": [ "r707", "r708", "r788" ], "lang": { "en-us": { "role": { "label": "Dividend or Interest Reinvestment Plan Only" } } }, "localname": "DividendOrInterestReinvestmentPlanOnly", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r682" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r678" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r789" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "submissionTypeItemType" }, "dei_EffectiveAfter60Days486a": { "auth_ref": [ "r837" ], "lang": { "en-us": { "role": { "label": "Effective after 60 Days, 486(a)" } } }, "localname": "EffectiveAfter60Days486a", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EffectiveOnDate486a": { "auth_ref": [ "r837" ], "lang": { "en-us": { "role": { "label": "Effective on Date, 486(a)" } } }, "localname": "EffectiveOnDate486a", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "dateItemType" }, "dei_EffectiveOnDate486b": { "auth_ref": [ "r838" ], "lang": { "en-us": { "role": { "label": "Effective on Date, 486(b)" } } }, "localname": "EffectiveOnDate486b", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "dateItemType" }, "dei_EffectiveOnSetDate486a": { "auth_ref": [ "r837" ], "lang": { "en-us": { "role": { "label": "Effective on Set Date, 486(a)" } } }, "localname": "EffectiveOnSetDate486a", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EffectiveOnSetDate486b": { "auth_ref": [ "r838" ], "lang": { "en-us": { "role": { "label": "Effective on Set Date, 486(b)" } } }, "localname": "EffectiveOnSetDate486b", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EffectiveUponFiling462e": { "auth_ref": [ "r836" ], "lang": { "en-us": { "role": { "label": "Effective Upon Filing, 462(e)" } } }, "localname": "EffectiveUponFiling462e", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EffectiveUponFiling486b": { "auth_ref": [ "r838" ], "lang": { "en-us": { "role": { "label": "Effective upon Filing, 486(b)" } } }, "localname": "EffectiveUponFiling486b", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EffectiveWhenDeclaredSection8c": { "auth_ref": [ "r840" ], "lang": { "en-us": { "role": { "label": "Effective when Declared, Section 8(c)" } } }, "localname": "EffectiveWhenDeclaredSection8c", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityAddressesAddressTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.", "label": "Entity Addresses, Address Type [Axis]" } } }, "localname": "EntityAddressesAddressTypeAxis", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r680" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpParentheticalDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r680" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r839" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Securities Act File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r680" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r830" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityInvCompanyType": { "auth_ref": [ "r829" ], "lang": { "en-us": { "role": { "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product).", "label": "Entity Inv Company Type" } } }, "localname": "EntityInvCompanyType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "invCompanyType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r680" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r680" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r680" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r680" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r831" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "yesNoItemType" }, "dei_ExhibitsOnly462d": { "auth_ref": [ "r835" ], "lang": { "en-us": { "role": { "label": "Exhibits Only, 462(d)" } } }, "localname": "ExhibitsOnly462d", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_ExhibitsOnly462dFileNumber": { "auth_ref": [ "r835" ], "lang": { "en-us": { "role": { "label": "Exhibits Only, 462(d), File Number" } } }, "localname": "ExhibitsOnly462dFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "fileNumberItemType" }, "dei_InvestmentCompanyActFileNumber": { "auth_ref": [ "r708", "r775", "r776", "r777" ], "lang": { "en-us": { "role": { "label": "Investment Company Act File Number" } } }, "localname": "InvestmentCompanyActFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "fileNumberItemType" }, "dei_InvestmentCompanyActRegistration": { "auth_ref": [ "r790" ], "lang": { "en-us": { "role": { "label": "Investment Company Act Registration" } } }, "localname": "InvestmentCompanyActRegistration", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_InvestmentCompanyRegistrationAmendment": { "auth_ref": [ "r790" ], "lang": { "en-us": { "role": { "label": "Investment Company Registration Amendment" } } }, "localname": "InvestmentCompanyRegistrationAmendment", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_InvestmentCompanyRegistrationAmendmentNumber": { "auth_ref": [ "r790" ], "lang": { "en-us": { "role": { "label": "Investment Company Registration Amendment Number" } } }, "localname": "InvestmentCompanyRegistrationAmendmentNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "sequenceNumberItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpParentheticalDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_NewEffectiveDateForPreviousFiling": { "auth_ref": [ "r708", "r775", "r776", "r777" ], "lang": { "en-us": { "role": { "label": "New Effective Date for Previous Filing" } } }, "localname": "NewEffectiveDateForPreviousFiling", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_NoSubstantiveChanges462c": { "auth_ref": [ "r834" ], "lang": { "en-us": { "role": { "label": "No Substantive Changes, 462(c)" } } }, "localname": "NoSubstantiveChanges462c", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_NoSubstantiveChanges462cFileNumber": { "auth_ref": [ "r834" ], "lang": { "en-us": { "role": { "label": "No Substantive Changes, 462(c), File Number" } } }, "localname": "NoSubstantiveChanges462cFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "fileNumberItemType" }, "dei_PostEffectiveAmendment": { "auth_ref": [ "r678" ], "lang": { "en-us": { "role": { "label": "Post-Effective Amendment" } } }, "localname": "PostEffectiveAmendment", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_PostEffectiveAmendmentNumber": { "auth_ref": [ "r678" ], "lang": { "en-us": { "role": { "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective.", "label": "Post-Effective Amendment Number" } } }, "localname": "PostEffectiveAmendmentNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "sequenceNumberItemType" }, "dei_PreEffectiveAmendment": { "auth_ref": [ "r678" ], "lang": { "en-us": { "role": { "label": "Pre-Effective Amendment" } } }, "localname": "PreEffectiveAmendment", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_PreEffectiveAmendmentNumber": { "auth_ref": [ "r678" ], "lang": { "en-us": { "role": { "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective.", "label": "Pre-Effective Amendment Number" } } }, "localname": "PreEffectiveAmendmentNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "sequenceNumberItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r679" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r681" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "ecd_Additional402vDisclosureTextBlock": { "auth_ref": [ "r791" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]", "terseLabel": "Additional 402(v) Disclosure" } } }, "localname": "Additional402vDisclosureTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AdjToCompAmt": { "auth_ref": [ "r797" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount", "terseLabel": "Adjustment to Compensation, Amount" } } }, "localname": "AdjToCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_AdjToCompAxis": { "auth_ref": [ "r797" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]", "terseLabel": "Adjustment to Compensation:" } } }, "localname": "AdjToCompAxis", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "stringItemType" }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "auth_ref": [ "r797" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]", "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "localname": "AdjToNonPeoNeoCompFnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AdjToPeoCompFnTextBlock": { "auth_ref": [ "r797" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]", "terseLabel": "Adjustment To PEO Compensation, Footnote" } } }, "localname": "AdjToPeoCompFnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AggtErrCompAmt": { "auth_ref": [ "r688", "r700", "r781", "r808" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount", "terseLabel": "Aggregate Erroneous Compensation Amount" } } }, "localname": "AggtErrCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "auth_ref": [ "r691", "r703", "r784", "r811" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]", "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "localname": "AggtErrCompNotYetDeterminedTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AllAdjToCompMember": { "auth_ref": [ "r797" ], "lang": { "en-us": { "role": { "label": "All Adjustments to Compensation [Member]", "terseLabel": "All Adjustments to Compensation" } } }, "localname": "AllAdjToCompMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "domainItemType" }, "ecd_AllExecutiveCategoriesMember": { "auth_ref": [ "r804" ], "lang": { "en-us": { "role": { "label": "All Executive Categories [Member]", "terseLabel": "All Executive Categories" } } }, "localname": "AllExecutiveCategoriesMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "domainItemType" }, "ecd_AllIndividualsMember": { "auth_ref": [ "r695", "r704", "r785", "r804", "r812", "r816", "r824" ], "lang": { "en-us": { "role": { "label": "All Individuals [Member]", "terseLabel": "All Individuals" } } }, "localname": "AllIndividualsMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "domainItemType" }, "ecd_AllTradingArrangementsMember": { "auth_ref": [ "r822" ], "lang": { "en-us": { "role": { "label": "All Trading Arrangements [Member]", "terseLabel": "All Trading Arrangements" } } }, "localname": "AllTradingArrangementsMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "domainItemType" }, "ecd_AwardExrcPrice": { "auth_ref": [ "r819" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price", "terseLabel": "Exercise Price" } } }, "localname": "AwardExrcPrice", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "perShareItemType" }, "ecd_AwardGrantDateFairValue": { "auth_ref": [ "r820" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value", "terseLabel": "Fair Value as of Grant Date" } } }, "localname": "AwardGrantDateFairValue", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_AwardTmgDiscLineItems": { "auth_ref": [ "r815" ], "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]", "terseLabel": "Award Timing Disclosures" } } }, "localname": "AwardTmgDiscLineItems", "nsuri": "http://xbrl.sec.gov/ecd/2023", "xbrltype": "stringItemType" }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "auth_ref": [ "r815" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]", "terseLabel": "Award Timing, How MNPI Considered" } } }, "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AwardTmgMethodTextBlock": { "auth_ref": [ "r815" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]", "terseLabel": "Award Timing Method" } } }, "localname": "AwardTmgMethodTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AwardTmgMnpiCnsdrdFlag": { "auth_ref": [ "r815" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]", "terseLabel": "Award Timing MNPI Considered" } } }, "localname": "AwardTmgMnpiCnsdrdFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "booleanItemType" }, "ecd_AwardTmgMnpiDiscTextBlock": { "auth_ref": [ "r815" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]", "terseLabel": "Award Timing MNPI Disclosure" } } }, "localname": "AwardTmgMnpiDiscTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AwardTmgPredtrmndFlag": { "auth_ref": [ "r815" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]", "terseLabel": "Award Timing Predetermined" } } }, "localname": "AwardTmgPredtrmndFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "booleanItemType" }, "ecd_AwardUndrlygSecuritiesAmt": { "auth_ref": [ "r818" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount", "terseLabel": "Underlying Securities" } } }, "localname": "AwardUndrlygSecuritiesAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "decimalItemType" }, "ecd_AwardsCloseToMnpiDiscIndName": { "auth_ref": [ "r817" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name", "terseLabel": "Name" } } }, "localname": "AwardsCloseToMnpiDiscIndName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "stringItemType" }, "ecd_AwardsCloseToMnpiDiscTable": { "auth_ref": [ "r816" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]", "terseLabel": "Awards Close in Time to MNPI Disclosures" } } }, "localname": "AwardsCloseToMnpiDiscTable", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "stringItemType" }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "auth_ref": [ "r816" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]", "terseLabel": "Awards Close in Time to MNPI Disclosures, Table" } } }, "localname": "AwardsCloseToMnpiDiscTableTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_ChangedPeerGroupFnTextBlock": { "auth_ref": [ "r795" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]", "terseLabel": "Changed Peer Group, Footnote" } } }, "localname": "ChangedPeerGroupFnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_CoSelectedMeasureAmt": { "auth_ref": [ "r796" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount", "terseLabel": "Company Selected Measure Amount" } } }, "localname": "CoSelectedMeasureAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "decimalItemType" }, "ecd_CoSelectedMeasureName": { "auth_ref": [ "r796" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name", "terseLabel": "Company Selected Measure Name" } } }, "localname": "CoSelectedMeasureName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "normalizedStringItemType" }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "auth_ref": [ "r801" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Company Selected Measure" } } }, "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "auth_ref": [ "r800" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]", "terseLabel": "Compensation Actually Paid vs. Net Income" } } }, "localname": "CompActuallyPaidVsNetIncomeTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "auth_ref": [ "r802" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Other Measure" } } }, "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "auth_ref": [ "r799" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]", "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "auth_ref": [ "r798" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]", "terseLabel": "Equity Valuation Assumption Difference, Footnote" } } }, "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_ErrCompAnalysisTextBlock": { "auth_ref": [ "r688", "r700", "r781", "r808" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]", "terseLabel": "Erroneous Compensation Analysis" } } }, "localname": "ErrCompAnalysisTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_ErrCompRecoveryTable": { "auth_ref": [ "r685", "r697", "r778", "r805" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]", "terseLabel": "Erroneously Awarded Compensation Recovery" } } }, "localname": "ErrCompRecoveryTable", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "stringItemType" }, "ecd_ExecutiveCategoryAxis": { "auth_ref": [ "r804" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]", "terseLabel": "Executive Category:" } } }, "localname": "ExecutiveCategoryAxis", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "stringItemType" }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "auth_ref": [ "r692", "r704", "r785", "r812" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "auth_ref": [ "r692", "r704", "r785", "r812" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount", "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "auth_ref": [ "r692", "r704", "r785", "r812" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount", "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "auth_ref": [ "r692", "r704", "r785", "r812" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]", "terseLabel": "Forgone Recovery, Explanation of Impracticability" } } }, "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_ForgoneRecoveryIndName": { "auth_ref": [ "r692", "r704", "r785", "r812" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name", "terseLabel": "Name" } } }, "localname": "ForgoneRecoveryIndName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "stringItemType" }, "ecd_IndividualAxis": { "auth_ref": [ "r695", "r704", "r785", "r804", "r812", "r816", "r824" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]", "terseLabel": "Individual:" } } }, "localname": "IndividualAxis", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "stringItemType" }, "ecd_InsiderTradingArrLineItems": { "auth_ref": [ "r822" ], "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]", "terseLabel": "Insider Trading Arrangements:" } } }, "localname": "InsiderTradingArrLineItems", "nsuri": "http://xbrl.sec.gov/ecd/2023", "xbrltype": "stringItemType" }, "ecd_InsiderTradingPoliciesProcLineItems": { "auth_ref": [ "r684", "r828" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]", "terseLabel": "Insider Trading Policies and Procedures:" } } }, "localname": "InsiderTradingPoliciesProcLineItems", "nsuri": "http://xbrl.sec.gov/ecd/2023", "xbrltype": "stringItemType" }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "auth_ref": [ "r684", "r828" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]", "terseLabel": "Insider Trading Policies and Procedures Adopted" } } }, "localname": "InsiderTrdPoliciesProcAdoptedFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "xbrltype": "booleanItemType" }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "auth_ref": [ "r684", "r828" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]", "terseLabel": "Insider Trading Policies and Procedures Not Adopted" } } }, "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "xbrltype": "textBlockItemType" }, "ecd_MeasureAxis": { "auth_ref": [ "r796" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]", "terseLabel": "Measure:" } } }, "localname": "MeasureAxis", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "stringItemType" }, "ecd_MeasureName": { "auth_ref": [ "r796" ], "lang": { "en-us": { "role": { "label": "Measure Name", "terseLabel": "Name" } } }, "localname": "MeasureName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "normalizedStringItemType" }, "ecd_MnpiDiscTimedForCompValFlag": { "auth_ref": [ "r815" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]", "terseLabel": "MNPI Disclosure Timed for Compensation Value" } } }, "localname": "MnpiDiscTimedForCompValFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "booleanItemType" }, "ecd_MtrlTermsOfTrdArrTextBlock": { "auth_ref": [ "r823" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement [Text Block]", "terseLabel": "Material Terms of Trading Arrangement" } } }, "localname": "MtrlTermsOfTrdArrTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "textBlockItemType" }, "ecd_NamedExecutiveOfficersFnTextBlock": { "auth_ref": [ "r797" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]", "terseLabel": "Named Executive Officers, Footnote" } } }, "localname": "NamedExecutiveOfficersFnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_NonGaapMeasureDescriptionTextBlock": { "auth_ref": [ "r796" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]", "terseLabel": "Non-GAAP Measure Description" } } }, "localname": "NonGaapMeasureDescriptionTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_NonNeosMember": { "auth_ref": [ "r692", "r704", "r785", "r804", "r812" ], "lang": { "en-us": { "role": { "label": "Non-NEOs [Member]", "terseLabel": "Non-NEOs" } } }, "localname": "NonNeosMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "domainItemType" }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "auth_ref": [ "r794" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount", "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_NonPeoNeoAvgTotalCompAmt": { "auth_ref": [ "r793" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount", "terseLabel": "Non-PEO NEO Average Total Compensation Amount" } } }, "localname": "NonPeoNeoAvgTotalCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_NonPeoNeoMember": { "auth_ref": [ "r804" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO [Member]", "terseLabel": "Non-PEO NEO" } } }, "localname": "NonPeoNeoMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "domainItemType" }, "ecd_NonRule10b51ArrAdoptedFlag": { "auth_ref": [ "r823" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "localname": "NonRule10b51ArrAdoptedFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "booleanItemType" }, "ecd_NonRule10b51ArrTrmntdFlag": { "auth_ref": [ "r823" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "localname": "NonRule10b51ArrTrmntdFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "booleanItemType" }, "ecd_OtherPerfMeasureAmt": { "auth_ref": [ "r796" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount", "terseLabel": "Other Performance Measure, Amount" } } }, "localname": "OtherPerfMeasureAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "decimalItemType" }, "ecd_OutstandingAggtErrCompAmt": { "auth_ref": [ "r690", "r702", "r783", "r810" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount", "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "localname": "OutstandingAggtErrCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_OutstandingRecoveryCompAmt": { "auth_ref": [ "r693", "r705", "r786", "r813" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount", "terseLabel": "Compensation Amount" } } }, "localname": "OutstandingRecoveryCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_OutstandingRecoveryIndName": { "auth_ref": [ "r693", "r705", "r786", "r813" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name", "terseLabel": "Name" } } }, "localname": "OutstandingRecoveryIndName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "stringItemType" }, "ecd_PayVsPerformanceDisclosureLineItems": { "auth_ref": [ "r792" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]", "terseLabel": "Pay vs Performance Disclosure" } } }, "localname": "PayVsPerformanceDisclosureLineItems", "nsuri": "http://xbrl.sec.gov/ecd/2023", "xbrltype": "stringItemType" }, "ecd_PeerGroupIssuersFnTextBlock": { "auth_ref": [ "r795" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]", "terseLabel": "Peer Group Issuers, Footnote" } } }, "localname": "PeerGroupIssuersFnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_PeerGroupTotalShareholderRtnAmt": { "auth_ref": [ "r795" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount", "terseLabel": "Peer Group Total Shareholder Return Amount" } } }, "localname": "PeerGroupTotalShareholderRtnAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_PeoActuallyPaidCompAmt": { "auth_ref": [ "r794" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount", "terseLabel": "PEO Actually Paid Compensation Amount" } } }, "localname": "PeoActuallyPaidCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_PeoMember": { "auth_ref": [ "r804" ], "lang": { "en-us": { "role": { "label": "PEO [Member]", "terseLabel": "PEO" } } }, "localname": "PeoMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "domainItemType" }, "ecd_PeoName": { "auth_ref": [ "r797" ], "lang": { "en-us": { "role": { "label": "PEO Name", "terseLabel": "PEO Name" } } }, "localname": "PeoName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "normalizedStringItemType" }, "ecd_PeoTotalCompAmt": { "auth_ref": [ "r793" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount", "terseLabel": "PEO Total Compensation Amount" } } }, "localname": "PeoTotalCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_PvpTable": { "auth_ref": [ "r792" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]", "terseLabel": "Pay vs Performance Disclosure" } } }, "localname": "PvpTable", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "stringItemType" }, "ecd_PvpTableTextBlock": { "auth_ref": [ "r792" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]", "terseLabel": "Pay vs Performance Disclosure, Table" } } }, "localname": "PvpTableTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "auth_ref": [ "r685", "r697", "r778", "r805" ], "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]", "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure" } } }, "localname": "RecoveryOfErrCompDisclosureLineItems", "nsuri": "http://xbrl.sec.gov/ecd/2023", "xbrltype": "stringItemType" }, "ecd_RestatementDateAxis": { "auth_ref": [ "r686", "r698", "r779", "r806" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]", "terseLabel": "Restatement Determination Date:" } } }, "localname": "RestatementDateAxis", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "stringItemType" }, "ecd_RestatementDeterminationDate": { "auth_ref": [ "r687", "r699", "r780", "r807" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date", "terseLabel": "Restatement Determination Date" } } }, "localname": "RestatementDeterminationDate", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "dateItemType" }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "auth_ref": [ "r694", "r706", "r787", "r814" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]", "terseLabel": "Restatement does not require Recovery" } } }, "localname": "RestatementDoesNotRequireRecoveryTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_Rule10b51ArrAdoptedFlag": { "auth_ref": [ "r823" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Adopted" } } }, "localname": "Rule10b51ArrAdoptedFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "booleanItemType" }, "ecd_Rule10b51ArrTrmntdFlag": { "auth_ref": [ "r823" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Terminated" } } }, "localname": "Rule10b51ArrTrmntdFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "booleanItemType" }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "auth_ref": [ "r689", "r701", "r782", "r809" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]", "terseLabel": "Stock Price or TSR Estimation Method" } } }, "localname": "StkPrcOrTsrEstimationMethodTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_TabularListTableTextBlock": { "auth_ref": [ "r803" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]", "terseLabel": "Tabular List, Table" } } }, "localname": "TabularListTableTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_TotalShareholderRtnAmt": { "auth_ref": [ "r795" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount", "terseLabel": "Total Shareholder Return Amount" } } }, "localname": "TotalShareholderRtnAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "auth_ref": [ "r802" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]", "terseLabel": "Total Shareholder Return Vs Peer Group" } } }, "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_TradingArrAxis": { "auth_ref": [ "r822" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]", "terseLabel": "Trading Arrangement:" } } }, "localname": "TradingArrAxis", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "stringItemType" }, "ecd_TradingArrByIndTable": { "auth_ref": [ "r824" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]", "terseLabel": "Trading Arrangements, by Individual" } } }, "localname": "TradingArrByIndTable", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "stringItemType" }, "ecd_TrdArrAdoptionDate": { "auth_ref": [ "r825" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Adoption Date", "terseLabel": "Adoption Date" } } }, "localname": "TrdArrAdoptionDate", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "stringItemType" }, "ecd_TrdArrDuration": { "auth_ref": [ "r826" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Duration", "terseLabel": "Arrangement Duration" } } }, "localname": "TrdArrDuration", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "durationItemType" }, "ecd_TrdArrIndName": { "auth_ref": [ "r824" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Name", "terseLabel": "Name" } } }, "localname": "TrdArrIndName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "stringItemType" }, "ecd_TrdArrIndTitle": { "auth_ref": [ "r824" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Title", "terseLabel": "Title" } } }, "localname": "TrdArrIndTitle", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "stringItemType" }, "ecd_TrdArrSecuritiesAggAvailAmt": { "auth_ref": [ "r827" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Securities Aggregate Available Amount", "terseLabel": "Aggregate Available" } } }, "localname": "TrdArrSecuritiesAggAvailAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "sharesItemType" }, "ecd_TrdArrTerminationDate": { "auth_ref": [ "r825" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Termination Date", "terseLabel": "Termination Date" } } }, "localname": "TrdArrTerminationDate", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "stringItemType" }, "ecd_UndrlygSecurityMktPriceChngPct": { "auth_ref": [ "r821" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent", "terseLabel": "Underlying Security Market Price Change" } } }, "localname": "UndrlygSecurityMktPriceChngPct", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "pureItemType" }, "slrc_ASCHoldcoLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ASC Holdco, LLC", "label": "ASC Holdco LLC [Member]", "verboseLabel": "ASC Holdco LLC [Member]" } } }, "localname": "ASCHoldcoLLCMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_AaCraneAndRiggingLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A&A Crane and Rigging LLC Member.", "label": "AA Crane and Rigging LLC [Member]", "terseLabel": "A&A Crane and Rigging, LLC [Member]" } } }, "localname": "AaCraneAndRiggingLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AcresCommercialMortgageLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ACRES Commercial Mortgage, LLC.", "label": "ACRES Commercial Mortgage, LLC [Member]", "terseLabel": "ACRES Commercial Mortgage, LLC [Member]" } } }, "localname": "AcresCommercialMortgageLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AdministrativeServicesPayable": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 8.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Administrative services payable.", "label": "Administrative Services Payable", "terseLabel": "Administrative services payable (see note 3)" } } }, "localname": "AdministrativeServicesPayable", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "slrc_AdvisoryAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Advisory Agreement (Member)", "label": "Advisory Agreement [Member]", "terseLabel": "Advisory Agreement [Member]" } } }, "localname": "AdvisoryAgreementMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_AegisToxicologySciencesCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aegis toxicology sciences corporation.", "label": "Aegis Toxicology Sciences Corporation [Member]", "terseLabel": "Aegis Toxicology Sciences Corporation [Member]" } } }, "localname": "AegisToxicologySciencesCorporationMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_AeroOperatingLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aero operating llc.", "label": "Aero Operating LLC [Member]", "terseLabel": "Aero Operating LLC [Member]" } } }, "localname": "AeroOperatingLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AerospaceAndDefenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aerospace and defense member.", "label": "Aerospace and Defense [Member]", "terseLabel": "Aerospace & Defense [Member]" } } }, "localname": "AerospaceAndDefenseMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AfgDallasIiiLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "AFG dallas III, LLC.", "label": "AFG Dallas III, LLC [Member]" } } }, "localname": "AfgDallasIiiLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AgreementAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement Axis", "label": "Agreement [Axis]" } } }, "localname": "AgreementAxis", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "slrc_AgreementDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement Domain", "label": "Agreement [Domain]" } } }, "localname": "AgreementDomain", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_AgreementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement [Line item]", "label": "Agreement [Line Items]" } } }, "localname": "AgreementLineItems", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "slrc_AgreementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreements Abstract", "label": "Agreements [Abstract]" } } }, "localname": "AgreementsAbstract", "nsuri": "http://www.slrinvestments.com/20230630", "xbrltype": "stringItemType" }, "slrc_AgreementsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreements [Table]", "label": "Agreements [Table]" } } }, "localname": "AgreementsTable", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "slrc_AgreementsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of Agreements.", "label": "Agreements [Text Block]", "terseLabel": "Agreements" } } }, "localname": "AgreementsTextBlock", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/Agreements" ], "xbrltype": "textBlockItemType" }, "slrc_AirMethodsCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Air methods corporation.", "label": "Air Methods Corporation [Member]", "terseLabel": "Air Methods Corporation [Member]" } } }, "localname": "AirMethodsCorporationMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AirlinesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Airlines member.", "label": "Airlines [Member]" } } }, "localname": "AirlinesMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AlimeraSciencesInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Alimera sciences, inc.", "label": "Alimera Sciences, Inc. [Member]", "terseLabel": "Alimera Sciences, Inc. [Member]" } } }, "localname": "AlimeraSciencesInc.Member", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AllStateAgPartsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All State Ag Parts, LLC.", "label": "All State Ag Parts LLC [Member]", "terseLabel": "All State Ag Parts, LLC [Member]", "verboseLabel": "All State Ag Parts, LLC [Member]" } } }, "localname": "AllStateAgPartsLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AmeraMexInternationalIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amera mex international inc.", "label": "Amera Mex International Inc [Member]", "terseLabel": "AmeraMex International, Inc. [Member]" } } }, "localname": "AmeraMexInternationalIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AmeriMarkIntermediateHoldingsLLCOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amerimark Intermediate Holdings LLC One.", "label": "AmeriMark Intermediate Holdings LLC One [Member]", "terseLabel": "AmeriMark Intermediate Holdings, LLC [Member]" } } }, "localname": "AmeriMarkIntermediateHoldingsLLCOneMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AmeriMarkIntermediateHoldingsOneLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "AmeriMark Intermediate Holdings One LLC [Member]", "verboseLabel": "AmeriMark Intermediate Holdings LLC [Member]" } } }, "localname": "AmeriMarkIntermediateHoldingsOneLLCMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_AmericanTeleconferencingServicesLtd.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "American teleconferencing services, ltd.", "label": "American Teleconferencing Services, Ltd. [Member]", "terseLabel": "American Teleconferencing Services, Ltd. [Member]" } } }, "localname": "AmericanTeleconferencingServicesLtd.Member", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AmericanTeleconferencingServicesLtdOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "American Teleconferencing Services, Ltd One [Member]", "terseLabel": "American Teleconferencing Services, Ltd. [Member]" } } }, "localname": "AmericanTeleconferencingServicesLtdOneMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AmerimarkIntermediateHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ameri mark intermediate holdings, llc", "label": "AmeriMark Intermediate Holdings, LLC [Member]", "terseLabel": "AmeriMark Intermediate Holdings, LLC [Member]", "verboseLabel": "AmeriMark Intermediate Holdings LLC [Member]" } } }, "localname": "AmerimarkIntermediateHoldingsLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_AmerimarkMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amerimark member.", "label": "Amerimark [Member]", "terseLabel": "Amerimark [Member]" } } }, "localname": "AmerimarkMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_ApeelTechnologyIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Apeel technology Inc.", "label": "Apeel Technology Inc [Member]", "terseLabel": "Apeel Technology, Inc [Member]" } } }, "localname": "ApeelTechnologyIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ApexServicesPartnersLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Apex services partners, LLC.", "label": "Apex Services Partners, LLC [Member]" } } }, "localname": "ApexServicesPartnersLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ArcutisBiotherapeuticsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arcutis Biotherapeutics, Inc.", "label": "Arcutis Biotherapeutics, Inc. [Member]" } } }, "localname": "ArcutisBiotherapeuticsInc.Member", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ArdelyxInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ardelyx, Inc.", "label": "Ardelyx, Inc. [Member]", "terseLabel": "Ardelyx, Inc. [Member]" } } }, "localname": "ArdelyxInc.Member", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ArdelyxIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ardelyx Inc.", "label": "Ardelyx Inc [Member]", "terseLabel": "Ardelyx, Inc [Member]" } } }, "localname": "ArdelyxIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "xbrltype": "domainItemType" }, "slrc_AtriaWealthSolutionsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Atria wealth solutions, inc.", "label": "Atria Wealth Solutions, Inc [Member]", "terseLabel": "Atria Wealth Solutions, Inc. [Member]", "verboseLabel": "Atria Wealth Solutions, Inc [Member]" } } }, "localname": "AtriaWealthSolutionsIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_AtyrPharmaIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Atyr pharma inc.", "label": "ATyr Pharma Inc [Member]", "terseLabel": "aTyr Pharma, Inc. Warrants [Member]" } } }, "localname": "AtyrPharmaIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AutoComponentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Auto components member.", "label": "Auto Components [Member]" } } }, "localname": "AutoComponentsMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AutoPartsAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Auto parts and equipment member.", "label": "Auto Parts and Equipment [Member]", "verboseLabel": "Auto Parts & Equipment [Member]" } } }, "localname": "AutoPartsAndEquipmentMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_BasicAndDilutedEarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Basic And Diluted Earnings Per Share.", "label": "Basic And Diluted Earnings Per Share [Abstract]", "terseLabel": "Earnings per share (basic\u00a0& diluted)" } } }, "localname": "BasicAndDilutedEarningsPerShareAbstract", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetails" ], "xbrltype": "stringItemType" }, "slrc_BasicFunInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Basic fun, Inc.", "label": "Basic Fun, Inc. [Member]", "terseLabel": "Basic Fun, Inc. [Member]" } } }, "localname": "BasicFunInc.Member", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_BaymarkHealthServicesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "BayMark health services, Inc.", "label": "BayMark Health Services Inc [Member]", "terseLabel": "BayMark Health Services, Inc [Member]", "verboseLabel": "BayMark Health Services Inc [Member]" } } }, "localname": "BaymarkHealthServicesIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_BaysideOpcoLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bayside Opco, LLC.", "label": "Bayside Opco LLC [Member]", "terseLabel": "Bayside Opco, LLC [Member]", "verboseLabel": "Bayside Opco LLC [Member]" } } }, "localname": "BaysideOpcoLLCMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_BaysideOpcoLLCOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bayside Opco, LLC one.", "label": "Bayside Opco LLC One [Member]", "terseLabel": "Bayside Opco, LLC [Member]", "verboseLabel": "Bayside Opco LLC [Member]" } } }, "localname": "BaysideOpcoLLCOneMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_BaysideParentLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bayside Parent, LLC.", "label": "Bayside Parent LLC [Member]", "terseLabel": "Bayside Parent, LLC [Member]" } } }, "localname": "BaysideParentLLCMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_BaysideParentLlcEquityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Bayside Parent, LLC (equity) [Member]", "verboseLabel": "Bayside Parent, LLC (equity) [Member]" } } }, "localname": "BaysideParentLlcEquityMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_BaysideParentLlcLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Bayside Parent, LLC (loan) [Member]", "verboseLabel": "Bayside Parent, LLC (loan) [Member]" } } }, "localname": "BaysideParentLlcLoanMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_BazziniLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bazzini, LLC.", "label": "Bazzini, LLC [Member]" } } }, "localname": "BazziniLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_BdgMediaInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "BDG media, Inc.", "label": "BDG Media, Inc. [Member]" } } }, "localname": "BdgMediaInc.Member", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_BiotechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Biotechnology member.", "label": "Biotechnology [Member]" } } }, "localname": "BiotechnologyMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_BlackScholesPricingModelMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Black scholes pricing model.", "label": "Black Scholes Pricing Model [Member]" } } }, "localname": "BlackScholesPricingModelMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "slrc_BoardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Board [Member].", "label": "Board [Member]", "terseLabel": "Board [Member]" } } }, "localname": "BoardMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_BoartLongyearCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boart longyear company.", "label": "Boart Longyear Company [Member]", "terseLabel": "Boart Longyear Company [Member]" } } }, "localname": "BoartLongyearCompanyMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_BowmanEnergySolutionsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bowman energy solutions, LLC.", "label": "Bowman Energy Solutions, LLC [Member]" } } }, "localname": "BowmanEnergySolutionsLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_BridgeBioPharmaIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bridge Bio Pharma, Inc member.", "label": "Bridge Bio Pharma, Inc [Member]" } } }, "localname": "BridgeBioPharmaIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_BridgebioPharmaInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bridgebio pharma, inc.", "label": "BridgeBio Pharma, Inc. [Member]", "terseLabel": "BridgeBio Pharma, Inc. [Member]" } } }, "localname": "BridgebioPharmaInc.Member", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_BuildingProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Building Products Member.", "label": "Building Products [Member]" } } }, "localname": "BuildingProductsMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CPortStoneLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "C Port Stone LLC.", "label": "C Port Stone LLC [Member]", "terseLabel": "C-Port/Stone LLC [Member]" } } }, "localname": "CPortStoneLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CVAUSAManagementLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CVAUSA Management, LLC,,", "label": "CVAUSA Management LLC [Member]", "terseLabel": "CVAUSA Management, LLC,, [Member]" } } }, "localname": "CVAUSAManagementLLCMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CapitalCityJetCenterIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capital city jet center inc.", "label": "Capital City Jet Center Inc [Member]", "terseLabel": "Capital City Jet Center, Inc. [Member]" } } }, "localname": "CapitalCityJetCenterIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CapitalMarketsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capital markets member.", "label": "Capital Markets [Member]" } } }, "localname": "CapitalMarketsMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CapitalShareTransactionsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capital share transactions.", "label": "Capital Share Transactions [Text Block]", "verboseLabel": "Capital Share Transactions" } } }, "localname": "CapitalShareTransactionsTextBlock", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactions" ], "xbrltype": "textBlockItemType" }, "slrc_CapitalizationOfPaymentInKindIncome": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Capitalization of\u00a0payment-in-kind\u00a0income.", "label": "Capitalization Of Payment In Kind Income", "terseLabel": "Capitalization of payment-in-kind income" } } }, "localname": "CapitalizationOfPaymentInKindIncome", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_CardioFocusIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cardio focus inc.", "label": "Cardio Focus Inc [Member]", "terseLabel": "CardioFocus, Inc. Warrants [Member]" } } }, "localname": "CardioFocusIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CarolinasContractingLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Carolina's Contracting, LLC Member.", "label": "Carolinas Contracting, LLC [Member]", "terseLabel": "Carolina's Contracting, LLC [Member]" } } }, "localname": "CarolinasContractingLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CashEquivalentsAtCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash equivalents at cost.", "label": "Cash Equivalents At Cost", "terseLabel": "Cash equivalents at cost" } } }, "localname": "CashEquivalentsAtCost", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "monetaryItemType" }, "slrc_CashEquivalentsAtFortyOnePointEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash Equivalents at Forty One Point Eight.", "label": "Cash Equivalents at Forty One Point Eight [Member]", "terseLabel": "Cash Equivalents \u2014 41.8% [Member]" } } }, "localname": "CashEquivalentsAtFortyOnePointEightMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CashEquivalentsThirtyFourPointZeroPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash equivalents thirty four point zero percent.", "label": "Cash Equivalents Thirty Four Point Zero Percent [Member]", "terseLabel": "Cash Equivalents \u2014 34.0% [Member]" } } }, "localname": "CashEquivalentsThirtyFourPointZeroPercentMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CcSagHoldingsCorp.SpectrumAutomotiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cc sag holdings corp. (spectrum automotive).", "label": "CC SAG Holdings Corp. (Spectrum Automotive) [Member]", "terseLabel": "CC SAG Holdings Corp. (Spectrum Automotive) [Member]" } } }, "localname": "CcSagHoldingsCorp.SpectrumAutomotiveMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CentrexionTherapeuticsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Centrexion therapeutics, inc.", "label": "Centrexion Therapeutics, Inc. [Member]", "terseLabel": "Centrexion Therapeutics, Inc. [Member]" } } }, "localname": "CentrexionTherapeuticsInc.Member", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CentrexionTherapeuticsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Centrexion therapeutics inc.", "label": "Centrexion Therapeutics Inc [Member]", "terseLabel": "Centrexion Therapeutics, Inc. Warrants [Member]" } } }, "localname": "CentrexionTherapeuticsIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CerapedicsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cerapedics, inc.", "label": "Cerapedics, Inc. [Member]", "terseLabel": "Cerapedics, Inc. [Member]" } } }, "localname": "CerapedicsInc.Member", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ChampionAirLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Champion air llc.", "label": "Champion Air LLC [Member]", "terseLabel": "Champion Air, LLC [Member]" } } }, "localname": "ChampionAirLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ChangeInUnrealizedGainLossOnInvestmentsAndCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Change in unrealized gain loss on investments and cash equivalents.", "label": "Change In Unrealized Gain Loss On Investments And Cash Equivalents [Abstract]", "terseLabel": "Net change in unrealized gain (loss) on investments and cash equivalents:" } } }, "localname": "ChangeInUnrealizedGainLossOnInvestmentsAndCashEquivalentsAbstract", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "slrc_CitiBankNaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Citi Bank NA.", "label": "Citi Bank NA [Member]" } } }, "localname": "CitiBankNaMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_CkdHoldingsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CKD holdings, Inc.", "label": "CKD Holdings, Inc. [Member]" } } }, "localname": "CkdHoldingsInc.Member", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ClubcorpHoldingsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Clubcorp holdings inc.", "label": "Clubcorp Holdings Inc [Member]", "terseLabel": "Clubcorp Holdings, Inc. [Member]" } } }, "localname": "ClubcorpHoldingsIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CollateralAgentAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collateral agent.", "label": "Collateral Agent [Axis]" } } }, "localname": "CollateralAgentAxis", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "slrc_CollateralAgentDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collateral agent.", "label": "Collateral Agent [Domain]" } } }, "localname": "CollateralAgentDomain", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_CollectionsOfPaymentInKindIncome": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Collections of\u00a0payment-in-kind\u00a0income.", "label": "Collections Of Payment In Kind Income", "terseLabel": "Collections of payment-in-kind income" } } }, "localname": "CollectionsOfPaymentInKindIncome", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_CommercialServicesAndSuppliesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commercial services and supplies member.", "label": "Commercial Services and Supplies [Member]", "verboseLabel": "Commercial Services & Supplies [Member]" } } }, "localname": "CommercialServicesAndSuppliesMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CommitmentFundedAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Commitment funded amount.", "label": "Commitment Funded Amount", "terseLabel": "Commitment funded amount" } } }, "localname": "CommitmentFundedAmount", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common equity or equity interests or warrants at fifty seven point one.", "label": "Common Equity Or Equity Interests Or Warrants At Fifty Seven Point one [Member]", "terseLabel": "Common Equity/Equity Interests/Warrants\u201457.1% [Member]" } } }, "localname": "CommonEquityOrEquityInterestsOrWarrantsAtFiftySevenPointOneMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common equity or equity interests or warrants fifty nine point nine percent.", "label": "Common Equity Or Equity Interests Or Warrants Fifty Nine Point Nine Percent [Member]", "terseLabel": "Common Equity/Equity Interests/Warrants\u201459.9% [Member]" } } }, "localname": "CommonEquityOrEquityInterestsOrWarrantsFiftyNinePointNinePercentMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CommunicationsEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Communications equipment member.", "label": "Communications Equipment [Member]" } } }, "localname": "CommunicationsEquipmentMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CompaniesLessThanFivePercentageOwnedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Companies less than five percentage owned.", "label": "Companies Less Than Five Percentage Owned [Member]", "terseLabel": "Companies less than 5% owned [Member]" } } }, "localname": "CompaniesLessThanFivePercentageOwnedMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "slrc_CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Companies More than Five Percentage and Less Than Twenty Five Percentage Owned.", "label": "Companies More than Five Percentage and Less Than Twenty Five Percentage Owned [Member]", "terseLabel": "Companies 5% to 25% owned [Member]" } } }, "localname": "CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "slrc_CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Companies more than five percentage less than twenty five percentage owned.", "label": "Companies More Than Five Percentage Less Than Twenty Five Percentage Owned [Member]", "terseLabel": "Companies more than 5% less than 25% owned [Member]" } } }, "localname": "CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_CompaniesMoreThanTwentyFivePercentageOwnedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Companies more than twenty five percentage owned.", "label": "Companies More Than Twenty Five Percentage Owned [Member]", "terseLabel": "Companies more than 25% owned [Member]" } } }, "localname": "CompaniesMoreThanTwentyFivePercentageOwnedMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "slrc_CompleteEquipmentRentalsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Complete Equipment Rentals, LLC Member.", "label": "Complete Equipment Rentals, LLC [Member]" } } }, "localname": "CompleteEquipmentRentalsLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CompositeTechnologyAcquisitionCorp.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Composite technology acquisition corp.", "label": "Composite Technology Acquisition Corp. [Member]" } } }, "localname": "CompositeTechnologyAcquisitionCorp.Member", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CompositeTechnologyAcquisitionCorpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Composite technology acquisition corp.", "label": "Composite Technology Acquisition Corp [Member]" } } }, "localname": "CompositeTechnologyAcquisitionCorpMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "xbrltype": "domainItemType" }, "slrc_ConstructionAndEngineeringMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Construction and engineering member.", "label": "Construction and Engineering [Member]", "verboseLabel": "Construction & Engineering [Member]" } } }, "localname": "ConstructionAndEngineeringMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ConsumerFinanceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consumer finance member.", "label": "Consumer Finance [Member]" } } }, "localname": "ConsumerFinanceMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ContainersAndPackagingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Containers and packaging member.", "label": "Containers and Packaging [Member]", "verboseLabel": "Containers & Packaging [Member]" } } }, "localname": "ContainersAndPackagingMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ConventusOrthopaedicsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conventus orthopaedics inc.", "label": "Conventus Orthopaedics Inc [Member]", "terseLabel": "Conventus Orthopaedics, Inc. Warrants [Member]" } } }, "localname": "ConventusOrthopaedicsIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CopperRiverSeafoodsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Copper river seafoods, Inc.", "label": "Copper River Seafoods, Inc. [Member]" } } }, "localname": "CopperRiverSeafoodsInc.Member", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Credit Facility.", "label": "Credit Facility [Member]", "terseLabel": "Credit Facility [Member]" } } }, "localname": "CreditFacilityMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_CreditFacilityOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Credit facility one.", "label": "Credit Facility One [Member]", "terseLabel": "SPV\u00a0Credit Facility [Member]", "verboseLabel": "SPV Credit Facility [Member]" } } }, "localname": "CreditFacilityOneMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_CrystalCapitalFinancialHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Crystal capital financial holdings LLC.", "label": "Crystal Capital Financial Holdings LLC [Member]" } } }, "localname": "CrystalCapitalFinancialHoldingsLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_CrystalFinancialMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Crystal Financial(Member)", "label": "Crystal Financial [Member]", "terseLabel": "Crystal Financial [Member]" } } }, "localname": "CrystalFinancialMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_DeepintentInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DeepIntent, inc.", "label": "DeepIntent, Inc. [Member]" } } }, "localname": "DeepintentInc.Member", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_DelphinusMedicalTechnologiesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Delphinus medical technologies inc.", "label": "Delphinus Medical Technologies Inc [Member]", "terseLabel": "Delphinus Medical Technologies, Inc. Warrants [Member]" } } }, "localname": "DelphinusMedicalTechnologiesIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_DescriptionOfFairValueMeasurementValuationProcess": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of fair value measurement valuation process.", "label": "Description Of Fair Value Measurement Valuation Process", "terseLabel": "Principal Valuation Technique/Methodology" } } }, "localname": "DescriptionOfFairValueMeasurementValuationProcess", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails" ], "xbrltype": "stringItemType" }, "slrc_DescriptionOfSignificantUnobservableInputUsed": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of significant unobservable input used.", "label": "Description of Significant Unobservable Input Used", "terseLabel": "Unobservable Input" } } }, "localname": "DescriptionOfSignificantUnobservableInputUsed", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails" ], "xbrltype": "stringItemType" }, "slrc_DiversifiedConsumerServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Diversified consumer services member.", "label": "Diversified Consumer Services [Member]" } } }, "localname": "DiversifiedConsumerServicesMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_DiversifiedFinancialServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Diversified financial services member", "label": "Diversified Financial Services [Member]", "terseLabel": "Diversified Financial Services (includes SLR Credit Solutions, SLR Business Credit and SLR Healthcare ABL) [Member]" } } }, "localname": "DiversifiedFinancialServicesMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_DongwonAutopartTechnologyIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dongwon autopart technology inc.", "label": "Dongwon Autopart Technology Inc [Member]", "terseLabel": "Dongwon Autopart Technology Inc. [Member]" } } }, "localname": "DongwonAutopartTechnologyIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_DrillersChoiceIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Drillers Choice, Inc", "label": "Drillers Choice, Inc [Member]" } } }, "localname": "DrillersChoiceIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EasyPakLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Easy pak llc.", "label": "Easy pak LLC [Member]", "terseLabel": "EasyPak, LLC [Member]" } } }, "localname": "EasyPakLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EnergyDrillingServicesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Energy drilling services, LLC.", "label": "Energy Drilling Services, LLC [Member]" } } }, "localname": "EnergyDrillingServicesLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EnergyEquipmentAndServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Energy equipment and services member.", "label": "Energy Equipment and Services [Member]", "verboseLabel": "Energy Equipment & Services [Member]" } } }, "localname": "EnergyEquipmentAndServicesMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EnhancedPermanentCapitalLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Enhanced permanent capital, llc.", "label": "Enhanced Permanent Capital, LLC [Member]", "terseLabel": "Enhanced Permanent Capital, LLC [Member]" } } }, "localname": "EnhancedPermanentCapitalLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EnsHoldingsIiiCorp.EsOpcoUsaLlcBluefinMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ENC holdings III corp. ES opco USALLC (Bluefin).", "label": "ENS Holdings III Corp. ES Opco USA LLC (Bluefin) [Member]", "terseLabel": "ENS Holdings III Corp. & ES Opco USA LLC (Bluefin) [Member]" } } }, "localname": "EnsHoldingsIiiCorp.EsOpcoUsaLlcBluefinMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EnsHoldingsIiiCorp.EsOpcoUsaLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ENS holdings III corp. & ES Opco USA LLC member.", "label": "ENS Holdings III Corp. ES Opco USA LLC [Member]", "terseLabel": "ENS Holdings III Corp. ES Opco USA LLC [Member]" } } }, "localname": "EnsHoldingsIiiCorp.EsOpcoUsaLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_EnsHoldingsIiiCorpLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ENS holdings III corp, LLC.", "label": "ENS Holdings III Corp, LLC [Member]" } } }, "localname": "EnsHoldingsIiiCorpLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "xbrltype": "domainItemType" }, "slrc_EnverusHoldingsIncFkaDrillingInfoHoldingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Enverus Holdings Inc fka Drilling Info Holdings Member.", "label": "Enverus Holdings Inc fka Drilling Info Holdings [Member]", "terseLabel": "Enverus Holdings, Inc. (fka Drilling Info Holdings) [Member]" } } }, "localname": "EnverusHoldingsIncFkaDrillingInfoHoldingsMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EnverusHoldingsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Enverus holdings Inc.", "label": "Enverus Holdings Inc [Member]", "terseLabel": "Enverus Holdings, Inc [Member]" } } }, "localname": "EnverusHoldingsIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "xbrltype": "domainItemType" }, "slrc_EnvironmentalProtectionImprovementCompanyLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Environmental protection\u00a0& improvement company llc.", "label": "Environmental Protection Improvement Company LLC [Member]", "terseLabel": "Environmental Protection & Improvement Company, LLC [Member]" } } }, "localname": "EnvironmentalProtectionImprovementCompanyLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EquipmentBackedLeasesAndLoansLargestPositionOutstanding": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equipment backed leases and loans largest position outstanding.", "label": "Equipment Backed Leases And Loans Largest Position Outstanding", "terseLabel": "Equipment backed leases and loans largest position outstanding" } } }, "localname": "EquipmentBackedLeasesAndLoansLargestPositionOutstanding", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_EquipmentBackedLeasesAndLoansaverageExposurePerCustomer": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equipment backed leases and loans average exposure per customer.", "label": "Equipment Backed Leases and LoansAverage Exposure Per Customer", "terseLabel": "Equipment backed leases and loans average exposure per customer" } } }, "localname": "EquipmentBackedLeasesAndLoansaverageExposurePerCustomer", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_EquipmentFinancingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment financing.", "label": "Equipment Financing [Member]", "terseLabel": "Equipment Financing [Member]" } } }, "localname": "EquipmentFinancingMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "slrc_EquipmentFinancingTwentySevenPointSevenPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment financing twenty seven point seven percent.", "label": "Equipment Financing Twenty Seven Point Seven Percent [Member]", "terseLabel": "Equipment Financing \u2014 27.7% [Member]" } } }, "localname": "EquipmentFinancingTwentySevenPointSevenPercentMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EquipmentFinancingTwentySixPointSixPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment financing twenty six point six percent.", "label": "Equipment Financing Twenty Six Point Six Percent [Member]", "terseLabel": "Equipment Financing \u2014 26.6% [Member]" } } }, "localname": "EquipmentFinancingTwentySixPointSixPercentMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EquipmentOperatingLeasesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment operating leases llc,", "label": "Equipment Operating Leases LLC [Member]", "terseLabel": "Equipment Operating Leases, LLC [Member]" } } }, "localname": "EquipmentOperatingLeasesLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_EquityMethodInvestmentAggregateEquityInvestment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity method investment aggregate equity investment.", "label": "Equity Method Investment Aggregate Equity Investment", "terseLabel": "Equity method investment aggregate equity investment" } } }, "localname": "EquityMethodInvestmentAggregateEquityInvestment", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_EquityMethodInvestmentAggregateInvestmentInInvesteeLeasesAndLoansHeld": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity method investment aggregate investment in investee leases and loans held.", "label": "Equity Method Investment Aggregate Investment In Investee Leases and Loans held", "terseLabel": "Equity method investment aggregate investment in investee leases and loans held" } } }, "localname": "EquityMethodInvestmentAggregateInvestmentInInvesteeLeasesAndLoansHeld", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_ErieConstructionMidwestLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Erie Construction mid-west LLC.", "label": "Erie Construction Midwest LLC [Member]", "terseLabel": "Erie Construction Mid-west, LLC [Member]" } } }, "localname": "ErieConstructionMidwestLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EspSscCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ESP SSC Corporation Member", "label": "ESP SSC Corporation [Member]", "terseLabel": "ESP SSC Corporation [Member]" } } }, "localname": "EspSscCorporationMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_EssenceGroupHoldingsCorporationLumerisMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Essence group holdings corporation (lumeris).", "label": "Essence Group Holdings Corporation (Lumeris) [Member]", "terseLabel": "Essence Group Holdings Corporation (Lumeris) Warrants [Member]" } } }, "localname": "EssenceGroupHoldingsCorporationLumerisMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expenses.", "label": "Expenses [Abstract]", "terseLabel": "EXPENSES:" } } }, "localname": "ExpensesAbstract", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "slrc_ExtremeSteelCraneRiggingLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extreme Steel Crane\u00a0& Rigging, LLC Member.", "label": "Extreme Steel Crane Rigging, LLC [Member]", "terseLabel": "Extreme Steel Crane & Rigging, LLC [Member]" } } }, "localname": "ExtremeSteelCraneRiggingLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_FairValueMeasurementWithUnobservableInputsReconciliationBasisRealizedGainLossIncludedInEarnings": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value measurement with unobservable inputs reconciliation basis realized gain loss included in earnings.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Basis Realized Gain Loss Included In Earnings", "terseLabel": "Net realized gain (loss)" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationBasisRealizedGainLossIncludedInEarnings", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "slrc_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value measurement with unobservable inputs reconciliation recurring basis liability realized gain loss included in earnings.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Realized Gain Loss Included In Earnings", "terseLabel": "Net realized (gain) loss" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details" ], "xbrltype": "monetaryItemType" }, "slrc_FairValueOfCommonStockPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "definitionGuidance": "Per share market value, end of period", "documentation": "Fair value of common stock per share.", "label": "Fair Value Of Common Stock Per Share", "verboseLabel": "Fair value of common stock per share" } } }, "localname": "FairValueOfCommonStockPerShare", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails", "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsParentheticalsDetails" ], "xbrltype": "perShareItemType" }, "slrc_FastPayPartnersLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fast Pay Partners LLC [Member].", "label": "Fast Pay Partners LLC [Member]", "terseLabel": "Fast Pay Partners LLC [Member]" } } }, "localname": "FastPayPartnersLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_FertilityInvestmentHoldcoLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fertility Investment Holdco, LLC Member.", "label": "Fertility Investment Holdco, LLC [Member]", "terseLabel": "Fertility (ITC) Investment Holdco, LLC [Member]" } } }, "localname": "FertilityInvestmentHoldcoLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_FertilityItcInvestmentHoldcoLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fertility (ITC) investment holdco, LLC.", "label": "Fertility ITC investment holdco LLC [Member]", "terseLabel": "Fertility (ITC) Investment Holdco, LLC [Member]" } } }, "localname": "FertilityItcInvestmentHoldcoLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_FgiWorldwideLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "FGI Worldwide LLC", "label": "FGI Worldwide LLC [Member]" } } }, "localname": "FgiWorldwideLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_FirstAmericanCommercialBancorpIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First american commercial bancorp inc.", "label": "First American Commercial Bancorp Inc [Member]", "terseLabel": "First American Commercial Bancorp, Inc. [Member]" } } }, "localname": "FirstAmericanCommercialBancorpIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_FirstLienBankDebtOrSeniorSecuredLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First lien bank debt or senior secured loans.", "label": "First Lien Bank Debt Or Senior Secured Loans [Member]", "terseLabel": "First Lien Bank Debt/Senior Secured Loans [Member]" } } }, "localname": "FirstLienBankDebtOrSeniorSecuredLoansMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_FirstLienLifeScienceSeniorSecuredLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First lien life science senior secured loans.", "label": "First Lien Life Science Senior Secured Loans [Member]", "terseLabel": "First Lien Life Science Senior Secured Loans [Member]" } } }, "localname": "FirstLienLifeScienceSeniorSecuredLoansMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_FirstNationalCapitalLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First national capital llc.", "label": "First National Capital LLC [Member]", "terseLabel": "First National Capital, LLC [Member]" } } }, "localname": "FirstNationalCapitalLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_FoodAndStaplesRetailingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Food and staples retailing.", "label": "Food and Staples Retailing [Member]", "terseLabel": "Food & Staples Retailing [Member]" } } }, "localname": "FoodAndStaplesRetailingMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_FoodProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Food products.", "label": "Food Products [Member]", "terseLabel": "Food Products [Member]" } } }, "localname": "FoodProductsMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_FootwearMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Footwear Member.", "label": "Footwear [Member]" } } }, "localname": "FootwearMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_FoundationConsumerBrandsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foundation consumer brands, llc", "label": "Foundation Consumer Brands, LLC [Member]", "terseLabel": "Foundation Consumer Brands, LLC [Member]", "verboseLabel": "Foundation Consumer Brands, LLC [Member]" } } }, "localname": "FoundationConsumerBrandsLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_FreightsolLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Freightsol llc.", "label": "Freightsol LLC [Member]", "terseLabel": "Freightsol LLC [Member]" } } }, "localname": "FreightsolLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_GardaClTechnicalServicesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Garda cl technical services inc.", "label": "Garda CL Technical Services Inc [Member]", "terseLabel": "Garda CL Technical Services, Inc. [Member]" } } }, "localname": "GardaClTechnicalServicesIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_GeorgiaJetIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Georgia Jet Inc.", "label": "Georgia Jet Inc [Member]", "terseLabel": "Georgia Jet, Inc. [Member]" } } }, "localname": "GeorgiaJetIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_GlookoInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Glooko, inc.", "label": "Glooko, Inc. [Member]", "terseLabel": "Glooko, Inc. [Member]" } } }, "localname": "GlookoInc.Member", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_GmtCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "GMT corporation.", "label": "GMT Corporation [Member]", "terseLabel": "GMT Corporation [Member]" } } }, "localname": "GmtCorporationMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_GrossIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gross income.", "label": "Gross Income", "terseLabel": "Gross income" } } }, "localname": "GrossIncome", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_GsmAcquisitionCorpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "GSM acquisition corp.", "label": "GSM Acquisition Corp [Member]", "terseLabel": "GSM Acquisition Corp [Member]" } } }, "localname": "GsmAcquisitionCorpMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_HawkeyeContractingCompanyLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hawkeye contracting company llc.", "label": "Hawkeye Contracting Company LLC [Member]", "terseLabel": "Hawkeye Contracting Company, LLC [Member]" } } }, "localname": "HawkeyeContractingCompanyLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_HealthCareEquipmentAndSuppliesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Health care equipment and supplies member.", "label": "Health Care Equipment and Supplies [Member]", "verboseLabel": "Health Care Equipment & Supplies [Member]" } } }, "localname": "HealthCareEquipmentAndSuppliesMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_HealthCareProvidersAndServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Health care providers and services.", "label": "Health Care Providers and Services [Member]", "verboseLabel": "Health Care Providers & Services [Member]" } } }, "localname": "HealthCareProvidersAndServicesMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_HealthCareTechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Health care technology member.", "label": "Health Care Technology [Member]" } } }, "localname": "HealthCareTechnologyMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_HigginbothamInsuranceAgencyIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Higginbotham Insurance Agency Inc Member.", "label": "Higginbotham Insurance Agency Inc [Member]", "terseLabel": "Higginbotham Insurance Agency, Inc [Member]" } } }, "localname": "HigginbothamInsuranceAgencyIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_HighStreetBuyerIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "High street buyer, Inc.", "label": "High Street Buyer Inc [Member]", "terseLabel": "High Street Buyer, Inc [Member]", "verboseLabel": "High Street Buyer Inc [Member]" } } }, "localname": "HighStreetBuyerIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_HotelsRestaurantsAndLeisureMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hotels, restaurants and leisure member.", "label": "Hotels, Restaurants and Leisure [Member]", "verboseLabel": "Hotels, Restaurants & Leisure [Member]" } } }, "localname": "HotelsRestaurantsAndLeisureMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_HtiLogisticsCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "HTI logistics corporation.", "label": "HTI Logistics Corporation [Member]", "terseLabel": "HTI Logistics Corporation [Member]" } } }, "localname": "HtiLogisticsCorporationMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_HumanInterestIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Human interest Inc.", "label": "Human Interest Inc [Member]", "terseLabel": "Human Interest, Inc [Member]" } } }, "localname": "HumanInterestIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_IcimsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "iCIMS, Inc.", "label": "iCIMS, Inc. [Member]", "terseLabel": "iCIMS, Inc. [Member]" } } }, "localname": "IcimsInc.Member", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_IcimsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ICIMS, inc.", "label": "ICIMS, Inc [Member]" } } }, "localname": "IcimsIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_IncreaseDecreaseInAdministrativeServicesExpensePayable": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 25.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in administrative services expense payable.", "label": "Increase Decrease In Administrative Services Expense Payable", "terseLabel": "Administrative services expense payable" } } }, "localname": "IncreaseDecreaseInAdministrativeServicesExpensePayable", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_IncreaseDecreaseInDeferredFinancingCosts": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 28.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in deferred financing costs.", "label": "Increase Decrease In Deferred Financing Costs", "terseLabel": "Deferred financing costs/market discount" } } }, "localname": "IncreaseDecreaseInDeferredFinancingCosts", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_IncreaseDecreaseInInvestmentIncomeAmortizationOfDiscount": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in investment income amortization of discount.", "label": "Increase Decrease In Investment Income Amortization Of Discount", "terseLabel": "Net accretion of discount on investments" } } }, "localname": "IncreaseDecreaseInInvestmentIncomeAmortizationOfDiscount", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_IncreaseDecreaseInNetAssetsFromOperation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in net assets from operation.", "label": "Increase Decrease In Net Assets From Operation", "terseLabel": "Numerator - net increase in net assets resulting from operations:" } } }, "localname": "IncreaseDecreaseInNetAssetsFromOperation", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetails" ], "xbrltype": "monetaryItemType" }, "slrc_IncreaseDecreaseInPayableForInvestmentsAndCashEquivalentsPurchased": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 22.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in payable for investments and cash equivalents purchased.", "label": "Increase Decrease In Payable For Investments And Cash Equivalents Purchased", "terseLabel": "Payable for investments and cash equivalents purchased" } } }, "localname": "IncreaseDecreaseInPayableForInvestmentsAndCashEquivalentsPurchased", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_IncreaseDecreaseInPaymentsToAcquireInvestments": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in payments to acquire investments.", "label": "Increase Decrease In Payments To Acquire Investments", "terseLabel": "Purchase of investments" } } }, "localname": "IncreaseDecreaseInPaymentsToAcquireInvestments", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_IncreaseDecreaseInPerformanceBasedIncentiveFeePayable": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 24.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease In performance-based incentive fee payable.", "label": "Increase Decrease In Performance Based Incentive Fee Payable", "terseLabel": "Performance-based incentive fee payable" } } }, "localname": "IncreaseDecreaseInPerformanceBasedIncentiveFeePayable", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_IncreaseDecreaseInProceedsFromSaleMaturityAndCollectionsOfInvestments": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in proceeds from sale maturity and collections of investments.", "label": "Increase Decrease IN Proceeds From Sale Maturity And Collections Of Investments", "terseLabel": "Proceeds from disposition of investments" } } }, "localname": "IncreaseDecreaseInProceedsFromSaleMaturityAndCollectionsOfInvestments", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_IncreaseDecreaseOfCashAcquiredInMerger": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 21.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase decrease of cash acquired in merger.", "label": "Increase Decrease Of Cash Acquired In Merger", "negatedLabel": "Cash acquired in merger" } } }, "localname": "IncreaseDecreaseOfCashAcquiredInMerger", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_IncreaseDecreaseReceivableForInvestmentsSold": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease receivable for investments sold.", "label": "Increase Decrease Receivable For Investments Sold", "terseLabel": "Receivable for investments sold" } } }, "localname": "IncreaseDecreaseReceivableForInvestmentsSold", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_InsuranceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Insurance member.", "label": "Insurance [Member]", "terseLabel": "Insurance [Member]" } } }, "localname": "InsuranceMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_InterestAndOtherCreditFacilityExpenses": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest and other credit facility expenses.", "label": "Interest And Other Credit Facility Expenses", "terseLabel": "Interest and other credit facility expenses (see note 7)" } } }, "localname": "InterestAndOtherCreditFacilityExpenses", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "slrc_InterestPayableAndOtherCreditFacilityRelatedExpenses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Interest payable and other credit facility related expenses.", "label": "Interest payable and other credit facility related expenses", "terseLabel": "Interest payable and other credit facility related expenses" } } }, "localname": "InterestPayableAndOtherCreditFacilityRelatedExpenses", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "slrc_InternationalAutomotiveComponentsGroupNorthAmericaIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "International automotive components group north america inc", "label": "International Automotive Components Group North America Inc [Member]", "terseLabel": "International Automotive Components Group, North America, Inc. [Member]" } } }, "localname": "InternationalAutomotiveComponentsGroupNorthAmericaIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_InternetAndCatalogRetailMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Internet and catalog retail member.", "label": "Internet and Catalog Retail [Member]", "verboseLabel": "Internet & Catalog Retail [Member]" } } }, "localname": "InternetAndCatalogRetailMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_InternetSoftwareServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Internet Software & Services Member.", "label": "Internet Software & Services [Member]" } } }, "localname": "InternetSoftwareServicesMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_InvestmentCompanyEarningsDistribution": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "order": 3.0, "parentTag": "us-gaap_InvestmentCompanyDividendDistribution", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investment company earnings distribution.", "label": "Investment Company Earnings Distribution", "negatedLabel": "From net investment income" } } }, "localname": "InvestmentCompanyEarningsDistribution", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentCompanyIncreaseDecreaseInNetAssets": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase (decrease) in net assets.", "label": "Investment Company Increase Decrease In Net Assets", "totalLabel": "Total increase (decrease) in net assets" } } }, "localname": "InvestmentCompanyIncreaseDecreaseInNetAssets", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentCompanyInterestAndOtherCreditFacilityExpensesRatioAfterIncentiveAllocation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment company interest and other credit facility expenses ratio after incentive allocation.", "label": "Investment Company Interest And Other Credit Facility Expenses Ratio After Incentive Allocation", "terseLabel": "Interest and other credit facility expenses" } } }, "localname": "InvestmentCompanyInterestAndOtherCreditFacilityExpensesRatioAfterIncentiveAllocation", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "percentItemType" }, "slrc_InvestmentCompanyNetAssetsFromOperationIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment Company Net Assets From Operation Increase Decrease", "label": "Investment Company Net Assets From Operation Increase Decrease [Abstract]", "verboseLabel": "Investment Company Change in Net Assets" } } }, "localname": "InvestmentCompanyNetAssetsFromOperationIncreaseDecreaseAbstract", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "stringItemType" }, "slrc_InvestmentCompanyOperatingExpenseRatioExcludingIncentiveFee": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment company operating expense ratio excluding incentive fee.", "label": "Investment Company Operating Expense Ratio Excluding Incentive Fee" } } }, "localname": "InvestmentCompanyOperatingExpenseRatioExcludingIncentiveFee", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsParentheticalsDetails" ], "xbrltype": "percentItemType" }, "slrc_InvestmentCompanyOperatingExpensesRatioAfterIncentiveAllocation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment company operating expenses ratio after incentive allocation.", "label": "Investment Company Operating Expenses Ratio After Incentive Allocation", "terseLabel": "Operating expenses" } } }, "localname": "InvestmentCompanyOperatingExpensesRatioAfterIncentiveAllocation", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "percentItemType" }, "slrc_InvestmentCompanyPercentageOfHolding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment company percentage of holding.", "label": "Investment Company Percentage of Holding", "verboseLabel": "Investment company percentage of holding" } } }, "localname": "InvestmentCompanyPercentageOfHolding", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_InvestmentCompanyPerformanceBasedIncentiveFeesWaived": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Investment company performance based incentive fees waived.", "label": "Investment Company Performance Based Incentive Fees Waived", "terseLabel": "Performance-based incentive fees waived (see note 3)" } } }, "localname": "InvestmentCompanyPerformanceBasedIncentiveFeesWaived", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentCompanyReturnOfCapitalDistribution": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "order": 2.0, "parentTag": "us-gaap_InvestmentCompanyDividendDistribution", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of distributions to stockholders return of capital.", "label": "Investment Company Return Of Capital Distribution", "negatedLabel": "From return of capital" } } }, "localname": "InvestmentCompanyReturnOfCapitalDistribution", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentHoldingsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment Holdings.", "label": "Investment Holdings [Axis]" } } }, "localname": "InvestmentHoldingsAxis", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "slrc_InvestmentHoldingsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment Holdings.", "label": "Investment Holdings [Domain]" } } }, "localname": "InvestmentHoldingsDomain", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "slrc_InvestmentInSeniorSecuredLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment in senior secured loans.", "label": "Investment in Senior Secured Loans [Member]", "terseLabel": "Senior Secured Loans [Member]" } } }, "localname": "InvestmentInSeniorSecuredLoansMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "slrc_InvestmentIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment income.", "label": "Investment Income [Abstract]", "terseLabel": "INVESTMENT INCOME:" } } }, "localname": "InvestmentIncomeAbstract", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "slrc_InvestmentIncomeInvestmentExpensesNet": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 14.0, "parentTag": "us-gaap_NetInvestmentIncome", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investment income investment expenses net.", "label": "Investment Income Investment Expenses Net", "terseLabel": "Net expenses" } } }, "localname": "InvestmentIncomeInvestmentExpensesNet", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentOwnedAcquisitionDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment owned acquisition date.", "label": "Investment Owned Acquisition Date", "terseLabel": "Acquisition Date" } } }, "localname": "InvestmentOwnedAcquisitionDate", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "dateItemType" }, "slrc_InvestmentOwnedAtFairValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment owned at fair value.", "label": "Investment Owned At Fair Value [Abstract]", "terseLabel": "Investments at fair value:" } } }, "localname": "InvestmentOwnedAtFairValueAbstract", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "stringItemType" }, "slrc_InvestmentOwnedInterestAndDividendIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Investment owned, interest and dividend income.", "label": "Investment Owned, Interest And Dividend Income", "negatedLabel": "Interest/Dividend Income" } } }, "localname": "InvestmentOwnedInterestAndDividendIncome", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentOwnedUnrecognizedRealizedGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Investment owned, unrecognized realized gain loss.", "label": "Investment Owned, Unrecognized Realized Gain Loss", "negatedLabel": "Net realized gain (loss)" } } }, "localname": "InvestmentOwnedUnrecognizedRealizedGainLoss", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentOwnedUnrecognizedUnrealizedAdditions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investment owned, unrecognized unrealized additions.", "label": "Investment Owned, Unrecognized Unrealized Additions", "terseLabel": "Gross Additions" } } }, "localname": "InvestmentOwnedUnrecognizedUnrealizedAdditions", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentOwnedUnrecognizedUnrealizedGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Investment owned, unrecognized unrealized gain loss.", "label": "Investment Owned, Unrecognized Unrealized Gain Loss", "negatedLabel": "Net change in unrealized gain (loss)" } } }, "localname": "InvestmentOwnedUnrecognizedUnrealizedGainLoss", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentOwnedUnrecognizedUnrealizedReductions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Investment owned, unrecognized unrealized reductions.", "label": "Investment Owned, Unrecognized Unrealized Reductions", "negatedLabel": "Gross Reductions" } } }, "localname": "InvestmentOwnedUnrecognizedUnrealizedReductions", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentsOwnedFloorRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments owned floor rate .", "label": "Investments Owned Floor Rate", "terseLabel": "Floor" } } }, "localname": "InvestmentsOwnedFloorRate", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "percentItemType" }, "slrc_InvestmentsOwnedIndustryName": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments owned industry name.", "label": "Investments Owned Industry Name", "terseLabel": "Industry" } } }, "localname": "InvestmentsOwnedIndustryName", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "stringItemType" }, "slrc_InvestmentsOwnedInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments owned interest rate.", "label": "Investments Owned Interest Rate", "terseLabel": "Interest Rate" } } }, "localname": "InvestmentsOwnedInterestRate", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "percentItemType" }, "slrc_InvestmentsOwnedSpreadAboveIndexRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments owned Spread above index rate.", "label": "Investments Owned Spread Above Index Rate", "terseLabel": "Spread Above Index", "verboseLabel": "Spread Above Index" } } }, "localname": "InvestmentsOwnedSpreadAboveIndexRate", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "stringItemType" }, "slrc_IssuanceOfCommonStockInConnectionWithTheMerger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of common stock in connection with the merger.", "label": "Issuance of Common Stock in Connection With the Merger", "terseLabel": "Issuance of common stock in connection with the Merger" } } }, "localname": "IssuanceOfCommonStockInConnectionWithTheMerger", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "perShareItemType" }, "slrc_ItServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "IT services member.", "label": "IT Services [Member]" } } }, "localname": "ItServicesMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_IvyFertilityServicesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ivy fertility services, llc.", "label": "Ivy Fertility Services, LLC [Member]", "terseLabel": "Ivy Fertility Services, LLC [Member]", "verboseLabel": "Ivy Fertility Services, LLC [Member]" } } }, "localname": "IvyFertilityServicesLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_KaseyaIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kaseya Inc.", "label": "Kaseya Inc [Member]", "terseLabel": "Kaseya, Inc [Member]", "verboseLabel": "Kaseya, Inc. [Member]" } } }, "localname": "KaseyaIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_KbhTopcoLlcKingsbridgeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kbh topco llc (kingsbridge).", "label": "KBH Topco LLC (Kingsbridge) [Member]", "terseLabel": "KBH Topco LLC (Kingsbridge) [Member]" } } }, "localname": "KbhTopcoLlcKingsbridgeMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_KbhtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "KBHT", "label": "KBHT [Member]" } } }, "localname": "KbhtMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_KidDistroHoldingsLlcDistroKidMember": { "auth_ref": [], "lang": { "en-us": { "role": { "definitionGuidance": "Kid Distro Holdings, LLC (Distro Kid) [Member]", "documentation": "Kid distro holdings, llc (distro kid).", "label": "Kid Distro Holdings, LLC (Distro Kid) [Member]", "terseLabel": "Kid Distro Holdings, LLC (Distro Kid) [Member]", "verboseLabel": "Kid Distro Holdings, LLC [Member]" } } }, "localname": "KidDistroHoldingsLlcDistroKidMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_KidDistroHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kid distro holdings, LLC.", "label": "Kid Distro Holdings, LLC [Member]" } } }, "localname": "KidDistroHoldingsLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_KingsbridgeHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kingsbridge Holdings, LLC.", "label": "Kingsbridge Holdings, LLC [Member]", "terseLabel": "Kingsbridge Holdings, LLC [Member]" } } }, "localname": "KingsbridgeHoldingsLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_KoolPakLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kool pak llc.", "label": "Kool Pak LLC [Member]", "terseLabel": "Kool Pak, LLC [Member]" } } }, "localname": "KoolPakLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_KoreWirelessGroupInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kore wireless group, inc..", "label": "KORE Wireless Group, Inc. [Member]", "terseLabel": "KORE Wireless Group, Inc. [Member]" } } }, "localname": "KoreWirelessGroupInc.Member", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_LeisureEquipmentAndProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Leisure Equipment & Products member.", "label": "Leisure Equipment and Products [Member]" } } }, "localname": "LeisureEquipmentAndProductsMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_LiabilitiesInExcessOfOtherAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Liabilities in excess of other assets.", "label": "Liabilities in Excess of Other Assets", "negatedLabel": "Liabilities in Excess of Other Assets" } } }, "localname": "LiabilitiesInExcessOfOtherAssets", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "monetaryItemType" }, "slrc_LifeSciencesToolsAndServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Life sciences tools and services member.", "label": "Life Sciences Tools and Services [Member]", "verboseLabel": "Life Sciences Tools & Services [Member]" } } }, "localname": "LifeSciencesToolsAndServicesMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_LineOfCreditAndTermLoanOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of credit and term loan outstanding.", "label": "Line Of Credit And Term Loan Outstanding", "terseLabel": "Credit Facility, Carrying Value", "verboseLabel": "Line of credit and term loan outstanding" } } }, "localname": "LineOfCreditAndTermLoanOutstanding", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "slrc_LineOfCreditFacilityCommitmentsAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Line Of Credit Facility Commitments Amount", "label": "Line Of Credit Facility Commitments Amount", "terseLabel": "Line of credit facility commitments amount" } } }, "localname": "LineOfCreditFacilityCommitmentsAmount", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_LineOfCreditFacilityMaximumBorrowingCapacityWithAccordionFeature": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of credit facility maximum borrowing capacity with accordion feature.", "label": "Line Of Credit Facility Maximum Borrowing Capacity with Accordion Feature", "terseLabel": "Line of credit facility maximum borrowing capacity with accordion feature" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacityWithAccordionFeature", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_LineOfCreditMaximumBorrowingCapacityAndDebtInstrumentFaceValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of credit maximum borrowing capacity and debt instrument face value.", "label": "Line Of Credit Maximum Borrowing Capacity And Debt Instrument Face Value", "terseLabel": "Line of credit maximum borrowing capacity and debt instrument face value" } } }, "localname": "LineOfCreditMaximumBorrowingCapacityAndDebtInstrumentFaceValue", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_LocPerformanceProductsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loc Performance Products, LLC.", "label": "Loc Performance Products, LLC [Member]" } } }, "localname": "LocPerformanceProductsLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_LogixHoldingCompanyLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Logix holding company, llc.", "label": "Logix Holding Company, LLC [Member]", "terseLabel": "Logix Holding Company, LLC [Member]" } } }, "localname": "LogixHoldingCompanyLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_LondonInterbankOfferedRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "London interbank offered rate.", "label": "London Interbank Offered Rate [Member]" } } }, "localname": "LondonInterbankOfferedRateMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_LongTermDebtMaximumAmountBorrowedDuringThePeriod": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long term debt maximum amount borrowed during the period.", "label": "Long Term Debt Maximum Amount Borrowed During The Period", "terseLabel": "Long term debt maximum amount borrowed during the period" } } }, "localname": "LongTermDebtMaximumAmountBorrowedDuringThePeriod", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_LongTermDebtOneAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long term debt one.", "label": "Long Term Debt One [Axis]" } } }, "localname": "LongTermDebtOneAxis", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "slrc_LongTermDebtOneDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long term debt one.", "label": "Long Term Debt One [Domain]" } } }, "localname": "LongTermDebtOneDomain", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_LongTermInvestmentsMeasurementInput": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long term investments measurement input.", "label": "Long Term Investments Measurement Input" } } }, "localname": "LongTermInvestmentsMeasurementInput", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "pureItemType" }, "slrc_LoyerCapitalLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loyer capital llc.", "label": "Loyer Capital LLC [Member]", "terseLabel": "Loyer Capital LLC [Member]" } } }, "localname": "LoyerCapitalLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_LuxCreditConsultantsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lux credit consultants llc.", "label": "Lux Credit Consultants LLC [Member]", "terseLabel": "Lux Credit Consultants, LLC [Member]" } } }, "localname": "LuxCreditConsultantsLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_LuxVendingLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lux vending llc.", "label": "Lux Vending LLC [Member]", "terseLabel": "Lux Vending, LLC [Member]" } } }, "localname": "LuxVendingLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_LuxuryAssetCapitalLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Luxury asset capital, LLC.", "label": "Luxury Asset Capital, LLC [Member]" } } }, "localname": "LuxuryAssetCapitalLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_MachineryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Machinery member.", "label": "Machinery [Member]" } } }, "localname": "MachineryMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_MauricesIncorporatedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maurices, incorporated.", "label": "Maurices, Incorporated [Member]", "terseLabel": "Maurices, Incorporated [Member]" } } }, "localname": "MauricesIncorporatedMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_MaxorAcquisitionInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maxor Acquisition Inc. Member.", "label": "Maxor Acquisition Inc. [Member]", "terseLabel": "Maxor Acquisition, Inc. [Member]" } } }, "localname": "MaxorAcquisitionInc.Member", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_MeasuredAtNetAssetValueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measured at net asset value.", "label": "Measured at Net Asset Value [Member]" } } }, "localname": "MeasuredAtNetAssetValueMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "domainItemType" }, "slrc_MeasurementInputComparableMultipleMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input comparable multiple.", "label": "Measurement Input Comparable Multiple [Member]", "terseLabel": "Comparable Multiple [Member]" } } }, "localname": "MeasurementInputComparableMultipleMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "slrc_MeasurementInputMarketYieldMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input market yield.", "label": "Measurement Input Market Yield [Member]", "terseLabel": "Market Yield [Member]" } } }, "localname": "MeasurementInputMarketYieldMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "slrc_MeasurementInputRecoverableAmountMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input recoverable amount.", "label": "Measurement Input Recoverable Amount [Member]", "terseLabel": "Recoverable Amount [Member]" } } }, "localname": "MeasurementInputRecoverableAmountMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails" ], "xbrltype": "domainItemType" }, "slrc_MeasurementInputReturnOnEquityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input return on equity.", "label": "Measurement Input Return on Equity [Member]", "terseLabel": "Return on Equity [Member]" } } }, "localname": "MeasurementInputReturnOnEquityMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "slrc_MeasurementInputTypeOneAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input type one.", "label": "Measurement Input Type One [Axis]" } } }, "localname": "MeasurementInputTypeOneAxis", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "stringItemType" }, "slrc_MeasurementInputTypeOneDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input type one.", "label": "Measurement Input Type One [Domain]" } } }, "localname": "MeasurementInputTypeOneDomain", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "slrc_MediaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Media", "label": "Media [Member]", "terseLabel": "Media [Member]" } } }, "localname": "MediaMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_MeditrinaInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Meditrina, inc.", "label": "Meditrina, Inc. [Member]" } } }, "localname": "MeditrinaInc.Member", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_MeditrinaIncWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Meditrina, Inc warrants.", "label": "Meditrina, Inc Warrants [Member]", "terseLabel": "Meditrina, Inc. Warrants [Member]" } } }, "localname": "MeditrinaIncWarrantsMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_MetalsAndMiningMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Metals and mining member.", "label": "Metals and Mining [Member]", "terseLabel": "Metals & Mining [Member]" } } }, "localname": "MetalsAndMiningMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_MirandaLogisticsEnterpriseIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Miranda logistics enterprise, inc.", "label": "Miranda Logistics Enterprise, Inc [Member]" } } }, "localname": "MirandaLogisticsEnterpriseIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_MontefioreNyackHospitalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Montefiore nyack Hospital.", "label": "Montefiore Nyack Hospital [Member]" } } }, "localname": "MontefioreNyackHospitalMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_MountainAirHelicoptersIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mountain air helicopters inc.", "label": "Mountain Air Helicopters Inc [Member]", "terseLabel": "Mountain Air Helicopters, Inc. [Member]" } } }, "localname": "MountainAirHelicoptersIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_MultiSectorHoldingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Multi-sector holdings member.", "label": "Multi Sector Holdings [Member]", "verboseLabel": "Multi-Sector Holdings (includes Kingsbridge Holdings, LLC, SLR Equipment Finance, Equipment Operating Leases, LLC and Loyer Capital LLC) [Member]" } } }, "localname": "MultiSectorHoldingsMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_NacHoldingsCorporationJaguarMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nac holdings corporation (jaguar).", "label": "NAC Holdings Corporation (Jaguar) [Member]", "terseLabel": "NAC Holdings Corporation (Jaguar) [Member]" } } }, "localname": "NacHoldingsCorporationJaguarMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_NacHoldingsCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NAC Holdings Corporation", "label": "NAC Holdings Corporation [Member]", "terseLabel": "NAC Holdings Corporation [Member]" } } }, "localname": "NacHoldingsCorporationMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "xbrltype": "domainItemType" }, "slrc_NationalSpineAndPainCentersLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "National Spine and Pain Centers LLC Member.", "label": "National Spine and Pain Centers LLC [Member]", "terseLabel": "National Spine and Pain Centers, LLC [Member]" } } }, "localname": "NationalSpineAndPainCentersLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_NefpassFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NEFPASS Facility [Member]", "verboseLabel": "NEFPASS Facility [Member]" } } }, "localname": "NefpassFacilityMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_NetAssetValuePerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net asset value per share.", "label": "Net Asset Value Per Share [Abstract]", "terseLabel": "Net Asset Value Per Share [Abstract]" } } }, "localname": "NetAssetValuePerShareAbstract", "nsuri": "http://www.slrinvestments.com/20230630", "xbrltype": "stringItemType" }, "slrc_NetAssetValuePerShareTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net asset value per share.", "label": "Net Asset Value Per Share [Text Block]", "terseLabel": "Net Asset Value Per Share" } } }, "localname": "NetAssetValuePerShareTextBlock", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/NetAssetValuePerShare" ], "xbrltype": "textBlockItemType" }, "slrc_NetAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net assets [Abstract].", "label": "Net Assets [Abstract]", "terseLabel": "Net Assets" } } }, "localname": "NetAssetsAbstract", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "stringItemType" }, "slrc_NetChangeInUnrealizedGainLossOnInvestments": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net change in unrealized gain loss on investments.", "label": "Net Change In Unrealized Gain Loss On Investments", "negatedLabel": "Net change in unrealized loss on investments" } } }, "localname": "NetChangeInUnrealizedGainLossOnInvestments", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_NetIncreaseInNetAssetsResultingFromoperations": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net increase in net assets resulting from\u00a0operations.", "label": "Net Increase In Net Assets Resulting From Operations", "negatedLabel": "Net increase (decrease) in net assets resulting from operations" } } }, "localname": "NetIncreaseInNetAssetsResultingFromoperations", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_NetRealizedGainLossOnInvestmentsAndCashEquivalents": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net realized (gain) loss on investments and cash equivalents.", "label": "Net Realized Gain Loss On Investments And Cash Equivalents", "negatedLabel": "Net realized (gain) loss on investments and cash equivalents" } } }, "localname": "NetRealizedGainLossOnInvestmentsAndCashEquivalents", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_NeuroneticsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Neuronetics, inc.", "label": "Neuronetics, Inc. [Member]", "terseLabel": "Neuronetics, Inc. [Member]" } } }, "localname": "NeuroneticsInc.Member", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_NmHoldcoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NM Holdco [Member].", "label": "NM Holdco [Member]", "terseLabel": "NM Holdco [Member]" } } }, "localname": "NmHoldcoMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_NmcSeniorCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NMC senior credit facility.", "label": "NMC Senior Credit Facility [Member]", "terseLabel": "NMC Senior Credit Facility [Member]" } } }, "localname": "NmcSeniorCreditFacilityMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_NmcsCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NMC's credit facility [Member].", "label": "NMCs Credit Facility [Member]", "terseLabel": "NMCs Credit Facility [Member]" } } }, "localname": "NmcsCreditFacilityMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_NoLimitConstructionServicesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No limit construction services, LLC.", "label": "No Limit Construction Services, LLC [Member]" } } }, "localname": "NoLimitConstructionServicesLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_NorthMillCapitalLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "North Mill Capital LLC Member", "label": "North Mill Capital LLC [Member]", "terseLabel": "North Mill Capital LLC [Member]" } } }, "localname": "NorthMillCapitalLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_NspcHoldingsLlcNationalSpineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NSPC Holdings, LLC (National Spine) .", "label": "NSPC Holdings, LLC (National Spine) [Member]" } } }, "localname": "NspcHoldingsLlcNationalSpineMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_NspcIntermediateCorpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NSPC Intermediate Corp Member.", "label": "NSPC Intermediate Corp [Member]", "terseLabel": "NSPC Intermediate Corp. (National Spine) [Member]" } } }, "localname": "NspcIntermediateCorpMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_NumberOfCustomers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Customers.", "label": "Number Of Customers", "terseLabel": "Number of Customers" } } }, "localname": "NumberOfCustomers", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "slrc_NumberOfFundedCommitment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of funded commitment.", "label": "Number Of Funded Commitment", "terseLabel": "Number of funded commitments" } } }, "localname": "NumberOfFundedCommitment", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "slrc_NumberOfIssuerInBusinessCredit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of issuer in business credit.", "label": "Number Of Issuer In Business Credit", "terseLabel": "Number of issuers in business credit" } } }, "localname": "NumberOfIssuerInBusinessCredit", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "slrc_NumberOfLoanInBusinessCredit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Loan in business credit.", "label": "Number Of Loan In Business Credit", "terseLabel": "Number of loans in business credit" } } }, "localname": "NumberOfLoanInBusinessCredit", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "slrc_OilGasAndConsumableFuelsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Oil, gas and consumable fuels member.", "label": "Oil, Gas and Consumable Fuels [Member]", "verboseLabel": "Oil, Gas & Consumable Fuels [Member]" } } }, "localname": "OilGasAndConsumableFuelsMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_OmniGuideHoldingsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Omni Guide Holdings, Inc member.", "label": "Omni Guide Holdings, Inc [Member]" } } }, "localname": "OmniGuideHoldingsIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_OmniguideHoldingsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "OmniGuide holdings, inc.", "label": "OmniGuide Holdings, Inc. [Member]", "terseLabel": "OmniGuide Holdings, Inc. [Member]" } } }, "localname": "OmniguideHoldingsInc.Member", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_OneTouchDirectLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "One touch direct, llc.", "label": "One Touch Direct, LLC [Member]", "terseLabel": "One Touch Direct, LLC [Member]" } } }, "localname": "OneTouchDirectLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_OnsMsoLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ONS MSO, LLC Member.", "label": "ONS MSO, LLC [Member]" } } }, "localname": "OnsMsoLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_OrthopedicCarePartnersManagementLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Orthopedic care partners management, LLC.", "label": "Orthopedic Care Partners Management, LLC [Member]" } } }, "localname": "OrthopedicCarePartnersManagementLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_OutsetMedicalInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Outset medical, inc.", "label": "Outset Medical, Inc. [Member]" } } }, "localname": "OutsetMedicalInc.Member", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_OzziesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ozzies, Inc", "label": "Ozzies, Inc [Member]", "terseLabel": "Ozzies, Inc. [Member]" } } }, "localname": "OzziesIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PackagedFoodsAndMeatsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Packaged foods and meats member.", "label": "Packaged Foods and Meats [Member]", "verboseLabel": "Packaged Foods & Meats [Member]" } } }, "localname": "PackagedFoodsAndMeatsMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PayableForInvestmentsAndCashEquivalentsPurchased": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payable for investments and cash equivalents purchased.", "label": "Payable For Investments And Cash Equivalents Purchased", "terseLabel": "Payable for investments and cash equivalents purchased" } } }, "localname": "PayableForInvestmentsAndCashEquivalentsPurchased", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "slrc_PcxAerostructuresLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PCX Aerostructures LLC.", "label": "PCX Aerostructures LLC [Member]" } } }, "localname": "PcxAerostructuresLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PediatricHomeRespiratoryServicesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pediatric home respiratory services, LLC.", "label": "Pediatric Home Respiratory Services, LLC [Member]" } } }, "localname": "PediatricHomeRespiratoryServicesLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PerShareDataAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share data.", "label": "Per Share Data [Abstract]", "terseLabel": "Per Share Data:" } } }, "localname": "PerShareDataAbstract", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "stringItemType" }, "slrc_PercentageOfCumulativeNetRealizedGainAndUnrealizedCapitalAppreciation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage Of Cumulative Net Realized Gain And Unrealized Capital Appreciation", "label": "Percentage Of Cumulative Net Realized Gain And Unrealized Capital Appreciation", "terseLabel": "Percentage of cumulative net realized gain and unrealized capital appreciation" } } }, "localname": "PercentageOfCumulativeNetRealizedGainAndUnrealizedCapitalAppreciation", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "slrc_PercentageOfCumulativeRealizedCapitalGainLoss": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage Of Cumulative Realized Capital Gain Loss", "label": "Percentage of Cumulative Realized Capital Gain Loss", "terseLabel": "Percentage of cumulative realized capital gain loss" } } }, "localname": "PercentageOfCumulativeRealizedCapitalGainLoss", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "slrc_PercentageOfEquityInterestContributedToAnotherEntity": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of equity interest contributed to another entity.", "label": "Percentage Of Equity Interest Contributed To Another Entity", "terseLabel": "Percentage of equity interest contributed to another entity" } } }, "localname": "PercentageOfEquityInterestContributedToAnotherEntity", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "slrc_PercentageOfExciseTax": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of excise tax.", "label": "Percentage Of Excise Tax", "terseLabel": "Percentage of excise tax" } } }, "localname": "PercentageOfExciseTax", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "slrc_PercentageOfGrossAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of gross assets.", "label": "Percentage Of Gross Assets", "terseLabel": "Percentage of gross assets" } } }, "localname": "PercentageOfGrossAssets", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "slrc_PercentageOfNonQualifyingAssetsInThePortfolioOfTotalAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of non qualifying\u00a0assets in the portfolio of total assets.", "label": "Percentage of Non Qualifying Assets in the Portfolio of Total Assets", "terseLabel": "Percentage of non-qualifying\u00a0assets in the portfolio of total assets" } } }, "localname": "PercentageOfNonQualifyingAssetsInThePortfolioOfTotalAssets", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageOfOutstandingVotingSecuritiesOfTheInvestment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of outstanding voting securities of the investment.", "label": "Percentage of Outstanding Voting Securities of the Investment", "terseLabel": "Percentage of outstanding voting securities of the investment" } } }, "localname": "PercentageOfOutstandingVotingSecuritiesOfTheInvestment", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageOfPreIncentiveFeeNetInvestmentIncome": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of pre-incentive fee net investment income.", "label": "Percentage of Pre Incentive Fee Net Investment Income", "terseLabel": "Percentage of pre-incentive fee net investment income" } } }, "localname": "PercentageOfPreIncentiveFeeNetInvestmentIncome", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "slrc_PercentageOfTotalNetAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of total net assets.", "label": "Percentage Of Total Net Assets", "terseLabel": "Percentage of total net assets" } } }, "localname": "PercentageOfTotalNetAssets", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "slrc_PercentageRepresentingCashEquivalentsInInvestmentsOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage representing cash equivalents in investments owned.", "label": "Percentage Representing Cash Equivalents in Investments Owned", "terseLabel": "Percentage representing cash equivalents in investments owned" } } }, "localname": "PercentageRepresentingCashEquivalentsInInvestmentsOwned", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageRepresentingCommonEquityOrEquityInterestsOrWarrantsOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage representing common equity or equity interests or warrants owned.", "label": "Percentage Representing Common Equity Or Equity Interests Or Warrants Owned", "terseLabel": "Percentage representing common equity or equity interests or warrants owned" } } }, "localname": "PercentageRepresentingCommonEquityOrEquityInterestsOrWarrantsOwned", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageRepresentingEquipmentFinancingInInvestmentsOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage representing equipment financing in investments owned.", "label": "Percentage Representing Equipment Financing in Investments Owned", "terseLabel": "Percentage representing equipment financing in investments owned" } } }, "localname": "PercentageRepresentingEquipmentFinancingInInvestmentsOwned", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageRepresentingLiabilitiesInExcessOfOtherAssetsInInvestmentsOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage representing liabilities in excess of other assets in investments owned.", "label": "Percentage Representing Liabilities in Excess of Other Assets in Investments Owned", "terseLabel": "Percentage representing liabilities in excess of other assets in investments owned" } } }, "localname": "PercentageRepresentingLiabilitiesInExcessOfOtherAssetsInInvestmentsOwned", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageRepresentingNetAssetsInInvestmentsOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage representing net assets in investments owned.", "label": "Percentage Representing Net Assets in Investments Owned", "terseLabel": "Percentage representing net assets in investments owned" } } }, "localname": "PercentageRepresentingNetAssetsInInvestmentsOwned", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageRepresentingPreferredEquityInInvestmentsOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage representing preferred equity in investments owned.", "label": "Percentage Representing Preferred Equity in Investments Owned", "terseLabel": "Percentage representing preferred equity in investments owned" } } }, "localname": "PercentageRepresentingPreferredEquityInInvestmentsOwned", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageRepresentingSeniorSecuredLoansInInvestmentsOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage representing senior secured loans in investments owned.", "label": "Percentage Representing Senior Secured Loans In Investments Owned", "terseLabel": "Percentage representing senior secured loans in investments owned" } } }, "localname": "PercentageRepresentingSeniorSecuredLoansInInvestmentsOwned", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageRepresentingTotalInvestmentsAndCashEquivalentsInInvestmentsOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage representing total investments and cash equivalents in investments owned.", "label": "Percentage Representing Total Investments and Cash Equivalents in Investments Owned", "terseLabel": "Percentage representing total investments and cash equivalents in investments owned" } } }, "localname": "PercentageRepresentingTotalInvestmentsAndCashEquivalentsInInvestmentsOwned", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageRepresentingTotalInvestmentsInInvestmentsOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage representing total investments in investments owned.", "label": "Percentage Representing Total Investments in Investments Owned", "terseLabel": "Percentage representing total investments in investments owned" } } }, "localname": "PercentageRepresentingTotalInvestmentsInInvestmentsOwned", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageSpreadAsCash": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage spread as cash.", "label": "Percentage Spread as Cash", "terseLabel": "Percentage spread as cash" } } }, "localname": "PercentageSpreadAsCash", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageSpreadAsPaidInKind": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage spread as paid in kind .", "label": "Percentage Spread as Paid in Kind", "terseLabel": "Percentage spread as paid in kind" } } }, "localname": "PercentageSpreadAsPaidInKind", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PerformanceBasedIncentiveFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Performance Based Incentive Fees", "label": "Performance Based Incentive Fees", "terseLabel": "Performance based incentive fees" } } }, "localname": "PerformanceBasedIncentiveFees", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_PerformanceBasedIncentiveFeesWaiver": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Performance based incentive fees waiver.", "label": "Performance Based Incentive Fees Waiver" } } }, "localname": "PerformanceBasedIncentiveFeesWaiver", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_PersonalProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Personal products member.", "label": "Personal Products [Member]", "terseLabel": "Personal Products [Member]" } } }, "localname": "PersonalProductsMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_PeterC.FoyAssociatesInsuranceServicesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Peter C. Foy Associates Insurance Services LLC.", "label": "Peter C. Foy Associates Insurance Services LLC [Member]", "terseLabel": "Peter C. Foy & Associates Insurance Services, LLC [Member]" } } }, "localname": "PeterC.FoyAssociatesInsuranceServicesLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "xbrltype": "domainItemType" }, "slrc_PeterCFoyandAssociatesInsuranceServicesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Peter C Foy\u00a0And Associates Insurance Services LLC Member.", "label": "Peter C FoyAnd Associates Insurance Services LLC [Member]", "terseLabel": "Peter C. Foy & Associates Insurance Services, LLC [Member]" } } }, "localname": "PeterCFoyandAssociatesInsuranceServicesLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PharmaceuticalsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pharmaceuticals member.", "label": "Pharmaceuticals [Member]" } } }, "localname": "PharmaceuticalsMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PhynetDermatologyLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Phynet dermatology llc.", "label": "PhyNet Dermatology LLC [Member]", "terseLabel": "PhyNet Dermatology LLC [Member]" } } }, "localname": "PhynetDermatologyLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_PinnacleTreatmentCentersInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pinnacle treatment centers, inc.", "label": "Pinnacle Treatment Centers, Inc. [Member]", "terseLabel": "Pinnacle Treatment Centers, Inc. [Member]" } } }, "localname": "PinnacleTreatmentCentersInc.Member", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PinnacleTreatmentCentersIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pinnacle treatment centers, inc.", "label": "Pinnacle Treatment Centers, Inc [Member]" } } }, "localname": "PinnacleTreatmentCentersIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_PlasticsManagementLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plastics Management LLC.", "label": "Plastics Management LLC [Member]", "terseLabel": "Plastics Management, LLC [Member]" } } }, "localname": "PlasticsManagementLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_PortfolioTurnoverRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Portfolio turnover ratio.", "label": "Portfolio Turnover Ratio", "terseLabel": "Portfolio turnover ratio" } } }, "localname": "PortfolioTurnoverRatio", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "percentItemType" }, "slrc_PptManagementHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ppt management holdings, llc.", "label": "PPT Management Holdings, LLC [Member]", "terseLabel": "PPT Management Holdings, LLC [Member]" } } }, "localname": "PptManagementHoldingsLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PreIncentiveFeeNetInvestmentIncomeAnnualHurdleRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pre-incentive fee net investment income annual hurdle rate.", "label": "Pre Incentive Fee Net Investment Income Annual Hurdle Rate", "terseLabel": "Pre-incentive fee net investment income Annual hurdle rate" } } }, "localname": "PreIncentiveFeeNetInvestmentIncomeAnnualHurdleRate", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "slrc_PreIncentiveFeeNetInvestmentIncomeQuarterHurdleRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pre-incentive fee net investment income Quarter hurdle rate.", "label": "Pre Incentive Fee Net Investment Income Quarter Hurdle Rate", "terseLabel": "Pre-incentive fee net investment income Quarter hurdle rate" } } }, "localname": "PreIncentiveFeeNetInvestmentIncomeQuarterHurdleRate", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "slrc_PreferredEquityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred equity.", "label": "Preferred Equity [Member]", "terseLabel": "Preferred Equity [Member]" } } }, "localname": "PreferredEquityMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "slrc_PreferredEquityzeroPointFourPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred EquityZero Point Four Percent Member.", "label": "Preferred EquityZero Point Four Percent [Member]", "terseLabel": "Preferred Equity \u2013 0.4% [Member]" } } }, "localname": "PreferredEquityzeroPointFourPercentMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RaneLightMetalCastingsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rane light metal castings inc.", "label": "Rane Light Metal Castings Inc [Member]", "terseLabel": "Rane Light Metal Castings Inc. [Member]" } } }, "localname": "RaneLightMetalCastingsIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RangoIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rango inc.", "label": "Rango Inc [Member]", "terseLabel": "Rango, Inc. [Member]" } } }, "localname": "RangoIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RayzorsEdgeLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rayzor's edge LLC.", "label": "Rayzors Edge LLC [Member]", "terseLabel": "Rayzor's Edge LLC [Member]" } } }, "localname": "RayzorsEdgeLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RdHoldcoInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "RD holdco, Inc.", "label": "RD Holdco, Inc. [Member]" } } }, "localname": "RdHoldcoInc.Member", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RdHoldcoIncClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "RD Holdco Inc Class B.", "label": "RD Holdco Inc Class B [Member]", "terseLabel": "RD Holdco Inc. (Rug Doctor, class B) [Member]" } } }, "localname": "RdHoldcoIncClassBMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_RdHoldcoIncCommonEquityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "RD Holdco Inc Common Equity.", "label": "RD Holdco Inc Common Equity [Member]" } } }, "localname": "RdHoldcoIncCommonEquityMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_RdHoldcoIncDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RD Holdco Inc Debt [Member]" } } }, "localname": "RdHoldcoIncDebtMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_RdHoldcoIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rd holdco inc.", "label": "RD Holdco Inc [Member]", "terseLabel": "RD Holdco Inc. (Rug Doctor) [Member]" } } }, "localname": "RdHoldcoIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RdHoldcoIncWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RD Holdco Inc Warrants [Member]", "terseLabel": "RD Holdco Inc. (Rug Doctor, Warrants) [Member]" } } }, "localname": "RdHoldcoIncWarrantsMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_ReceivableForInvestmentsSold": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 15.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Receivable for investments sold.", "label": "Receivable for Investments Sold", "terseLabel": "Receivable for investments sold" } } }, "localname": "ReceivableForInvestmentsSold", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "slrc_RecourseDebt": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Recourse debt.", "label": "Recourse Debt", "terseLabel": "Recourse debt" } } }, "localname": "RecourseDebt", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_RestrictedInvestmentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted investment term.", "label": "Restricted Investment Term", "terseLabel": "Restricted investment term" } } }, "localname": "RestrictedInvestmentTerm", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "slrc_RhLandConstructionLlcHarborDredgingLaIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rh land construction, llc & harbor dredging la, inc.", "label": "RH Land Construction, LLC Harbor Dredging LA, Inc [Member]" } } }, "localname": "RhLandConstructionLlcHarborDredgingLaIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RoadAndRailMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Road and rail member.", "label": "Road and Rail [Member]", "verboseLabel": "Road & Rail [Member]" } } }, "localname": "RoadAndRailMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RottenRockHardscapingAndTreeServiceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rotten Rock Hardscaping and Tree Service", "label": "Rotten Rock Hardscaping and Tree Service [Member]", "terseLabel": "Rotten Rock Hardscaping & Tree Service [Member]" } } }, "localname": "RottenRockHardscapingAndTreeServiceMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RoyalCoachLinesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Royal coach lines inc.", "label": "Royal Coach Lines Inc [Member]", "terseLabel": "Royal Coach Lines, Inc.[Member]" } } }, "localname": "RoyalCoachLinesIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RoyalExpressIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Royal express inc.", "label": "Royal Express Inc [Member]", "terseLabel": "Royal Express Inc. [Member]" } } }, "localname": "RoyalExpressIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RqmCorp.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "RQM Corp.", "label": "RQM Corp. [Member]", "terseLabel": "RQM+ Corp. [Member]" } } }, "localname": "RqmCorp.Member", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RqmCorpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "RQM+ Corp.", "label": "RQM Corp [Member]", "terseLabel": "RQM+ Corp [Member]" } } }, "localname": "RqmCorpMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_RscAcquisitionIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "RSC acquisition Inc.", "label": "RSC Acquisition Inc [Member]", "terseLabel": "RSC Acquisition, Inc [Member]" } } }, "localname": "RscAcquisitionIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_RxsenseHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "RxSense holdings LLC.", "label": "RxSense Holdings LLC [Member]", "terseLabel": "RxSense Holdings LLC [Member]" } } }, "localname": "RxsenseHoldingsLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_ScpEyeCareLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SCP eye care, LLC.", "label": "SCP Eye Care, LLC [Member]" } } }, "localname": "ScpEyeCareLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SecondLienAssetbasedSeniorSecuredLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Second lien asset based senior secured loans.", "label": "Second Lien AssetBased Senior Secured Loans [Member]", "terseLabel": "Second Lien Asset-Based Senior Secured Loans [Member]" } } }, "localname": "SecondLienAssetbasedSeniorSecuredLoansMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SecondLienBankDebtOrSeniorSecuredLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Second lien bank debt or senior secured loans.", "label": "Second Lien Bank Debt or Senior Secured Loans [Member]", "terseLabel": "Second Lien Bank Debt/Senior Secured Loans [Member]" } } }, "localname": "SecondLienBankDebtOrSeniorSecuredLoansMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SecuredOvernightFinancingRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Secured Overnight Financing Rate [Member]" } } }, "localname": "SecuredOvernightFinancingRateMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SeniorSecuredCommitmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior-secured commitments [Member].", "label": "Senior Secured Commitments [Member]", "terseLabel": "Senior Secured Commitments [Member]" } } }, "localname": "SeniorSecuredCommitmentsMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Secured Loans At One Hundred And Thirty Four Point Four Percent.", "label": "Senior Secured Loans At One Hundred And Thirty Four Point Four Percent [Member]", "terseLabel": "Senior Secured Loans \u2014 134.4% [Member]" } } }, "localname": "SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Secured Loans at One hundred and Twenty Four Point Six Percent.", "label": "Senior Secured Loans at One hundred and Twenty Four Point Six Percent [Member]", "terseLabel": "Senior Secured Loans \u2014 124.6% [Member]" } } }, "localname": "SeniorSecuredLoansAtOneHundredAndTwentyFourPointSixPercentMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SeniorSecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Senior Secured Notes [Member]", "verboseLabel": "Senior Secured Notes [Member]" } } }, "localname": "SeniorSecuredNotesMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_SeniorSecuredRevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "senior secured revolving credit facility member.", "label": "Senior Secured Revolving Credit Facility [Member]", "verboseLabel": "Senior Secured Revolving Credit Facility [Member]" } } }, "localname": "SeniorSecuredRevolvingCreditFacilityMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SenseonicsHoldingsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senseonics holdings inc.", "label": "Senseonics Holdings Inc [Member]", "terseLabel": "Senseonics Holdings, Inc. [Member]" } } }, "localname": "SenseonicsHoldingsIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SharesIssuedInConnectionWithTheMergersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued in connection with the mergers.", "label": "Shares Issued In Connection With The Mergers [Member]", "terseLabel": "Shares issued in connection with the Mergers [Member]" } } }, "localname": "SharesIssuedInConnectionWithTheMergersMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails" ], "xbrltype": "domainItemType" }, "slrc_ShoHoldingICorporationShoesForCrewsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SHO Holding I Corporation Shoes for Crews Member.", "label": "SHO Holding I Corporation Shoes for Crews [Member]", "terseLabel": "SHO Holding I Corporation (Shoes for Crews) [Member]" } } }, "localname": "ShoHoldingICorporationShoesForCrewsMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SignetMarineCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Signet marine corporation.", "label": "Signet Marine Corporation [Member]" } } }, "localname": "SignetMarineCorporationMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SlrBusinessCreditDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Business Credit Disclosure TextBlock", "label": "SLR Business Credit Disclosure [Text Block]", "terseLabel": "SLR Business Credit" } } }, "localname": "SlrBusinessCreditDisclosureTextBlock", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCredit" ], "xbrltype": "textBlockItemType" }, "slrc_SlrBusinessCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Business Credit Facility", "label": "SLR Business Credit Facility [Member]", "terseLabel": "SLR Business Credit Facility [Member]" } } }, "localname": "SlrBusinessCreditFacilityMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SlrBusinessCreditLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Business Credit [Line Item]", "label": "SLR Business Credit [Line Items]" } } }, "localname": "SlrBusinessCreditLineItems", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "slrc_SlrBusinessCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Business Credit [Member].", "label": "SLR Business Credit [Member]", "terseLabel": "SLR Business Credit [Member]" } } }, "localname": "SlrBusinessCreditMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SlrBusinessCreditTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Business Credit Table", "label": "SLR Business Credit [Table]" } } }, "localname": "SlrBusinessCreditTable", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "slrc_SlrCreditSolutionTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Credit Solution Text Block", "label": "SLR Credit Solution [Text Block]", "terseLabel": "SLR Credit Solutions" } } }, "localname": "SlrCreditSolutionTextBlock", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutions" ], "xbrltype": "textBlockItemType" }, "slrc_SlrCreditSolutionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Slr credit solutions.", "label": "SLR Credit Solutions [Member]", "terseLabel": "SLR Credit Solutions [Member]" } } }, "localname": "SlrCreditSolutionsMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_SlrEquipmentFinanceDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Equipment Finance Debt.", "label": "SLR Equipment Finance Debt [Member]" } } }, "localname": "SlrEquipmentFinanceDebtMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_SlrEquipmentFinanceEquityInterestsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Slr equipment finance equity interests.", "label": "SLR Equipment Finance Equity Interests [Member]", "terseLabel": "SLR Equipment Finance Equity Interests [Member]" } } }, "localname": "SlrEquipmentFinanceEquityInterestsMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SlrEquipmentFinanceEquityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Equipment Finance Equity.", "label": "SLR Equipment Finance Equity [Member]" } } }, "localname": "SlrEquipmentFinanceEquityMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_SlrEquipmentFinanceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR equipment finance.", "label": "SLR Equipment Finance [Member]", "terseLabel": "SLR Equipment Finance [Member]", "verboseLabel": "SLR Equipment Finance [Member]" } } }, "localname": "SlrEquipmentFinanceMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrEquipmentFinance", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SlrHealthcareAblCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Healthcare ABL Credit.", "label": "SLR Healthcare ABL Credit [Member]", "terseLabel": "SLR Healthcare ABL Credit [Member]" } } }, "localname": "SlrHealthcareAblCreditMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SlrHealthcareAblMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR healthcare ABL.", "label": "SLR Healthcare ABL [Member]", "terseLabel": "SLR Healthcare ABL [Member]" } } }, "localname": "SlrHealthcareAblMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SlrHealthcareAblTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR healthcare ABL.", "label": "SLR Healthcare ABL [Text Block]", "verboseLabel": "SLR Healthcare ABL" } } }, "localname": "SlrHealthcareAblTextBlock", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrHealthcareAbl" ], "xbrltype": "textBlockItemType" }, "slrc_SlrSeniorLendingProgramLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Senior Lending Program LLC", "label": "SLR Senior Lending Program LLC [Member]", "verboseLabel": "SLR Senior Lending Program LLC [Member]" } } }, "localname": "SlrSeniorLendingProgramLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpParentheticalDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_SlrSeniorLendingProgramSpvLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Senior Lending Program SPV LLC member.", "label": "SLR Senior Lending Program SPV LLC [Member]", "terseLabel": "SLR Senior Lending Program SPV LLC [Member]" } } }, "localname": "SlrSeniorLendingProgramSpvLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SlramiTopcoBlockerLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR-AMI topco blocker, LLC.", "label": "SLRAMI Topco Blocker, LLC [Member]" } } }, "localname": "SlramiTopcoBlockerLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_SmileyLiftingSolutionsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Smiley Lifting Solutions LLC Member.", "label": "Smiley Lifting Solutions LLC [Member]", "terseLabel": "Smiley Lifting Solutions, LLC [Member]" } } }, "localname": "SmileyLiftingSolutionsLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SoaggLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Soagg llc.", "label": "SOAGG LLC [Member]" } } }, "localname": "SoaggLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_SoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Software member.", "label": "Software [Member]" } } }, "localname": "SoftwareMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SointLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Soint llc.", "label": "SOINT LLC [Member]", "terseLabel": "SOINT, LLC [Member]" } } }, "localname": "SointLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_SouthernOrthodonticPartnersManagementLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Southern Orthodontic Partners Management LLC.", "label": "Southern Orthodontic Partners Management LLC [Member]", "terseLabel": "Southern Orthodontic Partners Management, LLC [Member]" } } }, "localname": "SouthernOrthodonticPartnersManagementLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SparMarketingForceInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SPAR marketing force, Inc.", "label": "SPAR Marketing Force, Inc. [Member]" } } }, "localname": "SparMarketingForceInc.Member", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SpecialtyRetailMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Specialty retail member.", "label": "Specialty Retail [Member]" } } }, "localname": "SpecialtyRetailMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SpectrumPharmaceuticalsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Spectrum pharmaceuticals, Inc.", "label": "Spectrum Pharmaceuticals, Inc. [Member]" } } }, "localname": "SpectrumPharmaceuticalsInc.Member", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SpectrumPharmaceuticalsInc.WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Spectrum Pharmaceuticals, Inc. Warrants", "label": "Spectrum Pharmaceuticals, Inc. Warrants [Member]" } } }, "localname": "SpectrumPharmaceuticalsInc.WarrantsMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SpreadAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Spread [Axis]" } } }, "localname": "SpreadAxis", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "stringItemType" }, "slrc_SpreadDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Spread [Domain]" } } }, "localname": "SpreadDomain", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_SpreadOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Spread One [Member]" } } }, "localname": "SpreadOneMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_SslpFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SSLP Facility [Member]", "verboseLabel": "SSLP Facility [Member]" } } }, "localname": "SslpFacilityMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_StCoachesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "St coaches llc.", "label": "ST Coaches LLC [Member]", "terseLabel": "ST Coaches, LLC [Member]" } } }, "localname": "StCoachesLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_StarCoachesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Star coaches inc.", "label": "Star Coaches Inc [Member]", "terseLabel": "Star Coaches Inc. [Member]" } } }, "localname": "StarCoachesIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_StrytenResourcesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stryten resources LLC.", "label": "Stryten Resources LLC [Member]" } } }, "localname": "StrytenResourcesLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SummitFinancialResourcesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summit Financial Resources [Member].", "label": "Summit Financial Resources [Member]", "terseLabel": "Summit Financial Resources [Member]" } } }, "localname": "SummitFinancialResourcesMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SunmedGroupHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sunmed group holdings, llc.", "label": "SunMed Group Holdings, LLC [Member]", "terseLabel": "SunMed Group Holdings, LLC [Member]" } } }, "localname": "SunmedGroupHoldingsLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_SunsCompanyMergerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUNS Company Merger [Member]" } } }, "localname": "SunsCompanyMergerMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SunsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SUNS [Member].", "label": "SUNS [Member]", "terseLabel": "SUNS [Member]" } } }, "localname": "SunsMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SunsSpvLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Suns SPV LLC.", "label": "SPV LLC [Member]" } } }, "localname": "SunsSpvLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SuperiorTransportationIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Superior transportation inc.", "label": "Superior Transportation Inc [Member]", "terseLabel": "Superior Transportation, Inc. [Member]" } } }, "localname": "SuperiorTransportationIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_TaucManagementLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "TAUC management, LLC.", "label": "TAUC Management LLC [Member]", "terseLabel": "TAUC Management, LLC [Member]" } } }, "localname": "TaucManagementLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_TermLoanAndCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term loan and credit facility.", "label": "Term Loan And Credit Facility [Member]", "terseLabel": "Credit Facility [Member]", "verboseLabel": "SLRCTerm Loan And Credit Facility [Member]" } } }, "localname": "TermLoanAndCreditFacilityMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails" ], "xbrltype": "domainItemType" }, "slrc_TermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term loan.", "label": "Term Loan [Member]" } } }, "localname": "TermLoanMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_TermLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Term Loans [Member]", "verboseLabel": "Term Loans [Member]" } } }, "localname": "TermLoansMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_TheSmedleyCompanySmedleyServicesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The smedley company\u00a0& smedley services inc.", "label": "The Smedley Company Smedley Services Inc [Member]", "terseLabel": "The Smedley Company & Smedley Services, Inc. [Member]" } } }, "localname": "TheSmedleyCompanySmedleyServicesIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ThriftsMortgageFinanceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Thrifts & mortgage finance.", "label": "Thrifts Mortgage Finance [Member]", "terseLabel": "Thrifts & Mortgage Finance [Member]" } } }, "localname": "ThriftsMortgageFinanceMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_TilleyDistributionIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tilley Distribution, Inc.", "label": "Tilley Distribution Inc [Member]", "terseLabel": "Tilley Distribution, Inc [Member]" } } }, "localname": "TilleyDistributionIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_TotalInvestmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Total Investment [Member]", "terseLabel": "Total Investments [Member]" } } }, "localname": "TotalInvestmentMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_TradingCompaniesAndDistributorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading Companies & Distributors member.", "label": "Trading Companies and Distributors [Member]" } } }, "localname": "TradingCompaniesAndDistributorsMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_TradingCompaniesDistributorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading companies &\ndistributors member.", "label": "Trading Companies Distributors [Member]", "terseLabel": "Trading Companies & Distributors [Member]" } } }, "localname": "TradingCompaniesDistributorsMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_TrancheAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche.", "label": "Tranche [Axis]" } } }, "localname": "TrancheAxis", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "slrc_TrancheDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche.", "label": "Tranche [Domain]" } } }, "localname": "TrancheDomain", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_TransportationInfrastructureMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transportation Infrastructure [Member]", "label": "Transportation Infrastructure [Member]" } } }, "localname": "TransportationInfrastructureMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_TrinityEquipmentRentalsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trinity equipment rentals inc.", "label": "Trinity Equipment Rentals Inc [Member]", "terseLabel": "Trinity Equipment Rentals, Inc. [Member]" } } }, "localname": "TrinityEquipmentRentalsIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_TwoThousandAndFortyTwoUnsecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Two Thousand And Forty Two Unsecured Notes [Member]", "verboseLabel": "2042 Unsecured Notes [Member]" } } }, "localname": "TwoThousandAndFortyTwoUnsecuredNotesMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_TwoThousandAndTwentyFiveUnsecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand and twenty five unsecured notes.", "label": "Two Thousand And Twenty Five Unsecured Notes [Member]", "terseLabel": "2025 Unsecured Notes [Member]", "verboseLabel": "2025 Unsecured Notes [Member]" } } }, "localname": "TwoThousandAndTwentyFiveUnsecuredNotesMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_TwoThousandAndTwentyFourUnsecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand and twenty four unsecured notes.", "label": "Two Thousand And Twenty Four Unsecured Notes [Member]", "terseLabel": "2024 Unsecured Notes [Member]", "verboseLabel": "2024 Unsecured Notes [Member]" } } }, "localname": "TwoThousandAndTwentyFourUnsecuredNotesMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand and twenty seven series F unsecured notes.", "label": "Two Thousand And Twenty Seven Series F Unsecured Notes [Member]", "terseLabel": "2027 Series F Unsecured Notes [Member]", "verboseLabel": "2027 Series F Unsecured Notes [Member]" } } }, "localname": "TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_TwoThousandAndTwentySevenUnsecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand and twenty seven unsecured notes.", "label": "Two Thousand And Twenty Seven Unsecured Notes [Member]", "terseLabel": "2027 Unsecured Notes [Member]", "verboseLabel": "2027 Unsecured Notes [Member]" } } }, "localname": "TwoThousandAndTwentySevenUnsecuredNotesMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_TwoThousandAndTwentySixUnsecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand and twenty six unsecured notes.", "label": "Two Thousand And Twenty Six Unsecured Notes [Member]", "terseLabel": "2026 Unsecured Notes [Member]", "verboseLabel": "2026 Unsecured Notes [Member]" } } }, "localname": "TwoThousandAndTwentySixUnsecuredNotesMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_TwoThousandAndTwentyThreeUnsecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand and twenty three unsecured notes.", "label": "Two Thousand And Twenty Three Unsecured Notes [Member]", "terseLabel": "2023 Unsecured Notes [Member]", "verboseLabel": "2023 Unsecured Notes [Member]" } } }, "localname": "TwoThousandAndTwentyThreeUnsecuredNotesMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_TwoThousandAndTwentyTwoTrancheCNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand and twenty two tranche C notes.", "label": "Two Thousand And Twenty Two Tranche C Notes [Member]", "terseLabel": "2022 Tranche C Notes [Member]", "verboseLabel": "2022 Tranche C Notes [Member]" } } }, "localname": "TwoThousandAndTwentyTwoTrancheCNotesMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_TwoThousandAndTwentyTwoUnsecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand and twenty two unsecured notes.", "label": "Two Thousand and Twenty Two Unsecured Notes [Member]", "terseLabel": "2022 Unsecured Notes [Member]", "verboseLabel": "2022 Unsecured Notes [Member]" } } }, "localname": "TwoThousandAndTwentyTwoUnsecuredNotesMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_U.s.CraneAndRiggingLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "U.S. Crane and Rigging, LLC", "label": "U.S. Crane and Rigging, LLC [Member]", "terseLabel": "U.S. Crane & Rigging, LLC [Member]" } } }, "localname": "U.s.CraneAndRiggingLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_U.s.TreasuryBillMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "U.S. treasury bill.", "label": "U.S. Treasury Bill [Member]", "terseLabel": "U.S. Treasury Bill [Member]" } } }, "localname": "U.s.TreasuryBillMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_UltimateBakedGoodsMidcoLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ultimate baked goods midco llc.", "label": "Ultimate Baked Goods Midco LLC [Member]", "terseLabel": "Ultimate Baked Goods Midco LLC (Rise Baking) [Member]", "verboseLabel": "Ultimate Baked Goods Midco LLC [Member]" } } }, "localname": "UltimateBakedGoodsMidcoLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_UnfundedDebtAndEquityCommitmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Unfunded Debt and Equity Commitments [Member]", "label": "Unfunded Debt and Equity Commitments [Member]", "terseLabel": "Unfunded Debt and Equity Commitments [Member]", "verboseLabel": "Unfunded Debt and Equity Commitments [Member]" } } }, "localname": "UnfundedDebtAndEquityCommitmentsMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_UnitedDigestiveMsoParentLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "United Digestive MSO Parent, LLC Member.", "label": "United Digestive MSO Parent, LLC [Member]" } } }, "localname": "UnitedDigestiveMsoParentLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_UpTruckingServicesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Up trucking services llc.", "label": "Up Trucking Services LLC [Member]", "terseLabel": "Up Trucking Services, LLC [Member]" } } }, "localname": "UpTruckingServicesLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_UrologyManagementHoldingsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Urology Management Holdings, Inc Member.", "label": "Urology Management Holdings, Inc [Member]" } } }, "localname": "UrologyManagementHoldingsIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "slrc_ValuationApproachMarketMultipleMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Valuation approach market multiple.", "label": "Valuation Approach Market Multiple [Member]", "terseLabel": "Market Multiple [Member]" } } }, "localname": "ValuationApproachMarketMultipleMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "slrc_ValuationTechniqueRecoveryApproachMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Valuation technique recovery approach.", "label": "Valuation Technique Recovery Approach [Member]", "terseLabel": "Recovery Analysis [Member]" } } }, "localname": "ValuationTechniqueRecoveryApproachMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails" ], "xbrltype": "domainItemType" }, "slrc_VapothermInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vapotherm, inc.", "label": "Vapotherm, Inc. [Member]", "terseLabel": "Vapotherm, Inc. [Member]" } } }, "localname": "VapothermInc.Member", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_VapothermIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vapotherm inc.", "label": "Vapotherm Inc [Member]", "terseLabel": "Vapotherm, Inc. Warrants [Member]" } } }, "localname": "VapothermIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_VenusConceptLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Venus concept ltd.", "label": "Venus Concept Ltd [Member]", "terseLabel": "Venus Concept Ltd. Warrants (f/k/a Restoration Robotics) [Member]" } } }, "localname": "VenusConceptLtdMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_VertosMedicalInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vertos Medical, Inc.", "label": "Vertos Medical, Inc. [Member]", "terseLabel": "Vertos Medical, Inc. [Member]" } } }, "localname": "VertosMedicalInc.Member", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_VertosMedicalInc.WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vertos medical, inc. warrants.", "label": "Vertos Medical, Inc. Warrants [Member]" } } }, "localname": "VertosMedicalInc.WarrantsMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_VesscoMidcoHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vessco midco holdings LLC.", "label": "Vessco Midco Holdings LLC [Member]", "terseLabel": "Vessco Midco Holdings, LLC [Member]" } } }, "localname": "VesscoMidcoHoldingsLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_WasteProOfFloridaInc.WasteProUsaIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Waste pro of florida, inc. & waste pro usa, inc.", "label": "Waste Pro of Florida, Inc. Waste Pro USA, Inc [Member]" } } }, "localname": "WasteProOfFloridaInc.WasteProUsaIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_WaterUtilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Water Utilities Member.", "label": "Water Utilities [Member]" } } }, "localname": "WaterUtilitiesMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_WindRiverEnvironmentalLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Wind river environmental llc.", "label": "Wind River Environmental LLC [Member]", "terseLabel": "Wind River Environmental, LLC [Member]" } } }, "localname": "WindRiverEnvironmentalLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_WirelessTelecommunicationServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Wireless telecommunication services member.", "label": "Wireless Telecommunication Services [Member]" } } }, "localname": "WirelessTelecommunicationServicesMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_WombleCompanyIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Womble company inc.", "label": "Womble Company Inc [Member]", "terseLabel": "Womble Company, Inc. [Member]" } } }, "localname": "WombleCompanyIncMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_WorldInsuranceAssociatesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "World Insurance associates LLC.", "label": "World Insurance Associates LLC [Member]", "terseLabel": "World Insurance Associates, LLC [Member]" } } }, "localname": "WorldInsuranceAssociatesLlcMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_WorldwideFlightServicesInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Worldwide flight services, Inc.", "label": "Worldwide Flight Services, Inc. [Member]" } } }, "localname": "WorldwideFlightServicesInc.Member", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ZamborelliEnterprisesPacificSoutherFoundationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Zamborelli Enterprises Pacific Souther Foundation.", "label": "Zamborelli Enterprises Pacific Souther Foundation [Member]" } } }, "localname": "ZamborelliEnterprisesPacificSoutherFoundationMember", "nsuri": "http://www.slrinvestments.com/20230630", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "srt_CondensedFinancialStatementsCaptionsLineItems": { "auth_ref": [ "r108", "r109", "r110", "r111", "r134", "r843" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Condensed Financial Statements, Captions [Line Items]" } } }, "localname": "CondensedFinancialStatementsCaptionsLineItems", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpParentheticalDetails" ], "xbrltype": "stringItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [ "r208", "r209", "r211" ], "lang": { "en-us": { "role": { "documentation": "Name of investment including named security. Excludes entity that is consolidated.", "label": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinance", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails", "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ManagementMember": { "auth_ref": [ "r867", "r894" ], "lang": { "en-us": { "role": { "documentation": "Person or persons designated as part of management.", "label": "Management [Member]", "terseLabel": "Management [Member]" } } }, "localname": "ManagementMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r226", "r227", "r228", "r229", "r292", "r405", "r435", "r488", "r489", "r555", "r574", "r580", "r581", "r617", "r639", "r640", "r644", "r652", "r658", "r662", "r882", "r898", "r899", "r900", "r901", "r902", "r903" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]", "terseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r226", "r227", "r228", "r229", "r292", "r405", "r435", "r488", "r489", "r555", "r574", "r580", "r581", "r617", "r639", "r640", "r644", "r652", "r658", "r662", "r882", "r898", "r899", "r900", "r901", "r902", "r903" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r226", "r227", "r228", "r229", "r284", "r292", "r315", "r316", "r317", "r381", "r405", "r435", "r488", "r489", "r555", "r574", "r580", "r581", "r617", "r639", "r640", "r644", "r652", "r658", "r662", "r665", "r878", "r882", "r899", "r900", "r901", "r902", "r903" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r226", "r227", "r228", "r229", "r284", "r292", "r315", "r316", "r317", "r381", "r405", "r435", "r488", "r489", "r555", "r574", "r580", "r581", "r617", "r639", "r640", "r644", "r652", "r658", "r662", "r665", "r878", "r882", "r899", "r900", "r901", "r902", "r903" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfCondensedFinancialStatementsTable": { "auth_ref": [ "r108", "r109", "r110", "r111", "r134", "r843" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows.", "label": "Condensed Financial Statements [Table]" } } }, "localname": "ScheduleOfCondensedFinancialStatementsTable", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpParentheticalDetails" ], "xbrltype": "stringItemType" }, "srt_ScheduleOfCondensedFinancialStatementsTableTextBlock": { "auth_ref": [ "r851", "r862" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows.", "label": "Condensed Financial Statements [Table Text Block]", "terseLabel": "Summary financial information for SSLP" } } }, "localname": "ScheduleOfCondensedFinancialStatementsTableTextBlock", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcTables" ], "xbrltype": "textBlockItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r208", "r209", "r211" ], "lang": { "en-us": { "role": { "documentation": "Information by name of investment including named security. Excludes entity that is consolidated.", "label": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinance", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails", "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r867", "r894" ], "lang": { "en-us": { "role": { "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Title of individual, or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_WeightedAverageMember": { "auth_ref": [ "r639", "r640", "r898", "r900", "r903" ], "lang": { "en-us": { "role": { "documentation": "Average of a range of values, calculated with consideration of proportional relevance.", "label": "Weighted Average [Member]" } } }, "localname": "WeightedAverageMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": { "auth_ref": [ "r53" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.", "label": "Accounts Payable and Accrued Liabilities", "terseLabel": "Accrued expenses and other payables" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesAndOtherLiabilities": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 9.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.", "label": "Accrued Liabilities and Other Liabilities", "terseLabel": "Other liabilities and accrued expenses" } } }, "localname": "AccruedLiabilitiesAndOtherLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r64" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "terseLabel": "Paid-in capital in excess of par" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdministrativeFeesExpense": { "auth_ref": [ "r51", "r523", "r921" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Organizational costs", "documentation": "Amount of expense for administrative fee from service provided, including, but not limited to, salary, rent, or overhead cost.", "label": "Administrative Fees Expense", "terseLabel": "Administrative services expense (see note 3)", "verboseLabel": "Administrative fees expense" } } }, "localname": "AdministrativeFeesExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetManagement1Member": { "auth_ref": [ "r885" ], "lang": { "en-us": { "role": { "documentation": "Management of investment fund portfolio. Excludes investment advisory, distribution and servicing, and performance fee.", "label": "Asset Management [Member]", "terseLabel": "Asset Management [Member]" } } }, "localname": "AssetManagement1Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r89", "r114", "r133", "r166", "r171", "r173", "r212", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r328", "r332", "r358", "r421", "r516", "r661", "r677", "r880", "r881", "r896" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 10.0, "parentTag": "us-gaap_AssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "disclosureGuidance": "total assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "terseLabel": "Assets", "totalLabel": "Total assets", "verboseLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNet": { "auth_ref": [ "r8" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net assets (liabilities).", "label": "Net Assets", "periodEndLabel": "Net assets at end of period", "periodStartLabel": "Net assets at beginning of period", "terseLabel": "Net assets", "totalLabel": "Total net assets", "verboseLabel": "Net assets, end of period" } } }, "localname": "AssetsNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails", "http://www.slrinvestments.com/role/NetAssetValuePerShareAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r324", "r656", "r657" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r39", "r41", "r324", "r656", "r657" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r40" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Business Acquisition, Percentage of Voting Interests Acquired", "terseLabel": "Percentage of voting interests acquired" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r0", "r1", "r9" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Business combination, consideration transferred" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Cash": { "auth_ref": [ "r100", "r423", "r474", "r510", "r661", "r677", "r852" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 11.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "terseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsAndShortTermInvestments": { "auth_ref": [ "r855" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.", "label": "Cash, Cash Equivalents, and Short-term Investments", "terseLabel": "Total Investments\u00a0& Cash Equivalents", "verboseLabel": "Cash and other assets" } } }, "localname": "CashCashEquivalentsAndShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r28", "r75", "r129" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "CASH AND CASH EQUIVALENTS AT END OF PERIOD", "periodStartLabel": "CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r4", "r75" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r852", "r907" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 12.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash Equivalents, at Carrying Value", "verboseLabel": "Cash equivalents (cost: $333,200 and $417,590, respectively)" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r105", "r115", "r116", "r117", "r133", "r151", "r152", "r154", "r156", "r164", "r165", "r212", "r230", "r232", "r233", "r234", "r237", "r238", "r269", "r270", "r272", "r275", "r282", "r358", "r448", "r449", "r450", "r451", "r459", "r463", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r475", "r502", "r526", "r547", "r631", "r632", "r633", "r634", "r635", "r841", "r859", "r865" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [ "r326" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r22", "r55", "r422", "r501" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies", "verboseLabel": "Commitments and contingencies (see note 10)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r79", "r224", "r225", "r638", "r879" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r663", "r664", "r665", "r667", "r668", "r669", "r670", "r863", "r864", "r887", "r910", "r923" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r63" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par or stated value per share", "verboseLabel": "Par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r63", "r502" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common Stock, shares authorized", "verboseLabel": "Shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r63" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares, issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r10", "r63", "r502", "r522", "r923", "r925" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares, outstanding", "verboseLabel": "Shares outstanding, end of period" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r63", "r424", "r661" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "verboseLabel": "Common stock, par value $0.01 per share, 200,000,000 and 200,000,000 common shares authorized, respectively, and 54,554,634 and 54,555,380 shares issued and outstanding, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r80", "r131", "r239", "r245", "r246", "r247", "r248", "r249", "r250", "r255", "r262", "r263", "r265" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Debt" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/Debt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r15", "r59", "r60", "r90", "r92", "r134", "r240", "r241", "r242", "r243", "r244", "r246", "r251", "r252", "r253", "r254", "r256", "r257", "r258", "r259", "r260", "r261", "r367", "r647", "r648", "r649", "r650", "r651", "r860" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Debt instrument variable interest rate spread" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r15", "r92", "r266" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-term Debt, Gross", "terseLabel": "Face Amount" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r48", "r50", "r240", "r367", "r648", "r649" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Debt instrument, face amount", "verboseLabel": "Debt instrument face value" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r253", "r357", "r648", "r649" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Debt Instrument, Fair Value Disclosure", "verboseLabel": "Debt Instrument, Fair Value Disclosure" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r19", "r241" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "verboseLabel": "Debt instrument stated interest rate percentage" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [ "r134", "r240", "r241", "r242", "r243", "r244", "r246", "r251", "r252", "r253", "r254", "r256", "r257", "r258", "r259", "r260", "r261", "r264", "r367", "r647", "r648", "r649", "r650", "r651", "r860" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r103", "r647", "r889" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Debt Instrument, Maturity Date", "terseLabel": "Debt Instrument, Maturity Date", "verboseLabel": "Debt instrument maturity date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r21", "r134", "r240", "r241", "r242", "r243", "r244", "r246", "r251", "r252", "r253", "r254", "r256", "r257", "r258", "r259", "r260", "r261", "r367", "r647", "r648", "r649", "r650", "r651", "r860" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentPaymentTerms": { "auth_ref": [ "r20", "r57" ], "lang": { "en-us": { "role": { "documentation": "Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment.", "label": "Debt Instrument, Payment Terms", "verboseLabel": "Debt instrument payment terms" } } }, "localname": "DebtInstrumentPaymentTerms", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r21", "r35", "r37", "r47", "r48", "r50", "r56", "r82", "r83", "r134", "r240", "r241", "r242", "r243", "r244", "r246", "r251", "r252", "r253", "r254", "r256", "r257", "r258", "r259", "r260", "r261", "r264", "r367", "r647", "r648", "r649", "r650", "r651", "r860" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "terseLabel": "Debt instrument term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r47", "r50", "r883" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "terseLabel": "Debt Instrument, Unamortized Discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Instruments [Abstract]" } } }, "localname": "DebtInstrumentsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_DebtLongtermAndShorttermCombinedAmount": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt.", "label": "Debt, Long-term and Short-term, Combined Amount", "terseLabel": "Debt outstanding", "verboseLabel": "Debt ($1,219,200 and $1,093,200 face amounts, respectively, reported net of unamortized debt issuance costs of $6,167 and $7,202, respectively. See notes 6 and 7)" } } }, "localname": "DebtLongtermAndShorttermCombinedAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsGross": { "auth_ref": [ "r49" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Gross", "terseLabel": "Debt issuance costs" } } }, "localname": "DeferredFinanceCostsGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r49", "r883" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "terseLabel": "Long term debt unamortized debt issuance costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFloorInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Floor rate on an interest rate derivative such as an interest rate floor or collar. If market rates falls below the floor rate, a payment or receipt is triggered on the contract.", "label": "Derivative, Floor Interest Rate", "terseLabel": "Floor" } } }, "localname": "DerivativeFloorInterestRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeMaturityDates": { "auth_ref": [ "r488", "r489", "r601", "r602", "r603", "r604", "r605", "r665" ], "lang": { "en-us": { "role": { "documentation": "Date derivative contract ends, in YYYY-MM-DD format.", "label": "Derivative, Maturity Date", "terseLabel": "Maturity Date", "verboseLabel": "Maturity Date" } } }, "localname": "DerivativeMaturityDates", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DividendsPayableAmountPerShare": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date.", "label": "Dividends Payable, Amount Per Share", "terseLabel": "Dividends payable, amount per share" } } }, "localname": "DividendsPayableAmountPerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DividendsPayableCurrentAndNoncurrent": { "auth_ref": [ "r60", "r61", "r91", "r674", "r905" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.", "label": "Dividends Payable", "terseLabel": "Distributions payable" } } }, "localname": "DividendsPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsReceivable": { "auth_ref": [ "r854", "r927" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 13.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of dividends declared but not received.", "label": "Dividends Receivable", "terseLabel": "Dividends receivable" } } }, "localname": "DividendsReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r125", "r140", "r141", "r142", "r143", "r144", "r149", "r151", "r154", "r155", "r156", "r160", "r343", "r344", "r419", "r433", "r641" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings (loss) Per Share, Basic", "terseLabel": "Earnings per share, Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r125", "r140", "r141", "r142", "r143", "r144", "r151", "r154", "r155", "r156", "r160", "r343", "r344", "r419", "r433", "r641" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings (loss) Per Share, Diluted", "terseLabel": "Earnings per share, Diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r148", "r157", "r158", "r159" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/EarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent": { "auth_ref": [ "r54", "r905" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Employee-related Liabilities", "terseLabel": "Performance-based incentive fee payable (see note 3)" } } }, "localname": "EmployeeRelatedLiabilitiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Employee Stock Option [Member]", "terseLabel": "Employee Stock Option" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "domainItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r10", "r112", "r121", "r122", "r123", "r135", "r136", "r137", "r139", "r145", "r147", "r161", "r214", "r215", "r283", "r319", "r320", "r321", "r322", "r323", "r334", "r335", "r336", "r337", "r338", "r339", "r342", "r359", "r360", "r361", "r362", "r363", "r364", "r369", "r436", "r437", "r438", "r459", "r547" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails", "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentAggregateCost": { "auth_ref": [ "r16" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the aggregate cost of investments accounted for under the equity method of accounting.", "label": "Equity Method Investment, Aggregate Cost", "terseLabel": "Equity method investment, aggregate cost" } } }, "localname": "EquityMethodInvestmentAggregateCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": { "auth_ref": [ "r113", "r133", "r212", "r358" ], "lang": { "en-us": { "role": { "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity.", "label": "Equity Method Investment, Nonconsolidated Investee [Axis]" } } }, "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": { "auth_ref": [ "r113", "r133", "r212", "r358" ], "lang": { "en-us": { "role": { "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity.", "label": "Equity Method Investment, Nonconsolidated Investee [Domain]" } } }, "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r208" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Equity method investment, ownership percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r169", "r207", "r853", "r874" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Equity method investments" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Method Investments and Joint Ventures [Abstract]" } } }, "localname": "EquityMethodInvestmentsAndJointVenturesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": { "auth_ref": [ "r104", "r210", "r213", "r842" ], "lang": { "en-us": { "role": { "definitionGuidance": "Kingsbridge Holdings, LLC", "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.", "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]", "terseLabel": "SLR Equipment Finance" } } }, "localname": "EquityMethodInvestmentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlc", "http://www.slrinvestments.com/role/SlrEquipmentFinance" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquitySecuritiesByIndustryAxis": { "auth_ref": [ "r478", "r482", "r485", "r561", "r576", "r597", "r623", "r645", "r665" ], "lang": { "en-us": { "role": { "documentation": "Information by industry sector, examples include but are not limited to, commercial, industrial, agricultural, financial services, technology, healthcare and real estate.", "label": "Industry Sector [Axis]", "verboseLabel": "Industry Sector [Axis]" } } }, "localname": "EquitySecuritiesByIndustryAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquitySecuritiesIndustryMember": { "auth_ref": [ "r478", "r482", "r485", "r561", "r576", "r597", "r623", "r665" ], "lang": { "en-us": { "role": { "documentation": "Industry sector consisting of government, private and corporate entities engaged in business activities, including but not limited to, commercial, industrial, agricultural, financial services, technology, healthcare and real estate.", "label": "Industry Sector [Domain]", "verboseLabel": "Industry Sector [Domain]" } } }, "localname": "EquitySecuritiesIndustryMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquitySecuritiesMember": { "auth_ref": [ "r33", "r671", "r672", "r673", "r929" ], "lang": { "en-us": { "role": { "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.", "label": "Equity Securities [Member]", "terseLabel": "Common Equity/Equity Interests/Warrants [Member]" } } }, "localname": "EquitySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList": { "auth_ref": [ "r352" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement in which net income is reported that includes unrealized gain (loss) from asset measured at fair value using unobservable input (level 3) and still held.", "label": "Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]" } } }, "localname": "FairValueAssetRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [ "r346", "r347", "r353" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r346", "r347", "r353" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "auth_ref": [ "r13", "r44", "r46", "r87" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.", "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]", "terseLabel": "Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "terseLabel": "Summary of Quantitative Information about the Company's Level 3 Asset and Liability" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss": { "auth_ref": [ "r352" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3) and still held.", "label": "Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss)", "terseLabel": "Net change in unrealized gain (loss)" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Class of asset.", "label": "Asset Class [Domain]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r12", "r46" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r12", "r46" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Summary of Changes in Fair Value of Level 3 Assets and Liabilities" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByAssetClassAxis": { "auth_ref": [ "r44", "r46" ], "lang": { "en-us": { "role": { "documentation": "Information by class of asset.", "label": "Asset Class [Axis]" } } }, "localname": "FairValueByAssetClassAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r253", "r285", "r286", "r287", "r288", "r289", "r290", "r347", "r378", "r379", "r380", "r648", "r649", "r653", "r654", "r655" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r46", "r86" ], "lang": { "en-us": { "role": { "documentation": "Information by class of liability.", "label": "Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r346", "r347", "r349", "r350", "r354" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r345" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValue" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r253", "r285", "r290", "r347", "r378", "r653", "r654", "r655" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r253", "r285", "r290", "r347", "r379", "r648", "r649", "r653", "r654", "r655" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r253", "r285", "r286", "r287", "r288", "r289", "r290", "r347", "r380", "r648", "r649", "r653", "r654", "r655" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value by Liability Class [Domain]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r12", "r46" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r12", "r46" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3)" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1": { "auth_ref": [ "r351" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings", "terseLabel": "Net change in unrealized gain (loss)" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases": { "auth_ref": [ "r45" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases", "terseLabel": "Purchase of investment securities" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales": { "auth_ref": [ "r45" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales", "terseLabel": "Proceeds from dispositions of investment securities" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net", "terseLabel": "Transfers in/out of Level\u00a03" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": { "auth_ref": [ "r12" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value", "periodEndLabel": "Closing balance", "periodStartLabel": "Opening balance" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "auth_ref": [ "r351" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "terseLabel": "Net change in unrealized (gain) loss" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": { "auth_ref": [ "r45" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances", "terseLabel": "Borrowings" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": { "auth_ref": [ "r45" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements", "terseLabel": "Repayments" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net", "terseLabel": "Transfers in/out of Level\u00a03" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r12" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Ending fair value", "periodStartLabel": "Beginning fair value" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r253", "r285", "r286", "r287", "r288", "r289", "r290", "r378", "r379", "r380", "r648", "r649", "r653", "r654", "r655" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r345", "r354" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Recurring Fair Value [Member]" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfIncomeExtensibleList": { "auth_ref": [ "r351" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement in which net income is reported that includes gain (loss) from asset measured at fair value using unobservable input (level 3).", "label": "Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]" } } }, "localname": "FairValueRecurringBasisUnobservableInputReconciliationAssetGainLossStatementOfIncomeExtensibleList", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r264", "r280", "r340", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r429", "r646", "r844", "r845", "r846", "r847", "r848", "r849", "r850", "r870", "r871", "r872", "r873" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialServicesSectorMember": { "auth_ref": [ "r665", "r928", "r930", "r931", "r932" ], "lang": { "en-us": { "role": { "documentation": "Sector of the economy consisting of companies engaged in financial services.", "label": "Financial Services Sector [Member]", "terseLabel": "Diversified Financial Services [Member]" } } }, "localname": "FinancialServicesSectorMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GrossInvestmentIncomeOperating": { "auth_ref": [ "r430", "r675", "r920" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 10.0, "parentTag": "us-gaap_NetInvestmentIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.", "label": "Gross Investment Income, Operating", "totalLabel": "Total investment income" } } }, "localname": "GrossInvestmentIncomeOperating", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_HealthcareSectorMember": { "auth_ref": [ "r665", "r928", "r930", "r931", "r932" ], "lang": { "en-us": { "role": { "documentation": "Sector of the economy consisting of companies engaged in healthcare-related business activities.", "label": "Healthcare Sector [Member]", "terseLabel": "Health Care Providers & Services [Member]" } } }, "localname": "HealthcareSectorMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]", "terseLabel": "IPO [Member]" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeApproachValuationTechniqueMember": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Valuation approach converting future amounts to single current discounted amount.", "label": "Valuation, Income Approach [Member]", "terseLabel": "Income Approach [Member]" } } }, "localname": "IncomeApproachValuationTechniqueMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r29" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Cash paid for interest" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet": { "auth_ref": [ "r5" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount due from borrowers for interest payments.", "label": "Increase (Decrease) in Accrued Interest Receivable, Net", "negatedLabel": "Interest receivable" } } }, "localname": "IncreaseDecreaseInAccruedInterestReceivableNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": { "auth_ref": [ "r858" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 27.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.", "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities", "terseLabel": "Other liabilities and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDividendsReceivable": { "auth_ref": [ "r5" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in cash disbursements due from investments, representing the shareholders' portion of profits.", "label": "Increase (Decrease) in Dividends Receivable", "negatedLabel": "Dividends receivable" } } }, "localname": "IncreaseDecreaseInDividendsReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInterestPayableNet": { "auth_ref": [ "r5" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 26.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.", "label": "Increase (Decrease) in Interest Payable, Net", "terseLabel": "Interest payable" } } }, "localname": "IncreaseDecreaseInInterestPayableNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInManagementFeePayable": { "auth_ref": [ "r926" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 23.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in fee payable for management of fund or trust.", "label": "Increase (Decrease) in Management Fee Payable", "terseLabel": "Management fee payable" } } }, "localname": "IncreaseDecreaseInManagementFeePayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Assets [Abstract]", "terseLabel": "(Increase) decrease in operating assets:" } } }, "localname": "IncreaseDecreaseInOperatingAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Liabilities [Abstract]", "terseLabel": "Increase (decrease) in operating liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r5" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r49", "r96", "r124", "r168", "r366", "r529", "r675", "r919" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "terseLabel": "Interest and other credit facility expenses" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrentAndNoncurrent": { "auth_ref": [ "r54", "r905" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 7.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables.", "label": "Interest Payable", "terseLabel": "Interest payable (see note 7)" } } }, "localname": "InterestPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateRiskMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The risk associated with changes in interest rates that effect the value of an interest-bearing asset or liability, and a servicing asset or liability.", "label": "Interest Rate Risk [Member]" } } }, "localname": "InterestRateRiskMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "us-gaap_InterestReceivable": { "auth_ref": [ "r854", "r927" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 14.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.", "label": "Interest Receivable", "terseLabel": "Interest receivable" } } }, "localname": "InterestReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyCapitalShareTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Company, Capital Share Transactions [Abstract]", "terseLabel": "Capital transactions (see note 12):" } } }, "localname": "InvestmentCompanyCapitalShareTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyCapitalShareTransactionsStockIssuedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Company, Capital Share Transactions, Stock Issued [Abstract]", "terseLabel": "Capital stock activity (see note 12):" } } }, "localname": "InvestmentCompanyCapitalShareTransactionsStockIssuedAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyDistributionToShareholdersAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Company, Distribution to Shareholders [Abstract]", "verboseLabel": "Distributions to stockholders:" } } }, "localname": "InvestmentCompanyDistributionToShareholdersAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyDistributionToShareholdersPerShare": { "auth_ref": [ "r455", "r470" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit amount of distribution to shareholders. Includes, but is not limited to, dividend and capital gain. Excludes distribution for tax return of capital.", "label": "Investment Company, Distribution to Shareholders, Per Share", "negatedLabel": "From distributable earnings" } } }, "localname": "InvestmentCompanyDistributionToShareholdersPerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_InvestmentCompanyDividendDistribution": { "auth_ref": [ "r455", "r458", "r459", "r545" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "order": 1.0, "parentTag": "slrc_InvestmentCompanyIncreaseDecreaseInNetAssets", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of dividend distribution from ordinary income and capital gain. Excludes distribution for tax return of capital.", "label": "Investment Company, Dividend Distribution", "negatedTotalLabel": "Net distributions to stockholders" } } }, "localname": "InvestmentCompanyDividendDistribution", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation": { "auth_ref": [ "r911" ], "lang": { "en-us": { "role": { "documentation": "Percentage of expense, after incentive allocation, to average net assets.", "label": "Investment Company, Expense Ratio after Incentive Allocation", "terseLabel": "Total expenses" } } }, "localname": "InvestmentCompanyExpenseRatioAfterIncentiveAllocation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentCompanyExpenseRatioExcludingIncentiveFee": { "auth_ref": [ "r461" ], "lang": { "en-us": { "role": { "documentation": "Percentage, after deduction of fee waiver and before deduction of incentive fee, of expense to average net assets.", "label": "Investment Company, Expense Ratio Excluding Incentive Fee", "terseLabel": "Investment company, expense ratio excluding incentive fee" } } }, "localname": "InvestmentCompanyExpenseRatioExcludingIncentiveFee", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsParentheticalsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentCompanyFinancialHighlightsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Company, Financial Highlights [Abstract]" } } }, "localname": "InvestmentCompanyFinancialHighlightsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyFinancialHighlightsTableTextBlock": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial highlights. Includes, but is not limited to, per share information, income and expense ratios, total return, capital commitment and fee waiver.", "label": "Investment Company, Financial Highlights [Table Text Block]", "terseLabel": "Schedule of financial highlights" } } }, "localname": "InvestmentCompanyFinancialHighlightsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentCompanyFinancialHighlightsTextBlock": { "auth_ref": [ "r454", "r460", "r464", "r468" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of financial highlights reported by investment company.", "label": "Investment Company, Financial Highlights [Text Block]", "terseLabel": "Financial Highlights" } } }, "localname": "InvestmentCompanyFinancialHighlightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlights" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentCompanyFinancialRatiosAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Company, Financial Ratios [Abstract]", "verboseLabel": "Ratios to average net assets:" } } }, "localname": "InvestmentCompanyFinancialRatiosAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare": { "auth_ref": [ "r468" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit amount of realized and unrealized gain (loss) on investment.", "label": "Investment Company, Gain (Loss) on Investment, Per Share", "terseLabel": "Net realized and unrealized loss" } } }, "localname": "InvestmentCompanyGainLossOnInvestmentPerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_InvestmentCompanyIncreaseDecreaseFromShareTransaction": { "auth_ref": [ "r546", "r676" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in equity from change in number of shares or units by investment company.", "label": "Investment Company, Capital Share Transaction, Increase (Decrease)", "verboseLabel": "Net increase, Value" } } }, "localname": "InvestmentCompanyIncreaseDecreaseFromShareTransaction", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare": { "auth_ref": [ "r469" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit amount of investment income (loss) and realized and unrealized gain (loss) on investment.", "label": "Investment Company, Investment Income (Loss) from Operations, Per Share", "totalLabel": "Net increase (decrease) in net assets resulting from operations" } } }, "localname": "InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit amount, after investment expense, of dividend and interest investment income (loss).", "label": "Investment Company, Investment Income (Loss), Per Share", "terseLabel": "Net investment income" } } }, "localname": "InvestmentCompanyInvestmentIncomeLossPerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_InvestmentCompanyInvestmentIncomeLossRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of investment income (loss) to average net assets.", "label": "Investment Company, Investment Income (Loss) Ratio", "terseLabel": "Net investment income" } } }, "localname": "InvestmentCompanyInvestmentIncomeLossRatio", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency": { "auth_ref": [ "r524", "r637", "r675", "r922" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of realized and unrealized gain (loss) on investment and derivative, classified as operating, and foreign currency transaction. Investment includes, but is not limited to, debt and equity securities, security sold short, real estate, and commodity.", "label": "Investment Company, Realized and Unrealized Gain (Loss) on Investment and Foreign Currency", "terseLabel": "Net realized and unrealized gain on investments", "totalLabel": "Net realized and unrealized gain (loss) on investments and cash equivalents" } } }, "localname": "InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrencyAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Company, Realized and Unrealized Gain (Loss) on Investment and Foreign Currency [Abstract]", "terseLabel": "REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND CASH EQUIVALENTS:" } } }, "localname": "InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrencyAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyTaxReturnOfCapitalDistributionPerShare": { "auth_ref": [ "r455", "r470" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit amount of capital distribution in excess of tax basis earnings.", "label": "Investment Company, Tax Return of Capital Distribution, Per Share", "terseLabel": "From return of capital" } } }, "localname": "InvestmentCompanyTaxReturnOfCapitalDistributionPerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_InvestmentCompanyTotalReturn": { "auth_ref": [ "r453", "r462", "r465" ], "lang": { "en-us": { "role": { "documentation": "Percentage increase (decrease) in fund net asset value, assuming reinvestment of dividends and capital gain distributions.", "label": "Investment Company, Total Return", "terseLabel": "Total Return" } } }, "localname": "InvestmentCompanyTotalReturn", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock": { "auth_ref": [ "r912", "r913", "r914", "r915", "r916", "r917" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of data and information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.", "label": "Investment Holdings, Schedule of Investments [Table Text Block]", "verboseLabel": "SSLP Portfolio" } } }, "localname": "InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentIncomeDividend": { "auth_ref": [ "r69" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 12.0, "parentTag": "us-gaap_GrossInvestmentIncomeOperating", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of dividend income on nonoperating securities.", "label": "Investment Income, Dividend", "terseLabel": "Dividends" } } }, "localname": "InvestmentIncomeDividend", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r71", "r167" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 11.0, "parentTag": "us-gaap_GrossInvestmentIncomeOperating", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "definitionGuidance": "Interest income", "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "verboseLabel": "Interest" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInvestmentExpense": { "auth_ref": [ "r73", "r675", "r908" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses related to the generation of investment income.", "label": "Investment Income, Investment Expense", "totalLabel": "Total expenses", "verboseLabel": "Total expenses" } } }, "localname": "InvestmentIncomeInvestmentExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeNet": { "auth_ref": [ "r70", "r72" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "order": 6.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.", "label": "Investment Income, Net", "terseLabel": "Net investment income" } } }, "localname": "InvestmentIncomeNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentInterestRate": { "auth_ref": [ "r555", "r556", "r574", "r575", "r579", "r580", "r617", "r618", "r665", "r868", "r869" ], "lang": { "en-us": { "role": { "documentation": "Rate of interest on investment.", "label": "Investment Interest Rate", "terseLabel": "Interest Rate" } } }, "localname": "InvestmentInterestRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentInterestRatePaidInKind": { "auth_ref": [ "r556", "r575", "r579", "r618" ], "lang": { "en-us": { "role": { "documentation": "Rate of interest paid in kind on investment.", "label": "Investment, Interest Rate, Paid in Kind", "terseLabel": "Investment interest rate, Paid in kind" } } }, "localname": "InvestmentInterestRatePaidInKind", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentOwnedAtCost": { "auth_ref": [ "r443", "r483", "r484", "r565", "r573", "r590", "r622", "r665", "r677", "r915" ], "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Cost", "documentation": "Cost of the investment.", "label": "Investment Owned, at Cost", "terseLabel": "Cost", "verboseLabel": "Investment owned, at cost" } } }, "localname": "InvestmentOwnedAtCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpParentheticalDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentOwnedAtFairValue": { "auth_ref": [ "r443", "r476", "r477", "r478", "r480", "r482", "r483", "r484", "r487", "r492", "r493", "r505", "r506", "r552", "r561", "r562", "r571", "r583", "r584", "r597", "r598", "r599", "r612", "r615", "r621", "r623", "r626", "r665", "r677", "r915" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 17.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Investments at fair value (cost $77,114 and $18,032, respectively)", "documentation": "Fair value of investment in security owned.", "label": "Investment Owned, at Fair Value", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "presentationGuidance": "Investments at fair value:", "terseLabel": "Fair Value", "verboseLabel": "Fair Value" } } }, "localname": "InvestmentOwnedAtFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentOwnedBalanceShares": { "auth_ref": [ "r476", "r487", "r559", "r587", "r620", "r665" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of investment owned.", "label": "Investment Owned, Balance, Shares", "terseLabel": "Shares/Units" } } }, "localname": "InvestmentOwnedBalanceShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "sharesItemType" }, "us-gaap_InvestmentOwnedPercentOfNetAssets": { "auth_ref": [ "r479", "r483", "r484", "r561", "r583", "r597", "r600", "r623", "r665", "r915" ], "lang": { "en-us": { "role": { "documentation": "Percentage of investment owned to net assets.", "label": "Investment Owned, Percent of Net Assets", "terseLabel": "Percentage of Total Investments (at fair value)" } } }, "localname": "InvestmentOwnedPercentOfNetAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentOwnedUnderlyingFaceAmountAtMarketValue": { "auth_ref": [ "r42", "r43" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Nominal or face amount on the investment owned.", "label": "Investment Owned, Face Amount", "terseLabel": "Par Amount", "verboseLabel": "Par Amount" } } }, "localname": "InvestmentOwnedUnderlyingFaceAmountAtMarketValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r477", "r479", "r480", "r483", "r487", "r552", "r561", "r576", "r584", "r597", "r606", "r607", "r623", "r627", "r628", "r629", "r630", "r665" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]", "terseLabel": "Investment Type [Axis]" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r477", "r479", "r480", "r483", "r487", "r552", "r561", "r576", "r584", "r597", "r606", "r607", "r623", "r627", "r628", "r629", "r630", "r665" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investments [Domain]", "terseLabel": "Investments [Domain]" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, Debt and Equity Securities [Abstract]" } } }, "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsFairValueDisclosure": { "auth_ref": [ "r346" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.", "label": "Investments, Fair Value Disclosure", "terseLabel": "Assets", "verboseLabel": "Investments at fair value" } } }, "localname": "InvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": { "auth_ref": [ "r88", "r97", "r98", "r107", "r175", "r176", "r355", "r356" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for investments in certain debt and equity securities.", "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]", "terseLabel": "SLR Senior Lending Program LLC" } } }, "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlc" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestorMember": { "auth_ref": [ "r892", "r893" ], "lang": { "en-us": { "role": { "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value.", "label": "Investor [Member]", "terseLabel": "Investor [Member]" } } }, "localname": "InvestorMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LaborAndRelatedExpense": { "auth_ref": [ "r857" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.", "label": "Labor and Related Expense", "terseLabel": "Performance-based incentive fees (see note 3)" } } }, "localname": "LaborAndRelatedExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r18", "r133", "r212", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r329", "r332", "r333", "r358", "r500", "r642", "r677", "r880", "r896", "r897" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 1.0, "parentTag": "us-gaap_AssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities", "verboseLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liabilities" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r66", "r93", "r426", "r661", "r861", "r875", "r890" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "terseLabel": "Total liabilities and members' equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r15", "r92", "r906" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-term Line of Credit", "presentationGuidance": "Line of credit", "terseLabel": "SPV Credit Facility, Carrying Value", "verboseLabel": "Long-term line of credit" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Line of Credit Facility [Abstract]" } } }, "localname": "LineOfCreditFacilityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityAverageOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Average amount borrowed under the credit facility during the period.", "label": "Line of Credit Facility, Average Outstanding Amount", "terseLabel": "Line of credit facility average outstanding amount" } } }, "localname": "LineOfCreditFacilityAverageOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityAxis": { "auth_ref": [ "r17", "r860" ], "lang": { "en-us": { "role": { "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.", "label": "Lender Name [Axis]" } } }, "localname": "LineOfCreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityExpirationDate1": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Date the credit facility terminates, in YYYY-MM-DD format.", "label": "Line of Credit Facility, Expiration Date", "terseLabel": "Line of credit facility, expiration date" } } }, "localname": "LineOfCreditFacilityExpirationDate1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "us-gaap_LineOfCreditFacilityInterestRateDuringPeriod": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "The effective interest rate during the reporting period.", "label": "Line of Credit Facility, Interest Rate During Period", "terseLabel": "Line of Credit Facility, Interest Rate During Period" } } }, "localname": "LineOfCreditFacilityInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityLenderDomain": { "auth_ref": [ "r17", "r860" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.", "label": "Line of Credit Facility, Lender [Domain]" } } }, "localname": "LineOfCreditFacilityLenderDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r17" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Line of credit facility, maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r15", "r92", "r252", "r267", "r648", "r649", "r906" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "Long-Term Debt", "presentationGuidance": "Non-recourse debt", "terseLabel": "Total", "verboseLabel": "Long term debt" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAverageAmountOutstanding": { "auth_ref": [ "r105", "r106", "r529" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Average amount outstanding of long-term debt.", "label": "Long-Term Debt, Average Amount Outstanding", "terseLabel": "Average debt outstanding" } } }, "localname": "LongTermDebtAverageAmountOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtTerm": { "auth_ref": [ "r889" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Long-term Debt, Term", "verboseLabel": "Long term debt term" } } }, "localname": "LongTermDebtTerm", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LongTermDebtWeightedAverageInterestRateOverTime": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of long-term debt outstanding calculated over time.", "label": "Long-term Debt, Weighted Average Interest Rate, over Time", "terseLabel": "Long term debt weighted average interest over a period of time" } } }, "localname": "LongTermDebtWeightedAverageInterestRateOverTime", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r21", "r34" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ManagementFeeExpense": { "auth_ref": [ "r51", "r528", "r675", "r918" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for investment management fee, including, but not limited to, expense in connection with research, selection, supervision, and custody of investment.", "label": "Management Fee Expense", "terseLabel": "Management fees (see note 3)", "verboseLabel": "Management fees" } } }, "localname": "ManagementFeeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ManagementFeePayable": { "auth_ref": [ "r494" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of fee payable for management of fund or trust.", "label": "Management Fee Payable", "terseLabel": "Management fee payable (see note 3)" } } }, "localname": "ManagementFeePayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketApproachValuationTechniqueMember": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Valuation approach using price and other relevant information generated by market transaction involving identical or comparable asset, liability, or group of assets and liabilities.", "label": "Valuation, Market Approach [Member]", "terseLabel": "Market Approach [Member]" } } }, "localname": "MarketApproachValuationTechniqueMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputEbitdaMultipleMember": { "auth_ref": [ "r888" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using earnings before interest, tax, depreciation and amortization (EBITDA) multiple.", "label": "Measurement Input, EBITDA Multiple [Member]" } } }, "localname": "MeasurementInputEbitdaMultipleMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r348" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MembersEquity": { "auth_ref": [ "r84", "r162", "r163", "r164", "r165" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of ownership interest in limited liability company (LLC), attributable to the parent entity.", "label": "Members' Equity", "terseLabel": "Members' equity" } } }, "localname": "MembersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetAssetValuePerShare": { "auth_ref": [ "r2", "r3", "r14", "r466", "r473", "r475", "r504", "r522", "r631", "r677" ], "lang": { "en-us": { "role": { "definitionGuidance": "Net asset value per share", "documentation": "Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure.", "label": "NAV Per Share", "periodEndLabel": "Net asset value, end of period", "periodStartLabel": "Net asset value, beginning of year", "presentationGuidance": "Net Asset Value Per Share" } } }, "localname": "NetAssetValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails", "http://www.slrinvestments.com/role/NetAssetValuePerShareAdditionalInformationDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r128" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net Cash Provided by (Used in) Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash Flows from Financing Activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r75", "r76", "r77" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net Cash Provided by (Used in) Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash Flows from Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r67", "r77", "r94", "r113", "r119", "r120", "r123", "r133", "r138", "r140", "r141", "r142", "r143", "r146", "r147", "r153", "r166", "r170", "r172", "r174", "r212", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r344", "r358", "r428", "r525", "r543", "r544", "r643", "r675", "r880" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss)", "presentationGuidance": "Net income (loss)", "terseLabel": "Net Income (Loss)", "verboseLabel": "Net income" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToReportingEntityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Increase (decrease) in net assets resulting from operations:" } } }, "localname": "NetIncomeLossAttributableToReportingEntityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "stringItemType" }, "us-gaap_NetInvestmentInLease": { "auth_ref": [ "r102", "r218", "r368", "r876" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of net investment in sales-type and direct financing leases.", "label": "Net Investment in Lease, before Allowance for Credit Loss", "terseLabel": "Net investment in lease" } } }, "localname": "NetInvestmentInLease", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentIncome": { "auth_ref": [ "r101", "r431", "r432", "r530", "r675" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 9.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.", "label": "Net Investment Income", "terseLabel": "Net investment income (loss)", "totalLabel": "Net investment income" } } }, "localname": "NetInvestmentIncome", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1": { "auth_ref": [ "r30", "r31", "r32" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The value of an asset or business acquired in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Noncash or Part Noncash Acquisition, Value of Assets Acquired", "terseLabel": "Noncash or part noncash acquisition, value of assets acquired" } } }, "localname": "NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoninterestIncome": { "auth_ref": [ "r95" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 13.0, "parentTag": "us-gaap_GrossInvestmentIncomeOperating", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of noninterest income which may be derived from: (1) fees and commissions; (2) premiums earned; (3) insurance policy charges; (4) the sale or disposal of assets; and (5) other sources not otherwise specified.", "label": "Noninterest Income", "terseLabel": "Other income", "verboseLabel": "Service fees" } } }, "localname": "NoninterestIncome", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r58", "r85", "r441", "r442" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "Organization" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/Organization" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherCommitment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.", "label": "Other Commitment", "terseLabel": "Other Commitment", "verboseLabel": "Other Commitment" } } }, "localname": "OtherCommitment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of other commitment.", "label": "Other Commitments [Axis]" } } }, "localname": "OtherCommitmentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other future obligation.", "label": "Other Commitments [Domain]" } } }, "localname": "OtherCommitmentsDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherCommitmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Other Commitments [Line Items]" } } }, "localname": "OtherCommitmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about obligations resulting from other commitments.", "label": "Other Commitments [Table]" } } }, "localname": "OtherCommitmentsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information about obligations resulting from other commitments.", "label": "Other Commitments [Table Text Block]", "terseLabel": "Summary of unfunded debt and equity commitments" } } }, "localname": "OtherCommitmentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherGeneralAndAdministrativeExpense": { "auth_ref": [ "r68", "r921" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of general and administrative expense classified as other.", "label": "Other General and Administrative Expense", "terseLabel": "Other general and administrative expenses", "verboseLabel": "Other general and administrative expenses" } } }, "localname": "OtherGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLongTermDebt": { "auth_ref": [ "r15", "r92", "r906" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt classified as other.", "label": "Other Long-term Debt", "terseLabel": "Other long term debt" } } }, "localname": "OtherLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOwnershipInterestsValue": { "auth_ref": [ "r38" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of capital contributed by other unit holders.", "label": "Other Ownership Interests, Contributed Capital", "terseLabel": "Other Ownership Interests, Contributed Capital" } } }, "localname": "OtherOwnershipInterestsValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-Allotment Option [Member]", "terseLabel": "Over-Allotment Option [Member]" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r26" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Repurchase of common stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDistributionsToAffiliates": { "auth_ref": [ "r26" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The distributions of earnings to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.", "label": "Payments of Distributions to Affiliates", "negatedLabel": "Cash distributions paid" } } }, "localname": "PaymentsOfDistributionsToAffiliates", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r24", "r325" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Payment to acquire business" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInvestments": { "auth_ref": [ "r74" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.", "label": "Payments to Acquire Investments", "terseLabel": "Payments to acquire investments", "verboseLabel": "Payments to Acquire Investments" } } }, "localname": "PaymentsToAcquireInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockLiquidationPreference": { "auth_ref": [ "r35", "r36", "r62", "r859", "r884" ], "lang": { "en-us": { "role": { "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.", "label": "Preferred Stock Liquidating Preference" } } }, "localname": "PreferredStockLiquidationPreference", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "us-gaap_PrepaidExpenseAndOtherAssets": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 16.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.", "label": "Prepaid Expense and Other Assets", "terseLabel": "Prepaid expenses and other assets" } } }, "localname": "PrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrentAndNoncurrent": { "auth_ref": [ "r52", "r118", "r515", "r904" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs.", "label": "Prepaid Expense", "terseLabel": "Prepaid Expense" } } }, "localname": "PrepaidExpenseCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]", "terseLabel": "Private Placement [Member]" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": { "auth_ref": [ "r126" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.", "label": "Proceeds from Debt, Net of Issuance Costs", "verboseLabel": "Proceeds from net debt" } } }, "localname": "ProceedsFromDebtNetOfIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfSecuredDebt": { "auth_ref": [ "r25" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.", "label": "Proceeds from Issuance of Secured Debt", "terseLabel": "Proceeds from secured borrowings" } } }, "localname": "ProceedsFromIssuanceOfSecuredDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfUnsecuredDebt": { "auth_ref": [ "r25" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of long-term debt that is not secured by collateral. Excludes proceeds from tax exempt unsecured debt.", "label": "Proceeds from Issuance of Unsecured Debt", "terseLabel": "Proceeds from unsecured borrowings" } } }, "localname": "ProceedsFromIssuanceOfUnsecuredDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r113", "r119", "r120", "r127", "r133", "r138", "r146", "r147", "r166", "r170", "r172", "r174", "r212", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r327", "r330", "r331", "r344", "r358", "r420", "r427", "r457", "r525", "r543", "r544", "r643", "r659", "r660", "r676", "r856", "r880" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "order": 5.0, "parentTag": "slrc_InvestmentCompanyIncreaseDecreaseInNetAssets", "weight": 1.0 }, "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net income (loss)", "totalLabel": "Net increase (decrease) in net assets resulting from operations" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet": { "auth_ref": [ "r99", "r877", "r891" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated depreciation, of lessor's underlying asset for which right to use has been conveyed to lessee under operating lease.", "label": "Property, Plant, and Equipment, Lessor Asset under Operating Lease, after Accumulated Depreciation", "terseLabel": "Assets under lease" } } }, "localname": "PropertySubjectToOrAvailableForOperatingLeaseNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits": { "auth_ref": [ "r877", "r891" ], "lang": { "en-us": { "role": { "documentation": "The number of units (items of property) under operating lease arrangements.", "label": "Property Subject to or Available for Operating Lease, Number of Units", "terseLabel": "Number of funded equipment-backed leases and loans" } } }, "localname": "PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_RealizedInvestmentGainsLosses": { "auth_ref": [ "r434" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "order": 7.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 }, "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 7.0, "parentTag": "us-gaap_InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "disclosureGuidance": "Realized gain on investments", "documentation": "Amount of realized gain (loss) on investment.", "label": "Realized Investment Gains (Losses)", "presentationGuidance": "Net realized gain (loss) on investments and cash equivalents (companies less than 5% owned)", "terseLabel": "Net realized gain (loss)" } } }, "localname": "RealizedInvestmentGainsLosses", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r291", "r370", "r371", "r495", "r496", "r497", "r498", "r499", "r521", "r523", "r551" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r291", "r370", "r371", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r495", "r496", "r497", "r498", "r499", "r521", "r523", "r551", "r895" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfSecuredDebt": { "auth_ref": [ "r27" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.", "label": "Repayments of Secured Debt", "negatedLabel": "Repayment of secured borrowings" } } }, "localname": "RepaymentsOfSecuredDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfUnsecuredDebt": { "auth_ref": [ "r27" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to repay long-term debt that is not secured by collateral. Excludes repayments of tax exempt unsecured debt.", "label": "Repayments of Unsecured Debt", "negatedLabel": "Repayment of unsecured borrowings" } } }, "localname": "RepaymentsOfUnsecuredDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r65", "r84", "r425", "r439", "r440", "r452", "r503", "r661" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit).", "label": "Retained Earnings (Accumulated Deficit)", "verboseLabel": "Accumulated distributable net loss" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility [Member]" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r326" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r21", "r35", "r37", "r47", "r48", "r50", "r56", "r82", "r83", "r648", "r650", "r862" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-term Debt Instruments [Table Text Block]", "terseLabel": "Schedule of Long-term Debt Instruments" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r866" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Summary of Computation of Basic And Diluted Net" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "auth_ref": [ "r133", "r208", "r209", "r211", "r212", "r358" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Equity Method Investments [Line Items]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinance", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "auth_ref": [ "r113", "r133", "r208", "r209", "r211", "r212", "r358" ], "lang": { "en-us": { "role": { "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.", "label": "Schedule of Equity Method Investments [Table]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinance", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Investments [Abstract]", "terseLabel": "Schedule of Investments [Abstract]" } } }, "localname": "ScheduleOfInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInvestmentsLineItems": { "auth_ref": [ "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r625", "r626" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Investments [Line Items]", "terseLabel": "Schedule of Investments [Line Items]" } } }, "localname": "ScheduleOfInvestmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInvestmentsTable": { "auth_ref": [ "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r608", "r609", "r610", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r625", "r626" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investments owned by investment company.", "label": "Schedule of Investments [Table]", "terseLabel": "Schedule of Investments [Table]" } } }, "localname": "ScheduleOfInvestmentsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.", "label": "Schedule of Stockholders Equity [Table Text Block]", "terseLabel": "Schedule of Stockholders Equity" } } }, "localname": "ScheduleOfStockholdersEquityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": { "auth_ref": [ "r886" ], "lang": { "en-us": { "role": { "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg.", "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]", "terseLabel": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]" } } }, "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "All Award Types", "terseLabel": "All Award Types" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "domainItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "presentationGuidance": "Share price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued, Price Per Share", "terseLabel": "Shares issued, price per share", "verboseLabel": "Shares Issued, Price Per Share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails", "http://www.slrinvestments.com/role/StockRepurchaseProgramAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r78", "r130" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r105", "r115", "r116", "r117", "r133", "r151", "r152", "r154", "r156", "r164", "r165", "r212", "r230", "r232", "r233", "r234", "r237", "r238", "r269", "r270", "r272", "r275", "r282", "r358", "r448", "r449", "r450", "r451", "r459", "r463", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r475", "r502", "r526", "r547", "r631", "r632", "r633", "r634", "r635", "r841", "r859", "r865" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r10", "r23", "r112", "r121", "r122", "r123", "r135", "r136", "r137", "r139", "r145", "r147", "r161", "r214", "r215", "r283", "r319", "r320", "r321", "r322", "r323", "r334", "r335", "r336", "r337", "r338", "r339", "r342", "r359", "r360", "r361", "r362", "r363", "r364", "r369", "r436", "r437", "r438", "r459", "r547" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails", "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [ "r135", "r136", "r137", "r161", "r406", "r443", "r475", "r492", "r495", "r496", "r497", "r498", "r499", "r502", "r505", "r506", "r507", "r508", "r509", "r511", "r512", "r513", "r514", "r517", "r518", "r519", "r520", "r521", "r523", "r527", "r528", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r547", "r666" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r135", "r136", "r137", "r161", "r406", "r443", "r475", "r492", "r495", "r496", "r497", "r498", "r499", "r502", "r505", "r506", "r507", "r508", "r509", "r511", "r512", "r513", "r514", "r517", "r518", "r519", "r520", "r521", "r523", "r527", "r528", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r547", "r666" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockAppreciationRightsSARSMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period.", "label": "Stock Appreciation Rights (SARs) [Member]", "terseLabel": "Stock Appreciation Rights (SARs)" } } }, "localname": "StockAppreciationRightsSARSMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "domainItemType" }, "us-gaap_StockIssued1": { "auth_ref": [ "r30", "r31", "r32" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of stock issued in noncash financing activities.", "label": "Stock Issued", "terseLabel": "Stock issued", "verboseLabel": "Issuance of shares in connection with the Mergers" } } }, "localname": "StockIssued1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r62", "r63", "r84" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock Issued During Period, Shares, Acquisitions", "terseLabel": "Stock issued during period, shares, acquisitions", "verboseLabel": "Shares" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r10", "r62", "r63", "r84", "r448", "r547", "r632" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuance of common stock", "verboseLabel": "Stock issued during period, shares" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease": { "auth_ref": [ "r10", "r923", "r924" ], "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the number of shares issued.", "label": "Stock Issued During Period, Shares, Period Increase (Decrease)", "terseLabel": "Net capital stock activity", "verboseLabel": "Net increase, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r10", "r23", "r84" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Stock Issued During Period, Value, Acquisitions", "verboseLabel": "Amount" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r10", "r62", "r63", "r84", "r459", "r547", "r632", "r676" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuance of common stock" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program, Authorized Amount", "terseLabel": "Stock repurchase program, authorized amount" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/StockRepurchaseProgramAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramExpirationDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expiration date for the purchase of an entity's own shares under a stock repurchase plan, in the YYYY-MM-DD format.", "label": "Stock Repurchase Program Expiration Date", "terseLabel": "Stock repurchase program expiration date" } } }, "localname": "StockRepurchaseProgramExpirationDate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/StockRepurchaseProgramAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r10", "r62", "r63", "r84", "r451", "r547", "r634" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Shares", "negatedLabel": "Shares repurchased, Shares", "negatedTerseLabel": "Repurchases of common stock", "verboseLabel": "Stock Repurchased During Period, Shares" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/StockRepurchaseProgramAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r10", "r62", "r63", "r84", "r459", "r547", "r634", "r676" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "order": 4.0, "parentTag": "slrc_InvestmentCompanyIncreaseDecreaseInNetAssets", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "negatedLabel": "Repurchases of common stock", "negatedTerseLabel": "Shares repurchased, Value", "verboseLabel": "Stock Repurchased During Period, Value" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/StockRepurchaseProgramAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r81", "r132", "r268", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r281", "r283", "r341", "r549", "r550", "r636" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Stock Repurchase Program" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/StockRepurchaseProgram" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityPeriodIncreaseDecrease": { "auth_ref": [ "r10", "r84", "r548", "r635", "r676", "r909" ], "lang": { "en-us": { "role": { "documentation": "The increase (decrease) in stockholders' equity during the period.", "label": "Stockholders' Equity, Period Increase (Decrease)", "terseLabel": "Net capital transactions" } } }, "localname": "StockholdersEquityPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [ "r365", "r373" ], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r365", "r373" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r365", "r373" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r365", "r373" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r365", "r373" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r372", "r374" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SummaryOfInvestmentHoldingsLineItems": { "auth_ref": [ "r456", "r476", "r477", "r478", "r479", "r480", "r481", "r483", "r484", "r485", "r486", "r487", "r490", "r491", "r526", "r665" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Summary of Investment Holdings [Line Items]" } } }, "localname": "SummaryOfInvestmentHoldingsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SummaryOfInvestmentHoldingsTable": { "auth_ref": [ "r456", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r490", "r491", "r526", "r665" ], "lang": { "en-us": { "role": { "documentation": "The summary of investment holding table is used for any listing of investment in a summary form. Table lists the 50 largest investments and any other investment the value of which exceeded 1 percent of net asset value of the registrant as of the close of the period.", "label": "Summary of Investment Holdings [Table]" } } }, "localname": "SummaryOfInvestmentHoldingsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental disclosure of cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TaxBasisOfInvestmentsCostForIncomeTaxPurposes": { "auth_ref": [ "r447" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost of investment for federal income tax purpose.", "label": "Tax Basis of Investments, Cost for Income Tax Purposes", "terseLabel": "Investment Owned tax costs" } } }, "localname": "TaxBasisOfInvestmentsCostForIncomeTaxPurposes", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxBasisOfInvestmentsGrossUnrealizedAppreciation": { "auth_ref": [ "r444" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cumulative increase in investment from unrealized gain when value exceeds cost for federal income tax purpose.", "label": "Tax Basis of Investments, Gross, Unrealized Appreciation", "terseLabel": "Tax Basis of Investments, Gross, Unrealized Appreciation" } } }, "localname": "TaxBasisOfInvestmentsGrossUnrealizedAppreciation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxBasisOfInvestmentsGrossUnrealizedDepreciation": { "auth_ref": [ "r445" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cumulative decrease in investment from unrealized loss when cost for federal income tax purpose exceeds value.", "label": "Tax Basis of Investments, Gross, Unrealized Depreciation", "terseLabel": "Tax Basis of Investments, Gross, Unrealized Depreciation" } } }, "localname": "TaxBasisOfInvestmentsGrossUnrealizedDepreciation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet": { "auth_ref": [ "r446" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cumulative increase (decrease) in investment from unrealized gain (loss) when value exceeds (is less than) cost for federal income tax purpose.", "label": "Tax Basis of Investments, Unrealized Appreciation (Depreciation), Net", "terseLabel": "Tax Basis of Investments, Unrealized Appreciation (Depreciation), Net" } } }, "localname": "TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_TechnologySectorMember": { "auth_ref": [ "r665", "r928", "r930", "r931", "r932" ], "lang": { "en-us": { "role": { "documentation": "Sector of the economy consisting of companies engaged in technology-related business activities.", "label": "Technology Sector [Member]", "terseLabel": "Software [Member]" } } }, "localname": "TechnologySectorMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryOfSslpSPortfolioDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r264", "r280", "r340", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r429", "r844", "r845", "r846", "r847", "r848", "r849", "r850", "r870", "r871", "r872", "r873" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnrealizedGainLossOnInvestments": { "auth_ref": [ "r6" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "order": 8.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 }, "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 8.0, "parentTag": "us-gaap_InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment.", "label": "Unrealized Gain (Loss) on Investments", "presentationGuidance": "Net change in unrealized gain (loss) on investments and cash equivalents", "terseLabel": "Net change in unrealized loss", "verboseLabel": "Net change in unrealized gain on investments" } } }, "localname": "UnrealizedGainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcSummaryFinancialInformationForSslpDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnsecuredDebt": { "auth_ref": [ "r15", "r92", "r906" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).", "label": "Unsecured Debt", "terseLabel": "Unsecured Debt" } } }, "localname": "UnsecuredDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationTechniqueAxis": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Information by valuation approach and technique.", "label": "Valuation Approach and Technique [Axis]" } } }, "localname": "ValuationTechniqueAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ValuationTechniqueDomain": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Valuation approach and technique.", "label": "Valuation Approach and Technique [Domain]" } } }, "localname": "ValuationTechniqueDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrSeniorLendingProgramLlcAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r150", "r156" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Denominator - weighted average shares, Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r149", "r156" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Denominator - weighted average shares, Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 10 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-7A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r104": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "https://asc.fasb.org//323/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r105": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r106": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r107": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1403", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "a", "Publisher": "SEC", "Section": "12", "Subsection": "04", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "c", "Publisher": "SEC", "Section": "5", "Subparagraph": "Schedule I", "Subsection": "04", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "c", "Publisher": "SEC", "Section": "7", "Subparagraph": "Schedule II", "Subsection": "05", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "9", "Subsection": "06", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "2C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2C", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org//260/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "https://asc.fasb.org//320/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aaa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aaa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(3)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(4)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "54B", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482134/820-10-35-54B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "59", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482134/820-10-35-59", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "808", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "https://asc.fasb.org//320/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iv)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "6B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "6B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479016/842-30-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org//855/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 4.F)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "10", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480679/815-10-10-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(19))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(16))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(2)(a))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "10", "SubTopic": "20", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480769/815-20-10-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(2)(b))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(2)(d))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(a))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(h)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(h)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(h)(2)(iii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(h)(2)(iv))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(g)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(h)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(3)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(4)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(g)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(g)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(11))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(14))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(15))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(17))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(19))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(7)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(1),(5))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(1)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column B)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column B))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 10))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(c)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(3)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org//205/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 10))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 12))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 13))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column F))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13A(Column C))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13B(Column D))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column D))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column B))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 5)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "36", "Publisher": "FASB", "Section": "45", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480228/946-830-45-36", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480191/946-405-45-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r678": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r679": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r681": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r682": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r683": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r684": { "Name": "Form 20-F", "Paragraph": "a", "Publisher": "SEC", "Section": "16", "Subsection": "J", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r685": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r686": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Subparagraph": "i", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r687": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Sentence": "A", "Subparagraph": "i", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r688": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Sentence": "B", "Subparagraph": "i", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r689": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Sentence": "C", "Subparagraph": "i", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Sentence": "D", "Subparagraph": "i", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r691": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Sentence": "E", "Subparagraph": "i", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r692": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Subparagraph": "ii", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r693": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Subparagraph": "iii", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r694": { "Name": "Form 20-F", "Paragraph": "2", "Publisher": "SEC", "Section": "6", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r695": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Subparagraph": "ii", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r696": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r697": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r698": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r699": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Sentence": "i", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Sentence": "ii", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r701": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Sentence": "iii", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r702": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Sentence": "iv", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r703": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Sentence": "v", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r704": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Subparagraph": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r705": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Subparagraph": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r706": { "Name": "Form 40-F", "Paragraph": "b", "Publisher": "SEC", "Section": "19", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r707": { "Name": "Form F-3", "Publisher": "SEC", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r708": { "Name": "Form N-2", "Publisher": "SEC", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r709": { "Name": "Form N-2", "Publisher": "SEC", "Section": "Item 10", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r710": { "Name": "Form N-2", "Paragraph": "a", "Publisher": "SEC", "Section": "Item 10", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r711": { "Name": "Form N-2", "Paragraph": "a", "Publisher": "SEC", "Section": "Item 10", "Subparagraph": "1", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r712": { "Name": "Form N-2", "Paragraph": "a", "Publisher": "SEC", "Section": "Item 10", "Subparagraph": "2", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r713": { "Name": "Form N-2", "Paragraph": "a", "Publisher": "SEC", "Section": "Item 10", "Subparagraph": "3", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r714": { "Name": "Form N-2", "Paragraph": "a", "Publisher": "SEC", "Section": "Item 10", "Subparagraph": "4", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r715": { "Name": "Form N-2", "Paragraph": "a", "Publisher": "SEC", "Section": "Item 10", "Subparagraph": "5", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r716": { "Name": "Form N-2", "Paragraph": "a", "Publisher": "SEC", "Section": "Item 10", "Subparagraph": "6", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r717": { "Name": "Form N-2", "Paragraph": "a", "Publisher": "SEC", "Section": "Item 10", "Subparagraph": "Instruction 2", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r718": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 10", "Subparagraph": "1", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r719": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 10", "Subparagraph": "2", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r720": { "Name": "Form N-2", "Paragraph": "c", "Publisher": "SEC", "Section": "Item 10", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r721": { "Name": "Form N-2", "Paragraph": "d", "Publisher": "SEC", "Section": "Item 10", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r722": { "Name": "Form N-2", "Publisher": "SEC", "Section": "Item 10", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r723": { "Name": "Form N-2", "Paragraph": "a", "Publisher": "SEC", "Section": "Item 10", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r724": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 10", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r725": { "Name": "Form N-2", "Paragraph": "c", "Publisher": "SEC", "Section": "Item 10", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r726": { "Name": "Form N-2", "Paragraph": "e", "Publisher": "SEC", "Section": "Item 10", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r727": { "Name": "Form N-2", "Publisher": "SEC", "Section": "Item 10", "Subsection": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r728": { "Name": "Form N-2", "Publisher": "SEC", "Section": "Item 10", "Subsection": "5", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r729": { "Name": "Form N-2", "Paragraph": "1", "Publisher": "SEC", "Section": "Item 10", "Subsection": "5", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r730": { "Name": "Form N-2", "Paragraph": "2", "Publisher": "SEC", "Section": "Item 10", "Subsection": "5", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r731": { "Name": "Form N-2", "Paragraph": "3", "Publisher": "SEC", "Section": "Item 10", "Subsection": "5", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r732": { "Name": "Form N-2", "Paragraph": "4", "Publisher": "SEC", "Section": "Item 10", "Subsection": "5", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r733": { "Name": "Form N-2", "Publisher": "SEC", "Section": "Item 3", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r734": { "Name": "Form N-2", "Paragraph": "Instruction 1", "Publisher": "SEC", "Section": "Item 3", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r735": { "Name": "Form N-2", "Paragraph": "Instruction 10", "Publisher": "SEC", "Section": "Item 3", "Subparagraph": "a", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r736": { "Name": "Form N-2", "Paragraph": "Instruction 10", "Publisher": "SEC", "Section": "Item 3", "Subparagraph": "a, g, h", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r737": { "Name": "Form N-2", "Paragraph": "Instruction 10", "Publisher": "SEC", "Section": "Item 3", "Subparagraph": "f", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r738": { "Name": "Form N-2", "Paragraph": "Instruction 10", "Publisher": "SEC", "Section": "Item 3", "Subparagraph": "g", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r739": { "Name": "Form N-2", "Paragraph": "Instruction 10", "Publisher": "SEC", "Section": "Item 3", "Subparagraph": "i", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r740": { "Name": "Form N-2", "Paragraph": "Instruction 11", "Publisher": "SEC", "Section": "Item 3", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r741": { "Name": "Form N-2", "Paragraph": "Instruction 4", "Publisher": "SEC", "Section": "Item 3", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r742": { "Name": "Form N-2", "Paragraph": "Instruction 5", "Publisher": "SEC", "Section": "Item 3", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r743": { "Name": "Form N-2", "Paragraph": "Instruction 6", "Publisher": "SEC", "Section": "Item 3", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r744": { "Name": "Form N-2", "Paragraph": "Instruction 7", "Publisher": "SEC", "Section": "Item 3", "Subparagraph": "a", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r745": { "Name": "Form N-2", "Paragraph": "Instruction 7", "Publisher": "SEC", "Section": "Item 3", "Subparagraph": "b", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r746": { "Name": "Form N-2", "Paragraph": "Instruction 8", "Publisher": "SEC", "Section": "Item 3", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r747": { "Name": "Form N-2", "Paragraph": "Instruction 9", "Publisher": "SEC", "Section": "Item 3", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r748": { "Name": "Form N-2", "Publisher": "SEC", "Section": "Item 4", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r749": { "Name": "Form N-2", "Paragraph": "Instruction 2", "Publisher": "SEC", "Section": "Item 4", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r750": { "Name": "Form N-2", "Paragraph": "Instruction 3", "Publisher": "SEC", "Section": "Item 4", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r751": { "Name": "Form N-2", "Paragraph": "Instruction 8", "Publisher": "SEC", "Section": "Item 4", "Subsection": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r752": { "Name": "Form N-2", "Publisher": "SEC", "Section": "Item 4", "Subsection": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r753": { "Name": "Form N-2", "Paragraph": "2", "Publisher": "SEC", "Section": "Item 4", "Subsection": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r754": { "Name": "Form N-2", "Paragraph": "3", "Publisher": "SEC", "Section": "Item 4", "Subparagraph": "Instruction 2", "Subsection": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r755": { "Name": "Form N-2", "Paragraph": "4", "Publisher": "SEC", "Section": "Item 4", "Subparagraph": "Instruction 3", "Subsection": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r756": { "Name": "Form N-2", "Paragraph": "5", "Publisher": "SEC", "Section": "Item 4", "Subsection": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r757": { "Name": "Form N-2", "Paragraph": "Instruction 1", "Publisher": "SEC", "Section": "Item 4", "Subsection": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r758": { "Name": "Form N-2", "Paragraph": "Instruction 4", "Publisher": "SEC", "Section": "Item 4", "Subsection": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r759": { "Name": "Form N-2", "Paragraph": "Instruction 5", "Publisher": "SEC", "Section": "Item 4", "Subsection": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r760": { "Name": "Form N-2", "Publisher": "SEC", "Section": "Item 8", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r761": { "Name": "Form N-2", "Paragraph": "b, d", "Publisher": "SEC", "Section": "Item 8", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r762": { "Name": "Form N-2", "Paragraph": "a", "Publisher": "SEC", "Section": "Item 8", "Subsection": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r763": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 8", "Subsection": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r764": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 8", "Subparagraph": "1", "Subsection": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r765": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 8", "Subparagraph": "2", "Subsection": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r766": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 8", "Subparagraph": "3", "Subsection": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r767": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 8", "Subsection": "5", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r768": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 8", "Subparagraph": "4", "Subsection": "5", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r769": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 8", "Subparagraph": "Instruction 2", "Subsection": "5", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r770": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 8", "Subparagraph": "Instruction 3", "Subsection": "5", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r771": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 8", "Subparagraph": "Instruction 4", "Subsection": "5", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r772": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 8", "Subparagraph": "Instructions 4, 5", "Subsection": "5", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r773": { "Name": "Form N-2", "Paragraph": "c", "Publisher": "SEC", "Section": "Item 8", "Subsection": "5", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r774": { "Name": "Form N-2", "Paragraph": "e", "Publisher": "SEC", "Section": "Item 8", "Subsection": "5", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r775": { "Name": "Form N-3", "Publisher": "SEC", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r776": { "Name": "Form N-4", "Publisher": "SEC", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r777": { "Name": "Form N-6", "Publisher": "SEC", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r778": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r779": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r78": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org//235/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r780": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Sentence": "i", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r781": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Sentence": "ii", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r782": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Sentence": "iii", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r783": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Sentence": "iv", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r784": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Sentence": "v", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r785": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Subparagraph": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r786": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Subparagraph": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r787": { "Name": "Form N-CSR", "Paragraph": "b", "Publisher": "SEC", "Section": "18", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r788": { "Name": "Form S-3", "Publisher": "SEC", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r789": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r79": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org//440/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r790": { "Name": "Investment Company Act", "Number": "270", "Publisher": "SEC", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r791": { "Name": "Regulation S-K", "Number": "229", "Publisher": "SEC", "Section": "402", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r792": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r793": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Subparagraph": "ii", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r794": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Subparagraph": "iii", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r795": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Subparagraph": "iv", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r796": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Subparagraph": "vi", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r797": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "3", "Publisher": "SEC", "Section": "402", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r798": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "4", "Publisher": "SEC", "Section": "402", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r799": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "5", "Publisher": "SEC", "Section": "402", "Subparagraph": "i", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147479910/205-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org//470/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r800": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "5", "Publisher": "SEC", "Section": "402", "Subparagraph": "ii", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r801": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "5", "Publisher": "SEC", "Section": "402", "Subparagraph": "iii", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r802": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "5", "Publisher": "SEC", "Section": "402", "Subparagraph": "iv", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r803": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "6", "Publisher": "SEC", "Section": "402", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r804": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "6", "Publisher": "SEC", "Section": "402", "Subparagraph": "i", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r805": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r806": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Subparagraph": "i", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r807": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Sentence": "A", "Subparagraph": "i", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r808": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Sentence": "B", "Subparagraph": "i", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r809": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Sentence": "C", "Subparagraph": "i", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r81": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org//505/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r810": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Sentence": "D", "Subparagraph": "i", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r811": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Sentence": "E", "Subparagraph": "i", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r812": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Subparagraph": "ii", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r813": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Subparagraph": "iii", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r814": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r815": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r816": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r817": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Sentence": "A", "Subparagraph": "ii", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r818": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Sentence": "C", "Subparagraph": "ii", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r819": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Sentence": "D", "Subparagraph": "ii", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r820": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Sentence": "E", "Subparagraph": "ii", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r821": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Sentence": "F", "Subparagraph": "ii", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r822": { "Name": "Regulation S-K", "Number": "229", "Publisher": "SEC", "Section": "408", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r823": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "408", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r824": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "408", "Subparagraph": "A", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r825": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "408", "Subparagraph": "B", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r826": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "408", "Subparagraph": "C", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r827": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "408", "Subparagraph": "D", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r828": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "408", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r829": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "313", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r830": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r831": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r832": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "413", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r833": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "462", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r834": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "462", "Subsection": "c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r835": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "462", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r836": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "462", "Subsection": "e", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r837": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "486", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r838": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "486", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r839": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r840": { "Name": "Securities Act", "Publisher": "SEC", "Section": "8", "Subsection": "c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r841": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r842": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Subparagraph": "(f)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481543/323-740-50-2", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r843": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-11", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r844": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r845": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r846": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r847": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r848": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r849": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r85": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org//810/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r850": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r851": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "12", "Subsection": "04", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r852": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r853": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(10))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r854": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r855": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r856": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r857": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(4))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r858": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r859": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r860": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r861": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r862": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r863": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r864": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r865": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r866": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r867": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r868": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r869": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r870": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r871": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r872": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r873": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r874": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r875": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r876": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r877": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r878": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r879": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org//450/tableOfContent", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r88": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "940", "URI": "https://asc.fasb.org//940-320/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r880": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r881": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r882": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r883": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r884": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r885": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r886": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480682/815-20-25-6A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r887": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r888": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r889": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r890": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r891": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r892": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r893": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r894": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r895": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r896": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r897": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r898": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r899": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r900": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r901": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r902": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r903": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r904": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r905": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r906": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r907": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r908": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(2)(c))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r909": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(5))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r910": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r911": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r912": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r913": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r914": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r915": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(3)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r916": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(4)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r917": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r918": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r919": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(i)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r920": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r921": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r922": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r923": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r924": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r925": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r926": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480369/946-230-45-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r927": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r928": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r929": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r930": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r931": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r932": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.13)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org//942-320/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "946", "URI": "https://asc.fasb.org//946-320/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-4", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" } }, "version": "2.2" } ZIP 89 0001193125-23-206195-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-23-206195-xbrl.zip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